<datawarrior-fileinfo>
<version="3.3">
<created="1667518226514">
<rowcount="1678">
</datawarrior-fileinfo>
<column properties>
<columnName="Structure of SMILES">
<columnProperty="specialType	idcode">
<columnName="SmilesFragFp">
<columnProperty="parent	Structure of SMILES">
<columnProperty="specialType	FragFp">
<columnProperty="version	1.2.1">
<columnName="Ring Systems">
<columnProperty="specialType	idcode">
<columnName="Ring Systems 2">
<columnProperty="specialType	idcode">
<columnName="CSK frequency">
<columnProperty="formula	frequency(CSK,"CSK")">
<columnName="Murcko frequency">
<columnProperty="formula	frequency(Murcko,"Murcko")">
<columnName="Core Fragment">
<columnProperty="specialType	idcode">
<columnName="R1">
<columnProperty="specialType	idcode">
<columnName="R2">
<columnProperty="specialType	idcode">
<columnName="R3">
<columnProperty="specialType	idcode">
<columnName="R4">
<columnProperty="specialType	idcode">
<columnName="R5">
<columnProperty="specialType	idcode">
<columnName="R6">
<columnProperty="specialType	idcode">
<columnName="R7">
<columnProperty="specialType	idcode">
<columnName="R8">
<columnProperty="specialType	idcode">
<columnName="R9">
<columnProperty="specialType	idcode">
<columnName="R10">
<columnProperty="specialType	idcode">
<columnName="Core frequency">
<columnProperty="formula	frequency(Core,"Core")">
</column properties>
SmilesFragFp	ID	Structure of SMILES	SMILES	pIC50	bioactivity	bioactivity1	TARGET	ASSAY_DESCRIPTION	YEAR	Ring Systems	Ring Systems 2	Total Molweight	cLogP	H-Acceptors	H-Donors	Polar Surface Area	Rotatable Bonds	pc1	pc2	pc3	CSK frequency	Murcko frequency	Core Fragment	R1	R2	R3	R4	R5	R6	R7	R8	R9	R10	Core frequency
yTuM2M9G8k4kZFA4FNH5VR2H04FF1392VHHo58VV3Nk96F10128V12F2p0Wc1DG109J@Xbca40@4J0F658V4F0	CHEMBL101907	ekhXHH@Ji@LSHhdhmLhhhdeEMgJFKGDfbineh@Jj@B@abh`hNJ@@	CC1=CC(C)(C)Nc2ccc3c(c21)C(c1cc(C)cc(Br)c1)Oc1ccccc1-3	5.91	group4-ia	ia	Androgen Receptor	Antagonistic activity was determined in Human androgen receptor(hAR) of CV-1 cells in cotransfection assay.	1998	fag@@@DjYfYUUW}aaNCUKR}jjjjjjjjj`@@	faga@@B`rQQQQIQKQIYHtyIwli[WmAT@@DAI@EAE@@	446.387	6.571	2	1	21.26	1	-1.4256523219606896	-2.507395124217326	-0.27541747936900407	14	13	egdXHL@Fe@@dcqX\\bbbfJbTTTRRbfsg@cgfWURpvtDPUP@PDLUDEAIP@@	eFACD`BL@	eFBH@c@@									13
yTuM2M9G8k4kZFA4FNH5VR2H04FF1392VHHo58VV3Nk96F10128V12F2p0Wc1DG109J@Xbca40@4J0F658V0F0	CHEMBL101914	fma@@B`rQQQQIQKQIYQFrgIN}eOZchJ`@@`Ibh@hHh@@	CC1=CC(C)(C)Nc2ccc3c(c21)C(c1ccccc1)Oc1ccccc1-3	6.13	group3-int	int	Androgen Receptor	Antagonistic activity was determined in Human androgen receptor(hAR) of CV-1 cells in cotransfection assay.	1998	fag@@@DjYfYUUW}aaNCUKR}jjjjjjjjj`@@	faga@@B`rQQQQIQKQIYHtyIwli[WmAT@@DAI@EAE@@	353.464	5.5019	2	1	21.26	1	-1.86470020510103	-1.520119863304007	-0.4338922480315618	14	13	egdXHL@Fe@@dcqX\\bbbfJbTTTRRbfsg@cgfWURpvtDPUP@PDLUDEAIP@@											13
yTuM2M9G8k4kZFA4FNH5VR2H04FF1392VHHo58VV3Nk96F10128V52F2p0dc1DG109J@Xbca40@4K0FL58V0F0	CHEMBL102403	ec`XH@@B`LdTTTRTRtRVTQJeGDcgfRWUPuAT@@DALUPAPHT@@	CC1=CC(C)(C)Nc2ccc3c(c21)C(c1ccc(C)cc1)Oc1ccccc1-3	5.91	group4-ia	ia	Androgen Receptor	Antagonistic activity was determined in Human androgen receptor(hAR) of CV-1 cells in cotransfection assay.	1998	fag@@@DjYfYUUW}aaNCUKR}jjjjjjjjj`@@	faga@@B`rQQQQIQKQIYHtyIwli[WmAT@@DAI@EAE@@	367.491	5.8458	2	1	21.26	1	-1.8070120628162116	-1.7788711872368432	-0.40901882922889676	14	13	egdXHL@Fe@@dcqX\\bbbfJbTTTRRbfsg@cgfWURpvtDPUP@PDLUDEAIP@@			eFBH@c@@								13
yTuM2M9G8k4kZFA4FNH5VR2H04FF13A2VHHo58VV3Nk96F10128V12F2p0Wc1DG10AJ@Xbca40@4J0F658V0F0	CHEMBL102541	ekhXHD@Ji@HabHrJIJHqJJJIIQSYrcbqqIhj[iZ@Hj`@`HXjHJ@R`@	CC1=CC(C)(C)Nc2ccc3c(c21)C(c1cc(Cl)cc(Cl)c1)Oc1ccccc1-3	5.96	group4-ia	ia	Androgen Receptor	Antagonistic activity was determined in Human androgen receptor(hAR) of CV-1 cells in cotransfection assay.	1998	fag@@@DjYfYUUW}aaNCUKR}jjjjjjjjj`@@	faga@@B`rQQQQIQKQIYHtyIwli[WmAT@@DAI@EAE@@	422.354	6.7139	2	1	21.26	1	-1.5589379613224255	-2.504177428218079	-0.31421863106503434	14	13	egdXHL@Fe@@dcqX\\bbbfJbTTTRRbfsg@cgfWURpvtDPUP@PDLUDEAIP@@	eFABH`BL@	eFABH`BL@									13
yTuM2M9G8k4kZFA4FNH5VR2H04FF13A2VHHo58VV3Nk96F10128V52F2p0dc1DG10AJ@Xbca40@4K0FL58V0F0	CHEMBL102720	ekhXHH@Ji@HcHhhdUDhhhdeEMgFNKGDfbinehBBj@B@abh`hAJ@@	CC1=CC(C)(C)Nc2ccc3c(c21)C(c1ccc(Cl)c(C)c1)Oc1ccccc1-3	5.85	group4-ia	ia	Androgen Receptor	Antagonistic activity was determined in Human androgen receptor(hAR) of CV-1 cells in cotransfection assay.	1998	fag@@@DjYfYUUW}aaNCUKR}jjjjjjjjj`@@	faga@@B`rQQQQIQKQIYHtyIwli[WmAT@@DAI@EAE@@	401.936	6.4518	2	1	21.26	1	-1.6541309409269096	-2.270899969693879	-0.3491820207456331	14	13	egdXHL@Fe@@dcqX\\bbbfJbTTTRRbfsg@cgfWURpvtDPUP@PDLUDEAIP@@	eFBH@c@@		eFABH`BL@								13
yTuM2M9G8k4kZFA4FNH5VR2H04FF13A2VHHo58VV3Nk96F10128V52G2p0dc1DG10AJ@Xbca40@4K0FL58V8F0	CHEMBL102754	ekhXHD@Ji@H`bPrJJKYQJJJIIQSYqcbqqIhj[iZB@j`@`HXjHJ@R`@	CC1=CC(C)(C)Nc2ccc3c(c21)C(c1ccc(Cl)c(F)c1)Oc1ccccc1-3	5.66	group4-ia	ia	Androgen Receptor	Antagonistic activity was determined in Human androgen receptor(hAR) of CV-1 cells in cotransfection assay.	1998	fag@@@DjYfYUUW}aaNCUKR}jjjjjjjjj`@@	faga@@B`rQQQQIQKQIYHtyIwli[WmAT@@DAI@EAE@@	405.899	6.2087	2	1	21.26	1	-1.6218231909702072	-2.139456926191145	-0.34392790607838275	14	13	egdXHL@Fe@@dcqX\\bbbfJbTTTRRbfsg@cgfWURpvtDPUP@PDLUDEAIP@@	eFABP`BL@		eFABH`BL@								13
RuJfgem0b8se989V19Q889p1MONX8Z01FNFG8s02g8OZ44@BFo850k0FF1080F212F808Q/!	CHEMBL103	fnk@`@@UrJIJZIPiSQHrcEZ]zNVfjjjjjZjXqBViZ^TT@	CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	7.86	group2-a	a	Androgen Receptor	Competitive displacement of [3H]R1881 from human AR-LBD expressed in LNCaP cells incubated for 24 hrs by scintillation counting method based radioligand competitive binding assay	2019	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmMUUUUUXDePt@@	314.467	4.019	2	0	34.14	1	-2.0692183472693193	-0.37570934792422106	0.6137200950908749	50	7	fjcAA@B`|WNNQQRIHsIREKDyIUoIsUUUUUMMTQBIAQR@@	eFBH@c@@	gCaHA`AIf`@									5
yTuM2M9G8k4kZFA4FNH5VR2H04FF1392VHHo58VV3Nk96F10128V52G2p0dc1DG109J@Xbca40@4K0FL58V8F0	CHEMBL103092	ekhXHH@Ji@ICHhhemDhhhdeEMgFNKGDfbinehBBj@B@abh`hAJ@@	CC1=CC(C)(C)Nc2ccc3c(c21)C(c1ccc(C)c(F)c1)Oc1ccccc1-3	5.91	group4-ia	ia	Androgen Receptor	Antagonistic activity was determined in Human androgen receptor(hAR) of CV-1 cells in cotransfection assay.	1998	fag@@@DjYfYUUW}aaNCUKR}jjjjjjjjj`@@	faga@@B`rQQQQIQKQIYHtyIwli[WmAT@@DAI@EAE@@	385.481	5.9466	2	1	21.26	1	-1.7170161705746914	-1.9061794676669452	-0.3788912957589815	14	13	egdXHL@Fe@@dcqX\\bbbfJbTTTRRbfsg@cgfWURpvtDPUP@PDLUDEAIP@@	eFABP`BL@		eFBH@c@@								13
yTuM2M9G8k4kZFA4FNH5VR2H04FF1392VHHo58VV3Nk96F10128V52F2p0dc1DG109J@Xbca40@4K0FL58V4F0	CHEMBL103232	ec`XHH@Ba@LSHhdlheEEDdhilyPpYYEUdLuM@AU@A@PqTPTGE@@	CC1=CC(C)(C)Nc2ccc3c(c21)C(c1ccc(Br)cc1)Oc1ccccc1-3	6.32	group3-int	int	Androgen Receptor	Antagonistic activity was determined in Human androgen receptor(hAR) of CV-1 cells in cotransfection assay.	1998	fag@@@DjYfYUUW}aaNCUKR}jjjjjjjjj`@@	faga@@B`rQQQQIQKQIYHtyIwli[WmAT@@DAI@EAE@@	432.36	6.2271	2	1	21.26	1	-1.483340441810085	-2.2486435136345415	-0.3002909006566863	14	13	egdXHL@Fe@@dcqX\\bbbfJbTTTRRbfsg@cgfWURpvtDPUP@PDLUDEAIP@@			eFACD`BL@								13
xvwUcTqlEEsX9cx6FAn@_h_HqJ4XBj9HFN2Kkt02WCGWFF3R09030428W0808F2020V94G120X8418!FN2V10	CHEMBL10560	fj}@`@@QrJIJYJSIHsJcIJ\F@BjjjkblBbdF@@	CC#C[C@@]1(O)CC[C@@]2(CC)c3ccc(O)cc3CC[C@@H]2C1	6.38	group3-int	int	Androgen Receptor	Binding affinity to human androgen receptor	2009	fgA@@@LdbbbTVKIBMjuUUUUT@@	fgA@@@LdbbTRrKI\TZpQEETUCb@@	284.398	4.0231	2	2	40.46	1	-1.5739424950636116	-0.2480642327371989	-1.5930979307397815	1	1	fj}@`@@QrJIJYJSIHsJcIJ\F@BjjjkblBbdF@@											1
:UvztOzfJbwYLQzUwQWHOvTDB8K1nC5Z7vKEDYfIQVR@kYeDHpbpj7SCZ2YkEVmdt5tXYHbG10o1GFr0cVcF0	CHEMBL1082407	e`TRDJ@DLCgeK`@bjPFdIiAZPrJJJJIQQKHsSJSJpt\AYIMMUPHT@EEU[T@@@	CNC(=O)c1ccc(N2C(=S)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1F	6.67	group3-int	int	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	flu@@@LdbbRbbsbRxXRhijjjjjjj@@	fluQB@DXT@HRYfY[]^gGQBejjA@@B@@@	464.442	3.5872	6	1	108.53	4	1.6682276640754403	-0.019560044463666937	0.3933827664789323	29	17	fakQA`AFB@IH`zBKNM_GlCdTTVVbbfrfRaYpsbm``JfjPBH`@@	eMBH@RZ@	gJPBAHJPt`PAIjj@@	eFABP`BL@	eMbA@Dg`@	gJYHDL@ILmP@						16
zqQlHkOK8F5s!2CRN2W0N2m04FF92904HIZ58V83OV8691V02FVCX0J1F081Dl0V9K@X_V6W!2G1FL18W8FV	CHEMBL1082780	el^\DF@LEmhD@@aPHbdDiCJPQdLddJbbRQfTbeRfRtRVTtl\zFVvAaVi`dBj`@i`@hH@@@	O=S(=O)(Nc1ccc(-c2ccc3c(cnn3-c3ccc(F)cc3)c2)c(C(F)(F)F)c1)c1ccsc1	5.6	group4-ia	ia	Androgen Receptor	Binding affinity to AR	2010	egdP@@@LddTQRaRrbRfRtRPdecfQSWQuuUUUUUUUUUUT@@@	egd\DD@LFnhD@@aPHrRPjJIIGJIJYKQIJZVNYEM]GWKTpRA@AS@AA@@@	517.526	4.8371	5	1	100.61	5	1.675332090814525	-1.2675586688161247	0.40464754559862404	1	1	el^\DF@LEmhD@@aPHbdDiCJPQdLddJbbRQfTbeRfRtRVTtl\zFVvAaVi`dBj`@i`@hH@@@											1
yLPl2F9G8F5k!25FN210N2m040F129!2HZ58V83NV869WV!FV524J1F!1DW0V9J@X_V6c!2G1FL18W8FV	CHEMBL1083783	ebQ\DJ@LMchD@@aJPrdBiCFPrRPjJIIKPjQRiSIZIKZNV^CS[GPhkT@@@UT@EL@DA@@@	O=S(=O)(Nc1ccc(-c2ccc3c(cnn3-c3ccc(F)cc3)c2)c(C(F)(F)F)c1)c1ccccc1	5.2	group4-ia	ia	Androgen Receptor	Binding affinity to AR	2010	eolP@@@LddTQRbrvTRTrVbRdL\|JjzFn^jjjjjjjjjjjh@@	eol\DH@LNahD@@cIIBhhddlUDeLehdmGKOBjnakgej@@@H@JX@@H@@@	511.498	5.0527	5	1	72.37	5	1.1792358722003768	-1.5819585942139291	0.3239693956187293	3	3	ejY\DF@ECkaI@GE`HrdBiBjPIdLbbRfdjbRfTbeRfRtRVhx|BfVNnQq`BEh@Jj@Bf@B@`@@											3
yLul2F9G8k5k!25FN210N2m040F129202HZ58V83NV869WV!FV52JJ1F!9DW0V9J@X_V6c!2G1FL18W8FV	CHEMBL1084013	efU\LJ@LKghDG@@`jPjdFiBfPrRPjJIIJZ[JSRiSIZIKZ^VAK[WOXdkT@@DEUP@Tp@PD@@@	COc1cccc(S(=O)(=O)Nc2ccc(-c3ccc4c(cnn4-c4ccc(F)cc4)c3)c(C(F)(F)F)c2)c1	5.5	group4-ia	ia	Androgen Receptor	Binding affinity to AR	2010	eolP@@@LddTQRbrvTRTrVbRdL\|JjzFn^jjjjjjjjjjjh@@	eol\DH@LNahD@@cIIBhhddlUDeLehdmGKOBjnakgej@@@H@JX@@H@@@	541.524	4.9827	6	1	81.6	6	1.8924332274520657	-1.5834912674957613	0.5111583572964886	3	3	ejY\DF@ECkaI@GE`HrdBiBjPIdLbbRfdjbRfTbeRfRtRVhx|BfVNnQq`BEh@Jj@Bf@B@`@@	eMJA@Hz@										3
yLPl2F9G8F5k!25FN210N2m040F129!2HZ58V83NV869WV!FV524J1F!1DW0V9J@X_V6c!2G1FL18W8FV	CHEMBL1084014	eaS\DA@LO`XD@@aJPrdBiAjPzdAiCfPrRPjJIIJZFQJRriSIZIKZNVAGW_@tlkT@@AEUU@AS@A@P@@@	O=S(=O)(Nc1ccc(-c2ccc3c(cnn3-c3ccc(F)cc3)c2)c(C(F)(F)F)c1)c1cccc(C(F)(F)F)c1	5.4	group4-ia	ia	Androgen Receptor	Binding affinity to AR	2010	eolP@@@LddTQRbrvTRTrVbRdL\|JjzFn^jjjjjjjjjjjh@@	eol\DH@LNahD@@cIIBhhddlUDeLehdmGKOBjnakgej@@@H@JX@@H@@@	579.495	5.901	5	1	72.37	6	1.6559447969797336	-2.4648906953389087	0.466385253936795	3	3	ejY\DF@ECkaI@GE`HrdBiBjPIdLbbRfdjbRfTbeRfRtRVhx|BfVNnQq`BEh@Jj@Bf@B@`@@	gJPBAHJPt`PAIjj@@										3
yLPl2F9G8F5k!25FN210N2m040F129!2HZ58V83N08691V!FV42041F!1DW!9J@X_V6V!2G1FL18W8FV	CHEMBL1084360	eod\DJ@LFnhD@@brP\dOIAzPrRPzIJYRJUJYKQIZQSHikhzyZ`@jh@JX@HH@@@	CS(=O)(=O)Nc1ccc(-c2ccc3c(cnn3-c3ccc(F)cc3)c2)c(C(F)(F)F)c1	5.3	group4-ia	ia	Androgen Receptor	Binding affinity to AR	2010	fjc@@@DjYU[wyWbiFl{IZjjjjjjj`@@	fjcP@@@PrQQJIIIHzIHeMNM[IYj@@@`@@@@@	449.427	3.8023	5	1	72.37	4	0.7526534893532512	-0.479280173855502	0.18920918162503006	7	7	fmoPB`Dy@xrdERFiA\adTRTrdTjTrVbRuF^BgHyp@UT@EL@DD@@@	gGXdMD@b`FRREZ`@										7
:UlIkOK9F5w!2ERN212N2u040F129!2IZ58V83O08691V!FV42049F!1EW!9K@X_V6V!2G1FL18W8FV	CHEMBL1084632	ehR\DJ@LAihD@@crPBdHi@FPrRPiQIZYRJUJYKQI[PrihZY{yZhHBj`@i`@``@@	CCCS(=O)(=O)Nc1ccc(-c2ccc3c(cnn3-c3ccc(F)cc3)c2)c(C(F)(F)F)c1	5.5	group4-ia	ia	Androgen Receptor	Binding affinity to AR	2010	fjc@@@DjYU[wyWbiFl{IZjjjjjjj`@@	fjcP@@@PrQQJIIIHzIHeMNM[IYj@@@`@@@@@	477.481	4.7537	5	1	72.37	6	1.1727013892258777	-1.3968931436399812	0.29254385830322127	7	7	fmoPB`Dy@xrdERFiA\adTRTrdTjTrVbRuF^BgHyp@UT@EL@DD@@@	dazDPLa@BJ@LddJruT@@										7
]yjxzy;vULMjvPjxAzbmxE81jMeEIvnUZi9H9EEGHZp4mdBE6nP@8HGB6N6IF3F_YV2ZWn0N0c!	CHEMBL1084843	eg`TDB@IKcO@@aZPvdCiCIELedhhlhcDeLiDqqXxuuP@USUT@EUYDEd@@	CSc1ccc(CN2CC(C)(C)[C@@H](Oc3ccc(C#N)c(C(F)(F)F)c3)C2=O)cc1	6.5	group3-int	int	Androgen Receptor	Displacement of [3H]DHT from human AR expressed in baculovirus Sf9 cells system by scintillation counting	2010	fbm@@@LdbRVfbQTRUNJLgMUUUUUUT@@	fbm``@D@XdsMoLjnSgdqruUT@@@PPp`@	434.481	4.3625	4	0	78.63	6	0.5444719838841064	-1.0633238629305155	1.2338627583443067	17	3	eg`TDB@IKcO@@aZPvdCiCIELedhhlhcDeLiDqqXxuuP@USUT@EUYDEd@@											1
:UlIlOGdF5k042EFN212N2m040F129!2IZ58V83O0869W#FV424J9F!1DW0V9J@X_V6c!2G1FH18W8FV	CHEMBL1085380	ehR\DJ@LAihD@@crPBdHi@FPrRPjIIJERJUJYKQIYPrihZY{yZ``bj`@i`@``@@	CCCNS(=O)(=O)c1ccc(-c2ccc3c(cnn3-c3ccc(F)cc3)c2)c(C(F)(F)F)c1	5.2	group4-ia	ia	Androgen Receptor	Binding affinity to AR	2010	fjc@@@DjYU[wyWbiFl{IZjjjjjjj`@@	fjcP@@@PrQQJIIIHzIHeMNM[IYj@@@`@@@@@	477.481	4.7397	5	1	72.37	6	1.1733600932400108	-1.3884771011976436	0.29247089819567285	7	7	fmoPB`Dy@xrdERFiA\adTRTrdTjTrVbRuF^BgHyp@UT@EL@DD@@@	dazDPLa@BB@LddNRuT@@										7
:UvItOIdJ5k062UFNH1HO2m240F129!3IZ58V83O0869W240FV424R9F!1DW0V9J@X_V6c!2G1Fm18W8FV	CHEMBL1085381	edZ\DJ@LIehD@@`JPbdDiBFPrRPjIIQRjQRiSIZIKJVM]SK_@kTDEEU@AS@AA@@@	CC(C)CNS(=O)(=O)c1ccc(-c2ccc3c(cnn3-c3ccc(F)cc3)c2)c(C(F)(F)F)c1	5.2	group4-ia	ia	Androgen Receptor	Binding affinity to AR	2010	fjc@@@DjYU[wyWbiFl{IZjjjjjjj`@@	fjcP@@@PrQQJIIIHzIHeMNM[IYj@@@`@@@@@	491.508	4.958	5	1	72.37	6	1.2369577483322765	-1.5717245424549302	0.31668976095990553	7	7	fmoPB`Dy@xrdERFiA\adTRTrdTjTrVbRuF^BgHyp@UT@EL@DD@@@	diFDPLa@BB@LddNTVjh@@										7
]yjxzy;vULMjvPjxAzbmxE81jMeEInnUZi9H9EEGHZl4mdBE6nP@82GB6N6IF3F_YV2ZWY0N0c!	CHEMBL1085593	fcoPc@EQLDD`bPqHYEHXhddUEEIjhdiZbe^zhHLjfjh@BHV`@	CC1(C)CN(Cc2ccccc2)C(=O)[C@@H]1Oc1ccc(C#N)c(C(F)(F)F)c1	7	group2-a	a	Androgen Receptor	Displacement of [3H]DHT from human AR expressed in baculovirus Sf9 cells system by scintillation counting	2010	fbm@@@LdbRVfbQTRUNJLgMUUUUUUT@@	fbm``@D@XdsMoLjnSgdqruUT@@@PPp`@	388.388	3.8853	4	0	53.33	5	-0.24126775433564432	-0.670285285851605	1.0650243657950587	17	3	fcoPc@EQLDD`bPqHYEHXhddUEEIjhdiZbe^zhHLjfjh@BHV`@											1
qHuF0F818V0k!24FN2!N0H040F0212022Z58!3808%20V!G61#9@V#J821020V204!21N0c!	CHEMBL1085594	fjmaB`BdAHRdHrBYCLadTTRRTJTrdSAV]AAD@EUX@@@	N#Cc1ccc(Oc2ccc(F)cc2F)cc1C(F)(F)F	7.22	group2-a	a	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-MB-453 cells coexpressing MMTV-ARE reporter gene assessed as inhibition of DHT-induced response	2010	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	299.198	3.9407	2	0	33.02	3	-1.846883287265025	-0.521880060215271	0.6375504172067015	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@	eFABP`BL@					gJPBAHJPt`PAIjj@@		eFABP`BL@	eMbA@Dg`@		34
zqQlHFOK8F5s!2CRN210N2m040F129!2IZ58V83O08691V!FV42041F!1DW!9K@X_V6V!2G1FL18W8FV	CHEMBL1085625	e`\\DJ@LNahD@@arP|d@iCzPrRPiSISJQRiSIZIKJZEU]CWOKU@AUP@Tp@PP@@@	CCS(=O)(=O)Nc1ccc(-c2ccc3c(cnn3-c3ccc(F)cc3)c2)c(C(F)(F)F)c1	5.3	group4-ia	ia	Androgen Receptor	Binding affinity to AR	2010	fjc@@@DjYU[wyWbiFl{IZjjjjjjj`@@	fjcP@@@PrQQJIIIHzIHeMNM[IYj@@@`@@@@@	463.454	4.2993	5	1	72.37	5	0.9616753293075632	-0.9508913684621672	0.24098755079441306	7	7	fmoPB`Dy@xrdERFiA\adTRTrdTjTrVbRuF^BgHyp@UT@EL@DD@@@	gNxdMD@b`FRREKU@@										7
]yjxzy;vULMzvPjxAzjnxE81jMfEInnUZi9H9EEIIZl4mdBE6nP@82GB6N6IF3F_YV2ZWYFN0c!	CHEMBL1085819	fkP``AGtxDaNPWH[dLbbbRLTVTQbRfTbYpujm`HJfjh@JjrHF`@	CC1(C)CN(Cc2ccccc2F)C(=O)[C@@H]1Oc1ccc(C#N)c(C(F)(F)F)c1	7.36	group2-a	a	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-MB-453 cells coexpressing MMTV-ARE reporter gene assessed as inhibition of DHT-induced response	2010	fbm@@@LdbRVfbQTRUNJLgMUUUUUUT@@	fbm``@D@XdsMoLjnSgdqruUT@@@PPp`@	406.378	3.9861	4	0	53.33	5	-0.15127186209412377	-0.7975935662817066	1.0951518992649738	17	3	fkP``AGtxDaNPWH[dLbbbRLTVTQbRfTbYpujm`HJfjh@JjrHF`@											1
zqQlHlOG8F5k!2CFN210N2m040F129!2IZ58V83O0869W#FV424J1F!1DW0V9J@X_V6c!2G1FH18W8FV	CHEMBL1085853	e`\\DJ@LNahD@@arP|d@iCzPrRPjIKSJQRiSIZIKJZEU]CWOKTDAUP@Tp@PP@@@	CCNS(=O)(=O)c1ccc(-c2ccc3c(cnn3-c3ccc(F)cc3)c2)c(C(F)(F)F)c1	5.5	group4-ia	ia	Androgen Receptor	Binding affinity to AR	2010	fjc@@@DjYU[wyWbiFl{IZjjjjjjj`@@	fjcP@@@PrQQJIIIHzIHeMNM[IYj@@@`@@@@@	463.454	4.2853	5	1	72.37	5	0.9623340557571191	-0.9424750393698829	0.24091458820184733	7	7	fmoPB`Dy@xrdERFiA\adTRTrdTjTrVbRuF^BgHyp@UT@EL@DD@@@	gNxdMD@``FRRGKU@@										7
:UvztOzfJbwYLQzUwQVH9vTDB8K1mC5Z7fKDDYfIAVR8k3eDFoblh2CBZ2YkEVX1s5tXYHbG10k1GFb0c0c!	CHEMBL1085883	fmwq@`DXVh@QvPGHSdLbbbbbTTRrLvTfipNTuZj`Ph@Hjn@@@	CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccccc1	6.7	group3-int	int	Androgen Receptor	Antagonist activity at human AR expressed in human HeLa cells co-transfected with MMTV-Luc-Hyg after 48 hrs by transient-luciferase reporter gene assay	2010	flu@@@LdbbRbbsbRxXRhijjjjjjj@@	fluQB@DXT@HRYfY[]^gGQBejjA@@B@@@	389.4	4.0476	4	0	79.43	3	-0.14086090210636718	-0.3385081894160175	1.0817567974210678	29	17	fakQA`AFB@IH`zBKNM_GlCdTTVVbbfrfRaYpsbm``JfjPBH`@@	eMBH@RZ@	gJPBAHJPt`PAIjj@@		eMbA@Dg`@							16
zrzpIlOGdF5k!2EHN212N2mV40F12d!2IZ58V83O0869W!1FV424J9F!1DW0V9J@X_V6c!2G1FH18Y8GV	CHEMBL1086086	ehR\LJ@LAihDM@@crPBdHi@FPrRPjIIJERJUJYKQIYPrihZY{yZ``bj`@i`@``@@	O=S(=O)(NCCO)c1ccc(-c2ccc3c(cnn3-c3ccc(F)cc3)c2)c(C(F)(F)F)c1	5	group4-ia	ia	Androgen Receptor	Binding affinity to AR	2010	fjc@@@DjYU[wyWbiFl{IZjjjjjjj`@@	fjcP@@@PrQQJIIIHzIHeMNM[IYj@@@`@@@@@	479.453	3.3586	6	2	92.6	6	2.094976845552962	-0.3101772146877414	-0.6581668723990782	7	7	fmoPB`Dy@xrdERFiA\adTRTrdTjTrVbRuF^BgHyp@UT@EL@DD@@@	dazLPLaN@HH@rRPyKUP@@										7
=jvRry4ySKCyiBsR28H8KxNWsc4W8HG2U8DJNco844050X80d!oFG4h1GH2V191V0FK4#V0H#VVFF	CHEMBL1094797	fmwp`@AYzAFQQJIQSIJIIQVHjLwlumSUUTEX@@aAd@@	CCCC1=C(C(=O)OCC)[C@H](c2ccnc3ccccc23)C(C#N)=C(C)N1	6.14	group3-int	int	Androgen Receptor	Inhibition of androgen receptor	2010	f`i@@@LdbbbTRQpiZ][uUUUUUP@@	f`iP@@@^RfV]{VcAJ]x@@HiXH@@	361.444	4.2008	5	1	75.01	6	0.6301048880838841	-0.6148520067937755	0.10544550074742956	4	1	fmwp`@AYzAFQQJIQSIJIIQVHjLwlumSUUTEX@@aAd@@											1
:UvztU:KzxvTQzUzUmPfvUiEeM5mSCjbjMDEnfvAWTcV3XyFobmC0hBg2YoEca1s5tXYLbF1Fk1GNb0dVck0	CHEMBL1095223	fcwh``DXsOZe`BJrCYCladTTTTRbRjfRdRlhstVjhFhHjjmh@@	CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1CCCNC(N)=O	6.1	group3-int	int	Androgen Receptor	Displacement of [3H]mibolerone from human AR expressed in CHO-K1 cells after 2 hrs by scintillation counting	2010	dk\@@DjYVYxqVjjjj`@	dk]H`DrPBDfYYwimMjhDB@@	413.423	1.8743	7	2	134.55	6	2.7365953224466386	1.2555314318826094	-0.5792277679709814	33	14	fleqC@NRlxGbXHBxyEEDdcEEMhpUoPPYTsUD@@	dayH`DpN@Df]Vjh@@	gJPBAHJPt`PAIjj@@									13
:UvztU:KzxvTQzUzUmPfvziEeM5mSCjbjMDEnfvAWTcd3XyFobmC0hBZ2YoEca1s5tXYLbk1Fm1GNb0dWck0	CHEMBL1095224	fkoib`LDDX|DQ@DZBIrByC\addarRbbdrLrTrdQkUZmUUMUH@UUp@@	CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1CCCNS(N)(=O)=O	7.05	group2-a	a	Androgen Receptor	Antagonist activity at AR in bicalutamide-resistant human LNCAP cells assessed as effect on cell proliferation after 6 days	2010	dk\@@DjYVYxqVjjjj`@	dk]H`DrPBDfYYwimMjhDB@@	449.477	1.7799	8	2	160	6	3.585027866833955	1.4861137689909716	-0.3670673266548907	33	14	fleqC@NRlxGbXHBxyEEDdcEEMhpUoPPYTsUD@@	diEDPLJD@HD@rRPyIZj`@	gJPBAHJPt`PAIjj@@									13
:UvztU:KzxvTQzUzUmPfvziEeM5mSCjbjMDEnjvAWycd3XyFobmC0hBZ2YoEci1s5tXYLbk1Fm1GNb0d1cV0	CHEMBL1095862	fcwIb`L\unB@`BEA@yB\`nPrRRiJJJSHsISJQZLVjuUSUR@EU\@@@	CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1CCCS(N)(=O)=O	6.4	group3-int	int	Androgen Receptor	Displacement of [3H]mibolerone from human AR expressed in CHO-K1 cells after 2 hrs by scintillation counting	2010	dk\@@DjYVYxqVjjjj`@	dk]H`DrPBDfYYwimMjhDB@@	434.462	2.1061	7	1	147.97	6	2.7762454149732916	1.1504813480503864	0.5774833595436736	33	14	fleqC@NRlxGbXHBxyEEDdcEEMhpUoPPYTsUD@@	dazDPLa@BN@LddjRuT@@	gJPBAHJPt`PAIjj@@									13
:UvztU:KzxvTQzUzUmPfvziEeM5mSCjbjMDEnjvAYycd3XyJobmC0hBZ2YoEci1s5tXYLbk1Fm1GNb0cWcF0	CHEMBL1095863	fkoIb`LBL^BH`BMADyA\anPrRPkIQQRYFYJYRHujmVjjfjd@Jjx@@	CNS(=O)(=O)CCCN1C(=S)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)C1(C)C	6.72	group3-int	int	Androgen Receptor	Antagonist activity at AR in human LNCAP cells assessed as effect on cell proliferation after 6 days	2010	dk\@@DjYVYxqVjjjj`@	dk]H`DrPBDfYYwimMjhDB@@	448.489	2.4675	7	1	133.98	6	2.608097209129876	0.7785903274650547	0.566837495131644	33	14	fleqC@NRlxGbXHBxyEEDdcEEMhpUoPPYTsUD@@	diFDPLa@BA@LddJrVjh@@	gJPBAHJPt`PAIjj@@									13
:UvztU:KzxvTQzUzUmPfvziEeM5mSCjbjMDEnjvAfycd3XyJobmC0hBZ2YoEci1s5tXYLbk1Fm1GNj0c1c!	CHEMBL1095864	fgIb`LRm^BD`BCAByC\`^PrRPqEJJJSHsISJQV\wjuUUMUH@UUp@@	CN(C)S(=O)(=O)CCCN1C(=S)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)C1(C)C	5.43	group4-ia	ia	Androgen Receptor	Antagonist activity at AR in human LNCAP cells assessed as effect on cell proliferation after 6 days	2010	dk\@@DjYVYxqVjjjj`@	dk]H`DrPBDfYYwimMjhDB@@	462.516	2.5607	7	0	125.19	6	2.260120038019021	0.6199475146114148	1.6547543220076963	33	14	fleqC@NRlxGbXHBxyEEDdcEEMhpUoPPYTsUD@@	defDPLa@BI@LddLQRuUP@@	gJPBAHJPt`PAIjj@@									13
>vSzy4yxOCqyBuRVSHTKxNVNjEW0HILU8DosdoB44041e90d03Jl18h1GHXV399V2Fp4H05W8H110VcF0	CHEMBL1097751	fikPa@OArTDPjPrJJIJKQSJISjQgKA`HJi[jZjJED@	CC1=C(C#N)[C@@H](c2ccc(F)cc2Cl)C(C(=O)OC(C)(C)C)=C(C)N1	6.61	group3-int	int	Androgen Receptor	Inhibition of androgen receptor	2010	dcl@@DjYU_egZjjjh@@	dcn@@@Re]eRi]iZ@B@@	362.831	4.4227	4	1	62.12	4	-0.14221695802370365	-0.7271460009234411	-0.06468564297397675	30	7	fdy`B`J@BRNLoFtQFPrJJJYJKQGLExLuUPTAICD@@	eFBH@c@@	eMbA@Dg`@	daxD`@S@AIgijj@@								1
:UvztU:KzxvTQzUzUmIfvziEeM5mSCbbfMDEnjvAYTcd3XTFqjmh0CBZ2YoEci1s_taYLbk1Fm1GNj8d1cV0	CHEMBL1097855	fmgIb`LLTnBO@BIAGY@\aNPrRRiQQRYFYJYRIVleVjiji@Bjn@@@	CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1CCS(N)(=O)=O	7.1	group2-a	a	Androgen Receptor	Antagonist activity at AR in bicalutamide-resistant human LNCAP cells assessed as effect on cell proliferation after 6 days	2010	dk\@@DjYVYxqVjjjj`@	dk]H`DrPBDfYYwimMjhDB@@	420.435	1.6517	7	1	147.97	5	2.5652192167792442	1.5964835230468344	0.5259269993337005	33	14	fleqC@NRlxGbXHBxyEEDdcEEMhpUoPPYTsUD@@	gNxdMD@a`FRRUKU@@	gJPBAHJPt`PAIjj@@									13
:Uvzt;KzxvTQzUzUkPfvziEeM_mSCjbjMDEnfvAWTcd3XTFobmC0hBZ6YqEcX1s5tXYLbk1Fm1GNb0d1cV0	CHEMBL1098171	fkoIb`LBL^BH`BMADyA\anPrRRiIQQRYFYJYRHujmVjjfjd@Jjx@@	CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1CCCCS(N)(=O)=O	6.96	group3-int	int	Androgen Receptor	Antagonist activity at AR in bicalutamide-resistant human LNCAP cells assessed as effect on cell proliferation after 6 days	2010	dk\@@DjYVYxqVjjjj`@	dk]H`DrPBDfYYwimMjhDB@@	448.489	2.5605	7	1	147.97	7	2.9872716243850506	0.7044793163789123	0.6290397185111382	33	14	fleqC@NRlxGbXHBxyEEDdcEEMhpUoPPYTsUD@@	diFDPLa@BA@LddjRVjh@@	gJPBAHJPt`PAIjj@@									13
:UvztU:KzxvTQzUjUmPfvziEeM5mSCjbjMDEnjv3Wqcd3XyFobmC0hBZ2YoCci1s1lVYLbk1Fm1GNb0d1VV0	CHEMBL1098173	fikIa@L\tNB@`BEAFRRUIQQRYFYJ[ZLVjuUSUR@E\@@@	Cc1cc(N2C(=O)C(C)(C)N(CCCS(N)(=O)=O)C2=S)ccc1C#N	6.52	group3-int	int	Androgen Receptor	Antagonist activity at AR in human LNCAP cells assessed as effect on cell proliferation after 6 days	2010	dk\@@DjYVYxqVjjjj`@	dk]H`DrPBDfYYwimMjhDB@@	380.492	1.6017	7	1	147.97	5	2.3572246268698973	1.7746620535800433	0.4599409206495272	33	14	fleqC@NRlxGbXHBxyEEDdcEEMhpUoPPYTsUD@@	dazDPLa@BN@LddjRuT@@	eFBH@c@@									13
;vztU:pzxvTQzUjUmPvvziEeM5mSEjbjrE7nju3Wqcd3XyFobmCGjBZ2YwCci1s1lVYL_k1Fm5GNb4W1VV0	CHEMBL1098174	fe{HQ@L\uNB@u@DJBLddjRbbdrLrTrvcEZmUTuT`DUp@@	COc1cc(N2C(=O)C(C)(C)N(CCCS(N)(=O)=O)C2=S)ccc1C#N	5.72	group4-ia	ia	Androgen Receptor	Displacement of [3H]mibolerone from human AR expressed in CHO-K1 cells after 2 hrs by scintillation counting	2010	dk\@@DjYVYxqVjjjj`@	dk]H`DrPBDfYYwimMjhDB@@	396.491	1.1878	8	1	157.2	6	3.012733839836768	2.031880704231048	0.6222564635246216	33	14	fleqC@NRlxGbXHBxyEEDdcEEMhpUoPPYTsUD@@	dazDPLa@BN@LddjRuT@@	eMJA@Hz@									13
?S:ozxOEmiUuSVCHzpxNVNg4W2HGLU8iotcqBZBY4Ge8cfV2JF10h1GHXV191X6FpBH!V8H680Y0F0	CHEMBL1099083	fcwPpBHA@aNZmaJNrJZIJFJJJJIReR\DxKP@ULuMMUQPe@@	COC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)(C)C)[C@@H]1c1cccc([N+](=O)[O-])c1	5.9	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor	2010	dcl@@DjYU_egZjjjh@@	dcn@@@Re]eRi]iZ@B@@	388.419	2.7003	8	1	110.45	7	2.305679199760771	0.6888327047226217	0.5239650118352429	30	7	flePcBJ^bd@RQqex~eOILsZso\pS`sUUAACICB@@	eFBH@c@@	daxD`@S@AIgijj@@	gJPh@l@ILmP@								1
:UvztU:KzxvTQzUjUmPvvziEeM5mUCjbjME7nju3Wqcd3XyFobmC1hBZ2YoCci1u1lVYL_k1Fm1GNb0W1VV0	CHEMBL1099086	fikIc@NRlMs^`bCAEPcHhhddXhimDTiFBmzBCJfZjiX`@@	CC1(C)C(=O)N(c2ccc(C#N)c(Cl)c2)C(=S)N1CCCS(N)(=O)=O	7.92	group2-a	a	Androgen Receptor	Antagonist activity at AR in bicalutamide-resistant human LNCAP cells assessed as effect on cell proliferation after 6 days	2010	dk\@@DjYVYxqVjjjj`@	dk]H`DrPBDfYYwimMjhDB@@	400.91	1.8638	7	1	147.97	5	2.452417612083237	1.5413846667183302	0.4949043097088716	33	14	fleqC@NRlxGbXHBxyEEDdcEEMhpUoPPYTsUD@@	dazDPLa@BN@LddjRuT@@	eFABH`BL@									13
:UvztU:KzxvTQzUzUmPvvziEeMCnSCjbjrEEnjvAWycd3XyFobmC0hCZXYpEdi1s5tXYTbk1Fr1GNb1h1cV0	CHEMBL1099087	fkoIb`L\t^B@`BEADyA\anPrRRiJJJSHsQJERKQjmVjjZjPHJjx@@	Cc1c(N2C(=O)C(C)(C)N(CCCS(N)(=O)=O)C2=S)ccc(C#N)c1C(F)(F)F	6.58	group3-int	int	Androgen Receptor	Displacement of [3H]mibolerone from human AR expressed in CHO-K1 cells after 2 hrs by scintillation counting	2010	dk\@@DjYVYxqVjjjj`@	dk]H`DrPBDfYYwimMjhDB@@	448.489	2.45	7	1	147.97	6	2.8339335460403987	0.8917298807925766	0.6023567795888473	33	14	fbuqC@AJ]xGcXHbxyEEEDeXhimFR\FBBrifjH@@	dazDPLa@BN@LddjRuT@@	gJPBAHJPt`PAIjj@@									1
:UvztOzfJbwXLQzUwQVH9vTDB8K1mC5Z7fKDDYfIAVR8V3XDFobkC0CBZ2YkEVX1s5tXYHbF10k1GFb0c0c!	CHEMBL1099140	ff}q@`DXjh@PfPsHEdLbbbbbTrlrdUFN|uU@tAUW@@@	CN1C(=S)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)C1(C)C	7.82	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from human AR expressed in CHO-K1 cells after 2 hrs by scintillation counting	2010	dk\@@DjYVYxqVjjjj`@	dk]H`DrPBDfYYwimMjhDB@@	327.329	2.5524	4	0	79.43	2	-0.5559253427129047	0.9113311540054927	0.9457208202824968	33	14	fleqC@NRlxGbXHBxyEEDdcEEMhpUoPPYTsUD@@	eFBH@c@@	gJPBAHJPt`PAIjj@@									13
=x;MzxvUUzU:kPfvUEEeM_mSCjbjMDErjvAWycV3XTFobkC0hBZ6YqEce1s5tXYLbF1Fk1GNb0c6c30	CHEMBL1099141	fmgq``DXVh\pAEYAlavPrJJJJIQIUSIRJJcOQZj`Z`bjin@@@	CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1CCCC(=O)O	6.4	group3-int	int	Androgen Receptor	Antagonist activity at AR in bicalutamide-resistant human LNCAP cells assessed as effect on cell proliferation after 6 days	2010	dk\@@DjYVYxqVjjjj`@	dk]H`DrPBDfYYwimMjhDB@@	399.392	2.5912	6	1	116.73	6	1.8214866276724255	0.6389105810568732	0.3542401517332794	33	14	fleqC@NRlxGbXHBxyEEDdcEEMhpUoPPYTsUD@@	gNph@f@IMjuT@@	gJPBAHJPt`PAIjj@@									13
:Uvzt;KzxvTQzUzUkPfvUEEeM_mSCjbjMDEnjvAWycV3YTFobkC0hBZ6YqEce1s5tXYLbF1Fk1GNb0d0cV0	CHEMBL1099142	fmgH``DXfmPpAEYAlavPrJJJJIQIUSIRJJcOQZj`Z`bjin@@@	CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1CCCC(N)=O	6.32	group3-int	int	Androgen Receptor	Displacement of [3H]mibolerone from human AR expressed in CHO-K1 cells after 2 hrs by scintillation counting	2010	dk\@@DjYVYxqVjjjj`@	dk]H`DrPBDfYYwimMjhDB@@	398.408	2.1934	6	1	122.52	6	1.9281466562196024	0.9241673575200839	0.3652858460627386	33	14	fleqC@NRlxGbXHBxyEEDdcEEMhpUoPPYTsUD@@	gNyHDF@IMjuT@@	gJPBAHJPt`PAIjj@@									13
LNsH42818V$24F801VN0H!F!2120HH058!20F16&V02G2k!898!81F280V!V&5N2010	CHEMBL113332	figA`@@Y{dTTTTRRVqbbvSAJ\[uVm@D@HPPEP@@@	COc1ccc(C=C2c3ccccc3C(=O)c3ccccc32)c(O)c1	6.63	group3-int	int	Androgen Receptor	Inhibition of R1881-induced full length AR transcriptional activity in human LNCAP cells harboring AR2PB-eGFP construct after 72 hrs by fluorescence assay	2018	ffs@@@LdbbbTRVJbrsIBuyIZuUUUUUUUP@@	ffsA@@@YEEEEDdelXdfBTxwbuZ@H@P`@`@@@	328.366	4.7427	3	1	46.53	2	-1.1513839193498947	-0.7852674482971181	-0.3001720063814366	5	5	few@a@F]Axd\\bbbfbNbbbbRRwAART[YpQASPA@BA@@@	eFJB@Hp@										1
:UvEntldN4mVJAeHk0dX9Hm140GWV90Z0F#XV3GkF0Np108!5a4FB38W042Fc841@V049&3!Y8F0	CHEMBL1163598	fcoQbBA]]MXIClk{HhdhXdhhehldmEQdRmG@AUPL@@PtACa@@	Cc1ccc(C(=O)CC(Nc2ccc([N+](=O)[O-])cc2)c2cccc(F)c2)cc1	6.85	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in african green monkey CV1 cells co-transfected with MMTV-Luc by luciferase reporter gene assay	2010	fns@@@DjYU^[V}~JCfkZjjjjjjjh@@	fnsa@@I@RYeV]nUWEiMRmZBBb@@@@HLh@@	378.402	3.5425	5	1	74.92	7	0.9074717403563571	-0.4034855013060328	0.15579688192084362	1	1	fcoQbBA]]MXIClk{HhdhXdhhehldmEQdRmG@AUPL@@PtACa@@											1
<jrtzduiy_qEeuwchXAHcWcGMtcj0Z2F01Bmo2dlN4Po16d20haZKB38W05@FcA!8V0490V0F!1!Y0FV	CHEMBL1163630	fegPRBM]Dx\pQGYgvQQIYSJIQQIHyRcDyjv@BZjdJ@fD`j`@	O=C(CC(Nc1ccc([N+](=O)[O-])cc1)c1ccco1)c1ccc(Cl)cc1	8.54	group1-p	p	Androgen Receptor	Binding affinity to androgen receptor	2010	ffc@@@LdbbRvfbRTJWI^BVmUUUUUUUP@@	ffc``@I@mdTTRRbrfbRQEjJRuZBBbdJ@D`r`@	370.791	2.8925	6	1	88.06	7	1.3541056232065087	0.23272212599575193	0.26187766558590725	1	1	fegPRBM]Dx\pQGYgvQQIYSJIQQIHyRcDyjv@BZjdJ@fD`j`@											1
:xjxyyirjyfzfxsgfzDUjp5UtpePwFpGsFOsuSmgcOZS4@Txo850k8FH!80F6W6#8O!F0G0V01(	CHEMBL1170	figA`@@E[dTRTtRaRfbQTuFJt{t\mMUUUUUMUSFHRuKSrb`@	CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	7.75	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting analysis	2013	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmMUUUUUXDePt@@	344.493	4.4352	3	0	43.37	3	-1.2203597443970124	-0.7903443374869262	0.8295499530064461	50	7	fjcAA@B`|WNNQQRIHsIREKDyIUoIsUUUUUMMTQBIAQR@@	eFBH@c@@	gGPh@b@ILkU@@									5
uTPI2G9G8F4kVFA4F8H1VN2H!FF1390VFHo18VV38k96F#28012!p0Vc041109020bVa#4F%VcF0	CHEMBL117465	ffcPB@IAAHYEDeDmLeLhcJ\lzNX@bp@ij``@@	CC1=CC(C)(C)Nc2ccc(-c3cc(F)cc(C#N)c3)cc21	6.68	group3-int	int	Androgen Receptor	Cross-reactivity as binding to human androgen receptor (hAR)	2000	f`i@@@DjYU[wxjQg^jjjjjj@@	f`i`@@@YHheEbhdj\EIwjBHH@D@@@	292.356	3.8098	2	1	35.82	1	-1.8727113371741768	-0.1695082702833618	-0.5062013601432392	4	1	ffcPB@IAAHYEDeDmLeLhcJ\lzNX@bp@ij``@@											1
}y>Uj<jzrytxUfzUyjl;fydzv:KmjLMDw@jLmLEgDnwhSqYKiuOkXA1tyX81c!	CHEMBL1208805	ejY\JJ@LNbXDKFa`@bjPadDYCFPrRPqQIIRJH{JHzIJYRIRpqIpHkjyyZhJBjbif@BjnJBIDiGHD`@	C[C@]12CN(S(=O)(=O)c3ccc(F)cc3)C[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	7.27	group2-a	a	Androgen Receptor	Antagonist activity at human wild type AR expressed in human MDA-MB-435 cells by transactivation assay	2010	ec`P@@@LddTTJRTRvtRLRRca`UgbVRvuUUUUUUUUUU@@@	ec`TJH@LBhDKLj`@cIICEDdeDbmEmDdiXXDyxdTmlmTEATTs@AEBCd|P@	537.489	2.3349	8	0	116.16	3	2.289507736102739	0.8947503689116658	1.7641831791437697	3	2	ejY\JJ@LNbXDKFa`@bjPadDYCFPrRPqQIIRJH{JHzIJYRIRpqIpHkjyyZhJBjbif@BjnJBIDiGHD`@											1
}y=yUjxU:jzrytxUfiUyjlMzjfwdaQ:KmjHK@g@jLmLEgD2whSqYJiH8kVA1ti28VcF0	CHEMBL1208812	fmoqc@EFWzMPRBICDadTabbRQbbfrdTtmARVhuuPPYTsUUTUDCDkJK@@	C[C@]12CNC[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	6.89	group3-int	int	Androgen Receptor	Antagonist activity at human wild type AR expressed in human MDA-MB-435 cells by transactivation assay	2010	flm@@@LdbbRbbvLRxXRgAbfjjjjjjj@@	flmQ`@DQ@hrSLsJr~tYhwdabuU@uAQQHpfH@	379.337	1.1122	6	1	82.43	2	0.5996368095565889	1.8340769863291437	0.12179594197852878	13	13	fcq``HNvrw`NHyB\`nPRYVfgyVvfcNRLxmZjjjfX@Jjz`aER\dd@											13
yyPnTYtF8N5k0F9WGNHGV8@!FN#9802GH18#Qk04FV408F0C24J!8V!2FdG02cI0402%F#V0V	CHEMBL1209236	fbuQ@@KYAdTTTbUrbbQUktV`j@ijlP@@	Cn1c(C#N)ccc1-c1ccc(C(=O)C(C)(C)C)cc1	7	group2-a	a	Androgen Receptor	Antagonist activity at androgen receptor ligand binding domain by two hybrid assay	2010	dmL@@DjYU^TYjjjj@@	dmN@@@rQQJEHjeZe@B@@	266.343	3.2644	3	0	45.79	3	-1.5379024455194805	0.2210363003078864	0.7010137895719053	36	26	fdyPB`IQ@D||]HIhFscdTTRbbrbnXIwhBHfjkD@@	eFBH@c@@				gNqHA`AIffj`@						24
yyPnPYtF8N5k0F91GNHGV8@V0FF#9802GH18#Qk04FV40@F0C24J0F8V!2FW102VI0402%F!3V1V	CHEMBL1209298	fjmq@@HNJCHeEEHe\hhd]FBfZBhBfjqABB@	Cn1c(C#N)ccc1-c1ccc(/C(=N\O)C(C)(C)C)cc1	6.78	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor ligand binding domain by two hybrid assay	2010	dmL@@DjYU^TYjjjj@@	dmN@@@rQQJEHjeZe@B@@	281.358	3.8858	4	1	61.31	3	-0.7175722639944884	0.012620139499995728	-0.22971493659964248	36	26	fdyPB`IQ@D||]HIhFscdTTRbbrbnXIwhBHfjkD@@	eFBH@c@@				dazH`H@`AIYjZjBH`						24
}y=yUjxU:jzrytxUfiUyjlMzjfydaQ:KmjHK@g@jLmLEgDHwjSqYJiHOkVA1tiX80c!	CHEMBL1209903	egh\LL@ECEoHj`IABPpdLbdLTRRLTTvTbfjTf`RQUPruTDFULuUUUEQ@TRVRJ`@	CCCN1C[C@@]2(C)O[C@@](C)(C1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	7.85	group2-a	a	Androgen Receptor	Antagonist activity at human wild type AR expressed in human MDA-MB-435 cells by transactivation assay	2010	flm@@@LdbbRbbvLRxXRgAbfjjjjjjj@@	flmQ`@DQ@hrSLsJr~tYhwdabuU@uAQQHpfH@	421.418	2.2258	6	0	73.64	4	0.6684610808951593	0.716341640636308	1.3134070682703902	13	13	fcq``HNvrw`NHyB\`nPRYVfgyVvfcNRLxmZjjjfX@Jjz`aER\dd@	gC`HL@IST@@										13
}y=yUjxU:jzrytxUfiUyjlMzjfydaQ:KmjHK@g@jLmLEgDHwjSqYJiHOkVA1tiX80c!	CHEMBL1209904	eod\BL@ECEoHjc`IABPpdLbdLTRRLTTvTbfjfdtBRJjFVj``rifjjjZJb@hdldU@@	CCC(=O)N1C[C@@]2(C)O[C@@](C)(C1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	6.89	group3-int	int	Androgen Receptor	Antagonist activity at human wild type AR expressed in human MDA-MB-435 cells by transactivation assay	2010	flm@@@LdbbRbbvLRxXRgAbfjjjjjjj@@	flmQ`@DQ@hrSLsJr~tYhwdabuU@uAQQHpfH@	435.401	1.8762	7	0	90.71	3	1.1193514142264884	1.241537954397904	1.4404824094383253	13	13	fcq``HNvrw`NHyB\`nPRYVfgyVvfcNRLxmZjjjfX@Jjz`aER\dd@	gJQHA`AIej@@										13
}y=yUjxU:jzrytxUfiUyjlMzjfydaQ:KmjHK@g@jLmLEgDHwjSqYJiHOkVA1tiX80c!	CHEMBL1209905	e`\\BL@ECEoHjc`IABPpdLbdLTRRLTTvTbfjfdf`RQUPruTDFULuUUSTUDAQIYHj@@	CC(C)C(=O)N1C[C@@]2(C)O[C@@](C)(C1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	5.79	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type human AR expressed in human LNCAP cells by transactivation assay	2010	flm@@@LdbbRbbvLRxXRgAbfjjjjjjj@@	flmQ`@DQ@hrSLsJr~tYhwdabuU@uAQQHpfH@	449.428	2.0945	7	0	90.71	3	1.1829490805364657	1.0582906564655907	1.4647012709600493	13	13	fcq``HNvrw`NHyB\`nPRYVfgyVvfcNRLxmZjjjfX@Jjz`aER\dd@	gGQHA`AIfZh@										13
}y=yUjxU:jzrytxUfiUyjlMzjfydaQ:KmjHK@g@jLmLEgDHwjSqYJiHOkVA1tiX80s!	CHEMBL1209906	e`R\BL@ECEoHjc`IABPpdLbdLTRRLTTvTbfjfdf`RQUPrswuTDFULuUUSTUQ@TRVRJ`@	C[C@]12CN(C(=O)C3CC3)C[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	7.16	group2-a	a	Androgen Receptor	Antagonist activity at human wild type AR expressed in human MDA-MB-435 cells by transactivation assay	2010	fag@@@LdbbRbbvLRJbgCBTxLTm{UUUUUUUUU@@@	fagPP@DQ@hq\bbbbbRbVrNfeFZMyHXmzuU@uAQMUEHpfH@	447.412	1.7399	7	0	90.71	3	1.1890164486567245	1.2789339977934047	1.4595359582993825	1	1	e`R\BL@ECEoHjc`IABPpdLbdLTRRLTTvTbfjfdf`RQUPrswuTDFULuUUSTUQ@TRVRJ`@											1
}y>UjzU:jzrytxUfzUyjlM:fydqv:KmjHKDw@jLmLEgDvwjSqYJiHOkVA1tiX80c!	CHEMBL1209970	el^\BL@ECEoHjc`IABPpdLbdLTRRLTTvTbfjfbRdtBRJjFVaQj``rifjjjX@BhHBbRrQT@@	C[C@]12CN(C(=O)c3ccccc3)C[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	7.27	group2-a	a	Androgen Receptor	Antagonist activity at human wild type AR expressed in human MDA-MB-435 cells by transactivation assay	2010	fm@@@LdbbRbbvLRJbfRxXRgAbfZzjjjjjjjjjh@@	fmPP@DQ@hq\bbbbbRbVrNfbRhsQoICFZvjhFhJI`@haFDq@@	483.445	2.8656	7	0	90.71	3	1.3258081876649654	0.4685993872103417	1.5246942103571541	1	1	el^\BL@ECEoHjc`IABPpdLbdLTRRLTTvTbfjfbRdtBRJjFVaQj``rifjjjX@BhHBbRrQT@@											1
}y=yUjxU:jzrytxzfiUyjlrzjfydaQ:KmjHK@g@jLmLEgiHwhSqYJiHOkVA1tiXcVcF0	CHEMBL1209971	ehRRBL@ECEkoHjc`IABPpdLbdLTRRLTTvTbfjfTdtBRJjFVj``rifjjjZhjHBbRrQT@@	CC(C)NC(=O)N1C[C@@]2(C)O[C@@](C)(C1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	5.34	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type human AR expressed in human LNCAP cells by transactivation assay	2010	flm@@@LdbbRbbvLRxXRgAbfjjjjjjj@@	flmQ`@DQ@hrSLsJr~tYhwdabuU@uAQQHpfH@	464.443	1.9164	8	1	102.74	3	1.984763353683997	1.3048929720215934	0.5209224019318968	13	13	fcq``HNvrw`NHyB\`nPRYVfgyVvfcNRLxmZjjjfX@Jjz`aER\dd@	gNyHDL@IL|uT@@										13
}y=yUjxU:jzrytxUjiUyjlMzjfydaQ:KqjHK@g@jLmLEgDHwhSqYJiHOkVA1tiXcVcF0	CHEMBL1209972	ebQRBL@ECEkoHjc`IABPpdLbdLTRRLTTvTbfjfTRTf`RQUPrrNMTDFULuUUSP@EPPEDedbh@@	C[C@]12CN(C(=O)Nc3ccccc3)C[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	6.91	group3-int	int	Androgen Receptor	Antagonist activity at wild type human AR expressed in human LNCAP cells by transactivation assay	2010	ec`P@@@LdbbRbbvLRJbtRWA`bc`TRRvuUUUUUUUUUU@@@	ec`\B@@DHj`ECBlbbbbbRbVrNfTRUCFagbPTRvsUTCTEDt@EDHXIa@@	498.46	2.8595	8	1	102.74	3	2.119529779445401	0.6118042004034169	0.5818117119146216	2	2	ebQRBL@ECEkoHjc`IABPpdLbdLTRRLTTvTbfjfTRTf`RQUPrrNMTDFULuUUSP@EPPEDedbh@@											1
~=yUjxU:jzrytxUfiUyjtMzjfydaQ:KmjHK@g@jLmLEgDHwhSqYJiHOkVA1tiX@0c!	CHEMBL1209973	e`\\JL@ECEoHjck`IABPpdLbdLTRRLTTvTbfjfTf`RQUPruTDFULuUUSTUDAQIYHj@@	CCOC(=O)N1C[C@@]2(C)O[C@@](C)(C1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	7.19	group2-a	a	Androgen Receptor	Antagonist activity at human wild type AR expressed in human MDA-MB-435 cells by transactivation assay	2010	flm@@@LdbbRbbvLRxXRgAbfjjjjjjj@@	flmQ`@DQ@hrSLsJr~tYhwdabuU@uAQQHpfH@	451.4	2.0313	8	0	99.94	4	1.7480890197727497	1.1567031556451801	1.6057632919192668	13	13	fcq``HNvrw`NHyB\`nPRYVfgyVvfcNRLxmZjjjfX@Jjz`aER\dd@	gGPh@l@IL{U@@										13
~=yUjxU:jzrytxUfiUyjtMzjfydaQ:KmjHK@g@jLmLEgDLwhSqYJiHOkVA1tiX@0c!	CHEMBL1210033	ehR\JL@ECEoHjck`IABPpdLbdLTRRLTTvTbfjfRdtBRJjFVj``rifjjjZhjHBbRrQT@@	CCCOC(=O)N1C[C@@]2(C)O[C@@](C)(C1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	7.27	group2-a	a	Androgen Receptor	Antagonist activity at wild type human AR expressed in human LNCAP cells by transactivation assay	2010	flm@@@LdbbRbbvLRxXRgAbfjjjjjjj@@	flmQ`@DQ@hrSLsJr~tYhwdabuU@uAQQHpfH@	465.427	2.4857	8	0	99.94	5	1.9591152291845086	0.710701123973706	1.6573196508867314	13	13	fcq``HNvrw`NHyB\`nPRYVfgyVvfcNRLxmZjjjfX@Jjz`aER\dd@	gNph@l@ILzuT@@										13
}y=yUjxU:jzrytxUjiUyjlMzjfydaQ:KqjHK@g@jLmLEgDHwhSqYJiHOkVAGtiXcVcF0	CHEMBL1210034	ejYRBB@NENbYOFa`IBFPQdLYAIe][eZ[~_e[ZZFGO@djnkgh@JZjjjfX@JjrhHlSdBbR@@	C[C@]12CN(C(=O)Nc3ccc(F)cc3)C[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	6.98	group3-int	int	Androgen Receptor	Antagonist activity at wild type human AR expressed in human LNCAP cells by transactivation assay	2010	ec`P@@@LdbbRbbvLRJbtRWA`bc`TRRvuUUUUUUUUUU@@@	ec`\B@@DHj`ECBlbbbbbRbVrNfTRUCFagbPTRvsUTCTEDt@EDHXIa@@	516.45	2.9603	8	1	102.74	3	2.2095258323980773	0.48449580680462817	0.6119392956006846	2	2	ejYRBB@NENbYOFa`IBFPQdLYAIe][eZ[~_e[ZZFGO@djnkgh@JZjjjfX@JjrhHlSdBbR@@											1
}y=yUjx;jzrytxUfiUyjlUzjfydjQ:KmjHK@g@jLmLEgDHwhSqYKimOkXA1tiX81c!	CHEMBL1210035	eod\JB@LHghDI@d`@cZPNdKiCIICLeHimhmhdieHaIECOHnaejjjjfX@Jjz`caBQRFH@	C[C@]12CN(S(C)(=O)=O)C[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	6.69	group3-int	int	Androgen Receptor	Antagonist activity at human wild type AR expressed in human MDA-MB-435 cells by transactivation assay	2010	flm@@@LdbbRbbvLRxXRgAbfjjjjjjj@@	flmQ`@DQ@hrSLsJr~tYhwdabuU@uAQQHpfH@	457.428	0.9837	8	0	116.16	2	1.7729292918896538	2.1247370753751516	1.5992953823958889	13	13	fcq``HNvrw`NHyB\`nPRYVfgyVvfcNRLxmZjjjfX@Jjz`aER\dd@	gJPdH`DD@cuh@										13
}y=yUjx;jzrytxUfiUyjlUzjfydjQ:KmjHK@g@jLmLEgDHwhSqYKimOkXA1tiX81c!	CHEMBL1210036	e`\\JB@LDohDEHl`@`zPndGiCIICDeiEMmEmDeLiEHiiXDdMLmUUUULp@UUuA@bdfdlP@	CCS(=O)(=O)N1C[C@@]2(C)O[C@@](C)(C1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	7.07	group2-a	a	Androgen Receptor	Antagonist activity at human wild type AR expressed in human MDA-MB-435 cells by transactivation assay	2010	flm@@@LdbbRbbvLRxXRgAbfjjjjjjj@@	flmQ`@DQ@hrSLsJr~tYhwdabuU@uAQQHpfH@	471.455	1.4807	8	0	116.16	3	1.9819509795460932	1.653126101430903	1.6510737004172429	13	13	fcq``HNvrw`NHyB\`nPRYVfgyVvfcNRLxmZjjjfX@Jjz`aER\dd@	gGPdH`DD@rRPkT@@										13
}y>Uj<jzrytxUfzUyjl;fydzv:KmjHKDw@jLmLEgDnwhSqYKiuOkXA1tiX81c!	CHEMBL1210090	ebQ\JB@LFlXDKJn`@`FPadDYCIICEDdeHhccEmDeLiDiXXdxDTt]\mTEAUQSL@EU\TDRIRNPI@@	C[C@]12CN(S(=O)(=O)c3ccccc3)C[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	7	group2-a	a	Androgen Receptor	Antagonist activity at human wild type AR expressed in human MDA-MB-435 cells by transactivation assay	2010	ec`P@@@LddTTJRTRvtRLRRca`UgbVRvuUUUUUUUUUU@@@	ec`TJH@LBhDKLj`@cIICEDdeDbmEmDdiXXDyxdTmlmTEATTs@AEBCd|P@	519.499	2.2341	8	0	116.16	3	2.1995118326435072	1.022058506016794	1.734055646916363	3	2	ebQ\JB@LFlXDKJn`@`FPadDYCIICEDdeHhccEmDeLiDiXXdxDTt]\mTEAUQSL@EU\TDRIRNPI@@											1
}y>Uj<jzrytxUfzUyjl;fydzv:KmjHKDw@zLmLEgDnwhSqYKiuOkXA1tiX81c0F	CHEMBL1210091	ebQRJB@LNFlXDKJn`@`FPadDYCIICEDdeHhccEmDeLiDiXXdxDTt]\mTEAUQSL@EU\TDRIRNPI@@	C[C@]12CN(S(=O)(=O)c3ccccn3)C[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	5.91	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type human AR expressed in human LNCAP cells by transactivation assay	2010	ec`P@@@LddTTJRTRvtRLRRca`UgbVRvuUUUUUUUUUU@@@	ec`\JH@LNBhDKLj`@cIICEDdeDbmEmDdiXXDyxdTmlmTEATTs@AEBCd|P@	520.487	1.3306	9	0	129.05	3	2.699335959237199	1.7769357038818252	1.8523284743829858	3	1	ebQRJB@LNFlXDKJn`@`FPadDYCIICEDdeHhccEmDeLiDiXXdxDTt]\mTEAUQSL@EU\TDRIRNPI@@											1
}y>Ujx;jzrytxUfyUyjnUzjfwdiv:KmjHK@g@jLnLEgDmwhSqbJiuOkVA1tiX91cV0	CHEMBL1210150	ejYRJB@LINbXDOFa`@bFPQdLYCIIKDeMLeHimhmhdieHaEGO@djnkgeh@bjjjfX@JjrhHlSdBbR@@	C[C@]12CN(c3cccc(S(N)(=O)=O)c3)C[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	6.47	group3-int	int	Androgen Receptor	Antagonist activity at wild type human AR expressed in human LNCAP cells by transactivation assay	2010	fiw@@@LdbbRRbVvbQbRyjUeF|Ghzjjjjjjjjj@@	fiwQ`@DQ@hvQQQQQIQKYGQITYhwdact[UTCTED@EDHpfH@	534.514	1.6243	9	1	142.18	4	3.4051875045236284	1.5099723904248477	0.8497444600717101	5	3	edV\LB@FBhSLj`GEzP~d@YAIe[mZ[~_e[ZZNMCKODbemh@bjjjfX@JjrhHTVdlgb@@	gJXdMD@``D^m@@										3
}y>Ujx;jzrytxUfyUyjnUzjfwdiQ:KmjHK@g@jLnLEgDHwhSqbJiuOkVA1tiX80c!	CHEMBL1210151	ejY\JB@INbXDOFa`@bFPQdLYCIICLeMLeHimhmhdieHaEGO@djnkgeh@bjjjfX@JjrhHlSdBbR@@	C[C@]12CN(c3cccc(S(C)(=O)=O)c3)C[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	6.82	group3-int	int	Androgen Receptor	Antagonist activity at wild type human AR expressed in human LNCAP cells by transactivation assay	2010	fiw@@@LdbbRRbVvbQbRyjUeF|Ghzjjjjjjjjj@@	fiwQ`@DQ@hvQQQQQIQKYGQITYhwdact[UTCTED@EDHpfH@	533.526	1.8623	8	0	116.16	4	2.4494109924946517	1.0727254194767795	1.781306248841194	5	3	edV\LB@FBhSLj`GEzP~d@YAIe[mZ[~_e[ZZNMCKODbemh@bjjjfX@JjrhHTVdlgb@@	gJPdH`DD@cuh@										3
}y=yUjxU:jzryvxUfiUyjnMzjfwdaQ:KmjHK@g@zLnLEgDHyhSqYJiHOkVA3tiX80c0F	CHEMBL1210152	edVZLB@DFNBhSLj`HazP~d@YAIeWeZ[~_e[ZZFMCKODbemh@JjjjfX@JjrhHTVdlgb@@	C[C@]12CN(c3cc(Cl)ncn3)C[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	6.98	group3-int	int	Androgen Receptor	Antagonist activity at wild type human AR expressed in human LNCAP cells by transactivation assay	2010	fiw@@@LdbbRRbVvbQbRyjUeF|Ghzjjjjjjjjj@@	fiwI`@DQJLBcYEEEEDeDmd]DeQfc^RFOQmUPMPTP@TPcBX`@	491.856	2.3519	8	0	99.42	3	1.7791524883427847	0.930960899255257	1.6465730202609017	5	1	edVZLB@DFNBhSLj`HazP~d@YAIeWeZ[~_e[ZZFMCKODbemh@JjjjfX@JjrhHTVdlgb@@											1
}y=yUjxU:jzrytxUfiUyjnMzjfwdaQ:KmjHK@g@zLnLEgDHwhSqYJiHOkVA3tiX80c0F	CHEMBL1210214	ehZZLL@ECEckoHj`IABPpdLbdLTRRLTTvTbfjbRdtBRJjFV~Aj``rifjjj@@jB@hdldU@@	C[C@]12CN(c3ncccn3)C[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	6.42	group3-int	int	Androgen Receptor	Antagonist activity at wild type human AR expressed in human LNCAP cells by transactivation assay	2010	fiw@@@LdbbRRbVvbQbRyjUeF|Ghzjjjjjjjjj@@	fiwI`@DQKTBcYEEEEDeDmd]DeQfc^RFOQmUPMPTP@TPcBX`@	457.411	1.6666	8	0	99.42	3	1.630002638939788	1.470660744645504	1.5863229924363678	5	1	ehZZLL@ECEckoHj`IABPpdLbdLTRRLTTvTbfjbRdtBRJjFV~Aj``rifjjj@@jB@hdldU@@											1
}y>UjxU:jzrytxUfyUyjnMzjfwdav:KmjHK@g@jLnLEgDuwhSqbJiHOkVA1tiX90cV0	CHEMBL1210783	ebQRBL@ECEl_HjdPIABPpdLbdLTRRLTTvTbfjbRfdf`RQUPrwtMTDFULuUUPACEPPEDedbh@@	C[C@]12CN(c3cccc(C(N)=O)c3)C[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	8.13	group1-p	p	Androgen Receptor	Antagonist activity at human wild type AR expressed in human MDA-MB-435 cells by transactivation assay	2010	fiw@@@LdbbRRbVvbQbRyjUeF|Ghzjjjjjjjjj@@	fiwQ`@DQ@hvQQQQQIQKYGQITYhwdact[UTCTED@EDHpfH@	498.46	1.9476	8	1	116.73	4	2.5459852273443224	1.1417872420475146	0.638776940904109	5	3	edV\LB@FBhSLj`GEzP~d@YAIe[mZ[~_e[ZZNMCKODbemh@bjjjfX@JjrhHTVdlgb@@	gCiHDL@ILt@@										3
}y=yUjzU:jzryxxUfjUyjlMzjjwdaQ:KmjmpehDjLmLEgDHwhSqYJjHSkVA_tie80c!	CHEMBL1210840	egh\JL@ECMoHjec`IABPpdLbdLTRRLTTvTbffLf`RQUPvuTDFULuUTsEQ@TRVRJ`@	CN1C(=O)[C@@]2(C)O[C@@](C)(C1=O)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	5.67	group4-ia	ia	Androgen Receptor	Antagonist activity at human wild type AR expressed in human MDA-MB-435 cells by transactivation assay	2010	fjc@@@LdbbRbbvLRfxXRgAbfjjjjjjjh@@	fjcQP@DFASfoYEDhihXleLePPeFmdkUSTuH@UBFQR@@	421.33	0.2327	8	0	107.78	2	1.4833827860993474	2.6485932832188586	1.5146522455015023	3	3	egh\JB@H@kbFAOH`GEZPvdCiAIf[koy~UmixDdt\BZzjYjjif@BjnhHhgBdVd@@	eFBH@c@@										3
}y=yUjzU:jzryxxUfjUyjlMzjjydaQ:KmjmpehDjLmLEgDHwjSqYJjHSkVA_tie80s!	CHEMBL1210841	ehZ\JL@ECMoHjec`IABPpdLbdLTRRLTTvTbffNTdtBRJjFv~Aj``rifjjfZhjb@hdldU@@	C[C@@]12O[C@@](C)(C(=O)N(CC3CC3)C1=O)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	5.48	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type human AR expressed in human LNCAP cells by transactivation assay	2010	fiw@@@LdbbRbbvLRfQTxXRgAbghzjjjjjjjjj@@	fiwQP@DA@pWlyEEEEEhXhjeLdrTcV\FOQmUSUTuH@UPcdL`@	461.395	0.9571	8	0	107.78	4	1.977363354438664	1.8229003331713	1.636567842624169	1	1	ehZ\JL@ECMoHjec`IABPpdLbdLTRRLTTvTbffNTdtBRJjFv~Aj``rifjjfZhjb@hdldU@@											1
~=yUjxU:jzrytxUfiUyjtrzjfydaQ:KmjHK@g@jLmLEgiHwhSqYJiHOkVA1tiX@0c!	CHEMBL1210842	ehR\JL@ECEoHjck`IABPpdLbdLTRRLTTvTbfjfTdtBRJjFVj``rifjjjZhjHBbRrQT@@	CC(C)OC(=O)N1C[C@@]2(C)O[C@@](C)(C1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	7.92	group2-a	a	Androgen Receptor	Antagonist activity at human wild type AR expressed in human MDA-MB-435 cells by transactivation assay	2010	flm@@@LdbbRbbvLRxXRgAbfjjjjjjj@@	flmQ`@DQ@hrSLsJr~tYhwdabuU@uAQQHpfH@	465.427	2.3906	8	0	99.94	4	1.8050525764243097	0.8886940417007987	1.6307169680827438	13	13	fcq``HNvrw`NHyB\`nPRYVfgyVvfcNRLxmZjjjfX@Jjz`aER\dd@	gNph@l@IL|uT@@										13
}y=yUjzU:jzryxxzfjUyjlrzjjydaQ:KmjmxehDjLmLEgiHwjSqYKjHSkkA_tie83c!	CHEMBL1210843	ehR\FLDECMoHjeck`IABPpdMin{HiCEDdcEEMeHiicCIM@dbjamjhHLjYjjifjJb@hdldU@@	CC(C)[N+]1([O-])C(=O)[C@@]2(C)O[C@@](C)(C1=O)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	5.3	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type human AR expressed in human LNCAP cells by transactivation assay	2010	fjc@@@LdbbRbbvLRfxXRgAbfjjjjjjjh@@	fjcQP@DFASfoYEDhihXleLePPeFmdkUSTuH@UBFQR@@	465.383	0.0249	9	0	121.61	3	2.3509182295710565	2.7116242271556046	1.7359132307578038	3	3	egh\JB@H@kbFAOH`GEZPvdCiAIf[koy~UmixDdt\BZzjYjjif@BjnhHhgBdVd@@	gJQHa@@]IRVj`@										3
LNsH42818V$24F801VN0H!F!2320HHV58!30F16$2#2G2l!89#83F284c!V!4#182010	CHEMBL1210876	fmoAa@N]fBH]DYEEDhhXmDmidhTqTcARt\DCPCA@AED@@@	COc1ccc(C=C2c3cccc(Cl)c3C(=O)c3c(Cl)cccc32)cc1O	5	group4-ia	ia	Androgen Receptor	Inhibition of R1881-induced transcriptional activity of human AR V7 truncated mutant expressed in human PC3 cells harboring pGL3-ARR3tk-NLuc after 24 hrs by luciferase reporter gene assay	2018	ffs@@@LdbbbTRVJbrsIBuyIZuUUUUUUUP@@	ffsA@@@YEEEEDdelXdfBTxwbuZ@H@P`@`@@@	397.256	5.9547	3	1	46.53	2	-0.84562167557129	-1.76932501321119	-0.18049838941490914	5	5	fc@``F]Axd\QqBxcHhhihchhhhddiipPTefw\DPTt@P@qA@@@		eFJB@Hp@									2
LNsH42818V$240801VN0H!F!2220HFV58!10F16$20V!F2k!89#83F284c%4#582010	CHEMBL1210878	fmoAa@NUFBH]DYEEDhhXmDmihmLqTcASv\DCPCA@PQD@@@	COc1cccc(C=C2c3cccc(Cl)c3C(=O)c3c(Cl)cccc32)c1O	5	group4-ia	ia	Androgen Receptor	Inhibition of R1881-induced transcriptional activity of human AR V7 truncated mutant expressed in human PC3 cells harboring pGL3-ARR3tk-NLuc after 24 hrs by luciferase reporter gene assay	2018	ffs@@@LdbbbTRVJbrsIBuyIZuUUUUUUUP@@	ffsA@@@YEEEEDdelXdfBTxwbuZ@H@P`@`@@@	397.256	5.9547	3	1	46.53	2	-0.84562167557129	-1.76932501321119	-0.18049838941490914	5	5	fewA@`J`|RNKX`\QdTTVaTTTTRRTtYqpT}KNB@f`B@FHH@@@	eFJB@Hp@	eMJA@Hz@									1
}y=yUjxU:jzrytxUfiUyjlMzjfydaQ:KmjHK@g@jLmLEgDHwhSqYJiHOkVA1tiXcVcF0	CHEMBL1210907	e`\RBL@ECEkoHjc`IABPpdLbdLTRRLTTvTbfjfTf`RQUPruTDFULuUUSTUDAQIYHj@@	CCNC(=O)N1C[C@@]2(C)O[C@@](C)(C1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	6.5	group3-int	int	Androgen Receptor	Antagonist activity at human wild type AR expressed in human MDA-MB-435 cells by transactivation assay	2010	flm@@@LdbbRbbvLRxXRgAbfjjjjjjj@@	flmQ`@DQ@hrSLsJr~tYhwdabuU@uAQQHpfH@	450.416	1.5571	8	1	102.74	3	1.9277997970324365	1.5729020859659746	0.49596872576841977	13	13	fcq``HNvrw`NHyB\`nPRYVfgyVvfcNRLxmZjjjfX@Jjz`aER\dd@	gGYHDL@IL{U@@										13
}y=yUjzU:jzryxxzfjUyjlrzjjydaQ:KmjmxehDjLmLEgiHwjSqYJjHSkkA_tie80c!	CHEMBL1210908	e`\\JL@ECMoHjec`IABPpdLbdLTRRLTTvTbffNdf`RQUPvuTDFULuUTsTUDAQIYHj@@	CC(C)N1C(=O)[C@@]2(C)O[C@@](C)(C1=O)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	7.5	group2-a	a	Androgen Receptor	Antagonist activity at human wild type AR expressed in human MDA-MB-435 cells by transactivation assay	2010	fjc@@@LdbbRbbvLRfxXRgAbfjjjjjjjh@@	fjcQP@DFASfoYEDhihXleLePPeFmdkUSTuH@UBFQR@@	449.384	0.9983	8	0	107.78	3	1.7536356672482296	1.963497207502892	1.590911610959124	3	3	egh\JB@H@kbFAOH`GEZPvdCiAIf[koy~UmixDdt\BZzjYjjif@BjnhHhgBdVd@@	gC`HL@Qz`@										3
}y=yUjxU:jzrytxUfiUyjlMzjfwdaQ:KmjHK@g@jLmLEgDHwhSqYKiHOkVA1tiX83c10	CHEMBL1210909	fcpS@EFWzM]`dDRFICHiCEDdcEEMeHikKPTejM]TDFULuUUQTPLRlhl@@	C[C@]12CN(O)C[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	6.74	group3-int	int	Androgen Receptor	Antagonist activity at human wild type AR expressed in human MDA-MB-435 cells by transactivation assay	2010	flm@@@LdbbRbbvLRxXRgAbfjjjjjjj@@	flmQ`@DQ@hrSLsJr~tYhwdabuU@uAQQHpfH@	395.336	0.4519	7	1	93.87	2	1.143747504210948	2.3764532826884888	0.2623457096750995	13	13	fcq``HNvrw`NHyB\`nPRYVfgyVvfcNRLxmZjjjfX@Jjz`aER\dd@	eFJB@Hp@										13
}y=yUjxU:jzrytxUfiUyjlMzjfydaQ:KmjHK@g@jLmLEgDHwhSqYKiHOkVA1tiX81c!	CHEMBL1210910	ek`\BL@ECEoHjm`IABPpdLbdLTRRLTTvTbfjdtBRJjFVj``rifjjjbh`JIKIEP@	CON1C[C@@]2(C)O[C@@](C)(C1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	6.75	group3-int	int	Androgen Receptor	Antagonist activity at wild type human AR expressed in human LNCAP cells by transactivation assay	2010	flm@@@LdbbRbbvLRxXRgAbfjjjjjjj@@	flmQ`@DQ@hrSLsJr~tYhwdabuU@uAQQHpfH@	409.363	0.6552	7	0	82.87	3	0.913581998254817	2.0145893050927883	1.3713180396344515	13	13	fcq``HNvrw`NHyB\`nPRYVfgyVvfcNRLxmZjjjfX@Jjz`aER\dd@	eMJA@Hz@										13
LNsH42818V$24F801VN0H!F!2320HHV58!30F16$20V02G2l!898!83F284c!V!4#5N2010	CHEMBL1210959	ek`PBD@NJim`HarHrJJIQPqZI[SQIRiaRPpIKiZBAhA``HJJH@@@	COc1ccc(C=C2c3cccc(Cl)c3C(=O)c3c(Cl)cccc32)c(OC)c1O	6.77	group3-int	int	Androgen Receptor	Inhibition of full length AR transcriptional activity in human LNCAP cells harboring AR2PB-eGFP construct assessed as reduction in R1881-induced secreted PSA level after 72 hrs by fluorescence assay	2018	ffs@@@LdbbbTRVJbrsIBuyIZuUUUUUUUP@@	ffsA@@@YEEEEDdelXdfBTxwbuZ@H@P`@`@@@	427.282	5.8847	4	1	55.76	3	-0.13242425896463528	-1.7708576585114513	0.0066905819728691925	5	5	fc@``F]Axd\QqBxcHhhihchhhhddiipPTefw\DPTt@P@qA@@@	eMJA@Hz@	eFJB@Hp@									2
=jtShy4y4GCqyBsRVNHPKxNVNfE10HH2U8DJFdo844040e90d01Jl18h1GH2V399V0FK4205W8H110VcF0	CHEMBL1215403	ff}Pa@OArTDPjPrJJIJKQSJISlyXLAAUK]SQPiP@	COC(=O)C1=C(C)NC(C)=C(C#N)C1c1ccc(F)cc1Cl	6.52	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor LBD expressed in human HUH7 cells coexpressing GAL4 by luciferase reporter gene assay	2010	dcl@@DjYU_egZjjjh@@	dcn@@@Re]eRi]iZ@B@@	320.75	3.2765	4	1	62.12	3	-0.4684310580964438	0.2387635584998971	-0.1660096386256621	30	7	fdy`B`J@BRNLoFtQFPrJJJYJKQGLExLuUPTAICE@@	eFBH@c@@	eMbA@Dg`@	gJPh@l@ILmP@								3
=jtSxy4y4KCyiBsRXNH8KxNWsf618HF2U8DJFco844050e90d!ok14h1GH2V399V0FK4201V8H010VVF0	CHEMBL1215406	fncPb@G^SdDQdTTRTLTRbTnSNF}@PUK]SUEBe@@	CCCC1=C(C(=O)OC)C(c2ccccc2Cl)C(C#N)=C(C)N1	6.52	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor LBD expressed in human HUH7 cells coexpressing GAL4 by luciferase reporter gene assay	2010	dcl@@DjYU_egZjjjh@@	dcn@@@Re]eRi]iZ@B@@	330.814	4.0845	4	1	62.12	5	-0.13637470344331384	-0.5259322545692361	-0.09302450313428731	30	7	fhi`@`J@BRNLoFtQdTTTrTVbKA^CMUTE@ICE@@	gC`HL@IST@@	eMbA@Dg`@	gJPh@l@ILmP@								2
=jvSxy4yKKCyiBsRXNH8KxNWsf618HF2U8DJFco844050e90d!ok14h1GH2V399V0FK4201V8H010VVF0	CHEMBL1215480	fasPb@G^SdDQdTTRTLTRbTnVYpwhBBi[jZjJEJ@@	CCCCC1=C(C(=O)OC)C(c2ccccc2Cl)C(C#N)=C(C)N1	6.05	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor LBD expressed in human HUH7 cells coexpressing GAL4 by luciferase reporter gene assay	2010	dcl@@DjYU_egZjjjh@@	dcn@@@Re]eRi]iZ@B@@	344.841	4.5389	4	1	62.12	6	0.07465149475073368	-0.9719344295656838	-0.041468142924314125	30	7	fhi`@`J@BRNLoFtQdTTTrTVbKA^CMUTE@ICE@@	gJPHB@IRuP@	eMbA@Dg`@	gJPh@l@ILmP@								2
=jtSxy4y4KCyyBsRXNHPKxNWsfE18HH2U8DJFdo844050e90d01ol1Bh1GH2V399V0FK4205W8H110VcF0	CHEMBL1215549	fasPa@OArTDPjPrJJIJKQSJIRyLyXLAAUK]SUEBe@@	CCCC1=C(C(=O)OC)C(c2ccc(F)cc2Cl)C(C#N)=C(C)N1	7	group2-a	a	Androgen Receptor	Antagonist activity at androgen receptor LBD expressed in human HUH7 cells coexpressing GAL4 by luciferase reporter gene assay	2010	dcl@@DjYU_egZjjjh@@	dcn@@@Re]eRi]iZ@B@@	348.804	4.1853	4	1	62.12	5	-0.046378811201793296	-0.6532405349993378	-0.06289696966437205	30	7	fdy`B`J@BRNLoFtQFPrJJJYJKQGLExLuUPTAICE@@	gC`HL@IST@@	eMbA@Dg`@	gJPh@l@ILmP@								3
>tzhy4y4IhyyBuRkOHPKxNoNfE10HH6U8DJFdoN4404De92d01Kl18h1GH2V399V1FKJ205l8H110VcF0	CHEMBL1215550	fikPb`OArTDPjPkHMdNrFQQQIQZJYQJVSLyXLAAUK]SUQPiP@	COC(=O)C1=C(C(F)(F)F)NC(C)=C(C#N)C1c1ccc(F)cc1Cl	6.1	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor LBD expressed in human HUH7 cells coexpressing GAL4 by luciferase reporter gene assay	2010	dcl@@DjYU_egZjjjh@@	dcn@@@Re]eRi]iZ@B@@	374.72	3.7608	4	1	62.12	4	-0.04846454400586411	-0.37333392015365385	-0.04857195128647189	30	7	fdy`B`J@BRNLoFtQFPrJJJYJKQGLExLuUPTAICE@@	gJPBAHJPt`PAIjj@@	eMbA@Dg`@	gJPh@l@ILmP@								3
=jtSzy5y5GC:BsRXNHuMxPVNfE10HP2U8DJFdo8440a0eO0d01JlG8hWGH3W399V8FK4305l@H110VcFV	CHEMBL1215552	fmwHa@OAkOIPQBiCHhhdhmELheKeLf\lFZxBBjVzfjeJaR`@	COC(=O)C1=C(Cn2ccnc2)NC(C)=C(C#N)C1c1ccc(F)cc1Cl	5.41	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor LBD expressed in human HUH7 cells coexpressing GAL4 by luciferase reporter gene assay	2010	fde@@@LdbbRRfNbWERLFMUUUUUU@@@	fdep@@@XxeJ{JoJxHkPXmMSS@AQAU@@	386.813	2.5079	6	1	79.94	5	1.0089010684896569	0.5865949008184701	0.21335429749179433	5	1	fmwHa@OAkOIPQBiCHhhdhmELheKeLf\lFZxBBjVzfjeJaR`@											1
>xxzy5y5GhzyBswXNHurxPkNfE10HH2U8DJFdo845F60et0d01JlG8hWGH3W399W8FK4305l8H110WcFV	CHEMBL1215620	fmwHa@OAkwIPQBiCHhhdhmELheKeLf\lFZxBBjVzfjeJaR`@	COC(=O)C1=C(Cn2cccn2)NC(C)=C(C#N)C1c1ccc(F)cc1Cl	6.1	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor LBD expressed in human HUH7 cells coexpressing GAL4 by luciferase reporter gene assay	2010	fde@@@LdbbRRfNbWERLFMUUUUUU@@@	fdep@@@PxeLJoJxhkPXsUSS@@qAU@@	386.813	2.2772	6	1	79.94	5	1.0197556177127416	0.7252798716003039	0.21215201382308382	5	1	fmwHa@OAkwIPQBiCHhhdhmELheKeLf\lFZxBBjVzfjeJaR`@											1
>xxzy5y5Gh:BswXNHurxPkNfE10HH2U8DJFdo845Fa0et0d01JlG8hWGH3W399W8FK4305l@H110WcFV	CHEMBL1215621	fmwha@OAku^R`bERFQQQIQZJYQJWJYLyXLupDETmuMUJUBe@@	COC(=O)C1=C(Cn2cncn2)NC(C)=C(C#N)C1c1ccc(F)cc1Cl	5.34	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor LBD expressed in human HUH7 cells coexpressing GAL4 by luciferase reporter gene assay	2010	fde@@@LdbbRRfNbWERLFMUUUUUU@@@	fdeH@@@PiqJY~U^UqQV`qfjff@AbBj@@	387.801	2.1535	7	1	92.83	5	1.4828899231647061	1.0113812423838469	0.33448878813393285	5	1	fmwha@OAku^R`bERFQQQIQZJYQJWJYLyXLupDETmuMUJUBe@@											1
>xxzy5y5Gh:BswXNHurxPkNfE10HH2U8DJFdo845Fa0et0d01JlG8hWGH3W399W8FK4305l@H110WcFV	CHEMBL1215622	fmwXa@OAkvZ|eADJdLbbbRbtTrbTnTrYrpYk`HJi[jZjTjEJ@@	COC(=O)C1=C(Cn2cnnn2)NC(C)=C(C#N)C1c1ccc(F)cc1Cl	5.57	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor LBD expressed in human HUH7 cells coexpressing GAL4 by luciferase reporter gene assay	2010	fde@@@LdbbRRfNbWERLFMUUUUUU@@@	fdeh@@@PQcbTklj|k`bmAbtuML@EDET@@	388.789	2.007	8	1	105.72	5	1.9470969895767452	1.3111889237055914	0.4567067401006919	5	1	fmwXa@OAkvZ|eADJdLbbbRbtTrbTnTrYrpYk`HJi[jZjTjEJ@@											1
>xxzy5y5Gh:BswXNHurxPkNfE10HH2U8DJFdo845Fa0et0d01JlG8hWGH3W399W8FK4305l@H110WcFV	CHEMBL1215623	fmwXa@OAkvZ|eADJdLbbbRbtTrbTnTrYrpYk`HJi[jZjTjED@	COC(=O)C1=C(Cn2cnnn2)NC(C)=C(C#N)[C@H]1c1ccc(F)cc1Cl	6.52	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor LBD expressed in human HUH7 cells coexpressing GAL4 by luciferase reporter gene assay	2010	fde@@@LdbbRRfNbWERLFMUUUUUU@@@	fdeh@@@PQcbTklj|k`bmAbtuML@EDEP@	388.789	2.007	8	1	105.72	5	1.9470969895767452	1.3111889237055914	0.4567067401006919	5	1	fmwXa@OAkvZ|eADJdLbbbRbtTrbTnTrYrpYk`HJi[jZjTjED@											1
qFuJ64918F0F01240N010N0H%22!HFV50V$960V!20V#4!1816l0c3F#c44&410a0I0	CHEMBL121626	fdy`b@N^BBHrJJIPzJIQLDzLADPPL@@@	Cc1c(Cl)cccc1Nc1ccccc1C(=O)O	4.33	group4-ia	ia	Androgen Receptor	Activity at androgen receptor ligand binding domain assessed as inhibition of SRC2-3 interaction after 2 hrs by fluorescence polarization assay	2007	dk\@@DjU^ukmNjjjj`@	dk^@@@RfYU\]Tz@@@@@@	261.707	3.625	3	2	49.33	3	-0.9701782361473242	0.019666494257504927	-1.4691730386322903	60	1	fdy`b@N^BBHrJJIPzJIQLDzLADPPL@@@											1
;j;erUyvtyxN0fzuUjr1yOpfewFGwtlUssGXgBOgS0TUooc70k8kF@680FL5X4V01Q1c081!V0V20X0G0	CHEMBL1253831	ec`XD@@D@MlbbRdtLbRLrTfVuGFc`TQUTrsTuUUUUUUUSBDIaRKR^RIYIY@@	C[C@@]1([C@H]2CC[C@H]3[C@@H]4CC=C5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@@]32C)CC=CC(=O)N1	5.52	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor expressed in human CV1 cells assessed as inhibition of receptor-mediated transactivation by MMTV-luciferase reporter gene assay	2010	fag@@@LdbbbTRervbRgIBMiw`u[UUUUUUUUU@@@	faga@@D@RYV{e^umZ\TYwdy[ujZjjjjjjfHqJeiy@@	383.574	4.0223	3	2	49.33	1	-0.6641717216631406	-0.42944300774038213	-1.318786623216679	2	2	ec`XD@@D@MlbbRdtLbRLrTfVuGFc`TQUTrsTuUUUUUUUSBDIaRKR^RIYIY@@											1
:UfzvzerSyvtyts0fUuUfr1UOpfeoFGwtlU8sGXgBOgC4TUoo870k8kF@680FL1X4!8Q0c081$V20V0F0	CHEMBL1253832	ec`XD@@D@MlbbRdtLbRLrTfVuGFc`TQUTrsTuUUUUUMMU\DIaRKR^RIYH@	C[C@@]1([C@H]2CC[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@H]4CC[C@@]32C)CC=CC(=O)N1	6.3	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in human CV1 cells assessed as inhibition of receptor-mediated transactivation by MMTV-luciferase reporter gene assay	2010	fiw@@@LdbbbTRaJRLRTxhQmN|EoZjjjjjjjjj@@	fiw``@D@FdrmwJ}kZ}NJL{r\mzuMUUUUSSUQFITmOH@	381.558	4.166	3	1	46.17	1	-1.00845833074924	-0.5176544825112428	-0.242674338622621	2	1	ec`XD@@D@MlbbRdtLbRLrTfVuGFc`TQUTrsTuUUUUUMMU\DIaRKR^RIYH@											1
;j;erUyvtyxN0fzuUjr1yOpfewFGwtlUssGXgBOgS0TUooc70k8kF@680FL5X4V01Q1c081!V0V20X0G0	CHEMBL1254922	ec`XD@@D@MlbbRdtLbRLrTfVuGFc`TQUTrsTuUUUUUUUSBDQaRKR^RIYIY@@	C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2[C@@]1(C)CC=CC(=O)N1	5.7	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor expressed in human CV1 cells assessed as inhibition of receptor-mediated transactivation by MMTV-luciferase reporter gene assay	2010	fag@@@LdbbbTRervbRgIBMiw`u[UUUUUUUUU@@@	faga@@D@RYV{e^umZ\TYwdy[ujZjjjjjjfHqJeiy@@	383.574	4.0223	3	2	49.33	1	-0.6641717216631406	-0.42944300774038213	-1.318786623216679	2	2	ec`XD@@D@MlbbRdtLbRLrTfVuGFc`TQUTrsTuUUUUUUUSBDQaRKR^RIYIY@@											1
:UfzvzerSyvtyts4fUuUfr1UOpfeoFGwvlU8sGXgBOgC4Tzoo870k8kFA681GL1X4!8Q0c081!V0V20V0F0	CHEMBL1255008	ec`XD@@D@MlbbRdtLbRLrTfVuGFc`TQUTrsTuUUUUUUMS\DQaRKR^RIYH@	C[C@]12CC[C@H]3[C@@H](CC=C4CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2[C@@]1(C)CC=CC(=O)N1	5.7	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor expressed in human CV1 cells assessed as inhibition of receptor-mediated transactivation by MMTV-luciferase reporter gene assay	2010	fiw@@@LdbbbTRaJRLRTxhQmN|EoZjjjjjjjjj@@	fiw``@D@FdrmwJ}kZ}NJL{r\mzuMUUUUUSTqFITmOH@	381.558	4.166	3	1	46.17	1	-1.00845833074924	-0.5176544825112428	-0.242674338622621	2	1	ec`XD@@D@MlbbRdtLbRLrTfVuGFc`TQUTrsTuUUUUUUMS\DQaRKR^RIYH@											1
:UvUtOrdJ7wVLQzUwHWHOvy6B8K1XB1ZMvpE4YVIAVO6cWXDHobo70CCg2fkElmVs5dXYmbN!VGGFb0VY8F0	CHEMBL1274	ff}pSBNVbkPT`dDRFICdz{HiCEDheXhiYHt\uPPLULuD@@	CC1(C)NC(=O)N(c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)C1=O	8.05	group1-p	p	Androgen Receptor	Inhibition of [3H]mibolerone binding to human Androgen receptor of PC3/AR Cell Lysate	2004	dk\@@DjYVYxqVjjjj`@	dk]D@DpIRYeg^ftvj`PH@@	317.222	1.1818	7	1	95.23	3	0.8784538250305765	2.116498220256988	0.16718314381890984	33	14	fhiP``AFuX@RRA|xa|TfYwf[v\LzB@jYjH@@		eMBH@RZ@	gJPBAHJPt`PAIjj@@	gChhhE`BRnRYh@							14
zvyziyznjEve9czYkAz@hj_1rSoXTw9GFuFSwtW2i9tZJ4@RNxPE0o2NF0881K2K2011cs4402!19N#2V10	CHEMBL1276308	e`RXD@@M`IlbbRfRfbTRRTRtNTUCDfcdQPuWSSTuUAPUEWUTUBdtcdbeR@@	CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C	7.64	group2-a	a	Androgen Receptor	Inhibition of human lymph node carcinoma of prostate (LNCaP) cell proliferation	2004	fag@@@LdbbbbbTRrRJHcR]xjVykUUUUUUUUU@@@	fagA@@@ILkZwKJjmFRtzI^uZtuMUPTEEQXUMQt@@	429.602	5.7109	3	1	40.54	2	-0.7601530590806731	-1.786651708232001	-0.14379127574366207	15	5	fmAA@E`|^nNQQIYQQJJJJIZ[tX[pRuft\@ESUUSUTeTSbtcSt@@	gJQHA@AIVn@@	gChHA`BOT@@									4
<f;jUyz9yjTPCzdiU4PX8opjvz10IHx_Om2n9GOTXG3DffX86bSt0e01Sv10E165jFTJ485F0Z_F4X8GV	CHEMBL1288321	fbmaB`ANADDbHrBYCLadTTVRRRTadYrRkA``JjjjahFH@@	OC1(C(F)(F)F)CCCc2c1[nH]c1cc(Cl)c(Cl)cc21	7.57	group2-a	a	Androgen Receptor	Binding affinity to androgen receptor by fluorescence binding assay	2010	dk|@@LdbbbRQKauSjjjjj@@	dk~@@@RfYU_JGUN`XJJH@@	324.128	4.2727	2	2	36.02	1	-1.4478731513802794	-0.5780102871702114	-1.5377238297996303	25	21	fde`B`N@BR^MgDLQFARYgmUgVBdiwjjihHJ`@@		gGQBJIARFdB@YEHZj@@		eFABH`BL@							7
<f;jUyz9yjTPCzdiU4PX8opjvy10IHx_Om2n9GOTXG3DffX84bSt0X01Sv10E165jNTJ485F0Z_F4X8GV	CHEMBL1288322	fbmaB`INADDbHrBYCLadTTTrTJTadXJRkA``bZjjbhFH@@	OC1(C(F)(F)F)CCCc2c1[nH]c1ccc(Cl)c(Cl)c21	7.02	group2-a	a	Androgen Receptor	Binding affinity to androgen receptor by fluorescence binding assay	2010	dk|@@LdbbbRQKauSjjjjj@@	dk~@@@RfYU_JGUN`XJJH@@	324.128	4.2727	2	2	36.02	1	-1.4478731513802794	-0.5780102871702114	-1.5377238297996303	25	21	fde`B`N@BR^MgGtQFArJJKSIIQRlEIS`uUSPQE@@@		gGQBJIARFdB@YEHZj@@		eFABH`BL@							4
<f;jTiz1qjTP9rdaU4PX8Fpfvy10IHx_9m2n9GtDXG3Dff284bSt0X01Kv10E165jNTJ485F0ZWG4X8GV	CHEMBL1288323	fluaB`BVADJb@rDYALadTTRTRQdLcI\D[tDEEUUPtMD@@	OC1(C(F)(F)F)CCc2c1[nH]c1c(Cl)cc(Cl)cc21	7.89	group2-a	a	Androgen Receptor	Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.	2015	dc\@@DjYeTnGYVjjjj`@	dc^@@@RfYU\h]eZA`hb@@	310.102	3.9307	2	2	36.02	1	-1.5056453841391968	-0.32040485451764633	-1.5625856899180404	3	3	fluaB`BVADJb@rDYALadTTRTRQdLcI\D[tDEEUUPtMD@@											1
LFuF20918F$24F8010N0H%20202HV50V03#6$2%61#94W!1F20Zc6)10X4GV	CHEMBL1288956	foQaB@AVAbILk[ZuFBdYt@E@DD@@@	Oc1cccc2c1[nH]c1ccc(Br)cc12	5.85	group4-ia	ia	Androgen Receptor	Binding affinity to androgen receptor by fluorescence binding assay	2010	dk|@@LdbbbRQKauSjjjjj@@	dk~@@@RfYU_JGUN`@@B@@@	262.106	3.3954	2	2	36.02	0	-1.891752144540468	0.3001978197578153	-1.6704590500700192	25	4	f`iaA@ILAx~\TfUg[UirRkN`BJ@BH@@	eFACD`BL@										1
LFuF20918F$24F8010N0H%21202HV50V03#6$2%61#94W!1F20Zc6)10XVGV	CHEMBL1288957	f`iQ@@B^@dsJv{kI\DZtDE@AX@@@	N#Cc1ccc2[nH]c3c(O)cccc3c2c1	5.34	group4-ia	ia	Androgen Receptor	Binding affinity to androgen receptor by fluorescence binding assay	2010	dk|@@LdbbbRQKauSjjjjj@@	dk~@@@RfYU_JGUN`@@B@@@	208.22	2.5058	3	2	59.81	0	-1.5062445191342344	1.3301624762983	-1.6146628236699707	25	4	f`iaA@AVAx~\TfUmmYhpTcN`@h@bH@@		eMbA@Dg`@									1
LFuF20918F$24F8010N0H%23202HV50V03#6$20V02161#9BW!3F20Zc6(410X4GV	CHEMBL1288958	fhyaC@NDAb^b@qBSL}jjkARUYtDDT@T@@@	Oc1c(Br)ccc2c1[nH]c1cc(Cl)c(Cl)cc12	7.47	group2-a	a	Androgen Receptor	Binding affinity to androgen receptor by fluorescence binding assay	2010	dk|@@LdbbbRQKauSjjjjj@@	dk~@@@RfYU_JGUN`@@B@@@	330.996	4.6074	2	2	36.02	0	-1.5859899007618634	-0.6838597451562569	-1.5507854331034918	25	4	fdea@`INAxdb@nL\QIf]VugYrRk^``J@Hh`@@		eFABH`BL@									1
LFuF20918F$24F8010N0H%22202HV50V03#6$20V!161#9BW!3F20Zc6(410X0GV	CHEMBL1288959	f`iaA@INADDbLbbbfRaRcARU[tDDPAA@@@	Oc1cccc2c1[nH]c1ccc(Cl)c(Cl)c12	7.82	group2-a	a	Androgen Receptor	Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.	2015	dk|@@LdbbbRQKauSjjjjj@@	dk~@@@RfYU_JGUN`@@B@@@	252.1	3.8822	2	2	36.02	0	-1.9673496528350967	0.04466404849925182	-1.684386781720876	25	4	fhyaC@ILAxfbONJSJsmsuNRtxL@QPPPP@@	eFABH`BL@										1
<f;jUyz9yjTPCzdiU4PX8opjvy10IHx_Om2n9GOTXG3Dff284bSt0X01Kv10E165jNTJ485F0ZWG4X8GV	CHEMBL1288979	fbmaB`BVADJbHrBYCLadTTRTRQdVdYK`oA``hjjjahZH@@	OC1(C(F)(F)F)CCCc2c1[nH]c1c(Cl)cc(Cl)cc21	7.47	group2-a	a	Androgen Receptor	Binding affinity to androgen receptor by fluorescence binding assay	2010	dk|@@LdbbbRQKauSjjjjj@@	dk~@@@RfYU_JGUN`XJJH@@	324.128	4.2727	2	2	36.02	1	-1.4478731513802794	-0.5780102871702114	-1.5377238297996303	25	21	fhy`@`N@BR^MgDLCdTTVfRRbKART{uUTtDE@@@	eFABH`BL@	gGQBJIARFdB@YEHZj@@		eFABH`BL@							8
<f;jUyz9yjTPCzdiU4PX8opjvq10IHx_Om2l8GOTXG3DffX84bSs0X01Kv107165ENTJ481F0ZZG4X8GV	CHEMBL1288980	fbmaB`BVADZbHrBYCL`dsJvkWtpWI^CAAEUUUCPTP@	OC1(C(F)(F)F)CCCc2c1[nH]c1c(Cl)ccc(Cl)c21	7.07	group2-a	a	Androgen Receptor	Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.	2015	dk|@@LdbbbRQKauSjjjjj@@	dk~@@@RfYU_JGUN`XJJH@@	324.128	4.2727	2	2	36.02	1	-1.4478731513802794	-0.5780102871702114	-1.5377238297996303	25	21	fde`B`N@BR^MgGtQFArJJKSIIQRlEIS`uUSPQE@@@	eFABH`BL@	gGQBJIARFdB@YEHZj@@									4
<f;jUyz9yjTPCzdiU4PX8opjvy10IHx_Om2n9GOTXG3Dff284bSt0X01Kv10E165jNTJ485F0ZWG4X8GV	CHEMBL1288981	fbmaB`BVADJdHrBYCLadTTRTRQdVdYK`oA``hjjjahZH@@	OC1(C(F)(F)F)CCCc2c1[nH]c1c(Cl)cc(F)cc21	7.05	group2-a	a	Androgen Receptor	Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.	2015	dk|@@LdbbbRQKauSjjjjj@@	dk~@@@RfYU_JGUN`XJJH@@	307.673	3.7675	2	2	36.02	1	-1.5107582203169052	-0.213289898311964	-1.567433054596831	25	21	fhy`@`N@BR^MgDLCdTTVfRRbKART{uUTtDE@@@	eFABH`BL@	gGQBJIARFdB@YEHZj@@		eFABP`BL@							8
<f;jQqz9qiDPCy9aS4PX8kphAx!IHp_OX0Y9FOL211De9284aKt0V01Kn!C124_0TJ085F0ZW04XVGV	CHEMBL1289012	fhyQ@@JA@dtsmn{qPiV]USU@EpPaP@	CC1(O)CCCc2c1[nH]c1ccc(C#N)cc21	5.04	group4-ia	ia	Androgen Receptor	Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.	2015	dk|@@LdbbbRQKauSjjjjj@@	dk~@@@RfYU_JGUN`XJJH@@	226.278	2.412	3	2	59.81	0	-1.4067344514144189	1.3195855626980442	-1.5854375339798414	25	21	fhy`@`N@BR^MgDLCdTTVfRRbKART{uUTtDE@@@		eMJB@Df`@		eMbA@Dg`@							8
<f;jUyz9yjTPCzdiU4PX8opjvx10IHx_Om2n9GOTXG3Dff284aSt0X01Kv10C165jFTJ485F0ZWF4XcGV	CHEMBL1289013	fbmQC@AYhBPQHXdLbdLfbRfVVRkZLFMUUMT@WA@e@@	N#Cc1ccc2[nH]c3c(c2c1)CCCC3(O)C(F)(F)F	6.32	group3-int	int	Androgen Receptor	Binding affinity to androgen receptor by fluorescence binding assay	2010	dk|@@LdbbbRQKauSjjjjj@@	dk~@@@RfYU_JGUN`XJJH@@	280.248	2.8963	3	2	59.81	1	-0.9867680288971287	0.7074879973038632	-1.4679998705062165	25	21	fhy`@`N@BR^MgDLCdTTVfRRbKART{uUTtDE@@@		gGQBJIARFdB@YEHZj@@		eMbA@Dg`@							8
:UvztOzfJbwYLQzUwQWHOvyDB8K1mE5Z7vKE6YfH3VJ8sYeDFoblh3CBZ2YkCVXWu1lXbH_t10k1GFb0W1VV0	CHEMBL1289887	fcoIc@NRmmtu`bCAGPcHhhddXhimEBeMHpUoMGAAeSMT@PlP@@	CC1(C)C(=O)N(c2ccc(C#N)c(Cl)c2)C(=S)N1c1cccc(S(N)(=O)=O)c1	6.4	group3-int	int	Androgen Receptor	Antagonist activity at human AR expressed in human HeLa cells co-transfected with MMTV-Luc-Hyg after 48 hrs by transient-luciferase reporter gene assay	2010	flu@@@LdbbRbbsbRxXRhijjjjjjj@@	fluQB@DXT@HRYfY[]^gGQBejjA@@B@@@	434.927	2.5693	7	1	147.97	3	2.281288936747844	1.23277631185549	0.502341229697691	29	17	fakQA`AFB@IH`zBKNM_GlCdTTVVbbfrfRaYpsbm``JfjPBH`@@	eMBH@RZ@	eFABH`BL@	gJXdMD@``D^m@@	eMbA@Dg`@							16
:UvztOzfJbwYLQzUwQWH9vyDB8K1mC5Z7vKDDYfIAVR8sYeDFoblh2CBZ2YkEVXWs5tXbHbt10k1GFb0d1cV0	CHEMBL1289999	eohRLJ@LIGGhDL`@bpHvdCiBzPrRRqISSQRYFYJYRHQQsshYZ@Hiji@Bjl`@@	CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1cccc(S(N)(=O)=O)c1	7	group2-a	a	Androgen Receptor	Antagonist activity at AR in human bicalutamide-resistant LNCAP cells assessed as inhibition of cell proliferation after 6 days	2010	flu@@@LdbbRbbsbRxXRhijjjjjjj@@	fluQB@DXT@HRYfY[]^gGQBejjA@@B@@@	468.479	2.8116	7	1	147.97	4	2.6051167396378987	0.8418729931875462	0.584920279532493	29	17	fakQA`AFB@IH`zBKNM_GlCdTTVVbbfrfRaYpsbm``JfjPBH`@@	eMBH@RZ@	gJPBAHJPt`PAIjj@@	gJXdMD@``D^m@@	eMbA@Dg`@							16
:UvztOzfJbwYLQzUwQWHOvyDB8K1mE5Z7vKE6YfH3VJ8sYeDFoblh3CBo2YkCVXWu1lXbH_t10k1IFb0W1VVF	CHEMBL1290000	fcoic@NRmg[ikADFBNaFQQQIHqQSZJEJZQ`k^ZNBCJfZh@aX`@@	CC1(C)C(=O)N(c2ccc(C#N)c(Cl)c2)C(=S)N1c1cccc(S(N)(=O)=O)n1	6.22	group3-int	int	Androgen Receptor	Antagonist activity at human AR expressed in human HeLa cells co-transfected with MMTV-Luc-Hyg after 48 hrs by transient-luciferase reporter gene assay	2010	flu@@@LdbbRbbsbRxXRhijjjjjjj@@	fluqB@DXth@PdsLrvz}NNbEKUTB@@D@@@	435.915	2.0172	8	1	160.86	3	2.764579674773972	1.776409727974349	0.6224454147774883	29	4	fmwI``AFRnpy`|RNN`ahQdTTVrbbftTJTtcNF]WlDATsU@DKD@@@	eFABH`BL@	eMbA@Dg`@									2
:UvztOzfJbwYLQzUwQWH9vyDB8K1mC5Z7vKDDYfIAVR8sYeDFoblh2CBo2YkEVXWs5tXbHbt10k1IFb0d1cVF	CHEMBL1290098	eohZLJ@LJIGGhDL`@bpHvdCiBzPrRRqISSQRYFYJYRHQQsshYZ@Hiji@Bjl`@@	CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1cccc(S(N)(=O)=O)n1	6.16	group3-int	int	Androgen Receptor	Antagonist activity at human AR expressed in human HeLa cells co-transfected with MMTV-Luc-Hyg after 48 hrs by transient-luciferase reporter gene assay	2010	flu@@@LdbbRbbsbRxXRhijjjjjjj@@	fluqB@DXth@PdsLrvz}NNbEKUTB@@D@@@	469.467	2.2595	8	1	160.86	4	3.0884074776640267	1.385506409306405	0.7050244646122903	29	4	fmwI``AFRnpy`|RNN`ahQdTTVrbbftTJTtcNF]WlDATsU@DKD@@@	gJPBAHJPt`PAIjj@@	eMbA@Dg`@									2
:UvztOzfJbwYLQzUwQWH9vyDB8K1mC5Z7vKDDYfIAVR8sYeDFoblh2CBo2YkEVXWs5tXbHbt10k1GFb0d1cVF	CHEMBL1290099	eohZLJ@LJEGGhDL`@bpHvdCiBzPrRRqIKQQRYFYJYRHRQsshYZ@Biji@Bjl`@@	CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccnc(S(N)(=O)=O)c1	6	group3-int	int	Androgen Receptor	Antagonist activity at human AR expressed in human HeLa cells co-transfected with MMTV-Luc-Hyg after 48 hrs by transient-luciferase reporter gene assay	2010	flu@@@LdbbRbbsbRxXRhijjjjjjj@@	fluqB@DXRh@PdsLrvz}NNbEKUTB@@D@@@	469.467	1.9081	8	1	160.86	4	3.104941021333891	1.596750006221404	0.7031931578365179	29	1	eohZLJ@LJEGGhDL`@bpHvdCiBzPrRRqIKQQRYFYJYRHRQsshYZ@Biji@Bjl`@@											1
:UvztOzfJbwYLQzUwQWHOvyDB8K1mE5Z7vKE6YfH3VJ8sYeDFoblh3CBo2YkCVXWu1lXbH_t10k1GFb0W1VVF	CHEMBL1290206	fcoic@NRmW[ikADFBAaFQQQIHqQSZJEIZQ`k^[vBCJfZh@IX`@@	CC1(C)C(=O)N(c2ccc(C#N)c(Cl)c2)C(=S)N1c1cncc(S(N)(=O)=O)c1	5.7	group4-ia	ia	Androgen Receptor	Antagonist activity at human AR expressed in human HeLa cells co-transfected with MMTV-Luc-Hyg after 48 hrs by transient-luciferase reporter gene assay	2010	flu@@@LdbbRbbsbRxXRhijjjjjjj@@	fluqB@DX|h@PdsLrvz}NNbEKUTB@@D@@@	435.915	1.5684	8	1	160.86	3	2.7856959339985656	2.0462051596774256	0.6201065121581152	29	2	fcoic@NRmW[ik@xfBAaFQQQIHqQSZJEIZQ`k^[vBCJfZh@IX`@@	eFABH`BL@										2
:UvztOzfJbwYLQzUwQWH9vyDB8K1mC5Z7vKDDYfIAVR8sYeDFoblh2CBo2YkEVXWs5tXbHbt10k1GFb0d1cVF	CHEMBL1290207	eohZLJ@LNEGGhDL`@bpHvdCiBzPrRRqIKQQRYFYJYRHRQsshYZ@Biji@Bjl`@@	CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1cncc(S(N)(=O)=O)c1	7.52	group2-a	a	Androgen Receptor	Antagonist activity at AR in human bicalutamide-resistant LNCAP cells assessed as inhibition of cell proliferation after 6 days	2010	flu@@@LdbbRbbsbRxXRhijjjjjjj@@	fluqB@DX|h@PdsLrvz}NNbEKUTB@@D@@@	469.467	1.8107	8	1	160.86	4	3.10952373688862	1.6553018410094822	0.7026855619929173	29	2	fcoic@NRmW[ik@xfBAaFQQQIHqQSZJEIZQ`k^[vBCJfZh@IX`@@	gJPBAHJPt`PAIjj@@										2
<f;jUyz9yjTPCzdiU4Qa8opjvy10IHx_Om2n9GOyXG3Dff284_St0X01Kv10E161jNTJ485F0ZWG4X8GV	CHEMBL1290632	fj}aB`BVADJbHrBYCLadTTRTRQdVdSI\DDlDEEUUUCPtP@	OC1(C(F)(F)F)CCCCc2c1[nH]c1c(Cl)cc(Cl)cc21	6.22	group3-int	int	Androgen Receptor	Binding affinity to androgen receptor by fluorescence binding assay	2010	fgA@@@DjYeWR\U[Qjjjjjh@@	fgA`@@@ISLjnxhKQkTCAQTP@@	338.155	4.6147	2	2	36.02	1	-1.3900956263709277	-0.8356195977144145	-1.512860311305837	1	1	fj}aB`BVADJbHrBYCLadTTRTRQdVdSI\DDlDEEUUUCPtP@											1
<f;jUyz9yzTuEzdjU5PuNopjvz1FIHxbSn2rCISTXQ7DvfX86bStXe01Sv10EWL5jFTJ485F0Z_F4X8GV	CHEMBL1290633	fnsaC`ANADDbHrBY@laVP[HYEEEdddeHYKHsdeVCA@UUUUUCPLP@	OC1(C(F)(F)C(F)(F)F)CCCc2c1[nH]c1cc(Cl)c(Cl)cc21	7.47	group2-a	a	Androgen Receptor	Binding affinity to androgen receptor by fluorescence binding assay	2010	dk|@@LdbbbRQKauSjjjjj@@	dk~@@@RfYU_JGUN`XJJH@@	374.135	4.9817	2	2	36.02	2	-1.0593486828035772	-1.3104899911486616	-1.425636145247238	25	21	fde`B`N@BR^MgDLQFARYgmUgVBdiwjjihHJ`@@		diDHXABPRPrPjPZPx@rJPrFjj`@		eFABH`BL@							7
<f;jUyz9yjTuEzdiU5PmNopzvy10IHx_Om2rCGOTXG7Dff28JbSt2X01Kv10E165jNTJ485F0ZWG4X8GV	CHEMBL1290751	ffcaC`BVADJbHrBYCL`VPkHYEEDeDdYEhiFRxIpXHJJjjjahZH@@	OC1(C(F)(F)F)c2[nH]c3c(Cl)cc(Cl)cc3c2CCC1(F)F	7	group2-a	a	Androgen Receptor	Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.	2015	dk|@@LdbbbRQKauSjjjjj@@	dk~@@@RfYU_JGUN`XJJH@@	360.109	4.4119	2	2	36.02	1	-1.2649399584162513	-0.7951191104085056	-1.4777922498429985	25	21	fhy`@`N@BR^MgDLCdTTVfRRbKART{uUTtDE@@@	eFABH`BL@	gGQBJIARFdB@YEHZj@@	eMCBP`AdDf`@	eFABH`BL@							8
zqvG@GOl8k4kVFABFs0V0N2H040F1V92442V10VV1FV!FG!24V5VG24!V8B1#4120841V085!L0VX0G0	CHEMBL1302748	ffsP`@EZAQJ[g^UeUnBlyI\uhHBj`@@@@@@	COc1cc(C2Nc3cccc4cccc(c34)N2)ccc1O	4.48	group4-ia	ia	Androgen Receptor	Displacement of SRC2-3 peptide from human AR ligand binding site expressed in Escherichia coli BL21 by AF2 FP assay	2011	flm@@@LdbbbbVIbRXhViFbfjjjjjjj@@	flmP@@@TrQQQQZISIFgIV]DJZB`@@@H@@@	292.337	2.6078	4	3	53.52	2	-0.3312867708295478	0.7761028560958192	-2.4376937870743163	5	5	fjcPA@IJAxd\TfY}eYUYgCVceIXHBj`@@@@@@	eMJA@Hz@	eFJB@Hp@									5
xvojgyqXbEuu9cxVbAz@Cjp1rOwmPw4GFuFSux12gBUoJ4@RNo0E0F01F1281W252FcFcQ5G04F!4$2010	CHEMBL131	fewAP@@Vkv^QQISQJFKIQJVZcEF|EIVejjjjjijjxqBfhZ^`Xf@@	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO	4.47	group4-ia	ia	Androgen Receptor	Displacement of [3H]methyltrienolone from androgen receptor in human LNCaP cells after 1440 mins by scintillation counting method	2018	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmKUUUUUXDePt@@	360.448	1.1414	5	3	94.83	2	1.005606830291271	1.8289198856792748	-2.1395637930330955	50	1	fewAP@@Vkv^QQISQJFKIQJVZcEF|EIVejjjjjijjxqBfhZ^`Xf@@											1
:UvEvtl9R4uVJAyMcH9XO3HLRNld3C0VIHpE8Xc39kG4F1j0P92t60Cx2eV1C3I0S1ecr0b028408F214VVFV	CHEMBL131681	ffcQB@FNr@HrQQKZIJYRIFDihwduKp@UUMQ@@@	CC1(C)Nc2ccc(-c3csc(C#N)c3)cc2C(C)(C)C1=O	5.96	group4-ia	ia	Androgen Receptor	Cross-reactivity as binding to human androgen receptor (hAR)	2000	f`i@@@LdbbRRQfSA\d{uUUUUUP@@	f`iaB@C^@DIRoJvk`deV]Rp@USD@@	310.42	3.4038	3	1	81.13	1	-0.7849312925254375	0.460781321130188	-0.27471487029531605	2	1	ffcQB@FNr@HrQQKZIJYRIFDihwduKp@UUMQ@@@											1
uyPnHlOG8F4kVFA4FNH1VN2H!FF1390VHIo18Vc3Ok96FW!280C24Jp0Vc1B1GV9022bVa#4F!F!VVFV	CHEMBL131855	fj}PB@E^@DYHhhhedYeDXQakASTrE`TuTP@@	CC1=CC(C)(C)Nc2ccc(-c3sc(C#N)cc3C)cc21	6.7	group3-int	int	Androgen Receptor	Cross-reactivity as binding to human androgen receptor (hAR)	2000	foQ@@@LdbbRRlRXKdkNjjjjjh@@	foQ`B@C@BLdTRaRfRIRRkNjT@JZH@@	294.421	4.1586	2	1	64.06	1	-1.4240403648762205	-0.17970045254606526	-0.42910293188094495	7	3	fbm`A@G@\TAFQQIISISJHpeMF}Ffj@BfjR@@	eMbA@Dg`@										1
vzUQAQtl9R4mVJATHsH8XO1H640ld330VF2p30XV18FG0F1A0P1204!cHc!43302482Y8a%80604V8FF	CHEMBL131963	fnsP@`DAADFdKRCiCHhdhdhiDfeEJLUyNX@BBjJjhJDZ@@	Cc1c2c(cc3c(C(F)(F)F)cc(Cl)nc13)C(C)CC(C)(C)N2	6.17	group3-int	int	Androgen Receptor	Inhibitory concentration against human androgen receptor (AR) dependent transcriptional activity in co-transfected mammalian CV-1 cells	2000	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	342.791	5.1904	2	1	24.92	1	-1.847383130113772	-1.2664364006554711	-0.4437616133323037	70	59	fnsPC`DN@Dt`Y^NWDlaVP[HILlvmnl}LyjpXuUAA@AUT@@@	eFABH`BL@	eFBH@c@@	eMBH@RZ@								5
uyPnHlOG8F4kVFA4FNH1VN2H!FF1390VHIo18Vc3Ok96FW!280C24Jp0Vc0B1GV9022bVa#4F!F!VVFV	CHEMBL132193	fbmPB@NN@DYHhhmBeLhcBLt[tZf\@JZjH@@	CC1=CC(C)(C)Nc2ccc(-c3ccc(C#N)s3)cc21	5.96	group4-ia	ia	Androgen Receptor	Cross-reactivity as binding to human androgen receptor (hAR)	2000	foQ@@@LdbbRRlRXKdkNjjjjjh@@	foQ`B@C@BLdTRaRfRIRRkNjT@JZH@@	280.394	3.8147	2	1	64.06	1	-1.4817283352321713	0.07905090154305791	-0.45397630170997083	7	3	flu`A@K@\TAFQQIZIJYQFDhkS`tu@ASUI@@@	eMbA@Dg`@										2
vzUQAGtl9N4mVJ3BIsH8XO0H040Gd310VF2p10XV10FG0F010@1204!VFc!431!402Y0a(604V8FF	CHEMBL132205	fakPA`JIAHHdLRCiCt`FPrJPqIQIJQJiJBeZIZuP@DEQUTD@@	CC1(C)CCc2cc3c(C(F)(F)F)cc(C(F)(F)F)nc3cc2N1	6.33	group3-int	int	Androgen Receptor	Inhibitory concentration against human androgen receptor (AR) dependent transcriptional activity in co-transfected mammalian CV-1 cells	2000	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	348.289	4.3664	2	1	24.92	2	-1.6211227957649474	-0.912301909639235	-0.41290189299871266	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	gJPBAHJPt`PAIjj@@		eMBH@RZ@								49
:UvAltldN4mVJ3DHsH9XO0m040Gd310VFHp10Xc10FG0O110@1X044FcFc!431!402b0a8!2#604V8FF	CHEMBL132295	fegQ@`BE`@HCHQdDrFRSQIIQIIRYUIPRoY[uhHHJBhjjB`B`@	CCCC[S+]([O-])c1cc(C(F)(F)F)c2cc3c(cc2n1)NC(C)(C)CC3	6.47	group3-int	int	Androgen Receptor	Inhibitory concentration against human androgen receptor (AR) dependent transcriptional activity in co-transfected mammalian CV-1 cells	2000	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	384.465	4.4729	3	1	61.2	5	-0.1317007218457695	-1.085973839128131	-0.09360554126193282	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	gNqDH@c@BU^mUPT@		eMBH@RZ@								49
vzUQAGtn9N4mVL3BHsH8XO0H040Gd310VF2p10Xc10FG0F11B@1X04!VFc!431!402Y0aF&604V8FF	CHEMBL132354	fegPC`LE@DBdIRBi@LaFPSHYHhdeHhjeHeTeNZ}eoZBBhHJbjhH@@	CC1(C)CCc2cc3c(C(F)(F)F)cc(SCC(F)(F)F)nc3cc2N1	6.05	group3-int	int	Androgen Receptor	Inhibitory concentration against human androgen receptor (AR) dependent transcriptional activity in co-transfected mammalian CV-1 cells	2000	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	394.382	5.02	2	1	50.22	4	-0.6851455186910257	-1.532206748452272	-0.21703711136052875	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	gNpJ@DH@LaYArBT}UU@@		eMBH@RZ@								49
yTur2K9G8k4kZFA4FNH5VN2H!FF1392VHHo58VV3Nk96FW!28V92JLpFWc1Dl1V9022bca40@4J!458V8FF	CHEMBL132363	egdTHH@Dja@ICHhdieDdeLeEDUEEPqIiYyeuM]@APPITpPUAD@PVH	CC1=CC(C)(C)Nc2ccc3c(c21)/C(=C/c1ncccc1C)Oc1ccc(F)cc1-3	6.69	group3-int	int	Androgen Receptor	Inhibition of human androgen receptor at 10e-12 to 10e-5 M	2003	fiw@@@LdbbbbbRrVtQVXXRgIcWhzjjjjjjjjj@@	fiwQ@@@y@eLsJksNk}NRlyI^mGPS@PDAHPA@HTP	398.48	5.4682	3	1	34.15	1	-1.173940817421386	-1.4513913889279306	-0.23863909954245419	10	1	egdTHH@Dja@ICHhdieDdeLeEDUEEPqIiYyeuM]@APPITpPUAD@PVH											1
vzUQAOtl9N5mVJAEHsI8XO0H640Gd310VF6p10XX1@FG0F010@G20B!VFc12431!482Y0a010F0146040c0F	CHEMBL132427	fnspC@EAbBPQHXdLbdLTRbVRRttdhsdyj`@@bzj``@@	CN1c2cc3nc(C#N)cc(C(F)(F)F)c3cc2CCC1(C)C	7.35	group2-a	a	Androgen Receptor	Inhibitory concentration against human androgen receptor (AR) dependent transcriptional activity in co-transfected mammalian CV-1 cells	2000	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	319.329	3.712	3	0	39.92	1	-1.6914146035661672	-0.04593655618492465	0.7233782355461498	70	59	fnsPC`DN@Dl`U^NWDlaVP[HYEEEEBeddhmIpQkAcUUA@@EUP@@@	eMbA@Dg`@		eMBH@RZ@								5
uTPI2G9G8F5kVFA5FNI1VN2H04FF1330VFHo18VX1@k96F#2N018!oFcc0411134@2YVa#FF106#80F	CHEMBL132516	fnsP@`D^ADZdCREiCHhdhdeHeUEEJLTzNX@BBhjfhH@@	CC1=CC(C)(C)N(C)c2cc3nc(Cl)cc(C(F)(F)F)c3cc21	6.47	group3-int	int	Androgen Receptor	Inhibitory concentration against human androgen receptor (AR) dependent transcriptional activity in co-transfected mammalian CV-1 cells	2000	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@jP`@@	340.775	4.4402	2	0	16.13	1	-2.240163239650828	-0.858578146308401	0.6133614203882588	70	9	fbmPA@NVAxj\\bbbTRrrbacNRtxL@@DTuTD@@	eFABH`BL@	gJPBAHJPt`PAIjj@@									2
vzUQAOtl9N5mVJAEHsI8XO02640Gd310VF6p10XX1@FG0F010@G20B!VFc12431!480Y0a010F014404080F	CHEMBL132609	fj}PC@E^AHHdLRFQRFJIQEIJZRTZpXuP@@EUTD@@	CN1c2cc3nccc(C(F)(F)F)c3cc2CCC1(C)C	6.14	group3-int	int	Androgen Receptor	Inhibitory concentration against human androgen receptor (AR) dependent transcriptional activity in co-transfected mammalian CV-1 cells	2000	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	294.319	3.8224	2	0	16.13	1	-2.4557412284749454	-0.31491544518725734	0.5336992471160348	70	59	fnsPC`DN@Dl`U^NWDlaVP[HYEEEEBeddhmIpQkAcUUA@@EUP@@@			eMBH@RZ@								5
:UQAGtl9N4mVJ3BHsH9XO0m040Gd310VFHp10Xc10FG0N010@1X04!VFc!431!402b0ac&604V8FF	CHEMBL132635	fakP``JI``@PzP}HAdLddLrTRRdRjR`iVbVjt@AATUUA@@@	CC1(C)CCc2cc3c(C(F)(F)F)cc(S(C)(=O)=O)nc3cc2N1	6.32	group3-int	int	Androgen Receptor	Inhibitory concentration against human androgen receptor (AR) dependent transcriptional activity in co-transfected mammalian CV-1 cells	2000	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	358.383	2.5635	4	1	67.44	2	-0.30967289298025524	0.6876746431222674	-0.1203663779724099	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	gJPdH`DD@cuh@		eMBH@RZ@								49
uTPI2G9G8F4kVFA4FNH1VN2H04FF1310VFHo18VV18k96F#2801#oFcc041101422YVa$F!6!V8FF	CHEMBL132803	ffcP@`D^AHZdCREiCHhdhdeHeThiQbgQS@@PUESTD@@	CC1=CC(C)(C)Nc2cc3nc(F)cc(C(F)(F)F)c3cc21	7.51	group2-a	a	Androgen Receptor	Inhibitory concentration against human androgen receptor (AR) dependent transcriptional activity in co-transfected mammalian CV-1 cells	2000	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@jP`@@	310.293	3.8307	2	1	24.92	1	-1.9545489124875979	-0.328541994674701	-0.5043225095560211	70	9	fluPA@NVAxj\\bbbTRrrbLYrVgA`@@bfjB@@	eFABP`BL@	gJPBAHJPt`PAIjj@@									4
:UvUvtl9R4uVJAyMsH9XO3HLRNld3C0VIIpE8Xc3OkG0FWj0P92x64Sx2XV1C3IVS1eer0b028408FH14VVFV	CHEMBL132889	fnsQB@E^J@HrQQQQKHsJQHpcCVCfidK@jjZb@@	Cc1cc(C#N)sc1-c1ccc2c(c1)C(C)(C)C(=O)C(C)(C)N2	6.82	group3-int	int	Androgen Receptor	Cross-reactivity as binding to human androgen receptor (hAR)	2000	f`i@@@LdbbRRQfSA\d{uUUUUUP@@	f`iaB@C^@DYHheBeLdbTdjsje@BjX`@@	324.447	3.9868	3	1	81.13	1	-0.738493093801051	0.05829537079382863	-0.2485954407330506	2	1	fnsQB@E^J@HrQQQQKHsJQHpcCVCfidK@jjZb@@											1
vzUQAQtl9R4mVJATHsH8XO1H640ld310VF2p30XV18FG0F1A0P1204!cHc!433!480Y8a%80604V8FF	CHEMBL133054	ffcPC@EAAHHdLRFQRFJIQFIZHrRcVcfj@@@jjhJGj@@	Cc1c2c(cc3c(C(F)(F)F)ccnc13)C(C)CC(C)(C)N2	6.61	group3-int	int	Androgen Receptor	Inhibitory concentration against human androgen receptor (AR) dependent transcriptional activity in co-transfected mammalian CV-1 cells	2000	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	308.346	4.487	2	1	24.92	1	-1.9956813645194775	-0.7158557532540706	-0.504105968685529	70	59	fnsPC`DN@Dt`Y^NWDlaVP[HILlvmnl}LyjpXuUAA@AUT@@@		eFBH@c@@	eMBH@RZ@								5
vzUQAOtl9N5mVJAEHsI8XO0H640Gd310VF6p10XX1@FG0F010@G20B!VFc12431!482Y0a010F0146040B0F	CHEMBL133167	ffcP@`D^AbZdCREiCHhdhdeHeUDiQbgQs@@PUEUTD@@	CN1c2cc3nc(Br)cc(C(F)(F)F)c3cc2CCC1(C)C	7.14	group2-a	a	Androgen Receptor	Inhibitory concentration against human androgen receptor (AR) dependent transcriptional activity in co-transfected mammalian CV-1 cells	2000	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	373.215	4.645	2	0	16.13	1	-2.0789641919564414	-1.1019910736308436	0.6678081915770195	70	59	fnsPC`DN@Dl`U^NWDlaVP[HYEEEEBeddhmIpQkAcUUA@@EUP@@@	eFACD`BL@		eMBH@RZ@								5
vzUQAOtl9N5mVJAEHsI8XO0H640Gd330VF6p10XX1@FG0F010@G20B!VFc1243102482Y0a010F014604080F	CHEMBL133289	ffcP@`D^ADZdCREiCHhdhdeHeUDiQbgQs@@PUEUTD@@	CN1c2cc3nc(Cl)cc(C(F)(F)F)c3cc2CCC1(C)C	6.6	group3-int	int	Androgen Receptor	Inhibitory concentration against human androgen receptor (AR) dependent transcriptional activity in co-transfected mammalian CV-1 cells	2000	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	328.764	4.5258	2	0	16.13	1	-2.307442833358084	-0.8654962057573448	0.5940436526854078	70	59	fnsPC`DN@Dl`U^NWDlaVP[HYEEEEBeddhmIpQkAcUUA@@EUP@@@	eFABH`BL@		eMBH@RZ@								5
vzUQAGtl9N4mVJ3BHsH8XO0H040Gd310VF2p10XV10FG0F010@1204!VFc!431!402Y0a%20605V8kF	CHEMBL133329	fj}pC@EVBBPQHXdLbdLTRbVVRtdhshij`@@bjhH@@	CC1(C)CCc2cc3c(C(F)(F)F)cc(N)nc3cc2N1	5.94	group4-ia	ia	Androgen Receptor	Inhibitory concentration against human androgen receptor (AR) dependent transcriptional activity in co-transfected mammalian CV-1 cells	2000	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	295.307	3.1382	3	2	50.94	1	-1.0615096499263963	0.4411633996476564	-1.46453777060064	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFbB@Hp@		eMBH@RZ@								49
uTPI2G9G8F4kVFA4FNH1VN2H04FF1330VFHo18VV18k96F#2801#oFcc041103422YVa$F!6!V8FF	CHEMBL133331	ffcP@`D^ADZdCREiCHhdhdeHeThiQbgQS@@PUESTD@@	CC1=CC(C)(C)Nc2cc3nc(Cl)cc(C(F)(F)F)c3cc21	7.52	group2-a	a	Androgen Receptor	Inhibitory concentration against human androgen receptor (AR) dependent transcriptional activity in co-transfected mammalian CV-1 cells	2000	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@jP`@@	326.748	4.0819	2	1	24.92	1	-1.8797130322624045	-0.5405708363934876	-0.4759369938272291	70	9	fluPA@NVAxj\\bbbTRrrbLYrVgA`@@bfjB@@	eFABH`BL@	gJPBAHJPt`PAIjj@@									4
vzUQAOtl9N5mVJAEHsI8XO0H640Gd310VF6p10XX1@FG0F010@G20B!VFc12431!482Y0a010F014604080F	CHEMBL133465	ffcP@`D^AHZdCREiCHhdhdeHeUDiQbgQs@@PUEUTD@@	CN1c2cc3nc(F)cc(C(F)(F)F)c3cc2CCC1(C)C	6.76	group3-int	int	Androgen Receptor	Inhibitory concentration against human androgen receptor (AR) dependent transcriptional activity in co-transfected mammalian CV-1 cells	2000	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	312.309	4.2746	2	0	16.13	1	-2.3822788742944336	-0.6534672508698713	0.565658086740468	70	59	fnsPC`DN@Dl`U^NWDlaVP[HYEEEEBeddhmIpQkAcUUA@@EUP@@@	eFABP`BL@		eMBH@RZ@								5
vzUQAGtl9N4mVJ3BHsH8XO0H040Gd310VF2p10XV10FG0F010@1204!VFc!431!402Y0a(604V8FF	CHEMBL133503	fj}P@`D^AHZdCREiCHhdhdeHeTeJLTzJX@BBhjjB@@	CC1(C)CCc2cc3c(C(F)(F)F)cc(F)nc3cc2N1	7.66	group2-a	a	Androgen Receptor	Inhibitory concentration against human androgen receptor (AR) dependent transcriptional activity in co-transfected mammalian CV-1 cells	2000	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	298.282	3.9163	2	1	24.92	1	-2.0218284949771426	-0.3354599107986713	-0.5236402785013806	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFABP`BL@		eMBH@RZ@								49
:UnIlOKdF4wVFADPRHWVN2uV0FF93C0ZHIo18Xc3Oo96OW!Y80CX4Jp0Vd0B1GV9023bVa1!6F!G!Y0FV	CHEMBL133656	fj}PbBL^xH@QbQ]dbbbfeRfTQaFFlEMSK@ASUQ@@@	CC1=CC(C)(C)Nc2ccc(-c3ccc([N+](=O)[O-])s3)cc21	5.84	group4-ia	ia	Androgen Receptor	Cross-reactivity as binding to human androgen receptor (hAR)	2000	foQ@@@LdbbRRlRXKdkNjjjjjh@@	foQ`B@C@BLdTRaRfRIRRkNjT@JZH@@	300.381	3.1649	4	1	86.09	2	-0.3434546874898988	0.6780347230167946	-0.16520134091633148	7	3	flu`A@K@\TAFQQIZIJYQFDhkS`tu@ASUI@@@	gChhhE`BRnRYh@										2
vzUQAGtl9N4mVJ3DHsH8XO0H040Gd310VF2p10Xc10FG0F110@1X04!cFc!431!402Y0a(604V8FF	CHEMBL133715	fi{P@`LY@D^d@rDYCIEDdeDdeIeTeNR\fkZBBB`jJj``@@	CCCCSc1cc(C(F)(F)F)c2cc3c(cc2n1)NC(C)(C)CC3	5.73	group4-ia	ia	Androgen Receptor	Inhibitory concentration against human androgen receptor (AR) dependent transcriptional activity in co-transfected mammalian CV-1 cells	2000	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	368.466	5.4445	2	1	50.22	5	-0.6830596251757989	-1.8121134764666424	-0.23136207952228116	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	gGPD@DH@RgZj@@		eMBH@RZ@								49
vzUQAGtl9N4mVJ3BHsH8XO0H040Gd330VF2p10XV10FG0F010@1204!VFc!43102402Y0a(604V8FF	CHEMBL133792	fj}P@`D^ADZdCREiCHhdhdeHeTeJLTzJX@BBhjjB@@	CC1(C)CCc2cc3c(C(F)(F)F)cc(Cl)nc3cc2N1	7.52	group2-a	a	Androgen Receptor	Inhibitory concentration against human androgen receptor (AR) dependent transcriptional activity in co-transfected mammalian CV-1 cells	2000	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	314.737	4.1675	2	1	24.92	1	-1.9469926035342375	-0.5474886091924842	-0.49525476401509727	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFABH`BL@		eMBH@RZ@								49
vzUQAQtl9R4mVJATHsH8XO1H640ld310VF2p30XV18FG0F1A0P1204!cHc!433!482Y8a%80604V8FF	CHEMBL133825	fnsP@`DAAHFdKRCiCHhdhdhiDfeEJLUyNX@BBjJjhJDZ@@	Cc1c2c(cc3c(C(F)(F)F)cc(F)nc13)C(C)CC(C)(C)N2	5.84	group4-ia	ia	Androgen Receptor	Inhibitory concentration against human androgen receptor (AR) dependent transcriptional activity in co-transfected mammalian CV-1 cells	2000	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	326.336	4.9392	2	1	24.92	1	-1.9222190103389654	-1.0544075589366848	-0.4721471290610958	70	59	fnsPC`DN@Dt`Y^NWDlaVP[HILlvmnl}LyjpXuUAA@AUT@@@	eFABP`BL@	eFBH@c@@	eMBH@RZ@								5
vzUQAQtl9R4mVJATHsH8XO1H640ld310VF2p30XV18FG0F1A0P1204!cHc!433!482Y8a%80604VBFF	CHEMBL134056	fnsP@`DAAbFdKRCiCHhdhdhiDfeEJLUyNX@BBjJjhJDZ@@	Cc1c2c(cc3c(C(F)(F)F)cc(Br)nc13)C(C)CC(C)(C)N2	6.11	group3-int	int	Androgen Receptor	Inhibitory concentration against human androgen receptor (AR) dependent transcriptional activity in co-transfected mammalian CV-1 cells	2000	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	387.242	5.3096	2	1	24.92	1	-1.6189043280009736	-1.5029313816976573	-0.3699970242245443	70	59	fnsPC`DN@Dt`Y^NWDlaVP[HILlvmnl}LyjpXuUAA@AUT@@@	eFACD`BL@	eFBH@c@@	eMBH@RZ@								5
;QAGtl9s4mVJ3BHsH8XO2H040Gd392VF2p10XV3FkG0F110@1X54F0VFc!43G!402Y0a0V#20L04V8FF	CHEMBL134117	egh\HL@EKHc`IABPpdLbdLTRbVRRRtTRNTbacbQRvuT@@DUUAPEA@@@	COc1ccc(CNc2cc(C(F)(F)F)c3cc4c(cc3n2)NC(C)(C)CC4)cc1	5.49	group4-ia	ia	Androgen Receptor	Inhibitory concentration against human androgen receptor (AR) dependent transcriptional activity in co-transfected mammalian CV-1 cells	2000	ffs@@@DjYUUu~UXKdk^KVjjjjjjjj@@	ffsp@@@XleLrjzrj}AJMDnZa@PDPTDA@@@	415.458	4.8106	4	2	46.18	5	0.2949203689933735	-1.4071126049144551	-1.0772584674288348	1	1	egh\HL@EKHc`IABPpdLbdLTRbVRRRtTRNTbacbQRvuT@@DUUAPEA@@@											1
vzUQAGtl9N4mVJ3BHsH8XO0H040Gd310VF2p10XV10FG0F010@1204!VFc!431!402Y0a(604VBFF	CHEMBL134140	fj}P@`D^AbZdCREiCHhdhdeHeTeJLTzJX@BBhjjB@@	CC1(C)CCc2cc3c(C(F)(F)F)cc(Br)nc3cc2N1	7.14	group2-a	a	Androgen Receptor	Inhibitory concentration against human androgen receptor (AR) dependent transcriptional activity in co-transfected mammalian CV-1 cells	2000	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	359.188	4.2867	2	1	24.92	1	-1.718513962132595	-0.7839834770659833	-0.42149022512348555	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFACD`BL@		eMBH@RZ@								49
:UvAGtl9N4mVJ3BHsH8XO2m040Gd310VH2p50Xc1FFG0O1W0@1X0404VFc!4Y1!402Y0aV!2020604W8FF	CHEMBL134180	fi{p``LLsA@@ct`FPcHYIH]DeDdiDjdiISduZmP@DEQUTD@@	CC1(C)CCc2cc3c(C(F)(F)F)cc(NS(C)(=O)=O)nc3cc2N1	6.3	group3-int	int	Androgen Receptor	Inhibitory concentration against human androgen receptor (AR) dependent transcriptional activity in co-transfected mammalian CV-1 cells	2000	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	373.398	2.8642	5	2	79.47	2	0.469613751417967	0.6464467607319059	-1.0616499486811712	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	gGXdMD@b`FRREZ`@		eMBH@RZ@								49
:UQAGtl9N4mVJ3BHsH9XO0m040Gd310VFHp10Xc10FG0N010@1X04!VFc!431!402b0a8&604V8FF	CHEMBL134209	fnsQ@`BQ`@HmHNdORFRSSIQIJQJiJ\DXNRm@@PUEUPT@T@@	C[S+]([O-])c1cc(C(F)(F)F)c2cc3c(cc2n1)NC(C)(C)CC3	7.2	group2-a	a	Androgen Receptor	Inhibitory concentration against human androgen receptor (AR) dependent transcriptional activity in co-transfected mammalian CV-1 cells	2000	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	342.384	3.0671	3	1	61.2	2	-0.7627748199124432	0.2776413056527956	-0.24849657815009715	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	gCaDH@c@D]jB`@		eMBH@RZ@								49
vzUQAGtl9N4mVJ3BHsH8XO0H040Gd310VF2p10Xc10FG0F010@1X04!VFc!431!402Y0a(604V8FF	CHEMBL134242	ffcP@`LA@DFdKRCiCIELeDdiDjdhsfoIsP@DEQUTD@@	CSc1cc(C(F)(F)F)c2cc3c(cc2n1)NC(C)(C)CC3	6.12	group3-int	int	Androgen Receptor	Inhibitory concentration against human androgen receptor (AR) dependent transcriptional activity in co-transfected mammalian CV-1 cells	2000	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	326.385	4.0387	2	1	50.22	2	-1.3141337232424726	-0.44849833168571596	-0.3862531164104455	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eMA@HPBN`@		eMBH@RZ@								49
vzUvQvtl9R4mVJATHsH9XO3H64FWd390VHIp38Xc3OkG0FWA0P92C64Jt2V01B3IV90@2a0a!84080H04VVFV	CHEMBL134260	fj}PB@E^@DYHhhhedYeDXQakASTrE`UUTTGT@@	Cc1cc(C#N)sc1-c1ccc2c(c1)C(C)CC(C)(C)N2	7.35	group2-a	a	Androgen Receptor	Cross-reactivity as binding to human androgen receptor (hAR)	2000	foQ@@@LdbbRRlRXKdkNjjjjjh@@	foQ`B@C@BLdTRaRfRIRRkNjT@JjH@@	296.437	4.9232	2	1	64.06	1	-1.44939844430125	-0.6468148060438992	-0.4218009199725369	7	1	fj}PB@E^@DYHhhhedYeDXQakASTrE`UUTTGT@@											1
yTur2M9G8k4kZFA4FNH5VN2H!FF1392VHHo58Vc3Nk96FW!28V92JLp0Wc1Dl1V9022bca40@4J!458V8FV	CHEMBL134277	ec`XHD@Ln@@bZPrQIYQJJJIIQSZjXDZFAEI]UCTlu@A@PqUTDAAP`	CC1=CC(C)(C)Nc2ccc3c(c21)/C(=C/c1ccsc1)Oc1ccc(F)cc1-3	6.67	group3-int	int	Androgen Receptor	Inhibition of human androgen receptor at 10e-12 to 10e-5 M	2003	fag@@@LdbbbbbRrVtQSCBTyLZm{UUUUUUUUU@@@	fagaB@L|@DIRnrsLjs~BZLDjVu{RsT@DABUA@aQ@	389.493	5.8556	2	1	49.5	1	-1.2373989884052934	-1.659206669214933	-0.300881072199612	2	1	ec`XHD@Ln@@bZPrQIYQJJJIIQSZjXDZFAEI]UCTlu@A@PqUTDAAP`											1
:UvQltl9N5mVJABIsH8XO@m040GdY10VH2p50Xc1FFG0O1W0@GX0404ZFc!4Y1!41XY0aV!203F604W8FF	CHEMBL134303	fkpR`LJ{AGA@BJAFY@laVPrRPsRJUJIIRIUIRsdmfmZiX@BBhjjB@@	CC1(C)CCc2cc3c(C(F)(F)F)cc(N(S(C)(=O)=O)S(C)(=O)=O)nc3cc2N1	6.2	group3-int	int	Androgen Receptor	Inhibitory concentration against human androgen receptor (AR) dependent transcriptional activity in co-transfected mammalian CV-1 cells	2000	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	451.489	2.88	7	1	113.2	2	1.636116723016885	0.8503610376886473	0.4166014860731749	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	defBpLaND@b`a`CIICMHmTl@@		eMBH@RZ@								49
yTur2K9G8k4kZFA4FNH5VN2H!FF1392VHHo58VV3Nk96FW!28V92JLp0Wc1Dl1V9022bca40@4J!458V0F0	CHEMBL134421	ec`XH@@L`LdTTTRRVbbrbVNeGDecbQPwTuALA@PDpQPD@PTH	CC1=CC(C)(C)Nc2ccc3c(c21)/C(=C/c1ccccc1)Oc1ccccc1-3	6.19	group3-int	int	Androgen Receptor	Inhibitory activity (IC50) against human androgen receptor expressed in CV-1 cells	1998	fiw@@@LdbbbbbRrVtQVXXRgIcWhzjjjjjjjjj@@	fiwa@@L`RfYeUygU~gIV\doVchI`HB@dH@`DJH	365.475	5.9704	2	1	21.26	1	-1.823491129938445	-1.8462983281734215	-0.41168676050443154	10	9	ekhXHH@Ji@GGHhhdcDhhhdeEMgFNKGDfbinehBAj@B@abh``HND											2
yTur2K9G8k4kZFA4FNH5VN2H!FF1392VHHo58VV3Nk96FW!28V92JLp0Wc1Dl1V9022bca40@4J!458V8F0	CHEMBL134602	ekhXHH@Da@ICHhdieDdeLeEDThjFIMKOLnich@JBAJfBB`b@HKD	CC1=CC(C)(C)Nc2ccc3c(c21)/C(=C/c1ccccc1)Oc1ccc(F)cc1-3	6.19	group3-int	int	Androgen Receptor	Inhibition of human androgen receptor at 10e-12 to 10e-5 M	2003	fiw@@@LdbbbbbRrVtQVXXRgIcWhzjjjjjjjjj@@	fiwa@@L`RfYeUygU~gIV\doVchI`HB@dH@`DJH	383.465	6.0712	2	1	21.26	1	-1.7334952376969244	-1.973606608603523	-0.3815592270345163	10	9	egdXHD@Ji@GGZPrJJIHqJJJIIQSZjL\VNIMES]KPDCT@DACETPPDGB@											3
xvwUcTqnEEuX9cx6kAr@hj_HLJZXTz9HFs2Okt12_9OWFFAR8N050J28W0808F202!94F020X8418#R2010	CHEMBL135	fb}@`@@YRYVum[ehrRkNBf@BjjjjJjBRhZNPT@	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O	7.72	group2-a	a	Androgen Receptor	Binding affinity to androgen receptor	2007	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@LdbbTRrLrYKbcV|DHbbjjJlXWIj@@	272.387	3.8766	2	2	40.46	0	-1.7888389696927471	0.0053682782916947835	-1.6397324030220253	35	1	fb}@`@@YRYVum[ehrRkNBf@BjjjjJjBRhZNPT@											1
<MwOK9o4wZ1ATTNH_XRHT640F13914Lno70eVIOk9!1X1250120Bh0YV17lX48582bFa40840N0212VcF0	CHEMBL136322	ffcPb@IAcTDadTRTRtrTrdUirshe`BK@BjiB@@	CC1(C)OC(=O)Nc2ccc(-c3cc(F)cc(C#N)c3)cc21	5.89	group4-ia	ia	Androgen Receptor	Antagonist activity against the Androgen Receptor (AR)	2002	fhy@@@DjYU_mVRxKpZjjjjjh@@	fhy``@L@PdrjklkQde^BuT@P@@@@@	296.3	3.3076	4	1	62.12	1	-0.9157268746212766	0.552383559056422	-0.258293781743347	3	2	ffcPb@IAcTCcdTRTRtrTrdUirshe`BK@BjiB@@	eFABP`BL@										1
yTur2K9G8k4kZFA4FNH5VN2H!FF1392VHHo58VV3Nk96FW!28V92JLp0Wc1Dl1V9022bca40@4J!458V8F0	CHEMBL137103	egdXHD@Fe@IBRPrJJIKJYQQQIJJ[NL\N^Y]UKC[PDCU@A@PqTPPDGB@	CC1=CC(C)(C)Nc2ccc3c(c21)/C(=C/c1cc(F)ccc1F)Oc1ccccc1-3	5.8	group4-ia	ia	Androgen Receptor	Inhibitory activity (IC50) against human androgen receptor expressed in CV-1 cells	1998	fiw@@@LdbbbbbRrVtQVXXRgIcWhzjjjjjjjjj@@	fiwa@@L`RfYeUygU~gIV\doVchI`HB@dH@`DJH	401.455	6.172	2	1	21.26	1	-1.643499345455404	-2.100914889033625	-0.351431693564601	10	9	egdXHD@Fe@GFRPrJJIKJYQQQIJJ[NL\N^Y]UKC[PDCU@A@PqTPPDGB@	eFABP`BL@										1
vJPl2184804F0F04FN0W080X!F#1!HH05!81#41VV02808!40F!1#V102#4%2#1!VV	CHEMBL1372017	f`iPB@LD@DYHhbhdidlTUiwjY`@@H@@@	Nc1nc(-c2ccc3ccccc3c2)cs1	5.04	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay	2014	foQ@@@LdbbRRlRXKdkNjjjjjh@@	foQ`B@L@BDi]e[WAIJlze`@@H@@@	226.302	3.5522	2	1	67.15	1	-1.7045369070549468	0.46010809654840956	-0.5364864099073571	7	2	f`i`A@L@\TABSKlkZdhkSoTu@@@H@@@	eFbB@Hp@										2
<MyOK9o4wZ1ATTNH_XRHT64FF13914Lno78eVIOk9401X12C0920Bx0fV1Elm495@2bFa40840N0212VVFV	CHEMBL138059	fbmQ`@LY@`NQQIRIEYQKJcMFCEjj`BZ[B@@	CC1(C)OC(=O)Nc2ccc(-c3coc(C#N)c3)cc21	6.89	group3-int	int	Androgen Receptor	Antagonist activity against the Androgen Receptor (AR)	2002	f`i@@@DjYU_mYK`g^jjjjjj@@	f`ia`@L@PyIeUWYZLdiwfj`BZP`@@	268.271	2.3955	5	1	75.26	1	-0.5642857605271985	1.4218684163703166	-0.1871763265902068	4	1	fbmQ`@LY@`NQQIRIEYQKJcMFCEjj`BZ[B@@											1
zrzxvdUExpzxMH8OUUBl3A8d48F48Vlc6PN073FC0832Z1VV6XN0B2040FFN1182k102#J!V!2!V!80V	CHEMBL1391700	fdeQA@LDl@HcHISOJl{~JJmxMLuTDAT@@@	Fc1ccc(-c2csc(N3CCOCC3)n2)cc1	6.19	group3-int	int	Androgen Receptor	Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay	2014	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyQB@LDl@HRf^UYwqQUoAifj``J@@@	264.323	2.8049	3	0	53.6	2	-1.5598428026782272	0.6828664734445369	0.6890679423121048	42	18	ffcQA`MAj@IIxlPUPKgGpQdTTTtraTQbRyJwbu`bHiZjjJ@@					eFABP`BL@						16
:xjxyyirjyjzfxsijziUjp5ztpePwFpMsFSsuSuggOoS4PTxoeE2k8FHV084F6h60V09Q1VF0GVcV308%	CHEMBL1393	ekhPBH@LNic`@cIEECDhheDhdcCeiECHdbjfemjZjjijjjffjnDIPnHIEDXdd@@	CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@@H]21	6.28	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor	2010	fn{@@@LddTRRRLJTrVhKdmVCDmZjjjjjjjj`@@	fn{A`@@IZdrmkZvmkQdeV\FIZmMUUUUUMUDDePtB`@	416.58	3.2098	4	0	85.74	2	-0.015355374230488605	0.23145086239580556	1.11206938745489	14	1	ekhPBH@LNic`@cIEECDhheDhdcCeiECHdbjfemjZjjijjjffjnDIPnHIEDXdd@@											1
<MyOK9o4wZ1ATTNH_XRHT64FF13914Lno78ecIOk9401X12C0920Bx0fV1Elm495@2bFa40840N0212VVFV	CHEMBL139749	fbmPb@FN}d@QdbbVtRTrdUISQoIjW`@jjX`@@	CC1(C)OC(=O)Nc2ccc(-c3csc(C#N)c3)cc21	6.55	group3-int	int	Androgen Receptor	Antagonist activity against the Androgen Receptor (AR)	2002	f`i@@@DjYU_mYK`g^jjjjjj@@	f`i`b@CV|@HRe^Um_AIJlze`@jfH@@	284.338	3.0734	4	1	90.36	1	-0.5134940396927409	0.9446773551116485	-0.20731477333329923	4	1	fbmPb@FN}d@QdbbVtRTrdUISQoIjW`@jjX`@@											1
:xjxyyirjyzxfxsWjzDUjr1zsxuPwLlHsGSltOmwgxgS4@Thq@78k8FLW2c0FL9aH808Q0WF4G0F49$F!	CHEMBL139835	ekhPBH@CFim`HcHhhdiDheh]EhUEFAIKKO@dljjVjjZjjjfZjaJHpaEHmIY@ee@@	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C	7.64	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	fl}@@@LdbbbbbUaRyhTaVLzJZjjjjjjj@@	fl}A@@@YEDhhTddieQeAJt{tTmMTuUUUUSDheKRm@@	416.943	3.7275	4	0	60.44	3	-0.28618564535563584	-0.38751415163723085	1.077072548966646	2	1	ekhPBH@CFim`HcHhhdiDheh]EhUEFAIKKO@dljjVjjZjjjfZjaJHpaEHmIY@ee@@											1
uJPl218G804F0F!FN01082V!F#1!HF05!80FV041VV0280C24J0F!1#V102#4,80k	CHEMBL1403349	fdePA@LV@DQdDigeV]EEV|FfP`@@h@@@	Fc1ccc(-c2csc(-c3ccncc3)n2)cc1	5.9	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay	2014	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyPB@LV@DISOJl{xhjw`trD@@D@@@	256.303	3.1648	2	0	54.02	2	-1.8570462641244228	0.3784820830260355	0.5902706958087128	42	2	fdePA@LV@DQdDigeV]EEV|FfP`@@h@@@											1
uJPl218F804F0F#N01082V!F&HF05!80FV041VV0280904J0F!1#V102#4.k	CHEMBL1416100	fhyPB@LV@DISOJl{xhjw`trD@@D@@@	c1ccc(-c2csc(-c3ccncc3)n2)cc1	6.2	group3-int	int	Androgen Receptor	Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days	2014	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyPB@LV@DISOJl{xhjw`trD@@D@@@	238.313	3.064	2	0	54.02	2	-1.9470422367215212	0.5057904200404806	0.5601431372307237	42	2	fhyPB@LV@DISOJl{xhjw`trD@@D@@@											1
yRsr468G8V4F4024FN05VN2H!F013920HFV58#Fk160W!20VC2JLV0W890V0c10280c040204!F5!8!	CHEMBL143978	fbmAb@ANbBPRYWYVU{hsQ`i`@ihDHb@@@	COc1cccc2oc(-c3ccc(F)cc3)cc(=O)c12	5.79	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay	2013	fhy@@@LdbbbRnbRYHRoAjjjjjj`@@	fhy@`@@\RYee~uYrVoAZA``@H@@@	270.258	3.4036	3	0	35.53	2	-1.847392065512859	0.16840293569842543	0.6559581825160961	32	23	flu@a@ANAxq\TfUvUe^hsQ`i`@ihDHH@@	eMJA@Hz@	eFABP`BL@									18
xvozgyqmjEue9cxXkAzAhj_1rSoXTw9GFuFSwt12gCtZJ4@RNx@E0q2NF0@81G2K@0W1gN4!2F018N0202810	CHEMBL146032	ebQPLJ@AHTPIABPpdJIAbPrJPrFSRIHqIJJYIKYJZNAQUC[OW_UUUUUUSAPLTmTUGDdVd|`T@@	CC(=O)c1ccc([C@H]2C[C@@]3(C)[C@@H](CC[C@@]3(O)C(F)(F)C(F)(F)F)[C@@H]3CCC4=CC(=O)CCC4=C32)cc1	7.27	group2-a	a	Androgen Receptor	In vitro antagonist potency in transactivation assay in CV-1 cells expressing androgen receptor	2000	fag@@@LdbbbbbTRrRJHcR]xjVykUUUUUUUUU@@@	fagA@@@ILkZwKJjmFRtzI^uZtuMUPTEEQXUMQt@@	508.525	6.338	3	1	54.37	4	0.16547829807080108	-2.5965046838876575	0.07676061504554003	15	5	fmAA@E`|^nNQQIYQQJJJJIZ[tX[pRuft\@ESUUSUTeTSbtcSt@@	diDHXABPRPrPjPZPx@rJPrFjj`@	gCaHA`AIf`@									4
=tU:pzxzTQzUzUnQvvUiEeM5mxjbbvMEEnbvQYTeVYXTIozqC0EBg3noEcatt_tabLbJWkk1GNz4d2cW0	CHEMBL146794	efQRFL@EC@j_HnelRPIABPpdLbdLTRRLTTvbJRRTRTrdf`RPLMTDFULuUUT@ELP@@@	CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)N1CCOCCOCc1ccc(O)c(C(N)=O)c1	7.11	group2-a	a	Androgen Receptor	Inhibition of 1.0 nM [3H]mibolerone binding to human androgen receptor of PC3/AR cell lysate	2003	feg@@@LdbbRbbsRRRTRWCBTN]UUUUUUUUT@@	fegPP@DX@irTfYf]]}UeZLmx\vjhFBJj@B@@@	534.49	2.1666	10	2	146.19	11	5.074676491053354	0.4746820489710517	0.047308807606170955	2	1	efQRFL@EC@j_HnelRPIABPpdLbdLTRRLTTvbJRRTRTrdf`RPLMTDFULuUUT@ELP@@@											1
:UvUtOrdJ7wVLQzUwHVH9vT6B8K1XC1Z7fKDBYVIAVN0V1XDFobk50CBg2YkEVX0s5dXYHbF!V1GFb0cVcF0	CHEMBL146858	fjmpc@EFCzHIADabPrJPqQIHqQRrV`ij``rifh`@@	CC1(C)NC(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C1=O	8.22	group1-p	p	Androgen Receptor	Inhibition of [3H]mibolerone binding to human Androgen receptor of PC3/AR Cell Lysate	2004	dk\@@DjYVYxqVjjjj`@	dk]D@DpIRYeg^ftvj`PH@@	297.235	1.939	5	1	73.2	2	-0.26487317666383703	1.4529508853446793	-0.12103212476862221	33	14	fhiP``AFuX@RRA|xa|TfYwf[v\LzB@jYjH@@		eMBH@RZ@	gJPBAHJPt`PAIjj@@	eMbA@Dg`@							14
vrUtvdUExKzxIH8OUUBl3A8d48F48VG86PN073FC0832Z1VV6XN0B2040FF81182V102#J%2!V!80V	CHEMBL1488607	fdePC@JB@D\BHrBTklnrnRde^CUUMP@T`@@	Fc1ccc(-c2csc(N3CCSCC3)n2)cc1	5.8	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay	2014	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyPA@JB@D\BDiWY]eRTdkpZjij@BP@@	280.39	3.2118	2	0	69.67	2	-1.4806990621058762	0.3757017570186697	0.6699862542783482	42	2	fdePC@JB@D\BHrBTklnrnRde^CUUMP@T`@@											1
zRsr468K8X4F4064kN0_VN2H!F013920LHV58#Fk160W!21VC2KLW0d89FV0c10280c04V@44J4F5F2010	CHEMBL150	fj}@p@@DEiI\bbbfbTtQRQXHwhyZdJH@BJ@@@	O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12	5.01	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-kb2 cells assessed as inhibition of DHT-induced luciferase activity by luciferase reporter gene assay	2009	fhy@@@LdbbbRnbRYHRoAjjjjjj`@@	fhy@`@@\RYee~uYrVoAZA``@H@@@	286.238	1.8359	6	4	107.22	1	1.14374281668058	2.005298385968998	-3.250804018333687	32	23	fj}@Q@AZ|TGbeqRYWYYm^ZLMZNX@JZ`PbH@@	eFJB@Hp@	eFJB@Hp@									1
:xjxyyirjyjzfxsijzDUjp5UtpePwFpIsFSsuSmggOoS4@Txo870k8FHV080F6d6#8Q1VF0GVVV3$F!	CHEMBL1509	emhPL@@@FelbbRfbbeRfbbeRhXTtTL|BRJJjFfZZjjjjjjfjjTXWDDRbLcdBTTRQT@@	C[C@]12CC[C@H]3[C@H]([C@@H]1[C@@H]1C[C@@H]1[C@@]21CCC(=O)O1)[C@H]1C[C@H]1C1=CC(=O)CC[C@@]13C	6.2	group3-int	int	Androgen Receptor	Binding Assay: The test was carried out as in 1, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.	2015	fi@@@LddTTRRNaTTJVis`iJLzJXy[vjjjjjjjjjj@@	fiA`@@EGdTRTrbaRfTTJUFRUKSoQRgK^mMUUUUUTuUPnPRdmRtCHiL@@	366.499	3.4384	3	0	43.37	0	-1.5331837297579765	0.0897467897525433	0.7822444118021339	5	1	emhPL@@@FelbbRfbbeRfbbeRhXTtTL|BRJJjFfZZjjjjjjfjjTXWDDRbLcdBTTRQT@@											1
=tQ:ojwrTQzUwQlHQvUDC@M1mCjZ7vMEDnYIQWT@VYXDHoboC0EBg3YoEcXdt5tXbHbJW0k1GFr4d2cW0	CHEMBL151601	ej^RJL@EC@b_Hid\PIABPpdLbdLTRRLTTvbJRRbRfTdtBR~Aj``rifjnj@BfH@@@	CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)N1CC#CCOCc1ccc(O)c(C(N)=O)c1	7.31	group2-a	a	Androgen Receptor	Inhibition of 1.0 nM [3H]mibolerone binding to human androgen receptor of PC3/AR cell lysate	2003	fi{@@@LdbbRbbsRRRbRxXRncjjjjjjjjj@@	fi{Q`@DX@jJSLsNn~kJtY[wQmUPLFUP@P@@@	514.459	2.8001	9	2	136.96	8	4.070527359896838	0.34205050298847683	-0.17271105236677803	2	1	ej^RJL@EC@b_Hid\PIABPpdLbdLTRRLTTvbJRRbRfTdtBR~Aj``rifjnj@BfH@@@											1
zqvG@GOl8F4kVFABFk0V0822040F1V9244$VV0FV!FF#405V!4!V041#41!841V081!J0VX0G0	CHEMBL1527972	fb}Q@@AR@drnrljmQfcASGL@EU@@@@@@@	Oc1ccc(C2Nc3cccc4cccc(c34)N2)cc1	4.51	group4-ia	ia	Androgen Receptor	Displacement of SRC2-3 peptide from human AR ligand binding site expressed in Escherichia coli BL21 by AF2 FP assay	2011	flm@@@LdbbbbVIbRXhViFbfjjjjjjj@@	flmP@@@TrQQQQZISIFgIV]DJZB`@@@H@@@	262.311	2.6778	3	3	44.29	1	-1.0444841762184915	0.7776356447210543	-2.6248827597046027	5	5	fjcPA@IJAxd\TfY}eYUYgCVceIXHBj`@@@@@@		eFJB@Hp@									5
vrUtvdUDxKzxIH8OEUBl3A8d48F48VF86PN073FC0832Z1VV6XN08!40FF81182V102#J%2!V$V	CHEMBL1549081	fhyPA@JB@D\BDiWY]eRTdkpZjij@BP@@	c1ccc(-c2csc(N3CCSCC3)n2)cc1	6.21	group3-int	int	Androgen Receptor	Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay	2014	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyPA@JB@D\BDiWY]eRTdkpZjij@BP@@	262.4	3.111	2	0	69.67	2	-1.5706951150585524	0.5030101506174582	0.6398586705922852	42	2	fhyPA@JB@D\BDiWY]eRTdkpZjij@BP@@											1
;QAQtl9R4mVJATHsH8XO1H640ld310VF2p30XV18FG0F0A0P1204!cHc!433!482Y0a%80604X8GF	CHEMBL156142	ffcQC@EAlBPQHXdLbdLTRbVVTQdeF]GMT@@DUUPTOT@@	CC1CC(C)(C)Nc2cc3nc(O)cc(C(F)(F)F)c3cc21	7.58	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	310.318	4.1488	3	2	45.15	1	-1.1231336316358704	-0.26449340024290746	-1.4493087451650057	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@	eFBH@c@@	eMBH@RZ@								49
:UvEQtl9R5mVJAUIcHdXO3H64Fld390VLmp78XV3AkO6FGf0POX165Jt2cc1RnIW90@VbVa!8BGOJ714V8F0	CHEMBL156278	fnsQC@EQlBPQHXdLbdLTRbRRJbLdhwdejiB`XjjhhAh@@	CC1CC(C)(C)Nc2cc3c(cc21)c(C(F)(F)F)cc(=O)n3C	7.14	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	foQ@@@DjYUU}`nRlzjjjjj`@@	foQQ@@DZ@drmjjtYIUgMR@EUD@@	324.345	3.1871	3	1	32.34	1	-1.4861342330604534	0.1815276281757064	-0.37712205764532813	38	10	ffcQB`DFRCqDxydBrEYCHhdhdldhhcIQbmNCUPPETsUD@@	eFBH@c@@	eMBH@RZ@									4
;QvQztUOxnfoQEHtIPXOBLT41nhY18dFDr1FXY1@GG0F610@G60B2VcFg32J31!49HY0i090k014604281F	CHEMBL156312	fnkQC@EAlBPQHXdLbdLTRbVVRfbdhshiJvj@@BJjjBhIh@@	CC12CCCN1c1cc3nc(O)cc(C(F)(F)F)c3cc1CC2	6.49	group3-int	int	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	fhe@@@LdbbbRRRjXhTmF|Fjjjjjj`@@	fheP@@@JRfV_VUipTcN|D@@BjjB`@@	322.329	4.0331	3	1	36.36	1	-1.4718985083618539	-0.2900806935958239	-0.3657978386164483	1	1	fnkQC@EAlBPQHXdLbdLTRbVVRfbdhshiJvj@@BJjjBhIh@@											1
zpzpnVUSlk4C702DDC8W2N0d!F0C10246FV53XB!20a!V0X5080F48FV115W!1124!4802!2$V0FV	CHEMBL1563710	fluQB@LDD@HrQQIIIIJEIgCVbffj``@@@@@	c1ccc(OCCSc2nc3ccccc3[nH]2)cc1	5.37	group4-ia	ia	Androgen Receptor	Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB assessed as reduction in PSA level after 3 days	2013	flu@@@DjU_VUUirshijjjjjjj@@	fluQB@LDD@HrQQIIIIJEIgCVbffj``@@@@@	270.355	3.4942	3	1	63.21	5	-0.6542480083162906	-0.05973072371616657	-0.28135570939766935	23	20	fluQB@LDD@HrQQIIIIJEIgCVbffj``@@@@@											1
;QAQtn9R6mVLATHsI8XO1HLJ0lfI10VG2p34XX58FG9F8E4P1204!cHc!J33044N2Y0a021!84a04X8GF	CHEMBL156641	fnsQC@EAlBPQHXdLbdLTRbVVTRtdhshyj`@@bjj`d^dX@	C[C@H]1[C@@H](C)c2cc3c(C(F)(F)F)cc(O)nc3cc2NC1(C)C	6.79	group3-int	int	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	324.345	4.4181	3	2	45.15	1	-1.061935534756397	-0.4783991999258672	-1.4248240998618513	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@	eFBH@c@@	eMBH@RZ@	eFBH@c@@							49
;QfQttER4mWJvTHsI8XO_HTJ0tdY1FVF2p30XX18FG0F0E0P120420cHc!J33!492Y0a0@#84604X8GF	CHEMBL156751	fakQC@EAlBPQHXdLbdLTRbVVTRfdeF\gMT@@DUUUAP}P@	CC(C)C1CC(C)(C)Nc2cc3nc(O)cc(C(F)(F)F)c3cc21	6.8	group3-int	int	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	338.372	4.8215	3	2	45.15	2	-0.8485097559141344	-0.8937427298466948	-1.373533524675817	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@	gC`HL@Qz`@	eMBH@RZ@								49
;QAItn9N6mVL3BHsI8XO0HFJ0lf310VG2p14XV10FG1F85B@1204!VFc!J3104402n0aF21#4a04X8GF	CHEMBL156806	fnsQC@EAlBPQHXdLbdLTRbVVRTTdhshij`@@bjj``@@	CC1(C)Cc2cc3c(C(F)(F)F)cc(O)nc3cc2NC1(C)C	7.08	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	324.345	4.0706	3	2	45.15	1	-1.045585496018672	-0.26950018458942715	-1.4266350810599784	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@		eMBH@RZ@	eMBH@RZ@							49
;QfQttCR4mWJfTHsH8XO5HL40tdY10VF2p30XV18FG0F0A0P1204!cHc!J33!492Y0a%84604X8GF	CHEMBL156982	fnsQC@EAlBPQHXdLbdLTRbVVTVTdhshyj`@@bjj`h^h@@	CCC1CC(C)(C)Nc2cc3nc(O)cc(C(F)(F)F)c3cc21	7.57	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	324.345	4.6032	3	2	45.15	2	-0.9121074334418229	-0.7104955752393552	-1.3977523849550324	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@	eMBD@ch@	eMBH@RZ@								49
uyPnPY9G0F5V0F@5F80G088X04F01V080HP258V!@F06$2N08!4FF0814V!103VV04%1F4%k	CHEMBL1572280	ek`\@@H@GL`IrRJJZKHiQQQGJYIbQPsJkXxHB@Rfjf`@B@HEH	Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1	6.4	group3-int	int	Androgen Receptor	Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days	2014	fnk@@DDSddTRRURbRtRSA\exMVuUUUUUUUT@@	fnkP@D@^AJTsL|krmNRuxMV`A@IML@@PBDh	382.529	1.1901	3	0	12.05	4	-1.2125803213516022	0.6688313624453437	0.8216102165751127	1	1	ek`\@@H@GL`IrRJJZKHiQQQGJYIbQPsJkXxHB@Rfjf`@B@HEH											1
;QAQtn9R6mVLATHsI8XO1HLJ0lfI10VG2p34XX58FG9F8EBP1204!cHc!J33044N2n0aF21!84a04X8GF	CHEMBL157344	fakQC@EAlBPQHXdLbdLTRbVVTRfdeF]GMT@@DUUUAP}P@	CC1c2cc3c(C(F)(F)F)cc(O)nc3cc2NC(C)(C)C1(C)C	7.24	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	338.372	4.7496	3	2	45.15	1	-1.0036639817364454	-0.7296964786383175	-1.4000153014487193	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@	eFBH@c@@	eMBH@RZ@	eMBH@RZ@							49
:UvzQztUOxnfoQEIdIvXODLT4GnhY98dLyr5NXY3AlO6FMW0@Oa1D7ot0gf3RnGW90AkbVi098wGGJ71408!	CHEMBL157407	fa{QC@EQlBPQHXdLbdLTRbRRJTtTeF|gM^uTaPLUUUEPsP@	Cn1c(=O)cc(C(F)(F)F)c2cc3c(cc21)N1CCCC1(C)CC3	7.57	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	fdu@@@LdbbbRRRjSEBehw`uUUUUUU@@@	fduQ@@DZ@drmjkJtYIUoAbuH@UUTT@@	336.356	3.0714	3	0	23.55	1	-1.8348992592798816	0.15594059131645036	0.7063887974445727	1	1	fa{QC@EQlBPQHXdLbdLTRbRRJTtTeF|gM^uTaPLUUUEPsP@											1
yTuI2G9G8F4kVFA4FNH1VN2H04FF1310VFHo18VV18k96F#2801#oFcc041101422bca$F!6!X8GF	CHEMBL157703	fnsQC@EQlBPQHXdLbdLTRbVbvbLdhsdej`@@bij``@@	CC1=CC(C)(C)Nc2c1cc1c(C(F)(F)F)cc(O)nc1c2C	7.64	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@jP`@@	322.329	3.7281	3	2	45.15	1	-1.0400872828680008	-0.05613091382151725	-1.431737284327075	70	9	fbmPA@NNAxj\\bbbTRtVtQcNRuzL@@DUMTD@@	eFJB@Hp@	gJPBAHJPt`PAIjj@@									1
:UvEQtl9NCmVoAEIcIdXO6HL4Gnd390VLqp58XX3AlO6FKW0@OX1D5Jl0cd3RnGW90@VbVa018RGGJ71408!	CHEMBL160230	fakQC@EQlBPQHXdLbdLTRbRRJTtteF|gMUHTCEUUQPsP@	CCC1(C)CCc2cc3c(C(F)(F)F)cc(=O)n(C)c3cc2N1C	7.62	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	foQ@@@DjYUU}`nRlzjjjjj`@@	foQQ@@DZ@drmjjtYIUgMR@EUD@@	338.372	3.3208	3	0	23.55	2	-1.677479767754767	-0.12228570601173797	0.7371129384113825	38	10	fnsQB`DVrCqdxedJrCYCHhheLedeEDYF\t[tZj``JifjH@@		gC`HD@IWT@@									3
zyPnTnOl8F5kVFA5G8HlVN@H04FF9Y98VLvq58VV3@k96FGV02OX125Jp8cc1RlGW90AVbVa!8BGGJ610V8F0	CHEMBL160239	fakQC@EIlBPQHXdLbdLTRbRRrTqdeF}fmUHTCESUQ@@@	CCn1c(=O)cc(C(F)(F)F)c2cc3c(cc21)NC(C)(C)C=C3C	6.16	group3-int	int	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	foQ@@@DjYUU}`nRlzjjjjj`@@	foQQ@@DZ@drmjjtYIUgMR@ESD@@	336.356	2.8288	3	1	32.34	2	-1.2474868382524922	0.23155490345041324	-0.3331183792500532	38	4	fnsQ@`HVHAq]H^d@rFQQQSIIIRIVJLDhr\uLBDUUMTP@@	eMBD@ch@										2
;QAItl9NBmVo3DHsH8XO4HF41nd310VF2p10XV10GG0F410@1204!VFc!431!402Y0a(604X8GF	CHEMBL160250	fnsQC@EAlBPQHXdLbdLTRbVVRtRdhshij`@@bjj``@@	CCC1(CC)CCc2cc3c(C(F)(F)F)cc(O)nc3cc2N1	7.57	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	324.345	4.3786	3	2	45.15	3	-0.7430027495300018	-0.6963014561869122	-1.3728158043563181	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@		gJPHD@IVuP@								49
;QAQtn9R6mVLATHsI8XO1HLJ0lfI10VG2p34XX58FG9F8E4P1204!cHc!J33044N2Y0a021!84a04X8GF	CHEMBL160257	fnsQC@EAlBPQHXdLbdLTRbVVTRtdhshyj`@@bjj`d^TX@	C[C@@H]1c2cc3c(C(F)(F)F)cc(O)nc3cc2NC(C)(C)[C@H]1C	5.15	group4-ia	ia	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	324.345	4.4181	3	2	45.15	1	-1.061935534756397	-0.4783991999258672	-1.4248240998618513	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@	eFBH@c@@	eMBH@RZ@	eFBH@c@@							49
zTPn6I9l8F5kVFA5G8HWVN2H04FF1390VLmo58VV3@k96FGV02OX125Jp0cc1RlGW90@VbVa!8BGGJ610V8F0	CHEMBL160386	fnsQC@EQlBPQHXdLbdLTRbRRJbLdhwdejiB`Xijh`@@	CC1=CC(C)(C)Nc2cc3c(cc21)c(C(F)(F)F)cc(=O)n3C	7.47	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	foQ@@@DjYUU}`nRlzjjjjj`@@	foQQ@@DZ@drmjjtYIUgMR@ESD@@	322.329	2.4225	3	1	32.34	1	-1.4607760041419793	0.6486417251798802	-0.38442401809507987	38	4	fnsQ@`HVHAq]H^d@rFQQQSIIIRIVJLDhr\uLBDUUMTP@@	eFBH@c@@										2
yTuI2G9G8F4kVFA4FNH1VN2H04FF1310VFHo18VV18k96F#2801#oFcc041101422YVa$F!6!X8GF	CHEMBL160451	ffcQC@EAlBPQHXdLbdLTRbVVTQdeF]GMT@@DTuPP@@	CC1=CC(C)(C)Nc2cc3nc(O)cc(C(F)(F)F)c3cc21	7.55	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@jP`@@	308.302	3.3842	3	2	45.15	1	-1.097775413935108	0.20262055343629265	-1.4566107043722487	70	9	fluPA@NVAxj\\bbbTRrrbLYrVgA`@@bfjB@@	eFJB@Hp@	gJPBAHJPt`PAIjj@@									4
;QAItn9N6mVL3BHsI8XO0HFJ0lf310VG2p14XV10FG1F854@1204!VFc!J3104402Y0a021#4a04X8GF	CHEMBL160665	ffcQC@EAlBPQHXdLbdLTRbVVRRdeF]EMT@@DUUPTHd@@	CC1Cc2cc3c(C(F)(F)F)cc(O)nc3cc2NC1(C)C	7.52	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	310.318	3.7391	3	2	45.15	1	-1.1038570490386235	-0.018202905876977094	-1.4514438794731104	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@		eMBH@RZ@	eFBH@c@@							49
;QfItl9NgmWo3DHsH8XO4HF41nd310VF2p1FXV10GG0F410@1204!cFc!431!402Y0a(604X8GF	CHEMBL160713	fnsQC@EAlBPQHXdLbdLTRbVVRtVdhshij`@@bjj`hIh@@	CCCC1(C)CCc2cc3c(C(F)(F)F)cc(O)nc3cc2N1	7.38	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	324.345	4.3786	3	2	45.15	3	-0.7430027495300018	-0.6963014561869122	-1.3728158043563181	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@		gJPHL@ISuP@								49
zTPn6I9l8F5kVFA5G8HWVN2H04FF1390VLmo58VV3@k96FGV02OX125Jp0cc1RlGW90@Vbca!8BGGJ610V8F0	CHEMBL160923	fakQC@EIlBPQHXdLbdLTRbRTQtQdeF}fmUHTCESUQ@@@	CC1=CC(C)(C)Nc2c1cc1c(C(F)(F)F)cc(=O)n(C)c1c2C	5.62	group4-ia	ia	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	foQ@@@DjYUU}`nRlzjjjjj`@@	foQQ@@DZ@drmjjtYIUgMR@ESD@@	336.356	2.7664	3	1	32.34	1	-1.4030880450037397	0.3898902277657834	-0.3595506470235452	38	4	fakQ@`HNXAq}HAdHrFQQQQQPiZQJqS`eVrVhF`hjjZd`@@	eFBH@c@@										1
:UvjQzvEOznWyfEGdMdaO7HJJIvjYO0ZUqZ5NVX7Ak97kU_4PSX1u5Jt0ccIRnGWh0EVbYD02CRGOJa1!8!	CHEMBL161892	fa{QC@EQlBPQHXdLbdLTRbRRJbRteF}EK^uTaPLUUUEHBdh@	CN1c2cc3c(cc2[C@H]2CCCC[C@H]21)c(C(F)(F)F)cc(=O)n3C	7.44	group2-a	a	Androgen Receptor	Antagonistic activity (IC50) against human androgen receptor (hAR) in co-transfected CV-1 cell	1998	fdu@@@LdbbRRRJRSI\DZpXuUUUUUU@@@	fduQ@@DZ@drmjjjtYIQkAbuH@UUTT`rm@@	336.356	3.2962	3	0	23.55	1	-1.845476215016356	0.02080234032818068	0.7075603339943903	7	6	fa{QB`HVJCqBxudFrGYAIfYUUv{zHrQmNbfhJBbjfZhiFHr@@	eFBH@c@@	eFBH@c@@									3
:UvjQzvEOzndyvEGdMfaObHRJIvjbOFZUqZ5sWX7Ak97kU_4PSX1y7Jt0ccIRnGYh0EVbYD2@CRGOJa1408!	CHEMBL161980	figQC@EQlBPQHXdLbdLTRbRRJbRrdhwhi[vjdJAbjjjJpEIST@	C[C@H]1CC[C@@H]2[C@H](C1)c1cc3c(C(F)(F)F)cc(=O)n(C)c3cc1N2C	7.27	group2-a	a	Androgen Receptor	Antagonistic activity (IC50) against human androgen receptor (hAR) in co-transfected CV-1 cell	1998	fdu@@@LdbbRRRJRSI\DZpXuUUUUUU@@@	fduQ@@DZ@drmjjjtYIQkAbuH@UUTT`rm@@	350.383	3.5655	3	0	23.55	1	-1.784278118136883	-0.19310345935477913	0.7320449792975446	7	6	figQB`HVjCqBxmdNr@yCHhhhdddlheLYBLd[ShyjB`hjjYjblXcHy@@	eFBH@c@@	eFBH@c@@									2
zyQv6IOl8F5k0JACG82WVO2H04FF13904LqZ58V03Ak96FGV02SX1X5Jl0cc1RlGW90@VbV6!BBGGJ61!8!	CHEMBL162103	fbmQC@EQlBPQHXdLbdLTRbRRJTeF}EMUHTCEUD@@	CN1CCc2cc3c(C(F)(F)F)cc(=O)n(C)c3cc21	6.71	group3-int	int	Androgen Receptor	Antagonistic activity (IC50) against human androgen receptor (hAR) in co-transfected CV-1 cell	1998	fgA@@@LdbbRRRKI\DZuUUUUT@@	fgAQ@@DZ@drmjkQdeFluH@UQ@@@	282.264	1.9017	3	0	23.55	1	-2.064722577264654	1.059693860194003	0.6112855355760255	5	5	fj}Q@`FFJAqcHIdLrBSLjklwRQ`eV}TDDTuULP@@											1
zrzxvdUDxpzxMH8OEUBl3A8d48F48Vkc6PN073FC0832Z1VV6XN08!40FFN1182k102#J!V!2!V$V	CHEMBL1623389	fhyQB@LDl@HRf^UYwqQUoAifj``J@@@	c1ccc(-c2csc(N3CCOCC3)n2)cc1	6.55	group3-int	int	Androgen Receptor	Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days	2014	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyQB@LDl@HRf^UYwqQUoAifj``J@@@	246.333	2.7041	3	0	53.6	2	-1.6498387752753256	0.8101748104589819	0.6589403837341156	42	18	fhyQB@LDl@HRf^UYwqQUoAifj``J@@@											1
;QfQzvEOyndyfDFtMcaO5HJJWvjbG0ZS2p1FVX_8F11kT5BP1!o20cFc!J302Z4C2l3DF258084a04X8GF	CHEMBL162368	fa{QC@EAlBPQHXdLbdLTRbVVTrTdeF\FIZuP@@QUUTEH|hh@	CC1(C)CCC[C@@H]2c3cc4c(C(F)(F)F)cc(O)nc4cc3N[C@@H]21	7.58	group2-a	a	Androgen Receptor	Antagonistic activity (IC50) against human androgen receptor (hAR) in co-transfected CV-1 cell	1998	fhe@@@DjYU_mVByKQoAjjjjjjh@@	fheP@@@JRfV_UUipTmF|D@@BjjBdZQh@	336.356	4.5004	3	2	45.15	1	-1.0025557450862133	-0.572414313245956	-1.4046313252669973	2	1	fa{QC@EAlBPQHXdLbdLTRbVVTrTdeF\FIZuP@@QUUTEH|hh@											1
zyQn6IOl8F5k0JACG82WVN2H04FF13904LmZ58V03@k96FGV02OX1X5Jl0cc1RlGW90@VbV6!BBGGJ610V8F0	CHEMBL162503	fluQC@EQlBPQHXdLbdLTRbRRJdhwhijiB`Xjb@@	Cn1c(=O)cc(C(F)(F)F)c2cc3c(cc21)NCC3	7.25	group2-a	a	Androgen Receptor	Antagonistic activity (IC50) against human androgen receptor (hAR) in co-transfected CV-1 cell	1998	fgA@@@LdbbRRRKI\DZuUUUUT@@	fgAQ@@DZ@drmjkQdeFluH@UQ@@@	268.237	1.5434	3	1	32.34	1	-1.7042723586585193	1.37770131343389	-0.47801287988197094	5	5	fbmQ@`FZrAqCHQdDrBSLkjs]IFBdYuPPEMUSD@@											1
:UvjQzvEOzndyfEGdMdaO7HJJnvjbO0ZUqp5NVXbAk97kU_BPSX1y7Jt0ccIRnGYh0EVrYDF2CRGOJa1408!	CHEMBL163142	fewQC@EQlBPQHXdLbdLTRbRRJbRtdeF}EK^uTaPLUUUTT`JR`@	CN1c2cc3c(cc2[C@H]2CCCC(C)(C)[C@H]21)c(C(F)(F)F)cc(=O)n3C	7.57	group2-a	a	Androgen Receptor	Antagonistic activity (IC50) against human androgen receptor (hAR) in co-transfected CV-1 cell	1998	fdu@@@LdbbRRRJRSI\DZpXuUUUUUU@@@	fduQ@@DZ@drmjjjtYIQkAbuH@UUTT`rm@@	364.41	3.897	3	0	23.55	1	-1.7260065651169314	-0.44440073806722924	0.7568537777106765	7	6	fewQB`H^ZCqRx}dArDyCHhhhdiDdjiimHSdgVCdmPTETUTsUEHpnP@	eFBH@c@@	eFBH@c@@									1
:UvjQzvEOznWyfEGdMdaO7HJJIvjYO0ZUqp5NVX7Ak97kU_BPSX1y5Jt0ccIRnGWh0EVrYDF2CRGOJa1!8!	CHEMBL163143	figQC@EQlBPQHXdLbdLTRbRRJdRQdhwhizNjdJAbjjjJPEIP@	CN1c2cc3c(cc2[C@@]2(C)CCCC[C@@H]12)c(C(F)(F)F)cc(=O)n3C	7.28	group2-a	a	Androgen Receptor	Antagonistic activity (IC50) against human androgen receptor (hAR) in co-transfected CV-1 cell	1998	fdu@@@LdbbRRRJRSI\DZpXuUUUUUU@@@	fduQ@@DZ@drmjjjtYIQkAbuH@UUTUBt@@	350.383	3.0682	3	0	23.55	1	-1.7608799127947994	0.10584764008959291	0.7294533212211232	7	1	figQC@EQlBPQHXdLbdLTRbRRJdRQdhwhizNjdJAbjjjJPEIP@											1
zyvQ@Itn8N4kVLABFsIVVO0H0J0l3310ZK2o10VX18F11kN4B@1!Z!VFc!43!V4B2l26F258080a!X8GF	CHEMBL165219	fj}QC@EAlBPQHXdLbdLTRbVVTfdhs`qj`@@bjhJDT@	C[C@H]1Nc2cc3nc(O)cc(C(F)(F)F)c3cc2C1(C)C	7.32	group2-a	a	Androgen Receptor	Antagonistic activity (IC50) against human androgen receptor (hAR) in co-transfected CV-1 cell	1998	dk|@@DjYU_X^gSjjjjj@@	dk}@@@UJYY}ZxYtp@@J``@	296.291	3.2808	3	2	45.15	1	-1.1561626080741663	0.30931989675245963	-1.4769134899556948	4	4	fj}QC@EAlBPQHXdLbdLTRbVVTfdhs`qj`@@bjhJDT@											1
:UvjQzvEOzndqvEGdMfaObHRJGvjYOFZUmZ5sWX3Ak97kU_4POX1a7Jt0cc1RnGYh0EVbYD0@CBGOJa14V8F0	CHEMBL165803	fa{QC@EQlBPQHXdLbdLTRbRRJfRTeF}EMVuTaPLUUUEXBdjj@@	C[C@H]1CC[C@H]2Nc3cc4c(cc3[C@H]2C1)c(C(F)(F)F)cc(=O)n4C	7.32	group2-a	a	Androgen Receptor	Antagonistic activity (IC50) against human androgen receptor (hAR) in co-transfected CV-1 cell	1998	fdu@@@LdbbRRRJRSI\DZpXuUUUUUU@@@	fduQ@@DZ@drmjjjtYIQkAbuH@UUTT`rm@@	336.356	3.2072	3	1	32.34	1	-1.4238278995307478	0.12490399388510792	-0.3572534361604518	7	6	figQB`HVjCqBxmdNr@yCHhhhdddlheLYBLd[ShyjB`hjjYjblXcHy@@	eFBH@c@@										2
:UvzQzvUOznvyfEGdMtqOELJJIvjYOBhUya5NVY7Ak97kU_4PSX1u5ot0geIRnGWh0EkbYD02CROOJa1!8!	CHEMBL165912	fewQC@EQlBPQHXdLbdLTRbRRJbRRteF}EKQuTaPLUUUTT`JR`@	CCCN1c2cc3c(cc2[C@H]2CCCC[C@H]21)c(C(F)(F)F)cc(=O)n3C	7.57	group2-a	a	Androgen Receptor	Antagonistic activity (IC50) against human androgen receptor (hAR) in co-transfected CV-1 cell	1998	fdu@@@LdbbRRRJRSI\DZpXuUUUUUU@@@	fduQ@@DZ@drmjjjtYIQkAbuH@UUTT`rm@@	364.41	4.1569	3	0	23.55	3	-1.4211606790039542	-0.8422866262414469	0.8104223820230292	7	6	fa{QB`HVJCqBxudFrGYAIfYUUv{zHrQmNbfhJBbjfZhiFHr@@	eFBH@c@@	gC`HL@IST@@									3
zyvG2GOG8F4k042BFN2VVN0H040F1210442Z10V010F&2#V!VF8!41#402W06!4$6!X8GF	CHEMBL166323	fdeQC@EAlBPQHXdLbdLTRbVVTeF\FMT@@DUA@@@	Oc1cc(C(F)(F)F)c2cc3c(cc2n1)NCC3	7.64	group2-a	a	Androgen Receptor	Antagonistic activity (IC50) against human androgen receptor (hAR) in co-transfected CV-1 cell	1998	dk|@@DjYU_X^gSjjjjj@@	dk}@@@UJYY}ZxYtp@@J``@	254.21	2.5051	3	2	45.15	1	-1.3412716768783581	0.9316802284309327	-1.5501995422935746	4	4	fdeQC@EAlBPQHXdLbdLTRbVVTeF\FMT@@DUA@@@											1
xvojgyqXbEue9cxVVAzeCh_1rGoXPw0F0FFKkt12g8tZJZPRNo@E0k0FF!80F25#48Q)8#2010	CHEMBL166444	fjc@`@@YRYVumUejLejs`iZZfijjjjIjVchE@@	C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3C=C[C@@]21C	9.52	group1-p	p	Androgen Receptor	Agonist activity at GAL4 DNA-binding domain fused androgen receptor (unknown origin) ligand binding domain expressed in UAS-bla GripTite 293 cells assessed as beta-lactamase transcriptional activation by FRET-based GeneBLAzer assay	2018	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvjmFRuYpXmMSTuUUHuKP@	284.398	3.2537	2	1	37.3	0	-2.023187810583125	0.32598084256303195	-0.5445340143699221	50	1	fjc@`@@YRYVumUejLejs`iZZfijjjjIjVchE@@											1
yRsr468G8V4F40240N05VN2H!F013020HFV58#Fk160W!20V90JLV0W890V0c10280c040204#5%	CHEMBL16685	fluA`@@\edTTRbbrtJSNJMEKPLQD@D@@@	COc1cccc2oc(-c3ccccc3)cc(=O)c12	5.06	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-kb2 cells assessed as inhibition of DHT-induced luciferase activity by luciferase reporter gene assay	2009	fhy@@@LdbbbRnbRYHRoAjjjjjj`@@	fhy@`@@\RYee~uYrVoAZA``@H@@@	252.268	3.3028	3	0	35.53	2	-1.9373879577543798	0.29571121612852713	0.6258306490461807	32	23	flu@a@ANAxq\TfUvUe^hsQ`i`@ihDHH@@	eMJA@Hz@										18
yRsr468G8V4F40240N05VN2H!F013020HFV58#Fk160W!20V90JLV0W890V0c10280c040204#502010	CHEMBL16807	fdeA`@@\edTTRbbqfRYqQ`qZAbH@B@@@	O=c1cc(-c2ccccc2)oc2cccc(O)c12	6.08	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay	2013	fhy@@@LdbbbRnbRYHRoAjjjjjj`@@	fhy@`@@\RYee~uYrVoAZA``@H@@@	238.241	3.0271	3	1	46.53	1	-1.7038160030267955	0.7010982584438687	-0.48351898978542807	32	23	flu@a@ANAxq\TfUvUe^hsQ`i`@ihDHH@@	eFJB@Hp@										18
yRsr468G8V4F4024FN05VN2H!F013920HFV58#Fk160W!20VC2JLV0W890V0c10280c040204!F502010	CHEMBL16972	fluA`@@\edTTRbbqfRsNJLFKPLQ@@T@@@	Cc1ccc(-c2cc(=O)c3c(O)cccc3o2)cc1	4.96	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay	2013	fhy@@@LdbbbRnbRYHRoAjjjjjj`@@	fhy@`@@\RYee~uYrVoAZA``@H@@@	252.268	3.371	3	1	46.53	1	-1.6461278719596883	0.44234679118605885	-0.4586455697402544	32	23	flu@a@ANAxq\TfUvUe^hsQ`i`@ihDHH@@	eFJB@Hp@	eFBH@c@@									18
<jrOzdmaw5q@izRPV2C0PVg8p12h243XK48X0390N0X1VD1Xm0Zk58$EV!s582W06GV2024Wb08XcG0	CHEMBL1738889	fcwqc@EFvxNPRBICDadTabbRQTtfrbRreh\zhHLijj@Bpaz@@	C[C@](O)(COc1ccc(C#N)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	8.42	group1-p	p	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	fdy@@@DjU^}YVg@qjjjjjj`@@	fdy``@D@DdrljoZjLFKUAA@@@@@	389.332	2.7147	6	2	106.14	6	1.8684541064278684	0.5104176388480908	-0.7753500504651512	3	1	fcwqc@EFvxNPRBICDadTabbRQTtfrbRreh\zhHLijj@Bpaz@@											1
zrzxvdUUzprhU@@UUEBWHs8d6EH4CWt646NVE3XC2920aV2XHXK0N0FB8FV115W2Fd1AZ0X48WX103F9%V	CHEMBL1738936	ek`TDH@LBI@`@cIEDeDdddeBdhlmfNGOJaemjZj`hHH@@H@@@@	Cc1ccc(OCCn2c(SCCOc3ccccc3)nc3ccccc32)cc1	4.88	group4-ia	ia	Androgen Receptor	Transcriptional activity at human androgen receptor BF3 site stably transfected in eGFP-expressing human LNCAP cells after 5 days by fluorometric analysis	2011	fc@@@DjU_YfW_VUipshyWnjjjjjjjjjj@@	fcPb@LDdD@QdbbRbRRRRaRTVVYqwjcWnfjhJBB@@@@@@	404.533	5.2456	4	0	61.58	9	0.5465921695182199	-1.9706779828911323	1.2241078507711904	2	2	ek`TDH@LBI@`@cIEDeDdddeBdhlmfNGOJaemjZj`hHH@@H@@@@											1
;xzhUUzrrhUADzUEBWHN8daEH4CWt66aNVE3aC2920aV2XHXK0PVFB8FV155W2Fd1AZ0X48WX103F180603V	CHEMBL1738937	fi{Qb@LDlzH@cIEDeDdeDduDef\|EoZZj`fB`@`@@@	Cc1ccc(OCCn2c(SCCC(=O)O)nc3ccccc32)cc1	4.3	group4-ia	ia	Androgen Receptor	Transcriptional activity at human androgen receptor BF3 site stably transfected in eGFP-expressing human LNCAP cells after 5 days by fluorometric analysis	2011	fde@@@DjU_Ye^gCNCFjjjjjj`@@	fdeQ@@AN@eLjo\k|dYpXtDDTB@P@@	356.445	3.2346	5	1	89.65	8	1.2017811094654842	-0.1497447108716048	0.18166357425129454	1	1	fi{Qb@LDlzH@cIEDeDdeDduDef\|EoZZj`fB`@`@@@											1
<jrOzdFaw1qAiURPW2CFuVB8p12h043mK4BXB39VN0fGVD1XX0ZZK8!V0EV!s582Y86t!204Vb08XcG0	CHEMBL1782494	e`TTBB@DohDMH`@`zPndGiCIICDheHhcB]DeLiDhxEdMLmA@U@LP@UU`P\H@	C[C@](O)(CS(=O)(=O)c1cccc2ccccc12)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	5.52	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor T877A mutant expressed in african green monkey CV1 cells assessed as inhibition of dihydrotestosterone-induced transcriptional activity by luciferase reporter gene assay	2011	fak@@@LddTQbRbtvLRRcNbwmUUUUUUUU@@@	fakab@@pQx@QddabTRTVfNbRTYtV}V``HAb@@@@@	462.447	3.2362	6	2	115.64	6	2.3817506438393297	-0.004530128482246598	-0.6281413000051693	1	1	e`TTBB@DohDMH`@`zPndGiCIICDheHhcB]DeLiDhxEdMLmA@U@LP@UU`P\H@											1
<jrOzdFaw1qAiURPWXSFuVB8p93h04Imp5BXB39kO6fGVD3XX0ZZKc0Vc1EV!sK82YVLt!304VbGBXcG0	CHEMBL1782495	elZTBB@HdXDM@`@czPAdHYCIICDheHdXYdeEeieHeGFimcehHbhfB@@BjlBCa@@	C[C@](O)(CS(=O)(=O)c1ccccc1Cc1ccccc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	5.52	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor W741L mutant expressed in african green monkey CV1 cells assessed as inhibition of dihydrotestosterone-induced transcriptional activity by luciferase reporter gene assay	2011	fmw@@@LddTQbRVfbrTVVTXoYkjjjjjjjjjh@@	fmwab@OPPx@QddabTRRttrRbrrcE{MZtDQDpP@@@@@@	502.512	3.8577	6	2	115.64	8	2.880572705612413	-0.7683649247177322	-0.5067619617697172	1	1	elZTBB@HdXDM@`@czPAdHYCIICDheHdXYdeEeieHeGFimcehHbhfB@@BjlBCa@@											1
<jrOzdFaw1qAiURPW2SFuVB8p93h043mp5BXB39VN6fGVD1XX0ZZK80VV0EV!t5@2YV6t!304VbFBXcG0	CHEMBL1782496	edRTBB@DhXDMH`@azP~d@YCIICDheHhcLbmLeLiDhDTtmlmAPU@LD@AUVAAp`@	C[C@](O)(CS(=O)(=O)c1ccccc1-c1ccccc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	5.52	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor T877A mutant expressed in african green monkey CV1 cells assessed as inhibition of dihydrotestosterone-induced transcriptional activity by luciferase reporter gene assay	2011	feg@@@LddTQbRbtRvtrRgIJN]UUUUUUUUT@@	fegab@@pQx@QddabTRTVbQVfRTyIQsV`hHA``@@@@@	488.485	3.701	6	2	115.64	7	2.6555395793696053	-0.5013246178985682	-0.5567668710169906	1	1	edRTBB@DhXDMH`@azP~d@YCIICDheHhcLbmLeLiDhDTtmlmAPU@LD@AUVAAp`@											1
:UvzvzUzS:QTQzUUUQAvxvUUer_qN9PvyiEql3UAdhiBfjqLF_JL2g9j4eHEtPXRCOmWkD@80VG1Fa!38!	CHEMBL178333	figPSBNVUhJPRBICDar]]dTabbTRlTTvTTcQsUoQuPPLULuUERHkL@@	O=C1[C@H]2C3CCC(C3)[C@H]2C(=O)N1c1ccc([N+](=O)[O-])c(C(F)(F)F)c1	7.92	group2-a	a	Androgen Receptor	Inhibition of human androgen receptor of breast carcinoma MDA-453 cells in reporter gene assay	2005	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdu``@D@UdTTTTRTRqhsQkA}EjjAjBJaFDq@@	354.283	1.7777	6	0	83.2	3	0.3312234366337026	1.4256221138399896	1.19882948017499	47	2	figPSBNVUhJPRBICDar]]dTabbTRlTTvTTcQsUoQuPPLULuUERHkL@@											1
:xzSesG9i5s40@yp8m02N@H2w80OYB2022lS#3WV#16!FVl0FD90X!8VF0NF1cG03!2455F24!1!	CHEMBL1783642	elRPBH@Lbim`GCIIEEDddcMMldeEMIiCOGHjh@h@HjjfZjh@@@	CC[Si](CC)(c1ccc(OCC(=O)C(C)(C)C)c(C)c1)c1ccc(OCC(=O)C(C)(C)C)c(C)c1	5.21	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of transcriptional activity by luciferase and beta-galactosidase reporter gene assay	2013	dk\@@DjU^ukmNjjjj`@	dk\@`@\DifUWGUN`@@@@@	496.761	7.3028	4	0	52.6	12	1.2666679733815291	-3.977712158781781	1.4420517511845434	60	9	fdy@@`@AHgBScGqrJJIESQISLx{tAAT@E@@@	gJPHD@IVuP@	diDD`@xPCHhiEVjj@@	diDD`@xPCHhiEVjj@@								9
:UvzvzUzS:QTQvEUUP2fxQzU@rhoF9@Ig6DUl3S@tZc4Aj6JH_Fo2g8j4XHKeA0JCGm1FR290V01Fa#8!	CHEMBL178469	ffs`c@IV|BPQHXdLbdLRTttTvTPeNBdnZuPAELuUEJGHL@@	O=C1[C@H]2C3C=CC(C3)[C@H]2C(=O)N1c1cccc(C(F)(F)F)c1	7.46	group2-a	a	Androgen Receptor	Inhibition of T877A androgen receptor of human prostate cancer cells in reporter gene assay	2005	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdu``@D@UdTTTTRTRqhsUcA}EjjAjBJQFDq@@	307.27	2.4239	3	0	37.38	2	-1.576629624371366	0.6336663201959912	0.7164641503380961	47	10	fjc`c@IF\@IIxl\\bbbfJbbfrbxJwhyRVBHJfZjbeEez@@	gJPBAHJPt`PAIjj@@										10
:UvzfzUrSzjQTQvEESP2fxQzU@bhoH9@Ig2DUl3R@tZc4Aj6JH_Fo2g8j4XHKeA0L9Gk0FR290V01Fa&	CHEMBL178886	fb}`a@AZlBHYDYEDeDXhilhj\LxJXy`BJfZjbeAdz@@	O=C1[C@H]2C3C=CC(C3)[C@H]2C(=O)N1c1cc(Cl)cc(Cl)c1	7.39	group2-a	a	Androgen Receptor	Inhibition of T877A androgen receptor of human prostate cancer cells in reporter gene assay	2005	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdu``@D@UdTTTTRTRqhsUcA}EjjAjBJQFDq@@	308.163	2.7876	3	0	37.38	1	-1.7475763165898295	0.5325407130819257	0.6937219102290664	47	10	fjc`c@IF\@IIxl\\bbbfJbbfrbxJwhyRVBHJfZjbeEez@@	eFABH`BL@	eFABH`BL@									10
:UvzvzUzS:QTQvEUUP2fxQzU@rhoF9@Ig6DUl3S@tZc4Aj6JH_Fo2g8j4XHKeA0JCGm1FR290V01Fa#8!	CHEMBL178957	few`a`IQrBPQHXdGRGi@LadTabRbTtbbcrbDiIVc{Nj@HjjYjjJTIQX@	O=C1[C@H]2C3C=CC(C3)[C@H]2C(=O)N1c1cc(C(F)(F)F)cc(C(F)(F)F)c1	5.76	group4-ia	ia	Androgen Receptor	Inhibition of human androgen receptor of breast carcinoma MDA-453 cells in reporter gene assay	2005	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdu``@D@UdTTTTRTRqhsUcA}EjjAjBJQFDq@@	375.267	3.2722	3	0	37.38	3	-1.0999207108097204	-0.24926592425396205	0.8588800098986705	47	10	fjc`c@IF\@IIxl\\bbbfJbbfrbxJwhyRVBHJfZjbeEez@@	gJPBAHJPt`PAIjj@@	gJPBAHJPt`PAIjj@@									10
qNuH62818V0F!240N01VN0V%2020HFV58V#F968V!2$F2V!81210c10280V48#J#503#	CHEMBL1802077	fjm`PBH@PXLIQvQSQQIESQQIBddkPDCLDD@BDh	COc1ccccc1C(=O)/C=C/c1ccccc1[N+](=O)[O-]	6.12	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor in human LNCAP cells assessed as decrease in transmembrane protease serine 2 mRNA level after 20 hrs by real time RT-PCR analysis	2012	f`q@@@DjYW~UyIwjjjjjj@@	f`qA@@@ILrj}jISoM@a@@@BEH	283.282	2.3122	5	0	72.12	5	-0.17375421534698768	0.9238279813587389	1.0202498176006993	17	17	fbuA@`M@BYPOgEObdsJowL|sd\pDCSAA@@ar@	eMJA@Hz@		gChhhE`BRnRYh@								2
:UvzfzUzSzjQTQzUESP@QxQzUebhqN9Pvi@ETl3UAl4c4AjLJH_Fo2g8j4XHSe32R9GkVFT290V11Fa#4!	CHEMBL180681	fjc`b@AZlCDrJJIEQQSYQQgCNceIXBBifjjIdFcd@	Cc1cc(N2C(=O)[C@H]3C4C=CC(CC4)[C@H]3C2=O)ccc1Br	7.17	group2-a	a	Androgen Receptor	Inhibition of androgen receptor in human MDA-453 cells	2005	flm@@@LdbbRbeQbRXK`iJbfjjjjjjj@@	flm``@D@TdsLrrn}NVCZOdmUPMPLUBLKd@@	346.223	2.9867	3	0	37.38	1	-1.5565131522187423	0.27171370653847604	0.75738658041889	4	4	fjc`a@AZlCqHxiLs{LwlsNF]GJRpPESMUTSHMGH@	eFBH@c@@	eFACD`BL@									3
:UvzfzUrSzjQTQzUESP2vxQzU@bhoP9@Ii2EUl3TAtZc4Aj6JH_Fo3g8j4XHSeA0T9GkVFR290V11Fa#8!	CHEMBL180859	fb}`a@AZlBHIHILsoLwllxYpTqsA@ULuUEJCIt@@	O=C1[C@H]2C3C=CC(C3)[C@H]2C(=O)N1c1ccc(F)c(Cl)c1	7.48	group2-a	a	Androgen Receptor	Inhibition of T877A androgen receptor of human prostate cancer cells in reporter gene assay	2005	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdu``@D@UdTTTTRTRqhsUcA}EjjAjBJQFDq@@	291.708	2.2824	3	0	37.38	1	-1.810461374308744	0.8972612452651467	0.664012684189357	47	10	fjc`c@IF\@IIxl\\bbbfJbbfrbxJwhyRVBHJfZjbeEez@@	eFABH`BL@		eFABP`BL@								10
:UvzfzUrSzjQTQzUESP2fxAzU@bhoF9@Ii2DUl3R@tZc4@j6JH5Fo2g8j4XHKeA0J9GkVFR290V01FZ&	CHEMBL181674	ffk``@D@UdTTTTRTRqaRhsUcA}DmVjhFhH@JPQaLP@	O=C1[C@H]2C3C=CC(C3)[C@H]2C(=O)N1c1ccc2ccccc2c1	6.58	group3-int	int	Androgen Receptor	Inhibition of L701H/T877A mutant androgen receptor of human prostate cancer MDAMB-PCa2b cell proliferation	2005	ffk@@@LdbbRRlTTVtSA\e[r\ekUUUUUUUUP@@	ffk``@D@UdTTTTRTRqaRhsUcA}DmVjhFhH@JPQaLP@	289.333	2.77	3	0	37.38	1	-1.8459103832791657	0.6129484189232697	0.6626457705647292	3	1	ffk``@D@UdTTTTRTRqaRhsUcA}DmVjhFhH@JPQaLP@											1
:UvzfzUrSzjQTQzUESP2fxAzU@bhoF9@Ii2DUl3R@tZc4@j6JH5Fo2g8z4XHKeA0J9GkVFR290V01FZ%F	CHEMBL181722	ffkP`@DQ@kHhhhhdhecBeQfkFCyIZmUPMPP@T`cBX`@	O=C1[C@H]2C3C=CC(C3)[C@H]2C(=O)N1c1ccc2cccnc2c1	5.98	group4-ia	ia	Androgen Receptor	Inhibition of human androgen receptor of breast carcinoma MDA-453 cells in reporter gene assay	2005	ffk@@@LdbbRRlTTVtSA\e[r\ekUUUUUUUUP@@	ffkP`@DQ@kHhhhhdhecBeQfkFCyIZmUPMPP@T`cBX`@	290.321	1.8916	4	0	50.27	1	-1.3472670685875316	1.3527366087248052	0.7810494564512196	3	1	ffkP`@DQ@kHhhhhdhecBeQfkFCyIZmUPMPP@T`cBX`@											1
:UvzfzUrS:QTQvUUSQ2fxdzU@bhoN9@Iw2DUl3TAtZcBej6JH5Jq2g8j4XHKeQVR9GkVFR@90V11FV!3#	CHEMBL182186	fjcPPBHR@`shRcdfyWYf}g`k^ceIV`@jYjjJTVWh@	O=C1[C@H]2C3C=CC(C3)[C@H]2C(=O)N1c1ccc([N+](=O)[O-])cc1	6.75	group3-int	int	Androgen Receptor	Inhibition of L701H/T877A mutant androgen receptor of human prostate cancer MDAMB-PCa2b cell proliferation	2005	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdu``@D@UdTTTTRTRqhsUcA}EjjAjBJQFDq@@	284.27	0.654	6	0	83.2	2	-0.14314436245502396	2.4815864276798143	1.0516611074268198	47	10	fjc`c@IF\@IIxl\\bbbfJbbfrbxJwhyRVBHJfZjbeEez@@			gChhhE`BRnRYh@								10
zqvG@GOl8k4kVFABFs0V0N2H040F1V92442V10VV3FV!FG!2405VG25!V8B1F!4120841V085!L0VX0G0	CHEMBL1822155	ffsP`@EZAQJ[gvUeUnBlyI\uhHBj`@@@@@@	COc1ccc(C2Nc3cccc4cccc(c34)N2)cc1O	5.09	group4-ia	ia	Androgen Receptor	Displacement of SRC2-3 peptide from human AR ligand binding site expressed in Escherichia coli BL21 by AF2 FP assay	2011	flm@@@LdbbbbVIbRXhViFbfjjjjjjj@@	flmP@@@TrQQQQZISIFgIV]DJZB`@@@H@@@	292.337	2.6078	4	3	53.52	2	-0.3312867708295478	0.7761028560958192	-2.4376937870743163	5	5	fjcPA@IJAxd\TfY}eYUYgCVceIXHBj`@@@@@@	eFJB@Hp@	eMJA@Hz@									5
zqvG@GOl8F4kVFABFs0V0N2H040F1V92442010VV1FV!FG#405V124!V8B1#4120841V081!L0VX0G0	CHEMBL1822156	fjcP`@IJ@QIf]yVUVYpuhyRVB@jh@@@@@@	Oc1ccc(C2Nc3cccc4cccc(c34)N2)cc1O	4.51	group4-ia	ia	Androgen Receptor	Displacement of SRC2-3 peptide from human AR ligand binding site expressed in Escherichia coli BL21 by AF2 FP assay	2011	flm@@@LdbbbbVIbRXhViFbfjjjjjjj@@	flmP@@@TrQQQQZISIFgIV]DJZB`@@@H@@@	278.31	2.3321	4	4	64.52	1	-0.09771486623921816	1.1814900137545639	-3.547043436858452	5	5	fjcPA@IJAxd\TfY}eYUYgCVceIXHBj`@@@@@@	eFJB@Hp@	eFJB@Hp@									5
<7ztpdN5w0KfjSN0W2NHu5RNGW2534Iq0C0V02@Z861kW0XkVpX1M9I1c9EkGd550Yc045$1F440b0I0	CHEMBL1822157	fi{HP@DDXhA^crJJJZIIKZYJEPgK^sUjfB``@bY@DJH	CC1=NN(c2ccccc2)C(=O)/C1=N\Nc1ccc(C(=O)O)c(O)c1	4.58	group4-ia	ia	Androgen Receptor	Displacement of SRC2-3 peptide from human AR ligand binding site expressed in Escherichia coli BL21 by AF2 FP assay	2011	fbm@@@LdbbRbVjTRWMBTgMUUUUUUT@@	fbmI@@DDXhBSLwNkviNF\gKULDD@@`BED	338.322	3.4956	8	3	114.59	4	2.147583278248746	0.7615996185964327	-1.7955557034865104	1	1	fi{HP@DDXhA^crJJJZIIKZYJEPgK^sUjfB``@bY@DJH											1
:UvzfzUzSzjQTQzUESP2vxQzU@bhqN9@Ii2EUl3UAtZc4Aj6JH_Fo2g8j4XHSeA0R9GkVFT290V11Fa#4!	CHEMBL182236	fb}`b@AZlCDrJJIEQQSYQLxYpTqs@PULuUEJCIt@@	Cc1cc(N2C(=O)[C@H]3C4C=CC(C4)[C@H]3C2=O)ccc1Br	6.66	group3-int	int	Androgen Receptor	Inhibition of human androgen receptor of breast carcinoma MDA-453 cells in reporter gene assay	2005	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdu``@D@UdTTTTRTRqhsUcA}EjjAjBJQFDq@@	332.196	2.6447	3	0	37.38	1	-1.6142905165169381	0.5293229039139924	0.7325231121412444	47	10	fjc`c@IF\@IIxl\\bbbfJbbfrbxJwhyRVBHJfZjbeEez@@	eFBH@c@@		eFACD`BL@								10
:UvzvzUzS:QTQvEUUP@AxQzUerhoF9PvgDDTl3S@l4c4AjLJH_Fo2g8j4XHKe32JCGm1FR290V01Fa#8!	CHEMBL182412	fnk`c@IV|BPQHXdLbdLRTttTvTTDip\uJvj@HifjjIdN`T@	O=C1[C@H]2C3C=CC(CC3)[C@H]2C(=O)N1c1cccc(C(F)(F)F)c1	7.18	group2-a	a	Androgen Receptor	Inhibition of mutant T877A Androgen receptor in human LNCaP cells	2005	flm@@@LdbbRbeQbRXK`iJbfjjjjjjj@@	flm``@D@TdsLrrn}NVCZOdmUPMPLUBLKd@@	321.297	2.7659	3	0	37.38	2	-1.5188520993620143	0.3760570096517881	0.7413276688318894	4	4	fjc`a@AZlCqHxiLs{LwlsNF]GJRpPESMUTSHMGH@	gJPBAHJPt`PAIjj@@										3
:UvzfzUrSzjQTQzUESP2vxQzU@bhoP9@Ii2EUl3TAtZc4Aj6JH_Fo3g8j4XHSeA0T9GkVFR290V11Fa&	CHEMBL182593	fb}`a@AZlBHIDILsoLwllxYpTqsA@ULuUEJCIt@@	O=C1[C@H]2C3C=CC(C3)[C@H]2C(=O)N1c1ccc(Cl)c(Cl)c1	7.39	group2-a	a	Androgen Receptor	Inhibition of mutant T877A Androgen receptor in human LNCaP cells	2005	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdu``@D@UdTTTTRTRqhsUcA}EjjAjBJQFDq@@	308.163	2.7876	3	0	37.38	1	-1.7475763165898295	0.5325407130819257	0.6937219102290664	47	10	fjc`c@IF\@IIxl\\bbbfJbbfrbxJwhyRVBHJfZjbeEez@@	eFABH`BL@		eFABH`BL@								10
:UvzvzUzS:QTQvEUUP@fxQzUerhoF9PvgDDyl3S@t4c4AjLJH_Fo@g8j4XHKeA2JCGm1FR290V01Fa#N!	CHEMBL182993	fag`c@IV|BPQHXdLbdLRTttTvTTpeNCfiVm{U@DTsUUQMD]@hlZ`@	O=C1[C@H]2C3C=CC([C@@H]4C[C@H]34)[C@H]2C(=O)N1c1cccc(C(F)(F)F)c1	7.52	group2-a	a	Androgen Receptor	Inhibition of mutant T877A Androgen receptor in human LNCaP cells	2005	fbc@@@LdbbbTTZLRSNLdJRmIsUUUUUUUT@@	fbc``@D@TdsLrrnwSe`vc{LTmUPMPMEQDpnPtc@@	333.308	2.6693	3	0	37.38	2	-1.4510548158275938	0.3895872535832242	0.7605881636146185	1	1	fag`c@IV|BPQHXdLbdLRTttTvTTpeNCfiVm{U@DTsUUQMD]@hlZ`@											1
<xyyzviixbfEyztv4HjHPWx9qMmCb!2KmDTmIdZB9F94E12oW4F1B12_8e80484N2IF2FZ3VV4130N0c!	CHEMBL1830768	fjmac@EFCDD`bPqHYEHXhddUEEIKTTuPPYUMTTKT@@	CC1(C)COC(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1	6.95	group3-int	int	Androgen Receptor	Binding affinity to human androgen receptor	2011	dk\@@DjU^ykeNjjjj`@	dk\L@@RdfV~UImMjj@BHp`@	299.247	2.3578	4	0	59.32	3	-0.8595630762309681	0.8641168916738425	0.8734168339164063	31	1	fjmac@EFCDD`bPqHYEHXhddUEEIKTTuPPYUMTTKT@@											1
<xyyzviixbfEyztv4HjHPWx9qMmCb!2KmDTmIdZB9F94E12oW4F1B12_8e80484N2IF2FZ3VV4130N0c!	CHEMBL1830769	fjmac@EFCDD`bPqHYEHXhddUEEIKTTuPPYUMTTKP@	CC1(C)COC(=O)[C@@H]1Oc1ccc(C#N)c(C(F)(F)F)c1	7.16	group2-a	a	Androgen Receptor	Binding affinity to human androgen receptor	2011	dk\@@DjU^ykeNjjjj`@	dk\L@@RdfV~UImMjj@BHq@@	299.247	2.3578	4	0	59.32	3	-0.8595630762309681	0.8641168916738425	0.8734168339164063	31	1	fjmac@EFCDD`bPqHYEHXhddUEEIKTTuPPYUMTTKP@											1
<xyyzviixbfEyztv4HjHPWx9qMmCb!2KmDTmIdZB9F94E12oW4F1B12_8e80484N2IF2FZ3VV4130N0c!	CHEMBL1830770	fjmac@EFCDD`bPqHYEHXhddUEEIKTTuPPYUMTTKH@	CC1(C)COC(=O)[C@H]1Oc1ccc(C#N)c(C(F)(F)F)c1	6	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor by cell based assay	2011	dk\@@DjU^ykeNjjjj`@	dk\L@@RdfV~UImMjj@BHr@@	299.247	2.3578	4	0	59.32	3	-0.8595630762309681	0.8641168916738425	0.8734168339164063	31	1	fjmac@EFCDD`bPqHYEHXhddUEEIKTTuPPYUMTTKH@											1
[vyixbyEyztQJHjHPWx9rbmh781XMXDHmI9ZB9H95E12ZW4kWBA2l8@8!B4N2IF2FZYV24WY0NVcF0	CHEMBL1830771	fjmPc@EQLDD`bPqHYEHXhddUEEIKTTuPPYUMTTKT@@	CC1(C)CNC(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1	7.09	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor by cell based assay	2011	dk\@@DjU^ykeNjjjj`@	dk^D@DBdfV~UImMjj@BHp`@	298.263	2.2143	4	1	62.12	3	-0.5368746804841473	0.9606923466124629	-0.2085472200140817	31	16	ff}P``HUIpCbfPsHEdLbbbrbLRTrdUFN}TuU@AUWDJT@@											16
]yjxby;vQJHjvPjxAzbmhE81aMeDInIEZB9H9EEGHZl4mdBE2lP@82FB4N2IF3F_YV24WY0N0c!	CHEMBL1830772	ff}Pc@EQLDD`bPqHYEHXhddUEEIiZbfjBCJijhhVh@@	CN1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O	5.92	group4-ia	ia	Androgen Receptor	Binding affinity to human androgen receptor	2011	dk\@@DjU^ykeNjjjj`@	dk^D@DBdfV~UImMjj@BHp`@	312.29	2.4672	4	0	53.33	3	-0.8923657230918569	0.7060458823021393	0.8802019181753078	31	16	ff}P``HUIpCbfPsHEdLbbbrbLRTrdUFN}TuU@AUWDJT@@	eFBH@c@@										16
]yjxzy;vULMjvPjxAzbmxE81iMeDInnEZi9H9EEGHZl4mdBE6nP@82FB6N2IF3F_YV2ZWY0N0c!	CHEMBL1830773	fncPc@EQLDD`bPqHYEHXhddUEEIkKTTuPPYUMUQPmP@	CCN1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O	6.4	group3-int	int	Androgen Receptor	Binding affinity to human androgen receptor	2011	dk\@@DjU^ykeNjjjj`@	dk^D@DBdfV~UImMjj@BHp`@	326.317	2.8735	4	0	53.33	4	-0.6790765572023699	0.2889590605726724	0.9315075570203344	31	16	ff}P``HUIpCbfPsHEdLbbbrbLRTrdUFN}TuU@AUWDJT@@	eMBD@ch@										16
{xzy;vULUjvPjxjzbmxEN1iMeDInnEZi9HAEEGHZl4mdBE6nP@82FB6NHIF3F_YV2ZWY0N0c!	CHEMBL1830774	fasPc@EQLDD`bPqHYEHXhddUEEIjiZbfjBCJijjbaZ`@	CCCN1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O	7.62	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor by cell based assay	2011	dk\@@DjU^ykeNjjjj`@	dk^D@DBdfV~UImMjj@BHp`@	340.344	3.3279	4	0	53.33	5	-0.46805034779061094	-0.1570429710988017	0.9830639159877989	31	16	ff}P``HUIpCbfPsHEdLbbbrbLRTrdUFN}TuU@AUWDJT@@	gC`HL@IST@@										16
{xzy;vULUjvQjzjzbmxEN1iMeDInnEZi9HAEEGHZl4mdBE6nP@82FB6NHIF3F_YV2ZWY0N0c!	CHEMBL1830775	fikPc@EQLDD`bPqHYEHXhddUEEIjeKTTuPPYUMUUEBu@@	CCCCN1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O	8	group1-p	p	Androgen Receptor	Antagonist activity at human androgen receptor by cell based assay	2011	dk\@@DjU^ykeNjjjj`@	dk^D@DBdfV~UImMjj@BHp`@	354.371	3.7823	4	0	53.33	6	-0.2570241495965635	-0.6030451460952493	1.034620276197772	31	16	ff}P``HUIpCbfPsHEdLbbbrbLRTrdUFN}TuU@AUWDJT@@	gJPHB@IRuP@										16
}y;vULUjvQjzjzbmxEN1iMeDInvEZi9HAEEGHZl4mdBE6nP@82FB6NHIF3F_YV2ZWY0N0c!	CHEMBL1830776	fe{Pc@EQLDD`bPqHYEHXhddUEEIjdiZbfjBCJijjjJEj@@	CCCCCN1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O	6.57	group3-int	int	Androgen Receptor	Binding affinity to human androgen receptor	2011	dk\@@DjU^ykeNjjjj`@	dk^D@DBdfV~UImMjj@BHp`@	368.398	4.2367	4	0	53.33	7	-0.04599795140251606	-1.0490473210916966	1.0861766364077454	31	16	ff}P``HUIpCbfPsHEdLbbbrbLRTrdUFN}TuU@AUWDJT@@	gGPHJ@IRmU@@										16
}y;vULUjzQjzjzbmxEN1iMeDInvEZi9HAEEGHZl4mdBE6nP@82FB6NHIFAF_YV2ZWY0N0c!	CHEMBL1830777	fmgPc@EQLDD`bPqHYEHXhddUEEIjdeKTTuPPYUMUUTTKT@@	CCCCCCN1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O	6.12	group3-int	int	Androgen Receptor	Binding affinity to human androgen receptor	2011	dk\@@DjU^ykeNjjjj`@	dk^D@DBdfV~UImMjj@BHp`@	382.425	4.6911	4	0	53.33	8	0.16502808608037545	-1.4950493829194575	1.1377329464015706	31	16	ff}P``HUIpCbfPsHEdLbbbrbLRTrdUFN}TuU@AUWDJT@@	gNpHF@IRkUT@@										16
}y;vUTUjvUjzjzbqxUt1iMeiInnEZi9HAUEGHZlCudBE6nP@BXFB6NHIF3FpYk2ZWY0N0c!	CHEMBL1830778	fe{Pc@EQLDD`bPqHYEHXhddUEEIkEiZbfjBCJijjjH@@	CCCC(C)N1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O	8.22	group1-p	p	Androgen Receptor	Antagonist activity at human androgen receptor by cell based assay	2011	dk\@@DjU^ykeNjjjj`@	dk^D@DBdfV~UImMjj@B@@	368.398	4.1416	4	0	53.33	6	-0.20006060416271454	-0.8710544033646039	1.0595739536037578	31	2	ff}P``HUIpCbfPsHEdLbbbrbLRTrdUFN}TuU@AUW@@@	gGPHL@YIDZj@@										2
{xzy;vULUjvTjxjzbqxUt1iMeiInnEZi9HAUEGHZlCudBE6nP@BXFB6NHIF3FpYk2ZWY0N0c!	CHEMBL1830779	fikPc@EQLDD`bPqHYEHXhddUEEIkEKTTuPPYUMUUD@@	CCC(C)N1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O	7.5	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor by cell based assay	2011	dk\@@DjU^ykeNjjjj`@	dk^D@DBdfV~UImMjj@B@@	354.371	3.6872	4	0	53.33	5	-0.4110868023567621	-0.4250522283681563	1.0080175933937845	31	2	ff}P``HUIpCbfPsHEdLbbbrbLRTrdUFN}TuU@AUW@@@	gJPHL@ITuP@										2
}y;vULUjvQ:jzbqxENWiMeDInnEhi9HAUEGHZl4mdBE6nP@82FB6NHIF3F_YV2ZWY0N0c!	CHEMBL1830780	fmgPc@EQLDD`bPqHYEHXhddUEEIjheKTTuPPYUMUUTTKT@@	CCC(CC)CN1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O	6.35	group3-int	int	Androgen Receptor	Binding affinity to human androgen receptor	2011	dk\@@DjU^ykeNjjjj`@	dk^D@DBdfV~UImMjj@BHp`@	382.425	4.455	4	0	53.33	7	0.017599565414016638	-1.2322943625303497	1.1103954464708132	31	16	ff}P``HUIpCbfPsHEdLbbbrbLRTrdUFN}TuU@AUWDJT@@	gNpHF@ITkUT@@										16
}y;vUTUjvQjzjzbqxEN1iMeDInvEZi9HAEEGHZl4mdBE6nP@82FB6NHIF3HhYV2ZWY0N0c!	CHEMBL1830781	fmgPc@EQLDD`bPqHYEHXhddUEEIjdiKTTuPPYUMUUTTKT@@	CC(C)CCCN1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O	6.1	group3-int	int	Androgen Receptor	Binding affinity to human androgen receptor	2011	dk\@@DjU^ykeNjjjj`@	dk^D@DBdfV~UImMjj@BHp`@	382.425	4.455	4	0	53.33	7	0.017599565414016638	-1.2322943625303497	1.1103954464708132	31	16	ff}P``HUIpCbfPsHEdLbbbrbLRTrdUFN}TuU@AUWDJT@@	gNpHF@YIDUUT@@										16
{xzy;vUqUjvPjxjzbmxER1iUeEInnEZi9mAEjGmZl4udBE2nP@82FgZN6IF3F_YV2ZWY0P0c!	CHEMBL1830782	fasQc@EQLEhIADabPrJPqQIHjJJSURuEMTDFUSUUEBu@@	COCN1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O	6.29	group3-int	int	Androgen Receptor	Binding affinity to human androgen receptor	2011	dk\@@DjU^ykeNjjjj`@	dk^D@DBdfV~UImMjj@BHp`@	342.316	2.3941	5	0	62.56	5	-0.02048530274848573	0.5855530093488648	1.0934818079069741	31	16	ff}P``HUIpCbfPsHEdLbbbrbLRTrdUFN}TuU@AUWDJT@@	gCaHA`AJZ`@										16
{xzy;vULUjvQjzjzbmxENWiMeDIrnEai9HAEEGHZl4mdBE6nP@82FB6N2IF3F_YV2ZWf0N0c!	CHEMBL1830783	fikQc@EQLGhIADabPrJPqQIHjJJSUJVhij``rjZjjJEj@@	COCCN1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O	5.75	group4-ia	ia	Androgen Receptor	Binding affinity to human androgen receptor	2011	dk\@@DjU^ykeNjjjj`@	dk^D@DBdfV~UImMjj@BHp`@	356.343	2.3747	5	0	62.56	6	0.21283325513341972	0.4243750776301312	1.142568928931337	31	16	ff}P``HUIpCbfPsHEdLbbbrbLRTrdUFN}TuU@AUWDJT@@	gJQH@PAJ^j@@										16
{xzy;vULUjvQjzjzbmxENWiMeDIznEai9HAEEGHZl4mdBE6nP@82FB6N2IF3F_YV2ZWf0N0c!	CHEMBL1830784	fikP``BCxh@QVP[H]dLdVTTVTQbRfTbEJJZjfjh@Jjx`J`@	CSCCN1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O	5.61	group4-ia	ia	Androgen Receptor	Binding affinity to human androgen receptor	2011	dk\@@DjU^ykeNjjjj`@	dk^D@DBdfV~UImMjj@BHp`@	372.41	3.0227	4	0	78.63	6	0.2806330685559135	-0.027726472902034505	1.1247437130833031	31	16	ff}P``HUIpCbfPsHEdLbbbrbLRTrdUFN}TuU@AUWDJT@@	gJPD@DD@Rgj`@										16
{xzy;vULUjvQjzjzbmxENWiMeDInnEZi9HAEEGHZl4mdBE6nP@86FB6NHIF3F_YV2ZWY0N2c10	CHEMBL1830785	fikQc@EQLDXIADabPrJPqQIHjJJSUJVhij``rjZjjJEj@@	CC1(C)CN(CCCO)C(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1	6.28	group3-int	int	Androgen Receptor	Binding affinity to human androgen receptor	2011	dk\@@DjU^ykeNjjjj`@	dk^D@DBdfV~UImMjj@BHp`@	356.343	2.4012	5	1	73.56	6	0.6645924420052318	0.4752548535833397	0.08398245538687343	31	16	ff}P``HUIpCbfPsHEdLbbbrbLRTrdUFN}TuU@AUWDJT@@	gJQH@PAIVj@@										16
{x>ULUjvQjzjzbmxEPWjMeEQrnEaidHAEEKHgn4mdBE6nP@8@GB6s2IJ3F_YV2ZWf0N0c!	CHEMBL1830786	fe{PS@EQLGhpRBICDadTabbRQTTTfjfejJZhHLjfjihhVh@@	COC(=O)CN1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O	6.52	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor expressed in human LNAR cells assessed as inhibition of R1881-induced luciferase activity by spectrophotometry	2012	dk\@@DjU^ykeNjjjj`@	dk^D@DBdfV~UImMjj@BHp`@	370.326	2.0251	6	0	79.63	6	0.8222606781627159	0.8287476244520466	1.295751333830524	31	16	ff}P``HUIpCbfPsHEdLbbbrbLRTrdUFN}TuU@AUWDJT@@	gGPh@j@ILkU@@										16
{x>ULUjvQjzjzbmxjPWjMeEQrvEaidHAEEKHgn4mdBE6nP@8@GB6s2IJ3F_YV2ZWf0N0c!	CHEMBL1830787	fmgPS@EQLGhpRBICDadTabbRQTTTfjfTmQSUAAeTuUMQPmP@	CCOC(=O)CN1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O	5.45	group4-ia	ia	Androgen Receptor	Binding affinity to human androgen receptor	2011	dk\@@DjU^ykeNjjjj`@	dk^D@DBdfV~UImMjj@BHp`@	384.353	2.4314	6	0	79.63	7	1.0355500047633588	0.41166068955389346	1.3470570228916983	31	16	ff}P``HUIpCbfPsHEdLbbbrbLRTrdUFN}TuU@AUWDJT@@	gNph@j@ILjuT@@										16
{xzy<ULUjvQjzjzbmxEPWjMeEIrvEaidHAEEKHgn4mdBE6nu@8@GB6s2IJ3F_YV2ZWf0NVcF0	CHEMBL1830788	fmgqc@EQFXOPRBICDadTabbRQTTTfjfTmQSUAAeTuUMQPmP@	CCNC(=O)CN1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O	5.31	group4-ia	ia	Androgen Receptor	Binding affinity to human androgen receptor	2011	dk\@@DjU^ykeNjjjj`@	dk^D@DBdfV~UImMjj@BHp`@	383.369	1.9572	6	1	82.43	6	1.215260904732978	0.8278596758378292	0.23726247616088889	31	16	ff}P``HUIpCbfPsHEdLbbbrbLRTrdUFN}TuU@AUWDJT@@	gNyHDJ@ILjuT@@										16
]yjxzy;vULMjvPjxAzbmxE81jMeEInnUZi9H9EEGHZl4mdBE6nP@82GB6N6IF3F_YV2ZWY0N0c!	CHEMBL1830789	fcoPc@EQLDD`bPqHYEHXhddUEEIjhdiZbe^zhHLjfjh@BHVh@@	CC1(C)CN(Cc2ccccc2)C(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1	7.96	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor by cell based assay	2011	fbm@@@LdbRVfbQTRUNJLgMUUUUUUT@@	fbm``@D@XdsMoLjnSgdqruUT@@@PPpP@	388.388	3.8853	4	0	53.33	5	-0.24126775433564432	-0.670285285851605	1.0650243657950587	17	11	eohTDF@EGk@`@dcqx\]i@zPndLbbbtJTTVTQbRfTbXD\|zF``bjZj`@jkH`\h@@											11
]yjxzy;vULMzvPjxAzjnxE8GjrfEInnUZj9H9EEIIZl4mfBE6nP@N3GB6N6IF3F_YV6Z_YJN0c!	CHEMBL1830937	eg`TLL@EHc@i`IABPpdLbdLTRRJbbduTTRTfdRVuuTDFUSUTDDDPVT@@	COc1ccccc1CN1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O	6.53	group3-int	int	Androgen Receptor	Binding affinity to human androgen receptor	2011	fbm@@@LdbRVfbQTRUNJLgMUUUUUUT@@	fbm``@D@XdsMoLjnSgdqruUT@@@PPpP@	418.414	3.8153	5	0	62.56	6	0.47192965105329915	-0.6718180744768399	1.2522133384253455	17	11	eohTDF@EGk@`@dcqx\]i@zPndLbbbtJTTVTQbRfTbXD\|zF``bjZj`@jkH`\h@@	eMJA@Hz@										11
]yjxzy;vULMjvPjxAzbmxE81jMeEInnUZi9H9EEGHZl4mdBE6nP@82GB6N6IF3F_YV2ZWY0N0c!	CHEMBL1830938	eg`TLL@EHc@m`IABPpdLbdLTRRJbbduTRTtfdRRquTDFUSUT@QDPVT@@	COc1cccc(CN2CC(C)(C)C(Oc3ccc(C#N)c(C(F)(F)F)c3)C2=O)c1	6.96	group3-int	int	Androgen Receptor	Binding affinity to human androgen receptor	2011	fbm@@@LdbRVfbQTRUNJLgMUUUUUUT@@	fbm``@D@XdsMoLjnSgdqruUT@@@PPpP@	418.414	3.8153	5	0	62.56	6	0.47192965105329915	-0.6718180744768399	1.2522133384253455	17	11	eohTDF@EGk@`@dcqx\]i@zPndLbbbtJTTVTQbRfTbXD\|zF``bjZj`@jkH`\h@@		eMJA@Hz@									11
]yjxzy;vULMjvPjxAzbmxE81jMeEInnUZi9H9EEGHZp4mdBE6nP@8HGB6N6IF3F_YV2ZWn0N0c!	CHEMBL1830939	eg`TLL@EHc@c`IABPpdLbdLTRRJbbduTRVTfdRRvuTDFUSUT@EDPVT@@	COc1ccc(CN2CC(C)(C)C(Oc3ccc(C#N)c(C(F)(F)F)c3)C2=O)cc1	6.55	group3-int	int	Androgen Receptor	Binding affinity to human androgen receptor	2011	fbm@@@LdbRVfbQTRUNJLgMUUUUUUT@@	fbm``@D@XdsMoLjnSgdqruUT@@@PPpP@	418.414	3.8153	5	0	62.56	6	0.47192965105329915	-0.6718180744768399	1.2522133384253455	17	11	eohTDF@EGk@`@dcqx\]i@zPndLbbbtJTTVTQbRfTbXD\|zF``bjZj`@jkH`\h@@			eMJA@Hz@								11
]yjxzy;vULMzvPjxAzjnxE81jMfEInnUZi9H9EEIIZl4mdBE6nP@82GB6N6IF3F_YV2ZWYFN0c!	CHEMBL1830940	fkP``AGtxDaNPWH[dLbbbRLTVTQbRfTbYpujm`HJfjh@JjrHFh@@	CC1(C)CN(Cc2ccccc2F)C(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1	6.76	group3-int	int	Androgen Receptor	Binding affinity to human androgen receptor	2011	fbm@@@LdbRVfbQTRUNJLgMUUUUUUT@@	fbm``@D@XdsMoLjnSgdqruUT@@@PPpP@	406.378	3.9861	4	0	53.33	5	-0.15127186209412377	-0.7975935662817066	1.0951518992649738	17	11	eohTDF@EGk@`@dcqx\]i@zPndLbbbtJTTVTQbRfTbXD\|zF``bjZj`@jkH`\h@@	eFABP`BL@										11
]yjxzy;vULMjvPjxAzbmxE81jMeEInnUZi9H9EEGHZl4mdBE6nP@82GB6N6IF3F_YV2ZWY0N0c!	CHEMBL1830941	fkP``AGtxDaNPWH[dLbbRaTTVTQbRfTbhpujm`@jfjh@JjrHFh@@	CC1(C)CN(Cc2cccc(F)c2)C(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1	7.21	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor by cell based assay	2011	fbm@@@LdbRVfbQTRUNJLgMUUUUUUT@@	fbm``@D@XdsMoLjnSgdqruUT@@@PPpP@	406.378	3.9861	4	0	53.33	5	-0.15127186209412377	-0.7975935662817066	1.0951518992649738	17	11	eohTDF@EGk@`@dcqx\]i@zPndLbbbtJTTVTQbRfTbXD\|zF``bjZj`@jkH`\h@@		eFABP`BL@									11
]yjxzy;vULMjvPjxAzbmxE81jMeEInnUZi9H9EEGHZp4mdBE6nP@82GB6N6IF3F_YV2ZWn0N0c!	CHEMBL1830942	fkP``AGtxDaNPWH[dLbbRrTTVTQbRfTbhpujm`@jfjh@JjrHFh@@	CC1(C)CN(Cc2ccc(F)cc2)C(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1	6.84	group3-int	int	Androgen Receptor	Binding affinity to human androgen receptor	2011	fbm@@@LdbRVfbQTRUNJLgMUUUUUUT@@	fbm``@D@XdsMoLjnSgdqruUT@@@PPpP@	406.378	3.9861	4	0	53.33	5	-0.15127186209412377	-0.7975935662817066	1.0951518992649738	17	11	eohTDF@EGk@`@dcqx\]i@zPndLbbbtJTTVTQbRfTbXD\|zF``bjZj`@jkH`\h@@			eFABP`BL@								11
]yjxzy;vULMzvPjxAzjnxE81jMfEInnUZi9H9EEIIZl4mfBE6nP@82GB6N6IF3F_YV2ZWYJN2c10	CHEMBL1830943	fkQc@EQLFXIADabPrJPqQIHjJJSUQQZVhiv^jBCJijjB@HaZ`@	CC1(C)CN(Cc2ccccc2O)C(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1	7.77	group2-a	a	Androgen Receptor	Binding affinity to human androgen receptor	2011	fbm@@@LdbRVfbQTRUNJLgMUUUUUUT@@	fbm``@D@XdsMoLjnSgdqruUT@@@PPpP@	404.387	3.5396	5	1	73.56	5	0.7055015556436289	-0.2664309168180954	0.14286368864120919	17	11	eohTDF@EGk@`@dcqx\]i@zPndLbbbtJTTVTQbRfTbXD\|zF``bjZj`@jkH`\h@@	eFJB@Hp@										11
]yjxzy;vULMjvPjxAzbmxE81jMeEInnUZi9H9EEGHZl4mdBE6nP@82GB6N6IF3F_YV2ZWY0N2c10	CHEMBL1830944	fkQc@EQLGXIADabPrJPqQIHjJJSUQIRVhiV^jBCJijj@HHaZ`@	CC1(C)CN(Cc2cccc(O)c2)C(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1	7.96	group2-a	a	Androgen Receptor	Binding affinity to human androgen receptor	2011	fbm@@@LdbRVfbQTRUNJLgMUUUUUUT@@	fbm``@D@XdsMoLjnSgdqruUT@@@PPpP@	404.387	3.5396	5	1	73.56	5	0.7055015556436289	-0.2664309168180954	0.14286368864120919	17	11	eohTDF@EGk@`@dcqx\]i@zPndLbbbtJTTVTQbRfTbXD\|zF``bjZj`@jkH`\h@@		eFJB@Hp@									11
]yjxzy;vULMjvPjxAzbmxE81jMeEInnUZi9H9EEGHZp4mdBE6nP@82GB6N6IF3F_YV2ZWn0N2c10	CHEMBL1830945	fkQc@EQLDxIADabPrJPqQIHjJJSUQIZVhiWnjBCJijj@BHaZ`@	CC1(C)CN(Cc2ccc(O)cc2)C(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1	7.77	group2-a	a	Androgen Receptor	Binding affinity to human androgen receptor	2011	fbm@@@LdbRVfbQTRUNJLgMUUUUUUT@@	fbm``@D@XdsMoLjnSgdqruUT@@@PPpP@	404.387	3.5396	5	1	73.56	5	0.7055015556436289	-0.2664309168180954	0.14286368864120919	17	11	eohTDF@EGk@`@dcqx\]i@zPndLbbbtJTTVTQbRfTbXD\|zF``bjZj`@jkH`\h@@			eFJB@Hp@								11
]yjxzy;vULMjvPjxAzbmxE81jMeEIvnUZi9H9EEGHZp4mdBE6nP@8HGB6N6IF3F_YV2ZWn0N0c!	CHEMBL1830946	eg`TDB@IKcO@@aZPvdCiCIELedhhlhcDeLiDqqXxuuP@USUT@EUYDEe@@	CSc1ccc(CN2CC(C)(C)C(Oc3ccc(C#N)c(C(F)(F)F)c3)C2=O)cc1	7.29	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor by cell based assay	2011	fbm@@@LdbRVfbQTRUNJLgMUUUUUUT@@	fbm``@D@XdsMoLjnSgdqruUT@@@PPpP@	434.481	4.3625	4	0	78.63	6	0.5444719838841064	-1.0633238629305155	1.2338627583443067	17	11	eohTDF@EGk@`@dcqx\]i@zPndLbbbtJTTVTQbRfTbXD\|zF``bjZj`@jkH`\h@@			eMA@HPBN`@								11
]yjxzy;vULMjvPjxAzbmxE81jMeEInnUZi9H9EEGHZl4mdBU6nP@82GB6N6IF3F_YV2ZWY0N0c0F	CHEMBL1830947	fcopc@EQzXHIADabPrJPqQIHjJJSUQIRuEJ}uPPYUMUP@DPmP@	CC1(C)CN(Cc2ccccn2)C(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1	6.12	group3-int	int	Androgen Receptor	Binding affinity to human androgen receptor	2011	fbm@@@LdbRVfbQTRUNJLgMUUUUUUT@@	fbmP`@DJ@qIf[^YU\gOIcejjh@@@`a``@	389.376	2.9384	5	0	66.22	5	0.260598515413016	0.11068153041598588	1.183071067144429	17	1	fcopc@EQzXHIADabPrJPqQIHjJJSUQIRuEJ}uPPYUMUP@DPmP@											1
]yjxzy;vULMjvPjxAzbmxE81jMeEInnUZi9H9EEGHZl4mdBU6nP@82GB6N6IF3F_YV2ZWY0N0c0F	CHEMBL1830948	fcopc@EQfXHIADabPrJPqQIHjJJSUQIRuEJ}uPPYUMUP@DPmP@	CC1(C)CN(Cc2cccnc2)C(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1	6.06	group3-int	int	Androgen Receptor	Binding affinity to human androgen receptor	2011	fbm@@@LdbRVfbQTRUNJLgMUUUUUUT@@	fbmP`@DN@qIf[^YU\gOIcejjh@@@`a``@	389.376	2.8844	5	0	66.22	5	0.26313924852393294	0.14314363363281746	1.1827896476342283	17	1	fcopc@EQfXHIADabPrJPqQIHjJJSUQIRuEJ}uPPYUMUP@DPmP@											1
]yjxzy;vULMjvPjxAzbmxE81jMeEInnUZi9H9EEGHZl4mdBU6nP@82GB6N6IF3F_YV2ZWY0N0c0F	CHEMBL1830949	fcopc@EQvXHIADabPrJPqQIHjJJSUQIRuEJ}uPPYUMUP@DPmP@	CC1(C)CN(Cc2ccncc2)C(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1	6.89	group3-int	int	Androgen Receptor	Binding affinity to human androgen receptor	2011	fbm@@@LdbRVfbQTRUNJLgMUUUUUUT@@	fbmP`@DI@qIf[^YU\gOIcejjh@@@`a``@	389.376	2.8844	5	0	66.22	5	0.26313924852393294	0.14314363363281746	1.1827896476342283	17	1	fcopc@EQvXHIADabPrJPqQIHjJJSUQIRuEJ}uPPYUMUP@DPmP@											1
{x>ULUjvQj;jmxjPYzMfEQrvEaihHAEUpHwv4mxBE6nPA8@lC6N2QJ3J_nVHZWf0N0c0V	CHEMBL1830950	e`TTJL@EHc@nck`IABPpdLbdLTRRJbbduTRVfTfdRTruTDFUSUUMSTSAYP@@	CCOC(=O)c1ccc(CN2CC(C)(C)C(Oc3ccc(C#N)c(C(F)(F)F)c3)C2=O)o1	6.78	group3-int	int	Androgen Receptor	Binding affinity to human androgen receptor	2011	flu@@@LdbRVfbQTRiqQhijjjjjjj@@	flua`@D@XkHhhiehhddR\]zJVjjiB`IHXH@@	450.412	3.4473	7	0	92.77	8	1.9502994086119372	-0.3476000794721911	1.6091493841395719	4	1	e`TTJL@EHc@nck`IABPpdLbdLTRRJbbduTRVfTfdRTruTDFUSUUMSTSAYP@@											1
{x>UqUjvvj;jmxETnzMfEQznEaihIAjErPgv4mxBU6vQQNAlC6s2QJMJ_YVHZWf0N0c0V	CHEMBL1830951	eoh\BB@LFGeMC@`@cZPNdKiCIEEdhhhmeLXdieHlJKGNajYjfZjh@JjzHKJ@@	COC(=O)c1csc(CN2CC(C)(C)C(Oc3ccc(C#N)c(C(F)(F)F)c3)C2=O)n1	6.67	group3-int	int	Androgen Receptor	Binding affinity to human androgen receptor	2011	flu@@@LdbRVfbQTRiqQhijjjjjjj@@	fluPb@LLdX@PeLL~rnJJuEMLuMT@EDET@@	453.44	2.6824	7	0	120.76	7	2.2938839234302186	0.42712562467893334	1.655285021931386	4	1	eoh\BB@LFGeMC@`@cZPNdKiCIEEdhhhmeLXdieHlJKGNajYjfZjh@JjzHKJ@@											1
{xzy<UMUzvvj;jnxEPYzrjEnznEaijHAjErIgv4mhBUanQAd@GC7P2QJ7N_YWHZWf0N0c0V	CHEMBL1830952	eod\DB@JIGk@`@cZPNdKiCIEEDlmMEeDXdieHlJAEGONajA`bfjh@JjxbAr`@	CC1(C)CN(Cc2nc3ccccc3s2)C(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1	7.29	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor by cell based assay	2011	fnk@@@LdbRVfbQTRRRiqQhijvjjjjjjjj`@@	fnkPb@JRlD@PeLr{wOlkb`eN}Um@pQSU@ADP]P@	445.464	3.8925	5	0	94.46	5	0.9652847333787287	-0.46371985299472934	1.3522178713412567	1	1	eod\DB@JIGk@`@cZPNdKiCIEEDlmMEeDXdieHlJAEGONajA`bfjh@JjxbAr`@											1
{xzy<UqUjvujx:jmxETnzMfEIvnEbi9IAjEIPgvZmxBU6nvPNAGC6N2QF7F_YV2ZWf0N0c0V	CHEMBL1830953	fcop``L\vjp@`\aNPWHYHhbeEEeDXdieHlTtXmZYjfjh@JjzHZh@@	Cc1nc(CN2CC(C)(C)C(Oc3ccc(C#N)c(C(F)(F)F)c3)C2=O)cs1	6.49	group3-int	int	Androgen Receptor	Binding affinity to human androgen receptor	2011	flu@@@LdbRVfbQTRiqQhijjjjjjj@@	fluPb@LLdX@PeKkL~rnBJuEMKUMT@EDET@@	409.431	3.1133	5	0	94.46	5	0.8121901465990146	0.13831651903449244	1.288865441480272	4	1	fcop``L\vjp@`\aNPWHYHhbeEEeDXdieHlTtXmZYjfjh@JjzHZh@@											1
{xzy<UrUjvujx:jmxETrzMfEInnUbiCIfjEIPgvZqxBU7nvPNAlC6P2QF3J_YV2aWf0N1c0V	CHEMBL1830954	ehRRLL@EHnac@i`IABPpdLbdLTRRJbbduTRrbRdtbRfV~Aj``rjZjff@@h`lh@@	CC1(C)CN(Cc2noc(-c3ccccc3)n2)C(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1	7.4	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor by cell based assay	2011	fig@@@LdbbRRqTTRJbRxhToQzNjjjjjjjjj@@	figq`@DJtAcdfYmyeW^uIqwhyzMjji`dH@B`a``@	456.423	3.7044	7	0	92.25	6	1.6444199949360545	-0.2866129495428273	1.5668425167854463	4	1	ehRRLL@EHnac@i`IABPpdLbdLTRRJbbduTRrbRdtbRfV~Aj``rjZjff@@h`lh@@											1
{xzy<UMUjvvj;jmxEPnzMjEIrnEaihIfjErPgv4mhBU6vQANElC6P2QJ3F_YVHaWf0N1c0V	CHEMBL1830955	ehRRLL@EHaic@n`IABPpdLbdLTRRJbbduTRrbRdtbRfV~Aj``rjZjij@@d`lh@@	CC1(C)CN(Cc2nc(-c3ccccc3)no2)C(=O)C1Oc1ccc(C#N)c(C(F)(F)F)c1	7.27	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor by cell based assay	2011	fig@@@LdbbRRqTTRJbRxhToQzNjjjjjjjjj@@	figq`@DZ\AbdfYmyeW^uIqwhyzMjjjPhH@BPa``@	456.423	3.7044	7	0	92.25	6	1.6444199949360545	-0.2866129495428273	1.5668425167854463	4	1	ehRRLL@EHaic@n`IABPpdLbdLTRRJbbduTRrbRdtbRfV~Aj``rjZjij@@d`lh@@											1
:Uvzv:rS:vTvzUzSvQfzjzUizjoNSzvz@DjlbTAvwdgyzqKmCLz@gBjJXMK:Yw9KoVRR@C1k9WNgc03#	CHEMBL183173	ec`\J@DHCF`D@dmhIPyInYYwn[vYqIMKHlfanif`@@bfZjjPiPbVT@@	CN1C(=O)C2C=CC1[C@@H]1C(=O)N(c3ccc([N+](=O)[O-])c4ccccc34)C(=O)[C@H]21	5.07	group4-ia	ia	Androgen Receptor	Inhibition of androgen dependent human prostate cancer cell MDA-MB-PCa2b proliferation	2005	fag@@@LdbbbTVtTNtTSMBM[vZe[UUUUUUUUU@@@	fagQ`@DFAjvQQJJ[JKZJIQFgFBT[IV}ZjjfX@@AhDLPh@	377.355	0.625	8	0	103.51	2	1.164666675988558	2.5445143519633797	1.4334676894999225	1	1	ec`\J@DHCF`D@dmhIPyInYYwn[vYqIMKHlfanif`@@bfZjjPiPbVT@@											1
yqupT59G8k5k41@5F80K0N@H04!1Y9@02PV58c038V8601V!FV12GL10V09BW0V90A0ZV64V@4K1065F$	CHEMBL1835807	ffc``@M@QdTRTrRRbbRQhrRbuZd@JhJ@`@@	CCN(CC)c1cc2oc(=O)ccc2cc1-c1ccccc1	5	group4-ia	ia	Androgen Receptor	Displacement of [3H]DHT from human recombinant androgen receptor-LBD expressed in Escherichia coli after 18 hrs by liquid scintillation counting	2011	fhy@@@DjYU_mVRxKpZjjjjjh@@	fhy@`@@HRYVuvUhrRoAZd@H@H@@@	293.365	3.8656	3	0	29.54	4	-1.5267115754175635	-0.48060100478613965	0.733355105143983	3	1	ffc``@M@QdTRTrRRbbRQhrRbuZd@JhJ@`@@											1
yqupT59G8k5k41@5FN0K0N@H04F01Y9@0HPV58c83NV960WV02GVC2KL10V89TlFV90A2ZV64V@4K14L5F#V	CHEMBL1835832	fj}`b@AQJ@HrQQJFIQIIHxeEVSfiP`hjfX`@@	CCN(CC)c1cc2oc(=O)ccc2cc1-c1cccs1	5.01	group4-ia	ia	Androgen Receptor	Displacement of [3H]DHT from human recombinant androgen receptor-LBD expressed in Escherichia coli after 18 hrs by liquid scintillation counting	2011	f`i@@@DjYU_mYK`g^jjjjjj@@	f`i@b@C^@DYHheBeLebTdjsje@BfX`@@	299.393	3.8891	3	0	57.78	4	-1.0418651284349798	-0.3099356756355713	0.8152793148571175	4	1	fj}`b@AQJ@HrQQJFIQIIHxeEVSfiP`hjfX`@@											1
:UvzvzUzS:QTQvEMUPAAxQUUer_oF9PfgDDql3S2WZc4AbqJF_FJ2g8j4XH5c22JCGm1FB280V01Fa#8!	CHEMBL183882	fa{`c@IV|BPQHXdLbdLRTttTvTTPeNBUm^uPAELuUTUH]@h@	O=C1[C@H]2C3CCCC(CC3)[C@H]2C(=O)N1c1cccc(C(F)(F)F)c1	6.18	group3-int	int	Androgen Receptor	Inhibition of androgen receptor in human MDA-453 cells	2005	fb}@@@LdbbRbbJlRWABMIR\uUUUUUUT@@	fb}``@D@TdsLrrnkSeh~rEKUTCTEQQHpnP@	337.34	3.3833	3	0	37.38	2	-1.4634157084565764	-0.05458462110099008	0.7709437026876684	1	1	fa{`c@IV|BPQHXdLbdLRTttTvTTPeNBUm^uPAELuUTUH]@h@											1
xvojgyqXbEue9cxVVAz@Cj_1rOoXPw0GFsFOst12g8tZJ4@RNo@C0k0FF!80F252#8N4&V8#2010	CHEMBL184228	ffs@`@@URYVumfv^cIJmyIVfijjjjjkFeyIP@	CC[C@H]1C[C@@]2(C)C(CC[C@@H]2O)C2CCC3=CC(=O)CCC3=C21	8.7	group1-p	p	Androgen Receptor	Inhibition of human androgen receptor expressed in Escherichia coli	2004	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmMSUUUU@@@	300.44	3.9548	2	1	37.3	1	-1.8131576842967418	-0.27579674441858737	-0.4883763666363292	50	5	fjc@b@He@xyEEDhhhheinrRg^rEMSUUSUTuRFST@@	eMBD@ch@										5
xvojgyqXbEue9cxVVAz@Cj_1rOoXPw0GFsFOst12g8tZJ4@RNo@C0k0FF!80F252#8N4&V8#2010	CHEMBL184313	fig@`@@MrJIJYJYQSJIHzcIJmyIVfijjjjjjkFeyIP@	CCCCC[C@H]1C[C@@]2(C)C(CC[C@@H]2O)C2CCC3=CC(=O)CCC3=C21	7.77	group2-a	a	Androgen Receptor	Inhibition of human lymph node carcinoma of prostate (LNCaP) cell proliferation	2004	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmMSUUUU@@@	342.521	5.318	2	1	37.3	4	-1.180079239208044	-1.6138030129142695	-0.333707337465066	50	5	fjc@b@He@xyEEDhhhheinrRg^rEMSUUSUTuRFST@@	gGPHJ@IRmU@@										5
:UvzfzUrSzjQTQzUESP@QxQzUebhoP9Pvi@ETl3TAl4c4AjLJH_Fo3g8j4XHSe32T9GkVFR290V11Fa&	CHEMBL184981	fjc`a@AZlBHIDILsoLwlsNF]GJRpPESMUTSHMGH@	O=C1[C@H]2C3C=CC(CC3)[C@H]2C(=O)N1c1ccc(Cl)c(Cl)c1	6.82	group3-int	int	Androgen Receptor	Inhibition of androgen receptor in human MDA-453 cells	2005	flm@@@LdbbRbeQbRXK`iJbfjjjjjjj@@	flm``@D@TdsLrrn}NVCZOdmUPMPLUBLKd@@	322.19	3.1296	3	0	37.38	1	-1.6897987915804777	0.2749314025377225	0.7185854287228596	4	4	fjc`a@AZlCqHxiLs{LwlsNF]GJRpPESMUTSHMGH@	eFABH`BL@	eFABH`BL@									3
;pz_zStnKxMKEjTScF2N@v1b01_Y9@@2dX53ZB2tX8VO1WF0FV5VFZ88ZV96WF10F9L0B4WV22010L10b0I0	CHEMBL185265	eoT|NH@LMAXDMh^[WP@cIIChheCLeEDdemeDeMdeLdeECFiae`TUj@bJh@@@h@bjZjX@@@@	Cc1c(NS(C)(=O)=O)cccc1N(Cc1ccccc1)Cc1ccc(Oc2cccc(OCCCC(=O)NCCCC(=O)O)c2)cc1	5.8	group4-ia	ia	Androgen Receptor	Inhibition of human androgen receptor	2005	fc@@@DjYU^[U_vUxhNTeWnjjjjjjjjjj@@	fca@@G@RfYU_vYUg\VeFjM^z@@@JhH@@@@@@	659.802	5.1417	10	3	142.65	17	6.76498246369737	-2.543276826003221	-0.6700804328194981	3	3	eb^TLL@@maHTPODaq~BLbbbvRbRrTTRbTTJVtcGEc`qspLDAP@UPQ@PDK@@@@	dgnB`FAANpAImUmUjjZj@@										2
:Uvzv:rS:vyvzUrSvUfzjzUjzboRCzjz@DrnYT7dqdgijqJoCqU@hDjJYq5duYg9lkVTC@S1k1GF_VV3#	CHEMBL185880	fiwpPBHFbA@TpeGIMsKN}s^rJVkQsUoQm@@AELuUAUcJKJh@	O=C1[C@H]2[C@H]3CC[C@H](C3)N2C(=O)N1c1ccc([N+](=O)[O-])c2ccccc12	5.89	group4-ia	ia	Androgen Receptor	In vitro antagonistic activity against androgen receptor of MDA-453 cells	2004	ffk@@@LdbbbTVtTNtSMBM[r\ekUUUUUUUUP@@	ffkP`@DX@kHhhhhdhhlXkQfcVbEIZmUPMPD@UAadyMH@	337.334	1.9886	7	0	86.44	2	0.3704091482542542	1.6271342199524663	1.2427246239356544	6	1	fiwpPBHFbA@TpeGIMsKN}s^rJVkQsUoQm@@AELuUAUcJKJh@											1
xvojgyqXbEue9cxVVAz@Cj_1rOoXPw0GFsFOst12g8tZJ4@RNo@C0k0FF!80F252#8N4&V8#2010	CHEMBL186254	eghPD@@@FlbbRfRfTTrbRNRRUCDbegbQSSTuUUUUUUUVFb|RR@@	CCCCCCCCCC[C@H]1C[C@@]2(C)C(CC[C@@H]2O)C2CCC3=CC(=O)CCC3=C21	7.77	group2-a	a	Androgen Receptor	Inhibition of human lymph node carcinoma of prostate (LNCaP) cell proliferation	2004	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmMSUUUU@@@	412.655	7.59	2	1	37.3	9	-0.12495371241710818	-3.843810040161156	-0.07592724376422216	50	5	fjc@b@He@xyEEDhhhheinrRg^rEMSUUSUTuRFST@@	dmT@`E@DiUUZjjh@@										5
xvojgyqXbEue9cxVVAz@Cj_1rOoXPw0GFsFOst12g8tZJ4@RNo@C0k0FF!80F252#8N4&V8#2010	CHEMBL186467	fc@`@@MrJIJYJYQSJIHyITYIUoIJtuMUUUUUUUXtoIJ@@	CCCCCCCC[C@H]1C[C@@]2(C)C(CC[C@@H]2O)C2CCC3=CC(=O)CCC3=C21	7.77	group2-a	a	Androgen Receptor	Inhibition of human lymph node carcinoma of prostate (LNCaP) cell proliferation	2004	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmMSUUUU@@@	384.602	6.6812	2	1	37.3	7	-0.5470008053370574	-2.9518094247349254	-0.1790383070512941	50	5	fjc@b@He@xyEEDhhhheinrRg^rEMSUUSUTuRFST@@	diD@`A@DiUVjj`@										5
]x<vzUzUyUjzUzUjUbqSSzjjTDjvbzEfydZUvrKqhmx@hDjHYqEgi3gCxqYLj2SGk9lNEce0c!	CHEMBL187605	eodRBL@EC@noHie`IABPpdLbdLTRRLTTvTQTrddtBRJZjzj``rifjjZjJlDedbd@@	CC(C)(C)OC(=O)N1C[C@@H]2C[C@H]1[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)N21	5.36	group4-ia	ia	Androgen Receptor	In vitro antagonistic activity against mutant androgen receptor of LNCap cells	2004	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdup`@DXBAVQQQQQIQKFcMVLGtVjhFhHjLLgEi@@	436.389	2.8066	8	0	93.95	4	1.5362179016082114	0.7023602208477527	1.5698563184929522	47	2	eodRBL@EC@noHie`IABPpdLbdLTRRLTTvTQTrddtBRJZjzj``rifjjZjJlDedbd@@											1
[rx<vzUrUzUjzjzUjUboRSzjzTDbvby7fqdgyvrKqCqz@hDjHYq5hyYg9poXTh@SGk9lNCcX3#	CHEMBL188129	e`RRF@DHCHa`D@demhIP{HihheEeihilhbieHIIiYEeUttLt@@DTsUUMUAUadbeT`@	CC(C)(C)OC(=O)N1C[C@@H]2C[C@H]1[C@@H]1C(=O)N(c3ccc([N+](=O)[O-])c4ccccc34)C(=O)N21	5.48	group4-ia	ia	Androgen Receptor	In vitro antagonistic activity against androgen receptor of MDA-453 cells	2004	ffk@@@LdbbbTVtTNtSMBM[r\ekUUUUUUUUP@@	ffkp`@DXbAVQQQQQIQQXqVcMVMDJRuZj`Z`H@jCCIqZP@	438.439	2.3955	10	0	115.98	4	2.41026399490138	1.3451899109810008	1.804253155848461	6	1	e`RRF@DHCHa`D@demhIP{HihheEeihilhbieHIIiYEeUttLt@@DTsUUMUAUadbeT`@											1
]x<vzUzUyUjzUzUjzbqSSzjjUDjvbzEfydZU:Kqjmx@hDjHYqEgi3whxqYLjHSGk9lNjce0c!	CHEMBL188261	e`\RBL@EC@aoHem`IABPpdLbdLTRRLTTvbbjfTdf`RQWSPuTDFULuUTuTUXIKIEH@	CC(C)(C)OC(=O)N1C[C@@H]2C[C@H]1[C@]1(C)C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)N21	6.11	group3-int	int	Androgen Receptor	In vitro antagonistic activity against androgen receptor of MDA-453 cells	2004	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdup`@DXBAVQQQQQIQKFcMVLGtVjhFhHjD\Vd@	450.416	3.1046	8	0	93.95	4	1.5960654945475556	0.4712016473266879	1.594490481800433	47	1	e`\RBL@EC@aoHem`IABPpdLbdLTRRLTTvbbjfTdf`RQWSPuTDFULuUTuTUXIKIEH@											1
:UvzvzUzS:QTQzUUUQAvxvUUer_qN9PvyiEql3UAdhiBfjqLF_JL2g9j4eHEtPXRCOmWkD@80VG1Fa!38!	CHEMBL188297	figPSBNVUhJPRBICDar]]dTabbTRlTTvTTcQsUoQuPPLULuUEQHkLJjp@	O=C1[C@H]2[C@H]3CC[C@H](C3)[C@H]2C(=O)N1c1ccc([N+](=O)[O-])c(C(F)(F)F)c1	8	group1-p	p	Androgen Receptor	In vitro antagonistic activity against androgen receptor of MDA-453 cells	2004	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdu``@D@UdTTTTRTRqhsQkA}EjjAjBJ`fDq\Vh@	354.283	1.7777	6	0	83.2	3	0.3312234366337026	1.4256221138399896	1.19882948017499	47	1	figPSBNVUhJPRBICDar]]dTabbTRlTTvTTcQsUoQuPPLULuUEQHkLJjp@											1
[rx<vzUrUzUjzjzUjUboRSzjzTDbvby7fqdgyvrKqCqz@hDjHYq5hyYg9poXTh@SGk9lNCcX3#	CHEMBL188545	e`RRF@DHCHa`D@demhIP{HihheEeihilhbieHIIiYEeUttLt@@DTsUUMUAUaeBeT`@	CC(C)(C)OC(=O)N1C[C@@H]2C[C@H]1[C@H]1C(=O)N(c3ccc([N+](=O)[O-])c4ccccc34)C(=O)N21	5.23	group4-ia	ia	Androgen Receptor	In vitro antagonistic activity against mutant androgen receptor of LNCap cells	2004	ffk@@@LdbbbTVtTNtSMBM[r\ekUUUUUUUUP@@	ffkp`@DXbAVQQQQQIQQXqVcMVMDJRuZj`Z`H@jCCEqZP@	438.439	2.3955	10	0	115.98	4	2.41026399490138	1.3451899109810008	1.804253155848461	6	1	e`RRF@DHCHa`D@demhIP{HihheEeihilhbieHIIiYEeUttLt@@DTsUUMUAUaeBeT`@											1
]x<vvUbUyUjzCzUjUboSSzjhTDbvby7fqdZTvrKqCmx@hDjHYq5gi3g9poXLh2SGk9lN9cX0V!	CHEMBL188803	fmoHP@DXBtBburJJJJIJIXyJKZRcMVLGtVjhFhHinjjLLgEi@@	CC(C)(C)OC(=O)N1C[C@@H]2C[C@H]1[C@@H]1C(=O)N(c3ccc(C#N)cc3)C(=O)N21	5.59	group4-ia	ia	Androgen Receptor	In vitro antagonistic activity against androgen receptor of MDA-453 cells	2004	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdup`@DXBAVQQQQQIQKFcMVLGtVjhFhHjLLgEi@@	368.392	1.9583	8	0	93.95	3	1.05950898243771	1.5852923936352195	1.427440459553632	47	2	fmoHP@DXBtBburJJJJIJIXyJKZRcMVLGtVjhFhHinjjLLgEi@@											1
]x<vvUbUyUjzCzUjUboSSzjhTDbvby7fqdZTvrKqCmx@hDjHYq5gi3g9poXLh2SGk9lN9cX0V!	CHEMBL188857	fmoHP@DXBtBburJJJJIJIXyJKZRcMVLGtVjhFhHinjjLLWEi@@	CC(C)(C)OC(=O)N1C[C@@H]2C[C@H]1[C@H]1C(=O)N(c3ccc(C#N)cc3)C(=O)N21	5.46	group4-ia	ia	Androgen Receptor	In vitro antagonistic activity against mutant androgen receptor of LNCap cells	2004	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdup`@DXBAVQQQQQIQKFcMVLGtVjhFhHjLLWEi@@	368.392	1.9583	8	0	93.95	3	1.05950898243771	1.5852923936352195	1.427440459553632	47	2	fmoHP@DXBtBburJJJJIJIXyJKZRcMVLGtVjhFhHinjjLLWEi@@											1
xvojgyqXbEue9cxVVAz@Cj_1rOoXPw0GFsFOst12g8tZJ4@RNo@C0k0FF!80F252#8N4&V8#2010	CHEMBL189306	e`\PD@@@FlbbRfRfTTrbRNRRRUCDbegbQSSTuUUUUUUUUXZKqIH@	CCCCCCCCCCCC[C@H]1C[C@@]2(C)C(CC[C@@H]2O)C2CCC3=CC(=O)CCC3=C21	9.7	group1-p	p	Androgen Receptor	Inhibition of human androgen receptor expressed in Escherichia coli	2004	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmMSUUUU@@@	440.709	8.4988	2	1	37.3	11	0.2970986839709866	-4.735814390154051	0.02718547665572421	50	5	fjc@b@He@xyEEDhhhheinrRg^rEMSUUSUTuRFST@@	dkL@`C@DiUUUjjjj@@										5
:Uvzv;S:vyvzUzEvUfzUzUjUbqSSzjzDDjnbUUfydozvqKqhmxDxDjJYqEgifgExqWLE2SGk9GNEcc0c!	CHEMBL189600	e`RRLL@EC@noHi`IABPpdLbdLTRRLTTvTQTtRTf`RQSUWSwuTDFULuUS@@UFBRrQR@@	N#Cc1ccc(N2C(=O)[C@H]3[C@@H]4C[C@@H](CN4C(=O)c4ccccc4)N3C2=O)cc1C(F)(F)F	6.52	group3-int	int	Androgen Receptor	In vitro antagonistic activity against androgen receptor of MDA-453 cells	2004	feo@@@LdbbRbbvLRLTrWCBTxOhcgUUUUUUUUUT@@	feoq`@DXBAV\bbbbbRbVNttRUFZlXOhcfuU@uADp@UAadxmH@	440.38	2.901	7	0	84.72	3	1.0010122692448176	0.5630793893949005	1.4387688983017097	5	5	eol\LB@MOFg@a`GDRPddEICHhhdiMXhilhbihdfNOHljbfkghBBjifjjX@BhpbRRrP@	eMbA@Dg`@										1
zrvpT_OK8k5o41ACHN0F0N@m04!9YA@02AV50X82OV80O1V02Gk5VG610VV9DWF12F92084WV@7450L1Fb8I0	CHEMBL190109	ee[TFB@BobEMCF^PHbFPIBIYCHhhdleDXdleEDheECDciDpIDd\CcSAAEM@AUADADDKP@@@@	Cc1c(NS(C)(=O)=O)cccc1N(Cc1ccc(Oc2ccc(Cl)c(OCC(=O)O)c2)cc1)Cc1ccc(F)cc1F	5.44	group4-ia	ia	Androgen Receptor	Inhibition of human androgen receptor	2005	fc@@@DjYU^[U_vUxhNTeWnjjjjjjjjjj@@	fca@@G@RfYU_vYUg\VeFjM^z@@@JhH@@@@@@	617.067	5.048	8	2	113.55	11	4.359413548272709	-2.0448143982990334	-0.06196879628200916	3	3	efYTLJ@@maD\PODaqnd@PbfPrJJKYJIKIQQJIQPqHzQL\VNCG_PpPE@AUADADDKP@@@@	gGQh@cPAImZh@	eFABH`BL@									1
zrvpT_OK8k5o41ACHN0F0N@m04!1Y9@029V50X82OV80O1V!Fk5VF4!VV16WF18F92084WV22050M10b0I0	CHEMBL190225	enUTFH@LMHDMdZVP@cIIChheCLeEDdemeDedeECFiae`XUj@bJh@@@h@Jf@@@@	Cc1c(NS(C)(=O)=O)cccc1N(Cc1ccccc1)Cc1ccc(Oc2ccc(OCC(=O)O)cc2)cc1	4.93	group4-ia	ia	Androgen Receptor	Inhibition of human androgen receptor	2005	fc@@@DjYU^[U_vUxhNTeWnjjjjjjjjjj@@	fca@@G@RfYU_vYUg\VeFjM^z@@@JhH@@@@@@	546.642	4.2404	8	2	113.55	11	4.0265406419003655	-1.298169054981794	-0.18206067170510334	3	3	eb^TLL@@maHTPODaq~BLbbbvRbRrTTRbTTJVtcGEc`qspLDAP@UPQ@PDK@@@@		gGQh@cPAImZh@									2
zvyziyznjEve9czYkAz@hj_1rSoXTw9GFuFSwtW2iCtZJ4@RNxPE0o2NF0881K2K20W1cs4402!19N#2010	CHEMBL1908373	ehZXL@@M`I`\bbRfRfbTRRTRtNTQhXdt\bJFjzZZfjhJBhjjjhjEIiGIDjh@@	CN(C)c1ccc([C@H]2C[C@]3(C)[C@@H](CC[C@]3(O)CCCO)[C@@H]3CCC4=CC(=O)CCC4=C32)cc1	6.57	group3-int	int	Androgen Receptor	Inhibitory activity against human Androgen receptor	1996	fag@@@LdbbbbbTRrRJHcR]xjVykUUUUUUUUU@@@	fagA@@@ILkZwKJjmFRtzI^uZtuMUPTEEQXUMQt@@	449.633	5.152	4	2	60.77	5	0.6934922420332801	-1.632055713756344	-0.9821071975038315	15	5	fmAA@E`|^nNQQIYQQJJJJIZ[tX[pRuft\@ESUUSUTeTSbtcKt@@	gGPhAR@IJmU@@	gChHA`BOT@@									1
{vzy:wfzwUSIrukxvzPQ7hInIlA1kafGgCGCbC7Pc@JIw8P489OFVVE!kF04Fc30201V0FWVFV	CHEMBL1914477	fcoHb@NIZNQPQFQQQIHjJQQMSQII`cVGNBCJjjjYihiBiZ@@	Cc1cc(C(=O)N[C@H]2C(C)(C)[C@H](Oc3ccc(C#N)c(Cl)c3)C2(C)C)nn1C	7.27	group2-a	a	Androgen Receptor	Antagonist activity at human AR overexpressed in human LNCAP cells by luciferase reporter gene assay	2011	flu@@@DjU^}YmirRhijjjjjjj@@	flup`@DTd@vQQJJIJiQIBuITTmSUMP@THIMP@	400.909	3.2208	6	1	79.94	4	0.8910537869099303	0.22658752332361648	0.21415721094825332	11	7	fcoHa@HHelRPNHxcHheDYeEHhfhdhTRak]gTmMUUU@DWPaTm@@	eFBH@c@@										1
?vzyi3xyrTkfrRUCGHuk1frPO2c1XIk81k7W0V9FC7C12c2JHc8@4088#B#F02Fc30201V0NVVF0	CHEMBL1916236	fncp`@DEZ@vQQZJQQMQISKLyGKUUUT@QwBBSd@@	CC(=O)N[C@H]1C(C)(C)[C@H](Oc2ccc(C#N)c(C#N)c2)C1(C)C	6.76	group3-int	int	Androgen Receptor	Antagonist activity at human AR overexpressed in human LNCAP cells by luciferase reporter gene assay	2011	dmL@@DjU^zzUjjjj@@	dmLH@@RfYWZQV`hH`@@	311.384	2.4924	5	1	85.91	3	0.14656321890543086	1.0402130970483277	-0.036406720703176465	7	5	ff}Pb@NIdTCcdTTRRJbdTSTXHuhHLjjjibPjV`@	eMbA@Dg`@										4
?vzyi3xyrTkfrRUSGHuk1frPQ2c1XIl01k6W0V9FC7C12c2JIc8@4088#D#F!Fc30201V0FVVF0	CHEMBL1916237	ff}Pb@NIdTDQdTTRRJbdTSTXHuhHLjjjibPjV`@	CC(=O)N[C@H]1C(C)(C)[C@H](Oc2ccc(C#N)c(Cl)c2)C1(C)C	7.5	group2-a	a	Androgen Receptor	Antagonist activity at human AR overexpressed in human LNCAP cells by luciferase reporter gene assay	2011	dmL@@DjU^zzUjjjj@@	dmLH@@RfYWZQV`hH`@@	320.819	3.2628	4	1	62.12	3	-0.4674230980396997	0.24674342372474511	-0.1659674969473643	7	5	ff}Pb@NIdTCcdTTRRJbdTSTXHuhHLjjjibPjV`@	eFABH`BL@										4
?vzyi3xyrTkfrRUCGHuk1frPO2c1XIk81k7W0V9FC7C12c2JHc8@4088#B#F02Fc30201V0NVVF0	CHEMBL1916238	ff}P`@DU@[HhmEHhfhdilsdTmUUUP@Up`dy@@	CC(=O)N[C@H]1C(C)(C)[C@H](Oc2ccc(C#N)c(C)c2)C1(C)C	7.16	group2-a	a	Androgen Receptor	Antagonist activity at human AR overexpressed in human LNCAP cells by luciferase reporter gene assay	2011	dmL@@DjU^zzUjjjj@@	dmLH@@RfYWZQV`hH`@@	300.401	3.0007	4	1	62.12	3	-0.5626160888618953	0.4800207389239711	-0.2009308853854544	7	5	ff}Pb@NIdTCcdTTRRJbdTSTXHuhHLjjjibPjV`@	eFBH@c@@										4
?vzyinxyrTkvrRUCGHuo1vrPO2c1XMk81k7d0c9FC7C12c2JHc8@408@#B482G02Fc30201X0NVcF0	CHEMBL1916239	fikPc@EUMtD`bPqHYEHXhddUEHhfiKW`uPPYUUUSDbtC@@	CC(=O)N[C@H]1C(C)(C)[C@H](Oc2ccc(C#N)c(C(F)(F)F)c2)C1(C)C	6.9	group3-int	int	Androgen Receptor	Antagonist activity at human AR overexpressed in human LNCAP cells by luciferase reporter gene assay	2011	dmL@@DjU^zzUjjjj@@	dmLH@@RfYWZQV`hH`@@	354.371	3.5051	4	1	62.12	4	-0.14359529514964509	-0.14415989494319878	-0.08338844711256223	7	5	ff}Pb@NIdTCcdTTRRJbdTSTXHuhHLjjjibPjV`@	gJPBAHJPt`PAIjj@@										4
?vzyi3xyrTkfrRUSGHuk1fzOQ2c1Xnl01k7W0V9FB7C3382JIe9@Z&D#F!Fc34601VF4VVF0	CHEMBL1916240	ff}Pb@CIHTDQdTTRRTrdTsTXKUhHHjzjibQrV`@	CC(=O)N[C@H]1C(C)(C)[C@H](Oc2ccc(C#N)cc2Cl)C1(C)C	6.79	group3-int	int	Androgen Receptor	Antagonist activity at human AR overexpressed in human LNCAP cells by luciferase reporter gene assay	2011	dmL@@DjU^zzUjjjj@@	dmLH@@RfYWZQV`hH`@@	320.819	3.2628	4	1	62.12	3	-0.4674230980396997	0.24674342372474511	-0.1659674969473643	7	5	fncPa@EYETCbRHrJJJZKFJQQMSdkN`bHzjjibQjN`@											1
?vryi3xyrPVfrRUCGFuk1frNN0c1VIk81k6W0V9FC7C12c2J2c8P4!8#B#F!F810201V!VVFF	CHEMBL1916241	ff}p`@DNj@vQQZJQQMQISYgHiZjjj`@kaAIr@@	CC(=O)N[C@H]1C(C)(C)[C@H](Oc2ccc(C#N)c(C)n2)C1(C)C	6.29	group3-int	int	Androgen Receptor	Antagonist activity at human AR overexpressed in human LNCAP cells by luciferase reporter gene assay	2011	dmL@@DjU^zzUjjjj@@	dmNH@LAJYe]iEZB`b@@	301.389	2.4052	5	1	75.01	3	-0.07728329581927745	1.04974405792062	-0.08105286817154705	7	1	ff}p`@DNj@vQQZJQQMQISYgHiZjjj`@kaAIr@@											1
?vzyiIxyrTkvrSUSIHuk1frPQ2c1nIl11k6l1V9Fh7C12c2JMs8P4088!VD!4F!Fc30201V0FVVFF	CHEMBL1916242	fmwHb@NI[NQPQFQQQIHjJQQMSQILDZtupPYUUUS@@PaTm@@	CC1(C)[C@H](NC(=O)c2cnccn2)C(C)(C)[C@H]1Oc1ccc(C#N)c(Cl)c1	7.09	group2-a	a	Androgen Receptor	Antagonist activity at human AR overexpressed in human LNCAP cells by luciferase reporter gene assay	2011	fbm@@@DjYW{ue^RtYNZjjjjjjh@@	fbmp`@DTTBrSKLk~rhmJLgKTEAE@A@`du@@	384.866	2.7588	6	1	87.9	4	0.9563330580625838	0.6221987017679795	0.20561260562134054	1	1	fmwHb@NI[NQPQFQQQIHjJQQMSQILDZtupPYUUUS@@PaTm@@											1
^yQzyrywfzwUSIrukxfzPQ7hInIl31kaWGgCGCbC72c2JIw8P4899FVVE!FF04Fc30201V0FWVFV	CHEMBL1916243	fegHb@NIZNQPQFQQQIHjJQQMSQI`cVGNBCJjjjYiJPjV`@	CC1(C)[C@H](NC(=O)c2cc[nH]n2)C(C)(C)[C@H]1Oc1ccc(C#N)c(Cl)c1	7.12	group2-a	a	Androgen Receptor	Antagonist activity at human AR overexpressed in human LNCAP cells by luciferase reporter gene assay	2011	flu@@@DjU^}YmirRhijjjjjjj@@	flup`@DTd@vQQJJIJiQIBuITTmSUMP@THIMP@	372.855	2.6542	6	2	90.8	4	1.2207295202707114	0.7370144021740137	-0.8940388747794789	11	7	fmwHa@HHDodPNOXcHhdmLhiEDuDeBbTtYhzefjjj`BKhQJF`@											6
^yQzyrywfzwUSIrukxfzPQ7hInIl31kaW1gCGCbC72c2JIwNP4899FVVE!FF04Fc30H01V0FWVFV	CHEMBL1916244	fegHb@NIGNQPQFQQQIHjJQQMSQI`cVGNBCJjjjZVJPjV`@	CC1(C)[C@H](NC(=O)c2cn[nH]c2)C(C)(C)[C@H]1Oc1ccc(C#N)c(Cl)c1	7.38	group2-a	a	Androgen Receptor	Antagonist activity at human AR overexpressed in human LNCAP cells by luciferase reporter gene assay	2011	flu@@@DjU^}YmirRhijjjjjjj@@	flup`@DRT@vQQJJIJiQIBuITTmTtuP@THIMP@	372.855	2.6002	6	2	90.8	4	1.2232702533816284	0.7694765053908452	-0.8943202942896794	11	3	fmwHa@HHDodPNOXcHheeLhiEDuDeBbTtYhzefjjj`BKhQJF`@											3
{vzyrzwfzwUSIrukxvzPQ7hInIl31kad1gCGCbC7Hc2JIwNP4899FVVE!kF04Fc30H01V0FWVFV	CHEMBL1916245	fmwHb@NIGNQPQFQQQIHjJQQMSQKLDZpypPYUUUSRtTaTm@@	Cn1cc(C(=O)N[C@H]2C(C)(C)[C@H](Oc3ccc(C#N)c(Cl)c3)C2(C)C)cn1	7.7	group2-a	a	Androgen Receptor	Antagonist activity at human AR overexpressed in human LNCAP cells by luciferase reporter gene assay	2011	flu@@@DjU^}YmirRhijjjjjjj@@	flup`@DRT@vQQJJIJiQIBuITTmTtuP@THIMP@	386.882	2.7689	6	1	79.94	4	0.838447110846946	0.550263053690116	0.1887209531251874	11	3	fmwHa@HHDodPNOXcHheeLhiEDuDeBbTtYhzefjjj`BKhQJF`@	eFBH@c@@										3
^yUzyrTyjzTUxIzunpfzPzbfYnIl31oaW_ghHCbxb2ceJnw8u4F890cVE#F40FcY0H41V0FWVFV	CHEMBL1916246	fmwIb@NI{NQV`bLbbbRQTTbbZfbRXHuas``rjjjffheBiZ@@	Cc1nnc(C(=O)N[C@H]2C(C)(C)[C@H](Oc3ccc(C#N)c(Cl)c3)C2(C)C)o1	7.52	group2-a	a	Androgen Receptor	Antagonist activity at human AR overexpressed in human LNCAP cells by luciferase reporter gene assay	2011	flu@@@DjU^}YmirRhijjjjjjj@@	fluq`@DLTBalbbTTRURbREjRhiZijj`@dPRZ`@	388.854	3.0116	7	1	101.04	4	1.4215723669740097	0.6726765896933569	0.3354842976544093	11	1	fmwIb@NI{NQV`bLbbbRQTTbbZfbRXHuas``rjjjffheBiZ@@											1
}yzUzjzyUxQzyvrjzyU7fYvIv71oyfjghlCbxbmceoIw8u4Vd90eWE0VWFJ5Hs30H21V0kVVFV	CHEMBL1916247	eghZDH@NDfemiB`HcHhhddUEHhfihhdlpHYXLl]]AAeUUUMMTiL`iKH@@	CC1(C)[C@H](NC(=O)c2cnc3ncccn23)C(C)(C)[C@H]1Oc1ccc(C#N)c(Cl)c1	7.8	group2-a	a	Androgen Receptor	Antagonist activity at human AR overexpressed in human LNCAP cells by luciferase reporter gene assay	2011	fnk@@@DjU^}YnUz\djNZmjjjjjjjjh@@	fnkH`@DTuXGdfVYew_eQFeipZmZijjfX@IaAHZ@@	423.903	2.9615	7	1	92.31	4	1.4680921693130282	0.508785202462846	0.3706741926131185	3	2	eghZDH@NDfemiB`HcHhhddUEHhfihhdlpHYXLl]]AAeUUUMMTiL`iKH@@											1
}yzUzjzyUxQzyvrjzyU7fnvIvE1oyfjghlCbxbuceoIw8u4cd90eWE0VWFJKHs30H21V0kVVFV	CHEMBL1916248	eodZDH@NDfeciB`HcHhhddUEHhfihhhdVACKAekghHLjjjiijiRYARVP@	Cc1nc2ncccn2c1C(=O)N[C@H]1C(C)(C)[C@H](Oc2ccc(C#N)c(Cl)c2)C1(C)C	7.16	group2-a	a	Androgen Receptor	Antagonist activity at human AR overexpressed in human LNCAP cells by luciferase reporter gene assay	2011	fnk@@@DjU^}YnUz\djNZmjjjjjjjjh@@	fnkH`@DTuXGdfVYew_eQFeipZmZijjfX@IaAHZ@@	437.93	3.3594	7	1	92.31	4	1.5232394065580621	0.2175717451568912	0.3958289819523449	3	2	eodZDH@NDfeciB`HcHhhddUEHhfihhhdVACKAekghHLjjjiijiRYARVP@											1
{vzy:yfzwUSIrykxvzPv7hInIn31kadGgCGCbC7Pc2JIw8P489OFXkE!kF0JFcY0201V0FWVFV	CHEMBL1916249	eg`RLH@NDfaiBc`HcHhhddUEHhfihdldpHYXMMAAeUUULtuQRBdl`@	COCCn1ccc(C(=O)N[C@H]2C(C)(C)[C@H](Oc3ccc(C#N)c(Cl)c3)C2(C)C)n1	6.87	group3-int	int	Androgen Receptor	Antagonist activity at human AR overexpressed in human LNCAP cells by luciferase reporter gene assay	2011	flu@@@DjU^}YmirRhijjjjjjj@@	flup`@DTd@vQQJJIJiQIBuITTmSUMP@THIMP@	430.934	2.5801	7	1	89.17	7	1.9481718419945393	0.3264863757949884	0.45058448434575143	11	7	fmwHa@HHDodPNOXcHhdmLhiEDuDeBbTtYhzefjjj`BKhQJF`@	gJQH@PAJ^j@@										6
{vzy:yfzwUSIrukxvzPv7hInIn31kadGgCGCbC7Pc2JIw8P489OFVkE!kF0JFc30201V0FYVGV	CHEMBL1916250	fkIb@NIZNQS`bLbbbRQTTbbZfbRrXHuas``rjjjfZZbdJeh@	CC1(C)[C@H](NC(=O)c2ccn(CCO)n2)C(C)(C)[C@H]1Oc1ccc(C#N)c(Cl)c1	6.87	group3-int	int	Androgen Receptor	Antagonist activity at human AR overexpressed in human LNCAP cells by luciferase reporter gene assay	2011	flu@@@DjU^}YmirRhijjjjjjj@@	flup`@DTd@vQQJJIJiQIBuITTmSUMP@THIMP@	416.908	2.1522	7	2	100.17	6	2.1889101954954158	0.8233646201595504	-0.659556682565792	11	7	fmwHa@HHDodPNOXcHhdmLhiEDuDeBbTtYhzefjjj`BKhQJF`@	gCaHA`AIZ`@										6
{vzy:yfzwUSIrukxvzPv7hInIn31kad1gCGCbC7Pc2JIwNP489OFVkE!kF0JFc30H01V0FYVGV	CHEMBL1916251	fkIb@NIGNQS`bLbbbRQTTbbZfbVRXHuas``rjjjfejbdJeh@	CC1(C)[C@H](NC(=O)c2cnn(CCO)c2)C(C)(C)[C@H]1Oc1ccc(C#N)c(Cl)c1	7.23	group2-a	a	Androgen Receptor	Antagonist activity at human AR overexpressed in human LNCAP cells by luciferase reporter gene assay	2011	flu@@@DjU^}YmirRhijjjjjjj@@	flup`@DRT@vQQJJIJiQIBuITTmTtuP@THIMP@	416.908	2.0982	7	2	100.17	6	2.1914509173886216	0.8558265800514084	-0.6598381008334838	11	3	fmwHa@HHDodPNOXcHheeLhiEDuDeBbTtYhzefjjj`BKhQJF`@	gCaHA`AIZ`@										3
{vzy:wfzwUSIrukxvzPQ7hIrIl31kadGgCGCbC7Pc2JIw8P489OFVVE!kF04Fc30201V0FWVFV	CHEMBL1916252	eg`ZDH@NDfakiB`HcHhhddUEHhfihdldpHYXMMAAeUUULtuYRBdl`@	CC1(C)[C@H](NC(=O)c2ccn(CCC#N)n2)C(C)(C)[C@H]1Oc1ccc(C#N)c(Cl)c1	7.05	group2-a	a	Androgen Receptor	Antagonist activity at human AR overexpressed in human LNCAP cells by luciferase reporter gene assay	2011	flu@@@DjU^}YmirRhijjjjjjj@@	flup`@DTd@vQQJJIJiQIBuITTmSUMP@THIMP@	425.919	2.7789	7	1	103.73	6	1.9880519739446119	0.4531995680921526	0.4543227534303521	11	7	fmwHa@HHDodPNOXcHhdmLhiEDuDeBbTtYhzefjjj`BKhQJF`@	gJXH@PAIWj@@										6
}y:yfzwUSIzykxvzPU7hInIn31kqdlgCGSbC7ucXJIw8P4cdOFXWE0VkFFJFc30201V0FWVFV	CHEMBL1916253	eohZLH@NDfakiBc`HcHhhddUEHhfihdlifACKAihHLjjjifffbdEIY@@	CNC(=O)Cn1ccc(C(=O)N[C@H]2C(C)(C)[C@H](Oc3ccc(C#N)c(Cl)c3)C2(C)C)n1	6.79	group3-int	int	Androgen Receptor	Antagonist activity at human AR overexpressed in human LNCAP cells by luciferase reporter gene assay	2011	flu@@@DjU^}YmirRhijjjjjjj@@	flup`@DTd@vQQJJIJiQIBuITTmSUMP@THIMP@	443.933	1.7563	8	2	109.04	6	2.737310387059577	1.147057823713724	-0.5060275975597043	11	7	fmwHa@HHDodPNOXcHhdmLhiEDuDeBbTtYhzefjjj`BKhQJF`@	gGYHDJ@ILkU@@										6
}y;fzwUSnzysxvzPUMhInIv31kqflgCGSbC7udmJIw8T4cdOFXWE0VkFFKFd30201V0FWVFV	CHEMBL1916254	e`TZLH@NDfakiBc`HcHhhddUEHhfihdlihpHYXMMAAeUUULttuEHJRr@@	CN(C)C(=O)Cn1ccc(C(=O)N[C@H]2C(C)(C)[C@H](Oc3ccc(C#N)c(Cl)c3)C2(C)C)n1	6.76	group3-int	int	Androgen Receptor	Antagonist activity at human AR overexpressed in human LNCAP cells by luciferase reporter gene assay	2011	flu@@@DjU^}YmirRhijjjjjjj@@	flup`@DTd@vQQJJIJiQIBuITTmSUMP@THIMP@	457.96	2.0228	8	1	100.25	6	2.3811792416913624	0.8842359014536665	0.5827923558815632	11	7	fmwHa@HHDodPNOXcHhdmLhiEDuDeBbTtYhzefjjj`BKhQJF`@	gNyHDF@ILruT@@										6
[r<yzQjjzyUhQxyvrjzwR5fYtIvE1oyfjghlCbxbmceo2w8u4VW90eWC0VWFJ5HN10H21V0VVVFk	CHEMBL1916412	eghVD@@DJMHfk`LlbbTTTRdTRsvbRfpadfbQTrsUMUUULp@UsBADL`@	Cc1nc(O[C@H]2C(C)(C)[C@H](NC(=O)c3cnc4ncccn34)C2(C)C)ccc1C#N	6.84	group3-int	int	Androgen Receptor	Antagonist activity at human AR overexpressed in human LNCAP cells by luciferase reporter gene assay	2011	fnk@@@DjU^}YnUz\djNZmjjjjjjjjh@@	fnkh`@DTuYHOILlsKnJbMKS`uZuSUULp@SBBPt@@	404.473	2.1039	8	1	105.2	4	1.8582317494673286	1.3117859218458374	0.4555887614627691	3	1	eghVD@@DJMHfk`LlbbTTTRdTRsvbRfpadfbQTrsUMUUULp@UsBADL`@											1
yJsK448G804F0124FN010N2H$11@#HV1!83FV#W!210101010W%c@!24!4!4&6030	CHEMBL1923999	fle@c@HiADDBIQFQQQIIFIJZLDxLDDT@Pp@@@	O=C(O)c1cccc(CSc2ccc(Cl)cc2Cl)c1	4.3	group4-ia	ia	Androgen Receptor	Transcriptional activity at human androgen receptor BF3 site stably transfected in eGFP-expressing human LNCAP cells after 5 days by fluorometric analysis	2011	dg|@@DjU_eZx{jjjjj@@	dg|@`@BDieV]~T{hH@@@@@	313.203	4.3181	2	1	62.6	4	-0.8805063368395549	-0.7184138717327644	-0.3227613208685003	6	1	fle@c@HiADDBIQFQQQIIFIJZLDxLDDT@Pp@@@											1
<EUtn9wDmZMATHsGCXQ3HLJ0nfn90VIHV7BuX7OlG9FhE4P105q4Fh2dV1R3IcB4OcZ0L569418Jm10V0F0	CHEMBL1924000	fewa`@M@POHheLeeDhhdd\hJS`isUkT@EUPTALRXUCQt@@	COC(=O)c1ccc([C@H]2Nc3ccc(C(C)=O)cc3[C@H]3C=CC[C@H]32)cc1	5.92	group4-ia	ia	Androgen Receptor	Transcriptional activity at human androgen receptor BF3 site stably transfected in eGFP-expressing human LNCAP cells after 5 days by fluorometric analysis	2011	flm@@@LdbbbRTRVNEiWcVbfjjjjjjj@@	flm`@@@YHhhheDedbpTkNbEMAQ@QADIaBYAH@	347.413	3.6992	4	1	55.4	4	-0.2974532722038762	-0.2843328325338575	-0.1109314224296378	3	1	fewa`@M@POHheLeeDhhdd\hJS`isUkT@EUPTALRXUCQt@@											1
<Uztn9wDmZMATHsGCXQ3HLJ0nfn9VVIIV7BuX7OlG9FhE4P105q4Fh2WV1R3IcB4OXZ0L569408Jm10V0F0	CHEMBL1924001	fa{``@C@QdTRbRtrbRQbRdiw`q[ujB@jih@BcFhz^`@	CCOC(=O)c1ccc2c(c1)[C@H]1C=CC[C@@H]1[C@@H](c1ccccc1)N2	6.05	group3-int	int	Androgen Receptor	Transcriptional activity at human androgen receptor BF3 site stably transfected in eGFP-expressing human LNCAP cells after 5 days by fluorometric analysis	2011	flm@@@LdbbbRTRVNEiWcVbfjjjjjjj@@	flm`@@@YHhhheDedbpTkNbEMAQ@QADIaBXaH@	319.403	4.2343	3	1	38.33	4	-0.9894772625153082	-0.7482021404710574	-0.28622825991269973	3	1	fa{``@C@QdTRbRtrbRQbRdiw`q[ujB@jih@BcFhz^`@											1
:UQAQtn9RDmVLATHsG9XQ3mLJ0nfn90VIHV7Bme7OlG9NhE4P1V5q!h2cV1R3IVB4OXZ0Ld69418Jm11W4k0	CHEMBL1924002	fa{Pa@A]jtFHTHrJIKJIQQIHyRTYjw`is@AUTE@RqIcddmH@	NS(=O)(=O)c1ccc2c(c1)[C@@H]1C=CC[C@@H]1[C@@H](c1ccc(Br)cc1)N2	6.3	group3-int	int	Androgen Receptor	Transcriptional activity at human androgen receptor BF3 site stably transfected in eGFP-expressing human LNCAP cells after 5 days by fluorometric analysis	2011	flm@@@LdbbbRTRVNEiWcVbfjjjjjjj@@	flm`@@@YHhhheDedbpTkNbEMAQ@QADIaBXaP@	405.315	3.4042	4	2	80.57	2	0.38518890802094874	0.09068468831349388	-1.0920621199838612	3	1	fa{Pa@A]jtFHTHrJIKJIQQIHyRTYjw`is@AUTE@RqIcddmH@											1
zyvrTbOG0k5k0G@CF80k0N8H04F01V8@4LPX58V02@F8401!2NV8VG6G!89BkFV901VV044020KGF6!603V	CHEMBL1924003	fj}`P@A@QDjSZsKmkZIPTyJtsTt@QTPHX`	Cc1cc(/C=C/C(=O)O)c(C)n1-c1ccc2c(c1)OCO2	4.3	group4-ia	ia	Androgen Receptor	Transcriptional activity at human androgen receptor BF3 site stably transfected in eGFP-expressing human LNCAP cells after 5 days by fluorometric analysis	2011	fgA@@@LdbbRReWEBdZuUUUUT@@	fgA``@I@heLkoKbgAFmPPERq@@@	285.298	2.566	5	1	60.69	3	-0.3999077761013148	0.9077097409951169	-0.1431428030745035	1	1	fj}`P@A@QDjSZsKmkZIPTyJtsTt@QTPHX`											1
=vxzjw5wbHvUUw8YmNmyaRHJ9WhM5LnVE3XgIOo94lGX2fSWtYrU5JcW1Cnm0d53ZBF41YeBRLF510W0FV	CHEMBL1928872	feohb@LDxHoQ`BLdTTRbTlRRVaReA\dGJZ}gSUU@@@QSJEAE@@	O=C1COc2ccc(C3=Nn4cnnc4SC3c3ccccc3)cc2N1	5.44	group4-ia	ia	Androgen Receptor	Displacement of [3H]testosterone from AR	2011	feo@@@LdbbbTRRRRfQQPmVRFlR}GUUUUUUUUUT@@	feohb@LDxHoQ`BLdTTRbTlRRVaReA\dGJZ}gSUU@@@QSJEAE@@	363.4	2.0805	7	1	106.7	2	1.1052957542643806	1.6099621295670266	0.25094071204022306	4	3	feohb@LDxHoQ`BLdTTRbTlRRVaReA\dGJZ}gSUU@@@QSJEAE@@											1
=vxzjw5wbHvUUw8YmNmyaRHJ9YhM5LnVE3XgIOo94lGX2fSWtYrU_JcW1Enm0d5AZBF41YeCRLF5G0W8FV	CHEMBL1928874	fmha@LDxJhy`BORFRJJIQJVJIKZEJTErTRyZM]MUT@P@QSJEAE@@	O=C1COc2ccc(C3=Nn4cnnc4SC3c3ccccc3F)cc2N1	5.23	group4-ia	ia	Androgen Receptor	Displacement of [3H]testosterone from AR	2011	feo@@@LdbbbTRRRRfQQPmVRFlR}GUUUUUUUUUT@@	feohb@LDxHoQ`BLdTTRbTlRRVaReA\dGJZ}gSUU@@@QSJEAE@@	381.39	2.1813	7	1	106.7	2	1.1952918072170569	1.4826537359682381	0.28106829572628605	4	3	fmha@LDxJhy`BORFRJJIQJVJIKZEJTErTRyZM]MUT@P@QSJEAE@@											1
=vxzjw5wbHvUUw8YmNmyaRHJ9WhM5LnVE3XgIOo94lGX2fSWtYrU5JcW1Cnm0d53aBF41YeBRLF710W8FV	CHEMBL1928875	fmha@LDxJhy`BLrFRJJIQJVIIJZUJTErPRiZM]MUT@@DQSJEAE@@	O=C1COc2ccc(C3=Nn4cnnc4SC3c3cccc(F)c3)cc2N1	5.33	group4-ia	ia	Androgen Receptor	Displacement of [3H]testosterone from AR	2011	feo@@@LdbbbTRRRRfQQPmVRFlR}GUUUUUUUUUT@@	feohb@LDxHoQ`BLdTTRbTlRRVaReA\dGJZ}gSUU@@@QSJEAE@@	381.39	2.1813	7	1	106.7	2	1.1952918072170569	1.4826537359682381	0.28106829572628605	4	3	fmha@LDxJhy`BLrFRJJIQJVIIJZUJTErPRiZM]MUT@@DQSJEAE@@											1
=vxzjw5wbHvUUw8YmNmyaRHJ9WhM5LnVE3XgIOo94lGX2fSWtYrU5JcW1Cnm0d53ZBF41YeBRLF510W0FV	CHEMBL1928877	feoHb@LDDWhpAFRJJIQJVIIKPiR`nRCeM^sijj`@@HieB`b`@	O=C1COc2ccc(C3=Nn4ccnc4SC3c3ccccc3)cc2N1	7.02	group2-a	a	Androgen Receptor	Displacement of [3H]testosterone from AR	2011	feo@@@LdbbbTRRRRfQQPmVRFlR}GUUUUUUUUUT@@	feoHb@LDDWhpAFRJJIQJVIIKPiR`nRCeM^sijj`@@HieB`b`@	362.412	2.4708	6	1	93.81	2	0.6296177814757057	1.1635944867959718	0.1299933133795937	4	1	feoHb@LDDWhpAFRJJIQJVIIKPiR`nRCeM^sijj`@@HieB`b`@											1
;rEntp9s4wZFABUs0WXN2u0JFF9Wh24LmV50Xc3Ok96FGV0@5VWXpL5FcV1CYF0953V4V49XeBJJF510V0F0	CHEMBL1928878	fmPb@NUGL@QdbbbbRftRrVaReNRmDnVcWPUA@@@DTrAPQP@	O=C1COc2ccc(C3=Nc4ccccc4SC3c3ccccc3)cc2N1	5.92	group4-ia	ia	Androgen Receptor	Displacement of [3H]testosterone from AR	2011	fm@@@LdbbbTRRRRfVRjEjrPuJt\zjjjjjjjjjh@@	fmPb@NUGL@QdbbbbRftRrVaReNRmDnVcWPUA@@@DTrAPQP@	372.447	3.6698	4	1	75.99	2	-0.15014455610103444	0.033186235136685865	-0.0696955221182833	1	1	fmPb@NUGL@QdbbbbRftRrVaReNRmDnVcWPUA@@@DTrAPQP@											1
;r7nOp9k5w4FACUN2W2N2u04FF93j20LmZ58X03Qk94GlV02OXh2pL1FVc1ElGWA5@Xb860VeC5KFK10W8FV	CHEMBL1929041	ek`\DJ@ACOBG@H`ZPfdEi@zPrJJIJIFIQFIQJQ]bPSSrKkZBBbiZ`bJbI@@@	Cc1cc(F)ccc1-n1nc(C(F)(F)F)cc1-c1cc(Cl)c2c(c1)NC(=O)CO2	5.35	group4-ia	ia	Androgen Receptor	Displacement of [3H]testosterone from AR	2011	ffs@@@LdbbRRQfbTJSA\exIZuUUUUUUUP@@	ffsp`@DF\BbSJvksOZtYIS`ejuP@Tu@AB@@@	425.768	3.3939	5	1	56.15	3	0.22785930968973425	-0.1441893853387362	0.0807565103323081	4	1	ek`\DJ@ACOBG@H`ZPfdEi@zPrJJIJIFIQFIQJQ]bPSSrKkZBBbiZ`bJbI@@@											1
=btKtuCw5KDfyNcpV9@c1lN0NVCcBLS2K8iF2fl@48VV0eR0ha4oF18E5GHFV132WV04C240V!1!3!V	CHEMBL1933081	fkPPBHN@bJXRclbfbRrbbbTURVbRxHsmgZ@Bejfjh@B@@@	CCOC(=O)c1c(-c2ccc([N+](=O)[O-])cc2)c(C)n(CCc2ccccc2)c1C	7.28	group2-a	a	Androgen Receptor	Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor T877A mutant expressed in HEK293 derived FreeStyle293F cells after 3 hrs	2012	flu@@@LdbbRRqRbRxhThijjjjjjj@@	flu`@@@ITj{LjnRchaSTmP@@A@@@	392.454	4.0655	6	0	77.05	8	1.118367175204207	-0.7404655179298772	1.3884430401623797	3	1	fkPPBHN@bJXRclbfbRrbbbTURVbRxHsmgZ@Bejfjh@B@@@											1
zxzrrbtKtu4R5G6XyNcpV82c1lN0N0CV4HG2K8iF2Wk848VV0e80h24JF18C5GHFV1121V04B2!V!1!Y0FV	CHEMBL1934427	fjmPPBHN@bJXRclbfbRrbbbTZxHsf`@iZijH@@	CCOC(=O)c1c(C)[nH]c(C)c1-c1ccc([N+](=O)[O-])cc1	7.66	group2-a	a	Androgen Receptor	Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor expressed in HEK293 derived FreeStyle293F cells after 3 hrs	2012	dmL@@DjYU^TYjjjj@@	dmN@@@Re^UpiVe`@`@@	288.302	2.2348	6	1	87.91	5	0.6311618502360888	1.1745394843604275	0.07011994806803691	36	2	fjmPPBHN@bJXRclbfbRrbbbTZxHsf`@iZijH@@											1
;rzbtKtu5w5GDYyNcpV8@c1lN0N0Cc4HG2K8iF2fk848VV0eN0h24JF18C5GHFV112WV04B2!V!1!3!V	CHEMBL1934428	ff}PPBHN@bJXRclbfbRrbbbTUwAF\t@EKUMTP@@	CCOC(=O)c1c(-c2ccc([N+](=O)[O-])cc2)c(C)n(C)c1C	5.21	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor W741C mutant expressed in COS7 cells assessed as inhibition of DHT-induced luciferase activity after 24 hrs by reporter gene assay	2012	dmL@@DjYU^TYjjjj@@	dmN@@@Re^UpiVe`@`@@	302.329	2.3676	6	0	77.05	5	0.24802798652618782	0.9769072206966896	1.1529741537175422	36	2	ff}PPBHN@bJXRclbfbRrbbbTUwAF\t@EKUMTP@@											1
;rzbtKtu5w5GDYyNcpV8@c1pN0OVCc4HO2K8iF2fk848VV0eN0h24JF18C5KmFV113WV04B2!V1F1!3!V	CHEMBL1934429	fmwPPBHN@bJXRclbfbRrbbbTUTRVxHsikZ@BejfhH@`@@	CCOC(=O)c1c(-c2ccc([N+](=O)[O-])cc2)c(C)n(-c2ccccc2)c1C	5.37	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor expressed in COS7 cells assessed as inhibition of DHT-induced luciferase activity after 24 hrs by reporter gene assay	2012	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhy`@@@ITrjZlyKW`u@hP@D@@@	364.4	3.6972	6	0	77.05	6	0.670883969036957	-0.173382179274777	1.288147115415029	42	1	fmwPPBHN@bJXRclbfbRrbbbTUTRVxHsikZ@BejfhH@`@@											1
;rzbtKtuCw5GEYyNcpV8@c1lN2NVCc4HO2K8iF2vk@4NVV0eN0h24JF18h5GHFW132WV04B2!V!1!3!V	CHEMBL1934430	fcoPPBHN@bJXRclbfbRrbbbTURTrWAF\o[P@TmTuT@A@@@	CCOC(=O)c1c(-c2ccc([N+](=O)[O-])cc2)c(C)n(Cc2ccccc2)c1C	6.47	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in COS7 cells assessed as inhibition of DHT-induced luciferase activity after 24 hrs by reporter gene assay	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fde`@@@ITj|rjyJVCzMRt@@@P@@@	378.427	3.7251	6	0	77.05	7	0.9019772058629226	-0.36299446564951565	1.3374807879453308	38	11	ffc`A@C@|UNNQQIYQQSHjIJcMFKV@BfZj@@`@@	gGPh@l@IL{U@@	gChhhE`BRnRYh@									9
=jzUzv:SUDfyOwxuAEcKlPVsVScBQS2KNyF@fl@48VV4uN0h24oF1BEMGHFV532WV0BB2!V!W!3!V	CHEMBL1934431	fcoPPBHN@bJXRclbfbRrbbbTURTrWAF\o[P@TmTuUUQP@@	CCOC(=O)c1c(-c2ccc([N+](=O)[O-])cc2)c(C)n(CC2CCCCC2)c1C	5.43	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor T877A mutant expressed in COS7 cells assessed as inhibition of DHT-induced luciferase activity after 24 hrs by reporter gene assay	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fde`@@@ITj|rjyJVCzMRuPTDT@@@	384.474	3.9677	6	0	77.05	7	0.9224073523539132	-0.5312572214598774	1.3486953169419305	38	1	fcoPPBHN@bJXRclbfbRrbbbTURTrWAF\o[P@TmTuUUQP@@											1
;rzbtKtuCw5GEYzNcpV8@c1lN2NVCc4Ht2K8iF2vk@4NVV0eN0h24JF98h5GHFd132WV04B2!V!1!3!V	CHEMBL1934432	fkQPBHN@bJZpeGYEMDeeEEDhjhmLepQg[Nt@EKUMSP@D@@@	CCOC(=O)c1c(-c2ccc([N+](=O)[O-])cc2)c(C)n(C(=O)c2ccccc2)c1C	6.82	group3-int	int	Androgen Receptor	Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor expressed in HEK293 derived FreeStyle293F cells after 3 hrs	2012	flu@@@LdbbRRqbfRxhThijjjjjjj@@	flua@@D@RYfUW{TTmVbej`TH@B@@@	392.41	4.1215	7	0	94.12	7	1.4763050209058073	-0.40707870991950357	1.4945509512172384	1	1	fkQPBHN@bJZpeGYEMDeeEEDhjhmLepQg[Nt@EKUMSP@D@@@											1
;rzrtptuCw_lEfzscpV8@c1lOHOVCc4HG2K8is2vk@4OVV0eN0h24JJ18h5GHFW112WV04g202k!1!3!V	CHEMBL1934433	eg`TFHDLMhDBjck`@cZ[nrRPqQQQI[ZJYYYZRZNQ]SKU@sAPCAEM@@@@	CCOC(=O)c1c(-c2ccc([N+](=O)[O-])cc2)c(C)n(S(=O)(=O)c2ccccc2)c1C	6.89	group3-int	int	Androgen Receptor	Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor expressed in HEK293 derived FreeStyle293F cells after 3 hrs	2012	fbm@@@LddTTJRVLRRkZLgMUUUUUUT@@	fbm`b@LPP@HrRPqQII[SIRTYr\kU@hP@D@@@	428.464	2.486	8	0	119.57	7	2.3972470738552825	0.7499335387103603	1.6986800135991302	1	1	eg`TFHDLMhDBjck`@cZ[nrRPqQQQI[ZJYYYZRZNQ]SKU@sAPCAEM@@@@											1
;rUbtKduCw4GEYyNVpV8@c1kN2NVC84HO2K8iF2vk@4NVV0eN0h24JF18h1GHFW132WV04B2!V!1!3!V	CHEMBL1934434	fmwPPBHN@bJXRclbfbRrbbbTUVbRxHsikZ@Bejfj@@`@@	COC(=O)c1c(-c2ccc([N+](=O)[O-])cc2)c(C)n(Cc2ccccc2)c1C	6.13	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor W741C mutant expressed in COS7 cells assessed as inhibition of DHT-induced luciferase activity after 24 hrs by reporter gene assay	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fde`@@@ITj|rjyJVCzMRt@@@P@@@	364.4	3.3188	6	0	77.05	6	0.6886878792622797	0.05409246924863792	1.2861750988841565	38	11	ffc`A@C@|UNNQQIYQQSHjIJcMFKV@BfZj@@`@@	gJPh@l@ILmP@	gChhhE`BRnRYh@									9
:urTbtK8PCw0GEWmNVlV8@V1FN2FVC80HO2K8a02Qk@4NVV0eN0C24JF18g1FHFW132WV04B2%1!703V	CHEMBL1934435	fegPPBHN@bJXRclbfbRrbbbTSTRWAF\N[P@TmTu@@P@@	Cc1c(C(=O)O)c(-c2ccc([N+](=O)[O-])cc2)c(C)n1Cc1ccccc1	6.72	group3-int	int	Androgen Receptor	Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor T877A mutant expressed in HEK293 derived FreeStyle293F cells after 3 hrs	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fde`@@@ITj|rjyJVCzMRt@@@P@@@	350.373	2.8909	6	1	88.05	5	0.9294209292950102	0.5509744481798646	0.17603227483973877	38	11	ffc`A@C@|UNNQQIYQQSHjIJcMFKV@BfZj@@`@@	gC`h@l@ILt@@	gChhhE`BRnRYh@									9
:urPYtG8PCs0FA1mNVlV8@V0FF2FVC80HO2K8X02Qk@4NV!eN0C24JF08c1FHFW132WV04B2%1!301V	CHEMBL1934436	fi{Q`BHN@bLIQvQSQIYQQQIUQI\DYwQm@ARuUP@D@@@	Cc1c(CO)c(-c2ccc([N+](=O)[O-])cc2)c(C)n1Cc1ccccc1	6.52	group3-int	int	Androgen Receptor	Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor expressed in HEK293 derived FreeStyle293F cells after 3 hrs	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fde`@@@ITj|rjyJVCzMRt@@@P@@@	336.39	2.8085	5	1	70.98	5	0.34031941442068214	0.40629786931747675	0.02059856057761999	38	11	ffc`A@C@|UNNQQIYQQSHjIJcMFKV@BfZj@@`@@	eMJA@Df`@	gChhhE`BRnRYh@									9
yyPnTYtG8NCu0FAWFN0OV8@VGFN20V980HO258V02Qk24NVV0eN0C24JF18c1F2FW132cV0482)3!V	CHEMBL1934437	fegQ`BHN@bLIQvQSQIYQQQJIjIK`cNGMh@JVjZ`@H@@	CC(=O)c1c(-c2ccc([N+](=O)[O-])cc2)c(C)n(Cc2ccccc2)c1C	6.89	group3-int	int	Androgen Receptor	Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor T877A mutant expressed in HEK293 derived FreeStyle293F cells after 3 hrs	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fde`@@@ITj|rjyJVCzMRt@@@P@@@	348.401	3.277	5	0	67.82	5	0.05461944898719959	0.07081709073236625	1.1214846751482528	38	11	ffc`A@C@|UNNQQIYQQSHjIJcMFKV@BfZj@@`@@	gCaHA`AIf`@	gChhhE`BRnRYh@									9
yyPnPYOG8FCk0FA1FN0GV8@V!F20V180HO258V02Pk24NV!2N0C204F08c1!FW122VV048*3!V	CHEMBL1934438	fnsP`BHF@bDhyInUvY]yW`cNjuh@IjZ`@H@@	Cc1cc(-c2ccc([N+](=O)[O-])cc2)c(C)n1Cc1ccccc1	5.51	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor W741C mutant expressed in COS7 cells assessed as inhibition of DHT-induced luciferase activity after 24 hrs by reporter gene assay	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fde`@@@ITj|rjyJVCzMRt@@@P@@@	306.364	3.4058	4	0	50.75	4	-0.8506938679248754	0.024034717693319996	0.8948821486040166	38	11	ffc`A@C@|UNNQQIYQQSHjIJcMFKV@BfZj@@`@@		gChhhE`BRnRYh@									9
;rUbtJduCw4GCYiNVpV8@81kN2NV484HO2K8DF0uk@4F0V0eN0d04JF10h1GH0W132W!442!V)V	CHEMBL1934439	fak``@I@PdrwLr{oZbdEK^mTsPTD@A@@@	COC(=O)c1c(-c2ccccc2)c(C)n(Cc2ccccc2)c1C	7.19	group2-a	a	Androgen Receptor	Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor T877A mutant expressed in HEK293 derived FreeStyle293F cells after 3 hrs	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fde`@@@ITj|rjyJVCzMRt@@@P@@@	319.403	4.2404	3	0	31.23	5	-1.2215062666277674	-0.9108956704107902	0.8085623139628497	38	11	ffc`A@C@|UNNQQIYQQSHjIJcMFKV@BfZj@@`@@	gJPh@l@ILmP@										9
;rUbtJduCw4GCYyNVpV8@81kN2NVC84HO2K8DF0vk@4F0V0eN0d24JF18h1GH0W132W!442!V!1#V0V	CHEMBL1934440	fegP`@IC@aIenYew^UTT`i{MjfZB``HL`@@	COC(=O)c1c(-c2ccc(C#N)cc2)c(C)n(Cc2ccccc2)c1C	7.57	group2-a	a	Androgen Receptor	Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor expressed in HEK293 derived FreeStyle293F cells after 3 hrs	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fde`@@@ITj|rjyJVCzMRt@@@P@@@	344.413	4.076	4	0	55.02	5	-0.45463907229487943	-0.6094549810070744	0.9979598412491518	38	11	ffc`A@C@|UNNQQIYQQSHjIJcMFKV@BfZj@@`@@	gJPh@l@ILmP@	eMbA@Dg`@									9
;rUrtJduCw4GCbyNXpV8@P1oNHNXC84HQ6K8DF1vk@4F1V0eN0d24JF18h1QH0W17@Y50642!V!3080c0V	CHEMBL1934441	eg`TDL@EHbj`IABPpdLbdLTRRLTTRbjtRTfgdQuuTDFTmTuP@D@@@	COC(=O)c1c(-c2ccc(C#N)c(C(F)(F)F)c2)c(C)n(Cc2ccccc2)c1C	8.33	group1-p	p	Androgen Receptor	Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor T877A mutant expressed in HEK293 derived FreeStyle293F cells after 3 hrs	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fde`@@@ITj|rjyJVCzMRt@@@P@@@	412.41	4.9243	4	0	55.02	6	0.02206985248447768	-1.4923870821320542	1.1403756995672176	38	11	feg`B`@`|QRDiAT`yqrJJIJSVJJYEQILyxHypDEULuT@A@@@	gJPh@l@ILmP@	eMbA@Dg`@									1
uyPnPYtF8NCk0F91FN0GV8@!FF20V980HO258#Pk24F#@N0924JF08c10201122V!402*V0V	CHEMBL1934442	fakp@@@V}dRbRrbbbRjbRYpuf}x@JYkj@@`@@	Cc1c(C#N)c(-c2ccc(C#N)cc2)c(C)n1Cc1ccccc1	8.52	group1-p	p	Androgen Receptor	Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor T877A mutant expressed in HEK293 derived FreeStyle293F cells after 3 hrs	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fde`@@@ITj|rjyJVCzMRt@@@P@@@	311.387	3.9986	3	0	52.51	3	-1.227153591496012	-0.338071613183756	0.7960644145277883	38	11	ffc`A@C@|UNNQQIYQQSHjIJcMFKV@BfZj@@`@@	eMbA@Dg`@	eMbA@Dg`@									9
uyPnPYtF8NCk0F91FN0GV8@!FF20V980HO258#Pk24F#@N0924JFF8c10201122V!402*V0k	CHEMBL1934443	fakH@@@V}WHeDeeEEDeUDdsakM{p@TsWT@A@@@	Cc1c(C#N)c(-c2ccc(C#N)cc2)c(C)n1Cc1cccnc1	7.19	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in COS7 cells assessed as inhibition of DHT-induced luciferase activity after 24 hrs by reporter gene assay	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fdeP@@@\rQIPjIKQIDhkPX`AUK@@P@@	312.375	2.9977	4	0	65.4	3	-0.7227465272814688	0.47535733428223703	0.9138297060769771	38	6	fakH@@@V}WHeDeeEEDeUDdsakM{p@TsWT@A@@@											1
uyPnPYtG8NCk0F91FN0GV8@!FF20VA80HO258#Qk24F#@N0C24JFF8c10201322V!402%F#V0k	CHEMBL1934444	fi{HB@DBbLDPdrnlsOmkmFZmUl@ETsU`AY@@@	Cc1c(C#N)c(-c2ccc(C#N)cc2)c(C)n1Cc1ccc(Cl)nc1	8.05	group1-p	p	Androgen Receptor	Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor expressed in HEK293 derived FreeStyle293F cells after 3 hrs	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fdeP@@@\rQIPjIKQIDhkPX`AUK@@P@@	346.82	3.7011	4	0	65.4	3	-0.5744481321646073	-0.07522342628785021	0.9741741116463501	38	6	fi{HB@DBbLDPdrnlsOmkmFZmUl@ETsU`AY@@@											1
yyurPYtF8NCk0F91FN0GV8@F0FF20V980HO258#Pk24F1!@N0924JFF8c10201122X!442)2V1k	CHEMBL1934445	fegI@@JRSLBRrklsOmkkNF\wm@AULuX@VP@@	Cc1c(C#N)c(-c2ccc(C#N)cc2)c(C)n1Cc1cncc(CO)c1	7	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in COS7 cells assessed as inhibition of DHT-induced luciferase activity after 24 hrs by reporter gene assay	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fdeP@@@\rQIPjIKQIDhkPX`AUK@@P@@	342.401	2.4004	5	1	85.63	4	0.4682666323541568	0.8576204299432524	0.0395460986305427	38	6	fegI@@JRSLBRrklsOmkkNF\wm@AULuX@VP@@											1
yyurPYtG8NCk0F91FN0GVN@F0FF20VA80HO258#Qk@4F1!@N0C24JFF8c1@201322X!442%F!2V1k	CHEMBL1934446	fmwIB@DJrlPHaIeg]fY}m]irwnc`BJjYjp@l`@@	Cc1c(C#N)c(-c2ccc(C#N)cc2)c(C)n1Cc1cnc(Cl)c(CO)c1	6.55	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor W741C mutant expressed in COS7 cells assessed as inhibition of DHT-induced luciferase activity after 24 hrs by reporter gene assay	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fdeP@@@\rQIPjIKQIDhkPX`AUK@@P@@	376.846	3.1038	5	1	85.63	4	0.6165650274710183	0.3070396693731652	0.09989050419991576	38	6	fmwIB@DJrlPHaIeg]fY}m]irwnc`BJjYjp@l`@@											1
yyurPYtG8N5k0F91FN0GVN@F0FF!VA80HO258#Qk84F1!@N0C24JFF8c1@201302X!442%F!2V1k	CHEMBL1934447	fegIB@DJKLPHaIeg]fWYWvgK^[v@Hjif`pKH@@	Cc1c(-c2ccc(C#N)cc2)c(C#N)cn1Cc1cnc(Cl)c(CO)c1	5.85	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor W741C mutant expressed in COS7 cells assessed as inhibition of DHT-induced luciferase activity after 24 hrs by reporter gene assay	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fdeP@@@\rQIPjIKQIDhkPX`AUK@@P@@	362.819	2.7059	5	1	85.63	4	0.5614176295148284	0.5982532398478067	0.07473566464454165	38	6	fegIB@DJKLPHaIeg]fWYWvgK^[v@Hjif`pKH@@											1
yyurPYtG8N5k0F91FN0GVN@F0FF!VA80HO258#Qk84F1!@N0C24JFF8c1@201302X!442%F!2V1k	CHEMBL1934448	fegIB@DJSLPHaIeg]fWVuvgK^[v@Hjifl@KH@@	Cc1c(C#N)c(-c2ccc(C#N)cc2)cn1Cc1cnc(Cl)c(CO)c1	6.04	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor T877A mutant expressed in COS7 cells assessed as inhibition of DHT-induced luciferase activity after 24 hrs by reporter gene assay	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fdeP@@@\rQIPjIKQIDhkPX`AUK@@P@@	362.819	2.7059	5	1	85.63	4	0.5614176295148284	0.5982532398478067	0.07473566464454165	38	6	fegIB@DJSLPHaIeg]fWVuvgK^[v@Hjifl@KH@@											1
[vyixbyEyztQJHjHPWx9rbmh781XMXDHmI9ZB9H95E12ZW4kWBA2l8@8!B4N2IF2FZYV24WY0NVcF0	CHEMBL1946622	fjmPc@EQLDD`bPqHYEHXhddUEEIKTTuPPYUMTTKP@	CC1(C)CNC(=O)[C@@H]1Oc1ccc(C#N)c(C(F)(F)F)c1	6.98	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor expressed in human LNAR cells assessed as inhibition of R1881-induced luciferase activity by spectrophotometry	2012	dk\@@DjU^ykeNjjjj`@	dk^D@DBdfV~UImMjj@BHq@@	298.263	2.2143	4	1	62.12	3	-0.5368746804841473	0.9606923466124629	-0.2085472200140817	31	9	flePa@NNeXGbeqrJJIIEQQRY`g^``rjZjJBh@		gJPBAHJPt`PAIjj@@									9
{xzy;vULUjvPjxjzbmxEN1jMeEInnEZi9HAEEGHgn4mdBE6nP@82GB6sPIF3F_YV2ZWY0N0c!	CHEMBL1946805	fikQc@EQLGhIADabPrJPqQIHjJJSURVhij``rjZjfJEh@	CC(=O)CN1CC(C)(C)[C@@H](Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O	6.58	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor expressed in human LNAR cells assessed as inhibition of R1881-induced luciferase activity by spectrophotometry	2012	dk\@@DjU^ykeNjjjj`@	dk^D@DBdfV~UImMjj@BHq@@	354.327	2.2749	5	0	70.4	5	0.17447244769529305	0.670177403167941	1.132580590893713	31	9	flePa@NNeXGbeqrJJIIEQQRY`g^``rjZjJBh@	gJQH@PAIej@@	gJPBAHJPt`PAIjj@@									9
{xzy<ULUjvvj;jmxjPYzMfEIrvEaihHAjErHgv4mhBU6nPA8@GC6N2QJ3F_YVHZWf0N1c0V	CHEMBL1946806	fcoIc@EQFlp^`dDRFICHiCEDdbhhiMUDeKTTsWUAAeTuUSTSBt@@	Cc1nnc(CN2CC(C)(C)[C@@H](Oc3ccc(C#N)c(C(F)(F)F)c3)C2=O)o1	6.2	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor expressed in human LNAR cells assessed as inhibition of R1881-induced luciferase activity by spectrophotometry	2012	flu@@@LdbRVfbQTRiqQhijjjjjjj@@	fluq`@DZ|AblbbbfVbbRQIqwhiZjjdJ@daa@@	394.352	2.1903	7	0	92.25	5	1.2302446664728635	0.9745884509944727	1.4307079908005198	4	1	fcoIc@EQFlp^`dDRFICHiCEDdbhhiMUDeKTTsWUAAeTuUSTSBt@@											1
{xzy<UMUjvzj;jqxzvYzMfjIrvUayhHfzErHhvCyxBU7nPABilC6P2UJ3JpYkHZdf0N1c0V	CHEMBL1946807	elVRLB@IMKDQHb`ICzPAdHYCHhdiidmEMEeDXdieHjNEMDlmch@bZjijj@BjlX@@@	CC(c1nnc(-c2cccc(F)c2)o1)N1CC(C)(C)C(Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O	7.11	group2-a	a	Androgen Receptor	Antagonist activity at androgen receptor expressed in human LNAR cells assessed as inhibition of R1881-induced luciferase activity by spectrophotometry	2012	fig@@@LdbbRRqTTRJbRxhToQzNjjjjjjjjj@@	figq`@DZ|AbdfYmyeU~uIqwhyzMjjjPhH@BP@@	488.44	3.9874	7	0	92.25	6	1.799712083261053	-0.5754669770468204	1.6210007773308246	4	1	elVRLB@IMKDQHb`ICzPAdHYCHhdiidmEMEeDXdieHjNEMDlmch@bZjijj@BjlX@@@											1
{xzy<UMUjvvj;jmxjPYzMfEIrvUaihHfjErHgv4qxBU7nPA8@lC6P2QJ3J_YVHZWf0N1c0V	CHEMBL1946809	ehRRLL@EHaec@n`IABPpdLbdLTRRJbbduTRVbRdtbRfV~Aj``rjZjij@@d`l`@	CC1(C)CN(Cc2nnc(-c3ccccc3)o2)C(=O)[C@@H]1Oc1ccc(C#N)c(C(F)(F)F)c1	7.15	group2-a	a	Androgen Receptor	Antagonist activity at androgen receptor expressed in human LNAR cells assessed as inhibition of R1881-induced luciferase activity by spectrophotometry	2012	fig@@@LdbbRRqTTRJbRxhToQzNjjjjjjjjj@@	figq`@DZ|AbdfYmyeU~uIqwhyzMjjjPhH@BPaa@@	456.423	3.5999	7	0	92.25	6	1.6493367739366436	-0.223792897044722	1.566297919034441	4	1	ehRRLL@EHaec@n`IABPpdLbdLTRRJbbduTRVbRdtbRfV~Aj``rjZjij@@d`l`@											1
{xzy;vULUjvPjxjzbmxEN1iMeDInnEZi9HAEEGHZl4mdBE6nP@82FB6NHIF3F_YV2ZWY0N0c!	CHEMBL1946811	fikpc@EQFXHIADabPrJPqQIHjJJSUJVhij``rjZjkJEh@	CC1(C)CN(CCC#N)C(=O)[C@@H]1Oc1ccc(C#N)c(C(F)(F)F)c1	6.88	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor expressed in human LNAR cells assessed as inhibition of R1881-induced luciferase activity by spectrophotometry	2012	dk\@@DjU^ykeNjjjj`@	dk^D@DBdfV~UImMjj@BHq@@	351.327	2.5735	5	0	77.12	5	0.25270802226038014	0.5510919765123894	1.1463055311730441	31	9	flePa@NNeXGbeqrJJIIEQQRY`g^``rjZjJBh@	gJXH@PAIWj@@	gJPBAHJPt`PAIjj@@									9
{xzy;vULUjvPjxjzbmxENWiMeDInnEai9HAEEGHZl4mdBE6nP@82FB6N2IF3F_YV2ZWf0N2c10	CHEMBL1946812	fasQc@EQLGhIADabPrJPqQIHjJJSURuEMTDFUSUUEBt@@	CC1(C)CN(CCO)C(=O)[C@@H]1Oc1ccc(C#N)c(C(F)(F)F)c1	6.58	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor expressed in human LNAR cells assessed as inhibition of R1881-induced luciferase activity by spectrophotometry	2012	dk\@@DjU^ykeNjjjj`@	dk^D@DBdfV~UImMjj@BHq@@	342.316	1.9468	5	1	73.56	5	0.4535664045223402	0.9212569154111006	0.03242614539304796	31	9	flePa@NNeXGbeqrJJIIEQQRY`g^``rjZjJBh@	gCaHA`AIZ`@	gJPBAHJPt`PAIjj@@									9
{xzy;vULUjvTjxjzbqxUtWiMeiInnEai9HAUEGHZlCudBE6nP@BXFB6N2IF3FpYk2ZWf0N2c10	CHEMBL1947177	fikQc@EQLDXIADabPrJPqQIHjJJSVJVhij``rjZjjJEh@	CC(CO)N1CC(C)(C)[C@@H](Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O	6.47	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor expressed in human LNAR cells assessed as inhibition of R1881-induced luciferase activity by spectrophotometry	2012	dk\@@DjU^ykeNjjjj`@	dk^D@DBdfV~UImMjj@BHq@@	356.343	2.3061	5	1	73.56	5	0.5105298004627447	0.653247914635406	0.05737977134037717	31	9	flePa@NNeXGbeqrJJIIEQQRY`g^``rjZjJBh@	gJQH@PAIZj@@	gJPBAHJPt`PAIjj@@									9
{xzy;vULUjvTjxjzbqxUtWiMeiInnEai9HAUEGHalCudBE6nP@BXFBaN2IFYFpYk2ZWf0N2c10	CHEMBL1947178	fe{Qc@EQLFXIADabPrJPqQIHjJJSVQRuEMTDFUSUUTTKP@	CC1(C)CN(C(C)(C)CO)C(=O)[C@@H]1Oc1ccc(C#N)c(C(F)(F)F)c1	6.12	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor expressed in human LNAR cells assessed as inhibition of R1881-induced luciferase activity by spectrophotometry	2012	dk\@@DjU^ykeNjjjj`@	dk^D@DBdfV~UImMjj@BHq@@	370.37	2.6867	5	1	73.56	5	0.5664911667767258	0.3724341475609427	0.08244445322606761	31	9	flePa@NNeXGbeqrJJIIEQQRY`g^``rjZjJBh@	gGQHAPAIZjh@	gJPBAHJPt`PAIjj@@									9
{xzy;vULUjvPjxjzbqxENWiMeDInnEiy9HAUEGHZl4mdBE6nP@82FB6NHIF3F_YV2ZWf0N2c10	CHEMBL1947179	fikQc@EQLGhIADabPrJPqQIHjJJSURVhij``rjZjjJEh@	CC(O)CN1CC(C)(C)[C@@H](Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O	6.01	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor expressed in human LNAR cells assessed as inhibition of R1881-induced luciferase activity by spectrophotometry	2012	dk\@@DjU^ykeNjjjj`@	dk^D@DBdfV~UImMjj@BHq@@	356.343	2.3061	5	1	73.56	5	0.5105298004627447	0.653247914635406	0.05737977134037717	31	9	flePa@NNeXGbeqrJJIIEQQRY`g^``rjZjJBh@	gJQH@PAIfj@@	gJPBAHJPt`PAIjj@@									9
{xzy;vULUjvQjzjzbqxENWiMeDInnEgi9HAUEGHZl4mdBE6nP@86FB6NHIF3F_YV2ZWY0N2c10	CHEMBL1947183	fe{Qc@EQLFXIADabPrJPqQIHjJJSUQRuEMTDFUSUUTTKP@	CC(CO)CN1CC(C)(C)[C@@H](Oc2ccc(C#N)c(C(F)(F)F)c2)C1=O	6.43	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor expressed in human LNAR cells assessed as inhibition of R1881-induced luciferase activity by spectrophotometry	2012	dk\@@DjU^ykeNjjjj`@	dk^D@DBdfV~UImMjj@BHq@@	370.37	2.6195	5	1	73.56	6	0.7281901195329205	0.29200769897600004	0.1082013156660889	31	9	flePa@NNeXGbeqrJJIIEQQRY`g^``rjZjJBh@	gGQHAPAIYjh@	gJPBAHJPt`PAIjj@@									9
{xzy;fULUzvPjtjzbmzEN1iIf6Inm7Za9HAEEGHZl4ndBE6nP882FD2FFHF1F_YV2ZWW0F0V!	CHEMBL1947185	ff}pb@NNkJpHcHhhddUEEIjdpSoPPYUMUUeAT@@	CC1(C)CN(CCC#N)C(=O)[C@@H]1Oc1ccc(C#N)c(Cl)c1	7.17	group2-a	a	Androgen Receptor	Antagonist activity at androgen receptor expressed in human LNAR cells assessed as inhibition of R1881-induced luciferase activity by spectrophotometry	2012	dk\@@DjU^ykeNjjjj`@	dk^D@DBdfV~UImMjj@BHq@@	317.775	2.3312	5	0	77.12	4	-0.0711197806296745	0.9419952951803332	1.063726481338242	31	9	flePa@NNeXGbeqrJJIIEQQRY`g^``rjZjJBh@	gJXH@PAIWj@@	eFABH`BL@									9
:xzCqslde4mZ0EgHsVhXSHH1Z0F9Y824FHVl02k3lkG6FG01@101ZJH_1Wc8020894184V250@44#4F2010	CHEMBL195033	fdeA`@@\MdTTRbVRaRYrV`qZB`b@BBCJ@@	O=C1CC(c2ccccc2)Oc2ccc(O)cc21	5.48	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-kb2 cells assessed as inhibition of DHT-induced luciferase activity by luciferase reporter gene assay	2009	fhy@@@LdbbbRnbRYHRoAjjjjjj`@@	fhy@`@@\RYee~uYrVoAZB``@HHLh@@	240.257	2.8471	3	1	46.53	1	-1.6847302520366538	0.8018290502571686	-0.4811397489227748	32	9	fde@b@AR@xyEDeLhbhdjLUhLX@JZ`@Hah`@	eFJB@Hp@										2
zyPvLntl8N5uVFA5FNHOVOHmFJFF12A0VHnL58VV2Qk841W!eNVC65JFN881RmFcA50XX0Z02!11FL!WVFV	CHEMBL1957607	eg`RHH@NIEIa`HcHhhddXeDbhdlieHpHYYTuAAeRuP@SUQ@@@	Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Cc1ccc(C(=O)NC(C)(C)C)cc1	6.96	group3-int	int	Androgen Receptor	Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fdeP@@@PRfVuWmRTTXLYjBB@@P@@	420.943	4.4667	5	1	70.71	5	0.7032290545316178	-0.9060559251862852	0.16768339260335438	38	14	fakpA@MVzCqJxyEDedhhh]DeBjLu[MX@Jej`BKH@@	eFABH`BL@	dazH`DC@AIgijj@@									10
<LztndN5u0LeEHNHOkS2mmJFF12f08InL58V02QkN43W0BfNXC25wFN8N1RmFcA50XV04F2!11kq!YVGV	CHEMBL1957608	eohRDH@NIEIac`HcHhhddXeDbhdlidiFACKJfhHLjVj@BZjb@@@	Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Cc1ccc(C(=O)NCC(C)(C)O)cc1	6.47	group3-int	int	Androgen Receptor	Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fdeP@@@PRfVuWmRTTXLYjBB@@P@@	436.942	3.54	6	2	90.94	6	1.8358719782551038	-0.2737579012160291	-0.731398049820042	38	14	fakpA@MVzCqJxyEDedhhh]DeBjLu[MX@Jej`BKH@@	eFABH`BL@	diFD`DAl@Df]ijj`@									10
=vvtxwCuKFAUIO0OYN@moJFH5Xfc0Pv278V42Qk@4GW!fNVC25JFNNN1RmHtA70XV0402V011FLV01V0V	CHEMBL1957609	eodRDH@NIEIag`HcHhhddXeDbhdlihdfACKJfkghHLjVj@BZjbH@@	Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Cc1ccc(C(=O)N2CCOCC2)cc1	6.29	group3-int	int	Androgen Receptor	Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs	2012	few@@@LdbbRRqTRVTTrWEBdFHyuUUUUUUUUT@@	fewp`@DIr@vQQQQIIXiQKJIJQmVSd\vjB`biZ@BH@@	434.926	3.556	6	0	71.15	4	0.6369613798211328	-0.15166257114002685	1.3362284258956771	2	1	eodRDH@NIEIag`HcHhhddXeDbhdlihdfACKJfkghHLjVj@BZjbH@@											1
<LxOrdm5s4LiEuNHKFS2mXZFF12f28InL58VF2QkN43W0BYNXC2Kw0N0N1RkFcA50XV04FV2011kq!YVGV	CHEMBL1957610	eohRLH@NIEI`ac`HcHhhddXeDbhdlidiFACKJfhHLjVj@BZjb@@@	Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Oc1ccc(C(=O)NCC(C)(C)O)cc1	5.75	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor expressed in Cos7 cells assessed as inhibition of dihydrotestosterone-induced luciferase activity after 24 hrs by reporter gene assay	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fdeQ@@IJAdbbbRRNbREjR`qhIAb@@`@@	438.914	3.1197	7	2	100.17	6	2.2592765355451334	0.16014830650814776	-0.6183040835571535	38	2	fakqA@MV{pCbVHrJIKIQQPzIJETYjvZp@UKU@DVP@@	diFD`DAl@Df]ijj`@										2
vyPn2ntl8N5u0F@1FN08V80VFJFF109!HF058V02Ak841#eN0C!JFF881Jm!950VV0402!11F#1c0V	CHEMBL1957611	fnspB@MVZBPrJIKIQQPzIKJcMVrV@BiZh@KH@@	Cc1nn(-c2ccc(C#N)cc2)c(C)c1Cc1ccc(F)cc1	6.16	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor expressed in Cos7 cells assessed as inhibition of dihydrotestosterone-induced luciferase activity after 24 hrs by reporter gene assay	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fdeP@@@PRfVuWmRTTXLYjBB@@P@@	305.355	3.3765	3	0	41.61	3	-1.4049627772003235	-0.021682258962178708	0.7551517353240105	38	14	fakpA@MVzCqJxyEDedhhh]DeBjLu[MX@Jej`BKH@@		eFABP`BL@									10
vyPn2ntl8N5u0F@5FN08VN0mFJFF12A!HH058V02Ak8411!eNVC01JFF881Rm!A50XV0402!11F6!1c0V	CHEMBL1957612	fakpA@NRTBH{HYEEDdcDhdUDefBMZkXHLjVj@BH@@	Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Cc1ccc(F)cc1	9.33	group1-p	p	Androgen Receptor	Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fdeP@@@PRfVuWmRTTXLYjBB@@P@@	339.8	3.9825	3	0	41.61	3	-1.2520818272398886	-0.5137110715755013	0.8149884948336352	38	14	fakpA@MVzCqJxyEDedhhh]DeBjLu[MX@Jej`BKH@@	eFABH`BL@	eFABP`BL@									10
vyPn2ntl8N5u0F@5FN28V80mFJFF129!HH458V03Ak8411!eNVC!JFF881Tm!958XW0602!11F6081c0V	CHEMBL1957613	fmwp@`MVVBP{HCdIrFQQIYJJJGQISJQTYjvRp@UKU@AUVP@@	Cc1nn(-c2ccc(C#N)c(C(F)(F)F)c2)c(C)c1Cc1ccc(F)cc1	6.96	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor expressed in Cos7 cells assessed as inhibition of dihydrotestosterone-induced luciferase activity after 24 hrs by reporter gene assay	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fdeP@@@PRfVuWmRTTXLYjBB@@P@@	373.352	4.2248	3	0	41.61	4	-0.9282540243498337	-0.9046143902434453	0.8975675446684372	38	14	fakpA@MVzCqJxyEDedhhh]DeBjLu[MX@Jej`BKH@@	gJPBAHJPt`PAIjj@@	eFABP`BL@									10
vyPn2ntl8N5u0F@5FN08VN0mFJFF11A!HHV58V03Ak841#eO0C01JGFc81Ln!A58VV04020411F0101c0V	CHEMBL1957614	fakpA@B\\BH{HYEEDhdeLeUDefRtZkXHJI[j@BH@@	Cc1nn(-c2ccc(C#N)cc2Cl)c(C)c1Cc1ccc(F)cc1	5.82	group4-ia	ia	Androgen Receptor	Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fdeP@@@PRfVuWmRTTXLYjBB@@P@@	339.8	3.9825	3	0	41.61	3	-1.2520818272398886	-0.5137110715755013	0.8149884948336352	38	14	fi{pC@MVFCqSDU\\bbRrTTTNbbtJhsUbm`@jVjBBKH@@		eFABP`BL@									1
zyvr2pOp8m5s4FDCsN040N2m0ZFF12A20HH058VF2Ak8411!XNVC0GJ0F081Rk0VA50XV04!2011F6!1c0V	CHEMBL1957615	fakqA@NRTDDQvPrJJIIFIQHjIKLDZuVpPYTmT@DP@@	Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Oc1ccc(F)cc1	6.96	group3-int	int	Androgen Receptor	Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fdeQ@@IJAdbbbRRNbREjR`qhIAb@@`@@	341.772	3.5622	4	0	50.84	3	-0.8286772085948929	-0.07980483586975388	0.9280824708065427	38	2	fakqA@MV{pCbVHrJIKIQQPzIJETYjvZp@UKU@DVP@@	eFABP`BL@										2
vTPn2Idl8N5k0F@5FN01VN0m0JFF12A!HH058V02@F8411V0@NVB25JFF881Bm!A42XV0402!G1F6!1c0V	CHEMBL1957616	fnspA@NRTBH[HYEEDdcDhdXdlpQkEkAAeRu@AD@@@	Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1-c1ccc(F)cc1	6.57	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor T877A mutant expressed in Cos7 cells assessed as inhibition of dihydrotestosterone-induced luciferase activity after 24 hrs by reporter gene assay	2012	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyP@@@PRfVuYwIQUoAfhH@@D@@@	325.773	3.8258	3	0	41.61	2	-1.4771147927715398	-0.24667087792502404	0.7649836358025095	42	1	fnspA@NRTBH[HYEEDdcDhdXdlpQkEkAAeRu@AD@@@											1
vyTn2ntldN5u0F@7FN08VN4mFJFF92A!HH058V02Ak8411!eNVCV1JFF881Rm!A40XV041#11F6!1c0V	CHEMBL1957617	fi{pA@NRTBHGHYEEDdcDhdThdlpQkM{AAeRuT@DP@@	Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1CCc1ccc(F)cc1	7.28	group2-a	a	Androgen Receptor	Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs	2012	flu@@@LdbbRRqRbRxhThijjjjjjj@@	fluP@@@PRfVuWyTeEFbfZ``b@A@@@	353.827	4.368	3	0	41.61	4	-1.0378138450602095	-0.9182940491379191	0.8661857849557302	3	2	fi{pA@CNFAqkDYEDedeEEChdhUQagE[@AUKU@DVP@@	eFABP`BL@										2
:uz2rtl8P5u0FE5kNVcVRFmFRFFG2E!HH0p8V02Ak841G!eNVC01KFF9c1Rm10A50Yc0442!11F6!3c1V	CHEMBL1957618	fi{qA@NRUDDPNPrJJIIFIQHsQIY`cV[vBCJejh@Hb@Z@@	Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1C(O)c1ccc(F)cc1	7.58	group2-a	a	Androgen Receptor	Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fdeP@@@PRfVuWmRTTXLYjBB@@P@@	355.799	3.2851	4	1	61.84	3	-0.28876463403481667	0.10156718366500686	-0.10900499286694779	38	14	fi{qA@CNFHGcUqrJIKJZJJGQIPjcCNJv@BjVj@HlbGB@@	eFABH`BL@	eFABP`BL@									1
zyPn6ntl8N5u0F@5FN09VN0mFJFF93A!Hm058V02@k961W!eNVC01JkF081Tm0cA50XVV402!11F6191VVV	CHEMBL1957619	fegIB@NRTOhHcHhhddXeDbhheDpQkMgAAeRuPPLD@@@	Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Cc1ccccc1C(N)=O	5.38	group4-ia	ia	Androgen Receptor	Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fdeP@@@PRfVuWmRTTXLYjBB@@P@@	364.835	2.969	5	1	84.7	4	0.5446972445613864	0.4257933159857219	0.07705683463006628	38	14	fmwIA@ENBnPOGkcdTRTrbLTTNbRaUFNBt\@EMRuPAEd@@@	eFABH`BL@										1
zyPn6ntl8N5u0F@5FN09VN0mFJFF12A!Hm058V03@k841W!eNVC01JFF081Rm0cA50XZ0402!11F6011VVV	CHEMBL1957620	fegIB@NRULXHcHhhddXeDbhdihpQkU{AAeRuPACD@@@	Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Cc1cccc(C(N)=O)c1	5.72	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor T877A mutant expressed in Cos7 cells assessed as inhibition of dihydrotestosterone-induced luciferase activity after 24 hrs by reporter gene assay	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fdeP@@@PRfVuWmRTTXLYjBB@@P@@	364.835	2.969	5	1	84.7	4	0.5446972445613864	0.4257933159857219	0.07705683463006628	38	14	fmwIA@ANBo`OGkcdTTRbjTTTNbRaSINBt\DCERuPAEd@@@	eFABH`BL@										1
zyPn6ntl8N5u0F@5FN09VN0mFJFF12A!Hm058V02Ak841W!eNVC21JFF881RmFcA50XV0402!11F6011VVV	CHEMBL1957621	fegIB@NRULXHcHhhddXeDbhdlhpQkU[AAeRuP@SD@@@	Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Cc1ccc(C(N)=O)cc1	6.85	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor T877A mutant expressed in Cos7 cells assessed as inhibition of dihydrotestosterone-induced luciferase activity after 24 hrs by reporter gene assay	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fdeP@@@PRfVuWmRTTXLYjBB@@P@@	364.835	2.969	5	1	84.7	4	0.5446972445613864	0.4257933159857219	0.07705683463006628	38	14	fakpA@MVzCqJxyEDedhhh]DeBjLu[MX@Jej`BKH@@	eFABH`BL@	gCiHDL@ILt@@									10
zyPn6ntl8N5u0F@5FN09VN2mFJFF12A!Hm058V02Qk841W!eNVC25JFF881RmFcA50XV0402!11FL!WVFV	CHEMBL1957622	fmwIB@NRULXHcHhhddXeDbhdlifBMZkXHLjVj@BZH@@	CNC(=O)c1ccc(Cc2c(C)nn(-c3ccc(C#N)c(Cl)c3)c2C)cc1	7.57	group2-a	a	Androgen Receptor	Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fdeP@@@PRfVuWmRTTXLYjBB@@P@@	378.862	3.3205	5	1	70.71	4	0.3770149656765892	0.05985377756202623	0.0663593957091604	38	14	fakpA@MVzCqJxyEDedhhh]DeBjLu[MX@Jej`BKH@@	eFABH`BL@	gJYHDL@ILmP@									10
zyPn6ntl8N5u0FA5GN09VN2mFJFF12A!Hm058V02Qk84GW!eNVC25JFF881RmFdA50XV0402!11FL!1V0V	CHEMBL1957721	fcoIB@NRULXHcHhhddXeDbhdlihpQkU[AAeRuP@STP@@	Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Cc1ccc(C(=O)N(C)C)cc1	6.04	group3-int	int	Androgen Receptor	Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fdeP@@@PRfVuWmRTTXLYjBB@@P@@	392.889	3.587	5	0	61.92	4	0.02088398101953045	-0.202968257866718	1.1551793993665755	38	14	fakpA@MVzCqJxyEDedhhh]DeBjLu[MX@Jej`BKH@@	eFABH`BL@	gGYHDL@ILsU@@									10
;rLntldN5u0F@EHN0OVN2mkJFF12f!Hn258V02Qk841W!fNVC25JFN8N1RmFcA50XV0402!11FL!YVGV	CHEMBL1957722	fkHb@NRULYpQFQQQIHqJIEQIYSILDZuVpPYTmT@DuQ@@@	Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Cc1ccc(C(=O)NCCO)cc1	5.68	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor T877A mutant expressed in Cos7 cells assessed as inhibition of dihydrotestosterone-induced luciferase activity after 24 hrs by reporter gene assay	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fdeP@@@PRfVuWmRTTXLYjBB@@P@@	408.888	2.8001	6	2	90.94	6	1.722947204783007	0.27506472330915527	-0.781416356410553	38	14	fakpA@MVzCqJxyEDedhhh]DeBjLu[MX@Jej`BKH@@	eFABH`BL@	gNxhDG`AIgVj`@									10
=xQxxqCsKFEUvO0K3N@mZZFH5Xfe0Pv278VJ2Qk@4GW!YNVC2KJ0NFN1RkHtA70XV040VX011FLV01V0V	CHEMBL1957723	eodRLH@NIEI`ag`HcHhhddXeDbhdlihdfACKJfkghHLjVj@BZjbH@@	Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Oc1ccc(C(=O)N2CCOCC2)cc1	5.52	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor expressed in Cos7 cells assessed as inhibition of dihydrotestosterone-induced luciferase activity after 24 hrs by reporter gene assay	2012	few@@@LdbbRRqTRVTTrWEBdFHyuUUUUUUUUT@@	fewq`@DIr@slbbbbRRqRbVTRTcZlgHymTEAERt@DP@@	436.898	3.1357	7	0	80.38	4	1.0603659371111624	0.2822436365841499	1.4493223921585656	2	1	eodRLH@NIEI`ag`HcHhhddXeDbhdlihdfACKJfkghHLjVj@BZjbH@@											1
zyvr6pOp8m5s4FDCsN040N2m0ZFF12A!Hm058VF2Ak8411V0XNVC01J0F081RkFVA50XV04$11F6!WVFk	CHEMBL1957724	fmwhb@NRTghY`bLbbbRQbTRJbRrTXHujm``riZh@JX`@@	CC(=O)Nc1ccc(Oc2c(C)nn(-c3ccc(C#N)c(Cl)c3)c2C)nc1	5.27	group4-ia	ia	Androgen Receptor	Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fdeq@@LRTCIEEDdd]DdKTeAcPRCD@A@@@	381.822	2.5156	7	1	92.83	4	1.2758292647096234	0.9367011837232921	0.30043043573321826	38	2	fakIA@BZmw`GDlQdTRVRbbatRTJhsUlu`@jVj@Hl`@@	gJYHDB@ILmP@										2
zyvz6pOr8m5s4LDhxNH40O2m0gNK12A!ImF58VF2Ak8411VDXNVC41J0F081RkFVQ50Xl04F#11Fa!WVFk	CHEMBL1957725	eg`ZDH@NIEDn`i`HcHhhddXeDbhdleMHpHYYTuAAeRuP@TuQ@@@	Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1Oc1ccc(NC(=O)C(C)(C)C)cn1	5.37	group4-ia	ia	Androgen Receptor	Displacement of [17-alpha-methyl-3H]mibolerone from androgen receptor expressed in HEK293 cells after 3 hrs	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fdeq@@LRTCIEEDdd]DdKTeAcPRCD@A@@@	423.903	3.7541	7	1	92.83	5	1.5977007567859003	-0.0846946024742219	0.4022355001847667	38	2	fakIA@BZmw`GDlQdTRVRbbatRTJhsUlu`@jVj@Hl`@@	dazH`D@`AIeijj@@										2
zyvr6pOp8m5s4FDCsN040N2m0ZFF12A!Hm058VF2Ak8411V0XNVC01J0F081RkFVA50XV04$13F6!WVFk	CHEMBL1957726	fmwhb@NRTWhY`bLbbbRQbTRJbRrTXHujm``riZh@JX`@@	CC(=O)Nc1ccc(Oc2c(C)nn(-c3ccc(C#N)c(Cl)c3)c2C)cn1	6.46	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor T877A mutant expressed in Cos7 cells assessed as inhibition of dihydrotestosterone-induced luciferase activity after 24 hrs by reporter gene assay	2012	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fdeq@@NRTCIEEDdd]DdKTeAcPRCD@A@@@	381.822	2.5156	7	1	92.83	4	1.2758292647096234	0.9367011837232921	0.30043043573321826	38	1	fmwhb@NRTWhY`bLbbbRQbTRJbRrTXHujm``riZh@JX`@@											1
<jztzfyiy5rzyURvhXUnujBNpfnhI0MmSr8v2nSlSDblYDQfY5aaUdk381EuFcSdD0rk6KB85FRVrJBY8G0	CHEMBL196374	eh\TJB@HkaK@o`PIAJPrdBiCHhdieIcIhiMXdieEJFIek`X@Jjjfj`@ifB`LH@@	Cc1noc(=O)c2ccc(NC(=O)C(O)(CC(C)(C)c3cc(F)ccc3O)C(F)(F)F)cc12	6.8	group3-int	int	Androgen Receptor	Binding affinity to human recombinant androgen receptor expressed in baculovirus infected Sf9 cells	2010	fns@@@LdbbbRnTVRbRXhTjmjjjjjjjj`@@	fnsQ`@BZ@brSKJ~mjrmNRUUkTBASU@A@@@	468.402	4.9126	7	3	108.22	6	2.735767766262332	-0.9818302111556902	-1.6266720108915134	2	2	eh\TBJ@Hkk@o`PGGRPRdLi@jPrJJIJSJrZJSVIJYQQcbYZxF@`jjijh@JY`hCB@@	eFJB@Hp@										2
:UvztU:KzxvTvUUzEmIftUDBXR5mOSzEeD6jnbQA3ycF3e6JJW4C@g8wF3kEcu285O6WF6010F1G07VcVcFF	CHEMBL197595	eh\ZHF@JEKL`S@IABPpdKiAzP~dLbdLRVRfbbVVbRfTbDdRrfVj`@ijjj@BjlaArIP@	C[C@H]1CN(C(=O)Nc2ccc(C(F)(F)F)nc2)[C@H](C)CN1c1ccc(C#N)c(C(F)(F)F)c1	6.96	group3-int	int	Androgen Receptor	Inhibition of AR mediated transcriptional activation using reporter assay	2006	fj}@@@DjYU_yyWbiZrVjjjjjjj`@@	fj}I@@DXtXBSLjsj}jKUoYJuUPPP@D@@@	471.404	4.1671	6	1	72.26	4	1.094245594078526	-0.6600310770948288	0.3155382606421468	23	18	eh\ZHN@JIKL`S@@dbAX|UGFzP^dOiAIf[u{fW^UmixDRrfV`bBijjj@BjlaArIP@				gJPBAHJPt`PAIjj@@							16
;vztU:pzxvTvUUzEmIvtUDBXRCnOSzUei7jnbQA3zcF3e6LKW0C@g8wk3lEce285O6WF6010F1147WgVcFF	CHEMBL197648	eohZDL@ECDfcje`IABPpdLbdLTRRLTRrtrbbRdtbRN^j``rjjihHHHPlTR@@	COc1ccncc1NC(=O)N1C[C@H](C)N(c2ccc(C#N)c(C(F)(F)F)c2)C[C@H]1C	5.92	group4-ia	ia	Androgen Receptor	Inhibition of AR mediated transcriptional activation using reporter assay	2006	fj}@@@DjYU_yyWbiZrVjjjjjjj`@@	fj}I@@DXtXBSLjsj}jKUoYJuUPPP@D@@@	433.433	3.1948	7	1	81.49	4	1.3332749071552195	0.2538301974714901	0.3600299959502963	23	18	eh\ZHN@JIKL`S@@dbAX|UGFzP^dOiAIf[u{fW^UmixDRrfV`bBijjj@BjlaArIP@		eMJA@Hz@									16
JNsH42018&4F801VN0H%23202H058!10F06$2#202V#1#830284020V&502010	CHEMBL1981815	fleAb@ARRBHrJIJYPiQIZc@q`@if@B@DEP	O=C(/C=C/c1ccc(O)cc1)c1cc(Cl)ccc1O	5.23	group4-ia	ia	Androgen Receptor	Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay	2018	f`q@@@DjYW~UyIwjjjjjj@@	f`qA@@@ILrj}jISoM@a@@@BEH	274.702	3.2184	3	2	57.53	3	-0.7507260739970648	0.276052611741383	-1.4290365153289306	17	17	fjm@``MQ@Dr`_NN_EIfU_nYnYqIXBAi`bH@DNP		eFABH`BL@		eFJB@Hp@							12
:UvztU:KzxvTvUUzEmIvtUDBXRCnOSzEei7jnbQA3ycF3e6JJW0C@g8wk3lEce285O6WF6010F1107WgVcFF	CHEMBL199284	eg`ZHL@ECDfej`IABPpdLbdLTRRLTRrtrbbTfdRQuuTDFUUUM@PDHVJI@@	Cc1ncccc1NC(=O)N1C[C@H](C)N(c2ccc(C#N)c(C(F)(F)F)c2)C[C@H]1C	6.17	group3-int	int	Androgen Receptor	Inhibition of AR mediated transcriptional activation using reporter assay	2006	fj}@@@DjYU_yyWbiZrVjjjjjjj`@@	fj}I@@DXtXBSLjsj}jKUoYJuUPPP@D@@@	417.434	3.6627	6	1	72.26	3	0.6752248003662761	-0.03585044322765889	0.1979958223692547	23	18	eh\ZHN@JIKL`S@@dbAX|UGFzP^dOiAIf[u{fW^UmixDRrfV`bBijjj@BjlaArIP@	eFBH@c@@										16
:UvztU:KzxvTvUUzEmIftUDBXR5mOSzEeD6jnbQA3ycF3e6JJW0C@g8wF3kEce285O6WF6010F1107VcVcFF	CHEMBL199899	fkiC@EFRt}PRBICDadTabbRQbbVVfTRTmQSl}TDFUUUM@@Pbrb`@	C[C@H]1CN(C(=O)Nc2ccncc2)[C@H](C)CN1c1ccc(C#N)c(C(F)(F)F)c1	6.85	group3-int	int	Androgen Receptor	Inhibition of AR mediated transcriptional activation using reporter assay	2006	fj}@@@DjYU_yyWbiZrVjjjjjjj`@@	fj}I@@DXuxBSLjsj}jKUoYJuUPPP@D@@@	403.407	3.2648	6	1	72.26	3	0.6200775519035308	0.25536287075332237	0.17284103427253691	23	1	fkiC@EFRt}PRBICDadTabbRQbbVVfTRTmQSl}TDFUUUM@@Pbrb`@											1
:UvztU:KzxvTvUUzEmIftUDBXR5mOSzEeD6jnbQA3ycF3e6JJW0C@g8wF3kEce285O6WF6010F1G07VcVcFF	CHEMBL200973	eohVHL@ECDfegj`IABPpdLbdLTRRLTRrtrbRrdtbRvNj``rjjih@KHPlTR@@	C[C@H]1CN(C(=O)Nc2ccc(C#N)nc2)[C@H](C)CN1c1ccc(C#N)c(C(F)(F)F)c1	6.7	group3-int	int	Androgen Receptor	Inhibition of AR mediated transcriptional activation using reporter assay	2006	fj}@@@DjYU_yyWbiZrVjjjjjjj`@@	fj}I@@DXtXBSLjsj}jKUoYJuUPPP@D@@@	428.417	3.1544	7	1	96.05	3	1.3844040355609248	0.5243417435901536	0.3625199785840223	23	18	eh\ZHN@JIKL`S@@dbAX|UGFzP^dOiAIf[u{fW^UmixDRrfV`bBijjj@BjlaArIP@				eMbA@Dg`@							16
:UvztU:KzxvTvUUzEmIftUDBXR5mOSzEeD6jnjQA3ycF3e6JJW0C@g8wF3kEcu285O6WF6010F1G07VcVcFF	CHEMBL201069	eohZHB@LAMHge@@cZPNdKiAJ[WVyewe[ZVN@hnaj@Bfjjh@JjrDCHE@@	CSc1ccc(NC(=O)N2C[C@H](C)N(c3ccc(C#N)c(C(F)(F)F)c3)C[C@H]2C)cn1	6.66	group3-int	int	Androgen Receptor	Inhibition of AR mediated transcriptional activation using reporter assay	2006	fj}@@@DjYU_yyWbiZrVjjjjjjj`@@	fj}I@@DXtXBSLjsj}jKUoYJuUPPP@D@@@	449.5	3.8394	6	1	97.56	4	1.4012345857862636	-0.19622739778869255	0.34218702142287694	23	18	eh\ZHN@JIKL`S@@dbAX|UGFzP^dOiAIf[u{fW^UmixDRrfV`bBijjj@BjlaArIP@				eMA@HPBN`@							16
;vztU:pzxvTvUUzEmIvtUDBXRCnOSzUei7jnbQA3zcF3e6LKW0C@g8wk3lEce285O6WF6010F1147WgVcFF	CHEMBL201077	eohZDL@ECDfmje`IABPpdLbdLTRRLTRrtrbbRdtbRN^j``rjjihHHHPlTR@@	COc1ncccc1NC(=O)N1C[C@H](C)N(c2ccc(C#N)c(C(F)(F)F)c2)C[C@H]1C	6.72	group3-int	int	Androgen Receptor	Inhibition of AR mediated transcriptional activation using reporter assay	2006	fj}@@@DjYU_yyWbiZrVjjjjjjj`@@	fj}I@@DXtXBSLjsj}jKUoYJuUPPP@D@@@	433.433	3.5462	7	1	81.49	4	1.3167413578764995	0.042586528894004216	0.36186130334732297	23	18	eh\ZHN@JIKL`S@@dbAX|UGFzP^dOiAIf[u{fW^UmixDRrfV`bBijjj@BjlaArIP@	eMJA@Hz@										16
zrUtUtOM9F7w02AEUN2VHOAP6B0J1Y904LfZCBX03OV90k1c6HKVGZ0B88VWGEW01cK9XW2611!1GJ61c0c!	CHEMBL2011362	ek`\HL@EC@o@IABPpdLbdLTRRLTTrRVfRdtBbjzvNj``ri```@B@@@	N#Cc1ccc(-n2c(=O)n(Cc3ccccc3)c3ccccc32)cc1C(F)(F)F	6.77	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor in human LNAR cells expressing ARE-PSA-LUC by luminescence analysis in presence of R1881	2012	fnk@@@LdbbRbbrQvbRxXRgAjvjjjjjjjj`@@	fnkQ@@DXAdTTTTRRRRbjuFNsxMVmUPA@@@@@@@	393.367	5.1864	4	0	47.34	4	-0.5311441604330244	-1.3940174450863585	1.0386436973790263	6	2	ek`\HL@EC@o@IABPpdLbdLTRRLTTrRVfRdtBbjzvNj``ri```@B@@@											1
:UvUtOM9J7wVHAUSN3VHOtT6B0J1n91ZLeZC8VXIA098k1X6HKWFh0B8BV0GEWW0cK9XWH61!F1GJ61c0c!	CHEMBL2011367	fi{qC@EFCxD`bPqHYEHXhddXhideEKPXuGUAAeSAAPP@@	CC(C)n1c(=O)n(-c2ccc(C#N)c(C(F)(F)F)c2)c2ccccc21	6.43	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor in human LNAR cells expressing ARE-PSA-LUC by luminescence analysis in presence of R1881	2012	f`i@@@LdbbRbbroCBT{uUUUUUP@@	f`iQ@@DX@dsKJjmFF}YsUP@@@@@@	345.323	4.5339	4	0	47.34	3	-0.9119893954304783	-0.702782069281489	0.9300805635252704	2	2	fnsq@`HTZPCcfPKHUdDfYmV]{ZZLU[pZfB@@Bjn@@@	gC`HL@Qz`@										2
zrUtUtOM9F7w02@ESN2VHO9P4B0J1Y904LeZC8V039090V1V6HKVFZ0488V0GEW!cK9XW261#1GJ61c0c!	CHEMBL2011369	fakqC@EFCxD`bPqHYEHXhddXhiddiZCFoZhHLjXHHH@@	CCn1c(=O)n(-c2ccc(C#N)c(C(F)(F)F)c2)c2ccccc21	6.53	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor in human LNAR cells expressing ARE-PSA-LUC by luminescence analysis in presence of R1881	2012	f`i@@@LdbbRbbroCBT{uUUUUUP@@	f`iQ@@DX@dsKJjmFF}YsUP@@@@@@	331.296	4.1746	4	0	47.34	3	-0.96895296329975	-0.4347730986620813	0.9051268886043021	2	2	fnsq@`HTZPCcfPKHUdDfYmV]{ZZLU[pZfB@@Bjn@@@	eMBD@ch@										2
zrUtUtOM9F7w02AEUN2VHOAP6B0J1Y904LfZCBX03OV90k1c6HKVGZ0B8NVWGEV01cK9XW2611!1IJ61c0c0F	CHEMBL2011371	ek`RHL@EC@ho@IABPpdLbdLTRRLTTrRVfRdtBRjzvNj``ri```@B@@@	N#Cc1ccc(-n2c(=O)n(Cc3ccccc3)c3cccnc32)cc1C(F)(F)F	7.22	group2-a	a	Androgen Receptor	Antagonist activity at androgen receptor in human LNAR cells expressing ARE-PSA-LUC by luminescence analysis in presence of R1881	2012	fnk@@@LdbbRbbrQvbRxXRgAjvjjjjjjjj`@@	fnkq@@DXTCHhhhhdddeEUjL]gpZmZj`B@@@@@@@	394.355	4.5369	5	0	60.23	4	-0.04327070685216709	-0.7918321941794221	1.158240286615223	6	1	ek`RHL@EC@ho@IABPpdLbdLTRRLTTrRVfRdtBRjzvNj``ri```@B@@@											1
zrUtUtOM9F7w02AEUN2VHOAP6B0J1Y904LfZCBX03OV90k1c6HKVGZ0B8NVWGEV01cK9XW2611!1IJ61c0c0F	CHEMBL2011372	ek`RHL@EC@bo@IABPpdLbdLTRRLTTrRVfRdtBbjzvNj``ri```@B@@@	N#Cc1ccc(-n2c(=O)n(Cc3ccccc3)c3ncccc32)cc1C(F)(F)F	6.23	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor in human LNAR cells expressing ARE-PSA-LUC by luminescence analysis in presence of R1881	2012	fnk@@@LdbbRbbrQvbRxXRgAjvjjjjjjjj`@@	fnkq@@DXtCHhhhhdddeEUjL]gpZmZj`B@@@@@@@	394.355	4.5369	5	0	60.23	4	-0.04327070685216709	-0.7918321941794221	1.158240286615223	6	1	ek`RHL@EC@bo@IABPpdLbdLTRRLTTrRVfRdtBbjzvNj``ri```@B@@@											1
zrUtUtOM9F7w02AEUN2VHOQP6B0J1Y904LfZCBX03OV90k1c6HKVGZ0B8NVWGEW01cK9XW2611!1GJ61c0c0F	CHEMBL2011373	ek`RHL@EC@ao@IABPpdLbdLTRRLTTrRVfRdtBbjzvNj``ri```@B@@@	N#Cc1ccc(-n2c(=O)n(Cc3ccccn3)c3ccccc32)cc1C(F)(F)F	6.52	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor in human LNAR cells expressing ARE-PSA-LUC by luminescence analysis in presence of R1881	2012	fnk@@@LdbbRbbrQvbRxXRgAjvjjjjjjjj`@@	fnkq@@DXbCHhhhhdddeEUjL]gpZmZj`B@@@@@@@	394.355	4.2395	5	0	60.23	4	-0.029277890684364136	-0.6130506288187677	1.1566903987283967	6	1	ek`RHL@EC@ao@IABPpdLbdLTRRLTTrRVfRdtBbjzvNj``ri```@B@@@											1
zrUtUtOM9F7w02AEUN2VHOAP6B0J1Y904LfZCBX03OV90k1c6HKVGZ0B8NVWGEW01cK9XW2611!1GJ61c0c0F	CHEMBL2011374	ek`RHL@EC@eo@IABPpdLbdLTRRLTTrRVfRdtBbjzvNj``ri```@B@@@	N#Cc1ccc(-n2c(=O)n(Cc3cccnc3)c3ccccc32)cc1C(F)(F)F	6.41	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor in human LNAR cells expressing ARE-PSA-LUC by luminescence analysis in presence of R1881	2012	fnk@@@LdbbRbbrQvbRxXRgAjvjjjjjjjj`@@	fnkq@@DXJCHhhhhdddeEUjL]gpZmZj`B@@@@@@@	394.355	4.1855	5	0	60.23	4	-0.026737168791158603	-0.5805886689269096	1.156408980460705	6	1	ek`RHL@EC@eo@IABPpdLbdLTRRLTTrRVfRdtBbjzvNj``ri```@B@@@											1
:UvUtOM9J7wVHAUUN3VmOvT6B0J1n91ZLfZEBXXIQk98k1e6HKWGh0BBBVWGEWY1cKOXWH6110F1GJ61c0c!	CHEMBL2011376	egh\HL@EC@o@IABPpdLbdLTRRLTTrRbtJTf`TUPquuTDFULDE@@DDFU@@	CC(c1ccccc1)n1c(=O)n(-c2ccc(C#N)c(C(F)(F)F)c2)c2ccccc21	6.44	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor in human LNAR cells expressing ARE-PSA-LUC by luminescence analysis in presence of R1881	2012	fnk@@@LdbbRbbrQvbRxXRgAjvjjjjjjjj`@@	fnkQ@@DXAdTTTTRRRRbjuFNsxMVmUPA@@@@@@@	407.394	5.4731	4	0	47.34	4	-0.47076475456784705	-1.6183833879833285	1.0632190234480032	6	2	egh\HL@EC@o@IABPpdLbdLTRRLTTrRbtJTf`TUPquuTDFULDE@@DDFU@@											1
zrzxzhUUzpbx7PQUUUBbHtQvaBH4CYz54LvVE7X5H9a9ZYYe6rSVtZ148NVdGClElfGAZcHJ11V1GIJDGV1V0k	CHEMBL2011377	eolVDH@NIKFnecJ`HcHhhddXhiddmLlhdfAKGDbnakghHLjXHHfh@BD@@@	N#Cc1ccc(-n2c(=O)n(Cc3nc(-c4ccccn4)no3)c3ccccc32)cc1Cl	6.9	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor in human LNAR cells expressing ARE-PSA-LUC by luminescence analysis in presence of R1881	2012	ec`P@@@LdbbRbbrQvbRtRWA`bc`QURvuUUUUUUUUUU@@@	ec`ZD@@DLDbn`HlbbbbbRRRTUQTRUCCfW`QURvsUT@PAIT@@B@@@	428.838	3.8533	8	0	99.15	4	1.5308412516358754	0.13928259483121533	1.576122333267883	2	2	eolVDH@NIKFnecJ`HcHhhddXhiddmLlhdfAKGDbnakghHLjXHHfh@BD@@@											1
=xU:rbxbPUU:CbHtvzagHJCnz5_LvVE7XrHAaOgnYe6rSdthdCBRVdGCljlfGQZcHK11VGGIJDGV1V0k	CHEMBL2011378	e`RVDH@NIKNamcF`HcHhhddXhideEhUeDdpIXxeTML}}AAeSAAQMP@DI@EP@@	CC(c1nc(-c2ccccn2)no1)n1c(=O)n(-c2ccc(C#N)c(Cl)c2)c2ccccc21	6.75	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor in human LNAR cells expressing ARE-PSA-LUC by luminescence analysis in presence of R1881	2012	ec`P@@@LdbbRbbrQvbRtRWA`bc`QURvuUUUUUUUUUU@@@	ec`ZD@@DLDbn`HlbbbbbRRRTUQTRUCCfW`QURvsUT@PAIT@@B@@@	442.865	4.14	8	0	99.15	4	1.5912205192253195	-0.08508294824712093	1.600697606635695	2	2	e`RVDH@NIKNamcF`HcHhhddXhideEhUeDdpIXxeTML}}AAeSAAQMP@DI@EP@@											1
zyQv6IOM8F5s0L@hSNHWVO3H0B8p13904Myo58V03QF92VWVDHKV4a5JW!2GDW0ctK8Xp26G04419Fq18VcF0	CHEMBL2011379	elV\DB@ADd^N`ICzPAdHYCHhheDmidieHdYdieHfIO@dlmchHFJ@Bji@BjlH@@@	CNC(=O)c1ccc(-c2ccc3c(c2)C(C)(C)C(=O)N3c2ccc(C#N)c(C(F)(F)F)c2)cc1F	6.71	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor in human LNAR cells expressing ARE-PSA-LUC by luminescence analysis in presence of R1881	2012	ffs@@@DjYU[wVuxjQkNKVjjjjjjjj@@	ffsa@@D@rJJIQIIIGQITX[ugEjuT@@A@@@@@@	481.448	5.2774	5	1	73.2	4	0.8652272280391995	-1.4786900193930912	0.2516992874779156	3	2	e`\\DD@NIGgK`GEZPrJJIIFJJIZJjIJESLBF^QES[PPYTCAQ@DSQ@@@@	gJPBAHJPt`PAIjj@@										2
zyvv63OM8k5s0L@hSNHWVO3H0B8_13924Myk50V03QF92VWVDHKV4aKLW!2ODW0ctG8Vp26G04459Fq50VcF0	CHEMBL2011380	ehR\LH@AD`^Nc`ICHhheDmidieHdYdiefIO@dlmkhHFJ@Bji@HkB@@@	CNC(=O)c1ccc(-c2ccc3c(c2)C(C)(C)C(=O)N3c2ccc(C#N)c(OC)c2)cc1F	6.78	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor in human LNAR cells expressing ARE-PSA-LUC by luminescence analysis in presence of R1881	2012	ffs@@@DjYU[wVuxjQkNKVjjjjjjjj@@	ffsa@@D@rJJIQIIIGQITX[ugEjuT@@A@@@@@@	443.477	4.3591	6	1	82.43	4	1.1017157812214633	-0.5972905355868021	0.29647241025764703	3	2	e`\\DD@NIGgK`GEZPrJJIIFJJIZJjIJESLBF^QES[PPYTCAQ@DSQ@@@@	eMJA@Hz@										2
zyvv63OM8k5c0L@hS8HWVO1H0B8_12924Myk50V03AF16V1VDHJV0aG6WF02OBW!tG@VpX6G04059Fa5!V0F	CHEMBL2011381	egh\L@@DAe`HilbbbdTRJRTJRfTVUCCbW`VusUU@@AEP\D@@@@	COc1cc(N2C(=O)C(C)(C)c3cc(-c4cccnc4OC)ccc32)ccc1C#N	7.1	group2-a	a	Androgen Receptor	Antagonist activity at androgen receptor in human LNAR cells expressing ARE-PSA-LUC by luminescence analysis in presence of R1881	2012	ffs@@@DjYU[wVuxjQkNKVjjjjjjjj@@	ffsQ@@DYAdTTRbRRRNbRhpwkNKUjh@@B@@@@@	399.449	4.1	6	0	75.45	4	0.49369801265449076	-0.31558624623902193	1.2916319933562475	3	1	egh\L@@DAe`HilbbbdTRJRTJRfTVUCCbW`VusUU@@AEP\D@@@@											1
:UvztU:KzxvTvUUzEmIftUDBXR5mOSzEeD6jnbQA3ycF3e6JJW0C@g8wF3kEce285O6WF6010F1307VcVcFF	CHEMBL201167	fkiC@EFRt]PRBICDadTabbRQbbVVfTRTmQSl}TDFUUUM@@Pbrb`@	C[C@H]1CN(C(=O)Nc2ccccn2)[C@H](C)CN1c1ccc(C#N)c(C(F)(F)F)c1	5.11	group4-ia	ia	Androgen Receptor	Inhibition of AR mediated transcriptional activation using reporter assay	2006	fj}@@@DjYU_yyWbiZrVjjjjjjj`@@	fj}I@@DXehBSLjsj}jKUoYJuUPPP@D@@@	403.407	3.6162	6	1	72.26	3	0.6035440138425223	0.04411934550080993	0.17467234042705496	23	1	fkiC@EFRt]PRBICDadTabbRQbbVVfTRTmQSl}TDFUUUM@@Pbrb`@											1
:UvztU:KzxvTvUUzEmIftUDBXR5mOSzEeD6jnbQA3ycF3e6JJW0C@g8wF3kEce285O6WF6010F1G07VcVcFF	CHEMBL201242	eg`ZHL@ECDfej`IABPpdLbdLTRRLTRrtrbRtfdRVquTDFUUUM@ADHVJI@@	Cc1ccc(NC(=O)N2C[C@H](C)N(c3ccc(C#N)c(C(F)(F)F)c3)C[C@H]2C)cn1	6.89	group3-int	int	Androgen Receptor	Inhibition of AR mediated transcriptional activation using reporter assay	2006	fj}@@@DjYU_yyWbiZrVjjjjjjj`@@	fj}I@@DXtXBSLjsj}jKUoYJuUPPP@D@@@	417.434	3.6627	6	1	72.26	3	0.6752248003662761	-0.03585044322765889	0.1979958223692547	23	18	eh\ZHN@JIKL`S@@dbAX|UGFzP^dOiAIf[u{fW^UmixDRrfV`bBijjj@BjlaArIP@				eFBH@c@@							16
=xU:pzxzUvUUzErIfvUDBXR5mOSzEuD6jvbQQ3ycFYe6JJW4EDw8wF3kEcuX85O6WF6410F1G0MVcVcFF	CHEMBL201327	eh\ZLL@ECDfejgo`IABPpdLbdLTRRLTRrtrbRrfdtbRvNj``rjjih@IhaBqQH@	COC(=O)c1ccc(NC(=O)N2C[C@H](C)N(c3ccc(C#N)c(C(F)(F)F)c3)C[C@H]2C)cn1	6.33	group3-int	int	Androgen Receptor	Inhibition of AR mediated transcriptional activation using reporter assay	2006	fj}@@@DjYU_yyWbiZrVjjjjjjj`@@	fj}I@@DXtXBSLjsj}jKUoYJuUPPP@D@@@	461.443	3.2318	8	1	98.56	5	2.156918443269837	0.2529584631286675	0.5644153846428394	23	18	eh\ZHN@JIKL`S@@dbAX|UGFzP^dOiAIf[u{fW^UmixDRrfV`bBijjj@BjlaArIP@				gJPh@l@ILmP@							16
xvojcyqXbEue9cx0VAzeCj_1qOoXPw0GFs0Ost12g8OZF0PRNoc50F!F$F2520V01O1#F!V$2010	CHEMBL201517	fnk@`@@MrJIJYQIIIPqJgIZ}GMZjZjjjjjjIA\TUe@@	CCC[C@]12CC[C@H](O)CC1=CCC1C3CC[C@H](O)[C@@]3(C)CCC12	5.75	group4-ia	ia	Androgen Receptor	Inhibitory activity against AR	2006	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@DjVU]{ZBxhuoAZjjjjjh@@	318.499	4.2613	2	2	40.46	2	-1.2470307594240062	-0.6385387266681902	-1.5096369088024557	35	20	fjcAA@B`|WNNQQRIHsIREKDyIUoIsUUUUUUULaBr`@	gC`HL@IST@@	eFJB@Hp@									20
xvwjcyqXbEue9cx0VAzeCj_1qOoXPw2GFu0Ott12g8OZF0PRNqc50F!F#1G2522V0WO1#F!V$2010	CHEMBL201569	fnk@b@@mADYDeHhhddbhXeHvk^cfluSUUUUUUDpkJJrhPP	C[C@]12CCC3C(CC=C4C[C@@H](O)CC[C@@]43/C=C\Cl)C1CC[C@@H]2O	6.76	group3-int	int	Androgen Receptor	Inhibitory activity against AR	2006	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@DjVU]{ZBxhuoAZjjjjjh@@	336.901	3.7447	2	2	40.46	1	-1.2843532752833433	-0.27540196697393693	-1.5081560362165671	35	20	fjcAA@B`|WNNQQRIHsIREKDyIUoIsUUUUUUULaBr`@	gC`DADX@RVXRH	eFJB@Hp@									20
:UvztU:KzxvTvUUzEmIvtUDBXRCnOSzEei7jnbQA3ycF3e6JJW0C@g8wk3lEce285O6WF6010F1107WgVcFF	CHEMBL201757	eg`ZHL@ECDfcj`IABPpdLbdLTRRLTRrtrbbTfdRQuuTDFUUUM@PDHVJI@@	Cc1ccncc1NC(=O)N1C[C@H](C)N(c2ccc(C#N)c(C(F)(F)F)c2)C[C@H]1C	6.48	group3-int	int	Androgen Receptor	Inhibition of AR mediated transcriptional activation using reporter assay	2006	fj}@@@DjYU_yyWbiZrVjjjjjjj`@@	fj}I@@DXtXBSLjsj}jKUoYJuUPPP@D@@@	417.434	3.6087	6	1	72.26	3	0.6777655222594815	-0.00338848333580076	0.19771440410156285	23	18	eh\ZHN@JIKL`S@@dbAX|UGFzP^dOiAIf[u{fW^UmixDRrfV`bBijjj@BjlaArIP@		eFBH@c@@									16
xvojcyqXbEue9cx0VAzeCj_1qOoXPw0GFs0Ost12g8OZF0PRNoc50F!F$F2520V01O1#F!V$2V10	CHEMBL201809	fnk@`@@MrJIJYQIIIPqJgEZCGMZjZjzjjjjIA\dUe@@	CC#C[C@]12CC[C@H](O)CC1=CCC1C2CC[C@@]2(C)C1CC[C@@H]2O	5.43	group4-ia	ia	Androgen Receptor	Inhibitory activity against AR	2006	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@DjVU]{ZBxhuoAZjjjjjh@@	314.467	3.8935	2	2	40.46	0	-1.5680330486759946	-0.16083698164882215	-1.5704023877170454	35	20	fjcAA@B`|WNNQQRIHsIREKDyIUoIsUUUUUUULaBr`@	gC`HL@ISt@@	eFJB@Hp@									20
xvwjcyqXbEue9cx0VAzeCj_1qOoXPw0GFu0Ott12g8OZF0PRNqc50F!F#1G2520V0WO1#F!V$2810	CHEMBL202007	fnk@b@@mAHYDeHhhddbhXeHvk^cfluSUUUUUUDpkJJrhPP	C[C@]12CCC3C(CC=C4C[C@@H](O)CC[C@@]43/C=C\F)C1CC[C@@H]2O	7.96	group2-a	a	Androgen Receptor	Inhibitory activity against AR	2006	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@DjVU]{ZBxhuoAZjjjjjh@@	320.446	3.3349	2	2	40.46	1	-1.3517269543936603	0.03196894029869812	-1.537368088575178	35	20	fjcAA@B`|WNNQQRIHsIREKDyIUoIsUUUUUUULaBr`@	gC`DAHX@RVXRH	eFJB@Hp@									20
qFuJ64918F0F0124FF01080m*2H040V03$8V$V4204!1!4WFc0F02Z84B&4!b0I0	CHEMBL2023820	fnsPPBHF@bkXRcdfyeg_e[aRuYIV`@@b@HX@@@	O=C(O)c1cccc(Nc2ccc([N+](=O)[O-])c3ccccc23)c1	5.33	group4-ia	ia	Androgen Receptor	Antagonistic activity at AR in human 22Rv1 cells assessed as reduction in cell number by CCK8 assay	2020	fhy@@@LdbbbRubRYHRoAjjjjjj`@@	fhy`@@@YHhhhdeEcHvoNCP@@@@@@@@	308.292	2.9479	6	2	95.15	4	0.9368747725206165	0.8317849965774804	-0.9876730146472495	2	1	fnsPPBHF@bkXRcdfyeg_e[aRuYIV`@@b@HX@@@											1
xvwjcyqXbEue9cx0VAzeCj_1qOoXPw0GFu0Ott12g8OZF0PRNqc50F!F#1G2520V0WO1#F!V$2810	CHEMBL202400	fnk@b@@mAHYDeHhhddbhXeHvk^cfluSUUUUUUDpkJJrhP`	C[C@]12CCC3C(CC=C4C[C@@H](O)CC[C@@]43/C=C/F)C1CC[C@@H]2O	7.07	group2-a	a	Androgen Receptor	Inhibitory activity against AR	2006	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@DjVU]{ZBxhuoAZjjjjjh@@	320.446	3.3349	2	2	40.46	1	-1.3517269543936603	0.03196894029869812	-1.537368088575178	35	20	fjcAA@B`|WNNQQRIHsIREKDyIUoIsUUUUUUULaBr`@	gC`DAHX@RVXRP	eFJB@Hp@									20
xvojcyqXbEue9cx0VAzeCj_1qOoXPw0GFu0Ost12g8OZF0PRNoc50F!F#1G2520V0WO1#F!V$2010	CHEMBL202415	fnk@`@@MrJIJYQIIIPqJgEZCGMZjZjZjjjjIA\dUePu@	C/C=C/[C@]12CC[C@H](O)CC1=CCC1C3CC[C@H](O)[C@@]3(C)CCC12	6.07	group3-int	int	Androgen Receptor	Inhibitory activity against AR	2006	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@DjVU]{ZBxhuoAZjjjjjh@@	316.483	4.0091	2	2	40.46	1	-1.4043183494351381	-0.35862933402022124	-1.5403755915746273	35	20	fjcAA@B`|WNNQQRIHsIREKDyIUoIsUUUUUUULaBr`@	gC`HL@IRtHH	eFJB@Hp@									20
:UvztU:KzxvTvUUzEmIftUDBXR5mOSzEeD6jnbQA3ycF3e6JJW4C@g8wF3kEcu285O6WF6010F1G07VcVcFF	CHEMBL202660	eh\ZHF@JEKL`S@IABPpdKiAzP~dLbdLRVRfbbVVbRfTbDdRrfVj`@ijjj@Bjl`@@	CC1CN(c2ccc(C#N)c(C(F)(F)F)c2)C(C)CN1C(=O)Nc1ccc(C(F)(F)F)nc1	6.68	group3-int	int	Androgen Receptor	Inhibition of AR mediated transcriptional activation using reporter assay	2006	fj}@@@DjYU_yyWbiZrVjjjjjjj`@@	fj}I@@DXtXBSLjsj}jKUoYJuUPPP@D@@@	471.404	4.1671	6	1	72.26	4	1.094245594078526	-0.6600310770948288	0.3155382606421468	23	18	eh\ZHN@JIKL`S@@dbAX|UGFzP^dOiAIf[u{fW^UmixDRrfV`bBijjj@Bjl`@@				gJPBAHJPt`PAIjj@@							1
:UvztU:KzxvTvUUzEmIftUDBXR5mQSzEeD6jnbQA3ycF3e6JJW0C@g8wF3kEce2@5O6WF6010F1G07VcVcFF	CHEMBL202710	eg`ZHB@DNE@ki@HaZPvdCiAIe][fW^UmihX|BZz`@ijjj@BjlaCR^P@	C[C@H]1CN(C(=O)Nc2ccc(Cl)nc2)[C@H](C)CN1c1ccc(C#N)c(C(F)(F)F)c1	6.14	group3-int	int	Androgen Receptor	Inhibition of AR mediated transcriptional activation using reporter assay	2006	fj}@@@DjYU_yyWbiZrVjjjjjjj`@@	fj}I@@DXtXBSLjsj}jKUoYJuUPPP@D@@@	437.852	3.9682	6	1	72.26	3	0.7683757975269477	-0.29521763332310486	0.23318538838325362	23	18	eh\ZHN@JIKL`S@@dbAX|UGFzP^dOiAIf[u{fW^UmixDRrfV`bBijjj@BjlaArIP@				eFABH`BL@							16
:UvztU:KzxvTvUUzEmIvtUDBXRCnOSzEei7jnbQA3ycF3e6LKW0CAg9gk3lEde285O6WF6010J1G07WgVcF0	CHEMBL202990	eohRHJ@BMHge@IBRPvdCiBzPrJJIIJVJIYZIJYRI`PJKhZBBIjjj@Bjla@rAP@	C[C@H]1CN(C(=O)Nc2ccc(F)cc2F)[C@H](C)CN1c1ccc(C#N)c(C(F)(F)F)c1	6.7	group3-int	int	Androgen Receptor	Inhibition of AR mediated transcriptional activation using reporter assay	2006	fj}@@@DjYU_yyWbiZrVjjjjjjj`@@	fj}q@@DXtAIfUYu^uEjwleZjhHH@B@@@	438.399	4.4673	5	1	59.37	3	0.2956622833897401	-0.8126824942479006	0.11533080842067	23	1	eohRHJ@BMHge@IBRPvdCiBzPrJJIIJVJIYZIJYRI`PJKhZBBIjjj@Bjla@rAP@											1
JNsH42018&4F801VN0H%22202H058!10F06$2%2V#1#83028402)502010	CHEMBL2030817	fdy@b@ARADYEDeLhThdjLCF@BfX@@AAT@	O=C(/C=C/c1ccccc1)c1cc(Cl)ccc1O	5.82	group4-ia	ia	Androgen Receptor	Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay	2018	f`q@@@DjYW~UyIwjjjjjj@@	f`qA@@@ILrj}jISoM@a@@@BEH	258.703	3.5641	2	1	37.3	3	-1.6974954453313038	-0.12780178527369712	-0.5068758478851002	17	17	fjm@``MQ@Dr`_NN_EIfU_nYnYqIXBAi`bH@DNP		eFABH`BL@									12
:UvztU:KzxvTvUUzEmIftUDBXR5mOSzEeD6jnbQA3ycF3e6JJW0C@g8wF3kEce285O6WF6010F1307VcVcFF	CHEMBL203085	fkYC@EFRtYz`dDRFICHiCEDdcEDlmLhdiZbgYzhHLjjjZ@@aEeE@@	C[C@H]1CN(C(=O)Nc2ccncn2)[C@H](C)CN1c1ccc(C#N)c(C(F)(F)F)c1	5.34	group4-ia	ia	Androgen Receptor	Inhibition of AR mediated transcriptional activation using reporter assay	2006	fj}@@@DjYU_yyWbiZrVjjjjjjj`@@	fj}i@@DXekpDfYUgU{TVk^rUjj```@H@@@	404.395	3.0539	7	1	85.15	3	1.087314507287137	0.5938846038034794	0.2947233182859167	23	1	fkYC@EFRtYz`dDRFICHiCEDdcEDlmLhdiZbgYzhHLjjjZ@@aEeE@@											1
:UvztU:KzxvTvUUzEmIftUDBXR5mOSzEeD6jnbQA3ycF3e6JJW0C@g8wF3kEce285O6WF6010F1107VcVcFF	CHEMBL203423	fkYC@EFRu^z`dDRFICHiCEDdcEDlmLhdiZbgYzhHLjjjZ@@aEeE@@	C[C@H]1CN(C(=O)Nc2cncnc2)[C@H](C)CN1c1ccc(C#N)c(C(F)(F)F)c1	6	group3-int	int	Androgen Receptor	Inhibition of AR mediated transcriptional activation using reporter assay	2006	fj}@@@DjYU_yyWbiZrVjjjjjjj`@@	fj}i@@DXtZpDfYUgU{TVk^rUjj```@H@@@	404.395	2.7025	7	1	85.15	3	1.1038480453481456	0.8051281290559917	0.29289201213139865	23	1	fkYC@EFRu^z`dDRFICHiCEDdcEDlmLhdiZbgYzhHLjjjZ@@aEeE@@											1
xvojcyqXbEue9cx0VAzeCj_1qOoXPw0GFs0Ost12g8OZF0PRNoc50F!F$F2520V01O1#F!V$2V10	CHEMBL203561	fnk@`@@MrJIJYQIIIPqJgIZ}GMZjZjjnjjjIA\TUe@@	C#CC[C@]12CC[C@H](O)CC1=CCC1C2CC[C@@]2(C)C1CC[C@@H]2O	5.76	group4-ia	ia	Androgen Receptor	Inhibitory activity against AR	2006	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@DjVU]{ZBxhuoAZjjjjjh@@	314.467	3.4278	2	2	40.46	1	-1.3875844765338596	-0.0017057698217042283	-1.5467222914990901	35	20	fjcAA@B`|WNNQQRIHsIREKDyIUoIsUUUUUUULaBr`@	gC`HL@IWt@@	eFJB@Hp@									20
xvojgyqXbEue9cxVVAz@Cj_1MOoXPw0GFuFOss12g8OZJ4@RNo850k0FF!81G212#cO$F(2010	CHEMBL203748	ffs@`@@UrJIJZIJEJZITXhw`iJtuUMUUUUXY@iJ@@	C=C[C@]12CCC(=O)C=C1CCC1C2CC[C@@]2(C)C1CC[C@@H]2O	8.1	group1-p	p	Androgen Receptor	Inhibitory activity against AR	2006	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmMUUUUU@@@	300.44	3.7651	2	1	37.3	1	-1.8042322112521045	-0.16175893934999364	-0.4893649798211366	50	1	ffs@`@@UrJIJZIJEJZITXhw`iJtuUMUUUUXY@iJ@@											1
xvwjcyqXbEue9cx0VAzeCj_1qOoXPw0GFu0Ott12g8OZF0PRNqc50F!F#1G2520V0WO1#F!V$2410	CHEMBL204317	fnk@b@@mAbYDeHhhddbhXeHvk^cfluSUUUUUUDpkJJrhP`	C[C@]12CCC3C(CC=C4C[C@@H](O)CC[C@@]43/C=C/Br)C1CC[C@@H]2O	6.92	group3-int	int	Androgen Receptor	Inhibitory activity against AR	2006	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@DjVU]{ZBxhuoAZjjjjjh@@	381.352	3.8757	2	2	40.46	1	-1.0564298432903434	-0.5189905610845111	-1.4343300006021522	35	20	fjcAA@B`|WNNQQRIHsIREKDyIUoIsUUUUUUULaBr`@	gC`DAbX@RVXRP	eFJB@Hp@									20
zvwjcyyXbjue9cx0VAzeCj_1qOoXPw0GFu0Ott12g8OZF0PRNqc50F!F#1G2520V0WO1#F!V$2010	CHEMBL204389	fa{A`@@Q{dbrdTTRRQTLRUXs`iJvfjZjjjjjhaDyIQUAD@	CO/C=C/[C@]12CC[C@H](O)CC1=CCC1C3CC[C@H](O)[C@@]3(C)CCC12	5.34	group4-ia	ia	Androgen Receptor	Inhibitory activity against AR	2006	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@DjVU]{ZBxhuoAZjjjjjh@@	332.482	3.0617	3	2	49.69	2	-0.7237076397766357	0.21930204807903292	-1.3808403521233181	35	20	fjcAA@B`|WNNQQRIHsIREKDyIUoIsUUUUUUULaBr`@	gJQH@PAJ^fDT@	eFJB@Hp@									20
xvojcyqXbEue9cx0VAzeCj_1qOoXPw0GFu0Sst12g8OZF0PRNoc70F!F#1G2520V0WO1#F!V$2010	CHEMBL204642	fnk@`@@MrJQRKHsIRYIF`eZ]xmZjjjjjfjfIAHUiU@@	C=C[C@]12CC[C@H](O)CC1=CCC1C2CC[C@@]2(C)C1CC[C@]2(C)O	6.77	group3-int	int	Androgen Receptor	Inhibitory activity against AR	2006	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@DjVU]{ZBxhuoAZjjjjjh@@	316.483	3.9194	2	2	40.46	1	-1.4000979210881819	-0.30470632257542896	-1.5408430593590765	35	20	fjcAA@B`|WNNQQRIHsIREKDyIUoIsUUUUUUULaBr`@	eMBD@cX@	eMJB@Df`@									20
zpzp7_NK9V4R4F2DT80_2N2uV0F093_202mV582010Z8630V0YVVd2lL8FV191V0V11214820VX1J4!JFY0GV	CHEMBL2086964	ek`TJ@@DB@JFamdfVUUYY]Y]QIO@lnjifjVh@@@Hbh@@`X`	COc1cc(/C=N/NC(=O)c2cc3c(ccc4ccccc43)o2)cc(OC)c1O	4.48	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type AR T877A mutant LBD assessed as inhibition of DHT-induced fluorescent labeled D11-FxxLF recruitment after 2 to 4 hrs by TR-FRET assay	2012	fa{@@@LdbbbRRZbrTRSIBUhs^uUUUUUUUU@@@	fa{P`@DDAQIeeUVVWWEKp\mkujej@@@@@@DFP	390.394	4.4159	7	2	93.29	5	1.6735806261155832	-0.36877574525779067	-0.7350073709793552	2	2	ek`TBH@CKBFOH`GGHhhhdcdeMDddidnILbnamchHbJZZZ@@@@@`t`	eFJB@Hp@										1
zJul618G804F0F04FN0W0N2m%31206m01#1FV861VV0210104L0F!92!c1020402)4FY4G0	CHEMBL2086965	fakQb@IJDXHLQIe[][f]UhqNV}`@ii``@@@DAP	O=C(N/N=C/c1cc(Br)ccc1O)c1cc2ccccc2cc1O	4.91	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type AR T877A mutant LBD assessed as inhibition of DHT-induced fluorescent labeled D11-FxxLF recruitment after 2 to 4 hrs by TR-FRET assay	2012	fj}@@@LdbbRRlVRbRXKdlejjjjjjjh@@	fj}Q@@DD@drrjwJkrtGJRmPHP@@@@BCH	385.216	4.4298	5	3	81.92	3	0.9322136098082563	-0.45526559428212715	-2.088425455444049	1	1	fakQb@IJDXHLQIe[][f]UhqNV}`@ii``@@@DAP											1
zJul618G804F0F04FN0W0N2X%31206m01#1FV861VV0210104L0F!92!c102#2)4FY0G0	CHEMBL2086966	fmoQ`@DD@INQQJIQKIQIQHkIJMFiVsVu@pP@D@@@@BCH	O=C(N/N=C/c1cc2ccccc2cc1O)c1cc2ccccc2cc1O	4.8	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type AR LBD assessed as inhibition of DHT-induced fluorescent labeled D11-FxxLF recruitment after 2 to 4 hrs by TR-FRET assay	2012	fig@@@LdbbRRlVRbRfRXKdlezNjjjjjjjjj@@	figQ@@DDAdTRbRRfbRRtJTmArdoQmPHP@@@@@@HL`	356.38	4.899	5	3	81.92	3	0.758281862895424	-0.6303916898556332	-2.1334293757328817	1	1	fmoQ`@DD@INQQJIQKIQIQHkIJMFiVsVu@pP@D@@@@BCH											1
zxzp7_NK9X4R4F2DT80_2N2eVVF093h202mV582031Z8630V0WV0d2kL8FV191V0V91210820VX1J4!JFW0FV	CHEMBL2086967	fcQ`@DDAPZSKJjllnozbexNVuzuRu@@@@ET@@`r@	CCCOc1ccc(/C=N/NC(=O)c2cc3c(ccc4ccccc43)o2)cc1	4.75	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type AR LBD assessed as inhibition of DHT-induced fluorescent labeled D11-FxxLF recruitment after 2 to 4 hrs by TR-FRET assay	2012	fa{@@@LdbbbRRZbrTRSIBUhs^uUUUUUUUU@@@	fa{P`@DDAQIeeUVVWWEKp\mkujej@@@@@@DFP	372.423	5.6923	5	1	63.83	6	0.43792923591135774	-1.6341860637236034	0.10282632040417088	2	2	figPb@ARuXCbdrnjwJjvmF^CdoQp@SSSP@@@@H\`	gJQH@`AJ^j@@										1
<jUttCw4m_KfTHcHhXO7HL4FtdY92VLHZ78eV39kO6FGf0P9X16KLt2c89RnIV90A0bV64V@BKN475FV8F0	CHEMBL2112216	ffc`c@@jlBPQHXdLbdLTRbVVTVTeF]GMUHTBUUTROKL@@	CC[C@H]1C[C@@H](C)Nc2cc3oc(=O)cc(C(F)(F)F)c3cc21	7.92	group2-a	a	Androgen Receptor	In vitro binding affinity at human androgen receptor transfected into COS cells.	1999	foQ@@@DjYUU}`nRlzjjjjj`@@	foQ``@M@PdrmjjtYIUgMR@EUD@@	311.302	3.5355	3	1	38.33	2	-1.3163340960132195	-0.056430951218327224	-0.3554142520535272	38	15	fj}`b`DFbCqDxidLrAYAIeYWUYzhqVg^jhHBifjH@@	eMBD@ch@	eFBH@c@@									11
<jUtvCwam57ATH8IhXO2HLJFkdn920MHZ7Be239k9DFGa4@9X16KLt2c89RnIVC0Q0bV64X@BKN4b5FV8F0	CHEMBL2112311	ffc`c@@jlBPQHXdLbdLTRbVVTRTeF]GMUHTBUUTRORL@@	CC[C@H]1c2cc3c(C(F)(F)F)cc(=O)oc3cc2NC[C@H]1C	8.7	group1-p	p	Androgen Receptor	In vitro binding affinity at human androgen receptor transfected into COS cells.	1999	foQ@@@DjYUU}`nRlzjjjjj`@@	foQ``@M@PdrmjjtYIUgMR@EUD@@	311.302	3.4801	3	1	38.33	2	-1.3137274925008893	-0.023127243757261884	-0.3557029675744825	38	15	ffc`b`DVRCqdxydBrEYAIef]uV^j\t[pZj``JfZhhXP@	eMBD@ch@										2
<jUtvCwam57ATH8IhXO2HLJFkdn920MHZ7Be239k9DFGa4@9X16KLt2c89RnIVC0Q0bV64X@BKN4b5FV8F0	CHEMBL2112312	ffc`c@@jlBPQHXdLbdLTRbVVTRTeF]GMUHTBUUTROJL@@	CC[C@@H]1c2cc3c(C(F)(F)F)cc(=O)oc3cc2NC[C@H]1C	9.52	group1-p	p	Androgen Receptor	In vitro binding affinity at human androgen receptor transfected into COS cells.	1999	foQ@@@DjYUU}`nRlzjjjjj`@@	foQ``@M@PdrmjjtYIUgMR@EUD@@	311.302	3.4801	3	1	38.33	2	-1.3137274925008893	-0.023127243757261884	-0.3557029675744825	38	15	ffc`b`DVRCqdxydBrEYAIef]uV^j\t[pZj``JfZhhXP@	eMBD@ch@										2
:vz6KOr8F4s0L2gUNH10S0m0B8K93g20Imo50X0390O6@WVD21X46W710V89DlFVN582_c6N!5F4Vb54Y8G0	CHEMBL2112349	fjuQSBIZyYpT`dDRFIBTn{HiCEEMEMYiEFj`bHZZh@@	CC(C)(O)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1O	7.82	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) expressed in CV-1 cell lines	1999	gFp@DiTvjh@	gFp@DiTt@@@	308.211	0.7575	7	3	115.38	4	1.8857579721573208	2.404207643853973	-1.9459066105438396	19	15	dg^DiMNpBR|VPQ\U`]f~RYf{~zXHbJX@@	gJPBAHJPt`PAIjj@@	eFJB@Hp@	dazD`DBb@DfVfjh@@								1
}y]U:j;xzpzv:Enr<UqrzEQprpjzUjiQfxzynfxStibzrKn8x7KsrMwXcG0	CHEMBL2112885	gkIV`Dp@EA`HRY^HdqEbUVoSY\~PRODR@dDDa`dLbdLTRRLTTvbJRRbRfTJRbbtQTTRbbfbLTQtVbrdZ@bSxBMVjtx]^plUIfjBCJfZjzh@JZjjjj`hJhfZ`XHHhbarPiZhFUY@@	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3OC1C[C@H](NCNC(=O)c2cc(COCC#CCN3C(=O)N(c4ccc(C#N)c(C(F)(F)F)c4)C(=O)C3(C)C)ccc2O)[C@H](O)[C@H](C)O1	7.05	group2-a	a	Androgen Receptor	Inhibition of 1.0 nM [3H]mibolerone binding to human androgen receptor of PC3/AR cell lysate	2003	gipD@@@@LdbbbRrVbbbRvfVJTTrTJRRTTRrfRXJAD`HdjCEfpeR}Qnpzjjjjjjjjjjjjjjjjjjjjj@@@	gipD`H@@MeptF@VDcSyr}YlbbbbbRRRJfQbRVRTtRTJRRTTVRfRXBEC`pDrEIbpeRCQnpyh@`AHjjjji`@jnjZd@HJHP^IL`@	1069.99	3.5252	21	8	315.05	16	15.688595721548369	-0.4472206759384303	-4.050447768152306	3	1	gkIV`Dp@EA`HRY^HdqEbUVoSY\~PRODR@dDDa`dLbdLTRRLTTvbJRRbRfTJRbbtQTTRbbfbLTQtVbrdZ@bSxBMVjtx]^plUIfjBCJfZjzh@JZjjjj`hJhfZ`XHHhbarPiZhFUY@@											1
=t;rzxzyvzU:YuvvUijfU7mSbbbvKEEnbvjrTfVnXyQqrmC0EBg@YoEeadt5xXbLbF_Fk9GNj4d3cW0	CHEMBL2113032	ei]RNL@EC@a_Hlamf^PIABPpdLbdLTRRLTTvbJRRRRbRfTdtBRqIj``rifjjjj`@ib@@@	CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)N1OCCOCCOCCCc1ccc(O)c(C(N)=O)c1	6.48	group3-int	int	Androgen Receptor	Inhibition of [3H]mibolerone binding to human Androgen receptor of PC3/AR Cell Lysate	2004	fk@@@LdbbRbbsRRRRRbRxXRmgjjjjjjjjjj`@@	fkQP@DX@qP\iLsLn{zjkJty[vsmUPLDUUT@D@@@	578.542	2.3412	11	2	155.42	14	6.167303074289132	0.032448013258566055	0.3110661829262995	2	1	ei]RNL@EC@a_Hlamf^PIABPpdLbdLTRRLTTvbJRRRRbRfTdtBRqIj``rifjjjj`@ib@@@											1
=t;rzxzyvzU:YuvvUijfU7mSbbbvKEEnbvjrTfVnXyQqrmC0EBg@YoEeadt5xXbLbF_Fk9GNj4d3cW0	CHEMBL2113034	efQRFL@EC@j_HlalRPIABPpdLbdLTRRLTTvbJRRTRTrdf`RPLMTDFULuUUT@ELP@@@	CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)N1OCCOCCCc1ccc(O)c(C(N)=O)c1	7.11	group2-a	a	Androgen Receptor	Inhibition of [3H]mibolerone binding to human Androgen receptor of PC3/AR Cell Lysate	2004	feg@@@LdbbRbbsRRRTRWCBTN]UUUUUUUUT@@	fegPP@DX@qPTfYfW]}UeZ\mx\vjhFBJj@B@@@	534.49	2.4337	10	2	146.19	11	5.062109300175812	0.31411522451416696	0.048700788797016004	2	1	efQRFL@EC@j_HlalRPIABPpdLbdLTRRLTTvbJRRTRTrdf`RPLMTDFULuUUT@ELP@@@											1
=t;ozxzyvzUzUWmvvUiCAU7mS7_7vKEDnbQErTfVnXTQqbkC0EBg@YoEeXdt5xXbHbF_0k9GFj4d3cW0	CHEMBL2113036	ej^RJL@EC@b_Hld\PIABPpdLbdLTRRLTTvbJRRbRfTdtBR~Aj``rifjkj@BfH@@@	CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)N1OCC#CCCc1ccc(O)c(C(N)=O)c1	7.31	group2-a	a	Androgen Receptor	Inhibition of [3H]mibolerone binding to human Androgen receptor of PC3/AR Cell Lysate	2004	fi{@@@LdbbRbbsRRRbRxXRncjjjjjjjjj@@	fi{Q`@DX@qRSLsKn~kJty[wQmUPLD]P@P@@@	514.459	3.0672	9	2	136.96	8	4.057960180237007	0.18148382185656553	-0.17131907241844163	2	1	ej^RJL@EC@b_Hld\PIABPpdLbdLTRRLTTvbJRRbRfTdtBR~Aj``rifjkj@BfH@@@											1
;QfQzvESqn9DvTHQM@XtZHqJZkhrGF0G2Z34X2W8F18F2L4A130408cHc!J32044O2W0D02#84aF0X8GF	CHEMBL2113247	fegQA`EAlBPQHXdNr@yB\adTabbTRrrbRJddhshyj`@@bjjj`d^dX@	C[C@@H]1CNc2cc3nc(O)cc(C(F)(F)F)c3cc2[C@@H]1CCC(F)(F)F	7.2	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in CV-1 cells using cotransfection assay	1999	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	378.315	5.1885	3	2	45.15	4	-0.33835587129536615	-1.5041328347385365	-1.253681266450453	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@	gNpBAHJPt`pCHiBjj`@		eFBH@c@@							49
;QfQzQERan1DATHQM8Xt_HLJ0khnG!G2Z34X218F18F264P1!480cHc!J32044O2W0D02#84a04X8GF	CHEMBL2113248	fakQC@EAlBPQHXdLbdLTRbVVTRQdeF]GMT@@DUUUAH}Hh@	CC(C)C[C@H]1c2cc3c(C(F)(F)F)cc(O)nc3cc2NC[C@@H]1C	7.54	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in CV-1 cells using cotransfection assay	1999	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	338.372	4.9225	3	2	45.15	3	-0.6947247190759687	-1.0752826540172988	-1.346900092267919	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@	gJPHB@ITuP@		eFBH@c@@							49
<dyyujjynhXhDnvrhjEJmooluTvO!FHBlRHm9dGOMlP41A@!64FWF890HH1014D21VH0205F013FB1c!	CHEMBL2159539	ffcQC@EQ\BPQHXdLbdLTRbRTvVTcN|VmTDCEUuQP@@	N#Cc1ccc(C2=NOC3CCCCCC23)c(C(F)(F)F)c1	6	group3-int	int	Androgen Receptor	Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay	2012	f`i@@@LdbbRbVQWMBT{uUUUUUP@@	f`ia@@H@rQJIIQIHxIhsoTuTE@T@@@	308.302	4.6204	3	0	45.38	2	-1.5458705738566834	-0.6319018374721597	0.7499726653923532	7	5	fj}a@`CN@xrdERFiCHhdieHiULdjL]{IX@JjZjjJ@@	eMbA@Dg`@										2
<fyyvjjynhXjDnvrhjUJmooluTuO!FHglJmmAdGOMtv41A@0464F1F890PIFV14D2_V682!F013!38!	CHEMBL2159540	fnsQcBNNUhHIADabPyNnrJPqQJIVISIJQ`qjvjBAbZjjJ@@	O=[N+]([O-])c1ccc(C2=NOC3CCCCCC23)cc1C(F)(F)F	6.98	group3-int	int	Androgen Receptor	Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay	2012	f`i@@@LdbbRbVQWMBT{uUUUUUP@@	f`ia@@H@rQJIIQIHxIhsoTuTE@T@@@	328.289	3.8632	5	0	67.41	3	-0.4025436335172359	0.031645469458579094	1.0381879242698664	7	5	fj}a@`CN@xbdIRBiCHhhdiMXeLdf\]{IXBBjZjjJ@@	gChhhE`BRnRYh@										3
<fyyvjjynhXjDnvrhjEJmooluTvO!FHBlRmmAdGOMtu41A@V464FWF890PHGV14D2_VL8205F017FB38!	CHEMBL2159541	fnsQcBEV]EHIADabPmJ^rJPqQJIISSHjQg^jvjBAbjZjJQi^P@	O=[N+]([O-])c1ccc(C2=NO[C@@H]3CCCCC[C@H]23)c(C(F)(F)F)c1	6.51	group3-int	int	Androgen Receptor	Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay	2012	f`i@@@LdbbRbVQWMBT{uUUUUUP@@	f`ia@@H@rQJIIQIHxIhsoTuTE@THQBP@	328.289	3.8632	5	0	67.41	3	-0.4025436335172359	0.031645469458579094	1.0381879242698664	7	1	fnsQcBEV]EHIADabPmJ^rJPqQJIISSHjQg^jvjBAbjZjJQi^P@											1
<fyyvjjynhXjDnvrhjEJmooluTvO!FHBlRmmAdGOMtu41A@V464FWF890PHGV14D2_VL8205F017FB38!	CHEMBL2159542	fnsQcBEV]EHIADabPmJ^rJPqQJIISSHjQg^jvjBAbjZjJQj^`@	O=[N+]([O-])c1ccc(C2=NO[C@H]3CCCCC[C@@H]23)c(C(F)(F)F)c1	6.41	group3-int	int	Androgen Receptor	Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay	2012	f`i@@@LdbbRbVQWMBT{uUUUUUP@@	f`ia@@H@rQJIIQIHxIhsoTuTE@THPbH@	328.289	3.8632	5	0	67.41	3	-0.4025436335172359	0.031645469458579094	1.0381879242698664	7	1	fnsQcBEV]EHIADabPmJ^rJPqQJIISSHjQg^jvjBAbjZjJQj^`@											1
<dyyvjjynhXhDnvrhjUJmooluTuO!FHBlJHm9dGNKlQ41A@!64F0F810P2!14D250202$13!18!	CHEMBL2159543	fj}a@`CNAHBdIRBiCHhhdiMXeLdf\]{IXBBjZjjJ@@	Fc1ccc(C2=NOC3CCCCCC23)cc1C(F)(F)F	4.96	group4-ia	ia	Androgen Receptor	Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay	2012	f`i@@@LdbbRbVQWMBT{uUUUUUP@@	f`ia@@H@rQJIIQIHxIhsoTuTE@T@@@	301.282	4.8856	2	0	21.59	2	-2.222741898383474	-1.0606510939559242	0.5907026740609836	7	5	fj}a@`CN@xbdIRBiCHhhdiMXeLdf\]{IXBBjZjjJ@@	eFABP`BL@										3
<dyyvjjynhXhDnvrhjEJmooluTvO!FHBlRHm9dGOMlP41A@!64FWF890HH1014D21VH0205F013FB18!	CHEMBL2159544	fj}a@`CNAHRdERFiCHhdieHiULdjL]{IX@JjZjjJ@@	Fc1ccc(C2=NOC3CCCCCC23)c(C(F)(F)F)c1	6.18	group3-int	int	Androgen Receptor	Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay	2012	f`i@@@LdbbRbVQWMBT{uUUUUUP@@	f`ia@@H@rQJIIQIHxIhsoTuTE@T@@@	301.282	4.8856	2	0	21.59	2	-2.222741898383474	-1.0606510939559242	0.5907026740609836	7	5	fj}a@`CN@xrdERFiCHhdieHiULdjL]{IX@JjZjjJ@@	eFABP`BL@										2
<dyyujjynhehDnvrhjEJmoopuTuO!FHBlRHm9dGNKlQ41A@!64F0F810P2!14D250202$13081c!	CHEMBL2159545	fnsQC@EV|BPQHXdLbdLTRRLRfRRekpZmj``rZjjb`@@	N#Cc1ccc(C2=NOC3CCCCCCC23)cc1C(F)(F)F	6.53	group3-int	int	Androgen Receptor	Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay	2012	fhy@@@LdbbRbVQRyhRoAjjjjjj`@@	fhya@@H@ReeVUWpPwgAijhJBJ@@@	322.329	5.6368	3	0	45.38	2	-1.5198238936213326	-1.2949256143312249	0.7783507910505818	6	6	ffca@`CN@xbdIRBiCHhhdiMXeLddscoEk@PUSUUTT@@	eMbA@Dg`@										3
<dyyujjynhehDnvrhjEJmoopuTvO!FHBlRHm9dGOMlP41A@!64FWF890HH1014D21VH0205F013FB1c!	CHEMBL2159546	fnsQC@EQ\BPQHXdLbdLTRbRTvVRdYwjmj``Xjnjb`@@	N#Cc1ccc(C2=NOC3CCCCCCC23)c(C(F)(F)F)c1	6.19	group3-int	int	Androgen Receptor	Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay	2012	fhy@@@LdbbRbVQRyhRoAjjjjjj`@@	fhya@@H@ReeVUWpPwgAijhJBJ@@@	322.329	5.6368	3	0	45.38	2	-1.5198238936213326	-1.2949256143312249	0.7783507910505818	6	6	ffca@`CN@xrdERFiCHhdieHiULdeQcoEk@AUSUUTT@@	eMbA@Dg`@										3
<fyyvjjynhejDnvrhjUJmoopuTuO!FHglJmmAdGOMtv41A@0464F1F890PIFV14D2_V682!F013!38!	CHEMBL2159547	fakQcBNNUhHIADabPyNnrJPqQJIVISIIRLFK^uPPLSUUTT@@	O=[N+]([O-])c1ccc(C2=NOC3CCCCCCC23)cc1C(F)(F)F	6.15	group3-int	int	Androgen Receptor	Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay	2012	fhy@@@LdbbRbVQRyhRoAjjjjjj`@@	fhya@@H@ReeVUWpPwgAijhJBJ@@@	342.316	4.8796	5	0	67.41	3	-0.37649696449959646	-0.6313784507254595	1.0665660511706037	6	6	ffca@`CN@xbdIRBiCHhhdiMXeLddscoEk@PUSUUTT@@	gChhhE`BRnRYh@										3
<fyyvjjynhejDnvrhjEJmoopuTvO!FHBlRmmAdGOMtu41A@V464FWF890PHGV14D2_VL8205F017FB38!	CHEMBL2159548	fakQcBEV]EHIADabPmJ^rJPqQJIISSHiRL{s^uPPLUSUTT@@	O=[N+]([O-])c1ccc(C2=NOC3CCCCCCC23)c(C(F)(F)F)c1	6.13	group3-int	int	Androgen Receptor	Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay	2012	fhy@@@LdbbRbVQRyhRoAjjjjjj`@@	fhya@@H@ReeVUWpPwgAijhJBJ@@@	342.316	4.8796	5	0	67.41	3	-0.37649696449959646	-0.6313784507254595	1.0665660511706037	6	6	ffca@`CN@xrdERFiCHhdieHiULdeQcoEk@AUSUUTT@@	gChhhE`BRnRYh@										3
<dyyvjjynhehDnvrhjUJmoopuTuO!FHBlJHm9dGNKlQ41A@!64F0F810P2!14D250202$13!18!	CHEMBL2159549	ffca@`CNAHBdIRBiCHhhdiMXeLddscoEk@PUSUUTT@@	Fc1ccc(C2=NOC3CCCCCCC23)cc1C(F)(F)F	5.55	group4-ia	ia	Androgen Receptor	Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay	2012	fhy@@@LdbbRbVQRyhRoAjjjjjj`@@	fhya@@H@ReeVUWpPwgAijhJBJ@@@	315.309	5.902	2	0	21.59	2	-2.196695378859279	-1.7236747576463025	0.6190807495030645	6	6	ffca@`CN@xbdIRBiCHhhdiMXeLddscoEk@PUSUUTT@@	eFABP`BL@										3
<dyyvjjynhehDnvrhjEJmoopuTvO!FHBlRHm9dGOMlP41A@!64FWF890HH1014D21VH0205F013FB18!	CHEMBL2159550	ffca@`CNAHRdERFiCHhdieHiULdeQcoEk@AUSUUTT@@	Fc1ccc(C2=NOC3CCCCCCC23)c(C(F)(F)F)c1	4.88	group4-ia	ia	Androgen Receptor	Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay	2012	fhy@@@LdbbRbVQRyhRoAjjjjjj`@@	fhya@@H@ReeVUWpPwgAijhJBJ@@@	315.309	5.902	2	0	21.59	2	-2.196695378859279	-1.7236747576463025	0.6190807495030645	6	6	ffca@`CN@xrdERFiCHhdieHiULdeQcoEk@AUSUUTT@@	eFABP`BL@										3
<dyyujjynhXhDnvrhjEJmooluTuO!FHBlRHm9dGNKlQ41A@!64F0F810P2!14D250202$13081c!	CHEMBL2159561	ffcQC@EV|BPQHXdLbdLTRRLRfRTm^BVmTDFSUUQP@@	N#Cc1ccc(C2=NOC3CCCCCC23)cc1C(F)(F)F	7.36	group2-a	a	Androgen Receptor	Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay	2012	f`i@@@LdbbRbVQWMBT{uUUUUUP@@	f`ia@@H@rQJIIQIHxIhsoTuTE@T@@@	308.302	4.6204	3	0	45.38	2	-1.5458705738566834	-0.6319018374721597	0.7499726653923532	7	5	fj}a@`CN@xbdIRBiCHhhdiMXeLdf\]{IXBBjZjjJ@@	eMbA@Dg`@										3
<fqyvdjyn_XEDnvnhYUJmkoGmTu9!FHglKmm3dGOMtt41A@4464F1F890PIFV14D2_V682!F013!38!	CHEMBL2159562	fj}QcBNNUhHIADabPyNnrJPqQJIVISJQ`qrVjBAbZjbd^TT@	O=[N+]([O-])c1ccc(C2=NO[C@@H]3CCC[C@H]23)cc1C(F)(F)F	6.52	group3-int	int	Androgen Receptor	Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay	2012	fgA@@@DjYVW^ZDhujjjjjh@@	fgAa@@H@rQJIIPiXIpQkTuT@EBDPd@@	300.235	3.1792	5	0	67.41	3	-0.5180986835359394	0.5468640905469855	0.9884608872822798	8	2	flua@`CN@xbdIRBiCHhhdiMXeLf\]zJXBBjZjbdVWd@	gChhhE`BRnRYh@										2
<fqyvdjyn_XEDnvnhYEJmkoGmTv9!FHBlSmm3dGOMts41A@Z464FWF890PHGV14D2_VL8205F017FB38!	CHEMBL2159563	fj}QcBEV]EHIADabPmJ^rJPqQJIISSJQg^rVjBAbjZb`@@	O=[N+]([O-])c1ccc(C2=NOC3CCCC23)c(C(F)(F)F)c1	6.57	group3-int	int	Androgen Receptor	Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay	2012	fgA@@@DjYVW^ZDhujjjjjh@@	fgAa@@H@rQJIIPiXIpQkTuT@E@@@	300.235	3.1792	5	0	67.41	3	-0.5180986835359394	0.5468640905469855	0.9884608872822798	8	4	flua@`CN@xrdERFiCHhdieHiULjL]zJX@JjZjb`@@	gChhhE`BRnRYh@										3
<dqyvdjyn_XCDnvnhYUJmkoGmTu9!FHBlKHm1dGNKlO41A@4064F0F810P2!14D250202$13!18!	CHEMBL2159564	flua@`CNAHBdIRBiCHhhdiMXeLf\]zJXBBjZjb`@@	Fc1ccc(C2=NOC3CCCC23)cc1C(F)(F)F	5.83	group4-ia	ia	Androgen Receptor	Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay	2012	fgA@@@DjYVW^ZDhujjjjjh@@	fgAa@@H@rQJIIPiXIpQkTuT@E@@@	273.228	4.2016	2	0	21.59	2	-2.338296948402177	-0.5454324728675181	0.540975637073397	8	4	flua@`CN@xbdIRBiCHhhdiMXeLf\]zJXBBjZjb`@@	eFABP`BL@										1
<dqyvdjyn_XCDnvnhYEJmkoGmTv9!FHBlSHm1dGOMlN41A@4064FWF890HH1014D21VH0205F013FB18!	CHEMBL2159565	flua@`CNAHRdERFiCHhdieHiULjL]zJX@JjZjb`@@	Fc1ccc(C2=NOC3CCCC23)c(C(F)(F)F)c1	5.87	group4-ia	ia	Androgen Receptor	Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay	2012	fgA@@@DjYVW^ZDhujjjjjh@@	fgAa@@H@rQJIIPiXIpQkTuT@E@@@	273.228	4.2016	2	0	21.59	2	-2.338296948402177	-0.5454324728675181	0.540975637073397	8	4	flua@`CN@xrdERFiCHhdieHiULjL]zJX@JjZjb`@@	eFABP`BL@										3
<dyyuhjyn_XhDnvrhbEJmooGuTuO!NHBlRHm1dGNKlO41A@!64F0F810P2!14D251202$13081c!	CHEMBL2159566	fj}QC@EV|BPQHXdLbdLTRRLRfRekp\ej``rZjhh@@	N#Cc1ccc(C2=NOC3CCCCC23)cc1C(F)(F)F	7.56	group2-a	a	Androgen Receptor	Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay	2012	foQ@@@LdbbRbVQyhRkNjjjjjh@@	foQa@@H@ReeV]|DEjsjZjB@h@@	294.275	4.2784	3	0	45.38	2	-1.6036480988660349	-0.37429252692795656	0.72510914689856	8	6	fhyaA@IZAxd\TfY}emV\t[pXHBZjhh@@	gJPBAHJPt`PAIjj@@	eMbA@Dg`@									3
<dyyuhjyn_XhDnvrhbEJmooGuTvO!NHBlRHm1dGOMlN41A@!64FWF890HH1014D21WH0205F013FB1c!	CHEMBL2159567	fj}QC@EQ\BPQHXdLbdLTRbRTvVdYwlej``Xjnhh@@	N#Cc1ccc(C2=NOC3CCCCC23)c(C(F)(F)F)c1	5.94	group4-ia	ia	Androgen Receptor	Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay	2012	foQ@@@LdbbRbVQyhRkNjjjjjh@@	foQa@@H@ReeV]|DEjsjZjB@h@@	294.275	4.2784	3	0	45.38	2	-1.6036480988660349	-0.37429252692795656	0.72510914689856	8	6	fj}aB`K^Axd\URFi@tadTTVfTbeTrSN^CdlDAUSUUE@@@		eMbA@Dg`@									3
<dyyuhjyn_XhDYvrhbEJmooGuTvF!NFBlRHm1cGOMlO41A@!44FVF090HH1014D05dF0201F010FB1c!	CHEMBL2159568	fj}QC@MV|BPQHXdLbdLTTRTjfRT[p\ej`bLZjhh@@	N#Cc1cccc(C2=NOC3CCCCC23)c1C(F)(F)F	7.1	group2-a	a	Androgen Receptor	Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay	2012	foQ@@@LdbbRbVQyhRkNjjjjjh@@	foQa@@H@ReeV]|DEjsjZjB@h@@	294.275	4.2784	3	0	45.38	2	-1.6036480988660349	-0.37429252692795656	0.72510914689856	8	6	fj}aB`K^Axd\URFi@tadTTVfTbeTrSN^CdlDAUSUUE@@@	eMbA@Dg`@										3
<fyyvhjyn_XjDnvrhbUJmooGuTuO!NHglJmm3dGOMtt41A@0464F1F890PIFV14D2_W682!F013!38!	CHEMBL2159569	ffcQcBNNUhHIADabPyNnrJPqQJIVISIRLFIZuPPLSUUE@@@	O=[N+]([O-])c1ccc(C2=NOC3CCCCC23)cc1C(F)(F)F	6.92	group3-int	int	Androgen Receptor	Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay	2012	foQ@@@LdbbRbVQyhRkNjjjjjh@@	foQa@@H@ReeV]|DEjsjZjB@h@@	314.262	3.5212	5	0	67.41	3	-0.4603211585265876	0.28925478000278226	1.0133244057760733	8	6	fhyaA@IZAxd\TfY}emV\t[pXHBZjhh@@	gJPBAHJPt`PAIjj@@	gChhhE`BRnRYh@									3
<fyyvhjyn_XjDnvrhbEJmooGuTvO!NHBlRmm3dGOMts41A@V464FWF890PHGV14D2_WL8205F017FB38!	CHEMBL2159570	ffcQcBEV]EHIADabPmJ^rJPqQJIISSHrL{qZuPPLUSUEHtoH@	O=[N+]([O-])c1ccc(C2=NO[C@@H]3CCCC[C@H]23)c(C(F)(F)F)c1	6.89	group3-int	int	Androgen Receptor	Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay	2012	foQ@@@LdbbRbVQyhRkNjjjjjh@@	foQa@@H@ReeV]|DEjsjZjB@hPbD`@	314.262	3.5212	5	0	67.41	3	-0.4603211585265876	0.28925478000278226	1.0133244057760733	8	1	ffcQcBEV]EHIADabPmJ^rJPqQJIISSHrL{qZuPPLUSUEHtoH@											1
<fyyvhjyn_XjDnvrhbEJmooGuTvO!NHBlRmm3dGOMts41A@V464FWF890PHGV14D2_WL8205F017FB38!	CHEMBL2159571	ffcQcBEV]EHIADabPmJ^rJPqQJIISSHrL{qZuPPLUSUEHuOP@	O=[N+]([O-])c1ccc(C2=NO[C@H]3CCCC[C@@H]23)c(C(F)(F)F)c1	6.58	group3-int	int	Androgen Receptor	Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay	2012	foQ@@@LdbbRbVQyhRkNjjjjjh@@	foQa@@H@ReeV]|DEjsjZjB@hPaDP@	314.262	3.5212	5	0	67.41	3	-0.4603211585265876	0.28925478000278226	1.0133244057760733	8	1	ffcQcBEV]EHIADabPmJ^rJPqQJIISSHrL{qZuPPLUSUEHuOP@											1
<dyyvhjyn_XhDnvrhbUJmooGuTuO!NHBlJHm1dGNKlO41A@!64F0F810P2!14D251202$13!18!	CHEMBL2159572	fbma@`CNAHBdIRBiCHhhdiMXeLdscoIs@PUSUUE@@@	Fc1ccc(C2=NOC3CCCCC23)cc1C(F)(F)F	5.96	group4-ia	ia	Androgen Receptor	Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay	2012	foQ@@@LdbbRbVQyhRkNjjjjjh@@	foQa@@H@ReeV]|DEjsjZjB@h@@	287.255	4.5436	2	0	21.59	2	-2.2805194233928257	-0.803041783411721	0.5658391555671903	8	6	fhyaA@IZAxd\TfY}emV\t[pXHBZjhh@@	gJPBAHJPt`PAIjj@@	eFABP`BL@									3
<dyyvhjyn_XhDnvrhbEJmooGuTvO!NHBlRHm1dGOMlN41A@!64FWF890HH1014D21WH0205F013FB18!	CHEMBL2159573	fbma@`CNAHRdERFiCHhdieHiULeQcoIs@AUSUUE@@@	Fc1ccc(C2=NOC3CCCCC23)c(C(F)(F)F)c1	6.01	group3-int	int	Androgen Receptor	Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay	2012	foQ@@@LdbbRbVQyhRkNjjjjjh@@	foQa@@H@ReeV]|DEjsjZjB@h@@	287.255	4.5436	2	0	21.59	2	-2.2805194233928257	-0.803041783411721	0.5658391555671903	8	6	fj}aB`K^Axd\URFi@tadTTVfTbeTrSN^CdlDAUSUUE@@@		eFABP`BL@									3
<dqyudjyn_XCDnvnhYEJmkoGmTu9!FHBlSHm1dGNKlO41A@4064F0F810P2!14D250202$13081c!	CHEMBL2159729	fbmQC@EV|BPQHXdLbdLTRRLRfTm^BgMTDFSUTTatC@@	N#Cc1ccc(C2=NO[C@H]3CCC[C@@H]23)cc1C(F)(F)F	6.21	group3-int	int	Androgen Receptor	Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay	2012	fgA@@@DjYVW^ZDhujjjjjh@@	fgAa@@H@rQJIIPiXIpQkTuT@EBDHb@@	280.248	3.9364	3	0	45.38	2	-1.6614256238753868	-0.11668321638375331	0.7002456284047667	8	2	flua@`CN@xbdIRBiCHhhdiMXeLf\]zJXBBjZjbdVgh@	eMbA@Dg`@										2
<dqyudjyn_XCDnvnhYEJmkoGmTu9!FHBlSHm1dGNKlO41A@4064F0F810P2!14D250202$13081c!	CHEMBL2159730	fbmQC@EV|BPQHXdLbdLTRRLRfTm^BgMTDFSUTTarB`@	N#Cc1ccc(C2=NO[C@@H]3CCC[C@H]23)cc1C(F)(F)F	6.65	group3-int	int	Androgen Receptor	Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay	2012	fgA@@@DjYVW^ZDhujjjjjh@@	fgAa@@H@rQJIIPiXIpQkTuT@EBDPd@@	280.248	3.9364	3	0	45.38	2	-1.6614256238753868	-0.11668321638375331	0.7002456284047667	8	2	flua@`CN@xbdIRBiCHhhdiMXeLf\]zJXBBjZjbdVWd@	eMbA@Dg`@										2
<dqyudjyn_XCDnvnhYEJmkoGmTv9!FHBlSHm1dGOMlN41A@4064FWF890HH1014D21VH0205F013FB1c!	CHEMBL2159731	fbmQC@EQ\BPQHXdLbdLTRbRTvTcN|gMTDCEUtT@@	N#Cc1ccc(C2=NOC3CCCC23)c(C(F)(F)F)c1	6.35	group3-int	int	Androgen Receptor	Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay	2012	fgA@@@DjYVW^ZDhujjjjjh@@	fgAa@@H@rQJIIPiXIpQkTuT@E@@@	280.248	3.9364	3	0	45.38	2	-1.6614256238753868	-0.11668321638375331	0.7002456284047667	8	4	flua@`CN@xrdERFiCHhdieHiULjL]zJX@JjZjb`@@	eMbA@Dg`@										3
<fqyvdjyn_XEDnvnhYUJmkoGmTu9!FHglKmm3dGOMtt41A@4464F1F890PIFV14D2_V682!F013!38!	CHEMBL2159732	fj}QcBNNUhHIADabPyNnrJPqQJIVISJQ`qrVjBAbZjbd^dX@	O=[N+]([O-])c1ccc(C2=NO[C@H]3CCC[C@@H]23)cc1C(F)(F)F	5.6	group4-ia	ia	Androgen Receptor	Displacement of [3H]R1881 from wild type human androgen receptor expressed in COS-1 cells co-transfected with pSG5 after 15 mins by scintillation assay	2012	fgA@@@DjYVW^ZDhujjjjjh@@	fgAa@@H@rQJIIPiXIpQkTuT@EBDHb@@	300.235	3.1792	5	0	67.41	3	-0.5180986835359394	0.5468640905469855	0.9884608872822798	8	2	flua@`CN@xbdIRBiCHhhdiMXeLf\]zJXBBjZjbdVgh@	gChhhE`BRnRYh@										2
<jztzfyiy5rzyURvhXUnujgNpfnhI4Mmxr8v2nSlSDblYDQfY5aqUdkY81UuFcSdD0rsLKB25JRZrJBY8G0	CHEMBL216272	edZTJL@IGjAJ`XPIABPpdLbdLfbrdTTJTRfTreaPwVrqstMUTuU@@PEELpU@QP@@	Cc1noc(=O)c2ccc(NC(=O)C(O)(CC(C)(C)c3cccc4c3OCC4)C(F)(F)F)cc12	6.2	group3-int	int	Androgen Receptor	Binding affinity to human recombinant androgen receptor expressed in baculovirus infected Sf9 cells	2010	few@@@LdbbbRnTVRbbTSEBdwhyuUUUUUUUUT@@	fewPP@BZ@bqTfVU}[UfUj\dih~sZ`PJZhHHhH@@	476.45	5.3833	7	2	97.22	6	2.302997288041815	-1.3614454246234766	-0.5522515590085971	1	1	edZTJL@IGjAJ`XPIABPpdLbdLfbrdTTJTRfTreaPwVrqstMUTuU@@PEELpU@QP@@											1
;OvOvGKFpk24@EFF2F288H460FWV0880D4!V1&2#F%8F4224$41HW04%106!281F	CHEMBL216949	fasQC@E^lBPQHXdLbdLTRbVQbRRTeF]U@@AEUUP@@@	CCCCN(CCCC)c1ccc2nc(O)cc(C(F)(F)F)c2c1	7.53	group2-a	a	Androgen Receptor	Antagonist activity against human androgen receptor in CV1 cells measured as inhibition of DHT-stimulated luciferase reporter gene activity by cotransfection assay	2006	det@@DjYUX^fjjj`@	dev@@@rQQJHtpr@@@@@@	340.388	5.3562	3	1	36.36	8	-0.3292890094884957	-1.998194875987893	-0.14643728576986198	5	5	f`qa@`A^@xfdKRCiAIe[YzZLej@@BJh@@@	def@`@p@Ri]Vjjh@@										5
qHuF2F91!1k!25FF2!80H040F&24!V,F&F#4$402W04%106!281F	CHEMBL217168	fdyQC@E^lBPQHXdLbdLTRbVQdeF]U@@AEP@@@	CN(C)c1ccc2nc(O)cc(C(F)(F)F)c2c1	7.47	group2-a	a	Androgen Receptor	Antagonist activity against human androgen receptor in CV1 cells measured as inhibition of DHT-stimulated luciferase reporter gene activity by cotransfection assay	2006	det@@DjYUX^fjjj`@	dev@@@rQQJHtpr@@@@@@	256.226	2.726	3	1	36.36	2	-1.599972145261371	0.6199873241318573	-0.45527400305729926	5	5	f`qa@`A^@xfdKRCiAIe[YzZLej@@BJh@@@	gChHA`BOT@@										5
yTuI2G9G0F4kVF34FF2!80H040F1#V024!VV%F,F#4$402W04(6!X8GF	CHEMBL217428	fleQC@E^lBPQHXdLbdLTRbVQTdhsjh@@Hj`@@	CC(C)Nc1ccc2nc(O)cc(C(F)(F)F)c2c1	7.78	group2-a	a	Androgen Receptor	Antagonist activity against human androgen receptor in CV1 cells measured as inhibition of DHT-stimulated luciferase reporter gene activity by cotransfection assay	2006	det@@DjYUX^fjjj`@	dev@@@rQQJHtpr@@@@@@	270.253	3.2422	3	2	45.15	3	-0.9743929947611814	0.18743387013931956	-1.4677455765012792	5	5	f`qa@`A^@xfdKRCiAIe[YzZLej@@BJh@@@	gJXH@`AJZj@@										5
;vzvOzfJbwYLQzUwQVm9vTiB8p1mC7Z7jKDDYYIQkR8k7eDGqbph0CBg@YkEVX1s5tXYHbGW4k1OFr0c2c10	CHEMBL2177238	fcoqc@EFCzNpRBICDadTabbRQbbfttrVehJYkj``rifj@BH`e@@	CN1C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)[C@@]1(C)c1ccc(O)cc1	8.02	group1-p	p	Androgen Receptor	Binding affinity to androgen receptor by competitive binding assay	2012	flu@@@LdbbRbbsbRxXRhijjjjjjj@@	fluP`@DXAIIfVU^]zLMzJVj`X@@H@@@	389.332	3.1323	6	1	84.64	3	0.7513080059937904	0.4780194479568474	0.18050265783977792	29	1	fcoqc@EFCzNpRBICDadTabbRQbbfttrVehJYkj``rifj@BH`e@@											1
=jzSzyozSGEqiEsSVNLQpxNVOf4Y0HGXU8DJOcq9q434Fe98fVFLk1Vh1Gm2c199c4sK4221Z8L2C0V0F0	CHEMBL2181926	fcoaP@L`yUh|bbbTRtlTTTTRekNRuGKPLDULuMMTTCP@	CCOC(=O)C1=C(C)NC(C)=C(C(C)=O)[C@H]1c1cccc2c(=O)cc(C)oc12	5.35	group4-ia	ia	Androgen Receptor	Antagonist activity against androgen receptor expressed in CHOK1 cells after 10 to 30 mins by luciferase reporter gene assay	2012	fhy@@@LdbbbTRaUyhQoAjjjjjj`@@	fhy``@@`ydTTRbLLRSNRUxKPLATmD@@	381.427	3.5504	6	1	81.7	5	0.9597948027264044	-0.00721960343058331	0.21440462694887918	1	1	fcoaP@L`yUh|bbbTRtlTTTTRekNRuGKPLDULuMMTTCP@											1
:UfvvzgrSwzvwdNEj8sEd7hqQKQcV41jnG2A20gNBrRZ9LAFqc8uV0JJ2485GHfV1!18FGV!2N!881W0kV	CHEMBL218490	flePS@KA`aw`AE@`pQddabbTNTboMRTmSUUKUJBKR@@	CCN[C@H]1C[C@H](C)S(=O)(=O)c2sc(S(N)(=O)=O)cc21	7.19	group2-a	a	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	dmL@@LddTQbxYVjjjh@@	dmLDPHP@b`cIICDeNTYViji@@	324.445	0.2792	6	2	151.33	3	1.8925559316161384	2.9090849786218675	-0.8581065252784146	1	1	flePS@KA`aw`AE@`pQddabbTNTboMRTmSUUKUJBKR@@											1
zqQlPWOK8F5s0FACRN0G0N@m!F0939802I258V82QV86OWV02GVC25J1!V0@VFW912XV84V!6#J!WcFV	CHEMBL2203836	ff}pc@L^kA@@cTaZPrRPiSIQ[QQHjMGJuPAESUX`@@	CCS(=O)(=O)Nc1cc(F)c(-c2ccc(C#N)n2C)c(F)c1	7	group2-a	a	Androgen Receptor	Antagonist activity at androgen receptor by cellular reporter gene assay	2012	dmL@@DjYU^TYjjjj@@	dmN@@@rQQJEHjeZe@B@@	325.338	1.902	5	1	83.27	3	0.20536476039143667	1.324020367440178	-0.0232424186422915	36	26	fdyPB`IQ@D||]HIhFscdTTRbbrbnXIwhBHfjkD@@	eFBH@c@@	eFABP`BL@	eFABP`BL@		gNxdMD@b`FRREKU@@						24
?yzU:OwxYhMzPCjz9IOaYqR0OPc_Qsk10ZHdZkJ8SN4F4GF#94V2#3#8F08+2010	CHEMBL223355	en]XL@@G`AklbbRfbTrRTrbRNRTtVbRhXTt|bJZiYZjjjjjjjjfj@BjNBHpaEiGIDbd@@	CN(Cc1ccccc1)C(=O)CCCCCCCC1C[C@H]2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12	5.8	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor expressed in HeLa cells assessed as inhibition of dihydrotestosterone-induced transcriptional activity by reporter gene assay	2007	el^P@@@LdbbbbbrRVNRrRbrbRXTDL\|braQjjjjjjjjjjjjj@@@	el^XD@@M`ElbbRfRbRRfRQRRfRbRhXdT\BrJaQZjjjjjjjfh@JhHH`bTed@@	535.81	7.4128	4	1	57.61	10	1.506721319699954	-3.9241243151232643	0.38069368955590577	1	1	en]XL@@G`AklbbRfbTrRTrbRNRTtVbRhXTt|bJZiYZjjjjjjjjfj@BjNBHpaEiGIDbd@@											1
;j;irUzjQwxdh7zPEbx9MQaYmR0OPcZQsm11Z29Zk48SN4F4FF0V09402#2#NF08+2010	CHEMBL223813	eb^XL@@G`AklbbRfbTrRTrbRNRTtVUCBfgdQSSUUUUUUUUTuUUWCBDRbtcdbQR@@	CCCCN(C)C(=O)CCCCCCC[C@@H]1CC2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@@H]21	6.55	group3-int	int	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells	2007	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmUUUUUUXDePt@@	501.793	7.3098	4	1	57.61	11	1.4909649132213232	-3.856884318691882	0.35028960120112795	50	9	ffs@b@Bu@xyEEDhheDhdbV\d{tTyjjjjjjijfHQIR\Tey@@	f`~aB@D@|@ILrzkjuUUUT@@										9
:pjxyqerEuAQcpVZ3z@CbpWvIZXHR0GFc0Skl18Z09ZFC8RN4060F#1&20V08F4$2&2810	CHEMBL224015	ee[PLF@HAYP@aRPtdGICrPBdLdfRRRdQdURRbbTTRbTRQJvurNMKOKUUUUUUUUUUUUTuWETZPtffrnVJ@@	C[C@]12CCC(=O)CC1C[C@@H](CCCCCCCCC[S+]([O-])CCCC(F)(F)C(F)(F)F)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12	5.54	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor expressed in HeLa cells assessed as inhibition of dihydrotestosterone-induced transcriptional activity by reporter gene assay	2007	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmUUUUUUXDePt@@	624.837	8.3404	3	1	73.58	15	2.7366637950843193	-5.419717371833992	0.614660791192331	50	9	ffs@b@Bu@xyEEDhheDhdbV\d{tTyjjjjjjijfHQIR\Tey@@	ffuAC`H@BERFiAtazPCHU@LdfRRRdQdURSUUUUUUP@@										9
;j;irUyEQwpcg7zPEbp9IIZYmR0GPcVQkm10Z09Zk48SN4040F0V094%2#NF08+X0G0	CHEMBL224047	ejQXL@@G`AklbbRfbTrRTrbRNRTrRRhXTt|bJZZjjjjjjjjfjjjnBHpaEiGIDbd@@	CCCCCCNC(=O)CCCCCCCC1C[C@H]2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12	5.18	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor expressed in HeLa cells assessed as inhibition of dihydrotestosterone-induced transcriptional activity by reporter gene assay	2007	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmUUUUUUDIAITM@@	515.82	7.9521	4	2	66.4	13	2.2691483167018998	-4.486066346606085	-0.6354176845213582	50	19	ffs@b@Bu@xyEEDhheDhdbV\d{tTyjjjjjjijnHQIRLWEI^P@	fhaaB@D@B@ILjjjkmUUUUP@@										19
=QUvUrblbPvUmf7nmtfL6ZJFCntTWLua7BXYYAkODFIXBHOX1ExLt0cOORlIk90Q0bVLFWeSKG471JV8F0	CHEMBL224263	fi{Pa`E^lDD`bPqHMdNr@yCHiCEDheeeDdYIJLzNZjPhDjjjhhQ`@	C[C@@H]1COc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc2N1CC(F)(F)F	7.16	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor in CV1 cells by transcriptional activation assay	2008	foQ@@@DjYUU}`nRlzjjjjj`@@	foQP`@DFAiIe[UUhrRkNZd@JjH@@	366.26	2.5117	4	1	41.57	3	-0.5233056134158127	0.37901831579845235	-0.14741787267293716	38	9	fj}Pb`DVXTGbQqcHIdLrBSL}jkORsbmNCUT@EMULP@@	gGPBAHJPtaPCHiCUP@	eFBH@c@@									8
:pjxyqerEuAQcpVZ3z@CbpWvIZXHR0GFc0Skl18Z09ZFC8RN4060F#1&20V08F4$2&2810	CHEMBL224278	egXpLF@HC[P@aRPtdGICrPBdLdfRRRdQdURRRRbbTTRbTRQKwtKOLjnkUUUUUUUUUUUUUUMUqMEd]Ki|hUr`@	C[C@]12CCC(=O)CC1C[C@@H](CCCCCCCCCCCCC[S+]([O-])CCCC(F)(F)C(F)(F)F)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12	5	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor expressed in HeLa cells assessed as inhibition of dihydrotestosterone-induced transcriptional activity by reporter gene assay	2007	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmUUUUUUXDePt@@	680.944	10.158	3	1	73.58	19	3.5807631236812076	-7.203722224084432	0.8208845246832017	50	9	ffs@b@Bu@xyEEDhheDhdbV\d{tTyjjjjjjijfHQIR\Tey@@	fesAC`H@BERFiAtazPCHS@LdfRRRdQdURRRSUUUUUUUT@@										9
;j;irUzjOwxWh7zPCbx9IOaYmw0OPcgQsk10Z29ak48SN4F4FF#9422#20208F08+2010	CHEMBL224352	elVXL@@G`AklbbRfbTrRTrbRNRTtRhXTt|bJZZjjjjjjjjfjjk`bLHQZQrQHi@@	CCN(CC)C(=O)CCCCCCCC1C[C@H]2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12	6.52	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor expressed in HeLa cells assessed as inhibition of dihydrotestosterone-induced transcriptional activity by reporter gene assay	2007	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmUUUUUUDIAITM@@	487.766	6.8073	4	1	57.61	10	1.2822018434338713	-3.3819669035971405	0.2984825698423559	50	19	ffs@b@Bu@xyEEDhheDhdbV\d{tTyjjjjjjijnHQIRLWEI^P@	do^H`DApCHhhddTdfjjjj@@										19
;j;irUzjtwxWh7zPCbxCIOaYmR0OucZQsk1XZ29Zk48SN4F4FN0V09402!V2#8F08#F0V$2010	CHEMBL224414	elVXL@@G`AklbbRfbTrRTrbRNRTtThXTt|bJZZjjjjjjjjfjjk`bLHQZQrQHi@@	CC(C)N(C)C(=O)CCCCCCCC1C[C@H]2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12	6.37	group3-int	int	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells	2007	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmUUUUUUDIAITM@@	487.766	6.7603	4	1	57.61	9	1.1258760622670771	-3.232889225968342	0.27213055818716714	50	19	ffs@b@Bu@xyEEDhheDhdbV\d{tTyjjjjjjijnHQIRLWEI^P@	do^H`DApCHhheLTdfjjjj@@										19
;j;ir:jUwxtj7zPEbx9MQaYmwVtPcgQum15Z2Aak48SN4F4FF#9JH2!2H0208F08!V%V02010	CHEMBL224654	ebQXB@@G`Akl\bbRfbTrRTrbRNRTtRUCBfgdQSRNKUUUUUUUUTuUUUpQFDHmHyHdT`@	C[C@]12CC[C@H]3[C@@H](C(CCCCCCCC(=O)N4CCOCC4)C[C@H]4CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O	5.89	group4-ia	ia	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells	2007	ehZP@@@LdbbbbbrRVNRrRbfRXTDL\|br~Ajjjjjjjjjjjj`@@	ehZXL@@M`E`\bbRfRbRRfRQRRfbRhXdT\BrJ~AZjjjjjjjfjjjbBHHeIY@@	501.749	5.9637	5	1	66.84	8	1.471700638253123	-2.4964873728809973	0.37692024780270994	2	1	ebQXB@@G`Akl\bbRfbTrRTrbRNRTtRUCBfgdQSRNKUUUUUUUUTuUUUpQFDHmHyHdT`@											1
;j;irUzjQwxdh7zPEbx9MQaYmw0OPcgQsm11Z29ak48SN4F4FF0V09J22#2020NF08)V02010	CHEMBL224707	ebQXL@@G`AklbbRfbTrRTrbRNRTtRUCBfgdQSRNKUUUUUUUUTuUUUpQFDHmHyHdT`@	C[C@]12CC[C@H]3[C@@H](C(CCCCCCCC(=O)N4CCCCC4)C[C@H]4CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O	6.31	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor expressed in HeLa cells assessed as inhibition of dihydrotestosterone-induced transcriptional activity by reporter gene assay	2007	ehZP@@@LdbbbbbrRVNRrRbfRXTDL\|br~Ajjjjjjjjjjjj`@@	ehZXD@@M`ElbbRfRbRRfRQRRfbRhXdT\BrJ~AZjjjjjjjfjjjbBHHeIY@@	499.777	7.1277	4	1	57.61	8	1.0133047895948668	-3.3774678568282406	0.2677020939377865	2	1	ebQXL@@G`AklbbRfbTrRTrbRNRTtRUCBfgdQSRNKUUUUUUUUTuUUUpQFDHmHyHdT`@											1
xvyjgzqabEuD9wpVZ7z@Cbp1IGZYmR0GHcVOkk10Z09ZF48SN4040F#1&2#8F08*120W0	CHEMBL224733	eodXL@@G`AklbbRfbTrRTrbRNRThXTt|bJZZjjjjjjjjfjnBHpaEiGIDbd@@	C[C@]12CC[C@H]3[C@@H](C(CCCCCCCC(N)=O)C[C@H]4CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O	6.35	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor expressed in HeLa cells assessed as inhibition of dihydrotestosterone-induced transcriptional activity by reporter gene assay	2007	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmUUUUUUDIAITM@@	431.658	5.3767	4	2	80.39	8	1.3794366257033086	-1.9190314297921072	-0.8822513240428631	50	19	ffs@b@Bu@xyEEDhheDhdbV\d{tTyjjjjjjijnHQIRLWEI^P@	dmVH`DAPAImUUjjj@@										19
;j;irUyEQwpcg7zPCbp9IGZYmR0GPcVQkm10Z09Zk48SN4040F0V094%2#NF08+X0G0	CHEMBL224734	edZXL@@G`AklbbRfbTrRTrbRNRTrUCBfgdQSSUUUUUUUUTuUUpQFDHmHyHdT`@	CCCNC(=O)CCCCCCCC1C[C@H]2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12	5.8	group4-ia	ia	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells	2007	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmUUUUUUDIAITM@@	473.739	6.5889	4	2	66.4	10	1.6360698603954906	-3.1480602214353772	-0.7900867124501127	50	19	ffs@b@Bu@xyEEDhheDhdbV\d{tTyjjjjjjijnHQIRLWEI^P@	dgnH`DBpAIeU]Ujjjj@@										19
:pjxyqerEuAQcpVZ3z@CbpWvIZXHR0GFc0Skl18Z09ZFC8RN4060F#1&20V08F4$2&2810	CHEMBL224736	efYPLF@HBZP@aRPtdGICrPBdLdfRRRdQdUbbTTRbTRQKWTswtJNKUUUUUUUUUUUSU\QQIERj]JY_H@	C[C@]12CCC(=O)CC1C[C@@H](CCCCC[S+]([O-])CCCC(F)(F)C(F)(F)F)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12	5.17	group4-ia	ia	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells	2007	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmUUUUUUXDePt@@	568.729	6.5228	3	1	73.58	11	1.8925593012950186	-3.635709184835523	0.408435453269751	50	9	ffs@b@Bu@xyEEDhheDhdbV\d{tTyjjjjjjijfHQIR\Tey@@	fdqAC`H@BERFiAtazPCHQ@LdfRRRdQdSUUUUU@@@										9
;j;irUzjQwxdh7zPEbx9MQaYmR0OPcZQsm11Z29Zk48SN4F4FF0V09402#2#NF08+2010	CHEMBL224770	eb^XL@@G`AklbbRfbTrRTrbRNRTtVUCBfgdQSSUUUUUUUUTuUUWADXPbtcdbQR@@	CCCCN(C)C(=O)CCCCCCCC1C[C@H]2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12	6.55	group3-int	int	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells	2007	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmUUUUUUDIAITM@@	501.793	7.3098	4	1	57.61	11	1.4909649132213232	-3.856884318691882	0.35028960120112795	50	19	ffs@b@Bu@xyEEDhheDhdbV\d{tTyjjjjjjijnHQIRLWEI^P@	f`~aB@D@|@ILrzkjuUUUT@@										19
;j;irUzjQwxdh7zPEbx9MQaYmR0OPcZQsm11Z29Zk48SN4F4FF0V09402#2#NF08+2010	CHEMBL224779	efYXL@@@PAolbbRfbTrRTrbRNRRTtVUCBfgdQSSUUUUUUUUUSUUU\LHQJKRNRIEH@	CCCCN(C)C(=O)CCCCCCCCC[C@@H]1CC2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@@H]21	5.75	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor expressed in HeLa cells assessed as inhibition of dihydrotestosterone-induced transcriptional activity by reporter gene assay	2007	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmUUUUUUXDePt@@	529.846	8.2186	4	1	57.61	13	1.9130120061412723	-4.748884934118113	0.4534006644881999	50	9	ffs@b@Bu@xyEEDhheDhdbV\d{tTyjjjjjjijfHQIR\Tey@@	fdqaB@D@b@ILrzkjkUUUUU@@@										9
;jj:ibEvj9wpWh7z@Cbp9IOaYmR0GHcZOsk10Z29Zk48SN4F4FF#1!2#2#8F08+2010	CHEMBL225147	e`\XL@@K`AclbbRfbTrRTrbRNRfeCBfgdQSSUUUUUUUUSUU\DQaBKRNRIEH@	CN(C)C(=O)CCCCCCC1C[C@H]2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12	6.96	group3-int	int	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells	2007	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmUUUUUUDIAITM@@	445.685	5.5403	4	1	57.61	7	0.6445971527496938	-2.101790971973073	0.14431488172618173	50	19	ffs@b@Bu@xyEEDhheDhdbV\d{tTyjjjjjjijnHQIRLWEI^P@	dcvH`DCPCHhhbdduUUP@@										19
<EUtn9yEkZqEUHc2_XU3H6ZGHd3d20MqZbBmk3ClO6HGe5HOX16KLt0c9QRlIkC0@0bV60WeBKGZ71FV8F0	CHEMBL227463	ffcPc@E^lDD`bPqHYEHXheDllhbiJLzNZjPhDjjhhYh@@	CCC1CN(C)c2cc3c(C(F)(F)F)cc(=O)[nH]c3cc2O1	7.17	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells by transcriptional activation assay	2007	foQ@@@DjYUU}`nRlzjjjjj`@@	foQP`@DFAiIe[UUhrRkNZd@JjH@@	312.29	2.0755	4	1	41.57	2	-0.9455352559129879	0.9622005543537092	-0.26460488886332845	38	9	fnsPb`D^XtGbQqsHEdJrBSLwZzl}KAFlEMUTDASUSECA@@	eFBH@c@@										1
JNsH42018&4F801VN0H%22202H058!10F06$2%2V#1#83028402)502010	CHEMBL2297673	fleAb@AR|BHrJIJYPiQQZcHi`@ifB@@DEP	O=C(/C=C/c1ccccc1O)c1cc(Cl)ccc1O	5.43	group4-ia	ia	Androgen Receptor	Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced cell growth treated for every 2 days for 4 days by hemocytometry	2018	f`q@@@DjYW~UyIwjjjjjj@@	f`qA@@@ILrj}jISoM@a@@@BEH	274.702	3.2184	3	2	57.53	3	-0.7507260739970648	0.276052611741383	-1.4290365153289306	17	17	fjm@``MQ@Dr`_NN_EIfU_nYnYqIXBAi`bH@DNP		eFABH`BL@	eFJB@Hp@								12
LNsH42818V$24F801VN0H%2320HHV58!30F16$20V02G2W#9#830284020V!4#502010	CHEMBL2297680	ff}@R@ARbTDQdTRTraRbRfVhpJX@JY`BJ`AAT@	COc1ccc(/C=C/C(=O)c2cc(Cl)ccc2O)cc1OC	5.28	group4-ia	ia	Androgen Receptor	Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay	2018	f`q@@@DjYW~UyIwjjjjjj@@	f`qA@@@ILrj}jISoM@a@@@BEH	318.755	3.4241	4	1	55.76	5	-0.2711006233357056	-0.13086721919919356	-0.13249790386703478	17	17	fncA``BVr@Ie@q\Z~NQQQQJZjZJJZLTUlDEPsADP@HJ`		eFABH`BL@		eMJA@Hz@							2
xvojgyqXbEue9cxVVAz@Cj_1rOoXPw0GFsFOst12g8tZJ4@RNo@C0k0FF!80F252#8N4(8#2010	CHEMBL2311179	fb}@`@@YRYVum[ehrRkNBeijZjjjjbJahyAP@	C[C@]12CCC3=C4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@H]2O	9.7	group1-p	p	Androgen Receptor	Inhibition of human androgen receptor expressed in Escherichia coli	2004	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmMSUUUUHUCP@	272.387	3.2311	2	1	37.3	0	-2.0853766871198283	0.3841073523691821	-0.5644157137740736	50	1	fb}@`@@YRYVum[ehrRkNBeijZjjjjbJahyAP@											1
vxUlnVzStF4C302DDC8WXN0d!F0C1!46FV53X8!F0a!V0e508!48FV115Y!1124!48$2$V0FV	CHEMBL2316535	fluPB@LD@DYHhddddeBdsakQSSUPP@@@@@	c1ccc(CCCSc2nc3ccccc3[nH]2)cc1	4.92	group4-ia	ia	Androgen Receptor	Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay	2013	flu@@@DjU_VUUirshijjjjjjj@@	fluPB@LD@DYHhddddeBdsakQSSUPP@@@@@	268.383	4.3718	2	1	53.98	5	-1.0991688144242973	-0.7685421414167657	-0.39206648545429884	23	1	fluPB@LD@DYHhddddeBdsakQSSUPP@@@@@											1
vxUlnVOSdF4B302DBB8WXN0cV0F091!46FV52V8!F06!V0Y508V048FV015W!112#49$2$V0FV	CHEMBL2316538	fdePB@LD@DYHhdddhddV\lxLZZj@@@@@@	c1ccc(CCSc2nc3ccccc3[nH]2)cc1	5.13	group4-ia	ia	Androgen Receptor	Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay	2013	fde@@@DjU_YUVgCVCFjjjjjj`@@	fdePB@LD@DYHhdddhddV\lxLZZj@@@@@@	254.356	3.9174	2	1	53.98	4	-1.3101949322627668	-0.32254002300466156	-0.4436228205561981	1	1	fdePB@LD@DYHhdddhddV\lxLZZj@@@@@@											1
zpzpnVUStk4C702DDC8W2N0d!F0C30246FV53XB!20a!V0X5080F68FV115W!1124!4802142!40V0FV	CHEMBL2316539	fbmQB@LDD@HrQQIIIIJFILxZr\tuTD@D@@@@	Cc1ccccc1OCCSc1nc2ccccc2[nH]1	4.72	group4-ia	ia	Androgen Receptor	Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay	2013	flu@@@DjU_VUUirshijjjjjjj@@	fluQB@LDD@HrQQIIIIJEIgCVbffj``@@@@@	284.382	3.8381	3	1	63.21	5	-0.5965600379603399	-0.3184820778052897	-0.25648233956864336	23	20	fnsQ@`G^d@IIxfBHnJSL}zkKNkNASUlDAUTuP@@@@											1
zpzpnVUStk4C702DDC8W2N0v!F0C10246FV53XB1020a01V0X5V80F48FV195W!1124!4802!2$V0FV	CHEMBL2316540	fbmQB@LDD@HrQQIIIIJEJLxZtTtuTD@@P@@@	Cc1cccc(OCCSc2nc3ccccc3[nH]2)c1	5.48	group4-ia	ia	Androgen Receptor	Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB assessed as reduction in PSA level after 3 days	2013	flu@@@DjU_VUUirshijjjjjjj@@	fluQB@LDD@HrQQIIIIJEIgCVbffj``@@@@@	284.382	3.8381	3	1	63.21	5	-0.5965600379603399	-0.3184820778052897	-0.25648233956864336	23	20	ffcQ@`KND@IIxzB@nJSL~jllzlyzIZpPEUMT@@@@@		eFBH@c@@									17
zpzpnVUStk4C702DTC8W2N0d!F0C19246FV53XB2120a!V0X5080F48FV115W!9124!48V2!201!V0FV	CHEMBL2316541	fbmQB@LDD@HrQQIIIIJEKLxZtTtuTD@@P@@@	Cc1ccc(OCCSc2nc3ccccc3[nH]2)cc1	5.16	group4-ia	ia	Androgen Receptor	Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay	2013	flu@@@DjU_VUUirshijjjjjjj@@	fluQB@LDD@HrQQIIIIJEIgCVbffj``@@@@@	284.382	3.8381	3	1	63.21	5	-0.5965600379603399	-0.3184820778052897	-0.25648233956864336	23	20	ffcQ@`KND@IIxzB@nJSL~jllzlyzIZpPEUMT@@@@@			eFBH@c@@								17
zpzpnVUStk4C702DDC8W2N0v!F0C30246FV53XB1020a!V0X5080F68FV115W!1124084802142!40V0FV	CHEMBL2316542	fj}QB@LDD@HrQQIIIIJFJIgCVRVfj``@b@@@@	Cc1cccc(C)c1OCCSc1nc2ccccc2[nH]1	5.17	group4-ia	ia	Androgen Receptor	Inhibition of BF3 site of androgen receptor in enzalutamide-resistant human LNCAP cells assessed as reduction in PSA level after 3 days	2013	flu@@@DjU_VUUirshijjjjjjj@@	fluQB@LDD@HrQQIIIIJEIgCVbffj``@@@@@	298.409	4.182	3	1	63.21	5	-0.5388719181109446	-0.5772336883880731	-0.23160891828096114	23	20	fakQ@`OAT@IIxvBDnNQQQZIEIJIQYIgHy[vB@jjfj@@@@@											1
zpzpnVUSlk4C702DDC8W2N0v!F0C12246FV53XB!20a01V0X5V80F48FV195W!3124!4802!2$V0FV	CHEMBL2316543	fbmQA@CVXBHTDILk^kJjtx{r\pAETu@@@@@	Clc1cccc(OCCSc2nc3ccccc3[nH]2)c1	5.3	group4-ia	ia	Androgen Receptor	Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay	2013	flu@@@DjU_VUUirshijjjjjjj@@	fluQB@LDD@HrQQIIIIJEIgCVbffj``@@@@@	304.8	4.1002	3	1	63.21	5	-0.5013670583558557	-0.5517595363294894	-0.22151894988804466	23	20	ffcQ@`KND@IIxzB@nJSL~jllzlyzIZpPEUMT@@@@@		eFABH`BL@									17
zpzpnVUSlk4C702DTC8W2N0d!F0C1@246FV53XB2120a!V0X5080F48FV115W!A124!4802!201!V0FV	CHEMBL2316544	fbmQA@CVxBHTDILkjkJjtX{r\p@UTu@@@@@	Clc1ccc(OCCSc2nc3ccccc3[nH]2)cc1	5.4	group4-ia	ia	Androgen Receptor	Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay	2013	flu@@@DjU_VUUirshijjjjjjj@@	fluQB@LDD@HrQQIIIIJEIgCVbffj``@@@@@	304.8	4.1002	3	1	63.21	5	-0.5013670583558557	-0.5517595363294894	-0.22151894988804466	23	20	ffcQ@`KND@IIxzB@nJSL~jllzlyzIZpPEUMT@@@@@			eFABH`BL@								17
zpzpnVUSlk4S702DTS8W2N0d!F0C18246FV53XB2120a8VV0X50B2F48FV115WFV9124!4c02!20101W0kV	CHEMBL2316545	fnsqa@L^CAB`AE`cIIKDeddeDddaRbfkUh@JjZ`@@@@	NS(=O)(=O)c1ccc(OCCSc2nc3ccccc3[nH]2)cc1	4.21	group4-ia	ia	Androgen Receptor	Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay	2013	flu@@@DjU_VUUirshijjjjjjj@@	fluQB@LDD@HrQQIIIIJEIgCVbffj``@@@@@	349.434	2.2582	6	2	131.75	6	2.0917294839345306	1.1206507153810574	-0.7781922787449007	23	20	ffcQ@`KND@IIxzB@nJSL~jllzlyzIZpPEUMT@@@@@			gJXdMD@``D^m@@								17
zpzpnVUStk4C702D@C8W2N09!F0C30246FV53XB!20a$V4080F480V115W!1124!4!2(V0FV	CHEMBL2316546	fluaB@LB@DYHhddddeBdsakQSTuPP@@@@@	c1ccc(OCCSc2cc3ccccc3[nH]2)cc1	5.27	group4-ia	ia	Androgen Receptor	Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay	2013	flu@@@DjU_VUUirshijjjjjjj@@	fluaB@LB@DYHhddddeBdsakQSTuPP@@@@@	269.367	3.7893	2	1	50.32	5	-1.125446771373438	-0.44886899122937934	-0.40279923927464556	23	2	fluaB@LB@DYHhddddeBdsakQSTuPP@@@@@											1
zpzpnVUStk4S702D@S8W2N0v!F0C3024LFV53XB1029a8V!X5V80F480V917l0V11264c4c02#4011W0kV	CHEMBL2316547	fnsQa@L\``H@bpQddebbRfJRTRTmJMUjtDDUU@@H@@	NS(=O)(=O)c1cccc2cc(SCCOc3ccccc3)[nH]c12	5.19	group4-ia	ia	Androgen Receptor	Inhibition of BF3 site of androgen receptor in enzalutamide-resistant human LNCAP cells assessed as reduction in PSA level after 3 days	2013	flu@@@DjU_VUUirshijjjjjjj@@	fluaB@LB@DYHhddddeBdsakQSTuPP@@@@@	348.446	2.5533	5	2	118.86	6	1.6205308815885395	0.7315123346991579	-0.8996357584057292	23	2	fnsQa@L\``H@bpQddebbRfJRTRTmJMUjtDDUU@@H@@											1
zrzxvdUUrlMhU@@EEC8WHs8d4EH4CW0646NVC3XB0820aV0V2XK0N0F48FV115W!W1AZ0X4802!3F8%V	CHEMBL2316554	fj}QB@LDd@HrQQIQIIIZEIgG^rVfjhJ@@@@@@	CCn1c(SCCOc2ccccc2)nc2ccccc21	4.92	group4-ia	ia	Androgen Receptor	Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay	2013	flu@@@DjU_VUUirshijjjjjjj@@	fluQB@LDD@HrQQIIIIJEIgCVbffj``@@@@@	298.409	3.883	3	0	52.35	6	-0.8170210159915146	-0.5840971725320667	0.8520208526779426	23	20	ffcQ@`KND@IIxzB@nJSL~jllzlyzIZpPEUMT@@@@@	eMBD@ch@										17
=xUUzprxzAQUUEB_HwPhBEm4C_xb66OVE7ehP9a0aX2VIXK0t0H48FVW15WXGd1fZ0m4@kX103F9%V	CHEMBL2316559	fmwQb@LDdFH@cIEDeDdddhiTeEV\]ylzZj`hFBBb@@@	Cc1ccc(OCCSc2nc3ccccc3n2CC(=O)OC(C)C)cc1	4.96	group4-ia	ia	Androgen Receptor	Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay	2013	flu@@@DjU_VUUirshijjjjjjj@@	fluQB@LDD@HrQQIIIIJEIgCVbffj``@@@@@	384.499	4.1441	5	0	78.65	9	1.0122571732562344	-0.9881562422711556	1.3173973864468644	23	20	ffcQ@`KND@IIxzB@nJSL~jllzlyzIZpPEUMT@@@@@	daxD`@R`AIeYjj@@		eFBH@c@@								17
zrzxvdUUzprhU@@UUEBWHs8d4EH4CWt646NVE3XC2920aV2VHXK0N0F48FV115W2Fd1AZ0X48VX103F9%V	CHEMBL2316560	fakPb@LDdD@QdbbRbRRRRaRvYqwjmijjB```H@@@	COCCn1c(SCCOc2ccc(C)cc2)nc2ccccc21	4.9	group4-ia	ia	Androgen Receptor	Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay	2013	flu@@@DjU_VUUirshijjjjjjj@@	fluQB@LDD@HrQQIIIIJEIgCVbffj``@@@@@	342.462	3.7281	4	0	61.58	8	0.13257697754863618	-0.7074327380758204	1.0879556555866463	23	20	ffcQ@`KND@IIxzB@nJSL~jllzlyzIZpPEUMT@@@@@	gJQH@PAJ^j@@		eFBH@c@@								17
=xUUzprxzAQUEEB_HwPzBEm4C_ob66OVE7ehO8a0aX3VIXKVt0H48FVW95WXGW1fZ0m4@FX103F8%V	CHEMBL2316561	fmwQb@LDdFH@cIEDeDdddhiTeEF\]ylzZj`hFBBb@@@	Cc1cccc(OCCSc2nc3ccccc3n2CC(=O)OC(C)C)c1	4.86	group4-ia	ia	Androgen Receptor	Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay	2013	flu@@@DjU_VUUirshijjjjjjj@@	fluQB@LDD@HrQQIIIIJEIgCVbffj``@@@@@	384.499	4.1441	5	0	78.65	9	1.0122571732562344	-0.9881562422711556	1.3173973864468644	23	20	ffcQ@`KND@IIxzB@nJSL~jllzlyzIZpPEUMT@@@@@	daxD`@R`AIeYjj@@	eFBH@c@@									17
zrzxzhUUzprxUAAUEEB_HsPv4Em4CWob66OVE7eCO8a0aX3VHXKVt0F48FVW95W2GW1fZ0m480X103F8%V	CHEMBL2316562	fegQb@LDdFH@cIEDeDdddhiTdhscoMGSUTE@pPQ@@@@	CCOC(=O)Cn1c(SCCOc2cccc(C)c2)nc2ccccc21	4.85	group4-ia	ia	Androgen Receptor	Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay	2013	flu@@@DjU_VUUirshijjjjjjj@@	fluQB@LDD@HrQQIIIIJEIgCVbffj``@@@@@	370.472	3.7848	5	0	78.65	9	0.9552936278223856	-0.720146985001801	1.292443709040879	23	20	ffcQ@`KND@IIxzB@nJSL~jllzlyzIZpPEUMT@@@@@	gNph@j@ILjuT@@	eFBH@c@@									17
zrzxvdUUzprhU@@UUEBWHs8v6EH4CWt646NVE3XC2920aV3XHXKVN0FB8FV195W2Fd1AZ0X48WX103F9%V	CHEMBL2316563	e`\TLH@LBI@a`@cIEDeDdddeBdhidmdqpyyUMm]SUTEAA@DAE@@@@	CCOc1cccc(OCCSc2nc3ccccc3n2CCOc2ccc(C)cc2)c1	4.64	group4-ia	ia	Androgen Receptor	Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay	2013	fc@@@DjU_YfW_VUipshyWnjjjjjjjjjj@@	fcPb@LDdD@QdbbRbRRRRaRTVVYqwjcWnfjhJBB@@@@@@	448.585	5.5819	5	0	70.81	11	1.473073547902406	-2.3892938565044535	1.46260084437725	2	2	e`\TLH@LBI@a`@cIEDeDdddeBdhidmdqpyyUMm]SUTEAA@DAE@@@@											1
zrzxvdUUzprhU@@UEEBWHs8v4EH4CWk646NVE3XC1820aV3VHXKVN0F48FV195W2FW1AZ0X480X103F8%V	CHEMBL2316564	fakPb@LDdD@QdbbRbRRRRaRtYqwjmijjB```H@@@	COCCn1c(SCCOc2cccc(C)c2)nc2ccccc21	4.62	group4-ia	ia	Androgen Receptor	Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay	2013	flu@@@DjU_VUUirshijjjjjjj@@	fluQB@LDD@HrQQIIIIJEIgCVbffj``@@@@@	342.462	3.7281	4	0	61.58	8	0.13257697754863618	-0.7074327380758204	1.0879556555866463	23	20	ffcQ@`KND@IIxzB@nJSL~jllzlyzIZpPEUMT@@@@@	gJQH@PAJ^j@@	eFBH@c@@									17
=xUUzprxzAQUUEB_HwPzBEm4Cbxb66QVEEehQ9a0aX3VIXKVt0H48FVW9CWXGd1fZ0m6@kX103F90N#V	CHEMBL2316565	fcoQb@LDdFH@cIEDeDdddhiTeEJscoMgSUTE@pPTT@@@	Cc1ccc(OCCSc2nc3ccccc3n2CC(=O)OC(C)C)cc1C	4.51	group4-ia	ia	Androgen Receptor	Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay	2013	flu@@@DjU_VUUirshijjjjjjj@@	fluQB@LDD@HrQQIIIIJEIgCVbffj``@@@@@	398.525	4.488	5	0	78.65	9	1.0699400120729068	-1.2469038316373275	1.3422691481166549	23	20	ffcQ@`KND@IIxzB@nJSL~jllzlyzIZpPEUMT@@@@@	daxD`@R`AIeYjj@@	eFBH@c@@	eFBH@c@@								17
zrzxzhUUzprxUAAUUEB_HsPd4EH4CWx766OVE7eCH9X0aX2VHXK0t0F48FVW15W2Gd1fZ0m48VX103F9%V	CHEMBL2316566	fi{Qb@LDdFH@cIEDeDdddhiTmf\]yoZZj`hFB@`@@@	COC(=O)Cn1c(SCCOc2ccc(C)cc2)nc2ccccc21	4.48	group4-ia	ia	Androgen Receptor	Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay	2013	flu@@@DjU_VUUirshijjjjjjj@@	fluQB@LDD@HrQQIIIIJEIgCVbffj``@@@@@	356.445	3.3785	5	0	78.65	8	0.7420044619328984	-0.3030601632723341	1.2411380701958523	23	20	ffcQ@`KND@IIxzB@nJSL~jllzlyzIZpPEUMT@@@@@	gGPh@j@ILkU@@		eFBH@c@@								17
zrzxvdUUzlMhU@@EEC8WHs8v4EH4CW0646NVC3XB1820aV1V2XKVN0F48FV195W!W1AZ0X4802!3F8%V	CHEMBL2316567	ffcQB@LDd@HrQQIQIIIZEJLx{vRtuUAP@A@@@@	CCn1c(SCCOc2cccc(C)c2)nc2ccccc21	4.46	group4-ia	ia	Androgen Receptor	Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay	2013	flu@@@DjU_VUUirshijjjjjjj@@	fluQB@LDD@HrQQIIIIJEIgCVbffj``@@@@@	312.436	4.2269	3	0	52.35	6	-0.7593328961421195	-0.8428487831148501	0.8768942739656248	23	20	ffcQ@`KND@IIxzB@nJSL~jllzlyzIZpPEUMT@@@@@	eMBD@ch@	eFBH@c@@									17
zrzxzhUUzprxUAAUUEB_HsPv4Em4CYxb66QVEEeCQ9a0aX3VHXKVt0F48FVW9CW2Gd1fZ0m68VX103F90N#V	CHEMBL2316568	fmwQb@LDdFH@cIEDeDdddhiTdhV\]yhzZj`hFBBJ@@@	CCOC(=O)Cn1c(SCCOc2ccc(C)c(C)c2)nc2ccccc21	4.39	group4-ia	ia	Androgen Receptor	Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay	2013	flu@@@DjU_VUUirshijjjjjjj@@	fluQB@LDD@HrQQIIIIJEIgCVbffj``@@@@@	384.499	4.1287	5	0	78.65	9	1.0129817701072037	-0.9788983089346375	1.3173171278435438	23	20	ffcQ@`KND@IIxzB@nJSL~jllzlyzIZpPEUMT@@@@@	gNph@j@ILjuT@@	eFBH@c@@	eFBH@c@@								17
zrzxncUUvk5h7@@EEC8WHs0v4BH4C10646FVC3XB1820aV1V2XKVN0F48FV195W!W1@Z0X4802!3F8%V	CHEMBL2316569	fj}QB@LDd@HrQQIQIYIPiQgKNSffjhH@@`@@@	Cc1cccc(OCCSc2nc3ccccc3n2C)c1	4.35	group4-ia	ia	Androgen Receptor	Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay	2013	flu@@@DjU_VUUirshijjjjjjj@@	fluQB@LDD@HrQQIIIIJEIgCVbffj``@@@@@	298.409	3.9709	3	0	52.35	5	-0.9796939128879522	-0.5161144847940012	0.8263718673233705	23	20	ffcQ@`KND@IIxzB@nJSL~jllzlyzIZpPEUMT@@@@@	eFBH@c@@	eFBH@c@@									17
;xzhUUzprxUAAUEEB_msPv4Em4CWob66OVE7eCO8q0aX3VHXKVt0F48FVW95W2GW1fZ0m480X103F8%V	CHEMBL2316570	fmwQb@LDdFH@cIEDeDdddhiTdiV\]yhzZj`hFBBJ@@@	CCOC(=O)Cn1c(SCCOc2cccc(CC)c2)nc2ccccc21	4.26	group4-ia	ia	Androgen Receptor	Inhibition of BF3 site of androgen receptor in human LNCAP cells expressing ARR2PB after 3 days by eGFP transcriptional assay	2013	flu@@@DjU_VUUirshijjjjjjj@@	fluQB@LDD@HrQQIIIIJEIgCVbffj``@@@@@	384.499	4.2004	5	0	78.65	10	1.1681453963716786	-1.1428244538152443	1.343797863394203	23	20	ffcQ@`KND@IIxzB@nJSL~jllzlyzIZpPEUMT@@@@@	gNph@j@ILjuT@@	eMBD@ch@									17
:xUOTsn9i7V4XDTm8n02S8HXo!Qn82022lp0203W0F8016B1Hk04FD90X!cVF08F1VG02!2551F3J42110	CHEMBL2334339	ehTPJH@Lbim`PGCIIEEDddcMMldeEMIcOGHjh@h@Hjjjjj@@@	CC[Si](CC)(c1ccc(OCC(O)CO)c(C)c1)c1ccc(OCC(O)C(C)(C)C)c(C)c1	5.17	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of transcriptional activity by luciferase and beta-galactosidase reporter gene assay	2013	dk\@@DjU^ukmNjjjj`@	dk\@`@\DifUWGUN`@@@@@	474.711	5.2	5	3	79.15	12	2.7495545546958855	-2.3578774960533133	-1.7092362749447396	60	9	fdy@@`@AHgBScGqrJJIESQISLx{tAAT@E@@@	gJPHD@IVuP@	diDD`@I@AJ^zjjh@@	gNqh@V`AJ^zj`@								9
:xUOTsn9i7V4XDTm8n02S8HXo!Qn82022lp0203W0F8016B1Hk04FD90X!cVF08F1VG02!2551F3J42110	CHEMBL2334342	ehTPJH@Lbim`PGCIIEEDddcMMldeEMIcOGHjh@h@HjjjjjACiCP@	CC[Si](CC)(c1ccc(OC[C@@H](O)CO)c(C)c1)c1ccc(OC[C@H](O)C(C)(C)C)c(C)c1	5.24	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of transcriptional activity by luciferase and beta-galactosidase reporter gene assay	2013	dk\@@DjU^ukmNjjjj`@	dk\@`@\DifUWGUN`@@@@@	474.711	5.2	5	3	79.15	12	2.7495545546958855	-2.3578774960533133	-1.7092362749447396	60	9	fdy@@`@AHgBScGqrJJIESQISLx{tAAT@E@@@	gJPHD@IVuP@	diDD`@I@AJ^zjjjLP@	gNqh@V`AJ^zjih@								9
:xUOTsn9i7V4XDTm8n02S8HXo!Qn82022lp0203W0F8016B1Hk04FD90X!cVF08F1VG02!2551F3J42110	CHEMBL2334343	ehTPJH@Lbim`PGCIIEEDddcMMldeEMIcOGHjh@h@HjjjjjACjCP@	CC[Si](CC)(c1ccc(OC[C@@H](O)CO)c(C)c1)c1ccc(OC[C@@H](O)C(C)(C)C)c(C)c1	5.08	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of transcriptional activity by luciferase and beta-galactosidase reporter gene assay	2013	dk\@@DjU^ukmNjjjj`@	dk\@`@\DifUWGUN`@@@@@	474.711	5.2	5	3	79.15	12	2.7495545546958855	-2.3578774960533133	-1.7092362749447396	60	9	fdy@@`@AHgBScGqrJJIESQISLx{tAAT@E@@@	gJPHD@IVuP@	diDD`@I@AJ^zjjjL`@	gNqh@V`AJ^zjih@								9
:xUOTsn9i7V4XDTm8n02S8HXo!Qn82022lp0203W0F8016B1Hk04FD90X!cVF08F1VG02!2551F3J42110	CHEMBL2334344	ehTPJH@Lbim`PGCIIEEDddcMMldeEMIcOGHjh@h@HjjjjjACiCH@	CC[Si](CC)(c1ccc(OC[C@H](O)CO)c(C)c1)c1ccc(OC[C@H](O)C(C)(C)C)c(C)c1	5.17	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of transcriptional activity by luciferase and beta-galactosidase reporter gene assay	2013	dk\@@DjU^ukmNjjjj`@	dk\@`@\DifUWGUN`@@@@@	474.711	5.2	5	3	79.15	12	2.7495545546958855	-2.3578774960533133	-1.7092362749447396	60	9	fdy@@`@AHgBScGqrJJIESQISLx{tAAT@E@@@	gJPHD@IVuP@	diDD`@I@AJ^zjjjLP@	gNqh@V`AJ^zjid@								9
:xUOTsn9i7V4XDTm8n02S8HXo!Qn82022lp0203W0F8016B1Hk04FD90X!cVF08F1VG02!2551F3J42110	CHEMBL2334345	ehTPJH@Lbim`PGCIIEEDddcMMldeEMIcOGHjh@h@HjjjjjACjCH@	CC[Si](CC)(c1ccc(OC[C@@H](O)C(C)(C)C)c(C)c1)c1ccc(OC[C@H](O)CO)c(C)c1	5.13	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of transcriptional activity by luciferase and beta-galactosidase reporter gene assay	2013	dk\@@DjU^ukmNjjjj`@	dk\@`@\DifUWGUN`@@@@@	474.711	5.2	5	3	79.15	12	2.7495545546958855	-2.3578774960533133	-1.7092362749447396	60	9	fdy@@`@AHgBScGqrJJIESQISLx{tAAT@E@@@	gJPHD@IVuP@	diDD`@I@AJ^zjjjL`@	gNqh@V`AJ^zjid@								9
:xzSysn9i7s4X@yr8m02S@HXw80OYB2022lS0203WVF!1641Hkl4FD90X!cVF0NF1cG03!2555F3J42110	CHEMBL2334724	ehTPJH@Lbim`PGCIIEEDddcMMldeEMIcOGHjh@h@HjjfjjB@Y@@	CC[Si](CC)(c1ccc(OCC(=O)C(C)(C)C)c(C)c1)c1ccc(OC[C@H](O)CO)c(C)c1	5.4	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of transcriptional activity by luciferase and beta-galactosidase reporter gene assay	2013	dk\@@DjU^ukmNjjjj`@	dk\@`@\DifUWGUN`@@@@@	472.696	5.1688	5	2	75.99	12	2.413502382686648	-2.3409517980505843	-0.6340338176785673	60	9	fdy@@`@AHgBScGqrJJIESQISLx{tAAT@E@@@	gJPHD@IVuP@	diDD`@xPCHhiEVjj@@	gNqh@V`AJ^zjid@								9
;UvUtvUTEX1azUH8HkqUdHq42XWXfN85DKY4m025GF0HG@BOFb0438866IHB20FD010X04F30c31Vb!2V10	CHEMBL2337505	ffcQB@NR\BHrJJIIFIJEQILDZqZpPYUUP@DPMP@	N#Cc1ccc(N2CCC(O)(Cc3ccccc3)C2)cc1Cl	7.23	group2-a	a	Androgen Receptor	Inhibition of Androgen receptor T877A mutant (unknown origin) expressed in Freestyle293F cells	2013	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fde`@@@ITrjrkNRtFMPTDP@P@@@	312.799	3.48	3	1	47.26	3	-1.0036735152980412	-0.08393898840922358	-0.30440249156547033	38	1	ffcQB@NR\BHrJJIIFIJEQILDZqZpPYUUP@DPMP@											1
;UQUtn9T7V0ayUH80F2S9Ha4!WXf801D0Y0X0210F02124GFZ0418820HFB!FD010V04#V31V7!2V10	CHEMBL2337506	foAQB@NR\BHrJJIIFII`cV``rjhhFh@@	N#Cc1ccc(N2CCC(O)C2)cc1Cl	7.09	group2-a	a	Androgen Receptor	Antagonist activity at wild type Androgen receptor (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay	2013	dmL@@DjYU^TYjjjj@@	dmN@@@rRJIIEneZ`hB@@	222.674	1.7401	3	1	47.26	1	-1.713499504409739	1.5378584101580497	-0.513983211863519	36	5	foAPA@NRAxn\\bbbRQbRXHuhHLjjH@@	eFJB@Hp@	eFABH`BL@									1
;UQUtn9T7k0ayUHNHkmSdHa40kWXfNB5DKY0X021FF0X12BOJb0Z18863IHB22Fi410W24K14V39Vb!2V10	CHEMBL2337507	fj}QB@NR\BHrJJIIFIJFII`cVrVBCJjh@BHFh@@	N#Cc1ccc(N2CCC(O)(c3ccccc3)C2)cc1Cl	6.42	group3-int	int	Androgen Receptor	Antagonist activity at wild type Androgen receptor (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay	2013	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhy`@@@ITrjZlyKW`uAPP@D@@@	298.772	3.3242	3	1	47.26	2	-1.22874898840143	0.1825602666350799	-0.35440271034261445	42	5	ffcQA@MUDAqSDYEDeeIdmDeBjLtZNX@Jjh@brH\H@@											2
;UQUtn9T7k0ayUHNHkmSdHa40kWXfNB5DKY0X021FF0X12BOJb4Z1886AIHB22Fi410W24K14V3OVb!2c10	CHEMBL2337508	ffcQA@NR\BHkHYEEDdcDeCDefBM[IXHLjj`@bHFh@@	N#Cc1ccc(N2CCC(O)(c3ccc(F)cc3)C2)cc1Cl	6.75	group3-int	int	Androgen Receptor	Inhibition of wild type Androgen receptor (unknown origin) expressed in Freestyle293F cells	2013	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhy`@@@ITrjZlyKW`uAPP@D@@@	316.762	3.425	3	1	47.26	2	-1.1387530961599095	0.05525198620497815	-0.3242751768726992	42	5	ffcQA@MUDAqSDYEDeeIdmDeBjLtZNX@Jjh@brH\H@@	eFABP`BL@										2
;UvUxvUT7mWqzUmsIuqSdHqJ0lYmfNg5DMY4XX63FF1mO7BOJb4gWc86EIHB22Fi4K0W24KE5sAOVb!2c10	CHEMBL2337509	fnsQA@NR|BH[HYEEDdcEDiXdlpQgEkAAeUU@ADHTcH@	C[C@@H]1N(c2ccc(C#N)c(Cl)c2)CC[C@@]1(O)c1ccc(F)cc1	8.09	group1-p	p	Androgen Receptor	Inhibition of Androgen receptor T877A mutant (unknown origin) expressed in Freestyle293F cells	2013	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhy`@@@ITrjZlyKW`uAPP@D@@@	330.789	3.7497	3	1	47.26	2	-1.0801616027927663	-0.19195752093904703	-0.29950181604858955	42	5	fnsQA@MMDAqsDYEDeeIhdXdhUQfkIK@AUUPAEdHyIP@	eFABP`BL@										3
;UzUxvUT7mWqzUmsIvqSdHqJ0lYmfNg5yMY4XX63FF1mt7BOJb4iWc86EIHB2Hsi4K0W24KE5sAOVb012VW0	CHEMBL2337510	fi{pb@NRG{hHcHhhddXheKDeeFBLxmXHLjjh@IbDJQd@	C[C@@H]1N(c2ccc(C#N)c(Cl)c2)CC[C@@]1(O)c1ccc(C(N)=O)cc1	7.77	group2-a	a	Androgen Receptor	Antagonist activity at wild type Androgen receptor (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay	2013	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhy`@@@ITrjZlyKW`uAPP@D@@@	355.824	2.7362	5	2	90.35	3	0.7166175303634745	0.7475468946037469	-1.0374334665421396	42	5	fnsQA@MMDAqsDYEDeeIhdXdhUQfkIK@AUUPAEdHyIP@	gCiHDL@ILt@@										3
=UxvUT7mWqzUmsIvqSfHqJ0lYmfNg5yMY4XX6IFF1mt7BOJb4i_s86EIHB2Hsi4K0W24KE5sAOVr!XVG0	CHEMBL2337511	fegpb@NRG{hHcHhhddXheKDeeLpQgEkAAeUU@AMDHTcH@	CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)c(Cl)c3)[C@H]2C)cc1	7.5	group2-a	a	Androgen Receptor	Inhibition of wild type Androgen receptor (unknown origin) expressed in Freestyle293F cells	2013	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhy`@@@ITrjZlyKW`uAPP@D@@@	369.851	3.0877	5	2	76.36	3	0.5489352514786774	0.3816073561800512	-1.0481309054630454	42	5	fnsQA@MMDAqsDYEDeeIhdXdhUQfkIK@AUUPAEdHyIP@	gJYHDL@ILmP@										3
=UxvUT7mWqzUnsIvLSvHqJ0lYmfNg5yMY4XX6IFF1mt7BGJb4i_s8L6IHB2Hki4K0W24KC1sAGVr!XVGF	CHEMBL2337512	fegHb@NRbOwPQFQQQIHqQJVIKJY`cNKVBCJjj@BZHPiFP@	CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)c(Cl)c3)[C@H]2C)nc1	6.92	group3-int	int	Androgen Receptor	Antagonist activity at wild type Androgen receptor (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay	2013	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyP@@@RrQQIPiZIJcIJ|DBBj`@H@@	370.839	2.1408	6	2	89.25	3	1.0508013605161817	1.1625742856163288	-0.9300842543298229	42	1	fegHb@NRbOwPQFQQQIHqQJVIKJY`cNKVBCJjj@BZHPiFP@											1
=UxvUT7mWqzUmsIvLSfHqJ0lYmfNg5yMY4XX6IFF1mt7BGJb4i_s8L6IHB2Hki4K0W24KC1sAGVr!XVGF	CHEMBL2337513	fegHb@NRrOwPQFQQQIHqQJVIKJY`cNKVBCJjj@BZHPiFP@	CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)c(Cl)c3)[C@H]2C)cn1	7	group2-a	a	Androgen Receptor	Inhibition of Androgen receptor T877A mutant (unknown origin) expressed in Freestyle293F cells	2013	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyP@@@RrQIPqIZIHeIJ|D@Jj`@H@@	370.839	2.1408	6	2	89.25	3	1.0508013605161817	1.1625742856163288	-0.9300842543298229	42	6	fnsqA@NRsxGbuqrJJIIFJIRqIY`cNKVBCJjj@BHPiFP@	gJYHDL@ILmP@	eFABH`BL@									5
=UxvUT7mWqzUnsIvLSvHqJ0lYmfNg5yMY4XX6IFF1mt7BGJb4i_s8L6IHB2Hli4K0W24KC1sAGVr!2V1F	CHEMBL2337514	fmwHb@NRrOwPQFQQQIHqQJVIKJZLDYqZpPYUUP@STPaRL`@	C[C@@H]1N(c2ccc(C#N)c(Cl)c2)CC[C@@]1(O)c1ccc(C(=O)N(C)C)nc1	5.96	group4-ia	ia	Androgen Receptor	Inhibition of wild type Androgen receptor (unknown origin) expressed in Freestyle293F cells	2013	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyP@@@RrQIPqIZIHeIJ|D@Jj`@H@@	384.866	2.4073	6	1	80.46	3	0.6946703758591231	0.8997522501875846	0.1587357493275924	42	6	fnsqA@NRsxGbuqrJJIIFJIRqIY`cNKVBCJjj@BHPiFP@	gGYHDL@ILsU@@	eFABH`BL@									5
=UxvUT7mWqzUmsIvLSfHqJ0lYmfNg5yMY4XX6IFF1mt7BGJb4i_s8L6IHB2Hki4K0W24KC1sAGVr!XVGF	CHEMBL2337515	fegHb@NRrOwPQFQQQIHqQJVIKJY`cNKVBCJjj@BZHPjF`@	CNC(=O)c1ccc([C@@]2(O)CCN(c3ccc(C#N)c(Cl)c3)[C@@H]2C)cn1	5.8	group4-ia	ia	Androgen Receptor	Inhibition of wild type Androgen receptor (unknown origin) expressed in Freestyle293F cells	2013	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyP@@@RrQIPqIZIHeIJ|D@Jj`@H@@	370.839	2.1408	6	2	89.25	3	1.0508013605161817	1.1625742856163288	-0.9300842543298229	42	6	fnsqA@NRsxGbuqrJJIIFJIRqIY`cNKVBCJjj@BHPjF`@	gJYHDL@ILmP@	eFABH`BL@									1
>xzUT7yWq;sIuLSdPrR0lYmfNg7iMb4XX63FF1mObBGJb4gWg8T6IHCXHFi5KVW24KC1sAIkb!2V1F	CHEMBL2337516	fcHb@NRrwtpQFQQQIHqQJVIKJJI`cNKU^xHLjjh@JfbIBdY@@	C[C@@H]1N(c2ccc(C#N)c(Cl)c2)CC[C@@]1(O)c1ccc(N2CCCC2=O)nc1	6.8	group3-int	int	Androgen Receptor	Antagonist activity at Androgen receptor T877A mutant (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay	2013	fnk@@@LdbbRbSTRVbRyhRoAjvjjjjjjjj`@@	fnkq@@D\|CHhheBeeDehdjLUkpZmZj@Bjh@H`@@	396.877	2.9242	6	1	80.46	3	0.7336021882987329	0.5444779557533003	0.18119347356441237	1	1	fcHb@NRrwtpQFQQQIHqQJVIKJJI`cNKU^xHLjjh@JfbIBdY@@											1
=UxvUy7mWqzUmsIvLSfHqJ0lYmdPg5yrY4XX6IFF1mt7BGJb4ipu8L6IPB2Hkg4K0W24KC1sEGVr40XVGF	CHEMBL2337517	fmwI`@DT\lFfyEDidliMDcDeLlJS`uzu@AUUPAEYBEPt@@	CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)c(OC)c3)[C@H]2C)cn1	6.92	group3-int	int	Androgen Receptor	Inhibition of wild type Androgen receptor (unknown origin) expressed in Freestyle293F cells	2013	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyP@@@RrQIPqIZIHeIJ|D@Jj`@H@@	366.42	1.4648	7	2	98.48	4	1.6111178716908001	1.6530702659235004	-0.8027320308778872	42	6	fnsqA@NRsxGbuqrJJIIFJIRqIY`cNKVBCJjj@BHPiFP@	gJYHDL@ILmP@	eMJA@Hz@									5
=UxvUT7mWqzQmkIvLCf0qJ0lYkdNg5wMX4XX6IFF1ms7BGJ74iZs8L6IH42Hkg4K0W24KC1sAGVl!XVGF	CHEMBL2337518	fi{H`@DT\LFlbbTrVTfbQbRrEIpZmZ`@jjh@KHPjF`@	CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)cc3)[C@H]2C)cn1	5.12	group4-ia	ia	Androgen Receptor	Inhibition of wild type Androgen receptor (unknown origin) expressed in Freestyle293F cells	2013	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyP@@@RrQIPqIZIHeIJ|D@Jj`@H@@	336.394	1.5348	6	2	89.25	3	0.8979203993380354	1.654602954904678	-0.9899210125969389	42	6	fnsqA@NRsxGbuqrJJIIFJIRqIY`cNKVBCJjj@BHPiFP@	gJYHDL@ILmP@										5
=UxvUT7mWqzUmsIvLSfHqJ0lYmdNg5yMY4XX6IFF1mt7BGJb4i_s8L6IHB2Hkg4K0W24KC1sAGVr!XcGF	CHEMBL2337519	fegHb@NRrOwPRFQQQIHqQJVIKJY`cNKVBCJjj@BZHPiFP@	CNC(=O)c1ccc([C@]2(O)CCN(c3ccc(C#N)c(F)c3)[C@H]2C)cn1	5.77	group4-ia	ia	Androgen Receptor	Antagonist activity at Androgen receptor T877A mutant (unknown origin) expressed in human Cos-7 cells co-expressing pGL3-MMTV-luc vector assessed as luciferase activity by reporter gene assay	2013	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyP@@@RrQIPqIZIHeIJ|D@Jj`@H@@	354.384	1.6356	6	2	89.25	3	0.9879162971884117	1.5272947461370632	-0.9597934797482779	42	6	fnsqA@NRsxGbuqrJJIIFJIRqIY`cNKVBCJjj@BHPiFP@	gJYHDL@ILmP@	eFABP`BL@									5
vrUtvtQyzJCsOmdQUO2kQ9fVa8HLBVC80PO6A8048UZu4GFeDnN3R02K0JHclFF3W120V10GF1!F20FV01c0V	CHEMBL2346967	fcxC@JLxHr]`dDRFICHiCDidiidleDeerVkQRN]TuSUUU@AZp@@	N#Cc1ccc(CN2CCN(c3ccc4nnc(C(F)(F)F)n4n3)CC2)cc1	5.82	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor-mediated cellular downregulation in human LNCAP cells assessed as decrease in nuclear receptor level after 20 to 22 hrs by laser-scanning fluorescence microplate cytometeric analysis	2013	ffs@@@LdbbRRfrQTRWERMYqZuUUUUUUUP@@	ffsX@@@PirSldTTTRcRrTRSA\eYqZsULuUP@M@@@	387.368	1.2933	7	0	73.35	4	0.7731483668895185	1.5219058358277027	1.3403257208542032	4	3	fmoX@`AV}FkPNHyB\`nPrJIKIQIYQISJFRcCVSfkX@JjjZZVjJ`@@	eMbA@Dg`@										2
vrUtvtQ:JCsOmdQUO2kQ9fVa8HLBVC80PO6A8048UZu4GFeDnN3R02K0JHclFF3W120V10GF1!F20FV0180V	CHEMBL2346968	fmoX@`AV}FkPR@yB\`nPrJIKIQIYQISJFRcCVSfkX@JjjZZVjJ`@@	Fc1ccc(CN2CCN(c3ccc4nnc(C(F)(F)F)n4n3)CC2)cc1	5.8	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor-mediated cellular downregulation in human LNCAP cells assessed as decrease in nuclear receptor level after 20 to 22 hrs by laser-scanning fluorescence microplate cytometeric analysis	2013	ffs@@@LdbbRRfrQTRWERMYqZuUUUUUUUP@@	ffsX@@@PirSldTTTRcRrTRSA\eYqZsULuUP@M@@@	380.348	1.5585	6	0	49.56	4	0.09627694861539379	1.0931567921566825	1.1810556883954504	4	3	fmoX@`AV}FkPNHyB\`nPrJIKIQIYQISJFRcCVSfkX@JjjZZVjJ`@@	eFABP`BL@										2
vrUtvtQ:JCsOmdUEO2kQOfma8HLBY480PO6A8049TZu4GGeDnO3N02K0JHclHF3W120X18GF1!F2!k0180V	CHEMBL2346969	fcXB`INBeoPRAIB\`nPwHYEEEMmDeeDeLhYFBl{IV}``bjjZZVjJ`@@	Fc1cccc(CN2CCN(c3ccc4nnc(C(F)(F)F)n4n3)CC2)c1F	5.68	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor-mediated cellular downregulation in human LNCAP cells assessed as decrease in nuclear receptor level after 20 to 22 hrs by laser-scanning fluorescence microplate cytometeric analysis	2013	ffs@@@LdbbRRfrQTRWERMYqZuUUUUUUUP@@	ffsX@@@PirSldTTTRcRrTRSA\eYqZsULuUP@M@@@	398.338	1.6593	6	0	49.56	4	0.18627300717692605	0.9658484702203807	1.211183271460259	4	3	ek`V@F@EOHlna`GDbPxdEiCZPNdLbbbtJTRVTRTradXD\|JjzF``bjjffejbh@@											1
<v<TCuOqxQUOHmqCfVqBFqcVCN8PSMfd20VEou41FeDuN3R!x0LUfIFH7W161V11GJ1!I@01V0381V	CHEMBL2346970	fmoi@`K^cUh`R@yB\`nPrJIKJSIYQISJFRcCVSfkX@JjjZZVjJ`@@	OC1(c2ccc(F)cc2)CCN(c2ccc3nnc(C(F)(F)F)n3n2)CC1	5.43	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor-mediated cellular downregulation in human LNCAP cells assessed as decrease in nuclear receptor level after 20 to 22 hrs by laser-scanning fluorescence microplate cytometeric analysis	2013	fjc@@@LdbbRRfrQbRxjQkNrVjjjjjjjh@@	fjch@@@PirVRJJJIQiYQILErUgYKMTsUT@CP@@	381.332	1.927	6	1	66.55	3	0.4749319536089097	1.099556394505718	0.1150107288532928	2	1	fmoi@`K^cUh`R@yB\`nPrJIKJSIYQISJFRcCVSfkX@JjjZZVjJ`@@											1
<v:yrTCuOqxQEOHmLCfVqBFqcV4N8PSMfd20VDou41FeDmN3N!x0LLfIFH7W161V11GJ1!H2!V0381k	CHEMBL2346971	fewYC@JLxHw\`dDRFICHiCDidiidmMDerVkQRN]TuSUUU@@l@@@	OC1(c2cccnc2)CCN(c2ccc3nnc(C(F)(F)F)n3n2)CC1	4.97	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor-mediated cellular downregulation in human LNCAP cells assessed as decrease in nuclear receptor level after 20 to 22 hrs by laser-scanning fluorescence microplate cytometeric analysis	2013	fjc@@@LdbbRRfrQbRxjQkNrVjjjjjjjh@@	fjcX@@@PirR\dTTTRcRrbRXKdkNrVZifjh@F`@@	364.33	0.8253	7	1	79.44	3	0.8893429035158105	2.0402937075889294	0.2026484270063997	2	1	fewYC@JLxHw\`dDRFICHiCDidiidmMDerVkQRN]TuSUUU@@l@@@											1
vzUtvt;KxxQydQUU@FUdfdaALMgVCB@uS6A305cUiyZG2YTrN3R02_0JL2nG0@1120V14GF1!F28NV0180V	CHEMBL2346972	fmoX@`AV}FoPR@yB\`nPRYWVUvUn^jLMYIZ}`@jjijifhj@@	Fc1ccc(CN2CCN(C3=Nn4c(nnc4C(F)(F)F)CC3)CC2)cc1	5.23	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor-mediated cellular downregulation in human LNCAP cells assessed as decrease in nuclear receptor level after 20 to 22 hrs by laser-scanning fluorescence microplate cytometeric analysis	2013	ffs@@@LdbbRRfrQTRWERMYqZuUUUUUUUP@@	ffsX@@@PirSldTTTRcRrTRSA\eYqZsULuUP@U@@@	382.364	1.7462	6	0	49.55	3	-0.06063570875866717	1.0935956032890735	1.1592186746194713	4	1	fmoX@`AV}FoPR@yB\`nPRYWVUvUn^jLMYIZ}`@jjijifhj@@											1
<vv;yCySqvQUCPkm9fcygHrdVC@BPS6A9202Eou41FeDvs3NVHx8LTfIGHIW921_10KGW20I@01V0180V	CHEMBL2346973	edV^HL@JFNACKoi`IABPpdLbdLRfRffRrbRrRTTWDfedRWPwtMTuSUUT@EUMRp`@@	Cn1nccc1CCOc1ccc(C2CCN(c3ccc4nnc(C(F)(F)F)n4n3)CC2)cc1	6.63	group3-int	int	Androgen Receptor	Inhibition of androgen receptor-mediated cellular downregulation in human LNCAP cells assessed as decrease in nuclear receptor level after 20 to 22 hrs by laser-scanning fluorescence microplate cytometeric analysis	2013	ekhP@@@LdbbRRfrQbRrRTRxTdLl\rJvNjjjjjjjjjjj@@@	ekh^H@@EKLjnmc`LdTRRVbRTJVTRTrxdl\RrFfvNhHHfjjiiiQj@@@	471.486	2.7331	8	0	73.37	7	1.8691094679592222	0.10296456874606186	1.653161183412976	1	1	edV^HL@JFNACKoi`IABPpdLbdLRfRffRrbRrRTTWDfedRWPwtMTuSUUT@EUMRp`@@											1
=v;xxvUyfQUAHkv9fVqDHqhVh@8ux6A825@Eou41FeDuN3N0Fx8TTvnFHIl921V10GFWm0G@01X0180V	CHEMBL2346974	ejY^DL@JFNACChYlPIABPpdLbdLRfRffRrbRrRTRVTxdtlbRzFAajfjZjj`@jjjfVH@@	CC(=O)N1CCN(CCOc2ccc(C3CCN(c4ccc5nnc(C(F)(F)F)n5n4)CC3)cc2)CC1	6.49	group3-int	int	Androgen Receptor	Inhibition of androgen receptor-mediated cellular downregulation in human LNCAP cells assessed as decrease in nuclear receptor level after 20 to 22 hrs by laser-scanning fluorescence microplate cytometeric analysis	2013	egdP@@@LdbbRRfrQbRrRTRWBdaecfQQuuUUUUUUUUUUT@@@	egd^H@@AHbfack`DieUyUg_YVwbQrKHjYXzz``bjjjiiiRj@@@	517.554	2.6035	9	0	79.1	7	2.454760678715145	0.17292199054567214	1.8314203594145049	3	2	ejY^DL@JFNACChYlPIABPpdLbdLRfRffRrbRrRTRVTxdtlbRzFAajfjZjj`@jjjfVH@@											1
^xvUyzQUQHmzCfVqDHqhVhP8uxMfd25eEou41FeDuN3R0Fx8TUvnFHMl961V11GJWm0I@01X0381V	CHEMBL2346975	efU^LL@JFNACKd\ebPIABPpdLbdLRfRffRttRVRRbRrgDfedRPttJMTuSUUU@AUUULlP@@	CC(=O)N1CCN(CCOc2ccc(C3(O)CCN(c4ccc5nnc(C(F)(F)F)n5n4)CC3)cc2)CC1	5.98	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor-mediated cellular downregulation in human LNCAP cells assessed as decrease in nuclear receptor level after 20 to 22 hrs by laser-scanning fluorescence microplate cytometeric analysis	2013	egdP@@@LdbbRRfrQbRrRTRWBdaecfQQuuUUUUUUUUUUT@@@	egd^H@@AHbfack`DieUyUg_YVwbQrKHjYXzz``bjjjiiiRj@@@	533.553	1.5911	10	1	99.33	7	3.432898508259422	0.9775621716825862	0.9057851723592618	3	2	efU^LL@JFNACKd\ebPIABPpdLbdLRfRffRttRVRRbRrgDfedRPttJMTuSUUU@AUUULlP@@											1
=v;xxzUyeQUEPFzdddLELphVhD@uw6A325eEyyZ12YTyN3N0Fh8TTInG2PF921k14GFWm0G@89X0180V	CHEMBL2346976	ejY^DL@JFNACChYlPIABPpdLbdLRfRffRrbRrRTRVTxdtlbRzFAajfjZjj`@jjjfZH@@	CC(=O)N1CCN(CCOc2ccc(C3CCN(C4=Nn5c(nnc5C(F)(F)F)CC4)CC3)cc2)CC1	5.75	group4-ia	ia	Androgen Receptor	Induction of androgen receptor degradation in human LNCaP cells	2020	egdP@@@LdbbRRfrQbRrRTRWBdaecfQQuuUUUUUUUUUUT@@@	egd^H@@AHbfack`DieUyUg_YVwbQrKHjYXzz``bjjjijiRj@@@	519.57	2.7912	9	0	79.09	6	2.2978478550210726	0.17336084318426342	1.8095832960436322	3	1	ejY^DL@JFNACChYlPIABPpdLbdLRfRffRrbRrRTRVTxdtlbRzFAajfjZjj`@jjjfZH@@											1
xvwjgyqabEuD9dpVZ7z@Cbp1IGZXHR0GHc0Okk50Z09ZF48RN4040F#1&2#8F)2#6030	CHEMBL235003	eodPB@@@AkglbbRfbTrRTrbRNRThXTt|bJZZjjjjjjjjfjaBHpaDhmHyHdT`@	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@H](CCCCCCCC(=O)O)C[C@H]1CC(=O)CC[C@@]13C	6.14	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HeLa cells assessed as inhibition of dihydrotestosterone induced transcriptional activity by reporter gene assay	2007	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmUUUUUUDIAITM@@	432.642	5.7745	4	2	74.6	8	1.2727764856639112	-2.2042881188934857	-0.8932970390348688	50	19	ffs@b@Bu@xyEEDhheDhdbV\d{tTyjjjjjjijnHQIRLWEI^P@	dmTD`@QPAImUUjjj@@										19
zrzxySSn@J_k2HeCHP2GFtAH04F01b8B0HuZ78X1Y1VO60YkBHNX940J10W8GDlFV9032ZV6J!4G10710X8G0	CHEMBL235126	fncPa`JERtD`bPqHVdGRGiCHiBhhdeHhxmcQKVjjBBjIiH@@	O=c1cc(O)c2cc(N(CC(F)(F)F)CC(F)(F)F)ccc2[nH]1	8.15	group1-p	p	Androgen Receptor	Antagonist activity at human AR	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	340.222	2.2425	4	2	52.57	5	0.12231975138514503	0.4625672647333357	-1.198176337434906	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	eFJB@Hp@		dcv@xJBPRPrPx@fPVPvPrJPjKRUUUT@@								37
:UvyQSnDJbkXHvCHe7nktfL04FF3r8RWLua7BXYbAkO7FQkBHOX1C4Jl0V8GRlGV90I0bV6F09RG14710V8F0	CHEMBL235128	fmgQBPE^lBPQHXdJrCYCl`NPgHKdLbdLTRbVQbbTfddhsjjPhDjjjjb@T@	C[C@H](N(CC(F)(F)F)c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1)C(F)(F)F	7.7	group2-a	a	Androgen Receptor	Antagonist activity at human AR	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	406.247	3.5465	3	1	32.34	6	-0.2790474507569696	-0.942362022088745	-0.10994535224756002	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gJPBAHJPt`PAIjj@@		dkN@xJBPRPrPD@VPvPNPrJPqSZRjjjjB`@								37
qHuF0F818V0k!24FN21080H040F0212!H408!3808*2F&2$4825020V%2080c!	CHEMBL235159	fbuaC@EIAHHdLRFQRFJIIFIKJV`qj``r@B`@@	COc1ccc(-c2ccc(C#N)c(C(F)(F)F)c2)cc1	9.1	group1-p	p	Androgen Receptor	Antagonist activity at human AR in MDA-MB453-MMTV-luci cells by functional assay	2007	dcl@@DjYU_egZjjjh@@	dcl@@DjYU_egX@@@@@@	277.244	3.9327	2	0	33.02	3	-1.962120714715071	-0.4356584823002215	0.6013837805441026	30	18	fle`B`N@BSNKoDLBeArJJIIFJJZU`oQ``rBHb@@@			gJPBAHJPt`PAIjj@@		eMJA@Hz@						17
oHuF0F018!k#4FN21080H040F0212!H408!1808*2(2$4825020V%2082c10	CHEMBL235378	fleaC@EIAHHdLRFQRFJIIFIKRtFMTDFP@P@@@	N#Cc1ccc(-c2ccc(O)cc2)cc1C(F)(F)F	7.92	group2-a	a	Androgen Receptor	Antagonist activity at human AR in MDA-MB453-MMTV-luci cells by functional assay	2007	dcl@@DjYU_egZjjjh@@	dcl@@DjYU_egX@@@@@@	263.218	3.657	2	1	44.02	2	-1.728543456519341	-0.030275174551544354	-0.5079642011546319	30	18	fle`B`N@BSNKoDLBeArJJIIFJJZU`oQ``rBHb@@@			gJPBAHJPt`PAIjj@@		eFJB@Hp@						17
kHHF0F!8!k#4FN21080H040F021#H408!18082)2(2$4@2502(2080c!	CHEMBL235379	fle`C@E@dDRFICHiCEDdcEDiZbfjBCHB@@@@	Cc1ccccc1-c1ccc(C#N)c(C(F)(F)F)c1	6.84	group3-int	int	Androgen Receptor	Displacement of [3H]DHT from human recombinant AR expressed in Sf9 cells	2007	dcl@@DjYU_egZjjjh@@	dcl@@DjYU_egX@@@@@@	261.245	4.3466	1	0	23.79	2	-2.617630000254619	-0.6928773042577697	0.43906822920149774	30	18	fle`B`N@BSNKoDLBeArJJIIFJJZU`oQ``rBHb@@@	eFBH@c@@		gJPBAHJPt`PAIjj@@								17
:xzhyyzjjyjCdzekEz@jj_1MtoXUw9IHsFSst52idOZJ4@RNw870kHFN0880F2G28!8O#VH!V2#6030	CHEMBL235445	ei[PJ@@@A`^Q\bbRfbTrRTrbRaLRVRRRThXTt|bJZ^~ZZjjjjjjh@JjijhxXPbTVd\dRJP@	C[C@]1(O)CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CCC(=O)C=C1C[C@H]3CCCCc1ccc(OCCCCCC(=O)O)cc1	6.38	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HeLa cells assessed as inhibition of dihydrotestosterone induced transcriptional activity by reporter gene assay	2007	ec`P@@@LdbbbbbrRVNRtRSB`acgdVRvuUUUUUUUUUU@@@	ec`PH@@@LbbRfRbRRfRQTRUCDbc`VQRvsSUUUUUT@ETDBJQJRr@@	564.804	7.7462	5	2	83.83	12	2.9033893821952907	-4.174409252132442	-0.4490835482908978	6	6	edVPDD@OhPODaqrJJKYIIQQJJIQJIHpl\QIESKGWOPPEUUUUMUUTeUpYKEy@hdbdl`@		dedL`@PY@DfuUZjj@@									6
kHHF0F!8!k#4FN21080H040F021#H408!1808*2(2$482502(2080c!	CHEMBL235601	fle`C@E@dDRFICHiCEDdcDeIZCFjBCH@H@@@	Cc1cccc(-c2ccc(C#N)c(C(F)(F)F)c2)c1	5.72	group4-ia	ia	Androgen Receptor	Displacement of [3H]DHT from human recombinant AR expressed in Sf9 cells	2007	dcl@@DjYU_egZjjjh@@	dcl@@DjYU_egX@@@@@@	261.245	4.3466	1	0	23.79	2	-2.617630000254619	-0.6928773042577697	0.43906822920149774	30	18	fle`B`N@BSNKoDLBeArJJIIFJJZU`oQ``rBHb@@@			gJPBAHJPt`PAIjj@@	eFBH@c@@							17
zrUtUWOMdFEw0H9EUN0l2A@c08F68Y384Ht25BH80PW@6lVV6XN0CX4J0N0d1380dY02V0V4#1F2#8#V	CHEMBL2356368	fnkPa@AF}DDQhHRYWYWf[uhqV`ijv@BejfX@H@@@	O=C1c2ccccc2C(=O)N1c1nc(-c2ccc(Cl)cc2)cs1	4.58	group4-ia	ia	Androgen Receptor	Antagonist activity at AR T877A mutant in human LNCAP cells assessed as inhibition of DHT-induced proliferation after 48 hrs by MTT assay	2017	ffs@@@LdbbRRqbbbvWEBdxIZuUUUUUUUP@@	ffsPb@LDeh@PeL|ls^jnJJLfnRtsTs@@@P@@@	340.789	4.4703	4	0	78.51	2	-0.5900778046054328	-0.2982738366567226	0.9755222766680152	14	14	fnkPa@AF}DCchHRYWYWf[uhqV`ijv@BejfX@H@@@	eFABH`BL@										6
:xzhyyrjjyiCdzekEzejj_1rtoXUw9IJsFSss52i9OZJ4@RNx870kHNN0880k2G28!8O!1VH!V$6030	CHEMBL235661	ejYPJ@@@AolR\bbRfbTrRTrbRaaRrRThXTt|bJZn^ZZjjjjjj`@jfjcaaBIQZQrQHi@@	C[C@]1(O)CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CCC(=O)C=C1C[C@H]3CCCc1ccc(OCCC(=O)O)cc1	6.77	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HeLa cells assessed as inhibition of dihydrotestosterone induced transcriptional activity by reporter gene assay	2007	fm@@@LdbbbbbrRVNRfRXhQg^cfZzjjjjjjjjjh@@	fmA@@@YEDeLeDdeLdcDeQdeNCdlumMUUUUU@AUAAJRUKP@	508.696	5.9286	5	2	83.83	8	2.0592847501302565	-2.390400665315339	-0.6553089389146429	4	4	e`RPDH@Ko`GGHhdldeEDhheDhdcCPqxDetLml]@AUUUUMUUTeUpiMEYGHDddL`@	gNqh@jpAImVj`@										3
zrUtUWOMdFEw0H9EUN0l2A@c08F68Y184Ht25BH80PW@6lVV6XN0CX4J0N0d1380dW02V0V4#1F2#8080V	CHEMBL2357456	fnkPa@LDeh@PvPrQQZIQQSYIIWEEFSWIZYjY`@@J@@@	O=C1c2ccccc2C(=O)N1c1nc(-c2ccc(F)cc2)cs1	4.54	group4-ia	ia	Androgen Receptor	Antagonist activity at AR T877A mutant in human LNCAP cells assessed as inhibition of DHT-induced proliferation after 48 hrs by MTT assay	2017	ffs@@@LdbbRRqbbbvWEBdxIZuUUUUUUUP@@	ffsPb@LDeh@PeL|ls^jnJJLfnRtsTs@@@P@@@	324.334	3.9651	4	0	78.51	2	-0.6529628623243473	0.06644669552649837	0.9458130506283059	14	14	fnkPa@AF}DCchHRYWYWf[uhqV`ijv@BejfX@H@@@	eFABP`BL@										6
zrzp5oNK9V4w412DTN252N2P040F9352!HZ18@018V86&FW2F280V102#14@25V2!214402480c!	CHEMBL235784	fasac@E^jtD`bPqHYEHXhddXhdmiiZcfjBCHHHf`@@	COC(=O)COc1ccccc1-c1ccc(C#N)c(C(F)(F)F)c1	5.88	group4-ia	ia	Androgen Receptor	Displacement of [3H]DHT from human recombinant AR expressed in Sf9 cells	2007	dcl@@DjYU_egZjjjh@@	dcl@@DjYU_egX@@@@@@	335.28	3.4906	4	0	59.32	6	-0.24749410261208782	-0.3129569686624032	1.016933257367994	30	18	fle`B`N@BSNKoDLBeArJJIIFJJZU`oQ``rBHb@@@	gNqh@jpAIevj`@		gJPBAHJPt`PAIjj@@								17
:xzhyyzjjyjCdzeVEz@jj_IrtoXUw0IHsFSss52hcOZJ4ARNw8b2kHFN!88F212#8O$H!V2#6030	CHEMBL235811	eaSPJ@@@Aof^\bbRfbTrRTrbRaLRTvRReCBfgdQSSpKSUUUUUUU@DUTuT\LHQJKRNRIEH@	C[C@]1(O)CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CCC(=O)C=C1C[C@H]3CCCCc1cccc(OCCCCC(=O)O)c1	6.48	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HeLa cells assessed as inhibition of dihydrotestosterone induced transcriptional activity by reporter gene assay	2007	ec`P@@@LdbbbbbrRVNRtRSB`acgdVRvuUUUUUUUUUU@@@	ec`PH@@@LbbRfRbRRfRQTRUCDbc`VQRvsSUUUUUT@ETDBJQJRr@@	550.777	7.2918	5	2	83.83	11	2.6923630232900875	-3.728406963967308	-0.5006399587170188	6	6	edVPDD@OhPODaqrJJKYIIQQJJIQJIHpl\QIESKGWOPPEUUUUMUUTeUpYKEy@hdbdl`@	diDL`@Sa@DfuUjj`@										6
:xzhyyzjjyiCdzeXEz@jj_IMtoXUw0IFsFSst56hcOZJ4ARNw8b0kHFN!88F212#BO$H!V$6030	CHEMBL235871	en]PJ@@@AojV\bbRfbTrRTrbRaLRTvRThXTt|bJZ^AZZjjjjjjh@bjZjNFDHeEiGIDbd@@	C[C@]1(O)CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CCC(=O)C=C1C[C@H]3CCCCc1cccc(OCCCC(=O)O)c1	6.17	group3-int	int	Androgen Receptor	Displacement of [3H]mibolerone from human androgen receptor expressed in CHOK1 cells	2007	ec`P@@@LdbbbbbrRVNRtRSB`acgdVRvuUUUUUUUUUU@@@	ec`PH@@@LbbRfRbRRfRQTRUCDbc`VQRvsSUUUUUT@ETDBJQJRr@@	536.75	6.8374	5	2	83.83	10	2.481336985807196	-3.282404902139547	-0.5521962687108442	6	6	edVPDD@OhPODaqrJJKYIIQQJJIQJIHpl\QIESKGWOPPEUUUUMUUTeUpYKEy@hdbdl`@	daxL`@Qn@DfuVjh@@										6
:xzhyyzjjyjCdzeVEz@jj_IMtoXUw0IHsFSst52hcOZJ4ARNw8b0kHFN!88F212#8O$H!V2#6030	CHEMBL235872	ei[PJ@@@AonQ\bbRfbTrRTrbRaLRTvRRThXTt|bJZ^AZZjjjjjjh@bjijhxXPbTVd\dRJP@	C[C@]1(O)CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CCC(=O)C=C1C[C@H]3CCCCc1cccc(OCCCCCC(=O)O)c1	6.28	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HeLa cells assessed as inhibition of dihydrotestosterone induced transcriptional activity by reporter gene assay	2007	ec`P@@@LdbbbbbrRVNRtRSB`acgdVRvuUUUUUUUUUU@@@	ec`PH@@@LbbRfRbRRfRQTRUCDbc`VQRvsSUUUUUT@ETDBJQJRr@@	564.804	7.7462	5	2	83.83	12	2.9033893821952907	-4.174409252132442	-0.4490835482908978	6	6	edVPDD@OhPODaqrJJKYIIQQJJIQJIHpl\QIESKGWOPPEUUUUMUUTeUpYKEy@hdbdl`@	dedL`@PY@DfuUZjj@@										6
xvwjgyqabEui9dxV_7z@Cbp1MGgaHw0GHc0Skl50g09ZF4@RN4060F#104!802F808F$F#@#6830	CHEMBL236699	emWPBJ@KGIUPIABPpdJIAbPrJPrEIQQEIIIQQJJIQJIHgXy{DegdVjjjijjjjjjjjjfjDZgRfbtvQr^QJ@@	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@H](CCCCCCCCC(CCCC(F)(F)C(F)(F)F)C(=O)O)C[C@H]1CC(=O)CC[C@@]13C	6.39	group3-int	int	Androgen Receptor	Displacement of [3H]mibolerone from human androgen receptor expressed in CHOK1 cells	2007	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmUUUUUUDIAITM@@	620.781	9.4581	4	2	74.6	15	3.1999958041890957	-5.962123248102664	-0.3817711050039917	50	19	ffs@b@Bu@xyEEDhheDhdbV\d{tTyjjjjjjijnHQIRLWEI^P@	fnm@a`KNAHHdLREIAd`t@rJPrEIQQEIIJjjjijjj@@										19
:xzhyyzjjyiCdzeXEz@jj_IMtoXUw0IFsFSst56hcOZJ4ARNw8b0kHNN!88F212#BO$H!V$6030	CHEMBL237971	efUPJ@@@AgbZ\bbRfbTrRTrbRaaRfrReCBfgdQSUwsSUUUUUUT@QUMUGCBDRbtcdbQR@@	C[C@]1(O)CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CCC(=O)C=C1C[C@H]3CCCc1cccc(OCCCC(=O)O)c1	5.24	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HeLa cells assessed as inhibition of dihydrotestosterone induced transcriptional activity by reporter gene assay	2007	fm@@@LdbbbbbrRVNRfRXhQg^cfZzjjjjjjjjjh@@	fmA@@@YEDeLeDdeLdcDeQdeNCdlumMUUUUU@AUAAJRUKP@	522.723	6.383	5	2	83.83	9	2.2703109483243042	-2.836402840311786	-0.6037525787046696	4	4	en]PJH@BO@bVPGGHhhdlddeDXheEDheDdXVAFnigohT\XHHjjZjjjZjjiJkbJIHjUSiSKy@@											1
:xzhyyzjjyjCdzekEz@jj_1rtoXUw9IHsFSss52idOZJ4@RNw872kHNN0880F2G28!8O#VH!V2#6030	CHEMBL237999	en]PJ@@@AojV\bbRfbTrRTrbRaaRrRRThXTt|bJZn^ZZjjjjjj`@jjZjNFDHeEiGIDbd@@	C[C@]1(O)CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CCC(=O)C=C1C[C@H]3CCCc1ccc(OCCCCC(=O)O)cc1	6.18	group3-int	int	Androgen Receptor	Displacement of [3H]mibolerone from human androgen receptor expressed in CHOK1 cells	2007	fm@@@LdbbbbbrRVNRfRXhQg^cfZzjjjjjjjjjh@@	fmA@@@YEDeLeDdeLdcDeQdeNCdlumMUUUUU@AUAAJRUKP@	536.75	6.8374	5	2	83.83	10	2.481336985807196	-3.282404902139547	-0.5521962687108442	4	4	e`RPDH@Ko`GGHhdldeEDhheDhdcCPqxDetLml]@AUUUUMUUTeUpiMEYGHDddL`@	diDL`@Sa@DfuUjj`@										3
:xzhyyzjjyiCdzemEz@jj_1MtoXUw9IFsFSst56idOZJ4@RNw870kHFN0880F2G28!BO#VH!V$6030	CHEMBL238000	en]PJ@@@A`ZV\bbRfbTrRTrbRaLRVRRThXTt|bJZ^~ZZjjjjjjh@JjZjNFDHeEiGIDbd@@	C[C@]1(O)CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CCC(=O)C=C1C[C@H]3CCCCc1ccc(OCCCC(=O)O)cc1	6.07	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HeLa cells assessed as inhibition of dihydrotestosterone induced transcriptional activity by reporter gene assay	2007	ec`P@@@LdbbbbbrRVNRtRSB`acgdVRvuUUUUUUUUUU@@@	ec`PH@@@LbbRfRbRRfRQTRUCDbc`VQRvsSUUUUUT@ETDBJQJRr@@	536.75	6.8374	5	2	83.83	10	2.481336985807196	-3.282404902139547	-0.5521962687108442	6	6	edVPDD@OhPODaqrJJKYIIQQJJIQJIHpl\QIESKGWOPPEUUUUMUUTeUpYKEy@hdbdl`@		daxL`@Qn@DfuVjh@@									6
:xzhyyzjjyjCdzekEz@jj_1rtoXUw9IHsFSss52idOZJ4@RNw872kHFN0880F2G28!8O#VH!V2#6030	CHEMBL238001	eaSPJ@@@A`V^\bbRfbTrRTrbRaLRVRRReCBfgdQSSwsSUUUUUUU@AUTuT\LHQJKRNRIEH@	C[C@]1(O)CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CCC(=O)C=C1C[C@H]3CCCCc1ccc(OCCCCC(=O)O)cc1	6.6	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HeLa cells assessed as inhibition of dihydrotestosterone induced transcriptional activity by reporter gene assay	2007	ec`P@@@LdbbbbbrRVNRtRSB`acgdVRvuUUUUUUUUUU@@@	ec`PH@@@LbbRfRbRRfRQTRUCDbc`VQRvsSUUUUUT@ETDBJQJRr@@	550.777	7.2918	5	2	83.83	11	2.6923630232900875	-3.728406963967308	-0.5006399587170188	6	6	edVPDD@OhPODaqrJJKYIIQQJJIQJIHpl\QIESKGWOPPEUUUUMUUTeUpYKEy@hdbdl`@		diDL`@Sa@DfuUjj`@									6
:UvyQxn@R_k2HfCH@HGktAH0JF01b8B0HuZ78X1Y9kO6F3oBPOX144Jl0V8GRnGV9030ZV6F284G14710V8F0	CHEMBL238124	fikQA`JIFBPQHXdKRCiCtadTaTTRRdTZbtQ`ykUUAATTuRP@@	CC(C)c1cc(=O)[nH]c2ccc(N(CC(F)(F)F)CC(F)(F)F)cc12	8.7	group1-p	p	Androgen Receptor	Antagonist activity at human AR	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	366.304	3.3756	3	1	32.34	6	-0.4813538064885293	-0.6915046459259133	-0.1765615454771862	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gC`HL@Qz`@		dcv@xJBPRPrPx@fPVPvPrJPjKRUUUT@@								37
zrvK0FNG8V4k402BHN210N0H040F9312!HZ182018086&F02F2!V!2#14@25V2!214!2482c10	CHEMBL238338	ff}`c@E^jBPQHXdLbdLTRRLTRVtmQsUAAdDDT@@@	N#Cc1ccc(-c2ccccc2OCCO)cc1C(F)(F)F	5.81	group4-ia	ia	Androgen Receptor	Displacement of [3H]DHT from human recombinant AR expressed in Sf9 cells	2007	dcl@@DjYU_egZjjjh@@	dcl@@DjYU_egX@@@@@@	307.27	3.4123	3	1	53.25	5	-0.6161885369636194	-0.22044756453466285	-0.24639198128562967	30	18	fle`B`N@BSNKoDLBeArJJIIFJJZU`oQ``rBHb@@@	gJPh@T@ISuP@		gJPBAHJPt`PAIjj@@								17
zrzKlFTOOWJl702DHO212N0H060FC31X!HZ182018086&F02F280V102#14@25V2!214!2480c!	CHEMBL238340	fe{ac@E^jLD`bPqHYEHXhddXhdmddiZcfjBCHHHjj@@@	COCCOCCOc1ccccc1-c1ccc(C#N)c(C(F)(F)F)c1	5.09	group4-ia	ia	Androgen Receptor	Displacement of [3H]DHT from human recombinant AR expressed in Sf9 cells	2007	dcl@@DjYU_egZjjjh@@	dcl@@DjYU_egX@@@@@@	365.35	3.7477	4	0	51.48	9	0.24827756315779392	-0.9990003179816106	1.126117902488456	30	18	fle`B`N@BSNKoDLBeArJJIIFJJZU`oQ``rBHb@@@	diDL`@ia@DiUVjj`@		gJPBAHJPt`PAIjj@@								17
kHPF0F018!k#4FN210N0H040F023#H418!18082)2(2#34@2502(2080c!	CHEMBL238365	fle`@`D`bOR@YBL`dsKN}mKIZMA@@AUV@@@	N#Cc1ccc(-c2ccccc2Cl)cc1C(F)(F)F	8.01	group1-p	p	Androgen Receptor	Displacement of [3H]DHT from human recombinant AR expressed in Sf9 cells	2007	dcl@@DjYU_egZjjjh@@	dcl@@DjYU_egX@@@@@@	281.664	4.6087	1	0	23.79	2	-2.5224316947465666	-0.9261582106986869	0.4740332735299537	30	18	fdy@A`@AIHcSc[q}@qP\bbbtttTtkANCAA@QDP@@@				gJPBAHJPt`PAIjj@@	eMbA@Dg`@						1
qHuF0F818V0k!24FN210N0H040F0212!HZ18!18086)2F2%2#14@25V2$4!2480c!	CHEMBL238366	fbuaC@E^AHHdLRFQRFJIIFJIJVhyj``rBB@@@	COc1ccccc1-c1ccc(C#N)c(C(F)(F)F)c1	7.7	group2-a	a	Androgen Receptor	Antagonist activity at human AR in MDA-MB453-MMTV-luci cells by functional assay	2007	dcl@@DjYU_egZjjjh@@	dcl@@DjYU_egX@@@@@@	277.244	3.9327	2	0	33.02	3	-1.962120714715071	-0.4356584823002215	0.6013837805441026	30	18	fle`B`N@BSNKoDLBeArJJIIFJJZU`oQ``rBHb@@@	eMJA@Hz@		gJPBAHJPt`PAIjj@@								17
yTsr4L8G8V4k4024FN25VN2H04FF13920HFZ58#Fk160W!20VC2JLV0W890VFc14281c040205!F502810	CHEMBL2386392	ffcAc@MQJBPQHXdLbdLRVTRTRV`iN}fmT@EM@aA@@@	O=c1cc(-c2ccc(C(F)(F)F)cc2)oc2cccc(O)c12	5.91	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay	2013	fhy@@@LdbbbRnbRYHRoAjjjjjj`@@	fhy@`@@\RYee~uYrVoAZA``@H@@@	306.238	3.8754	3	1	46.53	2	-1.2271070782474383	-0.1818338426811111	-0.34110313146736226	32	23	flu@a@ANAxq\TfUvUe^hsQ`i`@ihDHH@@	eFJB@Hp@	gJPBAHJPt`PAIjj@@									18
yRsr468G8V4F4024FN05VN2H!F013920HFV58#Fk160W!20VC2JLV0W890V0c10280c040204!F502810	CHEMBL2386393	fluAb@ANbBPRYWYVUzcMFBf@Bf`P``@@	O=c1cc(-c2ccc(F)cc2)oc2cccc(O)c12	6.48	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay	2013	fhy@@@LdbbbRnbRYHRoAjjjjjj`@@	fhy@`@@\RYee~uYrVoAZA``@H@@@	256.231	3.1279	3	1	46.53	1	-1.6138200995675631	0.5737901213387405	-0.45339145755802135	32	23	flu@a@ANAxq\TfUvUe^hsQ`i`@ihDHH@@	eFJB@Hp@	eFABP`BL@									18
yRsr468G8V4F40240N05VN2H!F013020HFV58#Fk160W!20V90JLV0W890V0c10280c040204#5!8!	CHEMBL2386394	fde@b@NRAHYEEDhhRhdfJehLXHFa`@H@@	O=c1cc(-c2ccccc2)oc2cccc(F)c12	6.11	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay	2013	fhy@@@LdbbbRnbRYHRoAjjjjjj`@@	fhy@`@@\RYee~uYrVoAZA``@H@@@	240.232	3.4736	2	0	26.3	1	-2.5605894709018027	0.16993572432366036	0.46876920988580895	32	23	flu@a@ANAxq\TfUvUe^hsQ`i`@ihDHH@@	eFABP`BL@										18
yRur668G8V4F4024FN05VN2m!F013920HFV58V02Fk168W!20VC2JLV0W890VFc1028Vc4B0204!F503010	CHEMBL2386395	fj}aPBH@PhNXRcdfyWYVU{`kNRUh@JZABB@@@	O=c1cc(-c2ccc([N+](=O)[O-])cc2)oc2cccc(O)c12	6.44	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay	2013	fhy@@@LdbbbRnbRYHRoAjjjjjj`@@	fhy@`@@\RYee~uYrVoAZA``@H@@@	283.238	2.1055	6	1	92.35	2	0.20637825343715335	1.6660864002780131	-0.005906165600501209	32	23	flu@a@ANAxq\TfUvUe^hsQ`i`@ihDHH@@	eFJB@Hp@	gChhhE`BRnRYh@									18
yRur468G8V4F4024FN05VN2H!F013920HFV58#Fk160W!20VC2JLV0W890V0c10280c040204!F502V10	CHEMBL2386396	fbma`@L`yKHhheEEcLedsbcAbtCDP@Ep@@@	N#Cc1ccc(-c2cc(=O)c3c(O)cccc3o2)cc1	6.6	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay	2013	fhy@@@LdbbbRnbRYHRoAjjjjjj`@@	fhy@`@@\RYee~uYrVoAZA``@H@@@	263.251	2.8627	4	1	70.32	1	-0.9369486255473283	1.0025391213288448	-0.29412141476799536	32	23	flu@a@ANAxq\TfUvUe^hsQ`i`@ihDHH@@	eFJB@Hp@	eMbA@Dg`@									18
yTur669G8V5k4025FN05VN2H04F013920HFV58V02Fk160W!2FVC2JLV0W894VFc1028Vc44020510F502010	CHEMBL2386397	fj}a`@D`yKHhheEEcLeeF\TXLV`Xb@@j`@@	CN(C)c1ccc(-c2cc(=O)c3c(O)cccc3o2)cc1	6.07	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay	2013	fhy@@@LdbbbRnbRYHRoAjjjjjj`@@	fhy@`@@\RYee~uYrVoAZA``@H@@@	281.31	2.9235	4	1	49.77	2	-1.016693018241574	0.6274587729864374	-0.29029017218551173	32	23	flu@a@ANAxq\TfUvUe^hsQ`i`@ihDHH@@	eFJB@Hp@	gChHA`BOT@@									18
yRur468G8V4F4024FN05VN2H!F013920HFV58V!Fk160W!20VC2JLV0W890V0c1028Vc440204!F5120W0	CHEMBL2386399	flua`@D`yKHhheEEcLef\TXLV`Xb@@h@@@	Nc1ccc(-c2cc(=O)c3c(O)cccc3o2)cc1	5.7	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay	2013	fhy@@@LdbbbRnbRYHRoAjjjjjj`@@	fhy@`@@\RYee~uYrVoAZA``@H@@@	253.256	2.3498	4	2	72.55	1	-0.6535010933465015	1.3504132738481072	-1.3942889087416699	32	23	flu@a@ANAxq\TfUvUe^hsQ`i`@ihDHH@@	eFJB@Hp@	eFbB@Hp@									18
yRsr468G8V4F4024FN05VN2H!F013920HFV58082Fk160W!20VC2JLV0W890VFc10280c040204!F502010	CHEMBL2386401	fbmAb@I^R@HRfuvUe^Ypuhyh@JZABB@@@	CSc1ccc(-c2cc(=O)c3c(O)cccc3o2)cc1	5.97	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay	2013	fhy@@@LdbbbRnbRYHRoAjjjjjj`@@	fhy@`@@\RYee~uYrVoAZA``@H@@@	284.334	3.5043	3	1	71.83	2	-0.918075970168245	0.3080597674843863	-0.31468052884250314	32	23	flu@a@ANAxq\TfUvUe^hsQ`i`@ihDHH@@	eFJB@Hp@	eMA@HPBN`@									18
yRsr468G8V4F4024FN05VN2H!F013A20HFV58#Fk160W!20VC2JLV0W890V0c30280c040204!F5!8!	CHEMBL2386404	flu@a@ANADQdDfUvUe^hsQ`i`@ihDHH@@	O=c1cc(-c2ccc(Cl)cc2)oc2cccc(F)c12	6.44	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay	2013	fhy@@@LdbbbRnbRYHRoAjjjjjj`@@	fhy@`@@\RYee~uYrVoAZA``@H@@@	274.678	4.0796	2	0	26.3	1	-2.4077030455443547	-0.3220967927000402	0.5286076755019471	32	23	flu@a@ANAxq\TfUvUe^hsQ`i`@ihDHH@@	eFABP`BL@	eFABH`BL@									18
yRsr468G8V4F4024FN05VN2H!F013920HFV58#Fk160W!20VC2JLV0W890V0c10280c040204!F5!8!	CHEMBL2386405	flu@a@NRAHIdLbbbTTITRVXjV`q``ZF@BH@@	O=c1cc(-c2ccc(F)cc2)oc2cccc(F)c12	6.72	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay	2013	fhy@@@LdbbbRnbRYHRoAjjjjjj`@@	fhy@`@@\RYee~uYrVoAZA``@H@@@	258.223	3.5744	2	0	26.3	1	-2.4705882751921364	0.04262370932689413	0.49889840048859857	32	23	flu@a@ANAxq\TfUvUe^hsQ`i`@ihDHH@@	eFABP`BL@	eFABP`BL@									18
yRur468G8V4F4024FN05VN2H!F013920HFV58#Fk160W!20VC2JLV0W890V0c10280c040204!F5!c!	CHEMBL2386406	fbm`b@L|dBPrJJIQPeQIYLUKPXpPMC@AY@@@	N#Cc1ccc(-c2cc(=O)c3c(F)cccc3o2)cc1	5.92	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay	2013	fhy@@@LdbbbRnbRYHRoAjjjjjj`@@	fhy@`@@\RYee~uYrVoAZA``@H@@@	265.243	3.3092	3	0	50.09	1	-1.7937168011719011	0.4713727093169985	0.6581684432786247	32	23	flu@a@ANAxq\TfUvUe^hsQ`i`@ihDHH@@	eFABP`BL@	eMbA@Dg`@									18
yRur478G8V4F4F24FN05VN2H!F013920HkV58#Fk160W!20VC2JLV0W890VFc10280c040204!F5120W0	CHEMBL2386408	fj}`P@B`yKNQQQJJKFYKJLxhpXm@qD@AM@@@	NC(=O)c1ccc(-c2cc(=O)c3c(O)cccc3o2)cc1	5.45	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay	2013	fhy@@@LdbbbRnbRYHRoAjjjjjj`@@	fhy@`@@\RYee~uYrVoAZA``@H@@@	281.266	2.1144	5	2	89.62	2	0.1829590949436438	1.513294564863105	-1.1913230983415526	32	23	flu@a@ANAxq\TfUvUe^hsQ`i`@ihDHH@@	eFJB@Hp@	gCiHDL@ILt@@									18
zyQnLItp8N5s0FA9SN0WV82m0JFF109!Hl058V83Pk849GV0@NV504JFF0c14m1W952XZ04V202G1F4!WVF0	CHEMBL2397333	fcoIb@L^SnBL`BLddJTrTttRrtRVRcQRNZuPADmS@AY@@@	CCS(=O)(=O)Nc1cccc(-c2cc(=O)n(-c3ccc(C#N)cc3)nc2C)c1	5.2	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor in human LNCAP cells after 1 day by luciferase reporter gene assay	2013	flu@@@LdbbbRQvbREiQhijjjjjjj@@	fluQ@@DD@dsJskN{NF}EKUJD@@D@@@	394.454	2.5197	7	1	111.01	4	1.634563026816927	1.0207469161090765	0.36751336691779307	4	4	fmwqa@NBKkhpNKPcHhdlheEChdimHZLM[MX@Jej`BIZD@@	eMbA@Dg`@										1
zyQnLItp8N5s0FACSN0WVN2m0JFF10@!Hn058V83Pk849GV0@NV505JFF0c1Bm1WA52XZ04V202G1F6!W0F0	CHEMBL2397334	fcoqc@ARjX\pQAHchQdTTVVbTTNbRftaYrsbm``Jej`BIZD@@	CCS(=O)(=O)Nc1cccc(-c2cc(=O)n(-c3ccc(Cl)c(Cl)c3)nc2C)c1	5.58	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor in human LNCAP cells after 1 day by luciferase reporter gene assay	2013	flu@@@LdbbbRQvbREiQhijjjjjjj@@	fluQ@@DD@dsJskN{NF}EKUJD@@D@@@	438.334	3.8961	6	1	87.22	4	1.1734578931160646	-0.2647515116899717	0.29778940886688793	4	4	fcoqc@ARjX\pNIHchQdTTVrbTTNbRftaYrsbm``Jej`BIZD@@	eFABH`BL@										2
zyQnLItp8N5s0FA9CN0WV82m0JFF102!Hl058V81Pk849GV0@NV104JFF0c14m1W352X404V202F1F6!W0F0	CHEMBL2397335	fcoqc@ARjX\pQCHchQdTRTQbTTNbRftairsbm`BJej`BIZD@@	CCS(=O)(=O)Nc1cccc(-c2cc(=O)n(-c3cc(Cl)cc(Cl)c3)nc2C)c1	4.88	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor in human LNCAP cells after 1 day by luciferase reporter gene assay	2013	flu@@@LdbbbRQvbREiQhijjjjjjj@@	fluQ@@DD@dsJskN{NF}EKUJD@@D@@@	438.334	3.8961	6	1	87.22	4	1.1734578931160646	-0.2647515116899717	0.29778940886688793	4	4	fkq``IJ[ZZpNIHadPLHrJJJXjIQPzIJ[RG`g^kvBHJej`BIZD@@											1
zyQnLItp8N5s0FACSN0WVN2m0JFF10@!Hn058V83Pk849GV0@NV505JFF0c1Bm1WA52XZ04V202G1F6!W8F0	CHEMBL2397336	fcoqc@ARjX\pQAIChQdTTVVbTTNbRftaYrsbm``Jej`BIZD@@	CCS(=O)(=O)Nc1cccc(-c2cc(=O)n(-c3ccc(F)c(Cl)c3)nc2C)c1	5.29	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor in human LNCAP cells after 1 day by luciferase reporter gene assay	2013	flu@@@LdbbbRQvbREiQhijjjjjjj@@	fluQ@@DD@dsJskN{NF}EKUJD@@D@@@	421.879	3.3909	6	1	87.22	4	1.1105726746859943	0.09996913366193619	0.2680801326110308	4	4	fcoqc@ARjX\pNIHchQdTTVrbTTNbRftaYrsbm``Jej`BIZD@@	eFABP`BL@										2
zyQnLItp8N5s0FACSN0WV82m0JFF1$Hn058V81Pk849GV0@NV104JFF0c14m1W152XZ04V202F1F4!W0F0	CHEMBL2397337	egh\LH@LODhDL`@cIIBeLeMMDlmDeLdhYDdML]\mT@QKTp@@A@@@@	CCS(=O)(=O)Nc1cccc(-c2cc(=O)n(-c3ccc4ccccc4c3)nc2C)c1	5.01	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor in human LNCAP cells after 1 day by luciferase reporter gene assay	2013	fnk@@@LdbbbRQfRTVVEiQ`yjvjjjjjjjj`@@	fnkQ@@DD@dsJskMjnsaoIjUkUJD@@@A@@@@	419.504	3.8785	6	1	87.22	4	1.0751236657155725	-0.18434369267994077	0.26671321898640304	1	1	egh\LH@LODhDL`@cIIBeLeMMDlmDeLdhYDdML]\mT@QKTp@@A@@@@											1
vzUvvv;S:vqAUSzCt3OPULBn7hlO9bLUX5@VfQQVWgkbY62KZCe5R90VX3CWlWd1AXZH4!8F0GJL1VVVFV	CHEMBL239957	fnkHB@DXBt@QdTTRTRRRlTRIFZ\ZrRmUEAQSUXR@@	Cn1c(C#N)ccc1-c1ccc2[nH]c(=S)n(C3CCCC3)c2c1	6	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor expressed in A549 cells by HRE-tk luciferase assay	2007	fb}@@@LdbbRRebTVWMBeYr\uUUUUUUT@@	fb}pB@DXB@HrJJIJIIIVIDYiqkIruTTEEMAH@@	322.435	2.9789	4	1	76.08	2	-0.3795620754726805	0.6346400418197317	-0.15536089274610504	1	1	fnkHB@DXBt@QdTTRTRRRlTRIFZ\ZrRmUEAQSUXR@@											1
zwvn4XNG804F!2BF80WVN2H$109244H01!811k#1#4V1X5H0F8088!8#84!1V#F$201F	CHEMBL240331	fnsPR@LDDhkPAFRJIIQQZYIKR|tGJZtDCP@@DP@@@	O=C(CSc1nc(O)c2ccccc2n1)c1ccc(O)c(O)c1	4.3	group4-ia	ia	Androgen Receptor	Transcriptional activity at human androgen receptor BF3 site stably transfected in eGFP-expressing human LNCAP cells after 5 days by fluorometric analysis	2011	fbm@@@LdbbRRjTTrSA\dgMUUUUUUT@@	fbmQB@LDD@HrQQIJJFIIK\UyL\tDC@@@@@@@	328.347	2.4975	6	3	128.84	4	1.8816278298075038	1.2614180940718005	-1.95798904046033	1	1	fnsPR@LDDhkPAFRJIIQQZYIKR|tGJZtDCP@@DP@@@											1
RuuI82VG880X!84F8H0VN0HF40V0X92022G50V010F#1!8%2!8!83#F1Vl060V!18F24120W0	CHEMBL2403348	fjma@@B`rJJIERJIIFYgHi`HJhJ@h@@@	CCC(CC)(c1ccc(N)c(C)c1)c1ccc(O)c(C)c1	5.27	group4-ia	ia	Androgen Receptor	Antagonist activity at human pSG5-AR assessed as inhibition of dihydrotestosterone-induced effect by reporter gene assay	2013	dk\@@DjU^ukmNjjjj`@	dk\@@DjU^ukmLHH@@@@	283.414	4.1305	2	2	46.25	4	-1.0154408060751468	-0.6289789329505506	-1.5010981668236372	60	4	fdyAA@H`|YNNQQQHjZIJYgG^`HJ`@h@@@	gJPHD@IVuP@	eFbB@Hp@									3
yqsGN08G805V!@4F82!N8H04!1X8202215#3%1#FV#6%8V!8F1V102$11F2402110	CHEMBL2403349	fjm@b@Le@xYIHhhdddYil[shuPAP@QT@@@	CC[Si](CC)(c1ccc(O)c(C)c1)c1ccc(O)c(C)c1	5.72	group4-ia	ia	Androgen Receptor	Antagonist activity at human pSG5-AR assessed as inhibition of dihydrotestosterone-induced effect by reporter gene assay	2013	dk\@@DjU^ukmNjjjj`@	dk\@`@\DifUWGUN`@@@@@	300.473	4.659	2	2	40.46	4	-1.043596652807285	-1.0524168391397426	-1.4850116388217023	60	9	fdy@@`@AHgBScGqrJJIESQISLx{tAAT@E@@@	gJPHD@IVuP@	eFJB@Hp@	eFJB@Hp@								9
:xOt8uGS0pV20@DF8202N8H46!1X8202215!131$3#FV#68$8V!8F1V102$11F2402110	CHEMBL2403350	fik@b@Nc@xIULrjjmvnZKluPAPAQEU@@@	CCCC[Si](CCCC)(c1ccc(O)c(C)c1)c1ccc(O)c(C)c1	5.09	group4-ia	ia	Androgen Receptor	Antagonist activity at human pSG5-AR assessed as inhibition of dihydrotestosterone-induced effect by reporter gene assay	2013	dk\@@DjU^ukmNjjjj`@	dk\@`@\DifUWGUN`@@@@@	356.58	6.4766	2	2	40.46	8	-0.199497324210397	-2.836421691390181	-1.2787879053308318	60	9	fdy@@`@AHgBScGqrJJIESQISLx{tAAT@E@@@	diD@`B@Di]Vjj`@	eFJB@Hp@	eFJB@Hp@								9
RusI82VG880X!84F8H0VN0HF40V0X92022G5#10F#1!8%2!8!82#F1VG020V!18F2402010	CHEMBL2403355	fjm@`@@ErJJIERJIIFYgHi`HJhJ@h@@@	CCC(CC)(c1ccc(O)c(C)c1)c1ccc(O)c(C)c1	5.35	group4-ia	ia	Androgen Receptor	Antagonist activity at human pSG5-AR assessed as inhibition of dihydrotestosterone-induced effect by reporter gene assay	2013	dk\@@DjU^ukmNjjjj`@	dk\@@DjU^ukmLHH@@@@	284.398	4.4621	2	2	40.46	4	-1.1189862139283686	-0.874439723267455	-1.5124888792506246	60	4	fdyAA@H`|YNNQQQHjZIJYgG^`HJ`@h@@@	gJPHD@IVuP@	eFJB@Hp@									3
RuwQc2kG88VX!84F8H8VN4HF40V0X92022G5F!11F#3!8%2!8!82#F1VG020V!18F2402010	CHEMBL2403356	fnc@`@@MrJJIERJIIIJUgHe`HJhJBb`@@	CCCC(CCC)(c1ccc(O)c(C)c1)c1ccc(O)c(C)c1	4.6	group4-ia	ia	Androgen Receptor	Antagonist activity at human pSG5-AR assessed as inhibition of dihydrotestosterone-induced effect by reporter gene assay	2013	dk\@@DjU^ukmNjjjj`@	dk\@@DjU^ukmLHH@@@@	312.451	5.3709	2	2	40.46	6	-0.6969392817195754	-1.766440225524999	-1.4093778661797003	60	4	fdyAA@H`|YNNQQQHjZIJYgG^`HJ`@h@@@	gNpHL@ISkUT@@	eFJB@Hp@									3
~:EzUyzjvUjjjzgroUjrhUejQrtTrzcmMfzSqbnduhZg6nT3TjKo4Oq3FlGIVt8ZVcN@V0F0	CHEMBL2407647	ejYTF@@LK@DIC@T\bbTTRbbtVTRrRtQVbVHh|bZVfn~aZjiihJ@H@@HjhA@bLP@	COc1cc(CNC(=O)[C@@]2(Cc3ccccc3)OC(=O)N([C@@H]3CCc4ccccc43)C2=O)cc(OC)c1	4.92	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) by NH Pro assay	2013	ehZP@@@DjfYWvYueg]~bPiZkh{yxFjjjjjjjjjjjj@@@	ehZTB@@LK@DICLbbTTRbbtVTRrRtQVHh|bZVfn~AZjiihJ@H@@B`DBHq@@	500.549	3.405	8	1	94.17	8	2.7597121788906405	-0.39085043563723215	0.6968131000865877	1	1	ejYTF@@LK@DIC@T\bbTTRbbtVTRrRtQVbVHh|bZVfn~aZjiihJ@H@@HjhA@bLP@											1
>vvzyjmxrhznt3xqEQHroAQindcgMz6YBNqCUltEmyf5QL05iaw5A5uMHH3x_4Ue1X657WRN4VHNB08!	CHEMBL2440233	ejQXBB@LcKHi`IBRPTdMICHhdieHhuEELeMDlmhdjFLjcglRX@JjZijXFAH@BAArAJ@z@	O=C(O[C@H]1C(=O)C=CN(C(=O)/C=C/c2ccccc2)[C@@H]1c1ccccc1)c1ccc(F)cc1C(F)(F)F	4.52	group4-ia	ia	Androgen Receptor	Displacement of Fluormone AL Green from androgen receptor ligand binding domain (unknown origin) after 4 hrs by fluorescence polarization assay	2013	e`\P@@@LdbbbbbRRQLVfbRRpacbVsuwuUUUUUUUUUUU@@@	e`\XB@@N@JMOLbbTRRTTTtRrRrLrSGAPwRswsSUTpL@HD@A@HXIaPEP	509.454	5.3928	5	0	63.68	7	1.0536918965437123	-2.0703428031452003	1.4391971206029948	1	1	ejQXBB@LcKHi`IBRPTdMICHhdieHhuEELeMDlmhdjFLjcglRX@JjZijXFAH@BAArAJ@z@											1
yJul619G8k4F0F24FN010N2H$128202mV50V03FV#WV#V10JL1#9BVFc8F02Z86!204!450X0G0	CHEMBL2441092	fmw`P@D@me^QQJJIIJZIZjIKJ\[pymP@@PUT@D@@@	COc1cccc(C(=O)Nc2cc(C)c(Oc3ccc(O)cc3)c(C)c2)c1	5.89	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor H874Y mutant (unknown origin) expressed in human 22Rv1 cells assessed as inhibition of DHT-induced cell growth after 3 days by WST-8 assay	2013	ffc@@@DjYW{WVUyJsbujjjjjjjj@@	ffc``@D@}dTRbbRRqRbRUXsbuZ`@@B`@@@@	363.412	4.4748	5	2	67.79	5	0.6289982449800645	-0.7328781066021757	-1.0210975246355019	3	3	fmw`P@D@me^QQJJIIJZIZjIKJ\[pymP@@PUT@D@@@											1
yJul619G8k4F0F24FN010N2H$128202mV50V03FV#WV#V10JL1#9BVFc8F02Z06!204!450X0G0	CHEMBL2441094	feg`P@D@lf^QQJJIIJZ[EQIYSc^zMj@@BBj@B@@@	COc1cccc(C(=O)Nc2ccc(Oc3ccc(O)cc3)c(C)c2)c1	7.37	group2-a	a	Androgen Receptor	Antagonist activity at androgen receptor T877A mutant (unknown origin) expressed in human LNCAP cells assessed as inhibition of DHT-induced cell growth after 6 days by WST-8 assay	2013	ffc@@@DjYW{WVUyJsbujjjjjjjj@@	ffc``@D@}dTRbbRRqRbRUXsbuZ`@@B`@@@@	349.385	4.1309	5	2	67.79	5	0.5713102858418252	-0.4741266091880791	-1.0459708957070364	3	3	feg`P@D@lf^QQJJIIJZ[EQIYSc^zMj@@BBj@B@@@											1
yJul619G8k4F0F20FF01082H$108202k040V03FV#WV#V10JJ$84VFc8F02Z04!2(X0G0	CHEMBL2441107	fi{`P@D@mDZSKLjmlkj\[s^mP@@PU@A@@@@	COc1cccc(C(=O)Nc2ccc(Oc3ccc(O)cc3)cc2)c1	4.7	group4-ia	ia	Androgen Receptor	Displacement of [3H]-DHT from human GST-tagged androgen receptor LBD (627 to 919) expressed in Escherichia coli HB-101 after 15 hrs by liquid scintillation counting analysis	2013	ffc@@@DjYW{WVUyJsbujjjjjjjj@@	ffc``@D@}dTRbbRRqRbRUXsbuZ`@@B`@@@@	335.358	3.787	5	2	67.79	5	0.5136221547747184	-0.21537514193026916	-1.0708443157522098	3	3	fi{`P@D@mDZSKLjmlkj\[s^mP@@PU@A@@@@											1
xvojcyqXbEue9cx0VAzeCj_1qOoXPw0GFs0Ost12g8OZFVPRNoc50F!F$F2520V41O1#F!V$2010	CHEMBL245378	ffk@`@@URYeg]UnU`aRt[pTejjZjjjjjhTDbBfdYN`Te@@	C[C@]12CC[C@H]3[C@@H](CC=C4[C@H]5CC[C@]43CC[C@@H]5O)[C@@H]1CC[C@@H]2O	5.86	group4-ia	ia	Androgen Receptor	Binding affinity to androgen receptor	2007	fl}@@@LddTTRTRljxhQiNmzJZjjjjjjj@@	fl}@@@LdbTbbRjtrhkdaF]zJVjjjjjjjhbXUDiV`@	302.456	3.3286	2	2	40.46	0	-1.604706432930091	0.22329249971987103	-1.5931102624915428	2	2	ffk@`@@URYeg]UnU`aRt[pTejjZjjjjjhTDbBfdYN`Te@@											1
xvojcyqXbEue9cx0VAzeCj_1qOoXPw0GFs0Ost12g8OZFVPRNoc50F!F$F2520V41O1#F!V$2010	CHEMBL245575	ffk@`@@URYeg]UnU`aRt[pTejjZjjjjjhTHbBfdYN`Te@@	C[C@]12CC[C@H]3[C@@H](CC=C4[C@H]5CC[C@]43CC[C@H]5O)[C@@H]1CC[C@@H]2O	5.95	group4-ia	ia	Androgen Receptor	Binding affinity to androgen receptor	2007	fl}@@@LddTTRTRljxhQiNmzJZjjjjjjj@@	fl}@@@LdbTbbRjtrhkdaF]zJVjjjjjjjhbXUDiV`@	302.456	3.3286	2	2	40.46	0	-1.604706432930091	0.22329249971987103	-1.5931102624915428	2	2	ffk@`@@URYeg]UnU`aRt[pTejjZjjjjjhTHbBfdYN`Te@@											1
<AzOr1J6w0qfTU8IW2SFuX8FpAli143Hp50X2H9FNDXGXDYYX8aWC9FX01CW!f16WjF4S485F2V_F4X8GV	CHEMBL246007	fleQB`ARLBHIDAdHrBYAIf]WZvf\djB@ijfhhZH@@	C=CC(O)(c1nc2cc(Cl)c(Cl)cc2[nH]1)C(F)(F)F	8.15	group1-p	p	Androgen Receptor	Binding affinity at androgen receptor expressed in COS cells by whole cell binding assay	2007	diT@@DjYVnXZjjh@@	diU@@@iJYWrnFP`H@@	311.09	3.3898	3	2	48.91	3	-0.7058073072185094	-0.02515175026887674	-1.3902089898696621	3	3	dcm@pDpGEXcXaIeUUJafZ`B`@@	diDHHJBPRPrPx@rJPrZjjXJ`@										3
xvojcyqXbEue9cx0VAzeCj_1qOoXPw0GFu0Ost12g8OZF0PRNoc50F!F#1G2520V0WO1#F!V$2010	CHEMBL246138	ffs@`@@URYVvU]nVgEZ|EIZjZjZjjjkdErJVdzART@	C=C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12	7.48	group2-a	a	Androgen Receptor	Binding affinity at AR	2007	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@DjVU]{ZBxhuoAZjjjjjkEDIZ`@	302.456	3.6214	2	2	40.46	1	-1.4599456747386825	-0.07354763588567725	-1.565477272882705	35	9	fjc@C@@AKgDocdTTbRLrTaRqNRU[r\uUUUUUUSDPbPTT`@	eMBD@cX@	eFJB@Hp@	eFJB@Hp@								8
xvojcyqXbEue9cx0VAzeCj_1qOoXPw0GFu0Ost12g8OZF0PRNoc50F!F#1G2520V0WO1#F!V$2010	CHEMBL246139	fnk@`@@MrJIJYQIIIPqJgEZCGMZjZjZjjjjyA\beiNdUePt`	C/C=C\[C@]12CC[C@H](O)CC1=CC[C@H]1[C@@H]3CC[C@H](O)[C@@]3(C)CC[C@@H]12	6.14	group3-int	int	Androgen Receptor	Binding affinity to androgen receptor	2007	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@DjVU]{ZBxhuoAZjjjjjkEDIZ`@	316.483	4.0091	2	2	40.46	1	-1.4043183494351381	-0.35862933402022124	-1.5403755915746273	35	9	fjc@C@@AKgDocdTTbRLrTaRqNRU[r\uUUUUUUSDPbPTT`@	gC`HL@IRtHD	eFJB@Hp@	eFJB@Hp@								8
xvojgyqXbEue9cxVVAz@Cj_1MOoXPw0GFuFOss12g8OZJ4@RNo850k0FF!81G212#cO$F(2010	CHEMBL246140	ffs@`@@UrJIJZIJEJZITXhw`iJtuUMUUUULYIHt]@iJ@@	C=C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12	8.1	group1-p	p	Androgen Receptor	Binding affinity at AR	2007	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmMUUUUUXDePt@@	300.44	3.7651	2	1	37.3	1	-1.8042322112521045	-0.16175893934999364	-0.4893649798211366	50	7	fjcAA@B`|WNNQQRIHsIREKDyIUoIsUUUUUMMTQBIAQR@@	eMBD@cX@	eFJB@Hp@									5
xvojcyqXbEue9cx0XAzeCj_1qOoXPw0GFu0Osx12g8toFVPRNoe50F!F!V1G2520V4WO1F!F!V$2010	CHEMBL246341	fn{@`@@MRYeg[u[eXJVcVCGMZjfjjjjjZaPRHJFUezQVT@	C[C@]12CC[C@H]3[C@@H](CC=C4[C@H]5CC=C[C@]43CC[C@@H]5O)[C@@H]1CC[C@@H]2O	7.07	group2-a	a	Androgen Receptor	Binding affinity to androgen receptor	2007	fbc@@@LddTTRTRecPcR\ku`isUUUUUUUT@@	fbc@@@LdbTbbRQvfSEBuJw`iruUUMUUUUQDqFIR]@@	314.467	3.3952	2	2	40.46	0	-1.5445877850345366	0.13871536605926937	-1.5729992581172265	2	1	fn{@`@@MRYeg[u[eXJVcVCGMZjfjjjjjZaPRHJFUezQVT@											1
<EItn9uDkZq3DmcXWXQ2H0VGIO3c2VLmZ5BmV3dlO6FKV429X14pLt0V89RlGV9020bcL!eCJ04554V8F0	CHEMBL246607	fj}Pc@CATxD`bPqHYEHXheEDeJUHuhaSUREDMETTDh@	CC[C@@H]1COc2c(ccc3[nH]c(=O)cc(C(F)(F)F)c23)N1	7.08	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells by transcriptional activation assay	2007	foQ@@@LdbbbTRnyHQmVjjjjjh@@	foQP`@DV@iIe[VuhrVkNZd@bjH@@	298.263	1.7172	4	2	50.36	2	-0.5850850373068529	1.2802080075935964	-1.3539033043213249	4	4	fbmP``DFidCbFPcHIdDfUm[YzZLdjwjj@BfjfH@@	eMBD@ch@										4
<vzUzrJixGqfTUCUWLUFva8FpEly143Hx50m@m91NiXGXDYYX86WC9FX05Cd!f161jF4N485F2V_F4X8GV	CHEMBL246800	fjmQA`ARLBHID^d@rDYAHQdTTVRVTfdUSNRUA@TuUUQPtP@	CCSCC(O)(c1nc2cc(Cl)c(Cl)cc2[nH]1)C(F)(F)F	7.77	group2-a	a	Androgen Receptor	Binding affinity at androgen receptor expressed in COS cells by whole cell binding assay	2007	diT@@DjYVnXZjjh@@	diU@@@iJYWrnFP`H@@	359.198	3.7671	3	2	74.21	5	0.25378143530748737	-0.4864314565916316	-1.192468468399863	3	3	dcm@pDpGEXcXaIeUUJafZ`B`@@	dmTHhJ@Hx@FPfPVPrQIRFRjjjcJ@@										3
=QUvUrblbPvUmv7nmtfLaZJFCnsT_Lva7BXYYQkODkMeBISY1hxTx0VtORlIld4Q0beLG1eSK14754V8F0	CHEMBL247453	eghTDF@C@eG@IABPpdAiBZPVdLbdLTRbbReVRbdRlaedPRQuuUHTPtUPU@QDBR@@	O=c1cc(C(F)(F)F)c2c3c(ccc2[nH]1)N(CC(F)(F)F)[C@H](c1ccccc1)CO3	7.19	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells by transcriptional activation assay	2007	fjc@@@LdbbbTRIRfRxhQmVrVjjjjjjjh@@	fjcP`@DV@iIe[VuvUhrVkNrUjPBJh@HbCd@	428.331	3.7032	4	1	41.57	4	-0.0939519622705351	-0.6882525298132987	-0.012964612984571746	2	2	eghTDF@C@eG@IABPpdAiBZPVdLbdLTRbbReVRbdRlaedPRQuuUHTPtUPU@QDBR@@											1
;r7IOl9k4k4F3BH82WXN2H!FF93c20LmZ58X039k96FGV029X10KLl0V89RlGV9020bcL!eCJ04550V8F0	CHEMBL247785	fluPc@CATxD`bPqHYEHXheEDeKHuhaSUREDMED@@	O=c1cc(C(F)(F)F)c2c3c(ccc2[nH]1)NCCO3	5.82	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells by transcriptional activation assay	2007	foQ@@@LdbbbTRnyHQmVjjjjjh@@	foQP`@DV@iIe[VuhrVkNZd@bjH@@	270.209	0.9381	4	2	50.36	1	-0.8547025737657433	1.9734195049028955	-1.4302329745180058	4	4	fbmP``DFidCbFPcHIdDfUm[YzZLdjwjj@BfjfH@@											4
<EIOn9m6kZH3Bmc2WXO2H0VFF93c2VLmZ5BXV39kO6FGV429X14pLl0V89RlGV9020bcL!eCJ04554V8F0	CHEMBL247786	fbmPc@CATxD`bPqHYEHXheEDeJYFmDJZjPhahjJBT@	C[C@@H]1COc2c(ccc3[nH]c(=O)cc(C(F)(F)F)c23)N1	7.14	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells by transcriptional activation assay	2007	foQ@@@LdbbbTRnyHQmVjjjjjh@@	foQP`@DV@iIe[VuhrVkNZd@bjH@@	284.236	1.2628	4	2	50.36	1	-0.7961112355009005	1.726210182590044	-1.4054596645312982	4	4	fbmP``DFidCbFPcHIdDfUm[YzZLdjwjj@BfjfH@@	eFBH@c@@										4
uTPI2G9G8F5kVFA11N30V8HF040F1080V!4080X2Pk80F1#FV18!4F0V0@!18482104#F1302#c0F	CHEMBL248690	ff}pC@EZLBPQHXdLbdLTRRLTtrTmEkUAAeU@@DKP@	C[C@H](c1ccccc1)N(C)c1cc(C(F)(F)F)c(C#N)cn1	7.7	group2-a	a	Androgen Receptor	Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cells	2007	dg|@@DjU_eZx{jjjjj@@	dg}@@@qJYWyVnNp`b@@@@	305.302	3.2952	3	0	39.92	4	-1.2700613091621895	-0.10583268861242967	0.7764461214119074	6	4	ff}pC@EZLBPQHXdLbdLTRRLTtrTmEkUAAeU@@DKP@											1
vzUQvQzQMSznQDPQ1QMPIAhFTL2k_kN8N9BB0sF1291c80364FFW04288LJ2H@!2B49H10B08!130XX!c0F	CHEMBL248841	ffcpC@EZLBPQHXdLbdLTRRLRTrTmAbVmTDFUUUQP@@	N#Cc1cnc(N2CCC3CCCCC3C2)cc1C(F)(F)F	6.58	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in MDA-MB-453 cells	2007	f`i@@@DjYU[wxjQg^jjjjjj@@	f`iP@@@XRfV]{V`eZ]xHJJjhh@@	309.334	3.4564	3	0	39.92	2	-1.5734868228926755	0.023957804845184533	0.7317066683675556	4	1	ffcpC@EZLBPQHXdLbdLTRRLRTrTmAbVmTDFUUUQP@@											1
vyUOuGOG0F_k24@91N2F088F040F1V88808408012908!3#FV%F020@#849H104$1302#c0F	CHEMBL248868	flypC@EZLBPQHXdLbdLTRRLRRejjBCJjh@@	CCCN(CCC)c1cc(C(F)(F)F)c(C#N)cn1	7.11	group2-a	a	Androgen Receptor	Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cells	2007	gFp@DiTvjh@	gFx@@eJf`@@@	271.285	3.3118	3	0	39.92	6	-1.132907783687643	-0.2313135408572576	0.7727723948068183	19	3	dkm@HDLGFYAYCYAIeUZZZ@Bjl@@	daz@`@p@Ri]jj`@										3
uTPI2G9G8F4kVFA!N20V8HF040F1080V!4080V2Nk80F1$V1#4F0V0@#8482104%202!VcFF	CHEMBL248878	fjmpC@EZLBPQHXdLbdLTRRJbfRekIZhHLj`@BEh@	C[C@@H](Nc1cc(C(F)(F)F)c(C#N)cn1)c1ccccc1	5.31	group4-ia	ia	Androgen Receptor	Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cells	2007	dg|@@DjU_eZx{jjjjj@@	dg}@@@qJYWyVnNp`b@@@@	291.275	3.0458	3	1	48.71	4	-0.914734881203047	0.1467097930688804	-0.31228476704057606	6	4	fjmpC@EZLBPQHXdLbdLTRRJbfRekIZhHLj`@BEh@											1
vyQQ@Gtl0N5kVJA91s3!8FF040G1080V!4080X2A080F1#FV08#F#@#8482104#F1302#c0F	CHEMBL249070	fdipC@EZLBPQHXdLbdLTRRLTtmUPPYUTPmP@	CCC(C)N(C)c1cc(C(F)(F)F)c(C#N)cn1	8.15	group1-p	p	Androgen Receptor	Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cells	2007	gFp@DiTvjh@	gFx@@eJf`@@@	257.258	2.8104	3	0	39.92	4	-1.5002597630484846	0.363766311767989	0.6948640229416564	19	3	dkm@HDLGFYAYCYAIeUZZZ@Bjl@@	gNxHA`CIHhZjiJ@@										3
vzUO3OtG1F5k04@A1N20280F440FW08#4408!2908!1#FV$8F!2@#8482104$1302#c0F	CHEMBL249071	fdipC@EZLBPQHXdLbdLTRRLVTmUPPYUT@@@	CCCCN(C)c1cc(C(F)(F)F)c(C#N)cn1	8.42	group1-p	p	Androgen Receptor	Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cells	2007	gFp@DiTvjh@	gFx@@eJf`@@@	257.258	2.9055	3	0	39.92	5	-1.346197110288286	0.18577339404089604	0.721466705745644	19	3	dkm@HDLGFYAYCYAIeUZZZ@Bjl@@	gNxHA`CIHbjj`@										3
vzUQvQtOKR5m14@Q1NHF28cFL40kWV8888B408!2908!12!FW#88LJ22@#8492104$1302V!c0F	CHEMBL249072	flepC@EZLBPQHXdLbdLTRRLRVehLZhHLjjb@@	CC1CCN(c2cc(C(F)(F)F)c(C#N)cn2)CC1	7.14	group2-a	a	Androgen Receptor	Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cells	2007	dcl@@DjYU_egZjjjh@@	dcm@@@qJYYwhUtHJJb@@	269.269	2.7963	3	0	39.92	2	-1.7534184350822335	0.5693494363697379	0.6623403148652575	30	2	flepC@EZLBPQHXdLbdLTRRLRVehLZhHLjjb@@											1
xvojcyqXbEue9cx0VAz@Cj_1LOoXPw0GFsFOss12g8OZJ0@RNo850k0FF!80F212$O$F(2010	CHEMBL249700	fjcA@@@YEEHdcLeIelSdeV\gMUUUUTtuSHIBIAQRL`@	C=C1C=C2CC[C@H]3[C@@H]4CC[C@H](O)[C@@]4(C)CC[C@@H]3[C@@]2(C)CC1	7.4	group2-a	a	Androgen Receptor	Binding affinity at AR	2007	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fdu@@@Dj]m[VvcIJlxLYfjjjjjlBRhZ@@	286.457	4.4477	1	1	20.23	0	-2.58786465787206	-0.6454901956201	-0.6669190523216606	50	2	fjcAB@B`\\bdTTRRVtLRyjRk^cfjZjjZjjjfErFgeE@@	eFBH@c@@										2
xvojcyqXbEue9cx0VAz@Cj_1LFoXPw0FFuFOkt12g8tZJ0@R8o850k0FF!c1F212#VQ$F(2010	CHEMBL249903	fnkA@@@YEEHdcLeIddTSdeV]dmUUUUULuSL`dHdEEHt@@	C=C[C@]12CCC(CC)=CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12	6.3	group3-int	int	Androgen Receptor	Binding affinity at AR	2007	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@LdbRbRJTrYK`cV|FYjjjjjlLTej@@	312.495	5.0927	1	1	20.23	2	-2.164017074622264	-1.3714354454950912	-0.5684984444643051	35	5	fjc@C@@AKgDocdTTbRLrTaRqNRU[r\uUUUUUMSDPbPTT`@	eMBD@cX@	eMBD@ch@	eFJB@Hp@								5
xvojcyqXbEuX9cx0VAr@Cj_0LFoXPw0FFuFSkt12g8tVJ0@R8F870k0FF!c1F212#VQ$F(2V10	CHEMBL249904	fa{A@@@YEHeHlcLeIddVRt[pZmjnjjjjfZfYAXSHjFSh@	C#C[C@]1(O)CC[C@H]2[C@@H]3CC=C4C=C(C)CC[C@]4(C=C)[C@H]3CC[C@@]21C	5.79	group4-ia	ia	Androgen Receptor	Binding affinity at AR	2007	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@LdbRbRJTrYK`cV|FYjjjjjlLTej@@	322.49	4.5572	1	1	20.23	1	-2.2447232100104837	-0.9657612054946436	-0.5809496626109499	35	5	fjc@C@@AKgDocdTTbRLrTaRqNRU[r\uUUUUUMSDPbPTT`@	eMBD@cX@	eFBH@c@@	gCaHA@AIZp@								5
<EIOn9m6kZHABms2WXO2H0ZFF9Yc2ZLmZ5BXV3OkO6kKV42CX1ZpLp0Vc9RlGVd430beL10eCJ04554V8F0	CHEMBL250083	figPc@CATxD`bPqHYEHXheEDeJUDeHuhaSt]UHTPtT@DQAJ@@	O=c1cc(C(F)(F)F)c2c3c(ccc2[nH]1)N[C@H](c1ccccc1)CO3	5.83	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells by transcriptional activation assay	2007	fjc@@@LdbbbTRIRfRxhQmVrVjjjjjjjh@@	fjcP`@DV@iIe[VuvUhrVkNrUjPBJh@HbCd@	346.307	2.4543	4	2	50.36	2	-0.3667574124267554	0.6589393671345796	-1.2710063558692937	2	2	figPc@CATxD`bPqHYEHXheEDeJUDeHuhaSt]UHTPtT@DQAJ@@											1
<jItv9uim_q3DmcXdXQ2H0VGItAc2VLmZ5BmV3dlO6FKW429X14pLt0V89RlGV9020bcL!eCJ04554V8F0	CHEMBL250084	ffcPc@CATxD`bPqHYEHXheEDeJTiFmDJZjPhahjhhIP@	CCC[C@@H]1COc2c(ccc3[nH]c(=O)cc(C(F)(F)F)c23)N1	6.95	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells by transcriptional activation assay	2007	foQ@@@LdbbbTRnyHQmVjjjjjh@@	foQP`@DV@iIe[VuhrVkNZd@bjH@@	312.29	2.1716	4	2	50.36	3	-0.37405883911280546	0.834205832597149	-1.3023469441113518	4	4	fbmP``DFidCbFPcHIdDfUm[YzZLdjwjj@BfjfH@@	gC`HL@IST@@										4
zxsp4ZsK8X4J416ZHNV0VN2H1#1192!2V10603Gk#1!@1010G210d!82F08!20804V244!1!6430	CHEMBL250104	ff}Ac@BIrCDEbEqLbbbRbQTRRbcIQkAAQTDCP@@@	O=C(O)CCc1cc(Br)c(OCc2cccc(Br)c2)c(Br)c1	5.11	group4-ia	ia	Androgen Receptor	Binding affinity at AR	2007	dg|@@DjU_eZx{jjjjj@@	dg|H@@RfUYwySn``@@@@@	492.988	5.1209	3	1	46.53	6	0.33189983893259256	-2.1063864979542877	0.07710993439171274	6	1	ff}Ac@BIrCDEbEqLbbbRbQTRRbcIQkAAQTDCP@@@											1
xvojcyqXbEue9cx0VAzeCj_1qOoXPw0GFu0Sst12g8OZF0PRNoc70F!F#1G2520V0WO1#F!V$2010	CHEMBL250109	fnk@`@@MrJQRKHsIRYIF`eZ]xmZjjjjjfjfyAHUIJZUiU@@	C=C[C@]12CC[C@H](O)CC1=CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O	6.77	group3-int	int	Androgen Receptor	Binding affinity at AR	2007	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@DjVU]{ZBxhuoAZjjjjjkEDIZ`@	316.483	3.9194	2	2	40.46	1	-1.4000979210881819	-0.30470632257542896	-1.5408430593590765	35	9	fjc@C@@AKgDocdTTbRLrTaRqNRU[r\uUUUUUUSDPbPTT`@	eMBD@cX@	eFJB@Hp@	eMJB@Df`@								8
xvojcyqXbEuX9cx0VAr@Cj_0LFoXPw0FFsFOkt12g8OVJ0@R8F850k0FF!80F212$Q$F(2010	CHEMBL250110	fjcA@@@YEEHdcLeIelSdeV\gMUUUUUSTsHIBIAQRL`@	CC1=CC2=CC[C@H]3[C@@H]4CC[C@H](O)[C@@]4(C)CC[C@@H]3[C@@]2(C)CC1	5.65	group4-ia	ia	Androgen Receptor	Binding affinity at AR	2007	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@LdbRbRJTrYK`cV|FYjjjjjlLTej@@	286.457	4.3694	1	1	20.23	0	-2.5841806043962854	-0.5984202677819217	-0.6673271095553189	35	5	fjc@C@@AKgDocdTTbRLrTaRqNRU[r\uUUUUUMSDPbPTT`@	eFBH@c@@	eFBH@c@@	eFJB@Hp@								5
xvojcyqXbEue9cx0VAzeCj_1qOoXPw0GFu0Sst12g8OZF0PRNoc70F!F#1G2520V0WQ1#F!V$2010	CHEMBL251515	fnk@`@@MRZWmeW[eXKQ`qsVjijijjjjnP`iiFWiEYP@	C=C[C@]12CC[C@@](C)(O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12	5.58	group4-ia	ia	Androgen Receptor	Binding affinity at AR	2007	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@DjVU]{ZBxhuoAZjjjjjkEDIZ`@	316.483	3.9194	2	2	40.46	1	-1.4000979210881819	-0.30470632257542896	-1.5408430593590765	35	9	fjc@C@@AKgDocdTTbRLrTaRqNRU[r\uUUUUUUSDPbPTT`@	eMBD@cX@	eMJB@Df`@	eFJB@Hp@								8
;UdTyvCfyn_XbDktrB6C4HFo1uM@O20824VN0k3d08GF945!V04F08#8@#84821120V3#120N0c!	CHEMBL251552	fjmQC@EYLBPQHXdLbdLTRRJbbReiIZhHLjjnH@@	N#Cc1ccc(OC2CCCCC2C#N)cc1C(F)(F)F	7.24	group2-a	a	Androgen Receptor	Displacement of [3H]DHT from androgen receptor expressed in Sf9 cells	2007	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]TzB`hb@@	294.275	3.3441	3	0	56.81	3	-1.2173134230693752	0.15037810203902935	0.7754413424895487	60	3	fjmQC@EYLBPQHXdLbdLTRRJbbReiIZhHLjjnH@@											1
zTur6I9l8k4k4F34FN2WVN2H!FF13920LmZ58V03Nk96FGV029X12JLl0W89Tl1V9022bc640@BJ04458X8G0	CHEMBL253535	fa{ac@ENcTD`bPqHYEHXheEEdcLhiJMzJV}jiB`dhBBH@@	O=c1cc(C(F)(F)F)c2c3c(ccc2[nH]1)-c1c(O)cccc1OC3	8.96	group1-p	p	Androgen Receptor	Activity at androgen receptor in human Saos2 cells assessed as IL6 repression	2008	flm@@@DjYee]YhTkA}Fjjjjjjj@@	flm``@D@ldrmkZvmFRUYtTmR@EP@Q@@@	333.264	2.3234	4	2	58.56	1	-0.45593501240861184	0.9669695467559254	-1.2983851666132897	11	9	ffs`c@L|j@I]xq\\bbbTTvRTLVsARuXNRpDPDEDtdP@@	gJPBAHJPt`PAIjj@@		eFJB@Hp@								8
yTur6K9G8k4kZFA4FN05VR2H04FF13920HmV58VV3Nk96F1V128V12FLp0Wc9Dl0V94@2Zc640@4J!658V0F0	CHEMBL253744	fnka`@D@]gHhdhdmLhhUDjLUipRuZdHBj@`hbAb@@	COc1cccc2c1-c1ccc3[nH]c(=O)cc(C)c3c1C(C)O2	7.21	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor african green monkey CV1 cells by cotransfection assay	2008	flm@@@DjYee]YhTkA}Fjjjjjjj@@	flm``@D@ldrmkZvmFRUYtTmR@EP@Q@@@	307.348	2.9491	4	1	47.56	1	-1.074859075644635	0.6201253542929497	-0.27904414541556777	11	9	ffs`c@L|j@I]xq\\bbbTTvRTLVsARuXNRpDPDEDtdP@@	eFBH@c@@	eFBH@c@@	eMJA@Hz@								8
zyvrDKOl8k4kZFABFs0_VN2H04FF9Y924LmV58VV3Nk96FGV02BV12FLp0Wc9Dl0V94A2Zc640@BJ!658V0F0	CHEMBL253746	fa{`P@D@]xjSJro[Mk[QbmNCUkTa@UPQAQDCT@@	COc1cccc2c1-c1ccc3[nH]c(=O)cc(C)c3c1C(OC)O2	6.95	group3-int	int	Androgen Receptor	Activity at androgen receptor in human Saos2 cells assessed as IL6 repression	2008	flm@@@DjYee]YhTkA}Fjjjjjjj@@	flm``@D@ldrmkZvmFRUYtTmR@EP@Q@@@	323.347	2.3173	5	1	56.79	2	-0.4090974973723086	1.0083343158565108	-0.11786416993761935	11	9	ffs`c@L|j@I]xq\\bbbTTvRTLVsARuXNRpDPDEDtdP@@	eFBH@c@@	eMJA@Hz@	eMJA@Hz@								8
=QUvUrjlbuvUmf7nmvfLaZKHCntTWLui7gmYYAlODFMXBIQX1ExLt0cOORlIk90Q0bVLFWeSKG47GJV8F0	CHEMBL254798	fegPc`E^lDD`bPqHMdNr@yB\adTabbTRrrbRrddhshyjiB`RjjjhhQ`@	O=c1cc(C(F)(F)F)c2cc3c(cc2[nH]1)OC[C@@H](CF)N3CC(F)(F)F	6.7	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor in CV1 cells by transcriptional activation assay	2008	foQ@@@DjYUU}`nRlzjjjjj`@@	foQP`@DFAiIe[UUhrRkNZd@JjH@@	384.25	2.2861	4	1	41.57	4	-0.25941528762591526	0.3271011949192899	-0.09288428618743348	38	9	fj}Pb`DVXTGbQqcHIdLrBSL}jkORsbmNCUT@EMULP@@	gGPBAHJPtaPCHiCUP@	eMABPPAIh@									8
}yzvjrzyUjxU:jzrwFxUfgDyrlMSafotZQzrKm_HJ2g8j4XL5gD2oCKq1KB280V@1Oi#8!	CHEMBL255157	ffsac@IV}dD`bPqHYEHXdiihilhaJ\ENRuj`BJYjjJdNPX@	O=C1[C@@H]2C3CCC(O3)[C@@H]2C(=O)N1c1cccc(C(F)(F)F)c1	4.94	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor in MDA453 cells by alkaline phosphatase reporter gene assay	2008	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdua`@D@T[HhhhhdhecQfcVCzKUTCTDUBLIb@@	311.258	1.6461	4	0	46.61	2	-1.1257878835578508	1.2750071271503864	0.831012309290574	47	25	fjcac@AZmD@RSqJxiLs{Lwl{NF\FJ\pPESMUTUHLgP@		gJPBAHJPt`PAIjj@@									8
;j;ir<yxtjjzyUjzhzv:uwJxUfxUvzGMwijyx_Pzrom7uG8p0z6Xr1BDYpeJl@Kh290VPV9c!1V0V	CHEMBL255216	fiwI`@D^JLBmYEEEEDiDhceD}SfgNSFiVmUTmUMUUuJcBy@@	CC12CCC(C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)n4nccc34)C(=O)[C@@H]12	7.06	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor in MDA453 cells by alkaline phosphatase reporter gene assay	2008	fjs@@@LdbbbTTTVsbEZVg^bgIZjjjjjjjh@@	fjsq`@DNRAQlbbbbbRbbqbhsQkQCeIVjjVjZjjUFDq@@	336.35	-0.0959	7	0	87.7	1	0.3250323229114994	3.013943359851366	1.207342313973357	4	1	fiwI`@D^JLBmYEEEEDiDhceD}SfgNSFiVmUTmUMUUuJcBy@@											1
{jzy;jzyUzxU:jjryOxUfiUzrlMybfotZQ:KmzHKAg@j6XLhgD2wdKoXKg28FVA1Oi!2Z10	CHEMBL255331	fa{PR@NRLyOPUfQQQIHqQSYRJY`k^bgMXHLjYjjjJlVWie@@	CC12C[C@H](O)C(C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(I)c3)C(=O)[C@@H]12	8	group1-p	p	Androgen Receptor	Antagonist activity at human androgen receptor in MDA453 cells by alkaline phosphatase reporter gene assay	2008	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdua`@D@T[HhhhhdhecQfcVCzKUTCTDUBLIb@@	438.216	0.8144	6	1	90.63	1	0.8970662895721481	1.975729712383098	0.21189373246385115	47	25	fnkac@AZmD@RSqZxiLs{LwmMlxYpXiKA@ULuUUERCIt@@	eFJB@Hp@	eFABl`BL@	eMbA@Dg`@								6
{jzy;jxyUzxU:jjryPxUfi@zrlMUbfotZQzrKm_HJ2g8j4XLCgD2y9KoVKD280VA1Oi&	CHEMBL255367	fb}ab@AZmDDQdTTRJbbfrbYps`qSf@`jYjjJdFSh@	Cc1cc(N2C(=O)[C@@H]3C4CCC(O4)[C@@H]3C2=O)ccc1Cl	6.3	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor in MDA453 cells by alkaline phosphatase reporter gene assay	2008	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdua`@D@T[HhhhhdhecQfcVCzKUTCTDUBLIb@@	291.733	1.7477	4	0	46.61	1	-1.3919275553807986	1.40715897856052	0.7733066795009454	47	25	fjcac@AZmD@RSqJxiLs{Lwl{NF\FJ\pPESMUTUHLgP@		eFBH@c@@	eFABH`BL@								8
:Uvzv;S:vyvvErUuUfzUzUjzboJCzjhDDrnYS6dqdZEjqJohmS@hDjJYq5ce3ZClm1LC2S1k01FaVV08!	CHEMBL255776	ffsPc@INmxD`bPqHYEHXdiihilhaJ\ENRuj`BJYjjJhAP@	O=C1[C@H]2C3CCC(C3)N2C(=O)N1c1cccc(C(F)(F)F)c1	6.89	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor in MDA453 cells by alkaline phosphatase reporter gene assay	2008	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fduP`@DX@kHhhhhdhecQfcVCzKUTCTDUDFP@	310.274	2.5641	4	0	40.62	2	-1.2705044106568604	0.682863951409473	0.8189301698140755	47	1	ffsPc@INmxD`bPqHYEHXdiihilhaJ\ENRuj`BJYjjJhAP@											1
=QUvUrjlbuvUmf7nmvfLaZKHCntTlLui7gmfYAlODFMXBIQX1ExLv0cOORlIk90Q0bVLFWeSKG47GJV8F0	CHEMBL255918	fmwPc`BYDl@PzP}HAdNr@yB\adbtTRbrTbUTVdPiVbUmUUAATTuTqPqP@	CSCC1COc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc2N1CC(F)(F)F	7.6	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor in CV1 cells by transcriptional activation assay	2008	foQ@@@DjYUU}`nRlzjjjjj`@@	foQP`@DFAiIe[UUhrRkNZd@JjH@@	412.353	2.6609	4	1	66.87	5	0.43640396312353524	0.06233280813060013	0.04581825383643033	38	9	fj}Pb`DVXTGbQqcHIdLrBSL}jkORsbmNCUT@EMULP@@	gGPBAHJPtaPCHiCUP@	gC`D@DX@Rfh@									8
=QzvUzjlbyvUmfbnmvfL6ZKISntThLya7hmYYflODFUXBPSX1jzLt0cQORnIk90Q4bVLGYiSSG471JV8F0	CHEMBL256082	eodTDF@EOK@`IABPpdNi@ZPfdLbdLTRbVVTRVTbeRdTL\brn^jiB`Rjjj`@bHHh@@	O=c1cc(C(F)(F)F)c2cc3c(cc2[nH]1)OC[C@@H](Cc1ccccc1)N3CC(F)(F)F	7.29	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor in CV1 cells by transcriptional activation assay	2008	ffs@@@DjYUUuyWXKdk^KVjjjjjjjj@@	ffsP`@DFAiIe[UUueZLdjsbuZd@Jj`@bHN`@	442.358	3.9536	4	1	41.57	5	0.12667254729866226	-1.011620267832239	0.037528608372154666	1	1	eodTDF@EOK@`IABPpdNi@ZPfdLbdLTRbVVTRVTbeRdTL\brn^jiB`Rjjj`@bHHh@@											1
=QUvUrblbPvUmv7nmtfLaZJFCntT_Lva7BXYYQkODkMeBISY5jxTx0ctORlIld4Q0bXLGWeSKG4M1JV8F0	CHEMBL256329	eodTDF@EOK@`IABPpdAiBZPVdLbdLTRbVVTRVbdRndTL\brNnjiB`RjjBhBbHHd@@	Cc1ccc([C@H]2COc3cc4[nH]c(=O)cc(C(F)(F)F)c4cc3N2CC(F)(F)F)cc1	7.36	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor in CV1 cells by transcriptional activation assay	2008	fjc@@@DjYUUv]U`nRlEIZjjjjjjj`@@	fjcP`@DFAiIe[UUvUhrRkNrUjP@jh@HbCd@	442.358	4.0471	4	1	41.57	4	-0.036263831203428326	-0.9470039970711086	0.011908807060601876	3	3	eodTDF@EOK@`IABPpdAiBZPVdLbdLTRbVVTRVbdRndTL\brNnjiB`RjjBhBbHHd@@											1
yTur6K9G8k4FZG34FN05VR2H!F013920HmV58cV3Fk96FWV129V12KLl0W89DlGc9022Zc640@4J0445NV0F0	CHEMBL256768	fmoaP@G@Peo\bbTTTRRbffjVtYsWkYBUj@B@ahjZhH@@	COc1c(OC(C)C)ccc2oc(=O)c3c(ccc4[nH]c(=O)cc(C)c43)c12	8.55	group1-p	p	Androgen Receptor	Activity at androgen receptor in human Saos2 cells assessed as IL6 repression	2008	fb}@@@LdbbbbbRJvsCBTzHTuUUUUUUT@@	fb}a`@G@QgHheEEDdhmjsfoVbEKT@DABSA@@@	365.384	2.9808	6	1	73.86	3	0.45893787622411275	0.5788266201048236	0.11286744569400642	8	8	fnkaa@Dr|tGbQqrJJKSJIIJEQEgEF\GMXHB``Rfdb@@	eMJA@Hz@	gJQH@`AJZj@@									8
:uzLpOl8k4FZG34HN2_VOHH!F093920HnZ58eV3GkO60lV029X56KLl0W89DlFc9022acq4V@5J04K5RV8F0	CHEMBL256769	eghXFL@IbFE@fk`IABPpdLbdJfbbRaTRRTJbIcdVUWRquULDDTDBTtdP@@	COc1c(C(=O)OC(F)(F)F)ccc2oc(=O)c3c(ccc4[nH]c(=O)cc(C)c43)c12	9.7	group1-p	p	Androgen Receptor	Activity at androgen receptor in human Saos2 cells assessed as IL6 repression	2008	fb}@@@LdbbbbbRJvsCBTzHTuUUUUUUT@@	fb}a`@G@QgHheEEDdhmjsfoVbEKT@DABSA@@@	419.31	3.3672	7	1	90.93	4	1.402620464656742	0.27180905418028467	0.36171807322988897	8	8	fnkaa@Dr|tGbQqrJJKSJIIJEQEgEF\GMXHB``Rfdb@@	eMJA@Hz@	daxDHBXIAICIC`CHiBiUS@@									8
yRur619G8k4F4F24FN01VN2H!F013920HmV58V03Fk9601V028V12FLl0W89Dl0V9022Zc640@4J!458V0F0	CHEMBL256947	ffsa`@D@\eIeYWm[YZLUiwleZdHBhBBb@@@	COc1cccc2c1-c1ccc3[nH]c(=O)cc(C)c3c1CO2	7.92	group2-a	a	Androgen Receptor	Activity at androgen receptor in human Saos2 cells assessed as IL6 repression	2008	flm@@@DjYee]YhTkA}Fjjjjjjj@@	flm``@D@ldrmkZvmFRUYtTmR@EP@Q@@@	293.321	2.1148	4	1	47.56	1	-1.1094734812267757	1.173679983094135	-0.30647321512087117	11	9	ffs`c@L|j@I]xq\\bbbTTvRTLVsARuXNRpDPDEDtdP@@	eFBH@c@@		eMJA@Hz@								8
yRur659G8k4F4G24FN05VN2H!F013920HmV58c03Fk960WV029V12KLl0W89DlFc9022Zc640@4J0445NV0F0	CHEMBL256977	fewaP@G@Peo\bbTTTRRbffjVsNZ}[HRmP@PDMESTD@@	CCOc1ccc2oc(=O)c3c(ccc4[nH]c(=O)cc(C)c43)c2c1OC	8	group1-p	p	Androgen Receptor	Activity at androgen receptor in human Saos2 cells assessed as IL6 repression	2008	fb}@@@LdbbbbbRJvsCBTzHTuUUUUUUT@@	fb}a`@G@QgHheEEDdhmjsfoVbEKT@DABSA@@@	351.357	2.6215	6	1	73.86	3	0.4019743195725525	0.8468357340492048	0.08791376953052951	8	8	fnkaa@Dr|tGbQqrJJKSJIIJEQEgEF\GMXHB``Rfdb@@	eMJA@Hz@	gCaH@`AJZ`@									8
yRur619G8k4F4F24FN01VN2H!F013920HmV58V03Fk9601V028V12FLl0W89Dl0V9022Zc640@4J!458X0G0	CHEMBL257151	ffsa`@D@]UIeYWm[YzLUiwdeZdHBh@bb@@@	Cc1cc(=O)[nH]c2ccc3c(c12)COc1cccc(CO)c1-3	9.52	group1-p	p	Androgen Receptor	Activity at androgen receptor in human Saos2 cells assessed as IL6 repression	2008	flm@@@DjYee]YhTkA}Fjjjjjjj@@	flm``@D@ldrmkZvmFRUYtTmR@EP@Q@@@	293.321	1.5875	4	2	58.56	1	-0.6316576712339833	1.5574758236994692	-1.3679457848663195	11	9	ffs`c@L|j@I]xq\\bbbTTvRTLVsARuXNRpDPDEDtdP@@	eFBH@c@@		eMJA@Df`@								8
=QUvUrblbPvUmv7nmtfLaZJFCntT_Lva7BXYYQkODkMeBISY1jxTx0ctORlIld4Q2bXLGWeSKG471JV8F0	CHEMBL257387	eodTDF@EOK@`IABPpdAiBZPVdLbdLTRbVVTRVbdRldTL\brNnjiB`RjjBhBbHHd@@	Cc1cccc([C@H]2COc3cc4[nH]c(=O)cc(C(F)(F)F)c4cc3N2CC(F)(F)F)c1	6.24	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor in CV1 cells by transcriptional activation assay	2008	fjc@@@DjYUUv]U`nRlEIZjjjjjjj`@@	fjcP`@DFAiIe[UUvUhrRkNrUjP@jh@HbCd@	442.358	4.0471	4	1	41.57	4	-0.036263831203428326	-0.9470039970711086	0.011908807060601876	3	3	eodTDF@EOK@`IABPpdAiBZPVdLbdLTRbVVTRVbdRldTL\brNnjiB`RjjBhBbHHd@@											1
[r:jzyzvjbzyUjxU:jjrwHxUfgUyrlMwafotZQzrKmbHK@g8j6XL5gD2qdKo2Kg280V@1Oi&	CHEMBL257668	ffsaa@AZmDDPrHrJIJHqQSYRJTxYpXiK@DULuUTUHMGH@	CC12CCC(C)(O1)[C@@H]1C(=O)N(c3cc(Cl)cc(Cl)c3)C(=O)[C@@H]12	7.8	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor in MDA453 cells by alkaline phosphatase reporter gene assay	2008	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdua`@D@T[HhhhhdhecQfcVCzKUTCTDUBLIb@@	340.205	2.6058	4	0	46.61	1	-1.1770392291864695	0.7115642598255039	0.8575384460126538	47	25	fa{a``IF\d@RSqYD]\\bbbfJbbfrdTwAV}ENZpQATsUUTUHloP@		eFABH`BL@									1
zTur6M9l8k4k4G34FN2_VN2H!FF13920LmZ58c03Nk96FlV029X12KLl0W89Tl1c9022bc640@BJ04458X8G0	CHEMBL257751	fig`S@CJ\ehIADabPrJPqQJJIJVHjJQkQCghzjPhahXHH@@@	O=c1cc(C(F)(F)F)c2c(ccc3c2oc(=O)c2cccc(O)c23)[nH]1	7.66	group2-a	a	Androgen Receptor	Activity at androgen receptor in human Saos2 cells assessed as IL6 repression	2008	fb}@@@LdbbbTRRRqsMBeZHTuUUUUUUT@@	fb}a`@O@QgHheEDeDmDSPRgVCEKT@@PPsA@@@	347.248	2.4938	5	2	75.63	1	0.12903129851430983	1.0587412586861489	-1.142491196230495	2	2	figa``HzLLCcVP[H]dLbbbTTtrLrbtbXJQg^RV@b@XBfjdb@@	eFJB@Hp@										2
=QUvUrjlbuvUmf7nmvfLaZKHErtTWLui7gmYbAlOEFUmBIQX1UxTt0eOORlIk90Q0bVLFWfSKG47GJV8F0	CHEMBL257988	fcoPbPE^lDD`bPqHMdNr@yB\`nPwHYEHXheDllhdmHiIJLzNZjPhDjjjjhhQ`@	O=c1cc(C(F)(F)F)c2cc3c(cc2[nH]1)OC[C@@H](C(F)(F)F)N3CC(F)(F)F	7.47	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor in CV1 cells by transcriptional activation assay	2008	foQ@@@DjYUU}`nRlzjjjjj`@@	foQP`@DFAiIe[UUhrRkNZd@JjH@@	420.23	2.996	4	1	41.57	4	-0.10333911054294448	-0.23307930618007203	-0.02998018409123831	38	9	fj}Pb`DVXTGbQqcHIdLrBSL}jkORsbmNCUT@EMULP@@	gGPBAHJPtaPCHiCUP@	gJPBAHJPt`PAIjj@@									8
zTur6K9l8k4kZFA4FN0_VN2H04FF13920LmV58VV3Nk96FGV028V12FLp0Wc9Dl0V94@2Zc640@BJ!658X0G0	CHEMBL258190	fnk`P@D@]{NQQIQIZYQPjITXkS`ejuHPETAAQDCT@@	COc1cccc2c1-c1ccc3[nH]c(=O)cc(C)c3c1C(O)O2	7.3	group2-a	a	Androgen Receptor	Activity at androgen receptor in human Saos2 cells assessed as IL6 repression	2008	flm@@@DjYee]YhTkA}Fjjjjjjj@@	flm``@D@ldrmkZvmFRUYtTmR@EP@Q@@@	309.32	1.8894	5	2	67.79	1	-0.16836428662842207	1.5052161816190506	-1.2280069437658894	11	9	ffs`c@L|j@I]xq\\bbbTTvRTLVsARuXNRpDPDEDtdP@@	eFBH@c@@	eFJB@Hp@	eMJA@Hz@								8
yRur659G8k4F4G24FN05VN2H!F013920HmV58c03Fk960WV028V12JLl0W81Dl0c9022Zc640@4J!458V8F0	CHEMBL258241	ffsab@Hb]TDadTRTrbRRaTQhrVk^RV@B``Rfdb@@	Cc1cc(=O)[nH]c2ccc3c4cc(F)ccc4oc(=O)c3c12	7.57	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor african green monkey CV1 cells by cotransfection assay	2008	fb}@@@LdbbbbbRJvsCBTzHTuUUUUUUT@@	fb}a`@G@QgHheEEDdhmjsfoVbEKT@DABSA@@@	295.268	2.456	4	1	55.4	0	-1.1477137760710123	1.1396797092740663	-0.30764227986264714	8	8	fnkaa@Dr|tGbQqrJJKSJIIJEQEgEF\GMXHB``Rfdb@@		eFABP`BL@									8
zyvrDMtl8u4kZFEBFs0_VR2H0ZFF9Y924HmV_8Vk3Nk96FGV1@8V1XFLp0Wc9Dn0V94A2Zc650@4J!658V0F0	CHEMBL258384	figa`@D@\UIeYWmfueZLUipZ}ZdHBjBHRbHFH@@	C=CCC1Oc2cccc(OC)c2-c2ccc3[nH]c(=O)cc(C)c3c21	6.84	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor african green monkey CV1 cells by cotransfection assay	2008	flm@@@DjYee]YhTkA}Fjjjjjjj@@	flm``@D@ldrmkZvmFRUYtTmR@EP@Q@@@	333.386	3.6724	4	1	47.56	3	-0.6546955458706134	-0.15288982342021973	-0.18021548032455392	11	9	ffs`c@L|j@I]xq\\bbbTTvRTLVsARuXNRpDPDEDtdP@@	eFBH@c@@	gC`HL@IVt@@	eMJA@Hz@								8
yRur659G8k4F4G24FN05VN2H!F013920HmV58c03Fk960WV028V12JLl0W89DlFc9022Zc640@4J!45NV0F0	CHEMBL258397	fnk`P@G@PVnQQJJJIIQSZiLykudaru@A@PqSPP@@	COc1ccc2oc(=O)c3c(ccc4[nH]c(=O)cc(C)c43)c2c1	7.32	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor african green monkey CV1 cells by cotransfection assay	2008	fb}@@@LdbbbbbRJvsCBTzHTuUUUUUUT@@	fb}a`@G@QgHheEEDdhmjsfoVbEKT@DABSA@@@	307.304	2.2852	5	1	64.63	1	-0.5245124849897116	1.2654552862660493	-0.1505809006284421	8	8	fnkaa@Dr|tGbQqrJJKSJIIJEQEgEF\GMXHB``Rfdb@@		eMJA@Hz@									8
<jztzfyiy5rzyURvhXUnujBNpfnhI0Mmxr8v2nSlSDblYDQfY5aqUdk381EuFcSdD0rkLKB85JRZrJBY8G0	CHEMBL263091	edRTJB@DgaGH`XPICJPJdJiCHhdieHeYMEIkDeLhiPpml}C@AUUUMU@ASLEAXP@@	COc1ccc(F)cc1C(C)(C)CC(O)(C(=O)Nc1ccc2c(=O)onc(C)c2c1)C(F)(F)F	6.3	group3-int	int	Androgen Receptor	Binding affinity to human recombinant androgen receptor expressed in baculovirus infected Sf9 cells	2010	fns@@@LdbbbRnTVRbRXhTjmjjjjjjjj`@@	fnsQ`@BZ@brSKJ~mjrmNRUUkTBASU@A@@@	482.429	5.1883	7	2	97.22	7	2.5021956396058807	-1.3872172836273184	-0.5173224210335435	2	2	eh\TBJ@Hkk@o`PGGRPRdLi@jPrJJIJSJrZJSVIJYQQcbYZxF@`jjijh@JY`hCB@@	eMJA@Hz@										2
zyQv6nOG8F5k04ACFN2WVOHH040F93104MTZ50V838k1!1!2KV5Z5JW0VX1BWF90Jce18410B011J61!8!	CHEMBL263660	eolXHB@NH`@cJPJdJiCIEEEDdelmEIiXeDZNIKMGEmkgj@H@`ij`@@H@@@@	O=C(CN1c2ccccc2Sc2ccc(C(F)(F)F)cc21)c1cccc2ccccc12	6.6	group3-int	int	Androgen Receptor	Inhibition of wild type androgen receptor expressed in CV1 cells assessed as dihydrotestosterone-stimulated transactivation by CAT reporter gene assay	2007	fm@@@LdbbbTVubbbbRvYhQde[LZzjjjjjjjjjh@@	fmaB@NA@DYHhhhddmcMEDhcSdkZ\wlut@PAAL@@A@@@@	435.468	6.8493	2	0	45.61	4	-0.9050789685644284	-2.8041856573908026	0.9350923312581754	1	1	eolXHB@NH`@cJPJdJiCIEEEDdelmEIiXeDZNIKMGEmkgj@H@`ij`@@H@@@@											1
}y]U:j;xzpzv:Enr<UqrzEQprpjzUjiQfxzynfxStibzrKn8x7KsrMwXcG0	CHEMBL264131	gkIV`Dp@EA`HRY^HdqEbUVoSY\~PRODR@dDDa`dLbdLTRRLTTvbJRRbRfTJRbbtQTTRbbfbLTQtVbrdZ@bSxBMVjtx]^plUIfjBCJfZjzh@JZjjjj`hJhfZ`XHHh`arPiZiVP@	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)CC3OC1C[C@H](NCNC(=O)c2cc(COCC#CCN3C(=O)N(c4ccc(C#N)c(C(F)(F)F)c4)C(=O)C3(C)C)ccc2O)[C@H](O)[C@H](C)O1	7.05	group2-a	a	Androgen Receptor	Inhibition of [3H]mibolerone binding to human Androgen receptor of PC3/AR Cell Lysate	2004	gipD@@@@LdbbbRrVbbbRvfVJTTrTJRRTTRrfRXJAD`HdjCEfpeR}Qnpzjjjjjjjjjjjjjjjjjjjjj@@@	gipD`H@@MeptF@VDcSyr}YlbbbbbRRRJfQbRVRTtRTJRRTTVRfRXBEC`pDrEIbpeRCQnpyh@`AHjjjji`@jnjZd@HJH`SH@@	1069.99	3.5252	21	8	315.05	16	15.688595721548369	-0.4472206759384303	-4.050447768152306	3	2	gkIVaxH@AA`yRL|KFSiLIRkP[LVG[`ND@x|Y@SHRYCHhheDTddheDmDbeEEDhiEEELkDXihbehmMEeHefDbitqFjSKTfW_ktFci``XjjjjzjjhIjhJibXFh@R`jhrh`HNDDQRXd@@	eFJB@Hp@										2
<EMtl9sBmZp3DHc2hXO6HF0GId392VLHZ58eV39lO6FKW0@9X16KLl0c89RnGV9020bV64V@BJF455FV8F0	CHEMBL266473	fj}`c@@jlBPQHXdLbdLTRbVVRrdhshijiB`RjjJBZ@@	CCC1CCc2cc3c(C(F)(F)F)cc(=O)oc3cc2N1	9	group1-p	p	Androgen Receptor	In vitro binding affinity at human androgen receptor transfected into COS cells.	1999	foQ@@@DjYUU}`nRlzjjjjj`@@	foQ``@M@PdrmjjtYIUgMR@EUD@@	297.275	2.8565	3	1	38.33	2	-1.3582555990777343	0.4037654861555366	-0.3820340329072949	38	15	fj}`b`DFbCqDxidLrAYAIeYWUYzhqVg^jhHBifjH@@		eMBD@ch@									11
zrzK1FNG9V4k402DHN212N0H040F9312!HZ182018086&F02F280V102#14@25V2!214!2480c!	CHEMBL266491	fnc`c@E^jBPQHXdLbdLTRRLTRVrejNZhHL``bh@@@	COCCOc1ccccc1-c1ccc(C#N)c(C(F)(F)F)c1	5.65	group4-ia	ia	Androgen Receptor	Displacement of [3H]DHT from human recombinant AR expressed in Sf9 cells	2007	dcl@@DjYU_egZjjjh@@	dcl@@DjYU_egX@@@@@@	321.297	3.8402	3	0	42.25	6	-0.8569215757786386	-0.7173294001409161	0.8637508415162793	30	18	fle`B`N@BSNKoDLBeArJJIIFJJZU`oQ``rBHb@@@	gGPh@Z@ISmU@@		gJPBAHJPt`PAIjj@@								17
<jUzvExanChvTHAMjat3HTJokjn920LH_7Ce2b9kO6kQa8P9X16MLt2c89RnIV9VU4bXL4e@CKN475JV8F0	CHEMBL266928	feg``P@jlBPQHXdBrEYCl`NPgHYEHXheDllheHyIJLyNZjPhDjjjjJGj@@	O=c1cc(C(F)(F)F)c2cc3c(cc2o1)NCCC3C(F)(F)C(F)(F)F	8.3	group1-p	p	Androgen Receptor	In vitro binding affinity at human androgen receptor transfected into COS cells.	1999	foQ@@@DjYUU}`nRlzjjjjj`@@	foQ``@M@PdrmjjtYIUgMR@EUD@@	387.225	3.9497	3	1	38.33	3	-0.7774608161248395	-0.7077965950348288	-0.20221859995351896	38	15	fj}`b`DFbCqDxidLrAYAIeYWUYzhqVg^jhHBifjH@@	dax@X@dDdLdJdFdN@LbdLeUT@@										11
;QAGtl9N4mVJ3BHs28XO0H040Gd310VF2Z10XV10FG0F010@1!4!VFc!43#402W06(6!X8GF	CHEMBL267141	fbmQC@EAlBPQHXdLbdLTRbVVRteF]EMT@@DUTEAL@@	C[C@@H]1CCc2cc3c(C(F)(F)F)cc(O)nc3cc2N1	7.72	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) expressed in CV-1 cell lines	1999	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	282.264	3.1718	3	2	45.15	1	-1.22490272763973	0.4268616106520212	-1.5005626893262543	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@		eFBH@c@@								49
<jUxvEw6k55vTH8M_XN2HD4FkYY920LHZ79e2Y9k96kGX0@9X12MLt2c89RnIV9VE4bX64V@BKN475FV8F0	CHEMBL267270	fns`a`@jlBPQHXdBrEYAladTabbTRrrbTdeF\gMUHTBUUUECu@@	O=c1cc(C(F)(F)F)c2cc3c(cc2o1)NCCC3C(F)(F)F	8.7	group1-p	p	Androgen Receptor	In vitro binding affinity at human androgen receptor transfected into COS cells.	1999	foQ@@@DjYUU}`nRlzjjjjj`@@	foQ``@M@PdrmjjtYIUgMR@EUD@@	337.218	3.2407	3	1	38.33	2	-1.1659852847015417	0.024683108943621107	-0.3143062845059112	38	15	fj}`b`DFbCqDxidLrAYAIeYWUYzhqVg^jhHBifjH@@	gJPBAHJPt`PAIjj@@										11
<hyqujjufhexmkfzEhj_WzxpeTwOGFuFSxtGHghtZS4@Rtx@U2q@NFF@81G652113gN4VF2F018O0203010	CHEMBL267431	ehZXB@@G`Ik`\bbRfRfbTRRTRtJRrhXdt\bJFjzZZfjhJBhjijhjEIiGIEJeA]@	COC[C@]1(OC)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(/C=N/O)cc3)C[C@@]21C	8.05	group1-p	p	Androgen Receptor	Antagonist activity at androgen receptor by cellular reporter gene assay	2012	fag@@@LdbbbbbTRrRJHcR]xjVykUUUUUUUUU@@@	fagA@@@ILkZwKJjmFRtzI^uZtuMUPTEEQXUMQt@@	449.589	5.7573	5	1	68.12	5	0.751703683367879	-1.8071245061255101	0.21495315566164952	15	5	fmAA@E`|^nNQQIYQQJJJJIZ[tX[pRuft\@ESUUSUTeTSbtcSt@@	gGPh@\@ISmU@@	gCiHHL@IKLIH									4
;QAItn9NDmVq3DHsI8XQ4HFJ1nf310VG2p14mV10GG1FB5B@1!4!cFc!J3104402n06F21#4a04X8GF	CHEMBL267471	fi{QC@EAlBPQHXdLbdLTRbVVRTRRdhshij`@@bjjjB`f@@	CC[C@H]1Nc2cc3nc(O)cc(C(F)(F)F)c3cc2CC1(CC)CC	7.32	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) expressed in CV-1 cell lines	1999	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	352.399	5.1358	3	2	45.15	4	-0.472354793362763	-1.3763476230703842	-1.2966002666548524	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@		eMBD@ch@	gJPHD@IVuP@							49
;QAQtn9NBmVq3DHsI8XO4HHJ1If310VG2Z10XV10GG1FB54@1!408VFc!43#402W06!1$a04X8GF	CHEMBL267850	ffcQC@EAlBPQHXdLbdLTRbVVRrdeF]EMT@@DUUPTDp@	CC(C)[C@@H]1CCc2cc3c(C(F)(F)F)cc(O)nc3cc2N1	7.6	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) expressed in CV-1 cell lines	1999	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	310.318	3.8445	3	2	45.15	2	-0.950279023846861	-0.2023877491080527	-1.4247875178107046	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@		gC`HL@Qz`@								49
;QAItn9N6mVL3BHsI8XO0HFJ0lf310VG2p14XV10FG1F85B@1!4!VFc!J3104402n06F21#4a04X8GF	CHEMBL267907	ffcQC@EAlBPQHXdLbdLTRbVVRTTeF]EMT@@DUUPTDp@	C[C@H]1Nc2cc3nc(O)cc(C(F)(F)F)c3cc2CC1(C)C	7.62	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) expressed in CV-1 cell lines	1999	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	310.318	3.7726	3	2	45.15	1	-1.105433238451461	-0.03834135457470189	-1.4512692958261157	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@		eFBH@c@@	eMBH@RZ@							49
;r7Mtl9k4k453BH82_XN2H!FFW3920LHZ58e039k96FGV0@9X12KLl0c89RnGV9020bV64V@BJF455FV8F0	CHEMBL268098	flu`c@@jlBPQHXdLbdLTRbVVRdhshijiB`Rjb@@	O=c1cc(C(F)(F)F)c2cc3c(cc2o1)NCCC3	9	group1-p	p	Androgen Receptor	In vitro binding affinity at human androgen receptor transfected into COS cells.	1999	foQ@@@DjYUU}`nRlzjjjjj`@@	foQ``@M@PdrmjjtYIUgMR@EUD@@	269.221	2.0774	3	1	38.33	1	-1.6278731411454803	1.096976911802349	-0.4583637024827213	38	15	fj}`b`DFbCqDxidLrAYAIeYWUYzhqVg^jhHBifjH@@											11
;QAQtl9R4mVJATHsH8XO1H640ld310VF2Z30XV18FG0F0A0P1!4!cHc!433!482W06%806!X8GF	CHEMBL268326	fj}QC@EAlBPQHXdLbdLTRbVVTQdhshyj`@@bjhIGef@@	C[C@H]1C[C@@H](C)Nc2cc3nc(O)cc(C(F)(F)F)c3cc21	7.82	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) expressed in CV-1 cell lines	1999	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	296.291	3.8508	3	2	45.15	1	-1.182981385286371	-0.03333471355315576	-1.4739429586886343	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@	eFBH@c@@	eFBH@c@@								49
;QfItl9NgmWo3DHs28XO4HF41Id310VF2Z1FXV10GG0F410@1!4!cFc!43#402W06(6!X8GF	CHEMBL268569	ffcQC@EAlBPQHXdLbdLTRbVVRrTeF]EMT@@DUUPTDp@	CCC[C@@H]1CCc2cc3c(C(F)(F)F)cc(O)nc3cc2N1	7.5	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) expressed in CV-1 cell lines	1999	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	310.318	4.0806	3	2	45.15	3	-0.8028504807450796	-0.46514248284721366	-1.3974500203649642	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@		gC`HL@IST@@								49
<EUtl9wBmZpATHcHhXO7HL4Gnd392VLHZ78eV3ClO6FKf0P9X16KLt2c89RnIV90@0bV64V@BKN475FV8F0	CHEMBL269305	ffc`c@@jlBPQHXdLbdLTRbVVTQTeF]GMUHTBUUTP@@	CCC1CC(C)c2cc3c(C(F)(F)F)cc(=O)oc3cc2N1	7.96	group2-a	a	Androgen Receptor	In vitro binding affinity at human androgen receptor transfected into COS cells.	1999	foQ@@@DjYUU}`nRlzjjjjj`@@	foQ``@M@PdrmjjtYIUgMR@EUD@@	311.302	3.5355	3	1	38.33	2	-1.3163340960132195	-0.056430951218327224	-0.3554142520535272	38	15	fj}`b`DFbCqDxidLrAYAIeYWUYzhqVg^jhHBifjH@@	eFBH@c@@	eMBD@ch@									11
[r:jzy;jxyUzxU:jjrwPxUfi@zrlMTbfotZQzrKm_HJ3g8j4XLCgD2y9KoVKB280VA1Oi&	CHEMBL270450	fb}aa@AZmDDPRHRYg^YoYYps`qSfB@jYjjJdFSh@	O=C1[C@@H]2C3CCC(O3)[C@@H]2C(=O)N1c1ccc(Cl)c(Cl)c1	6.32	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor in MDA453 cells by alkaline phosphatase reporter gene assay	2008	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdua`@D@T[HhhhhdhecQfcVCzKUTCTDUBLIb@@	312.151	2.0098	4	0	46.61	1	-1.2967345645586033	1.1738816633612938	0.8082700679390357	47	25	fjcac@AZmD@RSqJxiLs{Lwl{NF\FJ\pPESMUTUHLgP@		eFABH`BL@	eFABH`BL@								8
[r:jzy;jxyUzxU:jjrwPxUfi@zrlMTbfotZQzrKm_HJ3g8j4XLCgD2y9KoVKB280VA1Oi#4!	CHEMBL270586	fb}aa@AZmDEXRHRYgvYoYYps`qSfB@jYjjJdFSh@	O=C1[C@@H]2C3CCC(O3)[C@@H]2C(=O)N1c1ccc(I)c(Cl)c1	6.46	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor in MDA453 cells by alkaline phosphatase reporter gene assay	2008	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdua`@D@T[HhhhhdhecQfcVCzKUTCTDUBLIb@@	403.598	1.8409	4	0	46.61	1	-0.8072111322274215	0.9363017235114055	0.9578642966294664	47	25	fjcac@AZmD@RSqJxiLs{Lwl{NF\FJ\pPESMUTUHLgP@		eFABH`BL@	eFABl`BL@								8
;j;ir<yxtjjzyUjzhzvzjuwFxUvxUvzGMwifyxZPzrqu7Pl8o0z6eM1REYpcJl2Kw29FVPX9c8W!VV	CHEMBL271261	fagI`@DBcTBmYEEEEDiDhh\hj\tyvTmkujjejjjfZfQa\`@	CC12CCC(C)(O1)[C@@H]1C(=O)N(c3c(N)ccc4nccn34)C(=O)[C@@H]12	7.16	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor in MDA453 cells by alkaline phosphatase reporter gene assay	2008	fjs@@@LdbbbTTTVsbEZVg^bgIZjjjjjjjh@@	fjsq`@DBRAQlbbbbbRbbqbhsQkQCeIVjjVjjYjYFDq@@	326.355	0.0104	7	1	89.93	1	0.5793462768060452	2.9895863739376676	0.11040177985180338	4	1	fagI`@DBcTBmYEEEEDiDhh\hj\tyvTmkujjejjjfZfQa\`@											1
[r:jzy;j:Uzx;jjzxFxUvy:rlUwifpzZQzrMnbHMAg8zaXM5hD2pdUoaSg@88V@1SiG5!VV	CHEMBL271262	fagqb@JLu[vPAFRJIQZJZJWJQPeAF\ENRmhFBhYjjjJdN`T@	CC12CCC(C)(O1)[C@@H]1C(=O)N(c3c(N)ccc4ncsc34)C(=O)[C@@H]12	6.92	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor in MDA453 cells by alkaline phosphatase reporter gene assay	2008	fjs@@@LdbbbTTTVsbEZVg^bgIZjjjjjjjh@@	fjsQb@JLLyH@cIEDhmEhh\hbTEjwhirV`XJFZjhjQY^`@	343.406	0.6709	6	1	113.76	1	0.7765504342568496	2.583242780210515	0.11401332561736127	4	1	fagqb@JLu[vPAFRJIQZJZJWJQPeAF\ENRmhFBhYjjjJdN`T@											1
[r<y<xzUzx;jjrwPxUfyezrlMTbfwvgvzrMm_HJ3g8j4XLEhDXz9KqZKB@80VA1Oi!3#	CHEMBL271924	ffsQRBBJxJwl`bBRKlbbbTUTTTvTSINBgIZpPLULuUERGHL@@	O=C1[C@@H]2C3CCC(O3)[C@@H]2C(=O)N1c1ccc(Cl)c([N+](=O)[O-])c1	5.94	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor in MDA453 cells by alkaline phosphatase reporter gene assay	2008	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdua`@D@T[HhhhhdhecQfcVCzKUTCTDUBLIb@@	322.703	0.4822	7	0	92.43	2	0.46057856580940115	2.630898533905609	1.2260460841066394	47	25	fjcac@AZmD@RSqJxiLs{Lwl{NF\FJ\pPESMUTUHLgP@		gChhhE`BRnRYh@	eFABH`BL@								8
}y=yUzxU:jzryPxUfiDzrlMUjfwtZQzrMm_HJ2g8j4XLEgD2yCSqWKD280VA1Oi#8!	CHEMBL271925	fnka``MNBTDPJPeHJdLbbbRdubbfrbYst\ejv@`jjYjjJd^TX@	O=C1[C@@H]2C3CCC(O3)[C@@H]2C(=O)N1c1ccc(Cl)c(C(F)(F)F)c1	5.48	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor in MDA453 cells by alkaline phosphatase reporter gene assay	2008	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdua`@D@T[HhhhhdhecQfcVCzKUTCTDUBLIb@@	345.703	2.2521	4	0	46.61	2	-0.9729067616685485	0.7829783446933501	0.8908491177738377	47	25	fjcac@AZmD@RSqJxiLs{Lwl{NF\FJ\pPESMUTUHLgP@		gJPBAHJPt`PAIjj@@	eFABH`BL@								8
{jzy;jzyUzxU:jjryOxUfi:rlUybfotZQzrKmbHKAg8j6XLCgD2wdKoXKg280VA1Oi#V!	CHEMBL272509	fa{Qb@AJm{H@cIEMDdcEEMeHirS`irUmAAeSMUUERGPJ@@	CSc1cc(N2C(=O)[C@H]3[C@@H](C2=O)C2(C)CCC3(C)O2)ccc1C#N	7.72	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor in MDA453 cells by alkaline phosphatase reporter gene assay	2008	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdua`@D@T[HhhhhdhecQfcVCzKUTCTDUBLIb@@	342.418	1.7066	5	0	95.7	2	0.06980581466301103	1.6040241407019284	1.096100845586446	47	25	fnkac@AZmD@RSqZxiLs{LwmMlxYpXiKA@ULuUUERCIt@@		eMA@HPBN`@	eMbA@Dg`@								6
}yzvjrzyUjxU:jzrwFxUfgUyrlMxafotZQzrKmbHK@g8j6XL5gD2ohKq3Kg280V@1Oi#8!	CHEMBL272510	fa{ac@IV}dD`bPqHYEHXdiihiliEAJ\ENRmj`BJYjjhjPzAP@	CC12CCC(C)(O1)[C@@H]1C(=O)N(c3cccc(C(F)(F)F)c3)C(=O)[C@@H]12	7.44	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor in MDA453 cells by alkaline phosphatase reporter gene assay	2008	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdua`@D@T[HhhhhdhecQfcVCzKUTCTDUBLIb@@	339.312	2.2421	4	0	46.61	2	-1.006092387474561	0.8126896104459093	0.88028073758034	47	25	fnkac@AZmD@RSqZxiLs{LwmMlxYpXiKA@ULuUUERCIt@@		gJPBAHJPt`PAIjj@@									6
{jzy;jzyUzxU:jjryOxUfiUzrlMybfotZQ:KmzHKAg@j6XLhgD2wdKoXKg28FVA1Oi!2Z10	CHEMBL272574	fa{PR@NRLyOPUfQQQIHqQSYRJY`k^bgMXHLjYjjjJlVgef@@	CC12C[C@@H](O)C(C)(O1)[C@H]1C(=O)N(c3ccc(C#N)c(I)c3)C(=O)[C@H]12	7.72	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor in MDA453 cells by alkaline phosphatase reporter gene assay	2008	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdua`@D@T[HhhhhdhecQfcVCzKUTCTDUBLIb@@	438.216	0.8144	6	1	90.63	1	0.8970662895721481	1.975729712383098	0.21189373246385115	47	25	fa{`S@AZmGh@dgbuqRYgvYoZ[v\LxLTe``JfZjjhjpYNaX@		eFABl`BL@	eMbA@Dg`@								1
:UvjQttCR5m1JAUI8HWXN2HL4FkWY9!LmZ78X03Ak96FGX0@OX125Jt2cc1RnIW90AVbV6!8BGOJ710V8F0	CHEMBL27297	ffcQC@EQlBPQHXdLbdLTRbRRJbteF|dmUHTCEUTT@t@@	CCC1CCNc2cc3c(cc21)c(C(F)(F)F)cc(=O)n3C	7.7	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in CV-1 cells using cotransfection assay	1999	foQ@@@DjYUU}`nRlzjjjjj`@@	foQQ@@DZ@drmjjtYIUgMR@EUD@@	310.318	3.0188	3	1	32.34	2	-1.3935472818840497	0.21389364701303576	-0.3749732717830932	38	10	ffcQB`DFRCqDxydBrEYCHhdhdldhhcIQbmNCUPPETsUD@@	eMBD@ch@										4
:UvjQttER5m1JAUI8HWXNXHL4HkWY9!LqZ78X03Ak96FGX0@OY125Jt6cd3RnIW90AVbV6018BGOJ71!8!	CHEMBL27413	fnsQC@EQlBPQHXdLbdLTRbRRJbfdhwdejiB`XjjhhAh@@	CCC1CCN(C)c2cc3c(cc21)c(C(F)(F)F)cc(=O)n3C	6.67	group3-int	int	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in CV-1 cells using cotransfection assay	1999	foQ@@@DjYUU}`nRlzjjjjj`@@	foQQ@@DZ@drmjjtYIUgMR@EUD@@	324.345	3.3771	3	0	23.55	2	-1.7539975004901844	-0.10411380622685132	0.7143251436749033	38	10	fnsQB`DVrCqdxedJrCYCHhheLedeEDYF\t[tZj``JifjH@@	eMBD@ch@										3
:xzCqslde4mZ0Eg2sVhXSH01Z0F9Y024FFVl02k0kkG6FF01@101ZJHZ1Wc!20814180V050204#4%	CHEMBL274318	fhy@`@@\RYee~uYrVoAZB``@HHLh@@	O=C1CC(c2ccccc2)Oc2ccccc21	4.7	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-kb2 cells assessed as inhibition of DHT-induced luciferase activity by luciferase reporter gene assay	2009	fhy@@@LdbbbRnbRYHRoAjjjjjj`@@	fhy@`@@\RYee~uYrVoAZB``@HHLh@@	224.258	3.1928	2	0	26.3	1	-2.631499703726471	0.39797470982643174	0.4410208934129818	32	9	fhy@`@@\RYee~uYrVoAZB``@HHLh@@											1
yRsr468G8V4F4024FN05VN2H!F013A20HFV58#Fk160W!20VC2JLV0W890V0c30280c040204!F502010	CHEMBL274471	fluAb@ANbBHRYWYVUzcMFBf@Bf`P``@@	O=c1cc(-c2ccc(Cl)cc2)oc2cccc(O)c12	6.34	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay	2013	fhy@@@LdbbbRnbRYHRoAjjjjjj`@@	fhy@`@@\RYee~uYrVoAZA``@H@@@	272.686	3.6331	3	1	46.53	1	-1.550934881137493	0.20906947598683273	-0.4236821813021643	32	23	flu@a@ANAxq\TfUvUe^hsQ`i`@ihDHH@@	eFJB@Hp@	eFABH`BL@									18
yRsr468G8V4F40240N05VN2#F013020HFV58#Fk160V!2!90JLV0W810V0c10280V040204#5%	CHEMBL275638	fhy@`@@\RYee~uYrVoAZA``@H@@@	O=c1cc(-c2ccccc2)oc2ccccc12	5.23	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-kb2 cells assessed as inhibition of DHT-induced luciferase activity by luciferase reporter gene assay	2009	fhy@@@LdbbbRnbRYHRoAjjjjjj`@@	fhy@`@@\RYee~uYrVoAZA``@H@@@	222.242	3.3728	2	0	26.3	1	-2.6505853743610346	0.2972438614287886	0.43864167765840234	32	23	fhy@`@@\RYee~uYrVoAZA``@H@@@											1
;j;irUyEQwpcg7zPEbp9IIZYmR0GPcVQkm10Z09Zk48SN4040F0V094%2#NF08+X0G0	CHEMBL276621	elVXL@@G`AklbbRfbTrRTrbRNRTrRhXTt|bJZZjjjjjjjjfjjk`bLHQZQrQHi@@	CCCCNC(=O)CCCCCCCC1C[C@H]2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12	5.2	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor expressed in HeLa cells assessed as inhibition of dihydrotestosterone-induced transcriptional activity by reporter gene assay	2007	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmUUUUUUDIAITM@@	487.766	7.0433	4	2	66.4	11	1.847095897878382	-3.594062283263138	-0.7385304024562873	50	19	ffs@b@Bu@xyEEDhheDhdbV\d{tTyjjjjjjijnHQIRLWEI^P@	do^H`DApAIeUUuZjjjh@@										19
xvojgyqXbEu@9cpVZ3z@Cbp1IGZXHR0GFc0Okk10Z09ZF48RN4040F#1&2#8F-2010	CHEMBL27769	fjc@`@@ErJIJZIPiSQJcEZ]zNVjjjjjjjnDcDIZeiyQP@	C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O	8.59	group1-p	p	Androgen Receptor	Displacement of [17-alpha-methyl-3H]-mibolerone from human androgen receptor T877A mutant expressed in HEK293 derived FreeStyle293F cells after 3 hrs	2012	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmUUUUUUDIAITM@@	290.445	3.6007	2	1	37.3	0	-2.0076697316539303	0.09495823074342352	-0.5327754094759475	50	19	ffs@b@Bu@xyEEDhheDhdbV\d{tTyjjjjjjijnHQIRLWEI^P@											19
yRsr468G8V4F4024FN05VN2H!F013920HHV58#Fk160W!20VC2KLW0d890V0c10280c04V@04!F5F2010	CHEMBL28	fbmAP@@\e{NQQQJJKFIKYgEFbehFH`HB`@@	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12	5.28	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-kb2 cells assessed as inhibition of DHT-induced luciferase activity by luciferase reporter gene assay	2009	fhy@@@LdbbbRnbRYHRoAjjjjjj`@@	fhy@`@@\RYee~uYrVoAZA``@H@@@	270.239	2.3357	5	3	86.99	1	0.18972290035283923	1.508806939305342	-2.3278402744569413	32	23	fbmAa@ANrCqbxiLklkJ|tYhpTp@TtBDQ@@@	eFJB@Hp@	eFJB@Hp@									1
;Q3QtG9R4k04@THNH0XN0H640kW31!F2o30X018F1#20@1$8cHe!432!482l06%806!X8GF	CHEMBL281028	fj}QC@EAlBPQHXdLbdLTRbVVTbdhshej`@@bjhH@@	CC1(C)CCNc2cc3nc(O)cc(C(F)(F)F)c3cc21	7.8	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in CV-1 cells using cotransfection assay	1999	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	296.291	3.2981	3	2	45.15	1	-1.1569765764319575	0.29892009335228154	-1.4768233322860111	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@	eMBH@RZ@									49
;QfQzvESqn9DvTHQM@XtZHqJZkhrGF0G2Z34X2W8F18F2L4A130408cHc!J32044O2W0D02#84aF0X8GF	CHEMBL281945	fegQA`EAlBPQHXdNr@yB\adTabbTRrrbRJddhshyj`@@bjjj`hQP@	C[C@H]1CNc2cc3nc(O)cc(C(F)(F)F)c3cc2C1CCC(F)(F)F	7.21	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in CV-1 cells was determined as a function of maximal inhibition of dihydrotestosterone using cotransfection assay	1999	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	378.315	5.1885	3	2	45.15	4	-0.33835587129536615	-1.5041328347385365	-1.253681266450453	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@	gNpBAHJPt`pCHiBjj`@		eFBH@c@@							49
;QfQtOCRBm14@THNH0YN0HL40kWY1!F2p30X018FW#20@1$8cHe!J32!492l06%846!X8GF	CHEMBL282866	fnsQC@EAlBPQHXdLbdLTRbVVTbrdhshej`@@bjj``@@	CCC1(CC)CCNc2cc3nc(O)cc(C(F)(F)F)c3cc21	7.14	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in CV-1 cells using cotransfection assay	1999	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	324.345	4.2069	3	2	45.15	3	-0.7349241800438624	-0.5930842566406135	-1.3737106118660647	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@	gJPHD@IVuP@									49
;Q3QtG9R4k04@THNH0XN0H640kW31!F2Z30X018F1#20@1%cHc!432!482W06%806!X8GF	CHEMBL283449	fbmQC@EAlBPQHXdLbdLTRbVVTTeF]GMT@@DUTECu@@	CC1CCNc2cc3nc(O)cc(C(F)(F)F)c3cc21	6.59	group3-int	int	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in CV-1 cells using cotransfection assay	1999	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	282.264	3.5261	3	2	45.15	1	-1.2415727179423581	0.2138746804221826	-1.498716269296596	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@	eFBH@c@@									49
;Q3QtG9R4k04@THNH0XN0H640kW31!H2Z70X018F1!120@1%cHc11432!J8XW06%8F610X8GF	CHEMBL285602	ehRTHI@E@k@IABPpdMi@zPndGiCzPAdLbdLTRbVVTRaRbtbddTL\RrzFj`@@bj`@jjhH`|h@@	Oc1cc(C(F)(F)F)c2cc3c(cc2n1)NCCC3c1cc(C(F)(F)F)cc(C(F)(F)F)c1	6.6	group3-int	int	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in CV-1 cells using cotransfection assay	1999	fb}@@@DjYeeuu~ZD[rXyjjjjjjjh@@	fb}P@@@JRfV_UnuipTcNSd@@Bj`@BHZh@@	480.329	5.4875	3	2	45.15	4	0.1848004677595433	-2.0621761177210947	-1.0842607513608236	1	1	ehRTHI@E@k@IABPpdMi@zPndGiCzPAdLbdLTRbVVTRaRbtbddTL\RrzFj`@@bj`@jjhH`|h@@											1
yTuM2M9G8k4kZFA4FNH5VR2H04FF13A2VHHo58VV3Nk96F10128V52F2p0dc1DG10AJ@Xbca40@4K0FL58V0F0	CHEMBL286595	ec`XHH@Ba@HcHhdlheEEDdhilyPpYYEUdLuM@AU@A@PqTPTGE@@	CC1=CC(C)(C)Nc2ccc3c(c21)C(c1ccc(Cl)cc1)Oc1ccccc1-3	5.81	group4-ia	ia	Androgen Receptor	Antagonistic activity was determined in Human androgen receptor(hAR) of CV-1 cells in cotransfection assay.	1998	fag@@@DjYfYUUW}aaNCUKR}jjjjjjjjj`@@	faga@@B`rQQQQIQKQIYHtyIwli[WmAT@@DAI@EAE@@	387.909	6.1079	2	1	21.26	1	-1.7118190832117275	-2.0121486457610427	-0.374055439548298	14	13	egdXHL@Fe@@dcqX\\bbbfJbTTTRRbfsg@cgfWURpvtDPUP@PDLUDEAIP@@			eFABH`BL@								13
;G3GtG9F4k042BHN20XN0H040FW31!F2Z10X010F1%@1%VFc!43#402W06(6!X8GF	CHEMBL286684	fluQC@EAlBPQHXdLbdLTRbVVRdhshij`@@bjB@@	Oc1cc(C(F)(F)F)c2cc3c(cc2n1)NCCC3	7.92	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in CV-1 cells using cotransfection assay	1999	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	268.237	2.8471	3	2	45.15	1	-1.2834942322245846	0.6740709744710729	-1.5253360489078553	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@										49
RuJfgem0b8se989V19Q889p1MONX8Z01FNFG8s02g8tZ44@BFo850k0FF10c0F212F808Q/!	CHEMBL292284	fcA`@@]WdTRTtTTjTtRabLhqQoARUijjjjjjZZjXq\PdzART@	CC(=O)C[C@]1(C(C)=O)CC[C@H]2C3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C	8.21	group1-p	p	Androgen Receptor	Antagonist activity against Androgen receptor	2003	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmMUUUUUHDcP@	384.558	4.4756	3	0	51.21	3	-0.8851736437716282	-0.9056960022271495	0.9156428814318567	50	1	fcA`@@]WdTRTtTTjTtRabLhqQoARUijjjjjjZZjXq\PdzART@											1
;UAQtl9w4mZJATHsH9XO3m640Wd392VFHp38XV3OkO6NWA0P1X56F2d2W!TIIV90@2acqB0@5J8064BY0F0	CHEMBL293409	fa{Q`BHI@aTIQvQSQISJIKSJHs`mV|GMV`@hHBjjHhQh@@	CC1CC(C)(C)Nc2ccc3c(c21)COc1ccc([N+](=O)[O-])cc1-3	7.2	group2-a	a	Androgen Receptor	Inhibition of antagonist activity towards Androgen receptor	2003	fdu@@@DjYee]}faRlGtZjjjjjj`@@	fdua@@O@RfVU^]zLEhs`qhJ@@bhB@@	324.379	3.2167	5	1	67.08	1	-0.43901440213588927	0.6601372859051531	-0.11139349064405457	10	2	ffsaB@@b@xyEDeLhdmLhcJLejshy`@hHBjjHh^h@@	gChhhE`BRnRYh@										1
zRsr468K8X4F4064VN0_VN2#F013020LFV58#Fk160V!21090JLV0W81FV0c10280V040204440502010	CHEMBL294009	fdeA`@@DDdsMr|{lEipXmRE@@A@@@	O=c1c(O)c(-c2ccccc2)oc2ccccc12	4.63	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-kb2 cells assessed as inhibition of DHT-induced luciferase activity by luciferase reporter gene assay	2009	fhy@@@LdbbbRnbRYHRoAjjjjjj`@@	fhy@`@@\RYee~uYrVoAZA``@H@@@	238.241	2.873	3	1	46.53	1	-1.696565513779404	0.7937353517733605	-0.48432207654961723	32	23	fbmAa@AZ|CqRxiLkllvoTXZt\p@Tu@aA@@@											1
yTur2K9G8k4kZFA4FNH5VN2H!FF1392VHHo58VV3Nk96FW!28V92JLp0Wc1Dl1V9022bca40@4J!458V0F0	CHEMBL302362	ekhXH@@L`LdTTTRRVbbrbbqLhxdl\RJfFVhI`HB@fHb`H@`hP	CC1=CC(C)(C)Nc2ccc3c(c21)/C(=C/c1ccccc1C)Oc1ccccc1-3	5.97	group4-ia	ia	Androgen Receptor	Inhibitory activity (IC50) against human androgen receptor expressed in CV-1 cells	1998	fiw@@@LdbbbbbRrVtQVXXRgIcWhzjjjjjjjjj@@	fiwa@@L`RfYeUygU~gIV\doVchI`HB@dH@`DJH	379.502	6.3143	2	1	21.26	1	-1.7658030100890496	-2.1050499387562045	-0.3868133392167492	10	9	ekhXHH@Ji@GGHhhdcDhhhdeEMgFNKGDfbinehBAj@B@abh``HND	eFBH@c@@										2
:xzxiySzjwzU9SywEvDft6Q:NXRfCYHkHGOQBHWdphoJ36Fj90WZ1Pl08g8NHOZ0c94Q835284lc22JB2010	CHEMBL3039217	fnkA`@@HSdTRfRfbTJTJaJBeYt\mSUUPAEUPcdd`@	CC(C)c1ccc2c(c1O)CC[C@H]1C3=C(CC[C@]21C)C(=O)OC3	6.32	group3-int	int	Androgen Receptor	Antagonist activity at AR F876L mutant (unknown origin) expressed in human PC3 cells assessed as inhibition of DHT-induced receptor transactivation after 24 hrs by PSA-luciferase reporter gene assay	2016	fdu@@@LdbbbTRerwIBMiw`uUUUUUU@@@	fdu@`@@HRY[VumRTEHu`qZfjj@Bhar@@	312.408	3.6924	3	1	46.53	1	-1.3445417250796283	0.026119907505670836	-0.35801130204630394	1	1	fnkA`@@HSdTRfRfbTJTJaJBeYt\mSUUPAEUPcdd`@											1
;UvUztUUxYfwzUFfWP7whLq45A_eANdcD2lFVY67!FF7A01F_081c86J22B!2@01FV1B080k3106V02V10	CHEMBL3084689	fdeQB@NRbBHrJJIIFJJJlE[s`pPYUUTUaRu@h@	N#Cc1ccc(N2[C@H]3CC[C@@H]2C[C@H](O)C3)cc1Cl	7.5	group2-a	a	Androgen Receptor	Displacement of [3H]R1881 from pSG5-tagged human androgen receptor expressed in COS1 cells assessed as relative binding inhibition	2015	fgA@@@DjYVY~FeiUjjjjjh@@	fgA`@@@YIEEEDe^RD[Uj`j`baBEb@@	262.739	2.4383	3	1	47.26	1	-1.5353604301925752	0.9695630329757257	-0.4444182772656382	6	1	fdeQB@NRbBHrJJIIFJJJlE[s`pPYUUTUaRu@h@											1
yTuM2M9G8k4kZFA4FNH5VR2H04FF13A2VHHo58VV3Nk96F10128V52G2p0dc1DG10AJ@Xbca40@4K0FL58V0F0	CHEMBL317921	ekhXHD@Ji@H`bHrJJKKQJJJIIQSYqcbqqIhj[iZB@j`@`HXjHJ@R`@	CC1=CC(C)(C)Nc2ccc3c(c21)C(c1ccc(Cl)c(Cl)c1)Oc1ccccc1-3	6.02	group3-int	int	Androgen Receptor	Antagonistic activity was determined in Human androgen receptor(hAR) of CV-1 cells in cotransfection assay.	1998	fag@@@DjYfYUUW}aaNCUKR}jjjjjjjjj`@@	faga@@B`rQQQQIQKQIYHtyIwli[WmAT@@DAI@EAE@@	422.354	6.7139	2	1	21.26	1	-1.5589379613224255	-2.504177428218079	-0.31421863106503434	14	13	egdXHL@Fe@@dcqX\\bbbfJbTTTRRbfsg@cgfWURpvtDPUP@PDLUDEAIP@@	eFABH`BL@		eFABH`BL@								13
:Uvzv;S:vyQzUzUfHQvUECfr_nS5b7zKEDnfPUWReobfTHpbpj7SCo2YmEcmdxCtXYH_G10o1GFr0VVcFF	CHEMBL3183409	ehRZDJ@DLOKoeG`@ajPfdEiCZPrJJJJIQQKIYJERYVFcasHHiKijjAB`BJJjvj@@@	CNC(=O)c1ccc(N2C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1F	7.8	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	ffs@@@LddTTVbQVbrqILyyIZuUUUUUUUP@@	ffsqB@DX|h@PdsLrsKk}NNrDjZmUPHT@PT@@@	477.441	2.6891	7	1	121.42	4	2.231050084835989	0.6875301373378468	0.531447707749801	13	2	eghRHF@ACJkh`GDbPtBEiCZPNdLbbbvTTTfRtJRRdSGAegbSWTDATuTp@UUe@@@	gJYHDL@ILmP@										2
yTuM2M9G8k4kZFA4FNH5VR2H04FF1392VHHo58VV3Nk96F10128V12F2p0Wc1DG109J@Xbca40@4J0F658V8F0	CHEMBL318513	eolXHL@Nm@IABPpdLbdLRTLRbbbRTTv\Dd|BJFZvfNj`@j`@`HXjHJAR`@	CC1=CC(C)(C)Nc2ccc3c(c21)C(c1cccc(C(F)(F)F)c1)Oc1ccccc1-3	6.5	group3-int	int	Androgen Receptor	Antagonistic activity was determined in Human androgen receptor(hAR) of CV-1 cells in cotransfection assay.	1998	fag@@@DjYfYUUW}aaNCUKR}jjjjjjjjj`@@	faga@@B`rQQQQIQKQIYHtyIwli[WmAT@@DAI@EAE@@	421.461	6.3502	2	1	21.26	2	-1.387991280321673	-2.403051964428987	-0.291476389713496	14	13	egdXHL@Fe@@dcqX\\bbbfJbTTTRRbfsg@cgfWURpvtDPUP@PDLUDEAIP@@	gJPBAHJPt`PAIjj@@										13
yTuM2M9G8k4kZFA4FNH5VR2H04FF13A2VHHo58VV3Nk96F10128V12F2p0Wc1DG10AJ@Xbca40@4J0F658V0F0	CHEMBL320690	ec`XHH@Ba@HcHhdhXeEEDdhilyPpYYEUdLuM@AU@A@PqTPTGE@@	CC1=CC(C)(C)Nc2ccc3c(c21)C(c1cccc(Cl)c1)Oc1ccccc1-3	6.6	group3-int	int	Androgen Receptor	Antagonistic activity was determined in Human androgen receptor(hAR) of CV-1 cells in cotransfection assay.	1998	fag@@@DjYfYUUW}aaNCUKR}jjjjjjjjj`@@	faga@@B`rQQQQIQKQIYHtyIwli[WmAT@@DAI@EAE@@	387.909	6.1079	2	1	21.26	1	-1.7118190832117275	-2.0121486457610427	-0.374055439548298	14	13	egdXHL@Fe@@dcqX\\bbbfJbTTTRRbfsg@cgfWURpvtDPUP@PDLUDEAIP@@	eFABH`BL@										13
:Uvzv:rS:vyvvEjUvUvzhUQzjjpJSzvpvCuIbwDzgjZTzyqO5ss8o@za9nGydYp960QGCP81GFX0c20V8Fk	CHEMBL3221237	elQZDH@JAmc`RN`ICHhhmEEidmMDcLeDddfNCG@hljkghTZVjjjjjijZ`BjCab\RQFSrQKI@@	CN1C(=O)C(F)=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](C(=O)NCc5nc6cccnc6[nH]5)CC[C@H]4[C@@H]3CC[C@@H]12	6.71	group3-int	int	Androgen Receptor	Displacement of [3H]mibolerone from human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting analysis	2013	eobP@@@LdbbbTRaJRLVTRRRxTDLt\|BfVn^jjjjjjjjjjjj@@@	eobZD@@DBnac`LdfUm[Vu{VUUhXdTl\BbfVn^ZfjjjjZfh@j`hH`bTadBP@	479.598	2.6576	7	2	90.98	3	1.8718460901741267	0.5821308983097407	-0.6554811416079209	1	1	elQZDH@JAmc`RN`ICHhhmEEidmMDcLeDddfNCG@hljkghTZVjjjjjijZ`BjCab\RQFSrQKI@@											1
>U:rrxUqujzETmqS9PghepCYyDBMirEAY1YEJG0X3VTIrmFZnbd8VHOCWFFu19o18KG06565lbGR2V10	CHEMBL3233069	fmwPR@@kIHw`QFQQQIIYRFFJIKSLEfoYpPQUTuAAFQAR@@	COc1ccc(OC[C@](C)(O)C(=O)N2CCc3c(C#N)cccc32)c(Cl)c1	8.46	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting	2014	fbm@@@DjU_YnUz\\ENZjjjjjjh@@	fbm``@D@TdsKJn}krQgIruTEA@@P@@@	386.834	2.9536	6	1	82.79	5	1.0338803061932813	0.33949039010590226	0.22296609556268993	26	26	fmwQc@@kd[p@dgcqqrJJKPiJSPqQIZY`lu{NBBJjfhHHrHZP@	eFABH`BL@		eMJA@Hz@								26
>U:rrxUqujzETmqS9PghepCYyDBMirEAY1YEJG0X3VTIrmFZnbd8VHG5W0Fu19o18KG06565lbGB2c10	CHEMBL3233070	fegQa@OSEipHadadTRTJRdtLTRVfiqIVc`BJjfhHHrHJP@	C[C@](O)(COc1ccc(Cl)cc1F)C(=O)N1CCc2c(C#N)cccc21	8.3	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting	2014	fbm@@@DjU_YnUz\\ENZjjjjjjh@@	fbm``@D@TdsKJn}krQgIruTEA@@P@@@	374.798	3.1244	5	1	73.56	4	0.4106787316908923	0.2137148703194648	0.0659046466922993	26	26	fmwQc@@kd[p@dgcqqrJJKPiJSPqQIZY`lu{NBBJjfhHHrHZP@	eFABP`BL@		eFABH`BL@								26
>U:rrxUqujzETmqS9PghepCYyDBMirEAY1YEJG0X3VTIrmFZnbd8VHG5W0Fu19o18KG06565lbGB2V10	CHEMBL3233071	fegQa@OSIipHbTQdTTRRQdtLTRVfXIIVc``bjfhHHrHJP@	C[C@](O)(COc1ccc(Cl)cc1Cl)C(=O)N1CCc2c(C#N)cccc21	8.04	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting	2014	fbm@@@DjU_YnUz\\ENZjjjjjjh@@	fbm``@D@TdsKJn}krQgIruTEA@@P@@@	391.253	3.6296	5	1	73.56	4	0.4735637894098068	-0.1510056618637561	0.09561387273200868	26	26	fmwQc@@kd[p@dgcqqrJJKPiJSPqQIZY`lu{NBBJjfhHHrHZP@	eFABH`BL@		eFABH`BL@								26
>U:rrxUqujzETmqS9PghepCYwDBMirEAY1YEJG0X3VTIrmFZnbd8VHG5W0Fs19o18KG06565lbGB2g10	CHEMBL3233072	fegQa@OSEipLQdadTRTJRdtLTRVfiqIVc`BJjfhHHrHJP@	C[C@](O)(COc1ccc(Br)cc1F)C(=O)N1CCc2c(C#N)cccc21	7.43	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting	2014	fbm@@@DjU_YnUz\\ENZjjjjjjh@@	fbm``@D@TdsKJn}krQgIruTEA@@P@@@	419.249	3.2436	5	1	73.56	4	0.6391573618748236	-0.022780140879007704	0.13966918682641968	26	26	fmwQc@@kd[p@dgcqqrJJKPiJSPqQIZY`lu{NBBJjfhHHrHZP@	eFABP`BL@		eFACD`BL@								26
>U:rrxUqujjETmqS9PghepCYoDBMgrEAY1WDJG0X3VTIqmFZm_c8VHG5W0Fk19o18KG06125laGB2V10	CHEMBL3238273	fakQ`@DE@prSLts{msoKShmzuUPTE@XDDLP@	C[C@](O)(COc1ccccc1)C(=O)N1CCc2c(C#N)cccc21	7	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting	2014	fbm@@@DjU_YnUz\\ENZjjjjjjh@@	fbm``@D@TdsKJn}krQgIruTEA@@P@@@	322.363	2.4176	5	1	73.56	4	0.16780171756006945	0.8330519332066024	-0.024059695260879685	26	26	fmwQc@@kd[p@dgcqqrJJKPiJSPqQIZY`lu{NBBJjfhHHrHZP@											26
>U:rrxUqujzETmqS9PghepCYwDBMgrEAY1YEJG0X3VTIqmFZm_c8VHG5W0Fs19o18KG06125lbGB2c10	CHEMBL3238274	fi{Qb@GCxjpICHhdldiMCEDeijLcfoX@JjfhHHrHRP@	C[C@](O)(COc1ccc(F)cc1)C(=O)N1CCc2c(C#N)cccc21	7.9	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting	2014	fbm@@@DjU_YnUz\\ENZjjjjjjh@@	fbm``@D@TdsKJn}krQgIruTEA@@P@@@	340.353	2.5184	5	1	73.56	4	0.25779760980158994	0.7057436527765009	0.006067838209035574	26	26	fmwQc@@kd[p@dgcqqrJJKPiJSPqQIZY`lu{NBBJjfhHHrHZP@			eFABP`BL@								26
>U:rrxUqujjETmqS9PghepCYoDBMgrEAY1WDJG0X3VTIqmFZm_c8VHO5W0Fk19o18KG06125laGB2c10	CHEMBL3238275	fi{Qb@GCXjpICHhdiliMCEDeij\cfoX@bjfhHHrHRP@	C[C@](O)(COc1cccc(F)c1)C(=O)N1CCc2c(C#N)cccc21	7.47	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting	2014	fbm@@@DjU_YnUz\\ENZjjjjjjh@@	fbm``@D@TdsKJn}krQgIruTEA@@P@@@	340.353	2.5184	5	1	73.56	4	0.25779760980158994	0.7057436527765009	0.006067838209035574	26	26	fmwQc@@kd[p@dgcqqrJJKPiJSPqQIZY`lu{NBBJjfhHHrHZP@		eFABP`BL@									26
>U:rrxUqujjETmqS9PghepCYoDBMgrEAY1WDJG0X3VTIrmFZmbc8VHG5W0Fk19o18KG06165laGB2c10	CHEMBL3238276	fi{Qb@GCHjpICHhhdmiMCEDeifBcfoXHHjfhHHrHRP@	C[C@](O)(COc1ccccc1F)C(=O)N1CCc2c(C#N)cccc21	8	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting	2014	fbm@@@DjU_YnUz\\ENZjjjjjjh@@	fbm``@D@TdsKJn}krQgIruTEA@@P@@@	340.353	2.5184	5	1	73.56	4	0.25779760980158994	0.7057436527765009	0.006067838209035574	26	26	fmwQc@@kd[p@dgcqqrJJKPiJSPqQIZY`lu{NBBJjfhHHrHZP@	eFABP`BL@										26
>U:rrxUqujzETmqS9PghepCYyDBMgrEAY1YEJG0X3VTIqmFZm_c8VHG5W0Fu19o18KG06125lbGB2V10	CHEMBL3238277	fi{Qb@GCxjpHcHhdldiMCEDeijLcfoX@JjfhHHrHRP@	C[C@](O)(COc1ccc(Cl)cc1)C(=O)N1CCc2c(C#N)cccc21	7.44	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting	2014	fbm@@@DjU_YnUz\\ENZjjjjjjh@@	fbm``@D@TdsKJn}krQgIruTEA@@P@@@	356.808	3.0236	5	1	73.56	4	0.3206828282316604	0.34102300742459307	0.03577711446489268	26	26	fmwQc@@kd[p@dgcqqrJJKPiJSPqQIZY`lu{NBBJjfhHHrHZP@			eFABH`BL@								26
>U:rrxUqujjETmqS9PghepCYqDBMgrEAY1WDJG0X3VTIqmFZm_c8VHO5W0Fm19o18KG06125laGB2V10	CHEMBL3238278	fi{Qb@GCXjpHcHhdiliMCEDeij\cfoX@bjfhHHrHRP@	C[C@](O)(COc1cccc(Cl)c1)C(=O)N1CCc2c(C#N)cccc21	6.97	group3-int	int	Androgen Receptor	Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting	2014	fbm@@@DjU_YnUz\\ENZjjjjjjh@@	fbm``@D@TdsKJn}krQgIruTEA@@P@@@	356.808	3.0236	5	1	73.56	4	0.3206828282316604	0.34102300742459307	0.03577711446489268	26	26	fmwQc@@kd[p@dgcqqrJJKPiJSPqQIZY`lu{NBBJjfhHHrHZP@		eFABH`BL@									26
>U:rrxUqujjETmqS9PghepCYqDBMgrEAY1WDJG0X3VTIrmFZmbc8VHG5W0Fm19o18KG06165laGB2V10	CHEMBL3238279	fi{Qb@GCHjpHcHhhdmiMCEDeifBcfoXHHjfhHHrHRP@	C[C@](O)(COc1ccccc1Cl)C(=O)N1CCc2c(C#N)cccc21	7.25	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting	2014	fbm@@@DjU_YnUz\\ENZjjjjjjh@@	fbm``@D@TdsKJn}krQgIruTEA@@P@@@	356.808	3.0236	5	1	73.56	4	0.3206828282316604	0.34102300742459307	0.03577711446489268	26	26	fmwQc@@kd[p@dgcqqrJJKPiJSPqQIZY`lu{NBBJjfhHHrHZP@	eFABH`BL@										26
>U:rrxUqujzETmqS9PghepCYwDBMgrEAY1YEJG0X3VTIqmFZm_c8VHG5W0Fs19o18KG06125lbGB2Z10	CHEMBL3238280	fi{Qb@GCxjpLSHhdldiMCEDeijLcfoX@JjfhHHrHRP@	C[C@](O)(COc1ccc(Br)cc1)C(=O)N1CCc2c(C#N)cccc21	8.62	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting	2014	fbm@@@DjU_YnUz\\ENZjjjjjjh@@	fbm``@D@TdsKJn}krQgIruTEA@@P@@@	401.259	3.1428	5	1	73.56	4	0.5491614584155916	0.10452799622612052	0.10954165459901306	26	26	fmwQc@@kd[p@dgcqqrJJKPiJSPqQIZY`lu{NBBJjfhHHrHZP@			eFACD`BL@								26
>U:rrxUqujzUTmqS9PghepCYxDBMgrEAY1YEJG0X3VTIqmJZm_c8VHG5WFFs59o18KGV6135lbGB2c10	CHEMBL3238281	fcoQc@H{UXHIADabPrJPqIYIRZFJIKSBdUhuuP@UUMPPQdPL`@	C[C@](O)(COc1ccc(C(F)(F)F)cc1)C(=O)N1CCc2c(C#N)cccc21	7.48	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting	2014	fbm@@@DjU_YnUz\\ENZjjjjjjh@@	fbm``@D@TdsKJn}krQgIruTEA@@P@@@	390.36	3.2659	5	1	73.56	5	0.6445104816282705	-0.04988005474969047	0.11835611284103839	26	26	fmwQc@@kd[p@dgcqqrJJKPiJSPqQIZY`lu{NBBJjfhHHrHZP@			gJPBAHJPt`PAIjj@@								26
>U:rrxUqujzETmqS9PghepCYwDBMgrEAY1YEJG0X3VTIqmFZm_c8VHG5WFFs19o18KG06125lbGB2V10	CHEMBL3238282	fegPP@DE@pptfYigw[g_YZ]EoVjjB`hC@jBFH@	COc1ccc(OC[C@](C)(O)C(=O)N2CCc3c(C#N)cccc32)cc1	6.84	group3-int	int	Androgen Receptor	Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting	2014	fbm@@@DjU_YnUz\\ENZjjjjjjh@@	fbm``@D@TdsKJn}krQgIruTEA@@P@@@	352.389	2.3476	6	1	82.79	5	0.8809991843039789	0.8315191725629383	0.16312928707942626	26	26	fmwQc@@kd[p@dgcqqrJJKPiJSPqQIZY`lu{NBBJjfhHHrHZP@			eMJA@Hz@								26
>U:rrxUrujzUTrqSAPghepCYxDBMwrEAf1YUJG0XYVTIqmJaqpc8WHG5WFss19o18KKV6125lrGB2V10	CHEMBL3238283	fcoQP@H{@aU`yEDidldiMCEDeiaRJtZvh@JjfhHHrHFP@	COC(=O)c1ccc(OC[C@](C)(O)C(=O)N2CCc3c(C#N)cccc32)cc1	6.88	group3-int	int	Androgen Receptor	Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting	2014	fbm@@@DjU_YnUz\\ENZjjjjjjh@@	fbm``@D@TdsKJn}krQgIruTEA@@P@@@	380.399	2.3306	7	1	99.86	6	1.7071834535295132	0.863109541436947	0.3672332562617687	26	26	fmwQc@@kd[p@dgcqqrJJKPiJSPqQIZY`lu{NBBJjfhHHrHZP@			gJPh@l@ILmP@								26
>U:rrxUqujzUTnqS9ughupCYxDBMwrEAY1YEJG4YYVTIqmRam_cNVHG5WFkt1Ao18KGV6125lbGB2V1V	CHEMBL3238284	ek`\B@@DBi`FCCdfYigw[g_YYMGHfnmcfjjB`hC@iZB`p`@	C[C@](O)(COc1ccc(-c2cocn2)cc1)C(=O)N1CCc2c(C#N)cccc21	6.75	group3-int	int	Androgen Receptor	Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting	2014	fig@@@LdbbRRjRTTtRVxhTluzNjjjjjjjjj@@	figQ`@DU@hZSLlj{vnr|dYr\}FuTEA@@TmA@@@	389.41	2.7402	7	1	99.59	5	1.5724853807530677	0.7023066459641885	0.3574009939602865	1	1	ek`\B@@DBi`FCCdfYigw[g_YYMGHfnmcfjjB`hC@iZB`p`@											1
>U:rrxUqujzETmqS9PghepCYxDBMgrEAY1YEJG0X3VTIqmFZm_c8VHG5W0Fs19o18KGV6125lbGB2V10	CHEMBL3238285	fegq`@DEfAadfYigw[g_YZ]EoVjjB`hC@nBFH@	C[C@](O)(COc1ccc(C#N)cc1)C(=O)N1CCc2c(C#N)cccc21	7.79	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting	2014	fbm@@@DjU_YnUz\\ENZjjjjjjh@@	fbm``@D@TdsKJn}krQgIruTEA@@P@@@	347.373	2.2532	6	1	97.35	4	0.9346689231106691	1.134492765935292	0.16533783078291386	26	26	fmwQc@@kd[p@dgcqqrJJKPiJSPqQIZY`lu{NBBJjfhHHrHZP@			eMbA@Dg`@								26
>U:rrxUqujjUTmqS9PghepCYoDBMgrEAY1WDJO0X3VTIqmFZmbc8VHG7l0Fk59o18KG06165laKB2c10	CHEMBL3238286	fcoQc@H{yXHIADabPrJPqQI[RZFJIKSRtUhuuPPQUMPPQdPL`@	C[C@](O)(COc1ccccc1C(F)(F)F)C(=O)N1CCc2c(C#N)cccc21	7.21	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting	2014	fbm@@@DjU_YnUz\\ENZjjjjjjh@@	fbm``@D@TdsKJn}krQgIruTEA@@P@@@	390.36	3.2659	5	1	73.56	5	0.6445104816282705	-0.04988005474969047	0.11835611284103839	26	26	fmwQc@@kd[p@dgcqqrJJKPiJSPqQIZY`lu{NBBJjfhHHrHZP@	gJPBAHJPt`PAIjj@@										26
>U:rrxUqujjETmqS9PghepCYoDBMgrEAY1WDJG0X3VTIqmFZmbc8VHG5W0Fk19o18KG06165laKB2V10	CHEMBL3238287	fegq`@DEFAadfYigw[ggYZ]GlvjjB`hC`rBFH@	C[C@](O)(COc1ccccc1C#N)C(=O)N1CCc2c(C#N)cccc21	7.84	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting	2014	fbm@@@DjU_YnUz\\ENZjjjjjjh@@	fbm``@D@TdsKJn}krQgIruTEA@@P@@@	347.373	2.2532	6	1	97.35	4	0.9346689231106691	1.134492765935292	0.16533783078291386	26	26	fmwQc@@kd[p@dgcqqrJJKPiJSPqQIZY`lu{NBBJjfhHHrHZP@	eMbA@Dg`@										26
>U:rrxUqujzETmqS9PghepCYwDBMirEAY1YEJG0X3VTIqmFZmbd8VHG5W0Fs19o18MG06565lbKB2c10	CHEMBL3238288	fmwqb@AAWHw`RFQQISKIRZFJIKSTyfoYpAGUTuAAFQCR@@	C[C@](O)(COc1ccc(F)cc1C#N)C(=O)N1CCc2c(C#N)cccc21	8.04	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting	2014	fbm@@@DjU_YnUz\\ENZjjjjjjh@@	fbm``@D@TdsKJn}krQgIruTEA@@P@@@	365.363	2.354	6	1	97.35	4	1.0246649760633455	1.0071843723365035	0.1954654144689768	26	26	fmwQc@@kd[p@dgcqqrJJKPiJSPqQIZY`lu{NBBJjfhHHrHZP@	eMbA@Dg`@		eFABP`BL@								26
>U:rrxUqujzETmqS9PghepCYwDBMirEAY1YEJG0X3VTIrmFZnbd8VHG5W0Fs19o18KG06565lbGB2g10	CHEMBL3238289	fegQa@OSIipLRTadTTRRQdtLTRVfXIIVc``bjfhHHrHJP@	C[C@](O)(COc1ccc(F)cc1Br)C(=O)N1CCc2c(C#N)cccc21	7.94	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting	2014	fbm@@@DjU_YnUz\\ENZjjjjjjh@@	fbm``@D@TdsKJn}krQgIruTEA@@P@@@	419.249	3.2436	5	1	73.56	4	0.6391573618748236	-0.022780140879007704	0.13966918682641968	26	26	fmwQc@@kd[p@dgcqqrJJKPiJSPqQIZY`lu{NBBJjfhHHrHZP@	eFACD`BL@		eFABP`BL@								26
>U:rrxUqujzETmqS9PghepCYwDBMirEAY1YEJG0X3VTIqmFZmbd8VHG5W0Fs19o18MG06565lbKB2c10	CHEMBL3238290	fegQb@OSEipICHhdileIhXhdmMQbRmG@AUUMPPQdPT`@	Cc1cc(F)ccc1OC[C@](C)(O)C(=O)N1CCc2c(C#N)cccc21	7.97	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting	2014	fbm@@@DjU_YnUz\\ENZjjjjjjh@@	fbm``@D@TdsKJn}krQgIruTEA@@P@@@	354.38	2.8623	5	1	73.56	4	0.31548574086869674	0.44699218551869085	0.0309412582542092	26	26	fmwQc@@kd[p@dgcqqrJJKPiJSPqQIZY`lu{NBBJjfhHHrHZP@	eFBH@c@@		eFABP`BL@								26
>U:rrxUqujzETmqS9PghepCYxDBMirEAY1YEJG0X3VTIrmFZnbd8VHG5W0Fs19o18KGV6565lbGB2Z10	CHEMBL3238291	fmwqb@MAVPw`XfQQQIIYRFFJIKSLEfoYpPQWTuAAFQAR@@	C[C@](O)(COc1ccc(C#N)cc1Br)C(=O)N1CCc2c(C#N)cccc21	8.32	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting	2014	fbm@@@DjU_YnUz\\ENZjjjjjjh@@	fbm``@D@TdsKJn}krQgIruTEA@@P@@@	426.269	2.9784	6	1	97.35	4	1.3160288358950585	0.4059688591110967	0.29893922961644565	26	26	fmwQc@@kd[p@dgcqqrJJKPiJSPqQIZY`lu{NBBJjfhHHrHZP@	eFACD`BL@		eMbA@Dg`@								26
>U:rrxUqujzETmqS9PghepCYxDBMirEAY1YEJG0X3VTIrmFZnbd8VHG5W0Fs19o18KGV6565lbGB2c10	CHEMBL3238292	fmwqb@MAVPw`RFQQQIIYRFFJIKSLEfoYpPQWTuAAFQAR@@	C[C@](O)(COc1ccc(C#N)cc1F)C(=O)N1CCc2c(C#N)cccc21	8.49	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting	2014	fbm@@@DjU_YnUz\\ENZjjjjjjh@@	fbm``@D@TdsKJn}krQgIruTEA@@P@@@	365.363	2.354	6	1	97.35	4	1.0246649760633455	1.0071843723365035	0.1954654144689768	26	26	fmwQc@@kd[p@dgcqqrJJKPiJSPqQIZY`lu{NBBJjfhHHrHZP@	eFABP`BL@		eMbA@Dg`@								26
>U:rrxUqujzETmqS9PghepCYxDBMirEAY1YEJG0X3VTIrmFZnbd8VHO5W0Fs19o18KGV6565pbGB2V10	CHEMBL3238293	fcopP@DEvAajyEEEHhmeeMEhlbiZ]GlvjjB`hC`bxHX`@	COc1cc(C#N)ccc1OC[C@](C)(O)C(=O)N1CCc2c(C#N)cccc21	7.79	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting	2014	fbm@@@DjU_YnUz\\ENZjjjjjjh@@	fbm``@D@TdsKJn}krQgIruTEA@@P@@@	377.399	2.1832	7	1	106.58	5	1.64786640107229	1.132960148616601	0.35252681188071117	26	26	fmwQc@@kd[p@dgcqqrJJKPiJSPqQIZY`lu{NBBJjfhHHrHZP@	eMJA@Hz@		eMbA@Dg`@								26
>U:rrxUqujzETmqS9PghepCYyDBMirEAY1YEJG0X3VTIrmFZnbd8VHO5W0Fu19o18KG06565pbGB2V10	CHEMBL3238294	fmwPR@@kYHw`QFQQISKIRZFJIKSTyfoYpAEUTuAAFQCR@@	COc1cc(Cl)ccc1OC[C@](C)(O)C(=O)N1CCc2c(C#N)cccc21	6.44	group3-int	int	Androgen Receptor	Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting	2014	fbm@@@DjU_YnUz\\ENZjjjjjjh@@	fbm``@D@TdsKJn}krQgIruTEA@@P@@@	386.834	2.9536	6	1	82.79	5	1.0338803061932813	0.33949039010590226	0.22296609556268993	26	26	fmwQc@@kd[p@dgcqqrJJKPiJSPqQIZY`lu{NBBJjfhHHrHZP@	eMJA@Hz@		eFABH`BL@								26
>U:rrxUqujzETmqS9PghepCYwDBMirEAY1YEJG0X3VTIrmFZnbd8VHOCWFFs19o18KG06565lbGR2c10	CHEMBL3238295	fmwPR@@kIHw`RFQQQIIYRFFJIKSLEfoYpPQUTuAAFQAR@@	COc1ccc(OC[C@](C)(O)C(=O)N2CCc3c(C#N)cccc32)c(F)c1	6.37	group3-int	int	Androgen Receptor	Displacement of [3H]mibolerone from full length human AR expressed in COS cells after 3.5 hrs by liquid scintillation counting	2014	fbm@@@DjU_YnUz\\ENZjjjjjjh@@	fbm``@D@TdsKJn}krQgIruTEA@@P@@@	370.379	2.4484	6	1	82.79	5	0.9709950765454994	0.7042108921328365	0.1932568205493415	26	26	fmwQc@@kd[p@dgcqqrJJKPiJSPqQIZY`lu{NBBJjfhHHrHZP@	eFABP`BL@		eMJA@Hz@								26
zPur2K9b8F1k0J35GNHV0RFm04FK02X!IHJ50V038F843FV82FXB0VJ#81Dk10348XY064#11ka!381V	CHEMBL3262343	fbuq@`MF]DDPJPeHJdLbbbRdubVTcNN}@PUUKUD@@	CC(C)(O)c1cn(-c2ccc(Cl)c(C(F)(F)F)c2)nn1	4.31	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor in human LNCAP cells assessed as inhibition of androgen-stimulated cell growth measured every 3 days	2014	dmL@@DjYU^TYjjjj@@	dmO@@@aDi[m\jUZh@D@@	305.686	2.2582	4	1	50.94	3	-0.6796665919577611	0.8247675595619319	-0.22456184396270623	36	3	fbuq@`MF]DCbJPeHJdLbbbRdubVTcNN}@PUUKUD@@	eFABH`BL@										2
zPur2K9b8F1k0J35GNHW0RFm04FK02V!IHo50V038F96AkV82FXB2VJ1!81DlGV148XYV6B#G1ka!381V	CHEMBL3262347	ff}IcBNV\EVl`dDRFICdz{HiCEDheXeeIHpXuPPLUKUD@@	CC(C)(O)c1cn(-c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)nn1	4.35	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor in human LNCAP cells assessed as inhibition of androgen-stimulated cell growth measured every 3 days	2014	dmL@@DjYU^TYjjjj@@	dmO@@@aDi[m\jUZh@D@@	316.238	0.7306	7	1	96.76	4	1.0776465983629953	2.281784440172196	0.19321418207023006	36	3	fbuq@`MF]DCbJPeHJdLbbbRdubVTcNN}@PUUKUD@@	gChhhE`BRnRYh@										2
zPur2K9b8F1k0J311NHV0BFm04FK!V!IFJ50V018F843FV82FX80VJ#814k10140X3044$1ka!381V	CHEMBL3262348	fncqA`IFbTD`bPqHNdOR@YCHiCDeDiiDfiAJbfj@HjjVjH@@	CC(C)(O)c1cn(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)nn1	4.4	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor in human LNCAP cells assessed as inhibition of androgen-stimulated cell growth measured every 3 days	2014	dmL@@DjYU^TYjjjj@@	dmO@@@aDi[m\jUZh@D@@	339.238	2.5005	4	1	50.94	4	-0.3558387890677064	0.4338642408939879	-0.1419827941279042	36	3	fasqC`OASTCcJPUHZdCREiAt`TIBPdHdQdP`pbXdPpR\pDQUUTmTP@@											1
<j:vbxzndzfA3vKdEQKkqJrvjF80ZIJc5NHX6AGt7Gx_4IPZ4y5R9H09G@mFVC42X4VB551F13FY!7V3F	CHEMBL3263754	eghZL@@NCGDk`DFLbfbbRJbRRbbRRepbcggRptsPPQMUAPTUdTGd@@	COc1nc(C2=NN(c3ccc(C#N)c(C)n3)[C@@H](C3CCCC3)C2)ccc1C(=O)O	5.04	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) by Gal4-based cellular assay	2014	ffs@@@LdbbRbVfrTJWMRUxIZuUUUUUUUP@@	ffsH@@@XY{IEDhlieMDdcPTmQRVhPTMUAPAQCd@@	405.457	3.1658	8	1	111.7	5	2.0765328825541722	0.5966322915663458	0.5053943041976773	5	4	fciB@JJLGY@NNQQQIEQIIQQIIRy`cVjMoXHHfj`hJJrJEh@	gC`h@l@ILt@@										4
;vjvzvjxzndyfEHvKdEQKmqJrvjH90ZIqc5NmX7AGt7Gx54IPZ4y5R9H09GDmFVC42XZVD151F11Fb091VVF	CHEMBL3263760	eghZD@@DNCGK`FLbfbbRJbRRbbRRepbcggRptsPPQMUAPTUdTGd@@	COc1nc(C2=NN(c3ccc(C#N)c(C)c3)[C@@H](C3CCCC3)C2)ccc1C(N)=O	5.49	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) by Gal4-based cellular assay	2014	ffs@@@LdbbRbVfrTJWMRUxIZuUUUUUUUP@@	ffsp@@@LdeLl{kLjmARTfnRa@qUAPTDTEP@	403.485	3.5339	7	1	104.6	5	1.6898428916001096	0.20973004118669558	0.3974500437959078	5	1	eghZD@@DNCGK`FLbfbbRJbRRbbRRepbcggRptsPPQMUAPTUdTGd@@											1
;vjvzvbxzndyfA3vKdEQKkqJrvjF80ZIoc5NHX6AGt7Gx_4IPZ4y5R9H09G@mFVC42X4VB151F13FY011VVF	CHEMBL3263763	eghVD@@DNCGDk`FLbfbbRJbRRbbRRepbcggRptsPPQMUAPTUdTGd@@	COc1nc(C2=NN(c3ccc(C#N)c(C)n3)[C@@H](C3CCCC3)C2)ccc1C(N)=O	5.11	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) by Gal4-based cellular assay	2014	ffs@@@LdbbRbVfrTJWMRUxIZuUUUUUUUP@@	ffsH@@@XY{IEDhlieMDdcPTmQRVhPTMUAPAQCd@@	404.473	2.9384	8	1	117.49	5	2.1751756232877613	0.779453332201774	0.5173280512997962	5	4	fciB@JJLGY@NNQQQIEQIIQQIIRy`cVjMoXHHfj`hJJrJEh@	gCiHDL@ILt@@										4
;vjvzvbxzndyfA3vKdEQMkqJrvjG80ZIoc5NHX6QGt7Gx_4IQZ4y5R9H09G@mFVC42X4VB151J13Jn!WVFF	CHEMBL3263764	eodVD@@DAKOLg`NLbbTtRQTRRTTRRTndt|BFvfVZ``bZjB`hkHh@h@@	CNC(=O)c1ccc(C2=NN(c3ccc(C#N)c(C)n3)[C@@H](C3CCCC3)C2)nc1OC	5.07	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) by Gal4-based cellular assay	2014	ffs@@@LdbbRbVfrTJWMRUxIZuUUUUUUUP@@	ffsH@@@XY{IEDhlieMDdcPTmQRVhPTMUAPAQCd@@	418.499	3.2899	8	1	103.5	5	2.007488029717107	0.4135173850197695	0.5066289564885245	5	4	fciB@JJLGY@NNQQQIEQIIQQIIRy`cVjMoXHHfj`hJJrJEh@	gJYHDL@ILmP@										4
;vzvzvbxzndyfA3vKdEQMkqJrvjG80ZMpc5NHe6Qlt7Ox_4IUZ5y5R9H09G@mFVC42X4VBW51L1IJn!WVFF	CHEMBL3263767	edZVBH@LM@dfhXDFE@@cIICihhdbhddhhddi\Xxeel|]\mSAADuTEAQVQPYP@	COc1nc(C2=NN(c3ccc(C#N)c(C)n3)[C@@H](C3CCCC3)C2)ccc1C(=O)NS(C)(=O)=O	5	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) by Gal4-based cellular assay	2014	ffs@@@LdbbRbVfrTJWMRUxIZuUUUUUUUP@@	ffsH@@@XY{IEDhlieMDdcPTmQRVhPTMUAPAQCd@@	482.563	3.2266	10	1	146.02	5	3.521304852900373	0.7675986043188971	0.8970370337094166	5	4	fciB@JJLGY@NNQQQIEQIIQQIIRy`cVjMoXHHfj`hJJrJEh@	dazLPLaF@Hx@rRPzKTp@@										4
yTur2K9G8k4kZFA4FNH5VN2H!FF1392VHHo58VV3Nk96FW!28V92JLp0Wc1Dl1V9022bca40@4J!458V8F0	CHEMBL32812	ekhXHH@Ji@ICHhdhUDhhhdeEMgJFKGDfbineh@Ij@B@abh``HND	CC1=CC(C)(C)Nc2ccc3c(c21)/C(=C/c1cccc(F)c1)Oc1ccccc1-3	6.1	group3-int	int	Androgen Receptor	Inhibitory activity (IC50) against human androgen receptor expressed in CV-1 cells	1998	fiw@@@LdbbbbbRrVtQVXXRgIcWhzjjjjjjjjj@@	fiwa@@L`RfYeUygU~gIV\doVchI`HB@dH@`DJH	383.465	6.0712	2	1	21.26	1	-1.7334952376969244	-1.973606608603523	-0.3815592270345163	10	9	egdXHD@Fe@GDbPrJJJ[ZIQQQIJJ[NLBN^Y]UKC[PPPu@A@PqTPPD@b@											1
zrzxzhUSxpxx7FAUUE8K3N@QaAF2CY_9H2vXE@X5F2aea2320VFcvX1R88VlW5W2l13X08F501c1F!480V8FV	CHEMBL3317457	figQb@FFuGHIAIe[WnUfUZ\EJk^c`BJfjifjEP@@	O=C(c1cc2ccc(F)cc2[nH]1)N(Cc1ccco1)Cc1ccco1	5.39	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor binding function 3 in eGFP-expressing human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in androgen receptor transcriptional activity after 3 days	2014	fa{@@@LdbbRNbfRbbRUNLDVk^uUUUUUUUU@@@	fa{Q`@DL@YrSLrjsJjjkR\ejwkUSUSHUPB`@@	338.337	2.7727	5	1	62.38	5	0.21393600393624346	0.3575161808309382	0.0017250850861566455	1	1	figQb@FFuGHIAIe[WnUfUZ\EJk^c`BJfjifjEP@@											1
zrzxzhUSzppxUFAUUE8p2s@QaAH0C3_922nXEAX5N2a8a2120VkcvX1R88VlW5W@l11X18J501c1F08480VBFV	CHEMBL3318054	fj}Pa@NFPhFHVPrJIKJJFIIIHeG^Sffjiih@d@@@	CN(Cc1ccc(Br)o1)C(=O)c1cc2ccc(F)cc2[nH]1	5.09	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor binding function 3 in human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in PSA expression after 3 days by prostate surface antigen assay	2014	fde@@@LdbbRNbrbUNLDFMUUUUUU@@@	fdeP`@DT@iIeeVUUEIw`qZijdJ@P@@	351.174	2.9885	4	1	49.24	3	-0.5018218732820976	0.20459517163887364	-0.1502333969856459	16	14	ffcP``AVMD@RRA\xu|TfYu]nvUYrRle``JijijE@@	eFBH@c@@	eFACD`BL@	eFABP`BL@								13
zrzxzhUSzppxUFAUUE8K2N@QaAH0C3gd22nXE@X5Q3a8a2020VF8vV0R98VlW5W2l91X0gF701V5F!180V8FV	CHEMBL3318055	fj}Pb@AFtDD`drmnwOJtXJR\p@TsUSTR@@	Cc1ccc(CN(C)C(=O)c2cc3cc(F)ccc3[nH]2)o1	5.03	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor binding function 3 in eGFP-expressing human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in androgen receptor transcriptional activity after 3 days	2014	fde@@@LdbbRNbrbUNLDFMUUUUUU@@@	fdeP`@DT@iIeeVUUEIw`qZijdJ@P@@	286.305	2.5638	4	1	49.24	3	-0.8234516613378565	0.7004574861014788	-0.2591875533499129	16	14	ffcP``AVMD@RRA\xu|TfYu]nvUYrRle``JijijE@@	eFBH@c@@	eFBH@c@@		eFABP`BL@							13
:UtzdUSxJhx3JAUEU8G3N@9X9F2CY4982xXC@X1FHZeaF020WF0tV0w88VYW5W0W13X08F51101F%VVFV	CHEMBL3318056	fnsq@@DLrAIfYUYUUUVdmKUjij``C@@@@	N#CCCN(Cc1ccccc1)C(=O)c1cc2ccccc2[nH]1	5.12	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor binding function 3 in eGFP-expressing human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in androgen receptor transcriptional activity after 3 days	2014	flu@@@DjU_fuUirshijjjjjjj@@	fluQ@@DT@drrkJjhi^RFKUMP@@@@@@	303.364	2.9827	4	1	59.89	5	-0.26495806302548364	0.22184859783901906	-0.14961125054186503	1	1	fnsq@@DLrAIfYUYUUUVdmKUjij``C@@@@											1
zrzxzhUSxpxx7FAUUE8K3N@QaAF2CYg9H2vXE@X5I3aea2220VF8vV0R98VlW5W2l93X0gF701V5F!180V8FV	CHEMBL3318057	fnsQb@AFuGHIAIe[]nUeVcARKV@BfZjfjI@@	COCCN(Cc1ccco1)C(=O)c1cc2cc(F)ccc2[nH]1	5.19	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor binding function 3 in eGFP-expressing human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in androgen receptor transcriptional activity after 3 days	2014	fde@@@LdbbRNbrbUNLDFMUUUUUU@@@	fdeP`@DT@iIeeVUUEIw`qZijdJ@P@@	316.331	2.0734	5	1	58.47	6	0.2266000796423864	0.7100001387354256	-0.021975331933110243	16	14	ffcP``AVMD@RRA\xu|TfYu]nvUYrRle``JijijE@@	gJQH@PAJ^j@@			eFABP`BL@							13
=xUSzpxxbFQUUUAK3OPUiEFHCYh9X2vaE@XbI3aia2820VF8zc2R9cVlWCWml97X2hF701VKGV0380V8FV	CHEMBL3318058	fi{Pc@M^]TD`bPqHYEHXdieeMEDXdJVc]GU@ASMUTtR@@	CC(C)N(Cc1ccco1)C(=O)c1cc2cc(C(F)(F)F)ccc2[nH]1	5.28	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor binding function 3 in human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in PSA expression after 3 days by prostate surface antigen assay	2014	fde@@@LdbbRNbrbUNLDFMUUUUUU@@@	fdeP`@DT@iIeeVUUEIw`qZijdJ@P@@	350.339	3.679	4	1	49.24	5	-0.22163330421516234	-0.44904869979260564	-0.095794753048633	16	14	ffcP``AVMD@RRA\xu|TfYu]nvUYrRle``JijijE@@	gC`HL@Qz`@			gJPBAHJPt`PAIjj@@							13
zrUtzdUSzKpxQFAUUE8l2s@QaAH0C35922nXEAXCN2a8a0120VkcvX1R88VWW5W@W11X18J50181F08480VBFV	CHEMBL3318059	fj}QC@NFTCDPDEdLbbRrbabRRRIQwdyijjZZ@I@@@	CN(Cc1ccc(Br)s1)C(=O)c1cc2ccc(F)cc2[nH]1	5.45	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor binding function 3 in eGFP-expressing human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in androgen receptor transcriptional activity after 3 days	2014	fde@@@LdbbRNbrbUNLDFMUUUUUU@@@	fdeQB@FJD@HRf_[eU\TMXLZYiih@`@@	367.241	3.7737	3	1	64.34	3	-0.4560788830994662	-0.3370989220942776	-0.16981271512489873	16	2	fj}QC@NFTCDPDEdLbbRrbabRRRIQwdyijjZZ@I@@@											1
zrUtzdUSxKpx3FAUUE8G2N@QaAF0C35922nXE@XCF2a8a0120VFcvX1R88VWW5W2W11X08F50181F!480V8FV	CHEMBL3318060	fbmQA@FZd@HsHYHhmhhXdddlTlzJZYjZZ@J@@@	CN(Cc1cccs1)C(=O)c1cc2ccc(F)cc2[nH]1	5.47	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor binding function 3 in eGFP-expressing human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in androgen receptor transcriptional activity after 3 days	2014	fde@@@LdbbRNbrbUNLDFMUUUUUU@@@	fdeQB@FJD@HRf_[eU\TMXLZYiih@`@@	288.345	2.8438	3	1	64.34	3	-0.8278073998145545	0.5144799673358815	-0.30448084935839836	16	2	fbmQA@FZd@HsHYHhmhhXdddlTlzJZYjZZ@J@@@											1
=xUSzpxxzNQUEE9KAOPCiAH2CYZdX2tXE@XbN2aia2820VF8vc2R8cVlW5WXl13X08F501VGFV!80V0FV	CHEMBL3318061	ffcP`@DLA[HhhhhdcDddehtTyJuTuUHTDH@@	Cc1ccc(CN(C(=O)c2cc3ccccc3[nH]2)C(C)C)o1	5.47	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor binding function 3 in human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in PSA expression after 3 days by prostate surface antigen assay	2014	fde@@@LdbbRNbrbUNLDFMUUUUUU@@@	fdeP`@DT@iIeeVUUEIw`qZijdJ@P@@	296.369	3.2286	4	1	49.24	4	-0.6431948310383294	0.1426698308577326	-0.21305577181132468	16	14	ffcP``AVMD@RRA\xu|TfYu]nvUYrRle``JijijE@@	gC`HL@Qz`@	eFBH@c@@									13
=xUSzpxxzNQUUE9KAOPUiAH2CY_dX2vXE@XbO2aia2920VFcve3R8cVlW5WXl13X08F501cGFV0480V0FV	CHEMBL3318062	fnsP`@DLA[HhhhhdcDddemFbgIVjfjiB`hP@@	Cc1ccc2cc(C(=O)N(Cc3ccc(C)o3)C(C)C)[nH]c2c1	5.54	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor binding function 3 in eGFP-expressing human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in androgen receptor transcriptional activity after 3 days	2014	fde@@@LdbbRNbrbUNLDFMUUUUUU@@@	fdeP`@DT@iIeeVUUEIw`qZijdJ@P@@	310.396	3.5725	4	1	49.24	4	-0.5855066999712227	-0.11608163640007729	-0.18818235176615106	16	14	ffcP``AVMD@RRA\xu|TfYu]nvUYrRle``JijijE@@	gC`HL@Qz`@	eFBH@c@@	eFBH@c@@								13
=xUSzpxxzNQUUE9KAOPUiAH2CYhdX2vXE@XbQ3aia2820VF8vc2R9cVlW5WXl93X0gF701VKFV0180V0FV	CHEMBL3318063	fnsP`@DLA[HhhhhdcDddd]FbgIVjfjiB`hP@@	Cc1ccc2[nH]c(C(=O)N(Cc3ccc(C)o3)C(C)C)cc2c1	5.57	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor binding function 3 in eGFP-expressing human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in androgen receptor transcriptional activity after 3 days	2014	fde@@@LdbbRNbrbUNLDFMUUUUUU@@@	fdeP`@DT@iIeeVUUEIw`qZijdJ@P@@	310.396	3.5725	4	1	49.24	4	-0.5855066999712227	-0.11608163640007729	-0.18818235176615106	16	14	ffcP``AVMD@RRA\xu|TfYu]nvUYrRle``JijijE@@	gC`HL@Qz`@	eFBH@c@@		eFBH@c@@							13
=xUSzpxxbFQUUE9K3OPUiAF2CYh9X2vXE@XbI3aia2820VF8vc2R9cVlW5WXl93X0gF701VKFV0180V0FV	CHEMBL3318064	ffcP`@DLA[HhhhhdcDddkhtTyJuTuUHTDH@@	Cc1ccc2[nH]c(C(=O)N(Cc3ccco3)C(C)C)cc2c1	5.92	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor binding function 3 in human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in PSA expression after 3 days by prostate surface antigen assay	2014	fde@@@LdbbRNbrbUNLDFMUUUUUU@@@	fdeP`@DT@iIeeVUUEIw`qZijdJ@P@@	296.369	3.1746	4	1	49.24	4	-0.6406540979274126	0.17513193407456423	-0.21333719132152518	16	14	ffcP``AVMD@RRA\xu|TfYu]nvUYrRle``JijijE@@	gC`HL@Qz`@			eFBH@c@@							13
=xUSzpxxzNQUUE9KAOPUiAH2CYgdX2vXE@XbQ3aia2820VF8vc2R9cVlW5WXl93X0gF701VKFV0180V8FV	CHEMBL3318065	fnsPb@AFtdDadTRTrrfbbLRUFBdVl@ELuUSTR@@	Cc1ccc(CN(C(=O)c2cc3cc(F)ccc3[nH]2)C(C)C)o1	5.86	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor binding function 3 in human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in PSA expression after 3 days by prostate surface antigen assay	2014	fde@@@LdbbRNbrbUNLDFMUUUUUU@@@	fdeP`@DT@iIeeVUUEIw`qZijdJ@P@@	314.359	3.3294	4	1	49.24	4	-0.553198778085653	0.015361437258944108	-0.18292818812526174	16	14	ffcP``AVMD@RRA\xu|TfYu]nvUYrRle``JijijE@@	gC`HL@Qz`@	eFBH@c@@		eFABP`BL@							13
=xUSzpxxbFQUUE9K3OPUiAF2CY_9X2vXE@XbG2aia2920VFcve3R8cVlW5WXl13X08F501cGFV0480V0FV	CHEMBL3318066	ffcP`@DLA[HhhhhdcDddchtTyJuTuUHTDH@@	Cc1ccc2cc(C(=O)N(Cc3ccco3)C(C)C)[nH]c2c1	6.07	group3-int	int	Androgen Receptor	Inhibition of androgen receptor binding function 3 in human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in PSA expression after 3 days by prostate surface antigen assay	2014	fde@@@LdbbRNbrbUNLDFMUUUUUU@@@	fdeP`@DT@iIeeVUUEIw`qZijdJ@P@@	296.369	3.1746	4	1	49.24	4	-0.6406540979274126	0.17513193407456423	-0.21333719132152518	16	14	ffcP``AVMD@RRA\xu|TfYu]nvUYrRle``JijijE@@	gC`HL@Qz`@		eFBH@c@@								13
=xUSzpxxzNQUEE9KAOPUiAH2CYZdX2tXE@XbO2aia2820XG8vc2R8cVlW5WXl13X0BN501VGFV!90V8FV	CHEMBL3318067	fnsPb@BFtdDadTTRTqfbbLRSA\dVlDDTuUSTJ@@	Cc1ccc(CN(C(=O)c2cc3cccc(F)c3[nH]2)C(C)C)o1	5.92	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor binding function 3 in human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in PSA expression after 3 days by prostate surface antigen assay	2014	fde@@@LdbbRNbrbUNLDFMUUUUUU@@@	fdeP`@DT@iIeeVUUEIw`qZijdJ@P@@	314.359	3.3294	4	1	49.24	4	-0.553198778085653	0.015361437258944108	-0.18292818812526174	16	14	fnsPb`ANld@RRPY@~\V~NQQQSPiZZYQI\dkQZpQDUMUMPh@@	gC`HL@Qz`@	eFBH@c@@									1
=xUSzpxxzNQUUE9KAOPUiAH2CY_dX2vXE@XbN2aia2920VFcve3R8cVlW5WXl13X08F501cGFV0480V8FV	CHEMBL3318068	fnsPb@FFtdDadTRTrVfbbLRUNBdVl@QTuUSTJ@@	Cc1ccc(CN(C(=O)c2cc3ccc(F)cc3[nH]2)C(C)C)o1	5.66	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor binding function 3 in human enzalutamide-resistant MR49F cells assessed as reduction in PSA expression after 3 days by prostate surface antigen assay	2014	fde@@@LdbbRNbrbUNLDFMUUUUUU@@@	fdeP`@DT@iIeeVUUEIw`qZijdJ@P@@	314.359	3.3294	4	1	49.24	4	-0.553198778085653	0.015361437258944108	-0.18292818812526174	16	14	ffcP``AVMD@RRA\xu|TfYu]nvUYrRle``JijijE@@	gC`HL@Qz`@	eFBH@c@@	eFABP`BL@								13
=xUSzpxxbFQUUE9K3OPUiAF2CYg9X2vXE@XbI3aia2820VF8vc2R9cVlW5WXl93X0gF701VKFV0180V8FV	CHEMBL3318069	ffcPb@AFtdDadTRTrrfbbLRhpTbu`@ifjjZI@@	CC(C)N(Cc1ccco1)C(=O)c1cc2cc(F)ccc2[nH]1	6.22	group3-int	int	Androgen Receptor	Inhibition of androgen receptor binding function 3 in eGFP-expressing human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in androgen receptor transcriptional activity after 3 days	2014	fde@@@LdbbRNbrbUNLDFMUUUUUU@@@	fdeP`@DT@iIeeVUUEIw`qZijdJ@P@@	300.332	2.9315	4	1	49.24	4	-0.6083461760418428	0.30657500773358554	-0.2080830276806358	16	14	ffcP``AVMD@RRA\xu|TfYu]nvUYrRle``JijijE@@	gC`HL@Qz`@			eFABP`BL@							13
=xUSzpxxbFQUUE9K3OPUiAF2CY_9X2vXE@XbF2aia2920VFcve3R8cVlW5WXl13X08F501cGFV0480V8FV	CHEMBL3318070	ffcPb@FFtdDadTRTrVfbbLRipTbu`BJfjjZE@@	CC(C)N(Cc1ccco1)C(=O)c1cc2ccc(F)cc2[nH]1	6.28	group3-int	int	Androgen Receptor	Inhibition of androgen receptor binding function 3 in human LNCAP cells containing androgen-responsive probasin-derived promoter assessed as reduction in PSA expression after 3 days by prostate surface antigen assay	2014	fde@@@LdbbRNbrbUNLDFMUUUUUU@@@	fdeP`@DT@iIeeVUUEIw`qZijdJ@P@@	300.332	2.9315	4	1	49.24	4	-0.6083461760418428	0.30657500773358554	-0.2080830276806358	16	14	ffcP``AVMD@RRA\xu|TfYu]nvUYrRle``JijijE@@	gC`HL@Qz`@		eFABP`BL@								13
voQl21O4804N0F0BRN0W080X!F080104HH05!81#41VV0X808!40F081#V102#4%2$V0FV	CHEMBL3323467	fhyPB@LD@DISN|kZxihw`tsP@@D@@@	CNc1nc(-c2ccc3ccccc3c2)cs1	5.5	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay	2014	foQ@@@LdbbRRlRXKdkNjjjjjh@@	foQ`B@L@BDi]e[WAIJlze`@@H@@@	240.329	3.8765	2	1	53.16	2	-1.7124024039908767	-0.010303922631950041	-0.5212185618036824	7	2	f`i`A@L@\TABSKlkZdhkSoTu@@@H@@@	eMbA@Hz@										2
zrzxvdUUppzhM2@UUEBl3Q8v48F4CWke6DPV73kC0832a01V6XKV86148FkF91d2F1124V0480c!2!VJ201V	CHEMBL3323468	f`iPb@LD]x@PeLwJjnJJl[uLEAQTP@@	Oc1ccc2nc(N3CCOCC3)sc2c1	5.09	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days	2014	foQ@@@DjYU]wbaRlzjjjjj`@@	foQQB@LD\@HRf[eU|TUXsjXJBbb@@	236.294	1.7853	4	1	73.83	1	-0.9717626308757391	1.7759280342129296	-0.33515907873356654	1	1	f`iPb@LD]x@PeLwJjnJJl[uLEAQTP@@											1
JFeF#18&4F!108)12!F/$2#F/0V)201F	CHEMBL3323469	fhya@@A@RYWYVuhsQoA`@`@@@@@@	Oc1ccc(-c2ccc3ccccc3n2)cc1	5.01	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay	2014	f`i@@@DjYU[wxjQg^jjjjjj@@	f`i`@@@ISLrjRVgV|D@@@@@@@	221.258	3.3801	2	1	33.12	1	-2.27033516338384	0.3326536381212773	-0.632303885871496	4	1	fhya@@A@RYWYVuhsQoA`@`@@@@@@											1
zrzxvdUTxpzxM28Q@UBlIA@96AF4BVkc6@O0AAHC0NYXZ0V06VF0904R!FG4182k1021!401V%V$V	CHEMBL3323470	fhyaB@L^@DISLwZkdX[s`uLtEAE@@@	c1ccc(-c2ccc(N3CCOCC3)s2)cc1	6.29	group3-int	int	Androgen Receptor	Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days	2014	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyaB@L^@DISLwZkdX[s`uLtEAE@@@	245.345	3.2009	2	0	40.71	2	-2.1305275520900495	0.29978470540301294	0.5385480313375758	42	2	fhyaB@L^@DISLwZkdX[s`uLtEAE@@@											1
zrzxvtUDxpzxMH8OEUDl3A8v4BFJ8Vkc6PN473FC1832Z1VV6XN08!40FFN1182k142250J!V!202V!80V	CHEMBL3323471	fj}Q@`LDl@HSHYdBrFRJKQIJKKPrXhjw`tsUPPEUP@@	FC(F)(F)c1cccc(-c2csc(N3CCOCC3)n2)c1	6.21	group3-int	int	Androgen Receptor	Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay	2014	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyQB@LDl@HRf^UYwqQUoAifj``J@@@	314.33	3.5524	3	0	53.6	3	-1.173129942069258	-0.07275737740662803	0.8013562181866162	42	18	ffcQA`MAj@IIxlPUPKgGpQdTTTtraTQbRyJwbu`bHiZjjJ@@			gJPBAHJPt`PAIjj@@								16
zrzxvdUDxpzxMH8SUUBl3A8v48F48Xlc6PP07AFC183@a1VV6XN08!40FFN1382k102240L!V!2!W8#V	CHEMBL3323472	fluQB@LDl@HRf^UYyEEVCFfZjBHJ`@@	Cc1ccc(C)c(-c2csc(N3CCOCC3)n2)c1	6.21	group3-int	int	Androgen Receptor	Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay	2014	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyQB@LDl@HRf^UYwqQUoAifj``J@@@	274.387	3.3919	3	0	53.6	2	-1.5344626047144017	0.2926717892027319	0.7086871999588976	42	18	ffcQA`MAj@IIxlPUPKgGpQdTTTtraTQbRyJwbu`bHiZjjJ@@		eFBH@c@@		eFBH@c@@							16
vzUtvdzDxG:IL89CSBl2A8d48F4cVF8DPR052F90812Z1VV6XN08!40FF@3180V102#4%2!V$V	CHEMBL3323473	fhyPB@LD@DISOJl{xhjw`tsUPPE@@@	c1ccc(-c2csc(N3CCCCC3)n2)cc1	6.16	group3-int	int	Androgen Receptor	Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days	2014	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyPB@LD@DISOJl{xhjw`tsUPPE@@@	244.361	3.8681	2	0	44.37	2	-2.108234765644126	-0.07080564488548877	0.5497221950510993	42	1	fhyPB@LD@DISOJl{xhjw`tsUPPE@@@											1
zrzxvdQNxoCkKF9O2O0G38@0Z0F28VVc0PO2380B0PV@40V!2N0904J!FF1FF3l122#J!V0F#V$V	CHEMBL3323474	fhyaB@AA@DISKZl{dhjw`uJDEETP@@	c1ccc(-c2cc(N3CCOCC3)cs2)cc1	6.08	group3-int	int	Androgen Receptor	Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days	2014	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyaB@AA@DISKZl{dhjw`uJDEETP@@	245.345	3.0113	2	0	40.71	2	-2.1216067792664943	0.41376245730772143	0.5375599387638899	42	1	fhyaB@AA@DISKZl{dhjw`uJDEETP@@											1
zrzxvdUExpzxMH8SEUBl3Q8d48F48Xkc6PN073kC083@a1VV6XN08!40FFN1392k102#J!V!2!W1!VV	CHEMBL3323475	fdeqB@LD]X@QdbbtRRbtQqQU`qifj`hB`@@	Nc1ccccc1-c1csc(N2CCOCC2)n1	5.69	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days	2014	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyQB@LDl@HRf^UYwqQUoAifj``J@@@	261.348	2.0268	4	1	79.62	2	-0.5995238655950318	1.4594898258632205	-0.25182953522212614	42	18	ffcQA`MAj@IIxlPUPKgGpQdTTTtraTQbRyJwbu`bHiZjjJ@@		eFbB@Hp@									16
zrzxvdUTxpzxM28QPUBlIA@96AF4BVtc6@O0AAHC0OYXZ0V06VF0C24R!FG4182k1021!401V$GV!V0V	CHEMBL3323476	fluQB@LI|@HrQQQSSIIXhcC^\Fif`hHn`@@	N#Cc1ccc(-c2ccc(N3CCOCC3)s2)cc1	5.84	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay	2014	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyaB@L^@DISLwZkdX[s`uLtEAE@@@	270.355	3.0365	3	0	64.5	2	-1.3636601746105828	0.6012255682879891	0.7279456063550084	42	2	fluQB@LI|@HrQQQSSIIXhcC^\Fif`hHn`@@											1
<vzUizpzxzysOEzErUjdhi8rB@kkwUvRB7YGCcBALh3XXjqP380840oHPG18Dm102#JF0k!2V0V!80V	CHEMBL3323477	fj}Q@`LDl@HcHIdLrBTsrkMoSbbkAKSMUAPUEDIP@	FC(F)(F)[C@H]1CN(c2nc(-c3ccccc3)cs2)CCO1	6.8	group3-int	int	Androgen Receptor	Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days	2014	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyQB@LDl@HRf^UYwqQUoAifj``J@@@	314.33	3.5131	3	0	53.6	3	-1.171280848173181	-0.049132118754250845	0.8011514067893416	42	18	fegQBPMAj@IIxlPUPKgGpQvPGHSdLbbbffTJbLRTLgIV|VlDQEKUUUTUCL@@											1
zrzxvdUExpzxMH8SUUBl3Q8v48F48Xnc6PP073FC083@a1VV6XN0B2141FFN1382k302#J!V!2!W$V	CHEMBL3323478	fluQC@NVRBHUDFBLbbbTRRNbRYKQhi``dfjjJ@@	Clc1ccc(-c2csc(N3CCOCC3)n2)c(Cl)c1	5.78	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay	2014	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyQB@LDl@HRf^UYwqQUoAifj``J@@@	315.223	3.9161	3	0	53.6	2	-1.3440766230700103	-0.17388284119572026	0.7786139768350778	42	18	ffcQA`MAj@IIxlPUPKgGpQdTTTtraTQbRyJwbu`bHiZjjJ@@		eFABH`BL@			eFABH`BL@						16
zrzxvdUExpzxMH8SUUBl3Q8v48F48Vnc6PP073FC1832Z1VV6XN0B2140FFN1982k302240J!V!2!V$V	CHEMBL3323479	fluQC@IVRBHIDFBDfYwe^UYsQhi``JVjjJ@@	Clc1ccc(-c2csc(N3CCOCC3)n2)cc1Cl	5.53	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days	2014	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyQB@LDl@HRf^UYwqQUoAifj``J@@@	315.223	3.9161	3	0	53.6	2	-1.3440766230700103	-0.17388284119572026	0.7786139768350778	42	18	ffcQA`MAj@IIxlPUPKgGpQdTTTtraTQbRyJwbu`bHiZjjJ@@			eFABH`BL@		eFABH`BL@						16
zrzxvdUDzpzxUH8OEUBlQf8d4AH48Vog6PN0EAFC087DZ1VVLXs0N!40FFN5182k102104J40V0F208V0201V	CHEMBL3323480	fluPb@LDUx@PeLwJk^~JF}EMLuUPPE@@@	OCc1sc(N2CCOCC2)nc1-c1ccccc1	5.3	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay	2014	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyQB@LDl@HRf^UYwqQUoAifj``J@@@	276.359	2.189	4	1	73.83	3	-0.462692965373248	1.1430234677445448	-0.21491479699415783	42	18	ffcQA`MAj@IIxlPUPKgGpQdTTTtraTQbRyJwbu`bHiZjjJ@@	eMJA@Df`@										16
zRun239K8F4F0J24FN0WVN2V!F103920MFV50V80Fk961VV0290C24JkF0814l0V102#40V4#4F10X0GV	CHEMBL3323481	fjcQB@LAb@HrQQZIIQZIIGEEV\GIZYBBPJ@b@@@	Oc1ccc(-c2nc(-c3c[nH]c4ccccc34)cs2)cc1	5.19	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days	2014	fb}@@@LdbbRRqbbRwEBdxJ\uUUUUUUT@@	fb}PB@LA@DISOJl|{xhjs`isSHPRA@Q@@@	292.361	3.7586	3	2	77.15	2	-0.5261194795663219	0.15056752915945137	-1.3733295745530025	1	1	fjcQB@LAb@HrQQZIIQZIIGEEV\GIZYBBPJ@b@@@											1
;xvdUDzpzxUH8OEUBlQA8d4AH48Vkg6PN0EAFC08I6Z1VVLXs0N!40FFN5182k102104J!V!2!V$V	CHEMBL3323482	fluQB@LD|@HRf[eUo_EC^bffZjhHB`@@	CCc1sc(N2CCOCC2)nc1-c1ccccc1	5.07	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days	2014	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyQB@LDl@HRf^UYwqQUoAifj``J@@@	274.387	3.5458	3	0	53.6	3	-1.3831665200312735	0.07933134989284794	0.7355963164570974	42	18	ffcQA`MAj@IIxlPUPKgGpQdTTTtraTQbRyJwbu`bHiZjjJ@@	eMBD@ch@										16
zrzhvdUDppzxM29OEEBk3A@d48F48Vkc6PO037FC08Y@ZW0V6XN08!J0FFs1GN3l1!W!J!V!2!VV040V	CHEMBL3323483	fdeIC@DLDZHLRfIhHrJIPjIKQIDXkPXtmTmUUT@@	Brc1ncn(-c2csc(N3CCOCC3)n2)c1Br	6.77	group3-int	int	Androgen Receptor	Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days	2014	f`i@@@LdbbRRqbWEBd{uUUUUUP@@	f`iIB@LDDzp@aJYyUg\TUYwjYjjiZ`@@	394.09	3.6617	5	0	71.42	2	-0.14058392753643179	0.0590041236212365	1.1295122757846534	11	9	fdeIC@DLDZHOFcchHrJIPjIKQIDXkPXtmTmUUT@@	eFACD`BL@	eFACD`BL@									9
zrzxvdUExpzxMH@SUUBl3Q8v48F48Xle6PPV73FC183Aa1VV6XNVB2G61FFN9AN2k10224cJ!V042!_!80V	CHEMBL3323484	fj}Pc@LDlx@PfPKHYHhmDdhmEeKbbkAsSMUAPTU@@@	COc1c(-c2csc(N3CCOCC3)n2)ccc(F)c1F	6.75	group3-int	int	Androgen Receptor	Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay	2014	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyQB@LDl@HRf^UYwqQUoAifj``J@@@	312.339	2.8357	4	0	62.83	3	-0.7566494436927971	0.5540254323707707	0.9063844581223259	42	18	ffcQA`MAj@IIxlPUPKgGpQdTTTtraTQbRyJwbu`bHiZjjJ@@		eMJA@Hz@	eFABP`BL@		eFABP`BL@						16
;jvfzDpxzxML8OEEBk3A8d4NF5cVoc6QN03AFC08n@Z10W6XN08!JFHFN1GP2k5!1!J!V!2!V$V	CHEMBL3323485	fdeQA@LDl@HBDISOJl|~JJlxMLuULuU@@@	Cc1scc(-c2csc(N3CCOCC3)n2)c1C	6.6	group3-int	int	Androgen Receptor	Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay	2014	f`i@@@LdbbRRqbWEBd{uUUUUUP@@	f`iQA@LDl@H\DISOJl{bbkN}SMUMST@@	280.415	3.2585	3	0	81.84	2	-1.0422339388993114	0.5576572768462862	0.7897937321288416	11	2	fdeQA@LDl@HBDISOJl|~JJlxMLuULuU@@@											1
;jvfUDppzxML8OEEBk3A8d48F58Vkc6QN033FC08n@Z10V6XN08!JFFFN1GN2k1%J!V!2!V$V	CHEMBL3323486	f`iQA@LDl@H\DISOJl{bbkN}SMUMST@@	c1cc(-c2csc(N3CCOCC3)n2)cs1	6.66	group3-int	int	Androgen Receptor	Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days	2014	f`i@@@LdbbRRqbWEBd{uUUUUUP@@	f`iQA@LDl@H\DISOJl{bbkN}SMUMST@@	252.361	2.4885	3	0	81.84	2	-1.1537426482344666	1.1245746491161566	0.7396185098484451	11	2	f`iQA@LDl@H\DISOJl{bbkN}SMUMST@@											1
zrzxvdUExpzxMH8SEUBl3Q8v48F48Xke6PN073FC183@a1VV6XN08!60FFN1382k102248J!V!2!_0281V	CHEMBL3323487	fluPa@LDlx@QFPrQQZIIQZHsEEVBffZjB`b`@@	Oc1c(F)cccc1-c1csc(N2CCOCC2)n1	6.57	group3-int	int	Androgen Receptor	Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay	2014	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyQB@LDl@HRf^UYwqQUoAifj``J@@@	280.322	2.4592	4	1	73.83	2	-0.6130733699890218	1.0867208984411874	-0.23309271542170681	42	18	ffcQA`MAj@IIxlPUPKgGpQdTTTtraTQbRyJwbu`bHiZjjJ@@		eFJB@Hp@	eFABP`BL@								16
zrzxvdUExpzxMH@SUUBl3Q8v48F48Xle6PPV73FC083Aa1VV6XNVB2G61FFN93N2k102!VJ!V042!_!80V	CHEMBL3323488	fbmPa@LDlx@QfPrQQZIIQZKHxhjpTtsUPTDU@@@	COc1cc(F)ccc1-c1csc(N2CCOCC2)n1	6.64	group3-int	int	Androgen Receptor	Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days	2014	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyQB@LDl@HRf^UYwqQUoAifj``J@@@	294.349	2.7349	4	0	62.83	3	-0.8466453359343176	0.6813337128008725	0.8762569246524107	42	18	ffcQA`MAj@IIxlPUPKgGpQdTTTtraTQbRyJwbu`bHiZjjJ@@		eMJA@Hz@			eFABP`BL@						16
zrzhvdUDppzxM29OEEBk3A@d48F48Vmc6PO037FC08Y@ZW0V6XN08!J0FFs1GN3l3!W!J!V!2!VV040V	CHEMBL3323489	fdeIC@D\DZHLQdQhHrJJJJUKQITxkPXtuTmUTt@@	Clc1ncn(-c2csc(N3CCOCC3)n2)c1Br	6.48	group3-int	int	Androgen Receptor	Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay	2014	f`i@@@LdbbRRqbWEBd{uUUUUUP@@	f`iIB@LDDzp@aJYyUg\TUYwjYjjiZ`@@	349.639	3.5425	5	0	71.42	2	-0.369062557720363	0.29549913481970896	1.0557477356505331	11	9	fdeIC@DLDZHOFcchHrJIPjIKQIDXkPXtmTmUUT@@	eFACD`BL@	eFABH`BL@									9
zrzhvdUDppzxM29OEEBk3A@d48F48Vmc6PO037FC08Y@ZW0V6XN08!J0FFs1GN3l3!W!J!V!2!VV#V	CHEMBL3323490	fdeIC@DLDZHHbdQhHrJIPjIKQIDXkPXtmTmUUT@@	Clc1ncn(-c2csc(N3CCOCC3)n2)c1Cl	6.17	group3-int	int	Androgen Receptor	Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay	2014	f`i@@@LdbbRRqbWEBd{uUUUUUP@@	f`iIB@LDDzp@aJYyUg\TUYwjYjjiZ`@@	305.188	3.4233	5	0	71.42	2	-0.5975413486154502	0.5319942591868683	0.981983145300265	11	9	fdeIC@DLDZHOFcchHrJIPjIKQIDXkPXtmTmUUT@@	eFABH`BL@	eFABH`BL@									9
zrzxvdUExpzxMH8SUUBl3Q8v48F48Xle6PP073FC183@a1VV6XN0B2161FFN9A82k102248J!V!2!_0281V	CHEMBL3323491	fbmPc@LDlx@QFPsHYHhmDdhmDX\TUXJZYjhJBJ`@@	Oc1c(-c2csc(N3CCOCC3)n2)ccc(F)c1F	6.1	group3-int	int	Androgen Receptor	Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay	2014	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyQB@LDl@HRf^UYwqQUoAifj``J@@@	298.312	2.56	4	1	73.83	2	-0.5230773170363454	0.9594125048423987	-0.20296513173564382	42	18	ffcQA`MAj@IIxlPUPKgGpQdTTTtraTQbRyJwbu`bHiZjjJ@@		eFJB@Hp@	eFABP`BL@		eFABP`BL@						16
zrzhvdUDppzxM29OEEBk3A@d48F48Vmc6PN033FC08Y@ZW0V6XN08!J0FFs1GN3l3!V!J!V!2!VV#V	CHEMBL3323492	fhyIA@DTyhHHaPPdr{J|jRde^CRuKUUU@@@	Clc1cn(-c2csc(N3CCOCC3)n2)cn1	6.14	group3-int	int	Androgen Receptor	Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days	2014	f`i@@@LdbbRRqbWEBd{uUUUUUP@@	f`iIB@LDDzp@aJYyUg\TUYwjYjjiZ`@@	270.743	2.7199	5	0	71.42	2	-0.7458395830211557	1.0825749065882688	0.9216387899470396	11	9	fdeIC@DLDZHOFcchHrJIPjIKQIDXkPXtmTmUUT@@		eFABH`BL@									9
zrzxvdUExpzxMH8SUUBl3Q8v48F48Xle6PP073FC083@a1VV6XN0B2161FFN9382k102#J!V!2!_0281V	CHEMBL3323493	fluPa@LDlx@PfPrQQZIIQZH{EEVCFfZjB`J`@@	Oc1cc(F)ccc1-c1csc(N2CCOCC2)n1	6.09	group3-int	int	Androgen Receptor	Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days	2014	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyQB@LDl@HRf^UYwqQUoAifj``J@@@	280.322	2.4592	4	1	73.83	2	-0.6130733699890218	1.0867208984411874	-0.23309271542170681	42	18	ffcQA`MAj@IIxlPUPKgGpQdTTTtraTQbRyJwbu`bHiZjjJ@@		eFJB@Hp@			eFABP`BL@						16
zrzhvdUDppzxM29OEEBk3A@d48F48Vmc6PO037FC08Y@ZW0V6XN08!J0FFs1GN3l3!W!J!V!2!VV040V	CHEMBL3323494	fdeIC@DLDZHLRdQhHrJIPjIKQIDXkPXtmTmUUT@@	Clc1c(Br)ncn1-c1csc(N2CCOCC2)n1	5.89	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days	2014	f`i@@@LdbbRRqbWEBd{uUUUUUP@@	f`iIB@LDDzp@aJYyUg\TUYwjYjjiZ`@@	349.639	3.5425	5	0	71.42	2	-0.369062557720363	0.29549913481970896	1.0557477356505331	11	9	fdeIC@DLDZHOFcchHrJIPjIKQIDXkPXtmTmUUT@@	eFABH`BL@	eFACD`BL@									9
zrzhvdUDppzxM29OEEBk3A@d48F48Vkc6PO037FC08Y@ZW0V6XN08!J0FFs1GN3l1!W!J!V!2!VV040V	CHEMBL3323495	fdeIC@DLDZHJreYhHrJIPjIKQIDXkPXtmTmUUT@@	Ic1ncn(-c2csc(N3CCOCC3)n2)c1I	5.74	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days	2014	f`i@@@LdbbRRqbWEBd{uUUUUUP@@	f`iIB@LDDzp@aJYyUg\TUYwjYjjiZ`@@	488.082	3.0855	5	0	71.42	2	0.381505676758069	0.056834266318404464	1.2811716528972743	11	9	fdeIC@DLDZHOFcchHrJIPjIKQIDXkPXtmTmUUT@@	eFABl`BL@	eFABl`BL@									9
zrzxvdUDppzxMH8OEUBl3A8d48F48Vkc6PN073FC0832Z1VV6XN08!40FFN1182k102#J!V!2!V$k	CHEMBL3323496	fhyqB@LDuX@PeL|jsobbk^CSMUA@T@@@	c1ccc(-c2csc(N3CCOCC3)n2)nc1	5.59	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay	2014	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyqB@LDuX@PeL|jsobbk^CSMUA@T@@@	247.321	1.7942	4	0	66.49	2	-1.149713370943036	1.5688991674182637	0.7771799087573676	42	1	fhyqB@LDuX@PeL|jsobbk^CSMUA@T@@@											1
zrzhvdUDppzxM29OEEBk3A@d48F48Vmc6PO037FC08Y@ZW0V6XN08!J0FFs1GN3l3!W!J!V!2!VV040V	CHEMBL3323497	fdeIC@D\DZHJqdQhHrJJJJUKQITxkPXtuTmUTt@@	Clc1ncn(-c2csc(N3CCOCC3)n2)c1I	5.58	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay	2014	f`i@@@LdbbRRqbWEBd{uUUUUUP@@	f`iIB@LDDzp@aJYyUg\TUYwjYjjiZ`@@	396.635	3.2544	5	0	71.42	2	-0.10801775557311255	0.29441420616829295	1.1315774242068435	11	9	fdeIC@DLDZHOFcchHrJIPjIKQIDXkPXtmTmUUT@@	eFABl`BL@	eFABH`BL@									9
zrzhvdUDppzxM29OEEBk3A@d48F48Vkc6PN033FC08Y@ZW0V6XN08!J0FFs1GN3l1!V!J!V!2!VV040V	CHEMBL3323498	fhyIA@DTyhHLQPPdr{J|jRde^CRuKUUU@@@	Brc1cn(-c2csc(N3CCOCC3)n2)cn1	5.76	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor in human LNCaP cells assessed as inhibition of prostate-specific antigen secretion into media after 3 days	2014	f`i@@@LdbbRRqbWEBd{uUUUUUP@@	f`iIB@LDDzp@aJYyUg\TUYwjYjjiZ`@@	315.194	2.8391	5	0	71.42	2	-0.5173609528372245	0.8460798953897963	0.99540333008116	11	9	fdeIC@DLDZHOFcchHrJIPjIKQIDXkPXtmTmUUT@@		eFACD`BL@									9
zrzxvdUDppzxMH8OEUBl3A8d48F48Vkc6PN073FC0832Z1VV6XN08!40FFN1182k102#J!V!2!V$k	CHEMBL3323499	fhyqB@LDCX@PeL|jsobbk^CSMUA@T@@@	c1cc(-c2csc(N3CCOCC3)n2)ccn1	5.53	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay	2014	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyqB@LDCX@PeL|jsobbk^CSMUA@T@@@	247.321	1.7032	4	0	66.49	2	-1.1454317780246042	1.6236036582809177	0.7767056661945397	42	1	fhyqB@LDCX@PeL|jsobbk^CSMUA@T@@@											1
zrzxvdUExpzxMH@SUUBl3Q8v48F48Xke6PPV73FC383Aa1VV6XN080G61FFN93N2k10224cL!V042!_F281V	CHEMBL3323500	fj}Qa@LDlxh@aL`eL|jsslxhjp\tsUPTEEP@@	COc1c(F)cc(O)cc1-c1csc(N2CCOCC2)n1	5.52	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay	2014	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyQB@LDl@HRf^UYwqQUoAifj``J@@@	310.348	2.3892	5	1	83.06	3	0.10012397404495563	1.0851880818343815	-0.045903752501438765	42	18	ffcQA`MAj@IIxlPUPKgGpQdTTTtraTQbRyJwbu`bHiZjjJ@@		eMJA@Hz@	eFABP`BL@	eFJB@Hp@							16
zrzxvdUExpzxMH@SEUBl3Q8v48F48Xkc6PNV73FC183Aa9VV6XN08!40FFN13N2k10224cJc0V0F2!W!80V	CHEMBL3323501	ffcQc@CA`bh@cdaxHrRPsQSJEKQIJt{qZkPQAKUUE@@@	CS(=O)(=O)c1c(F)cccc1-c1csc(N2CCOCC2)n1	5.45	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay	2014	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyQB@LDl@HRf^UYwqQUoAifj``J@@@	342.414	1.8069	5	0	96.12	3	0.23035804922482908	1.426000813968064	1.1237931429355739	42	18	ffcQA`MAj@IIxlPUPKgGpQdTTTtraTQbRyJwbu`bHiZjjJ@@		gJPdH`DD@cuh@	eFABP`BL@								16
zrzhvdUDppzxMH9OEEBk3A@d48F48Vkc6PO03AFC0@Y@ZW0V6XN08!J0FFs1GN3l1!W!J!V!2!VV#V	CHEMBL3323502	fdeIB@LDDFp@aJYyUggqQUgAifjjfZh@@	Cc1ncn(-c2csc(N3CCOCC3)n2)c1C	5.45	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay	2014	f`i@@@LdbbRRqbWEBd{uUUUUUP@@	f`iIB@LDDzp@aJYyUg\TUYwjYjjiZ`@@	264.352	2.8123	5	0	71.42	2	-0.7838433429367936	1.05072863937776	0.911604013272267	11	9	fdeIC@DLDZHOFcchHrJIPjIKQIDXkPXtmTmUUT@@	eFBH@c@@	eFBH@c@@									9
zrzxvdUDxpzxMH8OEUBlIA8d4AF48Vkc6PN0EAFC0832Z1VV6XN0N!40FFN5182k1021!J!V!2!V$V	CHEMBL3323503	fdeQB@LD\@HRf[gV]|TtxLZYjjB@h@@	Cc1sc(N2CCOCC2)nc1-c1ccccc1	5.84	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay	2014	fhy@@@LdbbRRqbRxhToAjjjjjj`@@	fhyQB@LDl@HRf^UYwqQUoAifj``J@@@	260.36	3.1302	3	0	53.6	2	-1.5960182773628548	0.5020089620312649	0.6842421608612647	42	18	ffcQA`MAj@IIxlPUPKgGpQdTTTtraTQbRyJwbu`bHiZjjJ@@	eFBH@c@@										16
<v:v;njyxUnfW;UmqmKQyvfBgpL@nSHnCjGNEnUA5QT40T_s_HBGJsH2Fb0LF48P0Elx@Fc1FB3V10	CHEMBL3326454	fj}pb@AZlxhHcHhhhdkDhdefRmyNXHKIjjjJpZ^bT@	CO[C@@H]1C(c2ccc(C#N)c(Cl)c2C)=NN2CC[C@H](O)[C@@H]12	9.15	group1-p	p	Androgen Receptor	Displacement of [3H]DHT from androgen receptor in human MDA-MB-435 cells after 30 mins	2014	fgA@@@DjYU]~JEHujjjjjh@@	fgAP@@@PrQQQIRiXYpQkSUT@EDLH@	305.764	1.6944	5	1	68.85	2	-0.278413893458572	1.5364554614533465	-0.11934507623667798	1	1	fj}pb@AZlxhHcHhhhdkDhdefRmyNXHKIjjjJpZ^bT@											1
;rUntp9s5w4kACTN0lXN@u0FFF1Wh@0LnX58X03Qk94GlV0@OVhXpLGFcc1CnFW912V4041XeBJJ0K10W8FV	CHEMBL3337731	eol\DH@AEAck`IAIe]f[YY][wjFEKJinecgh@JZjB@@`iaB@@@	Cc1nn(Cc2ccccc2)c(-c2ccc(F)cc2)c1-c1ccc2c(c1)NC(=O)CO2	5.25	group4-ia	ia	Androgen Receptor	Displacement of [3H]testosterone from androgen receptor (unknown origin) expressed in 293 cells after 16 hrs by scintillation counting	2014	ekhP@@@LdbbRRQfbTVRVfRXDxd|BjzvNjjjjjjjjjjj@@@	ekh\D@@DG@`JDfUmWfUmV]zFIEG@fimcfj@BZfB@@BH@@@	413.451	3.8498	5	1	56.15	4	0.3000824670836131	-0.4934015107042021	0.08897205084119929	1	1	eol\DH@AEAck`IAIe]f[YY][wjFEKJinecgh@JZjB@@`iaB@@@											1
=vtpxs5w5ofETN0laN@u4FFFdWh@8LrX58X03Qk94GlV0@OVh2pqGFgc1CnFW912V4040XeBJJ0K10W8FV	CHEMBL3337823	fcpb@AJ[MXICHhdlhhieDdlhTiQbkE{O\@EMUAPTTpd@@	CCCCn1nc(C)c(-c2ccc3c(c2)NC(=O)CO3)c1-c1ccc(F)cc1	5.44	group4-ia	ia	Androgen Receptor	Displacement of [3H]testosterone from androgen receptor (unknown origin) expressed in 293 cells after 16 hrs by scintillation counting	2014	ffs@@@LdbbRRQfbTJSA\exIZuUUUUUUUP@@	ffsp`@DNBBbSJvksOZtYIS`ejuP@ST`AD@@@	379.434	3.6571	5	1	56.15	5	0.2885465113873616	-0.3722382161780806	0.05810049221695515	4	3	figpa@HHrwhGELadTRbTVRbrRaRaFF}DkQuLpP@AQSPP@@	gJPHB@IRuP@										3
<Uvtrdw5w4qAETNFlmOAu2FFF9Wh@8MnX58X03Uk94Glc4POVh2pyGFccGCnFW912V4040XeBJJ0p10W8FV	CHEMBL3337824	fcpb@AJ[MXICHhdlhhieDheYdiQbkU{O\@EMUATDTpd@@	Cc1nn(CC(C)C)c(-c2ccc(F)cc2)c1-c1ccc2c(c1)NC(=O)CO2	5.43	group4-ia	ia	Androgen Receptor	Displacement of [3H]testosterone from androgen receptor (unknown origin) expressed in 293 cells after 16 hrs by scintillation counting	2014	ffs@@@LdbbRRQfbTJSA\exIZuUUUUUUUP@@	ffsp`@DNBBbSJvksOZtYIS`ejuP@ST`AD@@@	379.434	3.421	5	1	56.15	4	0.14111797950329139	-0.10948333911394623	0.030762993528706074	4	3	figpa@HHrwhGELadTRbTVRbrRaRaFF}DkQuLpP@AQSPP@@	gJPHB@ITuP@										3
=vxpzw5w5ovUTN2naNeuaFFFdWhP8Lra59X0YQk94GlX0@OYh2rqGLic1CnJW9W2Z4040XeBJJ0K10W8FV	CHEMBL3337831	egh\DL@AEAmc`IBjPZdLbbRrbbfTRRtbcReCBeaTvut@EMUAPUQSBP@@	Cc1nn(CCC(C)(F)F)c(-c2ccc(F)cc2)c1-c1ccc2c(c1)NC(=O)CO2	5.04	group4-ia	ia	Androgen Receptor	Displacement of [3H]testosterone from androgen receptor (unknown origin) expressed in 293 cells after 16 hrs by scintillation counting	2014	ffs@@@LdbbRRQfbTJSA\exIZuUUUUUUUP@@	ffsp`@DNBBbSJvksOZtYIS`ejuP@ST`AD@@@	415.414	3.9117	5	1	56.15	5	0.4660447817700165	-0.6587157451600829	0.11863181655937424	4	3	figpa@HHrwhGELadTRbTVRbrRaRaFF}DkQuLpP@AQSPP@@	gNpLAHJPX@du}UP@										3
:UvzfzPzSynOTOyFQMQvAMHzJVXgrO0NtnQ0OG2_OGWDJf6BO282o6sWAB80N2Fe4V9BKV@G@84180XFBV0F0	CHEMBL3343778	eghXD@@J`NlbbbTRRbTftsTtRS@dfgbQusPQDUUUTp@QFCBDRd@@	CC(C)c1ccc2c(c1)C(=O)C[C@@H]1[C@]2(C)CCC[C@@]1(C)CNC(=O)c1ccccc1	4.08	group4-ia	ia	Androgen Receptor	Binding affinity to androgen receptor (unknown origin)	2014	fig@@@DjYegUnuYhToQzNjjjjjjjjj@@	fig``@@`RdsKJo_mrkARu[wQmADQUTp@QDFH@	403.564	5.692	3	1	46.17	4	-0.48875840037182094	-1.8790833734034038	-0.1201899694011687	2	2	eghXD@@J`NlbbbTRRbTftsTtRS@dfgbQusPQDUUUTp@QFCBDRd@@											1
vzUQAGtl9N4mVJ3BHsH8XO0H040Gd310VF2p10XV10FG0F010@1204!VFc!431!402Y0a(604VcFF	CHEMBL335316	ffcpC@EAbBPQHXdLbdLTRbVRRvdeF\gMT@@DWUPP@@	CC1(C)CCc2cc3c(C(F)(F)F)cc(C#N)nc3cc2N1	8.05	group1-p	p	Androgen Receptor	Inhibitory concentration against human androgen receptor (AR) dependent transcriptional activity in co-transfected mammalian CV-1 cells	2000	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	305.302	3.3537	3	1	48.71	1	-1.330964384960032	0.27207089705496246	-0.36592017991184667	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eMbA@Dg`@		eMBH@RZ@								49
uTPn2I9G8F4kVFA4F8H1VN2H!FF1390VHHo58Vc38k96F#2809204p0cc1B1G09020bVa#4F%VVFV	CHEMBL335992	fbmPB@FN@DYHhemDeLhcBTt[tZex@JZjH@@	CC1=CC(C)(C)Nc2ccc(-c3csc(C#N)c3)cc21	6.31	group3-int	int	Androgen Receptor	Cross-reactivity as binding to human androgen receptor (hAR)	2000	foQ@@@LdbbRRlRXKdkNjjjjjh@@	foQ`B@C@BDiWe[WAIJlze`@ih`@@	280.394	3.5756	2	1	64.06	1	-1.470478563600607	0.22278549779029416	-0.4552223614432105	7	1	fbmPB@FN@DYHhemDeLhcBTt[tZex@JZjH@@											1
yTur2K9G8k4kZFA4FNH5VN2H!FF1392VHHo58VV3Nk96FW!28V92JLp0Wc1Dl1V9022bca40@4J!458V8FV	CHEMBL336169	ec`XDH@DaJ`ICHhdieDdeLeEDTiPqIiYyetMM@APPITtuTQHDEb@	CC1=CC(C)(C)Nc2ccc3c(c21)/C(=C/c1ccco1)Oc1ccc(F)cc1-3	6.59	group3-int	int	Androgen Receptor	Inhibition of human androgen receptor at 10e-12 to 10e-5 M	2003	fag@@@LdbbbbbRrVtQSCBTyLZm{UUUUUUUUU@@@	fag``@L`BeLsJksNktyJsde{UmALA@Tdu@RBED	373.426	5.2599	3	1	34.4	1	-1.2920582732565205	-1.2314301890354893	-0.2803142420239616	2	1	ec`XDH@DaJ`ICHhdieDdeLeEDTiPqIiYyetMM@APPITtuTQHDEb@											1
yTur2K9G8k5kZFA5FNH5VN2H04FF1392VHHo58VV3Nk96FW!2NV92JLp0Wc1Dl1V90@2bca40@4J10458V8F0	CHEMBL336353	e`RTHH@Daa@ICHhdieDdeLeEDXeEEPqIiYyetm}@APPITpTETDPAAX`	CC1=CC(C)(C)Nc2ccc3c(c21)/C(=C/c1ccccc1N(C)C)Oc1ccc(F)cc1-3	5.82	group4-ia	ia	Androgen Receptor	Inhibition of human androgen receptor at 10e-12 to 10e-5 M	2003	fiw@@@LdbbbbbRrVtQVXXRgIcWhzjjjjjjjjj@@	fiwa@@L`RfYeUygU~gIV\doVchI`HB@dH@`DJH	426.533	5.9676	3	1	24.5	2	-1.0463775870573324	-2.0472423734850755	-0.18833207142248387	10	9	egdXHD@Ji@GGZPrJJIHqJJJIIQSZjL\VNIMES]KPDCT@DACETPPDGB@	gChHA`BOT@@										3
yTur2K9G8k4kZFA4FNH5VN2H!FF1392VHHo58VV3Nk96FW!28V92JLp0Wc1Dl1V9022bca40@4J!458V8F0	CHEMBL336736	egdXHH@Da@ICHhdieDdeLeEDXeEPqIiYyetm]@APPITpQEAD@PVH	CC1=CC(C)(C)Nc2ccc3c(c21)/C(=C/c1ccccc1C)Oc1ccc(F)cc1-3	6.09	group3-int	int	Androgen Receptor	Inhibition of human androgen receptor at 10e-12 to 10e-5 M	2003	fiw@@@LdbbbbbRrVtQVXXRgIcWhzjjjjjjjjj@@	fiwa@@L`RfYeUygU~gIV\doVchI`HB@dH@`DJH	397.492	6.4151	2	1	21.26	1	-1.6758071178475293	-2.232358219186306	-0.35668580574683395	10	9	egdXHD@Ji@GGZPrJJIHqJJJIIQSZjL\VNIMES]KPDCT@DACETPPDGB@	eFBH@c@@										3
vzUQAGtl9N4mVJ3BHsH8XO02040Gd310VF2p10XV10FG0F010@1204!VFc!431!4!Y0a(404V8FF	CHEMBL338922	fbmPC@E^AHHdLRFQRFJIQEIKRRcVCFj@@@jjB@@	CC1(C)CCc2cc3c(C(F)(F)F)ccnc3cc2N1	6.67	group3-int	int	Androgen Receptor	Inhibitory concentration against human androgen receptor (AR) dependent transcriptional activity in co-transfected mammalian CV-1 cells	2000	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	280.292	3.4641	2	1	24.92	1	-2.095290998651099	0.0030921513776031584	-0.5555991695844703	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@			eMBH@RZ@								49
vzUQvGtt9N5XWJAEFV1N28820401WX98c0D2!VX33#F01!F4080V8!2041!8010V84080k1104#V!	CHEMBL3402221	fdeP@@@ZRVYYwn^BT[t^@@BJjBaY@@	C[C@H]1CCCN1c1ccc(C#N)c2ccccc12	9.08	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor (unknown origin) after 3 hrs	2015	foQ@@@DjYegufaFlzjjjjj`@@	foQ`@@@YIEDeDXbsbmV]TE@@D@@@	236.317	3.5053	2	0	27.03	1	-2.570956825770667	0.17075195784834626	0.4643505226297916	14	14	fde`C@E@BWNL_EIfV]{gYrVoA`@@bjhH@@	eFBH@c@@		eMbA@Dg`@								14
vzUQvGtt9N5XWJAEFV1N28820401WX98c0D2!VX33#F01!F4080V8!2041!8010V84080k1104#V!	CHEMBL3402222	fdeP@@@ZRVYYwn^BT[t^@@BJjBaZ@@	C[C@@H]1CCCN1c1ccc(C#N)c2ccccc12	7.7	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor (unknown origin) after 3 hrs	2015	foQ@@@DjYegufaFlzjjjjj`@@	foQ`@@@YIEDeDXbsbmV]TE@@D@@@	236.317	3.5053	2	0	27.03	1	-2.570956825770667	0.17075195784834626	0.4643505226297916	14	14	fde`C@E@BWNL_EIfV]{gYrVoA`@@bjhH@@	eFBH@c@@		eMbA@Dg`@								14
vzUQvOttAN5XWJQEFVIN28868401WX98c0DM!VX33#F01!F6082V8!2041!8010X8Z080k1104#V!	CHEMBL3402223	fluP@@@ZRVYYwng`eF|g`@@bjhH@@	CC1(C)CCCN1c1ccc(C#N)c2ccccc12	8.15	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor (unknown origin) after 3 hrs	2015	foQ@@@DjYegufaFlzjjjjj`@@	foQ`@@@YIEDeDXbsbmV]TE@@D@@@	250.344	3.8033	2	0	27.03	1	-2.5111091524757447	-0.06040667225706209	0.48898471104534647	14	14	fde`C@E@BWNL_EIfV]{gYrVoA`@@bjhH@@	eMBH@RZ@		eMbA@Dg`@								14
vzUQvIzt9NhYYoAEFW1N28B2F413_X98c0D2!VY33#F61!F4080V8!2041!801FV8B080k1104#V!	CHEMBL3402224	fluP@@@ZRVYYwn_`eF}G`@@bjhJEd@	CC[C@H]1CCCN1c1ccc(C#N)c2ccccc12	8.96	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor (unknown origin) after 3 hrs	2015	foQ@@@DjYegufaFlzjjjjj`@@	foQ`@@@YIEDeDXbsbmV]TE@@D@@@	250.344	3.9597	2	0	27.03	2	-2.3599307079321976	-0.27525016056375795	0.515906857731691	14	14	fde`C@E@BWNL_EIfV]{gYrVoA`@@bjhH@@	eMBD@ch@		eMbA@Dg`@								14
vzUQvQzvANhYYyAEFWGNHdC2FJ13bX9Bc1D2!VY73!1FD54FF40R0V8!2F41!801FV8B081k110Z#V!	CHEMBL3402225	fbmP@@@ZRVYYwnVxIQ`qx@@Hjj`hV`@	CC(C)[C@H]1CCCN1c1ccc(C#N)c2ccccc12	8.85	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor (unknown origin) after 3 hrs	2015	foQ@@@DjYegufaFlzjjjjj`@@	foQ`@@@YIEDeDXbsbmV]TE@@D@@@	264.371	4.178	2	0	27.03	2	-2.296333030404509	-0.4584973151710976	0.5401257180109065	14	14	fde`C@E@BWNL_EIfV]{gYrVoA`@@bjhH@@	gC`HL@Qz`@		eMbA@Dg`@								14
:Uvzn:dSjrYoAjIb1N2@P2W49M_m98e1j224XYI3V!J61!F4380VB!XV4901B8l0V84080k1105010VV0	CHEMBL3402226	fbmq@@DDrCHihheCDhlmpUgARuUP@@QpPp`@	N#Cc1ccc(N2CCC[C@@H]2C(N)=O)c2ccccc12	7.47	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor (unknown origin) after 3 hrs	2015	foQ@@@DjYegufaFlzjjjjj`@@	foQ`@@@YIEDeDXbsbmV]TE@@D@@@	265.315	1.8312	4	1	70.12	2	-0.7222262335542825	1.492679103485852	-0.27050276931807427	14	14	fde`C@E@BWNL_EIfV]{gYrVoA`@@bjhH@@	gCiHDL@ILt@@		eMbA@Dg`@								14
vzUQvItt9N5XWJAEFV1N28820401WX98c0D2!VX33#F41!F4080V8!2041!8010V84080k1104#V!	CHEMBL3402227	flup@@@ZRdlrso\oAJLFO@@AEUXTKP@	N#Cc1ccc(N2CCC[C@@H]2C#N)c2ccccc12	9	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor (unknown origin) after 3 hrs	2015	foQ@@@DjYegufaFlzjjjjj`@@	foQ`@@@YIEDeDXbsbmV]TE@@D@@@	247.3	2.7509	3	0	50.82	1	-1.8501984863971597	0.878886891468752	0.6275921329600274	14	14	fde`C@E@BWNL_EIfV]{gYrVoA`@@bjhH@@	eMbA@Dg`@		eMbA@Dg`@								14
;UvUxvST7XWqzUmV1P6C92qJ01Ymd8c1D2X4XX730F1H834GF40BVc820HF410FB0G0V84081k31V5!2V10	CHEMBL3402228	fluQ@@BIAdTTRLTRbrqFFmzMUT@@D\BHID@@	C[C@H]1[C@@H](O)CCN1c1ccc(C#N)c2ccccc12	8.66	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor (unknown origin) after 3 hrs	2015	foQ@@@DjYegufaFlzjjjjj`@@	foQ`@@@YIEDeDXbsbmV]TE@@D@@@	252.316	2.6532	3	1	47.26	1	-1.60036111094493	0.8790280112295059	-0.4604492330578849	14	14	fde`C@E@BWNL_EIfV]{gYrVoA`@@bjhH@@	eFBH@c@@	eFJB@Hp@	eMbA@Dg`@								14
;UvUxvST7XWqzUmV1P6C92qJ01Ymd8c1D2X4XX730F1H834GF40BVc820HF410FB0G0V84081k31V5!2V10	CHEMBL3402229	fluQ@@BIAdTTRLTRbrqFFmzMUT@@D\BHQD@@	C[C@H]1[C@H](O)CCN1c1ccc(C#N)c2ccccc12	8.62	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor (unknown origin) after 3 hrs	2015	foQ@@@DjYegufaFlzjjjjj`@@	foQ`@@@YIEDeDXbsbmV]TE@@D@@@	252.316	2.6532	3	1	47.26	1	-1.60036111094493	0.8790280112295059	-0.4604492330578849	14	14	fde`C@E@BWNL_EIfV]{gYrVoA`@@bjhH@@	eFBH@c@@	eFJB@Hp@	eMbA@Dg`@								14
:UvznttdN5uWJAjKV9s29P2FR8GWXC8g1E2!VX33V!F01!k4Wc0WB20X04101B0W8V84180k1104#V!	CHEMBL3402230	fluQ@@BIAdTTRLTRbrqFFmzKUT@@D\DDP@	C[C@H]1C(=O)CCN1c1ccc(C#N)c2ccccc12	7.43	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor (unknown origin) after 3 hrs	2015	f`i@@@LdbbbTVrKMBMYuUUUUUP@@	f`ia@@B@rJIKQQJHdihsoMU@@@P@@@	250.3	2.7969	3	0	44.1	1	-1.9446476586760633	0.7908165644402163	0.615663061246192	1	1	fluQ@@BIAdTTRLTRbrqFFmzKUT@@D\DDP@											1
;UvQzvUUjXtLQUkXpP3f92qJ2Wnm98c1D2F1lX731V1F874GH40B0c8242H41!B014V84081k310Z!2V10	CHEMBL3402231	fbmQ@@JYAdRbbQbbTVVirs`ijjh@@HxDHVH@	C[C@H]1[C@@H](CO)CCN1c1ccc(C#N)c2ccccc12	8.39	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor (unknown origin) after 3 hrs	2015	foQ@@@DjYegufaFlzjjjjj`@@	foQ`@@@YIEDeDXbsbmV]TE@@D@@@	266.343	2.8479	3	1	47.26	2	-1.377115977555735	0.58914419674763	-0.41024631416355256	14	14	fde`C@E@BWNL_EIfV]{gYrVoA`@@bjhH@@	eFBH@c@@	eMJA@Df`@	eMbA@Dg`@								14
;UvUzvUUjXtTzUkXrP3jd2yJ6Wnq9Nc1DLk1lXb31V9F8U4GH70R2c8662H41!BV14V84281k310Z!2V10	CHEMBL3402232	ffcQ@@NUAdTbabQbbTVVyKpTejjj`@@c`PaT`@	C[C@H]1[C@@H](C(C)(C)O)CCN1c1ccc(C#N)c2ccccc12	8.85	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor (unknown origin) after 3 hrs	2015	foQ@@@DjYegufaFlzjjjjj`@@	foQ`@@@YIEDeDXbsbmV]TE@@D@@@	294.397	3.5878	3	1	47.26	2	-1.2641910545901933	0.040321315728785445	-0.3602279561143852	14	14	fde`C@E@BWNL_EIfV]{gYrVoA`@@bjhH@@	eFBH@c@@	gJQH@PAIjj@@	eMbA@Dg`@								14
{jxU;bxy3fOAzw@hrmO9i1D2H1xqMY3ZdkN76Km40g0c8Y46L49@0w054VN4191kf11Z#V!	CHEMBL3402233	ffcP`@NU@cHheMDcEDhlmrW`iJuUU@@AG@cBi@@	COC(=O)[C@H]1CCN(c2ccc(C#N)c3ccccc23)[C@H]1C	8.12	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor (unknown origin) after 3 hrs	2015	foQ@@@DjYegufaFlzjjjjj`@@	foQ`@@@YIEDeDXbsbmV]TE@@D@@@	294.353	2.9262	4	0	53.33	3	-1.0084214818492374	0.4966348206014604	0.85307893420009	14	14	fde`C@E@BWNL_EIfV]{gYrVoA`@@bjhH@@	eFBH@c@@	gJPh@l@ILmP@	eMbA@Dg`@								14
;UvUztUUxnfwzUFvYP7ghLq45Q_e9NdcD6kNVY7E08FF7A01F_080c86J22D!2849HW1D080k3106V82c10	CHEMBL3410850	fj}QC@EFJBPQHXdLbdLTRRLTTUehJXyj``rjjhiEdy@@	N#Cc1ccc(N2[C@H]3CC[C@H]2CC(O)C3)cc1C(F)(F)F	7.4	group2-a	a	Androgen Receptor	Displacement of [3H]R1881 from pSG5-tagged human androgen receptor expressed in COS1 cells assessed as relative binding inhibition	2015	fgA@@@DjYVY~FeiUjjjjjh@@	fgA`@@@YIEEEDe^RD[Uj`j`baBEa@@	296.291	2.6806	3	1	47.26	2	-1.2115327880136761	0.5786598274764686	-0.36183927764698387	6	4	fj}P@`FE@xqdDrFYCHhdhdXdieHjLxJsjjj`@jkhPRT`@	eFJB@Hp@										4
;UvUztUUxnfwzUFvnP7ghLq45v_i9NdcDMkNVYbE88FF7Q01Fb080c86L22D!2849HW1D0N0k3106V82c10	CHEMBL3410851	ffcQC@EFJBPQHXdLbdLTRRLTTUdmASGMTDFUUUQRKIr@@	CC1(O)C[C@@H]2CC[C@@H](C1)N2c1ccc(C#N)c(C(F)(F)F)c1	7.53	group2-a	a	Androgen Receptor	Displacement of [3H]R1881 from pSG5-tagged human androgen receptor expressed in COS1 cells assessed as relative binding inhibition	2015	fgA@@@DjYVY~FeiUjjjjjh@@	fgA`@@@YIEEEDe^RD[Uj`j`baBEa@@	310.318	2.9786	3	1	47.26	2	-1.1516850455808871	0.34750099746174357	-0.33720506288084656	6	4	fj}P@`FE@xqdDrFYCHhdhdXdieHjLxJsjjj`@jkhPRT`@	eMJB@Df`@										4
:UvzvztzOxvfofjJtAs69SLM51Q_X99h8D60OVY7A080JU9F0kZ0c0V83J26D!2849PW0D180k9106V80c!	CHEMBL3410852	fj}QC@EFJBPQHXdLbdLTRRLTTUehJXyj``rjjdh@@	N#Cc1ccc(N2C3CCC2CC(=O)C3)cc1C(F)(F)F	7.18	group2-a	a	Androgen Receptor	Displacement of [3H]R1881 from pSG5-tagged human androgen receptor expressed in COS1 cells assessed as relative binding inhibition	2015	foQ@@@LdbbRbbsxZVeVjjjjjh@@	foQa@@F@rJIJIFIJcNBlyjjh@J@@@	294.275	2.8243	3	0	44.1	2	-1.5558193357448096	0.490448380687179	0.714273016657093	1	1	fj}QC@EFJBPQHXdLbdLTRRLTTUehJXyj``rjjdh@@											1
vzUQvQztUSxnvwvUFv3PEdjLy47Q_X9NtcE60OVY7U1c0F7A01F_0B2c@6J22D402849LW1D080k1106V8VcF0	CHEMBL3410853	fcpC@EFJBPQHXdLbdLTRRLTTURTRTmASGJ}uPPYUUUP@EBKIr@@	N#Cc1ccc(N2[C@H]3CC[C@H]2CC(NCc2ccccc2)C3)cc1C(F)(F)F	6.63	group3-int	int	Androgen Receptor	Antagonist activity against pSG5-tagged human androgen receptor expressed in COS1 cells assessed as reduction in receptor-mediated transcriptional activity by AR-regulated rat probasin promoter fragment driven firefly luciferase reporter assay	2015	ffs@@@LdbbRbbsRTRWCRtjqZuUUUUUUUP@@	ffsP@@@NrRJJJIJ{IQI\dHvkEkTETDU@APHPlH@	385.432	4.0524	3	1	39.06	5	-0.4629196687741973	-0.9991783287763356	-0.1505614278136971	1	1	fcpC@EFJBPQHXdLbdLTRRLTTURTRTmASGJ}uPPYUUUP@EBKIr@@											1
:UvvvzvzSznvyvUFv7PEexqy4bQ_XONtcDD0Olf7E0c0O7AV1Fh288c@6J22D402849LW1DV80m1106V8WcF0	CHEMBL3410854	fi{p``LJGA@@bl`vP{HYIH]DeDcDeLiEIVcQRmUUU@AUWP`Te@@	CS(=O)(=O)NC1C[C@@H]2CC[C@@H](C1)N2c1ccc(C#N)c(C(F)(F)F)c1	5.58	group4-ia	ia	Androgen Receptor	Displacement of [3H]R1881 from pSG5-tagged human androgen receptor expressed in COS1 cells assessed as relative binding inhibition	2015	fgA@@@DjYVY~FeiUjjjjjh@@	fgA`@@@YIEEEDe^RD[Uj`j`baBEa@@	373.398	2.571	5	1	81.58	3	0.39979912429789033	0.7312340306949655	0.05502419207742535	6	4	fj}P@`FE@xqdDrFYCHhdhdXdieHjLxJsjjj`@jkhPRT`@	gGXdMD@b`FRREZ`@										4
:Uvvv;SzvvyvURvEPUexry4bQ_XOOtcDD0Qlf7E0c0O7AV5Fh288c@6J22D4V2849LW1DV80m1106V8WcF0	CHEMBL3410855	fegp``LZgA@@alavPGHYIHTidhdXdieHeZMYNUjjjj@BjnaDhj@@	CCS(=O)(=O)NC1C[C@@H]2CC[C@@H](C1)N2c1ccc(C#N)c(C(F)(F)F)c1	5.69	group4-ia	ia	Androgen Receptor	Displacement of [3H]R1881 from pSG5-tagged human androgen receptor expressed in COS1 cells assessed as relative binding inhibition	2015	fgA@@@DjYVY~FeiUjjjjjh@@	fgA`@@@YIEEEDe^RD[Uj`j`baBEa@@	387.425	3.068	5	1	81.58	4	0.6088208147587578	0.2596230925819606	0.10680250978815196	6	4	fj}P@`FE@xqdDrFYCHhdhdXdieHjLxJsjjj`@jkhPRT`@	gNxdMD@b`FRREKU@@										4
;UvUztUUxYfwzUFfnP7whLq45fhjANdcDrlFVYbE80FF7Q01Fb081c96q22B102@09FV9D0N0o3106k02V10	CHEMBL3410856	fbmQB@AJRBHrJJJIJqQQVLdxOhpPVUUUQP@@	Cc1c(N2C3CCC2CC(C)(O)C3)ccc(C#N)c1Cl	8.68	group1-p	p	Androgen Receptor	Displacement of [3H]R1881 from pSG5-tagged human androgen receptor expressed in COS1 cells assessed as relative binding inhibition	2015	fgA@@@DjYVY~FeiUjjjjjh@@	fgA`@@@YIEEEDe^RD[Uj`j`b`@@	290.793	3.0802	3	1	47.26	1	-1.417824717403835	0.4796528488718774	-0.39491069267047496	6	1	fbmQB@AJRBHrJJJIJqQQVLdxOhpPVUUUQP@@											1
xvwUcTqnEEum9cx6mQre_h_HqJZmTj9HFR2Kmt32WCOlFkIR8O2I0428W0A08F2020ZC4I3H4a8C1801FR2010	CHEMBL3421871	fewA`@@QsdTRTrTfRRfebRhrRgAGN@Bjjjj`@JBBbdyA`@	CC[C@@]12C[C@@](C)(O)[C@](O)(c3ccccc3)C[C@H]1CCc1cc(O)ccc12	6.52	group3-int	int	Androgen Receptor	Binding affinity to human AR	2015	fb}@@@LdbbbTRntRWIBMjr\uUUUUUUT@@	fb}@@@LdbbTRrNTRSI\TZr\aDTUT@APcbl`@	352.472	4.2141	3	3	60.69	2	-0.21965158062732337	-0.48078024091983573	-2.400666051717938	1	1	fewA`@@QsdTRTrTfRRfebRhrRgAGN@Bjjjj`@JBBbdyA`@											1
<j;jzyzC:yUUzjiUrvzBwpjvzG2MmSrNv2vSlSybnYDQfY5aaSdk381EuFcUdE0rkDKB85FRVrFBY8G0	CHEMBL3421892	edZTBJ@DggH`XPHcRPrdBiBjPrJJIJSKFSQRZqISJJL\RFK[OPpDEUUSUP@TsDTEa@@	Cc1noc(=O)c2ccc(NC(=O)C(O)(CC3(c4cc(F)ccc4Cl)CCC3)C(F)(F)F)cc12	7.4	group2-a	a	Androgen Receptor	Binding affinity to human AR	2015	few@@@Djf]]{yVul\T[I^cjjjjjjjjjh@@	fewQ`@BZ@brSKJ~mkSN}NRUehymPHEMUPPDP@@	498.859	5.5072	6	2	87.99	6	2.02193325169363	-1.7075836156430768	-0.62677168741694	1	1	edZTBJ@DggH`XPHcRPrdBiBjPrJJIJSKFSQRZqISJJL\RFK[OPpDEUUSUP@TsDTEa@@											1
yTur2K9G8k4kZFA4FNH5VN2H!FF1392VHHo58VV3Nk96FW!28V92KLp0Wc1Dl1V9022bca40@4J!458V8F0	CHEMBL342426	egdXHD@Fe@I@bPrJJKKJIQQQIJJ[NL\N^Y]UKC[PPDu@A@PqTPPD@b@	CC1=CC(C)(C)Nc2ccc3c(c21)/C(=C/c1ccc(F)c(F)c1)Oc1ccccc1-3	6.04	group3-int	int	Androgen Receptor	Inhibitory activity (IC50) against human androgen receptor expressed in CV-1 cells	1998	fiw@@@LdbbbbbRrVtQVXXRgIcWhzjjjjjjjjj@@	fiwa@@L`RfYeUygU~gIV\doVchI`HB@dH@`DJH	401.455	6.172	2	1	21.26	1	-1.643499345455404	-2.100914889033625	-0.351431693564601	10	9	eolXHL@Nm@GDbPDdLbbbffLRbbbRTTv\Xd|BJFZvfN``hZ`@`HXjHHBBQ@											1
<MwOK9o4wZ1ATTNH_XRHT640F13A14Lno70eVIOk9!1X1250121Bh0YV17lX4@582bFa40840N0212V8F0	CHEMBL343306	fj}`a@OAJBHIHYEEEehdieHjsakAsA@P@UUHP@@	CC1(C)OC(=O)Nc2ccc(-c3ccc(F)c(Cl)c3)cc21	6.68	group3-int	int	Androgen Receptor	Antagonist activity against the Androgen Receptor (AR)	2002	fhy@@@DjYU_mVRxKpZjjjjjh@@	fhy``@L@PdrjklkQde^BuT@P@@@@@	305.735	4.078	3	1	38.33	1	-1.5297130688564753	-0.24108605830401952	-0.38785453856749696	3	2	fj}`a@OAJAqIHYEEEehdieHjsakAsA@P@UUHP@@	eFABH`BL@										1
zTPn6I9l8F5kVFA5G8IWVN2H04FF1390VLmo58VX3@k96FGV02OX1@5Jp0cc1RlGW90@VbVa!8RGGJ61!8!	CHEMBL345342	fakQC@EQlBPQHXdLbdLTRbRRJbadeF|dmUHTCEMUQ@@@	CC1=CC(C)(C)N(C)c2cc3c(cc21)c(C(F)(F)F)cc(=O)n3C	7.34	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	foQ@@@DjYUU}`nRlzjjjjj`@@	foQQ@@DZ@drmjjtYIUgMR@ESD@@	336.356	2.7808	3	0	23.55	1	-1.8212263946769816	0.3306342417837063	0.7048743483892775	38	4	fakQ@`HVHAq]H^d@rFQQQSIIIRIRqQ`eFRVi`PbjjZh`@@	eFBH@c@@										1
;QfQztENwndoYDHtH8iO4HF41vh310VN2p1FXV10GG0F410@1204!cFc!431!402Y1i(604X8GF	CHEMBL345854	fa{QC@EAlBPQHXdLbdLTRbVVRtRTeF]EK^uP@@QUUTE@@@	Oc1cc(C(F)(F)F)c2cc3c(cc2n1)NC1(CCCCC1)CC3	7.46	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	flm@@@DjeUo]UYHVkNbfjjjjjjj@@	flmP@@@JRfV_U[VgARMZJP@@Jjj`h@@	336.356	4.2026	3	2	45.15	1	-0.9885441055986605	-0.39339224857981403	-1.4061832980833273	1	1	fa{QC@EAlBPQHXdLbdLTRbVVRtRTeF]EK^uP@@QUUTE@@@											1
yTuI2G9G8F4kVFA4F8H1VN2H!FF1310VFHo18VV18k96F#2801#oFcc041101020YVa$F!4!X0GF	CHEMBL346487	fluQ@@DF@drlkjluFJt{t@A@UMPP@@	CC1=CC(C)(C)Nc2cc3nc(O)cc(C)c3cc21	7.44	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@jP`@@	254.332	2.8798	3	2	45.15	0	-1.5167962076473578	0.8268011873034624	-1.574153142645141	70	9	fluPA@NVAxj\\bbbTRrrbLYrVgA`@@bfjB@@	eFJB@Hp@	eFBH@c@@									4
:UvEItl9N5mVJACIcHdXO2H04FGd390VLmp58XV3AkO6FGW0@OX165Jl0cc1RnGW90@VbVa!8BGGJ714V8F0	CHEMBL346827	ffcQC@EQlBPQHXdLbdLTRbRRJVdeF|gMUHTCEUTP@@	Cn1c(=O)cc(C(F)(F)F)c2cc3c(cc21)NC(C)(C)CC3	7.44	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	foQ@@@DjYUU}`nRlzjjjjj`@@	foQQ@@DZ@drmjjtYIUgMR@EUD@@	310.318	2.5081	3	1	32.34	1	-1.52805574734268	0.6417239222245967	-0.4037418372565871	38	10	ffcQB`DFRCqDxydBrEYCHhdhdldhhcIQbmNCUPPETsUD@@		eMBH@RZ@									4
=tU:pzxzTQzUzUnQvvUiEeM5mxjbjvMEEnbvQYTeVYXTIojqC2EBgInoEcattbtabLbJWkk1GNzad2cW0	CHEMBL347556	egXvFL@EC@eok_Hnd]SPIABPpdLbdLTRRLTTvbJRTRVRRTRTrdf`RSwplmTDFULuUUUUUP@TqP@@@	CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)N1CCOCCN1CCN(CCOCc2ccc(O)c(C(N)=O)c2)CC1	6.46	group3-int	int	Androgen Receptor	Inhibition of 1.0 nM [3H]mibolerone binding to human androgen receptor of PC3/AR cell lysate	2003	edZP@@@LdbbRbbsRRTRVRRTRWA`bcWPLMUUUUUUUUUUUT@@@	edZRB@@DLDn`EGEdfYf]]}YWUVUhXl|ZzAaZj`XHjjjj`@b@@@	646.665	1.9448	12	2	152.67	14	6.745261966371805	0.1188027426668663	0.5026408228500422	1	1	egXvFL@EC@eok_Hnd]SPIABPpdLbdLTRRLTTvbJRTRVRRTRTrdf`RSwplmTDFULuUUUUUP@TqP@@@											1
yTuI2G9G8F5kVFA5FNI1VN2H04FF1310VFHo18VX1@k96F#2N018!oFcc0411114@2YVa#FF106!281F	CHEMBL347870	fnsQC@EAlBPQHXdLbdLTRbVVTTLdhshyj`@@bfj``@@	CC1=CC(C)(C)N(C)c2cc3nc(O)cc(C(F)(F)F)c3cc21	6.81	group3-int	int	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@jP`@@	322.329	3.7425	3	1	36.36	1	-1.4582256325412426	-0.1153868998035944	-0.36731228891425227	70	9	fbmPA@NVAxj\\bbbTRrrbacNRtxL@@DTuTD@@	eFJB@Hp@	gJPBAHJPt`PAIjj@@									2
;QAQtl9R4mVJATHsH8XO1H640ld310VF2p30XV18FG0F1A0P1204!cHc!433!482Y8a%80604X8GF	CHEMBL347910	fnsQC@EQlBPQHXdLbdLTRbVbvbLdhsdej`@@bjj`hAh@@	Cc1c2c(cc3c(C(F)(F)F)cc(O)nc13)C(C)CC(C)(C)N2	7.66	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	324.345	4.4927	3	2	45.15	1	-1.0654455117864754	-0.523245010825691	-1.4244353238773233	70	59	fnsPC`DN@Dt`Y^NWDlaVP[HILlvmnl}LyjpXuUAA@AUT@@@	eFJB@Hp@	eFBH@c@@	eMBH@RZ@								5
=tU:pzxzTQzUzUnQvvUiEeM5mxjbbvMEEnbvQYTeVYXTIozqC0EBg3noEcatt_tabLbJWkk1GNz4d2cW0	CHEMBL348495	ei]RNL@EC@a_Hnekf^PIABPpdLbdLTRRLTTvbJRRRRbRfTdtBRqIj``rifjjjj`@ib@@@	CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)N1CCOCCOCCOCc1ccc(O)c(C(N)=O)c1	6.48	group3-int	int	Androgen Receptor	Inhibition of 1.0 nM [3H]mibolerone binding to human androgen receptor of PC3/AR cell lysate	2003	fk@@@LdbbRbbsRRRRRbRxXRmgjjjjjjjjjj`@@	fkQP@DX@irZiLsLz{zjkJtY[vsmUPLDUUT@D@@@	578.542	2.0741	11	2	155.42	14	6.179870265166674	0.19301483771545103	0.30967420173545446	2	1	ei]RNL@EC@a_Hnekf^PIABPpdLbdLTRRLTTvbJRRRRbRfTdtBRqIj``rifjjjj`@ib@@@											1
zyQvDItn8N5kVLACGcIWVO2H0JFl3390ZMmZ58VX3Ak97kOZ4@OX1X5Jl0cc1RnGWd0DVbX602CBGOJa10V8F0	CHEMBL348918	fj}QC@EQlBPQHXdLbdLTRbRRJfdhwhijiB`XjjI@Te@@	C[C@H]1Nc2cc3c(cc2[C@H]1C)c(C(F)(F)F)cc(=O)n3C	5.04	group4-ia	ia	Androgen Receptor	Antagonistic activity (IC50) against human androgen receptor (hAR) in co-transfected CV-1 cell	1998	fgA@@@LdbbRRRKI\DZuUUUUT@@	fgAQ@@DZ@drmjkQdeFluH@UQ@@@	296.291	2.5471	3	1	32.34	1	-1.6037595117203058	0.6702956254096613	-0.42661978966275005	5	5	fj}Q@`FFJAqcHIdLrFQQQQHiJJZQDYIUoUAPEMUSECB@@	eFBH@c@@										2
zyvn@ltl8N4kVJABFsH1VN2H0JFG9310VGHp18VV18k96F0402821#oFcc041101422YVa$F!6!X8GF	CHEMBL349539	fnsQC@EAlBPQHXdLbdLTRbVVTRtdhshyj`@@bfj``@@	CC1=C(C)C(C)(C)Nc2cc3nc(O)cc(C(F)(F)F)c3cc21	7.17	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@jP`@@	322.329	3.8244	3	2	45.15	1	-1.0446182399022739	-0.11402144718199048	-1.4312354214183558	70	9	fbmPA@NVAxj\TfYY]vWf\eipX@@HijhH@@	eFJB@Hp@	gJPBAHJPt`PAIjj@@									1
zyQvDItn8N5kVLACGcIWVO3H0JFl3390ZMqo58VX7Ak97kOZBPSX1i5Jl0ccGRnGWd0DVrX6F2CRGOJa1!8!	CHEMBL349631	fnsQC@EQlBPQHXdLbdLTRbRRJdRdhwhijiB`XjjhhIP@	C[C@H]1N(C)c2cc3c(cc2C1(C)C)c(C(F)(F)F)cc(=O)n3C	7.25	group2-a	a	Androgen Receptor	Antagonistic activity (IC50) against human androgen receptor (hAR) in co-transfected CV-1 cell	1998	fgA@@@LdbbRRRKI\DZuUUUUT@@	fgAQ@@DZ@drmjkQdeFluH@UQ@@@	324.345	2.6774	3	0	23.55	1	-1.879613428104884	0.4373334719311865	0.6845716130219792	5	5	ffcQ@`FVjAqSHYdBrBSLrn{MtdYKS`uAPQSUTqPp`@	eMBH@RZ@										1
;QAItn9NDmVL3DHsI8XQ0HFJ0nf310VG2p14mV10GG1F854@1204!cFc!J3104402Y0a021#4a04X8GF	CHEMBL350465	fnsQC@EAlBPQHXdLbdLTRbVVRRbdhshij`@@bjj`hQH@@	CCC1Cc2cc3c(C(F)(F)F)cc(O)nc3cc2NC1(C)C	7.34	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	324.345	4.1935	3	2	45.15	2	-0.8928308508445759	-0.4642050808734247	-1.399887519263137	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@		eMBH@RZ@	eMBD@ch@							49
yTuI2G9G8F4kVFA4FNH10N2H040F1310V0Ho18VV18k86F&1#4FVV041!1422YVa$F!6!X8GF	CHEMBL350877	fj}QC@EAlBPQHXdLbdLTRbVVRtdhshij`@@bfhH@@	CC1(C)C=Cc2cc3c(C(F)(F)F)cc(O)nc3cc2N1	7.57	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@jP`@@	294.275	3.306	3	2	45.15	1	-1.1679648542606316	0.301646943806425	-1.4800994404798407	70	9	fdePA@NVAxj\TfYY]uygIZ]z@@BJZ``@@	eFJB@Hp@	gJPBAHJPt`PAIjj@@									1
zyvQ2IOI8F4k06@BFNHVVO0H040k12104K2o10V018F10V!B2#Z!VF8!41!V482l26F04!80a!X8GF	CHEMBL351022	fbmQC@EAlBPQHXdLbdLTRbVVTdeF\FMT@@DUTD@@	CC1(C)CNc2cc3nc(O)cc(C(F)(F)F)c3cc21	8	group1-p	p	Androgen Receptor	Antagonistic activity (IC50) against human androgen receptor (hAR) in co-transfected CV-1 cell	1998	dk|@@DjYU_X^gSjjjjj@@	dk}@@@UJYY}ZxYtp@@J``@	282.264	2.9561	3	2	45.15	1	-1.2147539407301533	0.5565292907277979	-1.5016868005636566	4	4	fbmQC@EAlBPQHXdLbdLTRbVVTdeF\FMT@@DUTD@@											1
;QAItl9NBmVo3DHsH8XO4HF41nd310VF2p10XV10GG0F410@1204!VFc!431!402Y0a(604X8GF	CHEMBL351148	ffcQC@EAlBPQHXdLbdLTRbVVRtTeF]EMT@@DUUPTDt@@	CCC1(C)CCc2cc3c(C(F)(F)F)cc(O)nc3cc2N1	7.64	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	310.318	3.9242	3	2	45.15	2	-0.9540289477240493	-0.25029928119046485	-1.4243721645662915	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@		gC`HD@IWT@@								49
zyvI@Gtl8N4kVJ3BFs2VVN0H040G1310Z42Z10VV10F!FF!@1!V!VFc!43#402W060248#6!X8GF	CHEMBL351465	fluQC@EAlBPQHXdLbdLTRbVVVdhs`qj`@@bjBaE@@	C[C@@H]1Cc2cc3c(C(F)(F)F)cc(O)nc3cc2N1	8.15	group1-p	p	Androgen Receptor	Antagonistic activity (IC50) against human androgen receptor (hAR) in co-transfected CV-1 cell	1998	dk|@@DjYU_X^gSjjjjj@@	dk}@@@UJYY}ZxYtp@@J``@	268.237	2.8298	3	2	45.15	1	-1.2826802526490817	0.6844709211962243	-1.5254262078200476	4	4	fluQC@EAlBPQHXdLbdLTRbVVVdhs`qj`@@bjBaE@@											1
zyQvDItn8N5kVLACGcIWVO2H0JFl3390ZMmo58VX3Ak97kOZB@OX1a5Jl0cc1RnGWd0DVrX6F2CBGOJa10V8F0	CHEMBL351519	ffcQC@EQlBPQHXdLbdLTRbRRJdteF}EMUHTCEUTTDh@	C[C@H]1Nc2cc3c(cc2C1(C)C)c(C(F)(F)F)cc(=O)n3C	7.66	group2-a	a	Androgen Receptor	Antagonistic activity (IC50) against human androgen receptor (hAR) in co-transfected CV-1 cell	1998	fgA@@@LdbbRRRKI\DZuUUUUT@@	fgAQ@@DZ@drmjkQdeFluH@UQ@@@	310.318	2.3191	3	1	32.34	1	-1.5191631982810376	0.7553410684960471	-0.40472680367852576	5	5	fj}Q@`FFJAqcHIdLrFQQQQHiJJZQDYIUoUAPEMUSECB@@	eMBH@RZ@										2
:UvEQtl9R5mVJAUIcHdXO3H64Fld390VLmp78XV3AkO6FGf0POX165Jt2cc1RnIW90@Vbca!8BGOJ714V8F0	CHEMBL352002	fakQC@EIlBPQHXdLbdLTRbRTQtQdeF}fmUHTCEUUQPcP@	Cc1c2c(cc3c(C(F)(F)F)cc(=O)n(C)c13)C(C)CC(C)(C)N2	7.51	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	foQ@@@DjYUU}`nRlzjjjjj`@@	foQQ@@DZ@drmjjtYIUgMR@EUD@@	338.372	3.531	3	1	32.34	1	-1.4284461019933468	-0.07722383908210351	-0.35224863760015446	38	10	fnsQB`DVrCqDxedJrCYCHhdhdieeEDYJLT[tZjBBJifjH@@	eFBH@c@@	eMBH@RZ@									1
:UvzvzvCOznWqfEGdMtaODHJJGvjYO8ZUva5NVX3Ak97kU_4@OX1X5Jt8cc1RnGWh0EVbYD02CBGOJa10V8F0	CHEMBL352456	fa{QC@EIlBPQHXdLbdLTRbRRrTJTeF|gK^uTaPLUUUEHBlh@	CCn1c(=O)cc(C(F)(F)F)c2cc3c(cc21)N[C@@H]1CCCC[C@H]31	6.64	group3-int	int	Androgen Receptor	Antagonistic activity (IC50) against human androgen receptor (hAR) in co-transfected CV-1 cell	1998	fdu@@@LdbbRRRJRSI\DZpXuUUUUUU@@@	fduQ@@DZ@drmjjjtYIQkAbuH@UUTT`rm@@	336.356	3.3442	3	1	32.34	2	-1.2717366585918668	-0.07827699800511231	-0.3304323936449404	7	6	fa{QB`HVJCqBxudFrGYAIfYUUv{zHrQmNbfhJBbjfZhiFHr@@	eMBD@ch@										3
{x<UzUr:vzjjvzhpxSjMzrjbvqvUryinHfjzr7zjfhCwinMCvyKx5H_bF_OIVxOaVxN6W8FV	CHEMBL3576885	ejUZLH@ADlh\SKG@ICHhdlhihiXhdeDddecDjFKOJfcokglRX@JjYjZh@@BZR@dNEx`@	C[C@H](c1ccc(F)cc1)N1C(=O)O[C@](Cc2ccccc2)(c2nc3cc(-c4cc[nH]n4)ccc3[nH]2)C1=O	5.51	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CHOK1 cells assessed as inhibition of D(-)-norgestrel-induced protein interaction with steroid receptor co-activator peptide after 24 hrs by beta-galactosidase reporter gene assay	2015	elQP@@@DjfYU]e]Ugwg^IMCJefnk`XTZjjjjjjjjjjjjh@@	elQZL@@LMCOhPDILbbTTRTVbRbRRRrQLRHhBbjVfnvNaQZjif`h@@@BZX@hBH@@	495.513	3.5699	8	2	103.97	6	2.8420642239611595	-0.17164927623383625	-0.4246074130735461	2	1	ejUZLH@ADlh\SKG@ICHhdlhihiXhdeDddecDjFKOJfcokglRX@JjYjZh@@BZR@dNEx`@											1
{x<UzUr:vzjjvzhpzSj7zrjbvquUryimHfjzr7zhfhCwinM5fiKz5H_bF_OIVxOaVxN6V8FV	CHEMBL3578271	ehZ\LD@FI@mOD`H`FPRYVuzVW[e[wzNAIG@icgoh@ajjZXJ@@BJAARYP@	C[C@H](c1ccc(F)cc1)N1C(=O)O[C@](Cc2ccccc2)(c2nc3cc(Cl)ccc3[nH]2)C1=O	5.51	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CHOK1 cells assessed as inhibition of D(-)-norgestrel-induced protein interaction with steroid receptor co-activator peptide after 24 hrs by beta-galactosidase reporter gene assay	2015	egdP@@@LddTTRRVTRVRRbjwDfaeRsWQuuUUUUUUUUUUT@@@	egd\L@@LMC@DIDfVYV^UeUWTb`JJiZZ{XyjjfZB`@@@H@`H`@	463.895	4.5321	6	1	75.29	5	1.2447995245420795	-0.9502028002202476	0.3389042128738939	4	4	ehZ\LD@FI@mOD`GDFPRYVuzVW[e[wzNAIG@icgoh@ajjZXJ@@BJAARYP@	eFABH`BL@										3
{x<UzUr:vzjjvzhpxSj7zrjbvqvUryimHfjzr7zhfhCwinMCfyKx5HbbF_OIVxOaVzN6V8FV	CHEMBL3578274	ebQ\LB@ADlcKG@IBFPQdLYCHhdlhihiXhdeDddecIPqYyTt]}\}@AUSMSU@@@UQ@H\Kq@@	C[C@H](c1ccc(F)cc1)N1C(=O)O[C@](Cc2ccccc2)(c2nc3cc(C(F)(F)F)ccc3[nH]2)C1=O	5.52	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CHOK1 cells assessed as inhibition of D(-)-norgestrel-induced protein interaction with steroid receptor co-activator peptide after 24 hrs by beta-galactosidase reporter gene assay	2015	egdP@@@LddTTRRVTRVRRbjwDfaeRsWQuuUUUUUUUUUUT@@@	egd\L@@LMC@DIDfVYV^UeUWTb`JJiZZ{XyjjfZB`@@@H@`H`@	497.447	4.7744	6	1	75.29	6	1.5686273274321338	-1.3411061188881912	0.42148326270869585	4	4	ehZ\LD@FI@mOD`GDFPRYVuzVW[e[wzNAIG@icgoh@ajjZXJ@@BJAARYP@	gJPBAHJPt`PAIjj@@										3
{x<UzUr:vzjjvzhpxSj7zrjbvyuUryivIfjzrbzhfhCwinMCfyKx5HbbF_tIVzOaVxN6W8FV	CHEMBL3578276	ejYRJD@LEKBhDOLf`@`fPrRPzIJYKRIQKJZIJ[KZSPrqHjxEGEZ`BFjii`h@@HhDGIu@@	C[C@H](c1ccc(F)cc1)N1C(=O)O[C@](Cc2ccccc2)(c2nc3cc(NS(C)(=O)=O)ccc3[nH]2)C1=O	4.89	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CHOK1 cells assessed as inhibition of D(-)-norgestrel-induced protein interaction with steroid receptor co-activator peptide after 24 hrs by beta-galactosidase reporter gene assay	2015	egdP@@@LddTTRRVTRVRRbjwDfaeRsWQuuUUUUUUUUUUT@@@	egd\L@@LMC@DIDfVYV^UeUWTb`JJiZZ{XyjjfZB`@@@H@`H`@	522.556	2.9748	9	2	129.84	6	3.673356781896981	0.3964242483525076	-0.22881464769448698	4	4	ehZ\LD@FI@mOD`GDFPRYVuzVW[e[wzNAIG@icgoh@ajjZXJ@@BJAARYP@	gGXdMD@b`FRREZ`@										3
{x<UzUr:vzjzvzhpxSjMzrjbvqvUryinIfjzr7zjjxSwinMCvyKx5H_bF_OIVxOaVxN6W8FV	CHEMBL3578284	ef]RBH@ADllSKGJPICHhdlhihiXhdeDddecEEPqYyTt]}\}cS@AUSMSU@@@TmDAH\Kq@@	Cc1nocc1-c1ccc2[nH]c([C@@]3(Cc4ccccc4)OC(=O)N([C@H](C)c4ccc(F)cc4)C3=O)nc2c1	5.47	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CHOK1 cells assessed as inhibition of D(-)-norgestrel-induced protein interaction with steroid receptor co-activator peptide after 24 hrs by beta-galactosidase reporter gene assay	2015	elQP@@@DjfYU]e]Ugwg^IMCJefnk`XTZjjjjjjjjjjjjh@@	elQRB@@LMCDPDIH\bbTTRTVbRbRRRrQLRHhBbjVfnvNaQZjif`h@@@BZX@hBH@@	510.524	4.3935	8	1	101.32	6	2.5636579731007965	-0.7279818068157726	0.6843639095988565	2	1	ef]RBH@ADllSKGJPICHhdlhihiXhdeDddecEEPqYyTt]}\}cS@AUSMSU@@@TmDAH\Kq@@											1
{x<UzUr:vzjjvzhpxxjEzrjbvquUryimIfjzrbzhfhCwynMCfyKx5I_bF_OIVxObVzs6V8FV	CHEMBL3578285	ef]RBH@ADl`SKGJPICHhdlhihiXhdeDddecDePqYyTt]}\|SS@AUSMSU@@@UUDAH\Kq@@	C[C@H](c1ccc(F)cc1)N1C(=O)O[C@](Cc2ccccc2)(c2nc3cc(N4CCOCC4)ccc3[nH]2)C1=O	5.11	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CHOK1 cells assessed as inhibition of D(-)-norgestrel-induced protein interaction with steroid receptor co-activator peptide after 24 hrs by beta-galactosidase reporter gene assay	2015	ebYP@@@DjfYU]e]Ugwg_bSPriYkjxEGFjjjjjjjjjjjjj`@@	ebYRB@@LMCG`DIL\bbTTRTVbRbRRRrQLRQE@TURtuvqrNKUULtE@@@@UUPAPDP@	514.555	3.5951	8	1	87.76	6	2.404354317733814	-0.36243841295446433	0.6523200992451769	2	1	ef]RBH@ADl`SKGJPICHhdlhihiXhdeDddecDePqYyTt]}\|SS@AUSMSU@@@UUDAH\Kq@@											1
{x<UzUr:vzjjvzhpxSj7zrjbvqvUryimHfjzr7zjfhCwinM5fiKx5H_bF_OIVxOaVxN6V8Fk	CHEMBL3578286	ef]RLH@ADllSKG@ICHhdlhihiXhdeDddecDePqYyTt]}\|SS@AUSMSU@@@P@D@H\Kq@@	C[C@H](c1ccc(F)cc1)N1C(=O)O[C@](Cc2ccccc2)(c2nc3cc(-c4cccnc4)ccc3[nH]2)C1=O	5.43	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CHOK1 cells assessed as inhibition of D(-)-norgestrel-induced protein interaction with steroid receptor co-activator peptide after 24 hrs by beta-galactosidase reporter gene assay	2015	ebYP@@@DjfYU]e]Ugwg_bSPriYkjxEGFjjjjjjjjjjjjj`@@	ebYRL@@LMCHPDILbbTTRTVbRbRRRrQLRQE@TURtuvqrNKUULtE@@@@P@P@PDP@	506.536	4.5844	7	1	88.18	6	2.0775425069141873	-1.0451895900928123	0.5568045937626775	2	1	ef]RLH@ADllSKG@ICHhdlhihiXhdeDddecDePqYyTt]}\|SS@AUSMSU@@@P@D@H\Kq@@											1
{x<UzUr:vzjjvzhpxSj7xrjbvysUryivIfjzrbzhehBwinM7fiKp5Hb3s_tIVvOaVxO6W8FV	CHEMBL3578295	ejYRJD@LACBhDOLf`@`fPrRPzJIJXrIQKJZIJ[KYRsPqHjxEGEZ``Xjii`h@@HhDGIu@@	C[C@H](c1ccc(F)cc1)N1C(=O)O[C@](Cc2ccccc2)(c2nc3c(NS(C)(=O)=O)cccc3[nH]2)C1=O	4.96	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CHOK1 cells assessed as inhibition of D(-)-norgestrel-induced protein interaction with steroid receptor co-activator peptide after 24 hrs by beta-galactosidase reporter gene assay	2015	egdP@@@LddTTRRVTRVRRbjwDfaeRsWQuuUUUUUUUUUUT@@@	egd\L@@LMC@DIDfVYV^UeUWTb`JJiZZ{XyjjfZB`@@@H@`H`@	522.556	2.9748	9	2	129.84	6	3.673356781896981	0.3964242483525076	-0.22881464769448698	4	4	efURJL@BAGJeM@bn`GG`HidLbbbRfdRndRbVTtRTvVsDecfUStNILDEBsUTtpT@@DTBGdF`@											1
:xjxyyirjyvzfxshfzDUjr5ztxuPwJpGsGSsuSmggxZS4@Txo8EVk8GL12c0k6W6Fc08Q0WF4G0V41#2010	CHEMBL3590187	ek`PJ@@@BnimlbbRfbTJTtRaTTvhXTt\|brZZjjjjjfZjiaaBKRVSqQP@	CCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C	7.3	group2-a	a	Androgen Receptor	Displacement of [3H]methyltrienolone from androgen receptor in human prostate cancer cells	2014	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmMUUUUUXDePt@@	402.529	3.2079	5	1	80.67	5	0.8256797045908036	-0.007986715749010498	0.15617569929639905	50	7	fjcAA@B`|WNNQQRIHsIREKDyIUoIsUUUUUMMTQBIAQR@@	eFBH@c@@	dedB`@SiH@RYWmjih@@									5
:UvzfzUrSzjQTQzU7SPAfxAUUeb_oF9Pfi@Dql3R2dZc4@jqJF5FJ2g8j4XH5c@2J9GkVFB280V01FZ&	CHEMBL359911	ffk``@D@UdTTTTRTRqaRhsQkA}DmVjhFhH@J`QaLP@	O=C1[C@H]2C3CCC(C3)[C@H]2C(=O)N1c1ccc2ccccc2c1	5.92	group4-ia	ia	Androgen Receptor	Inhibition of human androgen receptor of breast carcinoma MDA-453 cells in reporter gene assay	2005	ffk@@@LdbbRRlTTVtSA\e[r\ekUUUUUUUUP@@	ffk``@D@UdTTTTRTRqaRhsQkA}DmVjhFhH@J`QaLP@	291.349	3.0454	3	0	37.38	1	-1.8482515061653682	0.43991624203966806	0.6673982846842064	3	1	ffk``@D@UdTTTTRTRqaRhsQkA}DmVjhFhH@J`QaLP@											1
:xjxyyirjyvzfxsjfziUjr5zsxePwFpKuGSkzSmggvwS4PyhJ@U0k8FH12g1lL_aFc0dQ1FJ0G0V010202010	CHEMBL3605560	efUPA@@@DEKBnkl\bbTTVdladRbQfRTTeTu@`VSPqwqMKTuUUUUUUTuTsTpaDxVd\PRj`rvP@	CC(=O)OC[C@]12CC[C@H]3[C@@H](CC=C4C=CCC(=O)[C@@]43C)[C@]1(O)CC[C@@]2(O)[C@@](C)(O)[C@H]1CC(C)=C(C)C(=O)O1	5.45	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor in human LNCAP cells assessed as inhibition of DHT-induced KLK3 gene expression by Array Plate assay	2015	feo@@@LdbbbbbqeRrbRcMBlYpX}GUUUUUUUUUT@@	feoA`@@H{dTRTJbbRtrTrbhsUoArT\vijjjjjifilDShE@@	528.64	2.3408	8	3	130.36	5	3.6163460709992368	0.7448997687251995	-1.4221604669333061	4	2	efUPA@@@DEKBnkl\bbTTVdladRbQfRTTeTu@`VSPqwqMKTuUUUUUUTuTsTpaDxVd\PRj`rvP@											1
:xjxyyirjyvzfxsjfziUjr5zsxePwFpKuGSkzSmggvwS4Pyho@U0k8FH12g1lL_aFc0dQ5FJ0G0V090202010	CHEMBL3605562	eeWPE@@@DEKBnaohV\bbTTVdladRbRtrRTTTgbM@`VSTsqHlkTuUUUUUUUSMTtuMHQNEiGDDliUIe]@@	CC(=O)OC[C@]12CC[C@H]3[C@@H](CC=C4CC=CC(=O)[C@@]43C)[C@]1(O)[C@@H](OC(C)=O)C[C@@]2(O)[C@@](C)(O)[C@H]1CC(C)=C(C)C(=O)O1	5.57	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor in human LNCAP cells assessed as inhibition of DHT-induced SPDEF gene expression by Array Plate assay	2015	feo@@@LdbbbbbqeRrbRcMBlYpX}GUUUUUUUUUT@@	feoA`@@H[dTRTJbbRtrTtVhsUoAsT\vijjjjjffilDShE@@	586.675	1.9733	10	3	156.66	7	5.168920174630296	0.9435833727881726	-1.0323309876901785	4	2	eeWPE@@@DEKBnaohV\bbTTVdladRbRtrRTTTgbM@`VSTsqHlkTuUUUUUUUSMTtuMHQNEiGDDliUIe]@@											1
:xjxyyirjyvzfxsjfziUjr5zsxePwFpKuGSkzSmggvwS4PyhJ@U0k8FH12g1lL_aFc0dQ5FJ0G0V090202010	CHEMBL3605563	eeWPE@@@DEKBnaoh^\bbTTVdladRbRtrRTTTgTu@`VSTsvHlkTuUUUUUUUSMULuMHQNEiGDDliUIe\`@	CC(=O)OC[C@]12CC[C@H]3[C@@H](CC=C4C=CCC(=O)[C@@]43C)[C@]1(O)[C@@H](OC(C)=O)C[C@@]2(O)[C@@](C)(O)[C@H]1CC(C)=C(C)C(=O)O1	5.92	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor in human LNCAP cells assessed as inhibition of DHT-induced SPDEF gene expression by Array Plate assay	2015	feo@@@LdbbbbbqeRrbRcMBlYpX}GUUUUUUUUUT@@	feoA`@@H{dTRTJbbRtrTrbhsUoArT\vijjjjjifilDShE@@	586.675	1.9733	10	3	156.66	7	5.168920174630296	0.9435833727881726	-1.0323309876901785	4	2	eeWPE@@@DEKBnaoh^\bbTTVdladRbRtrRTTTgTu@`VSTsvHlkTuUUUUUUUSMULuMHQNEiGDDliUIe\`@											1
:xjxyyirjyvzfxsjfziUjr5zsxePwFpKuGSkzSmggvwS4Pyho@U0k8FH12g1lL_aFc0dQ1FJ0G0V010202010	CHEMBL3605564	efUPA@@@DEKBnkd\bbTTVdladRbQfRTTebM@`VSPqpIMKTuUUUUUUTuSSTpaDxVd\PRj`rv`@	CC(=O)OC[C@]12CC[C@H]3[C@@H](CC=C4CC=CC(=O)[C@@]43C)[C@]1(O)CC[C@@]2(O)[C@@](C)(O)[C@H]1CC(C)=C(C)C(=O)O1	6.24	group3-int	int	Androgen Receptor	Inhibition of androgen receptor in human LNCAP cells assessed as inhibition of DHT-induced KLK2 gene expression by Array Plate assay	2015	feo@@@LdbbbbbqeRrbRcMBlYpX}GUUUUUUUUUT@@	feoA`@@H[dTRTJbbRtrTtVhsUoAsT\vijjjjjffilDShE@@	528.64	2.3408	8	3	130.36	5	3.6163460709992368	0.7448997687251995	-1.4221604669333061	4	2	efUPA@@@DEKBnkd\bbTTVdladRbQfRTTebM@`VSPqpIMKTuUUUUUUTuSSTpaDxVd\PRj`rv`@											1
:UvzvzUzS:QTQzUUUP2vxQzU@rhqN9@Ii6EUl3UAtgc4Aj6LH_Fo2g8j4XHUeA0RCOmWFT290V11Fa#B!	CHEMBL361222	fnk```MNBCDEHRdERFQQQIRZqQSYQLyzNZe[@PUULuUEJOJL@@	O=C1[C@H]2C3C=CC(C3)[C@H]2C(=O)N1c1ccc(Br)c(C(F)(F)F)c1	6.84	group3-int	int	Androgen Receptor	Inhibition of human androgen receptor of breast carcinoma MDA-453 cells in reporter gene assay	2005	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdu``@D@UdTTTTRTRqhsUcA}EjjAjBJQFDq@@	386.166	3.1491	3	0	37.38	2	-1.1952698835158437	-0.0948576167844907	0.8500655001979889	47	10	fjc`c@IF\@IIxl\\bbbfJbbfrbxJwhyRVBHJfZjbeEez@@	gJPBAHJPt`PAIjj@@		eFACD`BL@								10
:xjxyyirjyzxfxsWjzDUjr1zsxuPwLlHsGSltOmwgxgS4@Thq@78k8FLW2c0FL9aH808Q0WF4G0F49$F!	CHEMBL361245	ekhPBH@CFim`HcHhhdiDheh]EhUEFAIKKO@dljjVjjZjjjfZjbJIY@ee@@	CC(=O)O[C@]1(C(C)=O)CCC2C3C=C(Cl)C4=CC(=O)[C@@H]5CC5[C@]4(C)C3CC[C@@]21C	7.21	group2-a	a	Androgen Receptor	Inhibition of human lymph node carcinoma of prostate (LNCaP) cell proliferation	2004	fl}@@@LdbbbbbUaRyhTaVLzJZjjjjjjj@@	fl}A@@@YEDhhTddieQeAJt{tTmMTuUUUUCD@@	416.943	3.7275	4	0	60.44	3	-0.28618564535563584	-0.38751415163723085	1.077072548966646	2	1	ekhPBH@CFim`HcHhhdiDheh]EhUEFAIKKO@dljjVjjZjjjfZjbJIY@ee@@											1
:UvzfzUrS:QTQzUUSQ@AxfzUebhoN9Pvy@DTl3TAl4cBejLJH5Jq2g8j4XHKfIXR9GkVNR@90V11FZ!3#	CHEMBL361445	feoPPBHF@`JXRcdfyeg^yoYaRuZNVc{Mh@@HifjjBYDYe@@	O=C1[C@H]2C3C=CC(CC3)[C@H]2C(=O)N1c1ccc([N+](=O)[O-])c2ccccc12	6.65	group3-int	int	Androgen Receptor	Inhibition of androgen receptor in human MDA-453 cells	2005	fn{@@@LdbbbTVtTNtTYhQk^sTkZjjjjjjjj`@@	fn{``@D@UdTTTTRbTVVb]NVcYH\uZuU@u@L@U@cBy@@	348.357	2.1904	6	0	83.2	2	0.12206117612801251	1.320327335400327	1.1651220533172828	1	1	feoPPBHF@`JXRcdfyeg^yoYaRuZNVc{Mh@@HifjjBYDYe@@											1
zRPn63cF884F0F040N0WV82V!F!3#Lk058#Fk961VV0@80104JVF081HH0c102!V!2!F#18W0F0	CHEMBL3622573	fluQ@@DD@drrjLmNRuEKTBDPDD@@@	Cc1ccccc1Cc1n[nH]c(=O)c2ccccc12	5.02	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type AR expressed in human SC cells assessed as inhibition of 1 nM DHT-induced cell proliferation after 3 days by WST-8 assay	2015	fde@@@LdbbbTV\RSIBtFMUUUUUU@@@	fdeQ@@DD@drrjJtyKPXmPHQ@A@@@	250.3	3.2515	3	1	41.46	2	-1.5738770849241632	0.3634688950188282	-0.4493048751688892	16	16	fbmQA@EFRCqxxyEEDhkDhddfBmzNXBHf``P`@@	eFBH@c@@										14
zRun63cG8c4F0F240N0WVN2V!F!3020LkV58#Fk961VV0@9010JLVF081HH0c102!V!2!J04058W0F0	CHEMBL3622574	fbmP`@DDAyIeeU~YVgIZcejABHHH`@@	COc1ccccc1Cc1n[nH]c(=O)c2ccccc12	5.02	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type AR expressed in human SC cells assessed as inhibition of 1 nM DHT-induced cell proliferation after 3 days by WST-8 assay	2015	fde@@@LdbbbTV\RSIBtFMUUUUUU@@@	fdeQ@@DD@drrjJtyKPXmPHQ@A@@@	266.299	2.8376	4	1	50.69	3	-0.9183677302467484	0.6206875170670596	-0.2869892974757019	16	16	fbmQA@EFRCqxxyEEDhkDhddfBmzNXBHf``P`@@	eMJA@Hz@										14
zRPn63cG884F0F040N0WVN2V!F!3#Lk058#Fk961VV0@90104JVF081HH0c102!V!2!F#18W8F0	CHEMBL3622575	fluQB@IZbBPrJJIHqJIIIgCNBf@`f``P`@@	O=c1[nH]nc(Cc2ccccc2F)c2ccccc12	4.98	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type AR expressed in human SC cells assessed as inhibition of 1 nM DHT-induced cell proliferation after 3 days by WST-8 assay	2015	fde@@@LdbbbTV\RSIBtFMUUUUUU@@@	fdeQ@@DD@drrjJtyKPXmPHQ@A@@@	254.263	3.0084	3	1	41.46	2	-1.5415692433941715	0.4949120252621929	-0.44405073663607364	16	16	fbmQA@EFRCqxxyEEDhkDhddfBmzNXBHf``P`@@	eFABP`BL@										14
zTPn6IcF884k0F040N2WV82V04FF03#Lk458#Nk961VV0@80104JVF081HH0c14@01V!2!F#18W8F0	CHEMBL3622576	ffcQC@CNJBPQHXdLbdLTRQbTRRTe^cfmTAAMA@a@@@	O=c1[nH]nc(Cc2ccccc2C(F)(F)F)c2ccccc12	5.43	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type AR expressed in human SC cells assessed as inhibition of 1 nM DHT-induced cell proliferation after 3 days by WST-8 assay	2015	fde@@@LdbbbTV\RSIBtFMUUUUUU@@@	fdeQ@@DD@drrjJtyKPXmPHQ@A@@@	304.27	3.7559	3	1	41.46	3	-1.1548563715674909	-0.2607116822639984	-0.33176246200407083	16	16	fbmQA@EFRCqxxyEEDhkDhddfBmzNXBHf``P`@@	gJPBAHJPt`PAIjj@@										14
zRPn63cG884F0F240N0WVN2V!F!3#LkV58V!Fk969VV0@90104JVF081HI0c102!V482!F04018Y0F0	CHEMBL3622578	fj}q`BHZlAFXRclbfbbRLRbRREIpTeZ@`f``P`@@	O=c1[nH]nc(Cc2ccccc2[N+](=O)[O-])c2ccccc12	5.84	group4-ia	ia	Androgen Receptor	Antagonist activity at AR T877A mutant expressed in human LNCaP cells assessed as inhibition of 10 nM DHT-stimulated cell proliferation after 6 days by WST-8 assay	2015	fde@@@LdbbbTV\RSIBtFMUUUUUU@@@	fdeQ@@DD@drrjJtyKPXmPHQ@A@@@	281.27	1.986	6	1	87.28	3	0.278628954508245	1.5872084890326388	0.0034345044840445246	16	16	fbmQA@EFRCqxxyEEDhkDhddfBmzNXBHf``P`@@	gChhhE`BRnRYh@										14
zRPn63cG884F0F040N0WVN2V!F!3#Lk058V!Fk961VV0@90104JVF081HI0c102!V402!F#19W0k0	CHEMBL3622579	fluq@@DD|AIeeU~Yz\ejJVhDH``H@@@	Nc1ccccc1Cc1n[nH]c(=O)c2ccccc12	4.34	group4-ia	ia	Androgen Receptor	Displacement of [3H]-DHT from human GST fused AR-LBD (627 to 919 amino acids) transfected in Escherichia coli HB 101 after 15 hrs by liquid scintillation counting assay	2015	fde@@@LdbbbTV\RSIBtFMUUUUUU@@@	fdeQ@@DD@drrjJtyKPXmPHQ@A@@@	251.288	2.2303	4	2	67.48	2	-0.5812503063109761	1.2715353776808764	-1.3849482141703047	16	16	fbmQA@EFRCqxxyEEDhkDhddfBmzNXBHf``P`@@	eFbB@Hp@										14
:Qv6Itr8N4s0H2BEN2WVO2V08FJ934!LkZ58X!FkO61VVD@92144KVFV81Ln0c11201VJF201F0401BW8F0	CHEMBL3622581	fi{pc@F^cShIADabPrJPsJJIHqJIIHudeZNjZ@`f``P`@@	O=C(Nc1ccccc1Cc1n[nH]c(=O)c2ccccc12)C(F)(F)F	6	group3-int	int	Androgen Receptor	Antagonist activity at wild type AR expressed in human SC cells assessed as inhibition of 1 nM DHT-induced cell proliferation after 3 days by WST-8 assay	2015	fde@@@LdbbbTV\RSIBtFMUUUUUU@@@	fdeQ@@DD@drrjJtyKPXmPHQ@A@@@	347.295	3.0956	5	2	70.56	4	0.4950303785585458	0.29713503081952064	-1.0738616318577672	16	16	fbmQA@EFRCqxxyEEDhkDhddfBmzNXBHf``P`@@	dazHHFhIAICIC`CHiCMUM@@										14
zyPnT3dG8N5k0F@50N0lVN@V04F01Y080LsV58V!Nk961VV0@O0104JVFV81LI0c10A!V402!F14018W0F0	CHEMBL3622583	fnsq@@DD|AIeeU~YYvgIZbUjABHHJJ`@@	CCN(CC)c1ccccc1Cc1n[nH]c(=O)c2ccccc12	5.78	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type AR expressed in human SC cells assessed as inhibition of 1 nM DHT-induced cell proliferation after 3 days by WST-8 assay	2015	fde@@@LdbbbTV\RSIBtFMUUUUUU@@@	fdeQ@@DD@drrjJtyKPXmPHQ@A@@@	307.396	3.6166	4	1	44.7	5	-0.5178636583603409	-0.28559293639275696	-0.17833812459987167	16	16	fbmQA@EFRCqxxyEEDhkDhddfBmzNXBHf``P`@@	gGXHA`AJejh@										14
zRPn63dG8N4F0F240N0WVN2V!F013#LkV58V!Fk961VV0@90104JVFV81LI0c102!V402!F04018W0F0	CHEMBL3622584	fj}q@@DD|AIeeU~YWirVhyZ`PbBBJ@@@	CCNc1ccccc1Cc1n[nH]c(=O)c2ccccc12	5.43	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type AR expressed in human SC cells assessed as inhibition of 1 nM DHT-induced cell proliferation after 3 days by WST-8 assay	2015	fde@@@LdbbbTV\RSIBtFMUUUUUU@@@	fdeQ@@DD@drrjJtyKPXmPHQ@A@@@	279.342	2.9609	4	2	53.49	4	-0.375826407508397	0.38403622369304646	-1.3183746506548732	16	16	fbmQA@EFRCqxxyEEDhkDhddfBmzNXBHf``P`@@	gChH@`AJZ`@										14
zTPn63dG885k0F250N0WVN2V04F!3#LkV58V!Nk961VV0@O0104JVF081LI0c10@!V402!F14018W0F0	CHEMBL3622585	fj}q@@DD|AIeeU~YYirVheZ`PbBBb@@@	CN(C)c1ccccc1Cc1n[nH]c(=O)c2ccccc12	5.71	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type AR expressed in human SC cells assessed as inhibition of 1 nM DHT-induced cell proliferation after 3 days by WST-8 assay	2015	fde@@@LdbbbTV\RSIBtFMUUUUUU@@@	fdeQ@@DD@drrjJtyKPXmPHQ@A@@@	279.342	2.804	4	1	44.7	3	-0.944442150850471	0.5485808202348632	-0.2809494525060726	16	16	fbmQA@EFRCqxxyEEDhkDhddfBmzNXBHf``P`@@	gChHA`BOT@@										14
zRPn63dG884F0F240N0WVN2V!F!3#LkV58V!Fk961VV0@90104JVF081LI0c102!V402!F04018W0F0	CHEMBL3622586	fbmq@@DD|AIeeU~YVgIZcejABHHH`@@	CNc1ccccc1Cc1n[nH]c(=O)c2ccccc12	5.04	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type AR expressed in human SC cells assessed as inhibition of 1 nM DHT-induced cell proliferation after 3 days by WST-8 assay	2015	fde@@@LdbbbTV\RSIBtFMUUUUUU@@@	fdeQ@@DD@drrjJtyKPXmPHQ@A@@@	265.315	2.5546	4	2	53.49	3	-0.5891157341090401	0.8011231585912	-1.3696803397160475	16	16	fbmQA@EFRCqxxyEEDhkDhddfBmzNXBHf``P`@@	eMbA@Hz@										14
zRPn63cF884F0F040N0WV82m!F!3#Lk058!1Fk961VV0@80104JVF081HH0c102!c!2!F#18W0F0	CHEMBL3622587	fbmQ@@DD@drrjLsSdmQru@aDADP@@@	Cc1cccc(C)c1Cc1n[nH]c(=O)c2ccccc12	5.86	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type AR expressed in human SC cells assessed as inhibition of 1 nM DHT-induced cell proliferation after 3 days by WST-8 assay	2015	fde@@@LdbbbTV\RSIBtFMUUUUUU@@@	fdeQ@@DD@drrjJtyKPXmPHQ@A@@@	264.327	3.5954	3	1	41.46	2	-1.5161890454303457	0.10471734102038811	-0.42443147898928074	16	16	fbmQA@EFRCqxxyEEDhkDhddfBmzNXBHf``P`@@	eFBH@c@@	eFBH@c@@									14
zRPn63cG884F0F040N0WVN2m!F!3#Lk058#Fk961VV0@90104JVF081HH0c102!c!2!F#18W8F0	CHEMBL3622588	fbmQA@EFRBPyHYEEDhkDhddfBmzNXBHf``P`@@	O=c1[nH]nc(Cc2c(F)cccc2F)c2ccccc12	5.42	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type AR expressed in human SC cells assessed as inhibition of 1 nM DHT-induced cell proliferation after 3 days by WST-8 assay	2015	fde@@@LdbbbTV\RSIBtFMUUUUUU@@@	fdeQ@@DD@drrjJtyKPXmPHQ@A@@@	272.253	3.1092	3	1	41.46	2	-1.4515733511526507	0.36760374483209113	-0.4139232031661584	16	16	fbmQA@EFRCqxxyEEDhkDhddfBmzNXBHf``P`@@	eFABP`BL@	eFABP`BL@									14
zRPn63cG884F0F040N0WVN2m!F!32!Lk058#Fk961VV0@90104JVF081HH0c302!c!2!F#18W0F0	CHEMBL3622589	fbmQA@EFRBHyDYEEDhkDhddfBmzNXBHf``P`@@	O=c1[nH]nc(Cc2c(Cl)cccc2Cl)c2ccccc12	4.96	group4-ia	ia	Androgen Receptor	Displacement of [3H]-DHT from human GST fused AR-LBD (627 to 919 amino acids) transfected in Escherichia coli HB 101 after 15 hrs by liquid scintillation counting assay	2015	fde@@@LdbbbTV\RSIBtFMUUUUUU@@@	fdeQ@@DD@drrjJtyKPXmPHQ@A@@@	305.163	4.1196	3	1	41.46	2	-1.3258030525682432	-0.3618371460530906	-0.3545047033556092	16	16	fbmQA@EFRCqxxyEEDhkDhddfBmzNXBHf``P`@@	eFABH`BL@	eFABH`BL@									14
zRPn63cG884F0F04FN0WVN2m!F!32!Lm058!1Fk961WV0@90105JVF081HH0c302!c20280F#18W0F0	CHEMBL3622590	fj}QC@MVrBHIDRbLbbbfRLRbRRXIpTe``bf``P`@@	O=c1[nH]nc(Cc2c(Cl)ccc(Cl)c2Cl)c2ccccc12	4.25	group4-ia	ia	Androgen Receptor	Displacement of [3H]-DHT from human GST fused AR-LBD (627 to 919 amino acids) transfected in Escherichia coli HB 101 after 15 hrs by liquid scintillation counting assay	2015	fde@@@LdbbbTV\RSIBtFMUUUUUU@@@	fdeQ@@DD@drrjJtyKPXmPHQ@A@@@	339.608	4.7256	3	1	41.46	2	-1.172921930678941	-0.8538659285101265	-0.29466789487234546	16	16	fj}QC@MVrCqxxjbLbbbTQTrbRRXIpTe`Hbf``P`@@	eFABH`BL@	eFABH`BL@									1
]S:fUvUPzUvntfUiDoMhnSSxMUq59Y3pQGzikTADzCAgzExxXg3rMnCWW7AlBPJK14KOFJkG4a8IV	CHEMBL3623004	e`\TDL@IGCk`ICbPzdLbbbTTQbbTRRLbReS@gdQUSwtADUUKUUTC@PHTPrP^P	C[C@@H]1Cc2c([nH]c3ccccc23)[C@@H](c2c(F)cc(/C=C/C(=O)O)cc2F)N1CC(C)(C)F	4.52	group4-ia	ia	Androgen Receptor	Binding affinity to androgen receptor (unknown origin)	2015	flm@@@DjYeV_}DYSmVbfjjjjjjj@@	flmP@@@BRfV[U]vdmNMZJZjBPh@HBDD@	442.48	3.9346	4	2	56.33	5	0.6416903652714516	-0.9062604034799284	-1.0115234149725905	1	1	e`\TDL@IGCk`ICbPzdLbbbTTQbbTRRLbReS@gdQUSwtADUUKUUTC@PHTPrP^P											1
{jzy;jzyUzxU:jjryOxUfiUzrlMybfotZQ:KmzHKAg@j6XLhgD2wdKoXKg28FVA1Oi!2Z10	CHEMBL3623114	fa{PR@NRLyOPUfQQQIHqQSYRJY`k^bgMXHLjYjjjJjVWhFQfT@	C[C@@]12C[C@H](O)[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(I)c3)C(=O)[C@@H]12	8	group1-p	p	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of DHT-induced PSA expression by alkaline phosphatase reporter gene assay	2015	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdua`@D@T[HhhhhdhecQfcVCzKUTCTDUBLIb@@	438.216	0.8144	6	1	90.63	1	0.8970662895721481	1.975729712383098	0.21189373246385115	47	25	fnkac@AZmD@RSqZxiLs{LwmMlxYpXiKA@ULuUUEQCIt}@p@	eFJB@Hp@	eFABl`BL@	eMbA@Dg`@								8
~=yUjxU:jzryOxUfiUyzxrzjfwtZQzrKmjHp@g@j6aLjgi2whSqYKi2NFVfWQi880c!	CHEMBL3623116	e`\TJL@ECOHjmc`IABPpdLbdLTRRLTTvTbflrdf`RQUSPuTDFULuUUMTUTAIJYPjMP@	CC(C)OC(=O)[C@@H]1C[C@]2(C)O[C@]1(C)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	7.66	group2-a	a	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of DHT-induced PSA expression by alkaline phosphatase reporter gene assay	2015	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdua`@D@T[HhhhhdhecQfcVCzKUTCTDUBLIb@@	450.412	2.2642	7	0	96.7	5	1.593562872861645	0.7549172716971655	1.534666000745981	47	25	fnkac@AZmD@RSqZxiLs{LwmMlxYpXiKA@ULuUUEQCIt}@p@	gNph@l@IL|uT@@	gJPBAHJPt`PAIjj@@	eMbA@Dg`@								8
}y=yUjxU:jzryOxUfiUyzlMzjfwtZQzrKmjHp@g@j6XLEgD2whSqYKi28FVA1Oi880c!	CHEMBL3623117	ebQ\BL@ECCoHjm`IABPpdLbdLTRRLTTvTbfltTrTf`RQUSPrNMTDFULuUUMP@EQPDdieBhu@@	CN(C(=O)[C@@H]1C[C@]2(C)O[C@]1(C)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12)c1ccccc1	7.47	group2-a	a	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of DHT-induced PSA expression by alkaline phosphatase reporter gene assay	2015	fm@@@LdbbRbbvLRLVbRxXRgA}FZzjjjjjjjjjh@@	fmPP@DE@kV\bbbbbTRQftjbRisUkQ|fZvjhFhJF`@jCFIqFP@	497.472	2.9825	7	0	90.71	4	1.5527137706335257	0.2254850046816146	1.5744916524503798	2	1	ebQ\BL@ECCoHjm`IABPpdLbdLTRRLTTvTbfltTrTf`RQUSPrNMTDFULuUUMP@EQPDdieBhu@@											1
}y=yUjxU:jzrytxzfiUyzlMzjfwtaU:KmjHKeg@j6XLEgD2whSqYKi28kVA1ti090cV0	CHEMBL3623118	fmoqc@EFWzMPRBICDadTabbRQbbfrdTtmARVkQuPPYTsUUTUTBdsLKFp@	C[C@@]12C[C@@H](N)[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	7.22	group2-a	a	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of DHT-induced PSA expression by alkaline phosphatase reporter gene assay	2015	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdua`@D@T[HhhhhdhecQfcVCzKUTCTDUBLIb@@	379.337	0.8278	6	1	96.42	2	0.838030805779274	2.1076630943289083	0.15592426797897374	47	25	fnkac@AZmD@RSqZxiLs{LwmMlxYpXiKA@ULuUUEQCIt}@p@	eFbB@Hp@	gJPBAHJPt`PAIjj@@	eMbA@Dg`@								8
}y=yUjxU:jzrytxzfiUyzlrzjfwtaU:KmjHKeg@j6mLEgi2whSqYKiH8lVA1ti08VcF0	CHEMBL3623119	eod\BL@ECEoHjc`IABPpdLbdLTRRLTTvTbfjfdtBRJjZFj``rifjjjZJj@deLhUFh@@	CCC(=O)N[C@@H]1C[C@]2(C)O[C@]1(C)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	7.64	group2-a	a	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of DHT-induced PSA expression by alkaline phosphatase reporter gene assay	2015	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdua`@D@T[HhhhhdhecQfcVCzKUTCTDUBLIb@@	435.401	1.6904	7	1	99.5	4	1.7040913669489899	1.2830070264890543	0.401271243654155	47	25	fnkac@AZmD@RSqZxiLs{LwmMlxYpXiKA@ULuUUEQCIt}@p@	gGYHDB@ILkU@@	gJPBAHJPt`PAIjj@@	eMbA@Dg`@								8
}y=yUjx;jzrytxzfiUyzl:jfwtjU:KmjHKeg@j6XLEgi2whSqYKim8lXA1ti28WcF0	CHEMBL3623120	e`\RJB@LBHohDI@b`@`zPndGiCIIBeMHmLhbeLeLiEHXXyDdMLmUUUTuH@UUuEEDxRbLSd@@	CNS(=O)(=O)N[C@@H]1C[C@]2(C)O[C@]1(C)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	7.47	group2-a	a	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of DHT-induced PSA expression by alkaline phosphatase reporter gene assay	2015	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdua`@D@T[HhhhhdhecQfcVCzKUTCTDUBLIb@@	472.443	0.8805	9	2	136.98	3	3.14721732680851	2.2560889265277027	-0.3823360439263993	47	25	fnkac@AZmD@RSqZxiLs{LwmMlxYpXiKA@ULuUUEQCIt}@p@	gNtdLX`DL@rRPiZh@	gJPBAHJPt`PAIjj@@	eMbA@Dg`@								8
}y=yUjxU:jzrytxzfiUyzlrzjfwtaU:KmjHKeg@j6XLEgi2whSqYKiHNlVA1ti2cVcF0	CHEMBL3623121	ehRRBL@ECEkoHjc`IABPpdLbdLTRRLTTvTbfjfTdtBRJjZFj``rifjjjZhjhBRTraTZ`@	CC(C)NC(=O)N[C@@H]1C[C@]2(C)O[C@]1(C)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	7.22	group2-a	a	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of DHT-induced PSA expression by alkaline phosphatase reporter gene assay	2015	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdua`@D@T[HhhhhdhecQfcVCzKUTCTDUBLIb@@	464.443	1.7306	8	2	111.53	4	2.5695033064064985	1.3463620441127442	-0.5182887638522735	47	25	fnkac@AZmD@RSqZxiLs{LwmMlxYpXiKA@ULuUUEQCIt}@p@	dayH`DpJ@DfUfjh@@	gJPBAHJPt`PAIjj@@	eMbA@Dg`@								8
~=yUjzU:jzryxxzfjUyztrzjjytaU:KmjmKeg@jLXqEgi3whSqYKiHNlVA1tiX@WcF0	CHEMBL3623122	ejYZJL@ECEgl_Hjck`IABPpdLbdLTRRLTTvTbfjfTRVdtBRJjZFQqj``rifjjjZjjJj`IISJEQj@@	CN1CCN(OC(=O)N[C@@H]2C[C@]3(C)O[C@]2(C)[C@@H]2C(=O)N(c4ccc(C#N)c(C(F)(F)F)c4)C(=O)[C@@H]23)CC1	8.22	group1-p	p	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of DHT-induced PSA expression by alkaline phosphatase reporter gene assay	2015	ec`P@@@LdbbRbbvLRJbtRWA`bc`WdRvuUUUUUUUUUU@@@	ec`RJ@@D@fm`EMBjlbbbbbTRQfqfTRUGFeedWbRvsUTCTEDuUUQXXSaFH@	521.494	0.6	10	1	115.21	5	3.3543625293960204	1.9762092592451022	0.8689844518657	1	1	ejYZJL@ECEgl_Hjck`IABPpdLbdLTRRLTTvTbfjfTRVdtBRJjZFQqj``rifjjjZjjJj`IISJEQj@@											1
}y=yUjx;jzrytxzfiUyzl:jfwtjU:KmjHKeg@j6XLEgD2whSqYKim8lXA1ti08WcF0	CHEMBL3623123	eod\JB@L@ghDAOL`@cZPNdKiCIIChiEieDTidieHaMMK@hnaejjjjZd@JjzbbbLJQZJr@@	C[C@@]12C[C@@H](NS(C)(=O)=O)[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	7.7	group2-a	a	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of DHT-induced PSA expression by alkaline phosphatase reporter gene assay	2015	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdua`@D@T[HhhhhdhecQfcVCzKUTCTDUBLIb@@	457.428	1.116	8	1	124.95	3	2.3427023587897495	1.9749807294643857	0.5617419624745834	47	25	fnkac@AZmD@RSqZxiLs{LwmMlxYpXiKA@ULuUUEQCIt}@p@	gGXdMD@b`FRREZ`@	gJPBAHJPt`PAIjj@@	eMbA@Dg`@								8
}y>Uj<jzrytxzfzUyzl;fwtj;KmjHKiw@j6XLEgDXwhSqYKiu8lXA1ti08WcF0	CHEMBL3623124	ebQ\JB@LJlXDCBa`@`FPadDYCIIBhhdiDcMhbeLeLiEhDYyxeTt]\mPTETUMR@EUYTTTPQVKqIP@	C[C@@]12C[C@@H](NS(=O)(=O)c3ccccc3)[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	9	group1-p	p	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of DHT-induced PSA expression by alkaline phosphatase reporter gene assay	2015	ec`P@@@LddTQRbtVaTRLRTacgg`RVRvuUUUUUUUUUU@@@	ec`TJH@LLhDCDf`@cIIBhhdhdXXleLeixXxyEdTmlmPTEQST`@UFEDlTT@@	519.499	2.3664	8	1	124.95	4	2.7692849079568864	0.8723022675997587	0.6965022260631761	3	2	ebQ\JB@LJlXDCBa`@`FPadDYCIIBhhdiDcMhbeLeLiEhDYyxeTt]\mPTETUMR@EUYTTTPQVKqIP@											1
}y>U=j;txzf<l;fwvj;MnjHKiw@jaXLEgDXxhSqYKiu8lXA1tiFBWcF0	CHEMBL3623125	ejY\JJ@LFbXDKJi`@aRPadDYCFPrRPjJJIRKF[QEJYJYRHrJpHKIkjyyZ`jBjJfi@BjljJJHHgDDlh@@	C[C@@]12C[C@@H](NS(=O)(=O)c3ccccc3F)[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	8	group1-p	p	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of DHT-induced PSA expression by alkaline phosphatase reporter gene assay	2015	ec`P@@@LddTQRbtVaTRLRTacgg`RVRvuUUUUUUUUUU@@@	ec`TJH@LLhDCDf`@cIIBhhdhdXXleLeixXxyEdTmlmPTEQST`@UFEDlTT@@	537.489	2.4672	8	1	124.95	4	2.8592808001984067	0.7449939871696569	0.7266297595330913	3	2	ejY\JJ@LFbXDKJi`@aRPadDYCFPrRPjJJIRKF[QEJYJYRHrJpHKIkjyyZ`jBjJfi@BjljJJHHgDDlh@@											1
}y>Uj<jzrytxzfzUyzl;fwtj;KmjHKiw@z6XLEgDXwhSqYKiu8lXA1ti08WcFF	CHEMBL3623126	ebQRJB@LEJlXDCBa`@`FPadDYCIIBhhdiDcMhbeLeLiEhDYyxeTt]\mPTETUMR@EUYTTTPQVKqIP@	C[C@@]12C[C@@H](NS(=O)(=O)c3cccnc3)[C@](C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	8.15	group1-p	p	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of DHT-induced PSA expression by alkaline phosphatase reporter gene assay	2015	ec`P@@@LddTQRbtVaTRLRTacgg`RVRvuUUUUUUUUUU@@@	ec`\JH@LELhDCDf`@cIIBhhdhdXXleLeixXxyEdTmlmPTEQST`@UFEDlTT@@	520.487	1.3655	9	1	137.84	4	3.2736917501053067	1.6857313002528675	0.8142674576861981	3	1	ebQRJB@LEJlXDCBa`@`FPadDYCIIBhhdiDcMhbeLeLiEhDYyxeTt]\mPTETUMR@EUYTTTPQVKqIP@											1
}y=yUjx;jzrytxzfiUyzl:jfwtjU:KmjHKeg@j6XLEgi2whSqYKim8lXA1ti08WcF0	CHEMBL3623127	e`\\JB@LHohDI@b`@`zPndGiCIIBeMHmLhbeLeLiEHXXyDdMLmUUUTuH@UUuEEDxRbLSd@@	CCS(=O)(=O)N[C@@H]1C[C@]2(C)O[C@]1(C)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	7.8	group2-a	a	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of DHT-induced PSA expression by alkaline phosphatase reporter gene assay	2015	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdua`@D@T[HhhhhdhecQfcVCzKUTCTDUBLIb@@	471.455	1.613	8	1	124.95	4	2.5517240492506166	1.503369791351381	0.61352028018531	47	25	fnkac@AZmD@RSqZxiLs{LwmMlxYpXiKA@ULuUUEQCIt}@p@	gNxdMD@b`FRREKU@@	gJPBAHJPt`PAIjj@@	eMbA@Dg`@								8
;vzv;x:vzvzUzEuUfzUzUjUbqSUzjjDDjvbUEfydZUvqKqhmxPhDjFYqEgi3gCxqWLE2SIk9GNEce0c!	CHEMBL362566	edVRBB@E@bh^ILj`IAzP~d@YCHhdleMEDhUEmDeLiEPpyyxDdTmm@ASUUTs@AUVUFFblgb@@	N#Cc1ccc(N2C(=O)[C@H]3[C@@H]4C[C@@H](CN4C(=O)Oc4ccc(F)cc4)N3C2=O)cc1C(F)(F)F	5.41	group4-ia	ia	Androgen Receptor	In vitro antagonistic activity against mutant androgen receptor of LNCap cells	2004	fm@@@LdbbRbbvLRLVbRxXRgA}FZzjjjjjjjjjh@@	fmpP@DXBAVRyEEEEDeDl]ieDeQfkFCzLumUPMPQM@ATFFSbt`@	474.369	3.2787	8	0	93.95	4	1.7140148969642865	0.2777163983506505	1.6348120502532177	2	1	edVRBB@E@bh^ILj`IAzP~d@YCHhdleMEDhUEmDeLiEPpyyxDdTmm@ASUUTs@AUVUFFblgb@@											1
xvozgyqmjEue9cxXmAz@hj_1rOoXTw9GFuFKsx12g9toJJ@RNw@E1k2NF08c1G252#cQ4F02F!V80802V10	CHEMBL363151	eolPD@@@ElbbRfbTVRbRRbVavhXTL|RjfZFZZjfjB`jJnjJaaFSrIQi@@	CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(Cc4ccc(C)cc4)C3=CC[C@@]21C	5.19	group4-ia	ia	Androgen Receptor	Inhibition of human androgen receptor	2005	fiw@@@LddTTRTRLTJRVDZSkQjMoZjjjjjjjjj@@	fiwA@@@ILk\lzrjkQbc^ST[^mMUSUAPTUEabMOP@	414.587	6.0165	2	1	37.3	2	-1.1505055116466387	-2.0593010768994	-0.26369790548396044	1	1	eolPD@@@ElbbRfbTVRbRRbVavhXTL|RjfZFZZjfjB`jJnjJaaFSrIQi@@											1
[rx<vvUrUzUjzhzUjUboRSzjxTDbvby7fqdgyvrKqCqz@hDjHYq5gyYg9poXLh@SGk9lN9cX3#	CHEMBL364393	fcHpBHRlTBCN[vDh{HihdlhhilhbieIpUoQrdkP@ULuUSUQUctCHp@	CC(C)(C)OC(=O)N1C[C@H]2C[C@@H]1[C@H]1C(=O)N(c3ccc([N+](=O)[O-])cc3)C(=O)N12	5.62	group4-ia	ia	Androgen Receptor	In vitro antagonistic activity against mutant androgen receptor of LNCap cells	2004	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdup`@DXBAVQQQQQIQKFcMVLGtVjhFhHjLLWIj@@	388.379	1.2011	10	0	115.98	4	2.2028359841321232	2.248839728547529	1.715655728141164	47	1	fcHpBHRlTBCN[vDh{HihdlhhilhbieIpUoQrdkP@ULuUSUQUctCHp@											1
:Uvzv;S:vyvvUrCvzfzhzUjUboSSzjx@DbnbTMvqdwyvqSqCqzDxDjRYq5iyfgApoVLC@SGk9GNOcV3#	CHEMBL365482	ehZRJ@DHIKB`DCGFhIP{HihdlhhilhbihdldnAKOHldbmcf`@jYjjf@BjJcCqAJI@@	CCCCc1ccc(C(=O)N2C[C@@H]3C[C@H]2[C@@H]2C(=O)N(c4ccc([N+](=O)[O-])cc4)C(=O)N32)cc1	5.32	group4-ia	ia	Androgen Receptor	In vitro antagonistic activity against mutant androgen receptor of LNCap cells	2004	feo@@@LdbbRbbvLRLTrWCBTxOhcgUUUUUUUUUT@@	feoq`@DXBAV\bbbbbRbVNttRUFZlXOhcfuU@uADp@UAadxmH@	448.478	2.9638	9	0	106.75	6	2.3602223587432807	0.5361255965735869	1.7639085337534348	5	5	eol\LH@NMDeCB`GGHhdlhhilhbihdldjFMKOH`dieh@JfZji`@jbhplSb|P@	gChhhE`BRnRYh@										2
:Uvzv;S:vyvvUrCvUfzhzUjUboRSzjx@DbnbTMfqdwyvqKqCqzDxDjJYq5gyfgApoVLC@SGk9GN9cV3#	CHEMBL365650	ekhRJ@DHIKB`DCGFhIP{HihdlhhilhbihdnAKOHldbmcf`@jYjjf@@jLODDhd@@	O=C1[C@H]2[C@@H]3C[C@@H](CN3C(=O)c3ccccc3)N2C(=O)N1c1ccc([N+](=O)[O-])cc1	5.59	group4-ia	ia	Androgen Receptor	In vitro antagonistic activity against mutant androgen receptor of LNCap cells	2004	feo@@@LdbbRbbvLRLTrWCBTxOhcgUUUUUUUUUT@@	feoq`@DXBAV\bbbbbRbVNttRUFZlXOhcfuU@uADp@UAadxmH@	392.37	1.2955	9	0	106.75	3	1.6676302234499423	2.1095587694690487	1.5845682891511383	5	5	fmqb@NZRhqPNNQQIYQQSYQESQITYjwhaSM\@ESMUTp@EQbr\oH@	gChhhE`BRnRYh@										1
:xjxyyirjyjzfxsijzDUjp5UtpePwFpIsFSsuSmggOoS4@Txo870k8FHV080F6d6#8P1VF0GVV03$F!	CHEMBL3658376	fioA`@@EGdTRTrTrTtTTjUFRUYpTirwkSUUUUUUMURGHJ@@	C[C@]12CCC3C4CCC(=O)C=C4CCC3C1C1CC1[C@@]21CCC(=O)O1	8.22	group1-p	p	Androgen Receptor	Binding Assay: The test was carried out as in 1, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.	2015	faw@@@LddTTRRNaRfRuN\EIQgQSUmUUUUUUUUU@@@	fawA`@@Y{dTRTrTrTrbaRhrRkNCFJZmZZjjjjjfjj@T@	340.461	3.2035	3	0	43.37	0	-1.6592524168189038	0.327513568039897	0.7381751700649293	5	5	feAb@BmfAqrJJIQQIJJIZWKLyJs`abgOQuUUSUUUMMURIIr@@											4
:xjxyyirjyjzfxsijzDUjp5UtpePwFpIsFSsuSmggOoS4@Txo870k8FHV080F6d6#8P1VF0GVVV3$F!	CHEMBL3658377	feA`@@UgdTRTrTRVfbbeRhrRg^cgI^cZZjjjjjjZjd^TT@	CC1CC2=CC(=O)CCC2C2CC[C@@]3(C)C(C4CC4[C@@]34CCC(=O)O4)C12	7.21	group2-a	a	Androgen Receptor	Binding Assay: The test was carried out as in 1, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.	2015	faw@@@LddTTRRNaRfRuN\EIQgQSUmUUUUUUUUU@@@	fawA`@@Y{dTRTrTrTrbaRhrRkNCFJZmZZjjjjjfjj@T@	354.488	3.4728	3	0	43.37	0	-1.5980543199394304	0.11360776835693714	0.7626598153680836	5	5	feAb@BmfAqrJJIQQIJJIZWKLyJs`abgOQuUUSUUUMMURIIr@@	eFBH@c@@										4
:xjxyyirjyjzfxsijzDUjp5UtpePwFpIsFSsuSmggOoS4@Txo870k8FHV080F6d6#8P1VF0GVVV3$F!	CHEMBL3658378	em`PL@@@FelbbRfRbRRabbeRhXdT\BRJJjFfZZjjjjjjfji@IIH@	CCC1CC2=CC(=O)CCC2C2CC[C@@]3(C)C(C4CC4[C@@]34CCC(=O)O4)C12	7.13	group2-a	a	Androgen Receptor	Binding Assay: The test was carried out as in 1, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.	2015	faw@@@LddTTRRNaRfRuN\EIQgQSUmUUUUUUUUU@@@	fawA`@@Y{dTRTrTrTrbaRhrRkNCFJZmZZjjjjjfjj@T@	368.515	3.9272	3	0	43.37	1	-1.387028121745383	-0.33239440663951036	0.8142161755780568	5	5	feAb@BmfAqrJJIQQIJJIZWKLyJs`abgOQuUUSUUUMMURIIr@@	eMBD@ch@										4
:xjxyyirjyjzfxsijzDUjp5UtpePwFpIsFSsvSmggtoS4@Txo870k8FHV0c0F6d6#8P1VF0GVVV3$F!	CHEMBL3658379	em`PL@@@FelbbRfRbRRabbeRhXdT\BRJJjFfZZjjijjjfji@IIH@	C=CC1CC2=CC(=O)CCC2C2CC[C@@]3(C)C(C4CC4[C@@]34CCC(=O)O4)C12	7.26	group2-a	a	Androgen Receptor	Binding Assay: The test was carried out as in 1, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.	2015	faw@@@LddTTRRNaRfRuN\EIQgQSUmUUUUUUUUU@@@	fawA`@@Y{dTRTrTrTrbaRhrRkNCFJZmZZjjjjjfjj@T@	366.499	3.7417	3	0	43.37	1	-1.3889169883594565	-0.21340523435978476	0.8099321202491242	5	5	feAb@BmfAqrJJIQQIJJIZWKLyJs`abgOQuUUSUUUMMURIIr@@	eMBD@cX@										4
:xjxyyirjyjzfxsijzDUjp5UtpePwFpIsFSsuSmggOoS4@Txo870k8FHV080F6d6#8P1VF0GVVV3$F!	CHEMBL3658380	ecdPL@@@NmlbbRfRbRTTlTTjUCDbcdW`VUUSTrsSUUUUUUUMUTaDld@@	C[C@]12CCC3C4CCC(=O)C=C4CC(C4CC4)C3C1C1CC1[C@@]21CCC(=O)O1	7.11	group2-a	a	Androgen Receptor	Binding Assay: The test was carried out as in 1, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.	2015	emhP@@@LddTTRRNaTTTrNhxxDdTL\RrjZFfjjjjjjjjjjj@@@	emhPL@@@FelbbRfRbRTTjbaRhXdT\b|BrJJjFfZZjjjjjjfjj`rP@	380.526	3.7909	3	0	43.37	1	-1.3173630817062914	-0.2949982915815226	0.8332697238178597	1	1	ecdPL@@@NmlbbRfRbRTTlTTjUCDbcdW`VUUSTrsSUUUUUUUMUTaDld@@											1
:xjxyyirjyjzfxsijziUjp5UtpePwFpIsFSsuSmggOoSZ@Txoc70k8FHV080F6d6#9P1VF0GVVV3#2F10	CHEMBL3658381	em`PB@@@KFelbbRfTTrVfbbeRhXdt|BRJJjFfZZjjjjjjfjkCbAII@@	C[C@]12CCC3C4CCC(=O)C=C4[C@H](CO)CC3C1C1CC1[C@@]21CCC(=O)O1	5	group4-ia	ia	Androgen Receptor	Binding Assay: The test was carried out as in 1, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.	2015	faw@@@LddTTRRNaRfRuN\EIQgQSUmUUUUUUUUU@@@	fawA`@@Y{dTRTrTrTrbaRhrRkNCFJZmZZjjjjjfjj@T@	370.487	2.5461	4	1	63.6	1	-0.46541145757091046	0.7459057643456227	-0.13642163676533153	5	5	echPBH@KFam`GGHhhhhhddhhmi\lpHixDdedUULmUUUSUUUSSUUa`eDD`@											1
:xjxyyirjyjzfxsijzDUjp5UtpePwFpIsFSsuSmggOoS4@Txo870k8FHV080F6d6#8Q1VF0GVVV3$F!	CHEMBL3658382	emhPL@@@FelbbRfdRJRfbbeRhxdTtL|BRJJjFfZZjjjjjjfjjPBRR@@	C[C@]12CCC3C4CCC(=O)C=C4C4(CC4)CC3C1C1CC1[C@@]21CCC(=O)O1	7.58	group2-a	a	Androgen Receptor	Binding Assay: The test was carried out as in 1, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.	2015	ee`P@@@LddTTRRNaRbbQuGG@dbacdRQUWPuUUUUUUUUUU@@@	ee`PL@@@JilbbRfdRJRfTTJUGDbfag`RVVQWPsSUUUUUUSUUPIH@	366.499	3.5111	3	0	43.37	0	-1.5366043016280981	0.046043278891299944	0.7826232849927729	1	1	emhPL@@@FelbbRfdRJRfbbeRhxdTtL|BRJJjFfZZjjjjjjfjjPBRR@@											1
:xjxyyirjyjzfxsijzDUjp5UtpePwFpIsFSsuSmggOoS4@Txo870k8FHV080F6d6#8P1VF0GVVV3$F!	CHEMBL3658384	ee`PL@@@JilbbRfTTJTtTTjUCDbdfcgdVVQWPsSUUUUUUSUUH^JI@@	C[C@]12CCC3C4CCC(=O)C=C4C4CC4C3C1C1CC1[C@@]21CCC(=O)O1	6.48	group3-int	int	Androgen Receptor	Binding Assay: The test was carried out as in 1, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.	2015	fi@@@LddTTRRNaTTJVis`iJLzJXy[vjjjjjjjjjj@@	fiA`@@EGdTRTrbaRfTTJUFRUKSoQRgK^mMUUUUUTuUTHh@	352.472	3.1069	3	0	43.37	0	-1.591455282777928	0.3410440684649933	0.757435613389002	5	1	ee`PL@@@JilbbRfTTJTtTTjUCDbdfcgdVVQWPsSUUUUUUSUUH^JI@@											1
;vzv;x:vzvzUbCuUfzEzUjUbqSUzjj@DbvbU7fqdZTvqKqCmxPhDjFYq5hi3g9poVTC2SIk9GNCcX0c!	CHEMBL365921	ed^RBH@E@bh^ILj`ICHhdleMEDhUEmEDhlmPpyyxDdUl\|C@ASUUTs@@AFUAahkIx`@	N#Cc1ccc(N2C(=O)[C@H]3[C@@H]4C[C@@H](CN4C(=O)Oc4ccc(F)cc4)N3C2=O)c2ccccc12	5.73	group4-ia	ia	Androgen Receptor	In vitro antagonistic activity against mutant androgen receptor of LNCap cells	2004	eobP@@@LdbbbTVtTNtRLVbRXtDLl|RJrjn^jjjjjjjjjjjj@@@	eob\B@@DLH`ENalbbbbbRbbqbvtJbRhXtlLbBRJZn^Zj`Z`HBF`@j@pXgBtP@	456.432	3.6248	8	0	93.95	3	1.4447341492741985	0.2569986404029022	1.5809936692373423	2	2	ehV\BD@EOFg@ai`GDFPrJJIQYZZJ[JHjYQIYcbSSrKJhii{z@@BJYjjf`@`jLHddld@@	eMbA@Dg`@										2
:xjxyyirjy:fxsjjziUjrCzvxyPwJpMkGSvzSqwZpwxZPRrqeEul0GLW0g4kT_ZGcJ9AJk4JGVsZA0802010	CHEMBL3667040	fegAP@@LuyNQQQRJIKEKQYKKbmNMYijjjVjZjjQaVTLp	C/C=C/C1=CC2=C(CO1)C(=O)[C@]1(C)OC(=O)[C@H](C(O)CCCCC)C1C2	4.92	group4-ia	ia	Androgen Receptor	Inhibition Assay: To conduct the assays, the 250 uM monasuspiloin solution was further diluted with 10% DMSO to prepare 25 uM, and 5 uM monasuspiloin samples, and the final concentration of DMSO in the cell culture was 1%.The cell line used in glucocorticoid receptor (GR) assay was human A-549 cells (cultured in Ham's F12K medium (Gibco, USA), 10% FBS), the cell line used in progesterone receptor (PR) assay was human T-47D cells (cultured in RPMI 1640 medium (Gibco, USA), 10% FBS), and the cell line used in estrogen receptor (ER) assay was human MCF7 cells (cultured in MEM medium (Gibco, USA), 10% FBS). The cells in the exponential phase of growth were washed off with 1 ml of 0.05% trypsin, centrifuged and collected in a centrifuge tube. 1x107 cells were resuspended in 270 ul BES medium (5 mM BES in medium) and 8 to 10 ug of plasmid [pMMTV-SEAP plasmid was used for GR and PR (see FIG. 7), and pTA-ERE-SEAP plasmid (Clontech, USA) was used for ER (see FIG. 8)] were also added.	2015	foQ@@@LdbbbRQvYHRcVjjjjjh@@	foQ@P@@LT{Hhhhhdd^RU[Qffjjej@@	360.448	2.9637	5	1	72.83	6	0.6480031483452787	0.11653149211458352	0.0918104776735418	1	1	fegAP@@LuyNQQQRJIKEKQYKKbmNMYijjjVjZjjQaVTLp											1
:UvzfzUzSzjQTQzUESP2fxQzU@bhqO9@Ii2DUl3UAtZc4Aj6JH_Fo2g8j4XHSeA0R9GkVFT290V11Fa08$	CHEMBL366924	fb}``@D@UdTTTTRTRqahsUcA}EjjAjBJiDXSD@	Cc1ccc(N2C(=O)[C@H]3C4C=CC(C4)[C@H]3C2=O)cc1C	7.02	group2-a	a	Androgen Receptor	Inhibition of L701H/T877A mutant androgen receptor of human prostate cancer MDAMB-PCa2b cell proliferation	2005	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdu``@D@UdTTTTRTRqhsUcA}EjjAjBJQFDq@@	267.327	2.2634	3	0	37.38	1	-1.937962298234221	0.9990953434803778	0.6237951333528862	47	10	fjc`c@IF\@IIxl\\bbbfJbbfrbxJwhyRVBHJfZjbeEez@@	eFBH@c@@		eFBH@c@@								10
:UvzvzUzS:QTQvEMUPAfxQUUer_oF9PfgDDql3S2dZc4AjqJF_FJ2g8j4XH5c@2JCGm1FB280V01Fa#8!	CHEMBL367364	ffs`c@IV|BPQHXdLbdLRTttTvTPeNBgIZuPAELuUERGHL@@	O=C1[C@H]2C3CCC(C3)[C@H]2C(=O)N1c1cccc(C(F)(F)F)c1	6.9	group3-int	int	Androgen Receptor	Inhibition of human androgen receptor of breast carcinoma MDA-453 cells in reporter gene assay	2005	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdu``@D@UdTTTTRTRqhsQkA}EjjAjBJaFDq@@	309.286	2.6993	3	0	37.38	2	-1.578970597764124	0.4606338868187295	0.7212167159162296	47	2	ffs`c@IV|BPQHXdLbdLRTttTvTPeNBgIZuPAELuUERGHL@@											1
:UvzfzUrS:QTQzUUSQ@fxfzUebhoN9Pvy@Dyl3TAt4cBejLJH5Jq@g8j4XHKfQXR9GkVNR@90V11FZ!3F!	CHEMBL367375	em`TB@DHC@D@dhIPyInYYwn[v[DdtlbrZFzffVZ@@BJYjjhIhbJYKjSH@	O=C1[C@H]2C3C=CC([C@@H]4C[C@H]34)[C@H]2C(=O)N1c1ccc([N+](=O)[O-])c2ccccc12	6.11	group3-int	int	Androgen Receptor	Inhibition of androgen receptor in human MDA-453 cells	2005	faw@@@LdbbbTVtTNtTSMBM[vZe[WmUUUUUUUUU@@@	faw``@D@UdTTTTRbTVTtWirt[IBUNV}Zj`Z`F`Bh`fErFbX@	360.368	2.0938	6	0	83.2	2	0.189858459662433	1.3338575793317629	1.1843825481000119	1	1	em`TB@DHC@D@dhIPyInYYwn[v[DdtlbrZFzffVZ@@BJYjjhIhbJYKjSH@											1
<f;jUyz9yjTPCzdiU4PX8opjvz10IHx_Om2n9GOTXG3DffX86bSt0e01Sv10E165jFTJ485F0Z_F4X8GV	CHEMBL3682510	fbmaB`ANADDbHrBYCLadTTVRRRTadYrRkA``JjjjahF`@	O[C@]1(C(F)(F)F)CCCc2c1[nH]c1cc(Cl)c(Cl)cc21	7.89	group2-a	a	Androgen Receptor	Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.	2015	dk|@@LdbbbRQKauSjjjjj@@	dk~@@@RfYU_JGUN`XJJH@@	324.128	4.2727	2	2	36.02	1	-1.4478731513802794	-0.5780102871702114	-1.5377238297996303	25	21	fde`B`N@BR^MgDLQFARYgmUgVBdiwjjihHJ`@@		gGQBJIARFdB@YEHZj@@		eFABH`BL@							7
<f;jUyz9yjTPCzdiU4PX8opjvy10IHx_Om2n9GOTXG3Dff284bSt0X01Kv10E165jNTJ485F0ZWG4X8GV	CHEMBL3682511	fbmaB`BVADJbHrBYCLadTTRTRQdVdYK`oA``hjjjahZ`@	O[C@]1(C(F)(F)F)CCCc2c1[nH]c1c(Cl)cc(Cl)cc21	7.7	group2-a	a	Androgen Receptor	Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.	2015	dk|@@LdbbbRQKauSjjjjj@@	dk~@@@RfYU_JGUN`XJJH@@	324.128	4.2727	2	2	36.02	1	-1.4478731513802794	-0.5780102871702114	-1.5377238297996303	25	21	fhy`@`N@BR^MgDLCdTTVfRRbKART{uUTtDE@@@	eFABH`BL@	gGQBJIARFdB@YEHZj@@		eFABH`BL@							8
<f;jUyz9yjTuEzdiU5PmNopzvz10IHx_Om2rCGOTXG7DffX8LbSt2e01Sv10E165jFTJ485F0Z_F4X8GV	CHEMBL3682512	fj}aA`ANADDbHrBYCL`VPrJJKIIIJPrIgIJlFB@jjjja`@@	OC1(C(F)(F)F)c2[nH]c3cc(Cl)c(Cl)cc3c2CCC1F	6.85	group3-int	int	Androgen Receptor	Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.	2015	dk|@@LdbbbRQKauSjjjjj@@	dk~@@@RfYU_JGUN`XJJH@@	342.118	4.1217	2	2	36.02	1	-1.3460297817445257	-0.5539494498348012	-1.5089084917972309	25	21	fde`B`N@BR^MgDLQFARYgmUgVBdiwjjihHJ`@@		gGQBJIARFdB@YEHZj@@	eFABP`BL@	eFABH`BL@							7
<f;jUyz9yjTPCzdiU4PX8opjvy10IHx_Om2n9GOTXG3DffX84bSt0X01Sv10E165jNTJ485F0Z_F4X8GV	CHEMBL3682513	fbmaB`INADDdHrBYCLadTTTrTJTadXJRkA``bZjjbhFH@@	OC1(C(F)(F)F)CCCc2c1[nH]c1ccc(F)c(Cl)c21	6.28	group3-int	int	Androgen Receptor	Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.	2015	dk|@@LdbbbRQKauSjjjjj@@	dk~@@@RfYU_JGUN`XJJH@@	307.673	3.7675	2	2	36.02	1	-1.5107582203169052	-0.213289898311964	-1.567433054596831	25	21	fde`B`N@BR^MgGtQFArJJKSIIQRlEIS`uUSPQE@@@		gGQBJIARFdB@YEHZj@@		eFABP`BL@							4
<f;jUyz9yzTuEzfjz_QqNor:yG2IHZbxY2vCFOymOU6vfX84jSt2V01Sn50EW65iRT4685F0g5F4X8GV	CHEMBL3682514	fj}aA`I^ADDbHrBYCL`VPrJJJYJEQQRE`iJ\FBBIjjjb`@@	OC1c2[nH]c3ccc(Cl)c(Cl)c3c2C(C(F)(F)F)CC1F	7.16	group2-a	a	Androgen Receptor	Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.	2015	dk|@@LdbbbRQKauSjjjjj@@	dk~@@@RfYU_JGUN`XJJH@@	342.118	4.4081	2	2	36.02	1	-1.3595050575786085	-0.7261185742193028	-1.5074159282891828	25	21	ffc`@PN@BR^IiBt`zPbxybJpNQQQZIIRIVJU`eZRVjjZj`bJ@@@		eFJB@Hp@	eFABP`BL@	eFABH`BL@							1
<f;jUyz9yjTPCzdiU4PX8opjvz10IHx_Om2n9GOTXG3DffX86bSt0e01Sv10E165jFTJ485F0Z_F4X8GV	CHEMBL3682515	fbmaB`ANADDdHrBYCLadTTVRRRTadYrRkA``JjjjahFH@@	OC1(C(F)(F)F)CCCc2c1[nH]c1cc(Cl)c(F)cc21	7.7	group2-a	a	Androgen Receptor	Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.	2015	dk|@@LdbbbRQKauSjjjjj@@	dk~@@@RfYU_JGUN`XJJH@@	307.673	3.7675	2	2	36.02	1	-1.5107582203169052	-0.213289898311964	-1.567433054596831	25	21	fde`B`N@BR^MgDLQFARYgmUgVBdiwjjihHJ`@@		gGQBJIARFdB@YEHZj@@		eFABP`BL@							7
<f;jUyz9yjTuEzdiU5PmNopzvz10IHx_Om2rCGOTXG7DffX8LbSt2e01Sv10E165jFTJ485F0Z_F4X8GV	CHEMBL3682517	ffcaC`ANADDbHrBYCL`VPkHYEEEdddeHXiF\djwhHBjjjjahFH@@	OC1(C(F)(F)F)c2[nH]c3cc(Cl)c(Cl)cc3c2CCC1(F)F	6.66	group3-int	int	Androgen Receptor	Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.	2015	dk|@@LdbbbRQKauSjjjjj@@	dk~@@@RfYU_JGUN`XJJH@@	360.109	4.4119	2	2	36.02	1	-1.2649399584162513	-0.7951191104085056	-1.4777922498429985	25	21	fde`B`N@BR^MgDLQFARYgmUgVBdiwjjihHJ`@@		gGQBJIARFdB@YEHZj@@	eMCBP`AdDf`@	eFABH`BL@							7
<f;jUyz9yjTuEzdiU5PmNopzvy10IHx_Om2r9GOTXG7DffX8JbSt2X01Sv10E165jNTJ485F0Z_F4X8GV	CHEMBL3682519	fj}aB`INADDbHrBYCLadTTTrTJTadSARUXLDDSUUUE@@@	CC1CCc2c([nH]c3ccc(Cl)c(Cl)c23)C1(O)C(F)(F)F	6.4	group3-int	int	Androgen Receptor	Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.	2015	dk|@@LdbbbRQKauSjjjjj@@	dk~@@@RfYU_JGUN`XJJH@@	338.155	4.542	2	2	36.02	1	-1.386675054500806	-0.7919160868531714	-1.5132391844964759	25	21	fde`B`N@BR^MgGtQFArJJKSIIQRlEIS`uUSPQE@@@		gGQBJIARFdB@YEHZj@@	eFBH@c@@	eFABH`BL@							4
<f;jUyz9yjTPCzdiU4PX8opjvz10IHx_Om2n9GOTXG3DffX86bSt0e01Sv10E165jNTJ485F0Z_F4X8GV	CHEMBL3682520	fj}aA`E^ADDbFQBYCL`VPrJJJZESIRFS`eZ]FBHJZjjbhVH@@	OC1(C(F)(F)F)CCCc2c1[nH]c1cc(Cl)c(Cl)c(Cl)c21	6.39	group3-int	int	Androgen Receptor	Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.	2015	dk|@@LdbbbRQKauSjjjjj@@	dk~@@@RfYU_JGUN`XJJH@@	358.573	4.8787	2	2	36.02	1	-1.2949920294909774	-1.0700390696272475	-1.4778870213163666	25	21	flu`A`N@BR^MgGtQFHS@iLsvjs^pTeNCUUMADU@@@		gGQBJIARFdB@YEHZj@@		eFABH`BL@							1
<f;jUyz9yjTPCzdiU4PX8opjvz10IHx_Om2l9GOTXG3DffX86bSt0e01Sv107165ENRJ485F0ZZG4X8GV	CHEMBL3682521	fbmaB`FVADDbHrBYCL`dsMkkSupTe^CADEUUUCPtP@	OC1(C(F)(F)F)CCCc2c1[nH]c1c(Cl)c(Cl)ccc21	6.89	group3-int	int	Androgen Receptor	Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.	2015	dk|@@LdbbbRQKauSjjjjj@@	dk~@@@RfYU_JGUN`XJJH@@	324.128	4.2727	2	2	36.02	1	-1.4478731513802794	-0.5780102871702114	-1.5377238297996303	25	21	fde`B`N@BR^MgDLQFARYgmUgVBdiwjjihHJ`@@	eFABH`BL@	gGQBJIARFdB@YEHZj@@									7
<f;jTiz1qjTP9rdaU4PX8Fpfvz10IHx_9m2n9GtDXG3DffX86bSt0e01Sv10E165jFTJ485F0Z_F4X8GV	CHEMBL3682523	fluaB`ANADDb@rDYALadTTVRRRTLcNRTZtDAUUUPtCD@@	OC1(C(F)(F)F)CCc2c1[nH]c1cc(Cl)c(Cl)cc21	6.92	group3-int	int	Androgen Receptor	Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.	2015	dc\@@DjYeTnGYVjjjj`@	dc^@@@RfYU\h]eZA`hb@@	310.102	3.9307	2	2	36.02	1	-1.5056453841391968	-0.32040485451764633	-1.5625856899180404	3	3	fluaB`ANADDb@rDYALadTTVRRRTLcNRTZtDAUUUPtCD@@											1
<f;jUyz9yjTPCzdiU4PX8opjvy10IHx_Om2n9GOTXG3Dff284bSt0X01Kv10E165jNTJ485F0ZWG4X8GV	CHEMBL3682524	fbmaB`INADLdHrBYCLadTRTVTrTadirRkA`BJZjjbhFH@@	OC1(C(F)(F)F)CCCc2c1[nH]c1c(F)cc(Cl)cc21	7.27	group2-a	a	Androgen Receptor	Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.	2015	dk|@@LdbbbRQKauSjjjjj@@	dk~@@@RfYU_JGUN`XJJH@@	307.673	3.7675	2	2	36.02	1	-1.5107582203169052	-0.213289898311964	-1.567433054596831	25	21	fhy`@`N@BR^MgDLCdTTVfRRbKART{uUTtDE@@@	eFABP`BL@	gGQBJIARFdB@YEHZj@@		eFABH`BL@							8
<f;jTiz1qjTP9rdaU4PX8Fpfvy10IHx_9m2n9GtDXG3DffX84bSt0X01Sv10E165jNTJ485F0Z_F4X8GV	CHEMBL3682525	fluaB`INADDb@rDYALadTTTrTJTLcARTZtDDSUUQTCD@@	OC1(C(F)(F)F)CCc2c1[nH]c1ccc(Cl)c(Cl)c21	6.76	group3-int	int	Androgen Receptor	Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.	2015	dc\@@DjYeTnGYVjjjj`@	dc^@@@RfYU\h]eZA`hb@@	310.102	3.9307	2	2	36.02	1	-1.5056453841391968	-0.32040485451764633	-1.5625856899180404	3	3	fluaB`INADDb@rDYALadTTTrTJTLcARTZtDDSUUQTCD@@											1
<f;jUyz9yjTPSzdiU4PXBopjvx10IHx_Om2n9GOTXG3Dff284aSt0X01Mv10C5D7jNTJ485F0ZYG4XcGV	CHEMBL3682526	fakQA`NAbBPQHXdJrCYCladTabbRbRrdQddYVlej``hjzjhZCb@@	N#Cc1cc(C(F)(F)F)c2[nH]c3c(c2c1)CCCC3(O)C(F)(F)F	6.41	group3-int	int	Androgen Receptor	Biological Assay: In order to demonstrate the utility of the compounds of this invention, an androgen receptor binding assay was performed wherein many of the compounds of this invention are shown to demonstrate significant affinity for the androgen receptor. The assay was performed as specified by the manufacturer (Invitrogen, Madison, Wis.). Briefly, 1 ul of 10 mM compound was added to 500 ul of AR screening buffer in a 1.5 ml eppendorf tube to make a 2x10-5M stock. 10-fold serial dilutions of the test compounds were prepared ranging in concentration from 10-5M to 10-12M. Each dilution was added in triplicate to a black 384-microtiter plate. The test compounds will be diluted 2-fold in the final reaction. 2xAR-Fluormone complex was prepared with 2 nM Flourmone AL Green and 30 nM AR. 25 ul of 2x complex was aliquoted to each reaction well, such that the final reaction volume was 50 ul per well. The plate was sealed with a foil cover and incubated in the dark at room temperature.	2015	dk|@@LdbbbRQKauSjjjjj@@	dk~@@@RfYU_JGUN`XJJH@@	348.245	3.7446	3	2	59.81	2	-0.5100591041177717	-0.17544410382111672	-1.3255840121881506	25	21	fhy`@`N@BR^MgDLCdTTVfRRbKART{uUTtDE@@@	gJPBAHJPt`PAIjj@@	gGQBJIARFdB@YEHZj@@		eMbA@Dg`@							8
:pjxyqerjuvxexkVfzDSjb1UtpuPwFlFsGSssGHgcOgS4@Rto870k8FL!80FL12#8Q0VJ4F#1(	CHEMBL3687970	fn{@`@@YrJIJYJYJZIPjcIJlxJZmZZjjjjjZjXqBRhZNPT@	C[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]21C=CCO1	7.57	group2-a	a	Androgen Receptor	Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.	2015	ffk@@@LddTRRUfRfRuNBehw`yKUUUUUUUUP@@	ffk@`@@IRYVum[VvcIJlxLRuZZjjjjijjcDIJahE@@	312.451	3.5909	2	0	26.3	0	-2.3443271956215423	-0.04756580566206142	0.5621085482610488	11	9	fag@a@J]Ax~\\bdTbbRt\VRRwIJ]htTu[UUUSUUMMUTPlHR\hh@		eFBH@c@@									8
:UvzvzUzS:QTQzUUUQ2vxvzU@rhqN9@IyaEUl3UAthiBfj6LH_Jq2g9j4eHUvQVRCOmWkT@90VG1Fa!38!	CHEMBL368906	figPSBNVUhJPRBICDar]]dTabbTRlTTvTTcQsWkQuPPLULuUEJHkL@@	O=C1[C@H]2C3C=CC(C3)[C@H]2C(=O)N1c1ccc([N+](=O)[O-])c(C(F)(F)F)c1	6.92	group3-int	int	Androgen Receptor	Inhibition of human androgen receptor of breast carcinoma MDA-453 cells in reporter gene assay	2005	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdu``@D@UdTTTTRTRqhsUcA}EjjAjBJQFDq@@	352.267	1.5023	6	0	83.2	3	0.33356455951990516	1.5986542907235912	1.1940769660555128	47	10	fjc`c@IF\@IIxl\\bbbfJbbfrbxJwhyRVBHJfZjbeEez@@	gJPBAHJPt`PAIjj@@		gChhhE`BRnRYh@								10
:pjxyqerjunxexkVfrDSjb0zkpuPwFkFsGSktGHgcOcS4@RdF@70k8FL!80FL12#8Q0VJ4F#1(	CHEMBL3692346	fn{@`@@YrJIJYIIJZIPjgIJlxJZmZZfjjjjZjYqRRdZNPT@	C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@]21C=CCO1	6.18	group3-int	int	Androgen Receptor	Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.	2015	ffk@@@LddTRRUfRfRuNBehw`yKUUUUUUUUP@@	ffk@`@@IRYVuU[VvgIJlxLRuZZfjjjijjgEIJQhE@@	310.435	3.3155	2	0	26.3	0	-2.34198607273534	0.12546637122154014	0.5573560341415718	11	2	fn{@b@JM@xyEHiEDehtddmrRgZLFIZuUUTtuMMUTPlHR\`h@	eFBH@c@@										2
:pjxyqerjuvxexkVfzDSjb1UtpuPwFlFsGSssGHgcOgS4@Rto870k8FL!80FL12#8Q0VJ4F!V1(	CHEMBL3692347	fag@`@@ErJIJYJIKSQJETYISoQrwkSUUUUUTuUqbDiITmOJJ@@	C[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34C=CCO4)[C@@H]21	7.35	group2-a	a	Androgen Receptor	Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.	2015	ffk@@@LddTRRUfRfRuNBehw`yKUUUUUUUUP@@	ffk@`@@IRYVum[VvcIJlxLRuZZjjjjijjcDIJahE@@	326.478	3.8602	2	0	26.3	0	-2.283129098742069	-0.2614716053450212	0.5865931935642033	11	9	fag@a@J]Ax~\\bdTbbRt\VRRwIJ]htTu[UUUSUUMMUTPlHR\hh@	eFBH@c@@	eFBH@c@@									8
:pjxyqerjuvxexkVfzDSjb1UtpuPwFlFsGSssGHgcOgS4@Rto870k8FL!80FL12#8Q0VJ4F!V1(	CHEMBL3692348	fiw@`@@UrJIJYJIIJFIPjcIJ\EI^cZZjjjjjijkcDIRRiZART@	CC[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34C=CCO4)[C@@H]21	7.19	group2-a	a	Androgen Receptor	Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.	2015	ffk@@@LddTRRUfRfRuNBehw`yKUUUUUUUUP@@	ffk@`@@IRYVum[VvcIJlxLRuZZjjjjijjcDIJahE@@	340.505	4.3146	2	0	26.3	1	-2.0721029005480216	-0.7074737803414688	0.6381495537741764	11	9	fag@a@J]Ax~\\bdTbbRt\VRRwIJ]htTu[UUUSUUMMUTPlHR\hh@	eMBD@ch@	eFBH@c@@									8
:pjxyqerjuvxexkVfzDSjb1UtpuPwFlFsGSstGHgctgS4@Rto870k8FL!c0FL12#8Q0VJ4F!V1(	CHEMBL3692349	fiw@`@@UrJIJYJIIJFIPjcIJ\EI^cZZjjijjijkcDIRRiZART@	C=C[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34C=CCO4)[C@H]12	7.28	group2-a	a	Androgen Receptor	Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.	2015	ffk@@@LddTRRUfRfRuNBehw`yKUUUUUUUUP@@	ffk@`@@IRYVum[VvcIJlxLRuZZjjjjijjcDIJahE@@	338.489	4.1291	2	0	26.3	1	-2.073991606450939	-0.5884847212304299	0.6338655486613916	11	9	fag@a@J]Ax~\\bdTbbRt\VRRwIJ]htTu[UUUSUUMMUTPlHR\hh@	eMBD@cX@	eFBH@c@@									8
:pjxyqerjuvxexkVfzDSjb1UtpuPwFlFsGSssGHggOgS4@Rto870k8FL!80FL12#8Q0VJ4F#1$F!	CHEMBL3692350	fio@`@@YRYVum[enVcIJlxJZmzMijjjjjjfjicDIJahyAP@	C[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4CC[C@H]3[C@@H]1CC1(CC1)[C@@]21C=CCO1	6.85	group3-int	int	Androgen Receptor	Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.	2015	faw@@@LddTbbUQfRfRuALxkUgQSUmUUUUUUUUU@@@	faw@`@@IRYVum[VYZLdjs`qKUoVfjjjjjijjhqBRhZAP@	338.489	3.8985	2	0	26.3	0	-2.2216789197195803	-0.32903620797934535	0.6065567134050402	1	1	fio@`@@YRYVum[enVcIJlxJZmzMijjjjjjfjicDIJahyAP@											1
:pjxyqerjuvxexkVfzDSjb1UtpuPwFlFsGSssGHgcOgS4@Rto870k8FL!80FL12#8Q0VJ4F#1(	CHEMBL3692351	fag@`@@YRYVum[egZLdjs`i[uijjjjjjZjXqBRhZNPT@	CC[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]21C=CCO1	6.8	group3-int	int	Androgen Receptor	Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.	2015	ffk@@@LddTRRUfRfRuNBehw`yKUUUUUUUUP@@	ffk@`@@IRYVum[VvcIJlxLRuZZjjjjijjcDIJahE@@	326.478	4.0453	2	0	26.3	1	-2.133300997427495	-0.4935679806585088	0.613664908471022	11	9	fag@a@J]Ax~\\bdTbbRt\VRRwIJ]htTu[UUUSUUMMUTPlHR\hh@		eMBD@ch@									8
:pjxyqerjunxexkVfrDSjb0zkpuPwFkFsGSktGHgcOcS4@RdF@70k8FL!80FL12#8Q0VJ4F#1(	CHEMBL3692352	fag@`@@YRYVuU[egZ\djs`i[uijZjjjjZjYqRRdZNPT@	CC[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@]21C=CCO1	6	group3-int	int	Androgen Receptor	Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.	2015	ffk@@@LddTRRUfRfRuNBehw`yKUUUUUUUUP@@	ffk@`@@IRYVuU[VvgIJlxLRuZZfjjjijjgEIJQhE@@	324.462	3.7699	2	0	26.3	1	-2.1309598745412925	-0.3205358037749074	0.6089123943515449	11	2	fn{@b@JM@xyEHiEDehtddmrRgZLFIZuUUTtuMMUTPlHR\`h@	eMBD@ch@										2
:pjxyqerjuvxexkVfzDSjb1UtpuPwFlFsGSssGHgcOgS4@Rto870k8FL!80FL12#8Q0VJ4F!V1(	CHEMBL3692353	fiw@`@@ERYVue^yYvcIJ]zN^cZZjjjjjijkcDIRRiZ^TT@	CC[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4C[C@@H](C)[C@H]3[C@@H]1CC[C@@]21C=CCO1	7.09	group2-a	a	Androgen Receptor	Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.	2015	ffk@@@LddTRRUfRfRuNBehw`yKUUUUUUUUP@@	ffk@`@@IRYVum[VvcIJlxLRuZZjjjjijjcDIJahE@@	340.505	4.3146	2	0	26.3	1	-2.0721029005480216	-0.7074737803414688	0.6381495537741764	11	9	fag@a@J]Ax~\\bdTbbRt\VRRwIJ]htTu[UUUSUUMMUTPlHR\hh@	eFBH@c@@	eMBD@ch@									8
:pjxyqerjuvxexkVfzDSjb1UtpuPwFlFsGSssGHgcOgS4@Rto870k8FL!80FL12#8Q0VJ4F!V1(	CHEMBL3692354	feo@`@@UrJIJYJIIJFIQYTYIS`iJN[SUUUUUUSUWFHRdeRtBdh@	CC[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@@]3(CC)[C@@H](CC[C@@]34C=CCO4)[C@@H]21	6	group3-int	int	Androgen Receptor	Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.	2015	ffk@@@LddTRRUfRfRuNBehw`yKUUUUUUUUP@@	ffk@`@@IRYVum[VvcIJlxLRuZZjjjjijjcDIJahE@@	354.532	4.769	2	0	26.3	2	-1.861076702353974	-1.1534759553379164	0.6897059139841495	11	9	fag@a@J]Ax~\\bdTbbRt\VRRwIJ]htTu[UUUSUUMMUTPlHR\hh@	eMBD@ch@	eMBD@ch@									8
:pjxyqerjuvxexkVfzDSjb1UtpuPwFlFsGSstGHgctgS4@Rto870k8FL!c0FL12#8Q0VJ4F!V1(	CHEMBL3692355	feo@`@@UrJIJYJIIJFIQYTYIS`iJN[SUUUMUUSUWFHRdeRtBdh@	C=C[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@@]3(CC)[C@@H](CC[C@@]34C=CCO4)[C@H]12	5.89	group4-ia	ia	Androgen Receptor	Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.	2015	ffk@@@LddTRRUfRfRuNBehw`yKUUUUUUUUP@@	ffk@`@@IRYVum[VvcIJlxLRuZZjjjjijjcDIJahE@@	352.516	4.5835	2	0	26.3	2	-1.8629655689680473	-1.0344867830581905	0.685421858655217	11	9	fag@a@J]Ax~\\bdTbbRt\VRRwIJ]htTu[UUUSUUMMUTPlHR\hh@	eMBD@cX@	eMBD@ch@									8
:pjxyqerjuvxexkVfzDSjb1UtpuPwFlFsGSssGHgcOgS4@Rto870k8FL!80FL12#8Q0VJ4F!V1$F!	CHEMBL3692356	em`PD@@@FlbbRfRbRTTlRbrhXdT\b|BrjfVZZjjjjjjfjkaaBJQJRrQKI@@	CC[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4C[C@@H](C4CC4)[C@H]3[C@@H]1CC[C@@]21C=CCO1	6.72	group3-int	int	Androgen Receptor	Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.	2015	fio@@@LddTRRUfTTTrNipTmFCGIV}jjjjjjjjjj@@	fio@`@@UrJIJYJIIQRiSJcIJ]Gp\ezMijjjjjjfjicDIRRiZYP@	366.543	4.6327	2	0	26.3	2	-1.7914116623148824	-1.1160798402799286	0.7087594622239526	1	1	em`PD@@@FlbbRfRbRTTlRbrhXdT\b|BrjfVZZjjjjjjfjkaaBJQJRrQKI@@											1
:pjxyqerjuvxexkVfziSjb1UtpuPwFlFsGSssGHgcOgSZ@Rtoc70k8FL!80FL12#9Q0VJ4F!V1#2010	CHEMBL3692357	feoA`@@Vjdrmlvo\l{Qdm^BdhymMUUUUUUMU\XnPRuGPJR`@	CC[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4[C@H](CO)C[C@H]3[C@@H]1CC[C@@]21C=CCO1	6.85	group3-int	int	Androgen Receptor	Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.	2015	ffk@@@LddTRRUfRfRuNBehw`yKUUUUUUUUP@@	ffk@`@@IRYVum[VvcIJlxLRuZZjjjjijjcDIJahE@@	356.504	3.3879	3	1	46.53	2	-0.9394600493972127	-0.07517592767775669	-0.26093189711673015	11	9	feoAa@JMfCq|xyEHiEDehxmDdd^RT{QhizNjjjfjjfijibEaBSdEQP@		eMBD@ch@									1
;vzfzUrSzjQTQzUESP2fxAzU@bhoNA@Ii2DUl3TAtZc4@j6JH5Fo2i8z4XPKfA0R9GkVNR290V11FZ0F201F	CHEMBL369509	fn{Q`@DI@inQQQQQIQQXqETYjqharVkUTCTA@ERBLIb@@	O=C1[C@H]2C3C=CC(C3)[C@H]2C(=O)N1c1ccc(O)c2ncccc12	5.44	group4-ia	ia	Androgen Receptor	Inhibition of L701H/T877A mutant androgen receptor of human prostate cancer MDAMB-PCa2b cell proliferation	2005	ffk@@@LdbbbTVtTNtSMBM[r\ekUUUUUUUUP@@	ffkP`@DI@kHhhhhdhhlXcQfkFbGIZmUPMPD@T`cBX`@	306.32	1.5459	5	1	70.5	1	-0.40049769725329226	1.756591005739885	-0.14111121099261073	6	1	fn{Q`@DI@inQQQQQIQQXqETYjqharVkUTCTA@ERBLIb@@											1
:UvzfzUrS:QTQzUUSQ@AxfzUebhoN9PIy@DTl3TAl4cBejLJH5Jq2g8j4XHKfIVR9GkVNR@90V11FZ!3#	CHEMBL369542	fmPPBHF@`JXRcdfyeg^yoYlTmVcehykZ@@BJYjjhIdQfT@	O=C1[C@H]2C3C=CC(CCC3)[C@H]2C(=O)N1c1ccc([N+](=O)[O-])c2ccccc12	7.31	group2-a	a	Androgen Receptor	Inhibition of androgen receptor in human MDA-453 cells	2005	fag@@@LdbbbTVtTNtTSMBM[qVu{UUUUUUUUU@@@	fag``@D@UdTTTTRbTVRTWirtPeSeoVjhFhAh@haFEr@@	362.384	2.5324	6	0	83.2	2	0.17983870113736425	1.0627180248561237	1.1899855718110761	1	1	fmPPBHF@`JXRcdfyeg^yoYlTmVcehykZ@@BJYjjhIdQfT@											1
RuJfgem0b8se989V49Q889p1MOFX8Z01FNFG8s02g8OZ44@BFo850k0FF1080F212#8Q(V%F!	CHEMBL3695596	emhPD@@@ElbbRfbbeRfbbeRhXTtTL|BRJJjFfZZjjjjjjfjjHXQdBRR@@	C[C@]12CCC3[C@@H](C4CC4C4=CC(=O)CC[C@@]43C)C1C1CC1[C@@]21CCC(=O)C1	6.2	group3-int	int	Androgen Receptor	Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.	2015	fi@@@LddTTRRNaTTJVis`iJLzJXy[vjjjjjjjjjj@@	fi@`@@CrJIJYQPiSJJEJcIJeiwhiSeoVfjjjjjjZjiFiE@@	364.527	4.4383	2	0	34.14	0	-1.9838586572717505	-0.6925852928093723	0.6721710481654751	5	1	emhPD@@@ElbbRfbbeRfbbeRhXTtTL|BRJJjFfZZjjjjjjfjjHXQdBRR@@											1
:xjxyyerjynxfxsVfrDUjr0zkpuPwFkFsGSktOmgctcS4@ThF@70k8FL!c0FL1a#8Q0VJ4G0F01(	CHEMBL3695597	fagA`@@Y{dTRTrRRTtRaRirRkNBfkVfijjjjejigEIJQhyAP@	C[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@]21C=CC(=O)O1	5	group4-ia	ia	Androgen Receptor	Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.	2015	fn{@@@LddTRRRLJTrVhKdmVCDmZjjjjjjjj`@@	fn{A`@@IZdrmjjvmkSdeV\FIZmMSUUUTmUTxiIRM@h@	324.419	2.7493	3	0	43.37	0	-1.7223621511127734	0.6600439433089995	0.7094113041761203	14	2	fagAb@J^zAqrJQRJIKPyYIK\divcQSUmUUUMKTtuUQBpaIrb`@	eFBH@c@@										2
:xjxyyerjyvxfxsVfzDUjr1UtpuPwFlFsGSssOmgctgS4@Txo870k8FL!c0FL1a#8Q0VJ4G0FV1(	CHEMBL3695598	fiwA`@@EGdTRTrTRVfbTJUFRT{t\mztuUUUUUKUWFHRdeRt|hh@	C[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34C=CC(=O)O4)[C@@H]21	6.96	group3-int	int	Androgen Receptor	Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.	2015	fn{@@@LddTRRRLJTrVhKdmVCDmZjjjjjjjj`@@	fn{A`@@IZdrmkZvmkQdeV\FIZmMUUUUTmUTXaITM@h@	340.461	3.294	3	0	43.37	0	-1.6635104805876484	0.2731097013091027	0.7386468064658773	14	11	fiwAa@J^FCqBxyEHiEDeh]DTdmrRgZLgK^uUUTtuTtuUQBpaIrR`@	eFBH@c@@	eFBH@c@@									7
:xjxyyerjyvxfxsVfzDUjr1UtpuPwFlFsGSssOmgctgS4@Txo870k8FL!c0FL1a#8Q0VJ4G0FV1(	CHEMBL3695599	feoA`@@UgdTRTrTRRTLRaRhrRgARWhvfjjjjjjVjnLPeIJehEIP@	CC[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34C=CC(=O)O4)[C@@H]21	7.05	group2-a	a	Androgen Receptor	Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.	2015	fn{@@@LddTRRRLJTrVhKdmVCDmZjjjjjjjj`@@	fn{A`@@IZdrmkZvmkQdeV\FIZmMUUUUTmUTXaITM@h@	354.488	3.7484	3	0	43.37	1	-1.452484282393601	-0.1728924736873449	0.7902031666758506	14	11	fiwAa@J^FCqBxyEHiEDeh]DTdmrRgZLgK^uUUTtuTtuUQBpaIrR`@	eMBD@ch@	eFBH@c@@									7
:xjxyyerjyvxfxsVfzDUjr1UtpuPwFlFsGSstOmgctgS4@Txo870k8FL!c0FL1a#8Q0VJ4G0FV1(	CHEMBL3695600	feoA`@@UgdTRTrTRRTLRaRhrRgARWhvfjjjZjjVjnLPeIJehEIP@	C=C[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34C=CC(=O)O4)[C@H]12	6.89	group3-int	int	Androgen Receptor	Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.	2015	fn{@@@LddTRRRLJTrVhKdmVCDmZjjjjjjjj`@@	fn{A`@@IZdrmkZvmkQdeV\FIZmMUUUUTmUTXaITM@h@	352.472	3.5629	3	0	43.37	1	-1.4543731602253858	-0.053903444732592676	0.7859191125894267	14	11	fiwAa@J^FCqBxyEHiEDeh]DTdmrRgZLgK^uUUTtuTtuUQBpaIrR`@	eMBD@cX@	eFBH@c@@									7
:xjxyyerjyvxfxsVfzDUjr1UtpuPwFlFsGSssOmggtgS4@Txo870k8FL!c0FL1a#8Q0VJ4G0F01$F!	CHEMBL3695601	feA`@@YgdTRTrTrTtRfbQhrRkNBfk^cZZjjjjjiZjfLPdjFcdE@@	C[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4CC[C@H]3[C@@H]1CC1(CC1)[C@@]21C=CC(=O)O1	6.51	group3-int	int	Androgen Receptor	Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.	2015	fio@@@LddTbbURtJTrVhIgEZmyNV}jjjjjjjjjj@@	fioA`@@IGdTRTrTrTrTTRMFRUYpXejwkSUUUUUTmUUFHRUCPJ@@	352.472	3.3323	3	0	43.37	0	-1.6020604622763162	0.20554521184346544	0.7586102760905666	1	1	feA`@@YgdTRTrTrTtRfbQhrRkNBfk^cZZjjjjjiZjfLPdjFcdE@@											1
:xjxyyerjyvxfxsVfzDUjr1UtpuPwFlFsGSssOmgctgS4@Txo870k8FL!c0FL1a#8Q0VJ4G0F01(	CHEMBL3695602	fiwA`@@YFdrmkZwKN}FRUYpTmztuUUUUUKUSFHRUCQrB`@	CC[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@]21C=CC(=O)O1	7.55	group2-a	a	Androgen Receptor	Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.	2015	fn{@@@LddTRRRLJTrVhKdmVCDmZjjjjjjjj`@@	fn{A`@@IZdrmkZvmkQdeV\FIZmMUUUUTmUTXaITM@h@	340.461	3.4791	3	0	43.37	1	-1.5136823792730745	0.04101332599561497	0.7657185213726962	14	11	fiwAa@J^FCqBxyEHiEDeh]DTdmrRgZLgK^uUUTtuTtuUQBpaIrR`@		eMBD@ch@									7
:xjxyyerjynxfxsVfrDUjr0zkpuPwFkFsGSktOmgctcS4@ThF@70k8FL!c0FL1a#8Q0VJ4G0F01(	CHEMBL3695603	fiwA`@@YFdrmjjwKN}NRUYpTmztuMUUUUKUSNJRTcQrB`@	CC[C@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@]21C=CC(=O)O1	5.58	group4-ia	ia	Androgen Receptor	Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.	2015	fn{@@@LddTRRRLJTrVhKdmVCDmZjjjjjjjj`@@	fn{A`@@IZdrmjjvmkSdeV\FIZmMSUUUTmUTxiIRM@h@	338.445	3.2037	3	0	43.37	1	-1.511341256386872	0.21404550287921653	0.7609660072532191	14	2	fagAb@J^zAqrJQRJIKPyYIK\divcQSUmUUUMKTtuUQBpaIrb`@	eMBD@ch@										2
:xjxyyerjyvxfxsVfzDUjr1UtpuPwFlFsGSssOmgctgS4@Txo870k8FL!c0FL1a#8Q0VJ4G0FV1(	CHEMBL3695604	feoA`@@EfdrmkJ}rsoQdeN}GOQmMUUUUUTmU\XaJRUKSrb`@	CC[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4C[C@@H](C)[C@H]3[C@@H]1CC[C@@]21C=CC(=O)O1	7.37	group2-a	a	Androgen Receptor	Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.	2015	fn{@@@LddTRRRLJTrVhKdmVCDmZjjjjjjjj`@@	fn{A`@@IZdrmkZvmkQdeV\FIZmMUUUUTmUTXaITM@h@	354.488	3.7484	3	0	43.37	1	-1.452484282393601	-0.1728924736873449	0.7902031666758506	14	11	fiwAa@J^FCqBxyEHiEDeh]DTdmrRgZLgK^uUUTtuTtuUQBpaIrR`@	eFBH@c@@	eMBD@ch@									7
:xjxyyerjyvxfxsVfzDUjr1UtpuPwFlFsGSssOmgctgS4@Txo870k8FL!c0FL1a#8Q0VJ4G0FV1(	CHEMBL3695605	fmA`@@UWdTRTrTRRTLRbruFRTxJRcftuUUUUUTmU\XaJRUKPJR`@	CC[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@@]3(CC)[C@@H](CC[C@@]34C=CC(=O)O4)[C@@H]21	7.12	group2-a	a	Androgen Receptor	Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.	2015	fn{@@@LddTRRRLJTrVhKdmVCDmZjjjjjjjj`@@	fn{A`@@IZdrmkZvmkQdeV\FIZmMUUUUTmUTXaITM@h@	368.515	4.2028	3	0	43.37	2	-1.2414580729818423	-0.618894505358819	0.8417595256433151	14	11	fiwAa@J^FCqBxyEHiEDeh]DTdmrRgZLgK^uUUTtuTtuUQBpaIrR`@	eMBD@ch@	eMBD@ch@									7
:xjxyyerjyvxfxsVfzDUjr1UtpuPwFlFsGSstOmgctgS4@Txo870k8FL!c0FL1a#8Q0VJ4G0FV1(	CHEMBL3695606	fmA`@@UWdTRTrTRRTLRbruFRTxJRcftuUUSUUTmU\XaJRUKPJR`@	C=C[C@@H]1CC2=CC(=O)CC[C@@H]2[C@H]2CC[C@@]3(CC)[C@@H](CC[C@@]34C=CC(=O)O4)[C@H]12	7.3	group2-a	a	Androgen Receptor	Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.	2015	fn{@@@LddTRRRLJTrVhKdmVCDmZjjjjjjjj`@@	fn{A`@@IZdrmkZvmkQdeV\FIZmMUUUUTmUTXaITM@h@	366.499	4.0173	3	0	43.37	2	-1.2433469620313382	-0.49990561972904024	0.8374754727993999	14	11	fiwAa@J^FCqBxyEHiEDeh]DTdmrRgZLgK^uUUTtuTtuUQBpaIrR`@	eMBD@cX@	eMBD@ch@									7
:xjxyyerjyvxfxsVfzDUjr1UtpuPwFlFsGSssOmgctgS4@Txo870k8FL!c0FL1a#8Q0VJ4G0FV1$F!	CHEMBL3695607	echPL@@@FmlbbRfRbRTTlRbruCDbcdW`VUTrsSUUUUUUTmUWCBDTbTedbVR@@	CC[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4C[C@@H](C4CC4)[C@H]3[C@@H]1CC[C@@]21C=CC(=O)O1	7.03	group2-a	a	Androgen Receptor	Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.	2015	fe@@@LddTRRRLJbbfQuA\ejtTekt]UUUUUUUUUT@@	feA`@@UgdTRTrTRRbeRfRhrRgQ|GI^cZZjjjjjiZjfLPeIJeie@@	380.526	4.0665	3	0	43.37	2	-1.1717930553781735	-0.5814986769507781	0.8608130763681353	2	2	em`PLH@JOE`GGHiEHhdmCeMELcnIEKMCDljfaijjjjZZjiijjXPVBDeb\PR@@	eMBD@ch@										2
:xjxyyerjyvxfxsVfzDUjr1UtpuPwFlFsGSssOmgctgS4@Txo870k8FL!c0FL1a#8Q0VJ4G0FV1$F!	CHEMBL3695608	em`PL@@@FelbbRfRbRTTlRaRhXdT\b|BrjFfZZjjjjjjVjkaaBJQJRrQKI@@	C[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4C[C@@H](C4CC4)[C@H]3[C@@H]1CC[C@@]21C=CC(=O)O1	6.52	group3-int	int	Androgen Receptor	Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.	2015	fe@@@LddTRRRLJbbfQuA\ejtTekt]UUUUUUUUUT@@	feA`@@UgdTRTrTRRbeRfRhrRgQ|GI^cZZjjjjjiZjfLPeIJeie@@	366.499	3.6121	3	0	43.37	1	-1.3828192423545094	-0.1354963586293571	0.8092567149156534	2	2	em`PLH@JOE`GGHiEHhdmCeMELcnIEKMCDljfaijjjjZZjiijjXPVBDeb\PR@@	eFBH@c@@										2
:xjxyyirjyzxfxsZjzDUjr1UtpuPwLlHsGStsOmgcxgS4@Txq878k8FL!c0FL1a2!8Q0VJ4G0F01(	CHEMBL3695609	feoAb@BEfBHRYfu{VyYwXIVg^cghzVjjjjjjVjfLTejVgeE@@	CC[C@]12CC[C@@H]3[C@H]4CCC(=O)C(Cl)=C4CC[C@H]3[C@@H]1CC[C@@]21C=CC(=O)O1	6.77	group3-int	int	Androgen Receptor	Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.	2015	fn{@@@LddTRRRLJTrVhKdmVCDmZjjjjjjjj`@@	fn{A`@@IZdrmkZvmkQdeV\FIZmMUUUUTmUTXaITM@h@	374.906	3.8984	3	0	43.37	1	-1.3520169368018364	-0.3387811095340387	0.8245823511574141	14	11	feoAc@J^fCqBx}bLbdTbbRtNbJRTOIJ]hr\mGUUUSSUSTuUQBpaIrR`@		eMBD@ch@									2
:xjxyyirjyzxfxsZjzDUjr1UtpuPwLlHsGStsOmgcxgS4@Txq878k8FL!c0FL1a2!8Q0VJ4G0F01(	CHEMBL3695610	fiwAb@BEFBHrJJJYKSISQJEI`eZ]zNV}iZjjjjjejicEIZeiyQP@	C[C@]12CC[C@@H]3[C@H]4CCC(=O)C(Cl)=C4CC[C@H]3[C@@H]1CC[C@@]21C=CC(=O)O1	6.85	group3-int	int	Androgen Receptor	Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.	2015	fn{@@@LddTRRRLJTrVhKdmVCDmZjjjjjjjj`@@	fn{A`@@IZdrmkZvmkQdeV\FIZmMUUUUTmUTXaITM@h@	360.88	3.444	3	0	43.37	0	-1.5630378315277382	0.10721733089574442	0.7730276480803153	14	11	feoAc@J^fCqBx}bLbdTbbRtNbJRTOIJ]hr\mGUUUSSUSTuUQBpaIrR`@		eFBH@c@@									2
:xjxyyerjyvxfxsVfziUjr1UtpuPwFlFsGSssOmgctgSZ@Txoc70k8FL!c0FL1a#9Q0VJ4G0FV1#2010	CHEMBL3695611	fm@P@@VjmIe[Ym^yYwhrVoART\vfjjjjjjejkcErBVhzART@	CC[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4[C@H](CO)C[C@H]3[C@@H]1CC[C@@]21C=CC(=O)O1	6	group3-int	int	Androgen Receptor	Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.	2015	fn{@@@LddTRRRLJTrVhKdmVCDmZjjjjjjjj`@@	fn{A`@@IZdrmkZvmkQdeV\FIZmMUUUUTmUTXaITM@h@	370.487	2.8217	4	1	63.6	2	-0.3198414312427924	0.45940537897636713	-0.10887828421505594	14	11	fm@Q@J^zlGbEqrJQRJIKPzHqIIGdeNtYNQsjjjiijjZfjfHVDINTTe@@		eMBD@ch@									2
:xjxyyerjyvxfxsVfzDUjr1UtpuPwFlFsGSssOmgctgS4@Txo870k8FL!c0FL1a#8Q0VJ4G0FV1$F!	CHEMBL3695612	em`PL@@@JelbbRfdRJRfbTVVhxdTtL|BRJFfZZjjjjjjVjicaZHqNPIIH@	CC[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4C4(CC4)C[C@H]3[C@@H]1CC[C@@]21C=CC(=O)O1	7.38	group2-a	a	Androgen Receptor	Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.	2015	fio@@@LddTRRRLJTTRNhKdmVCGIV}jjjjjjjjjj@@	fioA`@@EGdTRTtbQRTrTrUNRUhw`irwkSUUUUUTmUUNKRLgQJ@@	366.499	3.7867	3	0	43.37	1	-1.3910342640822686	-0.24045696315298204	0.8101666363005399	2	2	feAb@J^fAqrJQRJIKPyZJIG\djvcQRVoQuUUTtuUMMUUDKBEKHJ@@	eMBD@ch@										2
:xjxyyerjyvxfxsVfziUjr1UtpuPwFlFsGSssOmgctgSZ@Txoc70k8FL!c0FL1a#9Q0VJ4G0FV1#2010	CHEMBL3695613	feo@P@@VkOHhdieELeiheBeQdm^BdoQmMUUUUUTmU\XnPRuGPJR`@	C[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4[C@H](CO)C[C@H]3[C@@H]1CC[C@@]21C=CC(=O)O1	6	group3-int	int	Androgen Receptor	Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.	2015	fn{@@@LddTRRRLJTrVhKdmVCDmZjjjjjjjj`@@	fn{A`@@IZdrmkZvmkQdeV\FIZmMUUUUTmUTXaITM@h@	356.46	2.3673	4	1	63.6	1	-0.5308676294368398	0.9054075539728146	-0.1604346444250291	14	11	fm@Q@J^zlGbEqrJQRJIKPzHqIIGdeNtYNQsjjjiijjZfjfHVDINTTe@@		eFBH@c@@									2
:xjxyyerjyvxfxsVfzDUjr1UtpuPwFlFsGSssOmgctgS4@Txo870k8FL!c0FL1a#8Q0VJ4G0FV1$F!	CHEMBL3695614	feA`@@UgdTRTtbQRTtRaRirRmF|EI^cZZjjjjjiZjf\VdYN`Te@@	C[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4C4(CC4)C[C@H]3[C@@H]1CC[C@@]21C=CC(=O)O1	7.43	group2-a	a	Androgen Receptor	Binding Assay: The test was carried out as in 1., with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.	2015	fio@@@LddTRRRLJTTRNhKdmVCGIV}jjjjjjjjjj@@	fioA`@@EGdTRTtbQRTrTrUNRUhw`irwkSUUUUUTmUUNKRLgQJ@@	352.472	3.3323	3	0	43.37	0	-1.6020604622763162	0.20554521184346544	0.7586102760905666	2	2	feAb@J^fAqrJQRJIKPyZJIG\djvcQRVoQuUUTtuUMMUUDKBEKHJ@@	eFBH@c@@										2
xvojcyqXbEue9cx0VAzeCj_1qOoXPw0GFs0Ost12g8tZF0PRNoc50F!F!V0F2520V01Q1#F!V$2010	CHEMBL369979	fnk@`@@MrJIJYQIIIPqJgIZ}GMZjZjjfjjjIA\TUe@@	C=CC[C@]12CC[C@H](O)CC1=CCC1C2CC[C@@]2(C)C1CC[C@@H]2O	5.75	group4-ia	ia	Androgen Receptor	Inhibitory activity against AR	2006	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@DjVU]{ZBxhuoAZjjjjjh@@	316.483	4.0758	2	2	40.46	2	-1.2489194653269236	-0.5195496675571513	-1.5139209139152405	35	20	fjcAA@B`|WNNQQRIHsIREKDyIUoIsUUUUUUULaBr`@	gC`HL@IVt@@	eFJB@Hp@									20
xvojcyqXbEue9cx0VAzeCj_1qOoXPw0GFu0Ost12g8OZF0PRNoc50F!F#1G2520V0WO1#F!V$2010	CHEMBL369991	fa{@`@@]RYVvUUYyz\UhLRmjijijjjjjIA\dTUPt`	CC/C=C\[C@]12CC[C@H](O)CC1=CCC1C3CC[C@H](O)[C@@]3(C)CCC12	5.42	group4-ia	ia	Androgen Receptor	Inhibitory activity against AR	2006	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@DjVU]{ZBxhuoAZjjjjjh@@	330.51	4.4635	2	2	40.46	2	-1.1932921512410908	-0.8046315090166688	-1.4888192313646542	35	20	fjcAA@B`|WNNQQRIHsIREKDyIUoIsUUUUUUULaBr`@	gJPHL@IRmP`P	eFJB@Hp@									20
xvwjcyqXbEue9cx0VAzeCj_1qOoXPw2GFu0Ott12g8OZF0PRNqc50F!F#1G2522V0WO1#F!V$2010	CHEMBL370236	fnk@b@@mADYDeHhhddbhXeHvk^cfluSUUUUUUDpkJJrhP`	C[C@]12CCC3C(CC=C4C[C@@H](O)CC[C@@]43/C=C/Cl)C1CC[C@@H]2O	5.84	group4-ia	ia	Androgen Receptor	Inhibitory activity against AR	2006	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@DjVU]{ZBxhuoAZjjjjjh@@	336.901	3.7447	2	2	40.46	1	-1.2843532752833433	-0.27540196697393693	-1.5081560362165671	35	20	fjcAA@B`|WNNQQRIHsIREKDyIUoIsUUUUUUULaBr`@	gC`DADX@RVXRP	eFJB@Hp@									20
:UvEItl9NBmVo3DHc2dXO6HF0GId390VLmZ58XV39lO6FKW0@9X165Jl0c81RnGV9020bV6!8BFF4510V8F0	CHEMBL3706874	fj}QC@EAlBPQHXdLbdLTRbVVRrdhshijiB`RjjJBZ@@	CCC1CCc2cc3c(C(F)(F)F)cc(=O)[nH]c3cc2N1	7.85	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	foQ@@@DjYUU}`nRlzjjjjj`@@	foQQ@@DZ@drmjjtYIUgMR@EUD@@	296.291	2.3062	3	2	41.13	2	-1.0164270729752864	0.7448880304827613	-1.4661181072707479	38	10	fj}QB`DFbCqDxidLrAYAIeYWUYzhqVg^jhHBifjH@@		eMBD@ch@									2
zyQn6IOl8F4k0J3BF82WVN2H!FF139!LmZ58V029k96FGV029X125Jl0c81RlGV9020YV4!8BFF4410V8F0	CHEMBL3706875	fleQC@E^lBPQHXdLbdLTRbVJRdhsjjPhDjh@@	CCCNc1ccc2c(C(F)(F)F)cc(=O)[nH]c2c1	7.5	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	270.253	2.0173	3	2	41.13	4	-0.8228807248194309	0.7734694340707277	-1.4582546216356105	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gJPBAHJPt`PAIjj@@	gJXH@`AJ^j@@									37
zTPn6I9l8F4k0F34F82WVN2H!FF139!LmZ58V!8k96FGV029X125Jl0c81Jl1V1020YV4!8BFF4411V8k0	CHEMBL3706876	f`qQC@E^lBPQHXdLbdLTRbVLeF]URE@e@@@	Nc1ccc2c(C(F)(F)F)cc(=O)[nH]c2c1	7.55	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	228.173	0.8323	3	2	55.12	1	-1.2393254330138612	2.106966708181866	-1.5763828461688763	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gJPBAHJPt`PAIjj@@	eFbB@Hp@									37
zTPn6I9l8F4k0F34F82WVN2H!FF139!LmZ58V028k96FGV029X125Jl0c81RlGV1020YV4!8BFF4410V8F0	CHEMBL3706877	fhiQC@E^lBPQHXdLbdLTRbVJdhsjjPhDj@@@	CNc1ccc2c(C(F)(F)F)cc(=O)[nH]c2c1	7.52	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	242.199	1.1566	3	2	41.13	2	-1.2471961001206768	1.6365582874716686	-1.5611166194481017	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gJPBAHJPt`PAIjj@@	eMbA@Hz@									37
zTPn6I9l8F4k0F34F82WVN2H!FF139!LmZ58V028k96FGV029X125Jl0c81RlGV9020YV4!8BFF4410V8F0	CHEMBL3706878	fdyQC@E^lBPQHXdLbdLTRbVJTeF]URE@eT@@@	CCNc1ccc2c(C(F)(F)F)cc(=O)[nH]c2c1	7.46	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	256.226	1.5629	3	2	41.13	3	-1.0339067679111782	1.2194714242360016	-1.5098109310081818	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gJPBAHJPt`PAIjj@@	gChH@`AJZ`@									37
:Un7Itl9F4k0J3DF82WXN2H!FFW39!LmZ58V029k96FGV029X125Jt0c81RlGV9020YV4!8BFF4410V8F0	CHEMBL3706879	fbuQC@E^lBPQHXdLbdLTRbVJRTeF]URE@eUP@@	CCCCNc1ccc2c(C(F)(F)F)cc(=O)[nH]c2c1	7.17	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	284.28	2.4717	3	2	41.13	5	-0.6118545266253834	0.32746725907428015	-1.4066982614256374	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gJPBAHJPt`PAIjj@@	gGXH@`AJ]jh@									37
zTPn6I9l8F4kVF34F82WVN2H!FF1390VLmZ58VV28k96FGV029X125Jl0c81RlGV9020YV4!8BFF4410V8F0	CHEMBL3706880	fleQC@E^lBPQHXdLbdLTRbVJTdhsjjPhDjh@@	CC(C)Nc1ccc2c(C(F)(F)F)cc(=O)[nH]c2c1	7.25	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	270.253	1.9222	3	2	41.13	3	-0.9769433775796295	0.9514623517978205	-1.4848573044395983	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gJPBAHJPt`PAIjj@@	gJXH@`AJZj@@									37
zyQv6IOn8F4k0L3BF8HWVO2H!FF139!MmZ58V029k96FGV429X165Jl0c81RlGV9020YV4!8BFF4Z10V8F0	CHEMBL3706881	fbuQC@E^lBPQHXdLbdLTRbVJRdeF]URE@eUP@@	CC(C)CNc1ccc2c(C(F)(F)F)cc(=O)[nH]c2c1	7.13	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	284.28	2.2356	3	2	41.13	4	-0.7592830585094535	0.5902221361384143	-1.4340357601138864	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gJPBAHJPt`PAIjj@@	gGXH@`AJ^jh@									37
zyQv6IOn8F4k0L3BF8HWVO2H!FF139!Mmo58V029k96FGVB29X165Jl0c81RlGV9020nV4F08BFF4Z10V8F0	CHEMBL3706882	fjmQC@E^lBPQHXdLbdLTRbVJRddhsjjPhDjj`@@	CC(C)(C)CNc1ccc2c(C(F)(F)F)cc(=O)[nH]c2c1	7.01	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	298.307	2.8014	3	2	41.13	4	-0.7120354309372017	0.19807582286966108	-1.4080059173940354	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gJPBAHJPt`PAIjj@@	gNxH@`AJ^jj`@									37
zyQnDItl8N4kVJ3BFcHWVN2H!FG1390VLmp58VV29k96FGV029X125Jl0c81RlGV9020YVZ!8BFF4410V8F0	CHEMBL3706883	fjmQC@E^lBPQHXdLbdLTRbVJTbdhsjjPhDjj`@@	CCC(C)(C)Nc1ccc2c(C(F)(F)F)cc(=O)[nH]c2c1	6.68	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	298.307	2.7572	3	2	41.13	4	-0.7099558018538893	0.22464655305188286	-1.4082362635864432	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gJPBAHJPt`PAIjj@@	gNxH@`AJZzj`@									37
zTPn6I9l8F4kVFA4F8HWVN2H!FF1390VLmo58VV28k96FGV029X125Jp0cc1RlGV9020YVZ!8BFF4410V8F0	CHEMBL3706884	fjmQC@E^lBPQHXdLbdLTRbVJTbdhsjjPhDji`@@	C=CC(C)(C)Nc1ccc2c(C(F)(F)F)cc(=O)[nH]c2c1	6.91	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	296.291	2.5717	3	2	41.13	4	-0.7118446796856739	0.34363558200663524	-1.4125203176728671	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gJPBAHJPt`PAIjj@@	gNxH@`AJZzjP@									37
:UnEItl9N4kVJ3DFc2WXN2H!FGW390VLmZ58VV29k96FKW029X125Jt0c81RlGV9020YV4!8BFF4410V8F0	CHEMBL3706885	fbmQC@E^lBPQHXdLbdLTRbVJTTeF\gMUHTBUUD@@	O=c1cc(C(F)(F)F)c2ccc(NC3CCC3)cc2[nH]1	7.37	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	f`i@@@LdbbRRQtSA\d{uUUUUUP@@	f`iQ@@DZ@drmj{MFRT{sT`AUTP@@	282.264	2.0283	3	2	41.13	3	-0.918683224022316	0.8431398531570714	-1.4645404474457642	1	1	fbmQC@E^lBPQHXdLbdLTRbVJTTeF\gMUHTBUUD@@											1
:UvjItt9NBmWo3DFc2dXN2HF0GIW390VLmZ58VV29k96FKW029a125Jt0c81RlGV9020YV4!8BFF4410V8F0	CHEMBL3706886	fj}QC@E^lBPQHXdLbdLTRbVJTRdhslejiB`RjjH@@	O=c1cc(C(F)(F)F)c2ccc(NC3CCCC3)cc2[nH]1	6.83	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	fhy@@@LdbbRRQtRXKdoAjjjjjj`@@	fhyQ@@DZ@drmj{KQde^BuH@UUQ@@@	296.291	2.3703	3	2	41.13	3	-0.8609058597241201	0.5855306557815548	-1.4396769791681185	1	1	fj}QC@E^lBPQHXdLbdLTRbVJTRdhslejiB`RjjH@@											1
:UvjQztCNBnWoYDFd2dXN6HF0GQ_390VTmZ58VV29k96FKW029X125Jt0c81RlGV9020YWB!8BFF4410V8F0	CHEMBL3706887	ffcQC@E^lBPQHXdLbdLTRbVJTRTeF\VmUHTBUUTP@@	O=c1cc(C(F)(F)F)c2ccc(NC3CCCCC3)cc2[nH]1	6.29	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	fde@@@LdbbRRQtRSA\dFMUUUUUU@@@	fdeQ@@DZ@drmj{JtYIPXmR@EUUD@@	310.318	2.7123	3	2	41.13	3	-0.8031283347147684	0.32792134523735167	-1.4148134606743255	1	1	ffcQC@E^lBPQHXdLbdLTRbVJTRTeF\VmUHTBUUTP@@											1
:Qv6IOn8F4k0H3BH82WVO2H!FF139!LmZ58X029kO6FGVB29X165Jl0c81RlGV9020YV4F08BFF4510V8F0	CHEMBL3706888	fjmQA`E^lBPQHXdDrFY@ladTabbTRqRTdeF]URE@eUT@@@	O=c1cc(C(F)(F)F)c2ccc(NCC(F)(F)F)cc2[nH]1	7.68	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	310.197	2.0472	3	2	41.13	4	-0.6139351166724643	0.6073702525219864	-1.3923716361310106	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gJPBAHJPt`PAIjj@@	gNxBJIARFdF@YEHUUT@@									37
:UvEQOn9J6k0qYTH83WXO2HX0FF3I9!Mm_58X029kODFGXB3AX165Rt0e81RlGV9020YV4F08BFF4510V8F0	CHEMBL3706889	fasQ@PE^lBPQHXdDrFYBl`vP{HYEHXheDlTeHYIJLzjdJAJjjh@@	O=c1cc(C(F)(F)F)c2ccc(NCC(F)(F)C(F)(F)F)cc2[nH]1	7.24	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	360.204	2.7562	3	2	41.13	5	-0.22541064809576192	-0.12510945145646366	-1.2802839515786182	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gJPBAHJPt`PAIjj@@	def@XABPRPrPjPZPd@rJPrEUUU@@									37
zTPn6I9l8F4k0F34FN2WVN2H!FF139!LmZ58V02Nk96FGV029X125Jl0c81RlGV9020YV4!8BFF4410V8F0	CHEMBL3706891	fnsQC@E^lBPQHXdLbdLTRbVJRbRdhsjmjiB`Rh@H@@@	O=c1cc(C(F)(F)F)c2ccc(NCc3ccccc3)cc2[nH]1	6.53	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	flu@@@LdbbRRQrbRXKdhijjjjjjj@@	fluQ@@DZ@drmjzrmFRUEKT`AT@D@@@	318.297	2.5747	3	2	41.13	4	-0.5960981425821756	0.26022697599295097	-1.3762941705858422	1	1	fnsQC@E^lBPQHXdLbdLTRbVJRbRdhsjmjiB`Rh@H@@@											1
zTPn6I9l8F5k0F35F82WVN2H04FF139!LmZ58V028k96FGV02OX125Jl0c81RlGV1020YV4!8BGG4610V8F0	CHEMBL3706892	fdyQC@E^lBPQHXdLbdLTRbVJdeF]URE@eT@@@	CN(C)c1ccc2c(C(F)(F)F)cc(=O)[nH]c2c1	5.94	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	256.226	1.406	3	1	32.34	2	-1.6025225224709636	1.384015877452845	-0.4723857316168726	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gJPBAHJPt`PAIjj@@	gChHA`BOT@@									37
zyPnTI9l8F5k0FA5F82lVN@H04FF1Y980LuZ58V028k96FGV02OX125Jl0c81RlGV9030YV4!8BGG4610V8F0	CHEMBL3706893	fbuQC@E^lBPQHXdLbdLTRbVJbTeF]URE@eUP@@	CCN(CC)c1ccc2c(C(F)(F)F)cc(=O)[nH]c2c1	6.23	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	284.28	2.2186	3	1	32.34	4	-1.1759440243719779	0.5498421924877115	-0.369774404331926	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gJPBAHJPt`PAIjj@@	gGXHA`AJejh@									37
:UvTQOn8J5k0HfCH82lkOAH04FF1Y980LuZ78X029kO6FGVBHOX165Jl0c8GRlGV9030YV4F08BGG4710V8F0	CHEMBL3706894	fncQA`E^lBPQHXdBrEYAladTabbTRqTRTdeF]URE@eUUP@@	CCN(CC(F)(F)F)c1ccc2c(C(F)(F)F)cc(=O)[nH]c2c1	7.38	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	338.25	2.7029	3	1	32.34	5	-0.7559775102813981	-0.062255286165839446	-0.2523367169927358	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gJPBAHJPt`PAIjj@@	diF@HJBPRPrPx@rJPjJjj`@									37
:UvyQSn@J_k2LfCH@2lkOAH04FF1Y9B8LuZ78X1X9kO6FIVBHOX165Jl0c@GRlGV9030YV4F08BGG4710V8F0	CHEMBL3706895	fasQA`E^lBPQHXdBrEYAladTabbTRqTRTbdhsjjPhDjjj`@@	CCCN(CC(F)(F)F)c1ccc2c(C(F)(F)F)cc(=O)[nH]c2c1	6.26	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	352.277	3.1573	3	1	32.34	6	-0.5449513120873506	-0.508257461162287	-0.2007803567827626	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gJPBAHJPt`PAIjj@@	def@HJBPRPrPx@rJPjKUUU@@									37
zTPn6I9l8F4k0F34F82WVN2H!FF139!LmZ58V038k96FGV029X125Jl0c81Rl1V9020bV6!8BFF4411V8k0	CHEMBL3706896	fhiQC@EAlBPQHXdLbdLTRbVVdhsjjPhDj@@@	Cc1cc2c(C(F)(F)F)cc(=O)[nH]c2cc1N	7.12	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	242.199	1.1762	3	2	55.12	1	-1.1816426082193279	1.8482189396594775	-1.5515110829459497	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gJPBAHJPt`PAIjj@@	eFbB@Hp@	eFBH@c@@								37
zTPn6I9l8F4k0F34F82WVN2H!FF139!LmZ58V038k96FGV029X125Jl0c81RlGV9020bV6!8BFF4411V8k0	CHEMBL3706897	fdyQC@EAlBPQHXdLbdLTRbVVTeF]URE@eT@@@	CCc1cc2c(C(F)(F)F)cc(=O)[nH]c2cc1N	7.64	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	256.226	1.5918	3	2	55.12	2	-0.9687908452788907	1.4255413991835475	-1.5001569279713716	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gJPBAHJPt`PAIjj@@	eFbB@Hp@	eMBD@ch@								37
zTPn6Idl8F4k0F34F82WVN2H!FF139!LmZ58V038k96FGV0@9X125Jl0c81RnGV9020bV6!8BFF4411V8k0	CHEMBL3706898	fleQC@EAlBPQHXdLbdLTRbVVVdhsjjPhDjh@@	CCCc1cc2c(C(F)(F)F)cc(=O)[nH]c2cc1N	7.72	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	270.253	2.0462	3	2	55.12	3	-0.7577648077959992	0.9795393373557868	-1.448600617977546	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gJPBAHJPt`PAIjj@@	eFbB@Hp@	gC`HL@IST@@								37
zTPn6Idl8N4k0FA4F8HWVN2H04Fk139!LmZ58V038k96FGV0@9X125Jl0c81RnGV90@0bV6!8BGN4611V8k0	CHEMBL3706899	fbuQC@EAlBPQHXdLbdLTRbVVTteF]URE@eUQCu@@	CCC(C)c1cc2c(C(F)(F)F)cc(=O)[nH]c2cc1N	7.85	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	284.28	2.4737	3	2	55.12	3	-0.7040100999293638	0.6705318280994927	-1.423291519731568	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gJPBAHJPt`PAIjj@@	eFbB@Hp@	gJPHL@ITuTE@@								37
zyQn6IOl8F4k0J3BF82WVN2H!FF939!LmZ58V039k96FGV029X125Jl0c81RlGV9020bV6!8BFF4410V8F0	CHEMBL3706900	fbuQC@EAlBPQHXdLbdLTRbVVrTeF]URE@eUP@@	CCCNc1cc2[nH]c(=O)cc(C(F)(F)F)c2cc1C	6.17	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	284.28	2.3612	3	2	41.13	4	-0.7651926049700356	0.5147178234879444	-1.4333812003479283	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gJPBAHJPt`PAIjj@@	gJXH@`AJ^j@@	eFBH@c@@								37
zyQv6IOn8F4k0L3BF8HWVO2H!FF939!MmZ58V039k96FGV429X165Jl0c81RlGV9020bV6!8BFF4Z14V8F0	CHEMBL3706901	fjmQC@EAlBPQHXdLbdLTRbVVrTdhsjjPhDjj`@@	Cc1cc2c(C(F)(F)F)cc(=O)[nH]c2cc1NCC(C)C	6.52	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	298.307	2.5795	3	2	41.13	4	-0.7015949274423469	0.3314706688806046	-1.4091623400687128	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gJPBAHJPt`PAIjj@@	gGXH@`AJ^jh@	eFBH@c@@								37
zTPn6I9l8F4k0F34F82WVN2H!FF139!LmZ58V038k96FGV029X125Jl0c81RlGV9020bV6!8BFF4410V8F0	CHEMBL3706902	fleQC@EAlBPQHXdLbdLTRbVVRdhsjjPhDjh@@	CCc1cc2c(C(F)(F)F)cc(=O)[nH]c2cc1NC	6.3	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	270.253	1.9161	3	2	41.13	3	-0.9766563724331445	0.9551293212441285	-1.484889094023243	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gJPBAHJPt`PAIjj@@	eMbA@Hz@	eMBD@ch@								37
:Qv6IOn8F4k0H3BH82WVO2H!FF939!LmZ58X039kO6FGVB29X165Jl0c81RlGV9020bVLF08CFF4514V8F0	CHEMBL3706903	fncQA`EAlBPQHXdBrEYAladTabbTRrrVTdeF]URE@eUUP@@	CCc1cc2c(C(F)(F)F)cc(=O)[nH]c2cc1NCC(F)(F)F	6.67	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	338.25	2.8067	3	2	41.13	5	-0.34340053174192187	-0.07405509230757598	-1.3161457176228786	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gJPBAHJPt`PAIjj@@	gNxBJIARFdF@YEHUUT@@	eMBD@ch@								37
:vz6MOn8k4k433BH82_VO2H!FF13920LHZ58e029kO6FGVB29X16KLl0c89RkGV9020YV4J0@BJF4550V8F0	CHEMBL3706904	fjm`a`OJlBPQHXdDrFY@ladTabbTRqRTdeF]URE@eUT@@@	O=c1cc(C(F)(F)F)c2ccc(NCC(F)(F)F)cc2o1	7.3	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	dmL@@DjYUVGijjjj@@	dmLD@@QIe[VfeVi@B@@	311.181	2.5975	3	1	38.33	4	-0.9557636539926236	0.26624756486978807	-0.308287560525049	41	4	dk\DPFTODwEIe[VZz]`BJZD@@	gJPBAHJPt`PAIjj@@	gNxBJIARFdF@YEHUUT@@									4
<yUSn@o_k63fCH@2pktAH04FF1b9D0LPZ78e1X9kO6FIkBHOX16KLl0c8ORkGV9030YV4J0@BKG475!8!	CHEMBL3706905	fe{`bPOJlBPQHXdBrEYAlavPGHSdLbdLTRbVJbRdTdeF]URE@eUUUP@@	O=c1cc(C(F)(F)F)c2ccc(N(CC(F)(F)F)CC(F)(F)F)cc2o1	7.2	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	dmL@@DjYUVGijjjj@@	dmLD@@QIe[VfeVi@B@@	393.205	3.7375	3	0	29.54	6	-0.6778343907539879	-1.0154790738695665	0.9491866528691425	41	4	dk\DPFTODwEIe[VZz]`BJZD@@	gJPBAHJPt`PAIjj@@	dcv@xJBPRPrPx@fPVPvPrJPjKRUUUT@@									4
zTPn6I9l8F4k0F34F82WVN2H!FF138!LmZ58V038k96FGV029X104Jl0V81RlGV9020bV6!8BF04410V8F0	CHEMBL3706906	fdyQC@E^lBPQHXdLbdLTRbVQTeF]URE@eT@@@	CCNc1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1	6.96	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	256.226	1.5629	3	2	41.13	3	-1.0339067679111782	1.2194714242360016	-1.5098109310081818	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gJPBAHJPt`PAIjj@@		gChH@`AJZ`@								37
:Qv6IOn8F4k0H3BH82WVO2H!FF138!LmZ58X039kO6FGVB29X144Jl0V81RlGV9020bV6F08BF04510V8F0	CHEMBL3706907	fjmQA`E^lBPQHXdDrFY@ladTabbTRrJTdeF]URE@eUT@@@	O=c1cc(C(F)(F)F)c2cc(NCC(F)(F)F)ccc2[nH]1	7.75	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	310.197	2.0472	3	2	41.13	4	-0.6139351166724643	0.6073702525219864	-1.3923716361310106	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gJPBAHJPt`PAIjj@@		gNxBJIARFdF@YEHUUT@@								37
:UvEQOn9J6k0qYTH83WXO2HX0FF3I8!Mm_58X039kODFGXB3AX144Rt0X81RlGV9020bV6F08BF04510V8F0	CHEMBL3706908	fasQ@PE^lBPQHXdDrFYBl`vP{HYEHXheDlbeHYIJLzjdJAJjjh@@	O=c1cc(C(F)(F)F)c2cc(NCC(F)(F)C(F)(F)F)ccc2[nH]1	7.77	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	360.204	2.7562	3	2	41.13	5	-0.22541064809576192	-0.12510945145646366	-1.2802839515786182	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gJPBAHJPt`PAIjj@@		def@XABPRPrPjPZPd@rJPrEUUU@@								37
:UvjItt9NBmWo3DFc2dXN2HF0GIW380VLmZ58VV39k96FKW029a104Jt0V81RlGV9020bV6!8BF04410V8F0	CHEMBL3706909	fj}QC@E^lBPQHXdLbdLTRbVQTRdhslejiB`RjjH@@	O=c1cc(C(F)(F)F)c2cc(NC3CCCC3)ccc2[nH]1	7.38	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	fhy@@@DjYU_yVRxKpZjjjjjh@@	fhyQ@@DZ@drmkkKQde^BuH@UUQ@@@	296.291	2.3703	3	2	41.13	3	-0.8609058597241201	0.5855306557815548	-1.4396769791681185	1	1	fj}QC@E^lBPQHXdLbdLTRbVQTRdhslejiB`RjjH@@											1
zyQv6IOn8F4k0L3BF8HWVO2H!FF138!MmZ58V039k96FGV429X144Jl0V81RlGV9020bV6!8BF04Z10V8F0	CHEMBL3706910	fbuQC@E^lBPQHXdLbdLTRbVQRdeF]URE@eUP@@	CC(C)CNc1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1	7.66	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	284.28	2.2356	3	2	41.13	4	-0.7592830585094535	0.5902221361384143	-1.4340357601138864	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gJPBAHJPt`PAIjj@@		gGXH@`AJ^jh@								37
zyQv6IOn8F4k0L3BF8HWVO2H!FF138!Mmo58V039k96FGVB29X144Jl0V81RlGV9020rV6F08BF04Z10V8F0	CHEMBL3706911	fjmQC@E^lBPQHXdLbdLTRbVQRddhsjjPhDjj`@@	CC(C)(C)CNc1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1	7.57	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	298.307	2.8014	3	2	41.13	4	-0.7120354309372017	0.19807582286966108	-1.4080059173940354	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gJPBAHJPt`PAIjj@@		gNxH@`AJ^jj`@								37
>U:ppxUQfUTD@pmtQQa5LF1Ygh0LvZ78e1n9oOaHIcBLOeW44Jt0VtGRlQl90Y0bk6F0cBG14710V8F0	CHEMBL3706928	fmgQa`E^lVhIADabP[H]dArFQRFJIQKHqIQRZrTYuUHTBUTuUP@@	CCOC(=O)CN(CC(F)(F)F)c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1	7.72	group2-a	a	Androgen Receptor	Antagonist activity at human AR	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	396.286	2.2608	5	1	58.64	8	0.9586491130392967	0.06044637079695225	0.1632127585886469	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gJPBAHJPt`PAIjj@@		dkNDHJePdDdLdN@LbdJbtrjjij@@								37
:UvyvSreJ_s2HfCU@@lktAH0BFJ1bBB0LuaE@X1YAqS6FIkDHOXG44Kl8V8GRlGV913VbV7F08BG1JE10V8F0	CHEMBL3706929	fmgPbPE^ldD`bPqHUdFrGY@\aNPWHYEHXheDlcEEiEIIQgUTaPITuUU@@@	O=C(N(CC(F)(F)F)c1ccc2[nH]c(=O)cc(C(F)(F)F)c2c1)C(F)(F)F	8.39	group1-p	p	Androgen Receptor	Antagonist activity at human AR	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	406.204	2.8376	4	1	49.41	5	0.11488462939094518	-0.14916032894943237	-0.007822030110227744	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gJPBAHJPt`PAIjj@@		dkNHxFhIAICI@PAYCY@yCHiCMEiJijj`@								37
:Uvzv;S:vyvvUrCvzfzCzUjUboSSzjx@DbnbTMvqdoyvqSqCqzDxDjRYq5iyfgApoVLC2SGk9GNOcV0V!	CHEMBL371392	e`RRL@@DL@f`EBlbbbbbRbVNRbtrVRUCFea`WdRvsUTCTDTv@EUTFCDxVb@@	CCCCc1ccc(C(=O)N2C[C@@H]3C[C@H]2[C@@H]2C(=O)N(c4ccc(C#N)cc4)C(=O)N32)cc1	5.17	group4-ia	ia	Androgen Receptor	In vitro antagonistic activity against mutant androgen receptor of LNCap cells	2004	feo@@@LdbbRbbvLRLTrWCBTxOhcgUUUUUUUUUT@@	feoq`@DXBAV\bbbbbRbVNttRUFZlXOhcfuU@uADp@UAadxmH@	428.491	3.721	7	0	84.72	5	1.2168954797587994	-0.1274216823755812	1.4756932845859405	5	5	eol\LH@NMDeCB`GGHhdlhhilhbihdldjFMKOH`dieh@JfZji`@jbhplSb|P@	eMbA@Dg`@										2
:UvztU:KzxvTvUUzEmIftUDBXR5mOSzEeD6jnbQA3ycF3e6JJW4C@g8wF3kEcu285O6WF6010F1G07VcVcFF	CHEMBL372390	eh\ZHF@JEKL`S@IABPpdKiAzP~dLbdLRVRfbbVVbRfTbDdRrfVj`@ijjj@BjlaAqIH@	C[C@H]1CN(c2ccc(C#N)c(C(F)(F)F)c2)[C@H](C)CN1C(=O)Nc1ccc(C(F)(F)F)nc1	5.89	group4-ia	ia	Androgen Receptor	Inhibition of AR mediated transcriptional activation using reporter assay	2006	fj}@@@DjYU_yyWbiZrVjjjjjjj`@@	fj}I@@DXtXBSLjsj}jKUoYJuUPPP@D@@@	471.404	4.1671	6	1	72.26	4	1.094245594078526	-0.6600310770948288	0.3155382606421468	23	18	eh\ZHN@JIKL`S@@dbAX|UGFzP^dOiAIf[u{fW^UmixDRrfV`bBijjj@BjlaAqIH@				gJPBAHJPt`PAIjj@@							1
xvojcyqXbEue9cx0VAzeCj_1qOoXPw0GFu0Ost12g8OZF0PRNoc50F!F#1G2520V0WO1#F!V$2010	CHEMBL373019	ffs@`@@URYVvU]nVgEZ|EIZjZjZjjjhdErART@	C=C[C@]12CC[C@H](O)CC1=CCC1C2CC[C@@]2(C)C1CC[C@@H]2O	7.48	group2-a	a	Androgen Receptor	Inhibitory activity against AR	2006	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@DjVU]{ZBxhuoAZjjjjjh@@	302.456	3.6214	2	2	40.46	1	-1.4599456747386825	-0.07354763588567725	-1.565477272882705	35	20	fjcAA@B`|WNNQQRIHsIREKDyIUoIsUUUUUUULaBr`@	eMBD@cX@	eFJB@Hp@									20
;j;irUzjQwxdh7zPEbx9MQaYmR0OPcZQsm11Z29Zk48SN4F4FF0V09402#2#NF08+2010	CHEMBL373460	ea]XL@@DPAh\bbRfbTrRTrbRNRRRTtVUCBfgdQSSUUUUUUUUUUMUUUppaDhmHyHdT`@	CCCCN(C)C(=O)CCCCCCCCCCC[C@@H]1CC2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@@H]21	5.46	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor expressed in HeLa cells assessed as inhibition of dihydrotestosterone-induced transcriptional activity by reporter gene assay	2007	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmUUUUUUXDePt@@	557.9	9.1274	4	1	57.61	15	2.335064402529367	-5.640889284111008	0.5565133849081462	50	9	ffs@b@Bu@xyEEDhheDhdbV\d{tTyjjjjjjijfHQIR\Tey@@	fbyaB@D@r@ILrzkjjmUUUUUP@@										9
tf4@cPaX6Cu28ck!2K@5X_0FFZV2J0FFc080F1!48$J/!2%1*2!4!	CHEMBL375107	dcL@H@qBqIqMqDfYwmnjjjj@@	BrCC(Br)C1CCC(Br)C(Br)C1	7.37	group2-a	a	Androgen Receptor	Activity against human androgen receptor expressed in HepG2 cells assessed as luciferase reporter gene activation	2006	gFp@DiTvjh@	gFp@DiTvjh@	427.799	4.2803	0	0	0	2	-2.3648315818143026	-1.5660122820969413	0.5636836664371465	19	1	dcL@H@qBqIqMqDfYwmnjjjj@@											1
;j;irUzjQwxdh7zPCbx9IOaYmR0OPcZQsm11Z29Zk48SN4F4FF0V09402#2#NF08+2010	CHEMBL375282	elVXL@@G`AklbbRfbTrRTrbRNRTtVhXTt|bJZZjjjjjjjjfjjk`bLHQZQrQHi@@	CCCN(C)C(=O)CCCCCCCC1C[C@H]2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12	6.52	group3-int	int	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells	2007	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmUUUUUUDIAITM@@	487.766	6.8554	4	1	57.61	10	1.2799387150272759	-3.410882143695434	0.2987332409911547	50	19	ffs@b@Bu@xyEEDhheDhdbV\d{tTyjjjjjjijnHQIRLWEI^P@	do^H`DApAIfWWUZjjjh@@										19
;j;irUzjQwxdh7zPEbx9MQaYmR0OPcZQsm11Z29Zk48SN4F4FF0V09402#2#NF08+2010	CHEMBL375675	enUXL@@HPA`\bbRfbTrRTrbRNRRRfbrhXTt|bJZZjjjjjjjjjfjjjxXPbTVd\dRJP@	CCCCN(C)C(=O)CCCCCCCCCC[C@@H]1CC2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@@H]21	5.72	group4-ia	ia	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells	2007	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmUUUUUUXDePt@@	543.873	8.673	4	1	57.61	14	2.1240380436241635	-5.194886995945873	0.5049569744820254	50	9	ffs@b@Bu@xyEEDhheDhdbV\d{tTyjjjjjjijfHQIR\Tey@@	fliaB@D@R@ILrzkjjuUUUUT@@										9
;j;irUzjOwxWh7zPCbx9IOaYmw0OPcgQsk10Z29ak48SN4F4FF#9422#20208F08+2010	CHEMBL376182	edZXL@@K`AclbbRfbTrRTrbRNRfbUCBfgdQSSUUUUUUUUSUUUpQFDHmHyHdT`@	CCN(CC)C(=O)CCCCCCC1C[C@H]2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12	6.48	group3-int	int	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells	2007	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmUUUUUUDIAITM@@	473.739	6.3529	4	1	57.61	9	1.0711758059509797	-2.9359648417693798	0.2469262598485304	50	19	ffs@b@Bu@xyEEDhheDhdbV\d{tTyjjjjjjijnHQIRLWEI^P@	dgnH`DBpCHhhddTduUUU@@										19
JNuF#18&408!VN(22!2!5%F$V02&VF!1$2F.10201F	CHEMBL378274	fluQB@IZbBHrJJIHqJIIIgCNBf@``@@`@@@	Oc1nnc(Cc2ccccc2Cl)c2ccccc12	4.07	group4-ia	ia	Androgen Receptor	Displacement of [3H]-DHT from human GST fused AR-LBD (627 to 919 amino acids) transfected in Escherichia coli HB 101 after 15 hrs by liquid scintillation counting assay	2015	fhy@@@LdbbbRubRYHRoAjjjjjj`@@	fhyP@@@PReeUYwHqUoA@HH@@@@@@	270.718	3.5058	3	1	46.01	2	-1.4051357445559556	0.16825567121145535	-0.4028004868777467	2	1	fluQB@IZbBHrJJIHqJIIIgCNBf@``@@`@@@											1
:xz5isG9i4s412yp8m5XN2H2sN0G3C20HHkS8802Wk9601a028Vl2GTt0e898VFVO028GV14V@0J4!5F$	CHEMBL3785926	fbu@P@@HMyIeYW][jcEZZdHBijh@@	Cc1cc(=O)oc2cc(OCC(=O)C(C)(C)C)ccc12	5.42	group4-ia	ia	Androgen Receptor	Antagonist activity against androgen receptor (unknown origin)	2016	dmL@@DjYUVGijjjj@@	dmLD@@QIe[VfeVi@B@@	274.315	2.5518	4	0	52.6	4	-0.949533634299142	0.6698334281108289	0.8424044967703124	41	4	dk\DPFTODwEIe[VZz]`BJZD@@	eFBH@c@@	diDD`@xPCHhiEVjj@@									4
:xzxyszSeDw_YjizcV5qT2P1dOTGYCX0HHVhBTk2Wo96F1V328kl2GMx0ch98cFV902!V04V@0o4015F$	CHEMBL3787387	fjmAP@@HLFJSJrn{LQbmMRDAUMUDKT@@	CCOC(=O)C(CC)Oc1ccc2c(C)cc(=O)oc2c1	5.3	group4-ia	ia	Androgen Receptor	Antagonist activity against androgen receptor (unknown origin)	2016	dmL@@DjYUVGijjjj@@	dmLD@@QIe[VfeVi@B@@	290.314	2.2835	5	0	61.83	6	-0.1423376917518131	0.7187012677166076	1.031585920110237	41	4	dk\DPFTODwEIe[VZz]`BJZD@@	eFBH@c@@	dedL`@Ra@DfVUZjjcB@@									4
zytrBqsl8e4kZ1Eglc0_VR2H0kNF13924LHV_88k21k96FGV1@BV1XKLp0cc98XFc90280V05X@8J4!5F$	CHEMBL3787517	fns@P@@HLGHhdhdllhhXdjLUjkViB@jf@BBEj@@	Cc1cc(=O)oc2cc(OC(C)C(=O)c3ccccc3)ccc12	5.29	group4-ia	ia	Androgen Receptor	Antagonist activity against androgen receptor (unknown origin)	2016	fj}@@@LdbbRRQrbfRXKdlejjjjjjjh@@	fj}@P@@HtyIe[UunUhrRleZd@Jf@B@@@	308.332	2.8248	4	0	52.6	4	-0.7832386751890591	0.3795742569109277	0.899801608231988	1	1	fns@P@@HLGHhdhdllhhXdjLUjkViB@jf@BBEj@@											1
xvwjcyqXbEue9cx0VAzeCj_1qOoXPw0GFu0Ott12g8OZF0PRNqc50F!F#1G2520V0WO1#F!V$2410	CHEMBL379441	fnk@b@@mAbYDeHhhddbhXeHvk^cfluSUUUUUUDpkJJrhPP	C[C@]12CCC3C(CC=C4C[C@@H](O)CC[C@@]43/C=C\Br)C1CC[C@@H]2O	7.7	group2-a	a	Androgen Receptor	Inhibitory activity against AR	2006	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@DjVU]{ZBxhuoAZjjjjjh@@	381.352	3.8757	2	2	40.46	1	-1.0564298432903434	-0.5189905610845111	-1.4343300006021522	35	20	fjcAA@B`|WNNQQRIHsIREKDyIUoIsUUUUUUULaBr`@	gC`DAbX@RVXRH	eFJB@Hp@									20
:UvztU:KzxvTvUUzEmIftUDBXR5mOSzEeD6jnbQA3ycF3e6JJW0C@g8wF3kEce285O6WF6010F1I07VdVckF	CHEMBL379465	eg`VHL@ECDfekj`IABPpdLbdLTRRLTRrtrbRtfdRVquTDFUUUM@ADHVJI@@	C[C@H]1CN(C(=O)Nc2ccc(N)nc2)[C@H](C)CN1c1ccc(C#N)c(C(F)(F)F)c1	6.43	group3-int	int	Androgen Receptor	Inhibition of AR mediated transcriptional activation using reporter assay	2006	fj}@@@DjYU_yyWbiZrVjjjjjjj`@@	fj}I@@DXtXBSLjsj}jKUoYJuUPPP@D@@@	418.422	2.9389	7	2	98.28	3	1.653858720457306	0.6934343615262504	-0.7360976230572986	23	18	eh\ZHN@JIKL`S@@dbAX|UGFzP^dOiAIf[u{fW^UmixDRrfV`bBijjj@BjlaArIP@				eFbB@Hp@							16
zvwjcyyXbjue9cx0VAzeCj_1qOoXPw0GFu0Ott12g8OZF0PRNqc50F!F#1G2520V0WO1#F!V$2010	CHEMBL380876	fa{A`@@Q{dbrdTTRRQTLRUXs`iJvfjZjjjjjhaDyIQUAB@	CO/C=C\[C@]12CC[C@H](O)CC1=CCC1C3CC[C@H](O)[C@@]3(C)CCC12	5.85	group4-ia	ia	Androgen Receptor	Inhibitory activity against AR	2006	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@DjVU]{ZBxhuoAZjjjjjh@@	332.482	3.0617	3	2	49.69	2	-0.7237076397766357	0.21930204807903292	-1.3808403521233181	35	20	fjcAA@B`|WNNQQRIHsIREKDyIUoIsUUUUUUULaBr`@	gJQH@PAJ^fDR@	eFJB@Hp@									20
;vztU:pzxvTvUUzEmIftUDBXR5mOSzEeD6jnbQA3ycF3e6JJW0C@g8wF3kEcu285O6WF6010F1G07VcVcFF	CHEMBL381253	eohZDL@ECDfejk`IABPpdLbdLTRRLTRrtrbRrdtbRvNj``rjjih@JHPlTR@@	COc1ccc(NC(=O)N2C[C@H](C)N(c3ccc(C#N)c(C(F)(F)F)c3)C[C@H]2C)cn1	6.77	group3-int	int	Androgen Receptor	Inhibition of AR mediated transcriptional activation using reporter assay	2006	fj}@@@DjYU_yyWbiZrVjjjjjjj`@@	fj}I@@DXtXBSLjsj}jKUoYJuUPPP@D@@@	433.433	3.5462	7	1	81.49	4	1.3167413578764995	0.042586528894004216	0.36186130334732297	23	18	eh\ZHN@JIKL`S@@dbAX|UGFzP^dOiAIf[u{fW^UmixDRrfV`bBijjj@BjlaArIP@				eMJA@Hz@							16
:UvztU:KzxvTvUUzEnIftUDBXR5mOSzEuD6jnbQAIycF3e6JJW0E@g8wF3kEcu285ODWF6010F1G07VcVcFF	CHEMBL381358	e`TZDL@ECDfejg`IABPpdLbdLTRRLTRrtrbRrdfdRVquTDFUUUM@ALPaXhd@@	CC(=O)c1ccc(NC(=O)N2C[C@H](C)N(c3ccc(C#N)c(C(F)(F)F)c3)C[C@H]2C)cn1	6.3	group3-int	int	Androgen Receptor	Inhibition of AR mediated transcriptional activation using reporter assay	2006	fj}@@@DjYU_yyWbiZrVjjjjjjj`@@	fj}I@@DXtXBSLjsj}jKUoYJuUPPP@D@@@	445.444	3.19	7	1	89.33	4	1.5228501357046889	0.269683140575537	0.3997249803269736	23	18	eh\ZHN@JIKL`S@@dbAX|UGFzP^dOiAIf[u{fW^UmixDRrfV`bBijjj@BjlaArIP@				gCaHA`AIf`@							16
;vztU:pzxvTvUUzEmIftUDBXR5mOSzEeD6jnbQA3ycF3e6JJW0C@g8wF3kEce285O6WF6010F1107VcVcFF	CHEMBL381558	eohZDL@ECDfejk`IABPpdLbdLTRRLTRrtrbRVdtbRvNj``rjjih@JHPlTR@@	COc1cncc(NC(=O)N2C[C@H](C)N(c3ccc(C#N)c(C(F)(F)F)c3)C[C@H]2C)c1	6.36	group3-int	int	Androgen Receptor	Inhibition of AR mediated transcriptional activation using reporter assay	2006	fj}@@@DjYU_yyWbiZrVjjjjjjj`@@	fj}I@@DXtXBSLjsj}jKUoYJuUPPP@D@@@	433.433	3.1948	7	1	81.49	4	1.3332749071552195	0.2538301974714901	0.3600299959502963	23	18	eh\ZHN@JIKL`S@@dbAX|UGFzP^dOiAIf[u{fW^UmixDRrfV`bBijjj@BjlaArIP@			eMJA@Hz@								16
xvojcyqXbEue9cx0VAzeCj_1qOoXPw0GFu0Sst12g8OZF0PRNoc70F!F#1G2520V0WO1#F!V$2V10	CHEMBL381566	fa{@`@@]rJQJQYFYJSIHlehw`u[U]UUUUMULRBpgQj@@	C#C[C@]1(O)CCC2C3CC=C4C[C@@H](O)CC[C@]4(C=C)C3CC[C@@]21C	6.54	group3-int	int	Androgen Receptor	Inhibitory activity against AR	2006	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@DjVU]{ZBxhuoAZjjjjjh@@	326.478	3.5403	2	2	40.46	1	-1.3296256007151437	-0.11387542755670377	-1.5263721320618853	35	20	fjcAA@B`|WNNQQRIHsIREKDyIUoIsUUUUUUULaBr`@	eMBD@cX@	gCaHA@AIZp@									20
:UvztU:KzxvTvUUzEmIftUDBXR5mOSzEeD6jnbQA3ycF3e6JJW0C@g8wF3kEce285O6WF6010F1107VcVcFF	CHEMBL381776	eg`ZHL@ECDfej`IABPpdLbdLTRRLTRrtrbRTfdRVquTDFUUUM@ADHVJI@@	Cc1cncc(NC(=O)N2C[C@H](C)N(c3ccc(C#N)c(C(F)(F)F)c3)C[C@H]2C)c1	6.6	group3-int	int	Androgen Receptor	Inhibition of AR mediated transcriptional activation using reporter assay	2006	fj}@@@DjYU_yyWbiZrVjjjjjjj`@@	fj}I@@DXtXBSLjsj}jKUoYJuUPPP@D@@@	417.434	3.6087	6	1	72.26	3	0.6777655222594815	-0.00338848333580076	0.19771440410156285	23	18	eh\ZHN@JIKL`S@@dbAX|UGFzP^dOiAIf[u{fW^UmixDRrfV`bBijjj@BjlaArIP@			eFBH@c@@								16
xvojcyqXbEue9cx0VAzeCj_1qOoXPw0GFs0Ost12g8OZF0PRNoc50F!F$F2520V01O1#F!V$2010	CHEMBL382097	ffs@`@@URYVvUWnVgIZ|EIZjZjjjjjhdEqART@	CC[C@]12CC[C@H](O)CC1=CCC1C3CC[C@H](O)[C@@]3(C)CCC12	7.48	group2-a	a	Androgen Receptor	Inhibitory activity against AR	2006	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@DjVU]{ZBxhuoAZjjjjjh@@	304.472	3.8069	2	2	40.46	1	-1.4580569576180538	-0.19253655167174277	-1.5611932690124288	35	20	fjcAA@B`|WNNQQRIHsIREKDyIUoIsUUUUUUULaBr`@	eMBD@ch@	eFJB@Hp@									20
<jrOzdFaw1qAiURPW2SFuVB8p12g04Imp54XB39VO6flVD3XX4aZK9!c0ElFVs582bV6t!2F4Vb!Y8G0	CHEMBL3827008	ejVTFEDHohDE@lRP@aJPrdBiBjPZdNi@FPadDYCzR^JHbBaDQHaHSHJHRHpXQDcDbDbRpzyZBBhijjh@JjXHNJ@@	CC(O)(CS(=O)(=O)c1cc(C(F)(F)F)cc(C(F)(F)F)c1)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1	5.51	group4-ia	ia	Androgen Receptor	Antagonist activity at GAL4 DBD-fused androgen receptor LBD (unknown origin) transfected in UAS-bla GripTite 293 cells assessed as inhibition of R1881-induced receptor activation after 16 to 24 hrs by beta-lactamase reporter gene assay	2016	fbu@@@LddTQRVftRTmIsUUUUUUT@@	fbuab@KPPX@QddabRRtJbReiNUhHHZ@@@@@	568.368	2.9812	8	2	137.67	9	4.271067206510968	-0.20319704938533645	-0.14369181274624238	4	4	ebZXBC@MKOLb`ODRPddEIAHHn\WiCzPAdHYAFPqdLbbbRduTtftabRbRdTcGDrtAAUSURp@UUUA@xP@@		gChhhE`BRnRYh@									1
<jrOzdFaw1q@iURPW2S0uVB8p12g04Imp50X8390O6eWVD3XX4aV59!80ElFVs582WV6O#F4Vb!Y8G0	CHEMBL3828139	elRTBEDOKaGHTP@`JPbdDiCJPJdJiAzP~d@YBzT^JHRDQDbDaL`haHcAaDRLRHRNMEmjBBhijjh@JjXHJJ@@	CC(O)(CSc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1	6.15	group3-int	int	Androgen Receptor	Antagonist activity at GAL4 DBD-fused androgen receptor LBD (unknown origin) transfected in UAS-bla GripTite 293 cells assessed as inhibition of R1881-induced receptor activation after 16 to 24 hrs by beta-lactamase reporter gene assay	2016	fdy@@@DjU^}YVg@qjjjjjj`@@	fdyaB@MJ@DYHhddmBhdnRCF``ah@@@@	536.37	4.4564	6	2	120.45	9	3.266606387466462	-1.3393698808683465	-0.4095785524267867	3	1	elRTBEDOKaGHTP@`JPbdDiCJPJdJiAzP~d@YBzT^JHRDQDbDaL`haHcAaDRLRHRNMEmjBBhijjh@JjXHJJ@@											1
xvojcyqXbEue9cx0VAzeCj_1qOoXPw0GFu0Ost12g8OZF0PRNoc50F!F#1G2520V0WO1#F!V$2010	CHEMBL383253	fnk@`@@MrJIJYQIIIPqJgEZCGMZjZjZjjjjIA\dUePt`	C/C=C\[C@]12CC[C@H](O)CC1=CCC1C3CC[C@H](O)[C@@]3(C)CCC12	6.14	group3-int	int	Androgen Receptor	Inhibitory activity against AR	2006	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@DjVU]{ZBxhuoAZjjjjjh@@	316.483	4.0091	2	2	40.46	1	-1.4043183494351381	-0.35862933402022124	-1.5403755915746273	35	20	fjcAA@B`|WNNQQRIHsIREKDyIUoIsUUUUUUULaBr`@	gC`HL@IRtHD	eFJB@Hp@									20
oHuF0F01#k#4FF2!80H040F&24!V/$F)402W04(60128WF	CHEMBL385509	f`qQC@E^lBPQHXdLbdLTRbVTeF]U@@AD@@@	Nc1ccc2nc(O)cc(C(F)(F)F)c2c1	7.58	group2-a	a	Androgen Receptor	Antagonist activity against human androgen receptor in CV1 cells measured as inhibition of DHT-stimulated luciferase reporter gene activity by cotransfection assay	2006	det@@DjYUX^fjjj`@	dev@@@rQQJHtpr@@@@@@	228.173	2.1523	3	2	59.14	1	-1.236775047390985	1.3429382623546087	-1.5592711185411845	5	5	f`qa@`A^@xfdKRCiAIe[YzZLej@@BJh@@@	eFbB@Hp@										5
~]U:j;xzpzv:Ezr<UqrzEQprpjzUjivfxzynfxStibzrKn@xbKwrMwXcG0	CHEMBL386437	gdlvaDp@EA`HRe^HdqEby^dq[]~pdVLdsY@RBBPpRFQRFJIIFJJ[QEIIQISJKJKIJZKQEQQJJJZHqQGQZKJQhBIO`JLfWOkrDSi|qZhHLjYjkj`@ijZjjjjhJBjIfhFBBJHHZeZPZKd@@	CCCC(=O)Oc1ccc(COCC#CCN2C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)C2(C)C)cc1C(=O)NCN[C@H]1CC(OC2C[C@](O)(C(=O)CO)Cc3c(O)c4c(c(O)c32)C(=O)c2c(OC)cccc2C4=O)O[C@@H](C)[C@H]1O	7.2	group2-a	a	Androgen Receptor	Inhibition of [3H]mibolerone binding to human Androgen receptor of PC3/AR Cell Lysate	2004	gipD@@@@LdbbbRrVbbbRvfVJTTrTJRRTTRrfRXJAD`HdjCEfpeR}Qnpzjjjjjjjjjjjjjjjjjjjjj@@@	gipD`H@@MeptF@VDcSyr}YlbbbbbRRRJfQbRVRTtRTJRRTTVRfRXBEC`pDrEIbpeRCQnpyh@`AHjjjji`@jnjZd@HJH`SH@@	1140.08	4.7664	22	7	321.12	20	16.699787472013263	-1.7573224114741548	-2.633499043375503	3	2	gkIVaxH@AA`yRL|KFSiLIRkP[LVG[`ND@x|Y@SHRYCHhheDTddheDmDbeEEDhiEEELkDXihbehmMEeHefDbitqFjSKTfW_ktFci``XjjjjzjjhIjhJibXFh@R`jhrh`HNDDQRXd@@	gNph@b@ILnuT@@										2
xvojgyqXbEue9cxVVAz@Cj_1MOoXPw0GFsFOss12g8OZJ4@RNo850k0FF!80F212#8O$F(2010	CHEMBL386630	fjc@`@@ErJIJZIPiSQJcEZ]zNVfjjjjjjfLPejVgeE@@	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O	8.57	group1-p	p	Androgen Receptor	Binding affinity at AR	2007	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmMUUUUUXDePt@@	288.429	3.4962	2	1	37.3	0	-2.0133697035432347	0.16525417653541513	-0.536637334918325	50	7	fjcAA@B`|WNNQQRIHsIREKDyIUoIsUUUUUMMTQBIAQR@@	eFBH@c@@	eFJB@Hp@									5
;j;irUyEOwpVg7zPCbp9IGZYmR0GPcVQkk10Z09Zk48SN4040F#94%2#8F08+X0G0	CHEMBL387651	ehRXL@@G`AklbbRfbTrRTrbRNRTrhXTt|bJZZjjjjjjjjfjjxHcBDVd\dRJP@	CCNC(=O)CCCCCCCC1C[C@H]2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12	6.03	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor expressed in HeLa cells assessed as inhibition of dihydrotestosterone-induced transcriptional activity by reporter gene assay	2007	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmUUUUUUDIAITM@@	459.712	6.1345	4	2	66.4	9	1.425043662201443	-2.70205804643893	-0.8416430726600861	50	19	ffs@b@Bu@xyEEDhheDhdbV\d{tTyjjjjjjijnHQIRLWEI^P@	dkNH`D@pAIeWUVjjj`@										19
:pjxyqerEuAQcpVZ3z@CbpWvIZXHR0GFc0Skl18Z09ZFC8RN4060F#1&20V08F4$2&2810	CHEMBL387850	ea]PLF@HF^P@aRPtdGICrPBdLdfRRRdQdURbbTTRbTRQHtvpLNIMKUUUUUUUUUUUUMUqeBduNiLmeB`@	C[C@]12CCC(=O)CC1C[C@@H](CCCCCCC[S+]([O-])CCCC(F)(F)C(F)(F)F)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12	6.02	group3-int	int	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells	2007	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmUUUUUUXDePt@@	596.783	7.4316	3	1	73.58	13	2.3146116976831133	-4.527713534828417	0.5115481736896973	50	9	ffs@b@Bu@xyEEDhheDhdbV\d{tTyjjjjjjijfHQIR\Tey@@	fbyAC`H@BERFiAtazPCHY@LdfRRRdQdUSUUUUUT@@										9
;jj:ibEvj9wpWh7z@Cbp9IOaYmR0GHcZOsk10Z29Zk48SN4F4FF#1!2#2#8F08+2010	CHEMBL389277	ehRXL@@G`AklbbRfbTrRTrbRNRTthXTt|bJZZjjjjjjjjfjjxHcBDVd\dRJP@	CN(C)C(=O)CCCCCCCC1C[C@H]2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12	6.58	group3-int	int	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells	2007	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmUUUUUUDIAITM@@	459.712	5.9947	4	1	57.61	8	0.8556233509437412	-2.5477931469695205	0.1958712419361549	50	19	ffs@b@Bu@xyEEDhheDhdbV\d{tTyjjjjjjijnHQIRLWEI^P@	dkNH`D@pCHhhbddfjjj`@										19
]vyQzyriBdwyTjaYPVxfh@FJBQl2WPFk1VGgJG0V_28080@o8N481GJ0V5!F098(V!WVFk	CHEMBL3893153	ek`RL@@DJNc`A@lbbTRRfRvRbbTQfDd\|ZzfvZfijjh@@HzACb^P@	Cc1cc(C(=O)NC[C@H]2CC[C@H](Oc3ccnc4c(C#N)cccc34)CC2)no1	6.19	group3-int	int	Androgen Receptor	Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37° C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 μg/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Cölbe, Germany), 600 μg/ml Geneticin (G418-sulphate, Invitrogen) and 10 μg/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.12×10^−12 to 1×10^−5 M in the presence of 1×10^−1° R1881 (methyltrienolone). The test plates were incubated overnight at 37° C. and 5% CO2. After 16 hours, 15 μl of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).	2016	few@@@LdbbbRubRrRbfSIBUxHyuUUUUUUUUT@@	fewq`@DTZ@WlbbTRRaRrTTRbHiV]UhymSTuUP@@E@cd]@@	390.442	2.9559	7	1	101.04	5	1.5910928384192762	0.579448128395174	0.3639140897449498	10	7	fcqb@BY{jlpNNQQQISHjIKIJZIYdaJCFZx@@BjjjYi`iAiF@@	eMbA@Dg`@										4
:Uvzv;S:vyvzUzUeUf;UjzbqOKMfbSDzlEzS9gdhAzyKmjJp@BDb20JEgD2wCOaWGinSFX1WFq291cV0	CHEMBL3893320	fmoq``LVWAA`AGY@\aNPrRPqRJZIQHfERI`g^CeIUjj`ZhHjkjBD`iJNP@	N#Cc1ccc(N2C[C@H]3[C@H]4CC[C@H](C4)[C@@]3(C(N)=O)S2(=O)=O)cc1C(F)(F)F	7.26	group2-a	a	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of testosterone-induced transactivation	2016	fdu@@@LddTTJbfJuARUipXuUUUUUU@@@	fdu`b@LPP@HrRPqQSJIHlyhu`~bmUPUAEQcdEMH@	399.392	1.2858	6	1	112.64	3	1.3415119389380443	1.7561201417111136	0.25870510117301904	11	8	fewPa`CSUhGcqqDDMdNr@yCHhheIYD]DeLiEQcIFlgMUURu@AUWTXQFRR@@	gCiHDL@ILt@@										6
=x:vrrzrMQzUxv_HOzUEg8KhvC_a7vKEEffIvZRuoYfDHpbpj7SCZ3YkEVmht5tXYLjK10o1GFr0cYcG0	CHEMBL3894825	eaURJJ@DLCfUKgj^P@bjPFdIiAZPrJJJJIQQKHsSJSJpiIIST\AYIMMUPHT@EEU[UUMP@@@	CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(C(=O)OCCCCCC(=O)NO)c(F)c1	7.37	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor (unknown origin) in membranes after 24 hrs by HAP adsorption assay	2016	flu@@@LdbbRbbsbRxXRhijjjjjjj@@	fluQB@DXT@HRYfY[]^gGQBejjA@@B@@@	580.558	4.4946	9	2	155.06	11	5.105618490770908	-1.151415313425571	0.06927788169772087	29	17	fakQA`AFB@IH`zBKNM_GlCdTTVVbbfrfRaYpsbm``JfjPBH`@@	eMBH@RZ@	gJPBAHJPt`PAIjj@@	eFABP`BL@	eMbA@Dg`@	dkNB`D@itpAIeuUfjji`@						16
:Uvzv;S:vyQzUzUemQvUjCfr_mS5b7jKE6nfQElRco7fTQoblh2CBZ@YmEfm1wCtXYHbG10k1GFb0VVcF0	CHEMBL3895477	elVRDBDDLNhU@P@`ZPfdEiCjSnrJJJJIQQKIZXjQJyJZcasHHiIijjAB`BHjkjZh@@@	[C-]#[N+]c1ccc(N2C(=O)C3(CCC3)N(c3ccc(CCCC(=O)NC)cc3)C2=S)cc1C(F)(F)F	7.04	group2-a	a	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	ffs@@@LddTTVbQVbrqILyyIZuUUUUUUUP@@	ffsQB@DXT@HRYfYYeu~gGYBUMVjhDJ@HJ@@@	500.544	4.3649	6	1	89.1	7	1.984858849635033	-1.1259450617321392	0.48570461660044506	13	10	ek`\HJDNMA``GEPHfdEiCZPFd{lbbRrbbdrVaRfTbhXtL\bjZ`@jZjX@Jjr`@@	dazH`DC`AIeujj@@										9
?tzvwIxwrDFtVUDSqHNV5A_@AFc8n2W10k1l10FF_1W#467k8N4!840c2!649808%F!VcFF	CHEMBL3895604	egh\DD@EAkiH`H`bPrJJKYSJIKIQQJHsL\^A]CKGPPDuUU@@AFPHZPJ@@	N#Cc1cccc2c(O[C@H]3CC[C@H](NC(=O)c4ccc(Cl)c(F)c4)CC3)ccnc12	7.21	group2-a	a	Androgen Receptor	Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37° C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 μg/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Cölbe, Germany), 600 μg/ml Geneticin (G418-sulphate, Invitrogen) and 10 μg/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.12×10^−12 to 1×10^−5 M in the presence of 1×10^−1° R1881 (methyltrienolone). The test plates were incubated overnight at 37° C. and 5% CO2. After 16 hours, 15 μl of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).	2016	few@@@LdbbbRubRrTTrSIBUxHyuUUUUUUUUT@@	fewP`@DMA{HheEDdebeEDhbjqgUZN[TEAQT@@@PHIGP@	423.874	4.6058	5	1	75.01	4	0.6227429028700563	-0.8481796629703746	0.15806947051017334	16	16	ek`TDL@BDmB`@eYqN|\bbbRfQTRVRfbRaXdDTBbfv`@@Jjjf@H`a@rQP@	eFABP`BL@	eFABH`BL@	eMbA@Dg`@								15
;j;irUzjQwxdh7zPEbx9MQaYmR0OPcZQsm11Z29Zk48SN4F4FF0V09402#2#NF08+2010	CHEMBL389631	ejQXL@@O`AglbbRfbTrRTrbRNRRfbrhXTt|bJZZjjjjjjjjijjjnFDHeEiGIDbd@@	CCCCN(C)C(=O)CCCCCCCC[C@@H]1CC2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@@H]21	5.47	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor expressed in HeLa cells assessed as inhibition of dihydrotestosterone-induced transcriptional activity by reporter gene assay	2007	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmUUUUUUXDePt@@	515.82	7.7642	4	1	57.61	12	1.7019911114153705	-4.30288649368833	0.40184596141110107	50	9	ffs@b@Bu@xyEEDhheDhdbV\d{tTyjjjjjjijfHQIR\Tey@@	fhaaB@D@B@ILrzkjmUUUUP@@										9
:Uvvv;S:vivUUzUeMf:yUbyjqOK7n7SDUlAUStwddQyDKHbJp@BBa2VFUiA0g5SXYFymO0X9WFq081c!	CHEMBL3898284	figP``LC``@QVP[H]dLddLTbfbrQaTbXJsgQBeZjhJ`RjnhHQ\Phy@@	C[C@@]12[C@@H]3C=C[C@@H](C3)[C@@H]1CN(c1ccc(C#N)c(C(F)(F)F)c1)S2(=O)=O	7.52	group2-a	a	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of testosterone-induced transactivation	2016	fdu@@@LddTTJbfJuARUipXuUUUUUU@@@	fdu`b@LPP@HrRPqQSQIHlDZu`~bmUPU@eQcbEKH@	368.378	2.6845	4	0	69.55	2	-0.5048775131064113	0.6072253431763959	0.9888058678371079	11	1	figP``LC``@QVP[H]dLddLTbfbrQaTbXJsgQBeZjhJ`RjnhHQ\Phy@@											1
[rvyUzyriBdwyTjafQnxfh8JJBQl2WHFk0VGgJG0W_a!V0@oNQ4851J0V5!G098$F!V!W8Fk	CHEMBL3898984	fcqb@BYgjnpRFQQQISHjIKIJZJIdaJCF^x@@BjjjZV`iAiF@@	Cc1nocc1C(=O)NC[C@H]1CC[C@H](Oc2ccnc3c(F)cccc23)CC1	6.68	group3-int	int	Androgen Receptor	Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37° C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 μg/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Cölbe, Germany), 600 μg/ml Geneticin (G418-sulphate, Invitrogen) and 10 μg/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.12×10^−12 to 1×10^−5 M in the presence of 1×10^−1° R1881 (methyltrienolone). The test plates were incubated overnight at 37° C. and 5% CO2. After 16 hours, 15 μl of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).	2016	few@@@LdbbbRubRrRbfSIBUxHyuUUUUUUUUT@@	fewq`@DRZ@WlbbTRRaRrTTRbHiV]UhymSTuUP@@E@cd]@@	383.422	3.1671	6	1	77.25	5	0.9167622470034027	0.18316097512824087	0.20436267890337972	10	1	fcqb@BYgjnpRFQQQISHjIKIJZJIdaJCF^x@@BjjjZV`iAiF@@											1
?tzvwIxwrDFlVUDCq2NV5A_89Fc8l2V10k0l10FFZ1W#466k8N4#40c#409808%F!VBFF	CHEMBL3899806	fcPa@BItTFInPrJJIJYEQIYJZIKLdIPXsW@@@UUUL@DDHMHp@	O=C(N[C@H]1CC[C@H](Oc2ccnc3c(Br)cccc23)CC1)c1ccc(F)cc1	6.32	group3-int	int	Androgen Receptor	Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37° C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 μg/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Cölbe, Germany), 600 μg/ml Geneticin (G418-sulphate, Invitrogen) and 10 μg/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.12×10^−12 to 1×10^−5 M in the presence of 1×10^−1° R1881 (methyltrienolone). The test plates were incubated overnight at 37° C. and 5% CO2. After 16 hours, 15 μl of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).	2016	few@@@LdbbbRubRrTTrSIBUxHyuUUUUUUUUT@@	fewP`@DMA{HheEDdebeEDhbjqgUZN[TEAQT@@@PHIGP@	443.315	4.8894	4	1	51.22	4	0.08435432750338792	-1.3861155068975364	0.0424364846005002	16	16	ek`TDL@BDmB`@eYqN|\bbbRfQTRVRfbRaXdDTBbfv`@@Jjjf@H`a@rQP@		eFABP`BL@	eFACD`BL@								15
;j;irUzjOwxWh7zPCbx9IOaYmR0OPcZQsk10Z29Zk48SN4F4FF#9402#2#8F08+2010	CHEMBL390071	edZXL@@G`AklbbRfbTrRTrbRNRTtUCBfgdQSSUUUUUUUUTuUUpQFDHmHyHdT`@	CCN(C)C(=O)CCCCCCCC1C[C@H]2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12	6.18	group3-int	int	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor expressed in CHOK1 cells	2007	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmUUUUUUDIAITM@@	473.739	6.401	4	1	57.61	9	1.0689126775443842	-2.964880081867674	0.24717693099732924	50	19	ffs@b@Bu@xyEEDhheDhdbV\d{tTyjjjjjjijnHQIRLWEI^P@	dgnH`DBpAIfWuUjjjj@@										19
:Uvzv;S:vyvzUzUuMQvzjCfz_mRSbEjKE6njQEWycx7fTIoblh2CBZHYmEdm1wCtXYIbl10m1GFbVV1c!	CHEMBL3900828	efUZLJDLI@bhXDI`@cHHQdLY@fPafglddLrVTRVTTTfRtJTrdPdcgaUWRswruUT@ESUS@AUWE@@@	[C-]#[N+]c1ccc(N2C(=O)C3(CCC3)N(c3ccc(N4CCN(S(C)(=O)=O)CC4)cc3)C2=S)cc1C(F)(F)F	6.86	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	ec`P@@@LddTTVbQVbrRtrQDcGGbQSRvuUUUUUUUUUU@@@	ec`RHH@DLFme@@cHhhhheEDlemUDeQpydDTeTmluU@aPAAUUPP@@	563.624	3.4162	8	0	109	4	2.4196406114766638	-0.025532088586090296	1.8207048709936702	3	2	efUZLJDLI@bhXDI`@cHHQdLY@fPafglddLrVTRVTTTfRtJTrdPdcgaUWRswruUT@ESUS@AUWE@@@											1
:Uvzv;S:vyvzUzUeUf;UjzbqSKMfbSDzlEzSAwdhAzyKmjop@CDb20JEgD2wCOaWKinSFX1WNy28WcF0	CHEMBL3902310	ek`\LJ@LKChDC@@bjPfdEiCZPrRPqRJZIQKIZMRI`QpKpiIiZjhFjBhjkjJBHIIDxoD@@	CNC(=O)[C@@]12[C@H]3C[C@H](C[C@@H]3F)[C@@H]1CN(c1ccc(C#N)c(C(F)(F)F)c1)S2(=O)=O	7.24	group2-a	a	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of testosterone-induced transactivation	2016	fdu@@@LddTTJbfJuARUipXuUUUUUU@@@	fdu`b@LPP@HrRPqQSJIHlyhu`~bmUPUAEQcdEMH@	431.409	1.4863	6	1	98.65	3	1.2756728577601335	1.4142414104665417	0.2768229512808736	11	8	fewPa`CSUhGcqqDDMdNr@yCHhheIYD]DeLiEQcIFlgMUURu@AUWTXQFRR@@	gJYHDL@ILmP@	eFABP`BL@									6
=xOzfobwbMQzUwQZHOvTDB8K1mD7Z7fKE6ffIAVR8k3eDHoblhHCBZ2YkEWm1u5tXYHbG12k1GFb0V0c!	CHEMBL3903040	e`T\LJDMOMlBB`HapHNdKiAzPvg{lbTrbRrbbdrLrTrdTbg`PtuM@ATuT`AUVP@@@	[C-]#[N+]c1ccc(N2C(=O)C(C)(C)N(c3ccc(OC(=O)CCl)cc3)C2=S)cc1C(F)(F)F	6.88	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	flu@@@LdbbRbbsbRxXRhijjjjjjj@@	fluQB@DXT@HRYfY[]^gGQBejjA@@B@@@	481.881	4.1864	6	0	86.3	6	1.4153189178268146	-0.8352695618998622	1.5075547112457384	29	17	fakQA`AFB@IH`zBKNM_GlCdTTVVbbfrfRaYpsbm``JfjPBH`@@	eMBH@RZ@	gJPBAHJPt`PAIjj@@		eMbQ@B[h~@	gGPdLQDT@RVzZ@@						16
:Uvzt:vKrznLQzUxQlHOzyDB8KhnC5i7vMEDYfIQVR@tYeDHpbpj7xCg6YkEVmdt5tXYHjl10q1GFr0dWck0	CHEMBL3903756	eeSVBF@LBMJiiXDKG`@bJPFBFYCfPEdLddNRRRTtTVrbbdrLrTrdVQTrrNJuUUSA@UMUH@UUd@@@	CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(C(=O)NCCCCCCNS(N)(=O)=O)c(F)c1	6.96	group3-int	int	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor (unknown origin) in membranes after 24 hrs by HAP adsorption assay	2016	flu@@@LdbbRbbsbRxXRhijjjjjjj@@	fluQB@DXT@HRYfY[]^gGQBejjA@@B@@@	628.67	4.1779	10	3	189.1	11	6.442254293055085	-0.7827800922752379	-0.7647379381626268	29	17	fakQA`AFB@IH`zBKNM_GlCdTTVVbbfrfRaYpsbm``JfjPBH`@@	eMBH@RZ@	gJPBAHJPt`PAIjj@@	eFABP`BL@	eMbA@Dg`@	do_LPLKXRpBG@LddNRRRTVjjjX@@						16
:UvztOzfJbwYLQzUwQVHOvTDB8K1mB5Z7fKE6YfIAVR8k3eDHoblh2CBZ2YkEWX1s5tXYHbG10k1GFb0W0cV0	CHEMBL3904234	fcoI@bDXZmP@cl`NPgHMg_YEEEEDhhedYliDj\CeMVjhDJ@BJjx@@@	[C-]#[N+]c1ccc(N2C(=O)C(C)(C)N(c3ccc(N)cc3)C2=S)cc1C(F)(F)F	6.56	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	flu@@@LdbbRbbsbRxXRhijjjjjjj@@	fluQB@DXT@HRYfY[]^gGQBejjA@@B@@@	404.415	3.2931	5	1	86.02	3	0.6005773065387516	0.21469224164781653	0.1211269874865557	29	17	fakQA`AFB@IH`zBKNM_GlCdTTVVbbfrfRaYpsbm``JfjPBH`@@	eMBH@RZ@	gJPBAHJPt`PAIjj@@		eMbQ@B[h~@	eFbB@Hp@						16
?tzvwIxwrD0lVUDCqHNV5A_80Fc8l2V10k1k10FF_1W$46k8N4#40c#649808)VBFF	CHEMBL3904554	fcPa@BItTFHnPrJJIJYEQIYJZIJLdIPXsw@@@UUUL@PDHMHp@	O=C(N[C@H]1CC[C@H](Oc2ccnc3c(Br)cccc23)CC1)c1cccc(F)c1	7.03	group2-a	a	Androgen Receptor	Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37° C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 μg/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Cölbe, Germany), 600 μg/ml Geneticin (G418-sulphate, Invitrogen) and 10 μg/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.12×10^−12 to 1×10^−5 M in the presence of 1×10^−1° R1881 (methyltrienolone). The test plates were incubated overnight at 37° C. and 5% CO2. After 16 hours, 15 μl of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).	2016	few@@@LdbbbRubRrTTrSIBUxHyuUUUUUUUUT@@	fewP`@DMA{HheEDdebeEDhbjqgUZN[TEAQT@@@PHIGP@	443.315	4.8894	4	1	51.22	4	0.08435432750338792	-1.3861155068975364	0.0424364846005002	16	16	ek`TDL@BDmB`@eYqN|\bbbRfQTRVRfbRaXdDTBbfv`@@Jjjf@H`a@rQP@	eFABP`BL@		eFACD`BL@								15
[rvyQzyriBdwyTjaYPVxfh8FJBQl2WHFk0VGgJG0V_2$@o8N4811J0V5!F098(V!W8Fk	CHEMBL3905727	fmoqb@BY{jlpRFQQQISHjIKIJZILdIPXsW@@@UUUSMHT`tc@@	O=C(NC[C@H]1CC[C@H](Oc2ccnc3c(F)cccc23)CC1)c1ccon1	6.13	group3-int	int	Androgen Receptor	Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37° C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 μg/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Cölbe, Germany), 600 μg/ml Geneticin (G418-sulphate, Invitrogen) and 10 μg/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.12×10^−12 to 1×10^−5 M in the presence of 1×10^−1° R1881 (methyltrienolone). The test plates were incubated overnight at 37° C. and 5% CO2. After 16 hours, 15 μl of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).	2016	few@@@LdbbbRubRrRbfSIBUxHyuUUUUUUUUT@@	fewq`@DTZ@WlbbTRRaRrTTRbHiV]UhymSTuUP@@E@cd]@@	369.395	2.8232	6	1	77.25	5	0.8590741159362959	0.4419124423860508	0.1794892588582061	10	7	fmoqb@BY{jlpNNQQQISHjIKIJZILdIPXsW@@@UUUSMHT`tc@@	eFABP`BL@										3
=QOtSo5k5FAUHN2lXN@Ha4FF1Yd@0LvZ78X03Ok96FGX03OX12KLt0ct9RlIl90A0bV60WeBKG471FV8F0	CHEMBL390577	fewPc@E^lDD`bPqHYEHXheDllhmhdiJLzNQsjiB`Rjh@H`@@	O=c1cc(C(F)(F)F)c2cc3c(cc2[nH]1)OCCN3Cc1ccccc1	6.65	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells by transcriptional activation assay	2007	ffs@@@DjYe]^U]XhT`qsVjjjjjjjj@@	ffsP`@DFAkHhdidddhUDeQdeV\VkT`AUT@DP@@	360.334	2.7145	4	1	41.57	3	-0.5640548292245213	0.2790808118467777	-0.15611211081900414	1	1	fewPc@E^lDD`bPqHYEHXheDllhmhdiJLzNQsjiB`Rjh@H`@@											1
?tzvwIxwrDFtVUDSqHNV5A_@AFc8n2W10k1l10FF_1W#467k8N4!840c2!649808%F!VcFF	CHEMBL3907028	egh\DD@EAkiH`H`bPrJJKKSJIKIQQJHsL\^A]CKGPPDuUU@@AFPHZPJ@@	N#Cc1cccc2c(O[C@H]3CC[C@H](NC(=O)c4ccc(F)c(Cl)c4)CC3)ccnc12	7.17	group2-a	a	Androgen Receptor	Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37° C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 μg/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Cölbe, Germany), 600 μg/ml Geneticin (G418-sulphate, Invitrogen) and 10 μg/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.12×10^−12 to 1×10^−5 M in the presence of 1×10^−1° R1881 (methyltrienolone). The test plates were incubated overnight at 37° C. and 5% CO2. After 16 hours, 15 μl of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).	2016	few@@@LdbbbRubRrTTrSIBUxHyuUUUUUUUUT@@	fewP`@DMA{HheEDdebeEDhbjqgUZN[TEAQT@@@PHIGP@	423.874	4.6058	5	1	75.01	4	0.6227429028700563	-0.8481796629703746	0.15806947051017334	16	16	ek`TDL@BDmB`@eYqN|\bbbRfQTRVRfbRaXdDTBbfv`@@Jjjf@H`a@rQP@	eFABH`BL@	eFABP`BL@	eMbA@Dg`@								15
:UvjQttCR4m1JATH8HWXN2HL4FkWY9!LmZ78X039k96FGX0@9X125Jt2c81RnIV90A0bV6!8BGN4710V8F0	CHEMBL390728	fj}QC@EAlBPQHXdLbdLTRbVVTVdhshyjiB`RjjJGj@@	CCC1CCNc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc21	5.13	group4-ia	ia	Androgen Receptor	Antagonist activity against Human Androgen receptor expressed in CV-1 cells	1999	foQ@@@DjYUU}`nRlzjjjjj`@@	foQQ@@DZ@drmjjtYIUgMR@EUD@@	296.291	2.6605	3	2	41.13	2	-1.0330970632779146	0.5319011002529227	-1.4642716872410897	38	10	fj}QB`DFbCqDxidLrAYAIeYWUYzhqVg^jhHBifjH@@	eMBD@ch@										2
<v<U:vizU;@Uj:yUbyryOKIf7SyzlAzSAwt9AyyKHjJK@BDa20FEgD2B_OaWKimNFX1WNy283c10	CHEMBL3907304	fewQ``LS`aH@alavPGHYIHXiELideiUHf\MYtPyVjjBhJJjz`aIrBad@	C[C@@]12[C@@H]3CC[C@@H](C3O)[C@@H]1CN(c1ccc(C#N)c(C(F)(F)F)c1)S2(=O)=O	6.49	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of testosterone-induced transactivation	2016	fdu@@@LddTTJbfJuARUipXuUUUUUU@@@	fdu`b@LPP@HrRPqQSJIHlyhu`~bmUPUAEQcdEMH@	386.393	2.1078	5	1	89.78	2	0.46337719764908525	1.1424689491895084	0.06875867287255559	11	8	fmoQa`KKUhpOGcbHH{HCdIrFQQQJQFQWQISJQTXrUgYKUUUKT@EU]QaDYIH@	eFBH@c@@										1
;r7IOl9k4k4F3BH82WXN2H!FF13d20LmZ58X039k96FGV029X12KLl0c89RlGV9020bV60VeBJF451FV8F0	CHEMBL390754	fluPc@E^lDD`bPqHYEHXheDlleIQgQSURE@eUD@@	O=c1cc(C(F)(F)F)c2cc3c(cc2[nH]1)OCCN3	6.53	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells by transcriptional activation assay	2007	foQ@@@DjYUU}`nRlzjjjjj`@@	foQP`@DFAiIe[UUhrRkNZd@JjH@@	270.209	0.9381	4	2	50.36	1	-0.8547025737657433	1.9734195049028955	-1.4302329745180058	38	9	fj}Pb`DVXTGbQqcHIdLrBSL}jkORsbmNCUT@EMULP@@											8
:Uvzv:vKrznTvzUxQlHOzUiERKhnC5i7vMETYfnQoRikneTqpbxj7xCg6YkEXmdt5tffHjG10o1GFr0cVcFV	CHEMBL3908221	e`|rLI@DLCgeKmP@bjPFdIiAZPYBKYAvP}dLbbbbbTTRrLtrdrlJRRRbRtteG@VRSPlkUTBE@AQUVuUUMSUPH@@	CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(C(=O)NCCCCCCc2ccc(C(=O)C(F)(F)F)s2)c(F)c1	7.17	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor (unknown origin) in membranes after 24 hrs by HAP adsorption assay	2016	ehRP@@@LdbbRbbsbRrbrRRTRxLDTbR~Ajjjjjjjjjjjj@@@	ehR\DD@DLJeB`@bxHrJJJJISKIXjYIIIQJcarHIKxEjjA@@BZjjfhD@@	712.709	7.5573	7	1	153.84	13	5.1892354240061325	-3.9610344709681504	1.2614337983194888	1	1	e`|rLI@DLCgeKmP@bjPFdIiAZPYBKYAvP}dLbbbbbTTRrLtrdrlJRRRbRtteG@VRSPlkUTBE@AQUVuUUMSUPH@@											1
:Uvzv;S:vyvzUzUeUQzUUCfz_mS5bEjKEqnfQEWwco7fyHoblh2CBZ2YmEdX1wCtXYIjG10k1GFb2V0c!	CHEMBL3910485	eod\HBDDLIe@@aZPvdCiBZWnRYfYYeuVZ^c`JiKhhYjjAB`BbJjnB@@@	[C-]#[N+]c1ccc(N2C(=O)C3(CCCCC3)N(c3ccc(C)cc3)C2=S)cc1C(F)(F)F	6.71	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	fa{@@@DjfYVWwo]gE^bUoZjjjjjjjj`@@	fa{QB@DXT@HRYfYYeuWz\CUKR}Zj`Ph@hJB@@	443.492	5.0471	4	0	60	3	-0.2155383894006451	-1.2824692708525438	1.1265155474928723	2	1	eod\HBDDLIe@@aZPvdCiBZWnRYfYYeuVZ^c`JiKhhYjjAB`BbJjnB@@@											1
[rvyQzyriBdwyTjaYPVxfh8FJBQl2WHFk0VGgJG0V_2$@o8N4811J0V5!F09B(V!W8Fk	CHEMBL3911299	fmoHb@BY{OUPRFQQQISHjIKIJZILdIPXsW@@@UUUSMHT`tc@@	O=C(NC[C@H]1CC[C@H](Oc2ccnc3c(F)cccc23)CC1)c1cc[nH]n1	6.38	group3-int	int	Androgen Receptor	Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37° C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 μg/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Cölbe, Germany), 600 μg/ml Geneticin (G418-sulphate, Invitrogen) and 10 μg/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.12×10^−12 to 1×10^−5 M in the presence of 1×10^−1° R1881 (methyltrienolone). The test plates were incubated overnight at 37° C. and 5% CO2. After 16 hours, 15 μl of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).	2016	few@@@LdbbbRubRrRbfSIBUxHyuUUUUUUUUT@@	fewH`@DTDtGlbbTRRaRrTTRbHiV]UhymSTuUP@@E@cd]@@	368.411	2.3065	6	2	79.9	5	1.196909374497848	0.7617361083434602	-0.9048014686854134	10	1	fmoHb@BY{OUPRFQQQISHjIKIJZILdIPXsW@@@UUUSMHT`tc@@											1
=x;KrzvTQzUzQlHOzUDBPKhnhCi7zMEDYfQQZRDmYeDHpbxjbxCg6nnEVmtt5tXfHjG10oGKFr0cXcG0	CHEMBL3912767	ekPzBJ@DLCgjUKa]P@bjPFdIiAZPrJJJJIQQKHsSJSJpiIIJJKRc`KIIiTujjAB`@hjkZjjifXH@@	CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(C(=O)NCCCCCCn2cccc(O)c2=O)c(F)c1	6.6	group3-int	int	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor (unknown origin) in membranes after 24 hrs by HAP adsorption assay	2016	elVP@@@LdbbRbbsbRrbrRRTTRxLDTbRaQjjjjjjjjjjjjh@@	elVRLH@DLJceBo`@cHhhhheLlebidddeEEjNGH`dhTVjhD@@IjjjfVB@@@	643.66	4.6287	9	2	149.07	11	5.335273635482675	-1.5099689222897674	0.1585629122514735	1	1	ekPzBJ@DLCgjUKa]P@bjPFdIiAZPrJJJJIQQKHsSJSJpiIIJJKRc`KIIiTujjAB`@hjkZjjifXH@@											1
?tzvwIxwrDFtVUDSqHNV5A_@9Fc8n2W10k1l10FF_1W#467k8N4!840c#649808%F!VBFF	CHEMBL3913554	ek`TDD@BDmB`LQZPrJJIJYEQIYJZIJEbPQPJJ[Z@@@jjjX@bBDCIE@@	Cc1ccc(C(=O)N[C@H]2CC[C@H](Oc3ccnc4c(Br)cccc34)CC2)cc1F	7.17	group2-a	a	Androgen Receptor	Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37° C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 μg/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Cölbe, Germany), 600 μg/ml Geneticin (G418-sulphate, Invitrogen) and 10 μg/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.12×10^−12 to 1×10^−5 M in the presence of 1×10^−1° R1881 (methyltrienolone). The test plates were incubated overnight at 37° C. and 5% CO2. After 16 hours, 15 μl of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).	2016	few@@@LdbbbRubRrTTrSIBUxHyuUUUUUUUUT@@	fewP`@DMA{HheEDdebeEDhbjqgUZN[TEAQT@@@PHIGP@	457.342	5.2333	4	1	51.22	4	0.14204244735278315	-1.64486711748032	0.06730990588818245	16	16	ek`TDL@BDmB`@eYqN|\bbbRfQTRVRfbRaXdDTBbfv`@@Jjjf@H`a@rQP@	eFABP`BL@	eFBH@c@@	eFACD`BL@								15
?tzvwIxwrDFlVUDCq2NV5A_89Fc8l2V10k0l10FFZ1W#466k8N4#40c#409808%F!VZFF	CHEMBL3913672	ek`\DH@BDcmB`LSHhhdidUDedihdlfIAE@hieh@@Bjji`@lHPLdT@@	N#Cc1ccc(C(=O)N[C@H]2CC[C@H](Oc3ccnc4c(Br)cccc34)CC2)cc1	6.58	group3-int	int	Androgen Receptor	Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37° C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 μg/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Cölbe, Germany), 600 μg/ml Geneticin (G418-sulphate, Invitrogen) and 10 μg/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.12×10^−12 to 1×10^−5 M in the presence of 1×10^−1° R1881 (methyltrienolone). The test plates were incubated overnight at 37° C. and 5% CO2. After 16 hours, 15 μl of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).	2016	few@@@LdbbbRubRrTTrSIBUxHyuUUUUUUUUT@@	fewP`@DMA{HheEDdebeEDhbjqgUZN[TEAQT@@@PHIGP@	450.335	4.6242	5	1	75.01	4	0.7612256520301784	-0.9573662504137721	0.2017064759318698	16	16	ek`TDL@BDmB`@eYqN|\bbbRfQTRVRfbRaXdDTBbfv`@@Jjjf@H`a@rQP@		eMbA@Dg`@	eFACD`BL@								15
?tzvwIxwrD0lVUDCqHNV5A_80Fc8l2V10k1k10FF_1W$46k8N4#40c#641808)V8FF	CHEMBL3914094	fmoPb@I]DDDadTRTtJbRrTTRbMNN|wlupACUUT@@@PHUOP@	O=C(N[C@H]1CC[C@H](Oc2ccnc3ccccc23)CC1)c1cccc(F)c1	7.5	group2-a	a	Androgen Receptor	Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37° C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 μg/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Cölbe, Germany), 600 μg/ml Geneticin (G418-sulphate, Invitrogen) and 10 μg/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.12×10^−12 to 1×10^−5 M in the presence of 1×10^−1° R1881 (methyltrienolone). The test plates were incubated overnight at 37° C. and 5% CO2. After 16 hours, 15 μl of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).	2016	few@@@LdbbbRubRrTTrSIBUxHyuUUUUUUUUT@@	fewP`@DMA{HheEDdebeEDhbjqgUZN[TEAQT@@@PHIGP@	364.419	4.1642	4	1	51.22	4	-0.29700541335213426	-0.6575915699170546	-0.09116486525939256	16	16	ek`TDL@BDmB`@eYqN|\bbbRfQTRVRfbRaXdDTBbfv`@@Jjjf@H`a@rQP@	eFABP`BL@										15
:xjxyyirjyjzfxsijzDUjp5UtpePwFpIsFSsuSmggOoS4@Txo870k8FHV080F6d6#8P1VF0GVVV3$F!	CHEMBL3915005	ee`PL@@@JilbbRfTTJTtTTjUCDbdfcgdVVQWPsSUUUUUUSUUD\RQ^JI@@	C[C@]12CCC3C4CCC(=O)C=C4[C@@H]4C[C@@H]4C3C1C1CC1[C@@]21CCC(=O)O1	6.38	group3-int	int	Androgen Receptor	Binding Assay: The test was carried out as in 1, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.The results of the binding tests and the ratio of the competition factors CF(PR) and CR(MR) are shown in Table 1, which for comparison also shows receptor binding values of drospirenone as reference substance A.	2015	fi@@@LddTTRRNaTTJVis`iJLzJXy[vjjjjjjjjjj@@	fiA`@@EGdTRTrbaRfTTJUFRUKSoQRgK^mMUUUUUTuUVNRRb`@	352.472	3.1069	3	0	43.37	0	-1.591455282777928	0.3410440684649933	0.757435613389002	5	1	ee`PL@@@JilbbRfTTJTtTTjUCDbdfcgdVVQWPsSUUUUUUSUUD\RQ^JI@@											1
oHuF0F018!k#4FN210N0H040F0212!H418!18082)202%2#14@2502(2482c10	CHEMBL391548	fleaC@E^AHHdLRFQRFJIIFJKRuEMTDFPP@@@@	N#Cc1ccc(-c2ccccc2O)cc1C(F)(F)F	10.7	group1-p	p	Androgen Receptor	Antagonist activity against human androgen receptor expressed in human MDA-MB-453 cells assessed as inhibition of dihydrotestosterone-induced effect by luciferase receptor gene assay	2008	dcl@@DjYU_egZjjjh@@	dcl@@DjYU_egX@@@@@@	263.218	3.657	2	1	44.02	2	-1.728543456519341	-0.030275174551544354	-0.5079642011546319	30	18	fle`B`N@BSNKoDLBeArJJIIFJJZU`oQ``rBHb@@@	eFJB@Hp@		gJPBAHJPt`PAIjj@@								17
oHuF0F018!k#4FN21080H040F0212!H408!1808*2&82$482502(2082c10	CHEMBL391549	fleaC@EQAHHdLRFQRFJIIFIJRtEMTDFPA@@@@	N#Cc1ccc(-c2cccc(O)c2)cc1C(F)(F)F	6.64	group3-int	int	Androgen Receptor	Displacement of [3H]DHT from human recombinant AR expressed in Sf9 cells	2007	dcl@@DjYU_egZjjjh@@	dcl@@DjYU_egX@@@@@@	263.218	3.657	2	1	44.02	2	-1.728543456519341	-0.030275174551544354	-0.5079642011546319	30	18	fle`B`N@BSNKoDLBeArJJIIFJJZU`oQ``rBHb@@@			gJPBAHJPt`PAIjj@@	eFJB@Hp@							17
xvwjgyqabEui9dxVVEz@Cj_1MOoXPw0GHsFSss52g8OZJ4@RNo870k0FF!80F212#8O$F!V2#6030	CHEMBL391648	edZPB@@@A`X\bbRfbTrRTrbRaJRReCBfgdQSSSUUUUUUUUTuUppaDhmHyHdT`@	C[C@]1(O)CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CCC(=O)C=C1C[C@H]3CCCCCCCCCC(=O)O	5.7	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HeLa cells assessed as inhibition of dihydrotestosterone induced transcriptional activity by reporter gene assay	2007	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmMUUUUUXDePt@@	472.707	6.8768	4	2	74.6	10	1.7489766638132025	-3.2571552097841407	-0.7694120305336711	50	7	ehRPLD@Ao`POGqqrJJQIFYQR[IKIYIIPcbQRpHijjjjjjijfjijjaADPRJKR@@	eFBH@c@@	eMJB@Df`@									1
?vzvyIxyrDFtoUTzaHPV_e_8OF89n2WFFk1l1VFFW0_#42Es8N4!840c4!2418(k!V8FF	CHEMBL3916504	ek`TDD@EIiD`I@bPrJJKKSIQIYJJIQEc`JHZ[XzB@fjjj@@@HDCIE@@	O=C(NC[C@H]1CC[C@H](Oc2ccnc3ccccc23)CC1)c1ccc(F)c(F)c1	6.98	group3-int	int	Androgen Receptor	Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37° C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 μg/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Cölbe, Germany), 600 μg/ml Geneticin (G418-sulphate, Invitrogen) and 10 μg/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.12×10^−12 to 1×10^−5 M in the presence of 1×10^−1° R1881 (methyltrienolone). The test plates were incubated overnight at 37° C. and 5% CO2. After 16 hours, 15 μl of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).	2016	fmo@@@LdbbbRubRrRbfRYHRoAfnjjjjjjjjjh@@	fmoP`@D]@GHheDdhlmdhheDYF]yoYkZ``hjh@@@`Qr^`@	396.436	4.4597	4	1	51.22	5	0.01623568141644785	-1.0747838647383492	-0.01083438654456248	4	4	ek`TDD@EIiD`GDbPrJJKYSIQIYJJIQEc`JHZ[XzB@fjjj@@@HDCIE@@	eFABP`BL@										2
?vzvyIxyrDFloUTja2PV_e_8OF89l2VFFk0l1VFFV0_#42Ds8N4#40c4$98(k!V8FF	CHEMBL3917362	ek`TDD@BLmJ`I@zPrJJIJYEQIYISQIYbPQPJI[Z@@@jjjf@BBDCIE@@	O=C(NC[C@H]1CC[C@H](Oc2ccnc3c(F)cccc23)CC1)c1ccc(F)cc1	6.62	group3-int	int	Androgen Receptor	Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37° C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 μg/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Cölbe, Germany), 600 μg/ml Geneticin (G418-sulphate, Invitrogen) and 10 μg/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.12×10^−12 to 1×10^−5 M in the presence of 1×10^−1° R1881 (methyltrienolone). The test plates were incubated overnight at 37° C. and 5% CO2. After 16 hours, 15 μl of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).	2016	fmo@@@LdbbbRubRrRbfRYHRoAfnjjjjjjjjjh@@	fmoP`@D]@GHheDdhlmdhheDYF]yoYkZ``hjh@@@`Qr^`@	396.436	4.4597	4	1	51.22	5	0.01623568141644785	-1.0747838647383492	-0.01083438654456248	4	4	ek`TDD@IAaH`GGZPrJIKJYJIKIQQJHracpKhYXz@BZjjh@@HHDMHE@@	eFABP`BL@										1
:Uvvv;S:vivUUzU@Uf:yUbybqOKIf7BDylAUS9gd9AyqKH_JK2BDa!FEg@2B5OXWGDXN0X11Fq281c!	CHEMBL3917372	fa{P``L]``@PVPkHMdLddLTTrbRLJdSNZMXOhkUTEPQUWTDINPTt`@	N#Cc1ccc(N2C[C@H]3[C@H]4CC[C@H](C4)[C@H]3S2(=O)=O)cc1C(F)(F)F	6.89	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of testosterone-induced transactivation	2016	fdu@@@LddTTJbfJuARUipXuUUUUUU@@@	fdu`b@LPP@HrRPqQSJIHlyhu`~bmUPUAEPPdyASR@@	356.367	2.4021	4	0	69.55	2	-0.5548425131601511	0.8215300969079727	0.9675702818304155	11	1	fa{P``L]``@PVPkHMdLddLTTrbRLJdSNZMXOhkUTEPQUWTDINPTt`@											1
xvojcyqXbEue9cx0VAzeCj_1qOoXPw0GFs0Ost12g8OZF0PRNoc50F!F$F2520V01O1#F!V$2010	CHEMBL391795	ffs@`@@URYVvUWnVgIZ|EIZjZjjjjjkdEqRVdzART@	CC[C@]12CC[C@H](O)CC1=CC[C@H]1[C@@H]3CC[C@H](O)[C@@]3(C)CC[C@@H]12	7.06	group2-a	a	Androgen Receptor	Binding affinity to androgen receptor	2007	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@DjVU]{ZBxhuoAZjjjjjkEDIZ`@	304.472	3.8069	2	2	40.46	1	-1.4580569576180538	-0.19253655167174277	-1.5611932690124288	35	9	fjc@C@@AKgDocdTTbRLrTaRqNRU[r\uUUUUUUSDPbPTT`@	eMBD@ch@	eFJB@Hp@	eFJB@Hp@								8
zrUtyOSn@J_k2HeCH@2GFtAH04!1b8B02uZ78X1Y1VN603kBFFX140J10V0GBWFV9030ZV6F!4G10710V8F0	CHEMBL391798	ff}QA`JIjBPQHXdKRCiCtadTaTTRRdTZVLGIZjhHJbfR@@	O=c1ccc2cc(N(CC(F)(F)F)CC(F)(F)F)ccc2[nH]1	9	group1-p	p	Androgen Receptor	Antagonist activity at human AR	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	324.223	2.6247	3	1	32.34	5	-0.8261669618246336	0.0367709608793195	-0.27582545185781915	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@			dcv@xJBPRPrPx@fPVPvPrJPjKRUUUT@@								37
:Uvzv;S:vyvzUzUfUQ:UCfz_mR5b7zKEanfQEWwcwbfyHobpj2CBZ2YmEdmWwCtXYHjO10k1GFb0V3c!	CHEMBL3919228	e`\RLBBDLAceGo`@bZPVdMi@ZSin{{lbbbbbTTRrRTuTbUeG@URWVQSUTBE@EDUUmA@@@	[C-]#[N+]c1ccc(N2C(=O)C3(CCCC3)N(c3ccc([N+](=O)[O-])cc3)C2=S)cc1C(F)(F)F	6.3	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	fnk@@@LddTTRTRjtVVYrR`yjvjjjjjjjj`@@	fnkQB@DXT@HRYfYYeuWipMTmrUjjAB`B```@@	460.435	3.4396	7	0	105.82	4	1.5791902109868448	0.19887964878361342	1.5543914331388322	3	3	egh\HJDNMI``GEPHVdMi@zPff{lbbRrbbdrRTjTrdUCFadRSWT@ESUSP@UUe@@@	gChhhE`BRnRYh@										3
xvojcyqXbEue9cx0XAzeCj_1qOoXPw0GFu0Osx12g8toFVPRNoe50F!F!V1G2520V4WO1#F!V$2010	CHEMBL392000	fig@`@@CRYegYU}nU`cNSfoZjfjfZjjjhTDbBadyQfUU@@	C=CC[C@@H]1C2=CC[C@@H]3[C@H](CC[C@]4(C)[C@@H](O)CC[C@@H]34)[C@@]2(C=C)CC[C@@H]1O	7.82	group2-a	a	Androgen Receptor	Binding affinity to androgen receptor	2007	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@DjVU]{ZBxhuoAZjjjjjkEDIZ`@	342.521	4.614	2	2	40.46	3	-0.978584036867476	-1.0604684699568332	-1.4421639637310455	35	9	fa{@C@@AKgFocdTTbRLrTaRfVIrRk^SfjjjjjjjZZbDRBbeE@@	eMBD@cX@	eFJB@Hp@	eFJB@Hp@								1
:Uvyvxn@R_m2HeCH@2OktAH04F09b8B0HuZ78X1Y1kO603kBPOX144Jl0V8GRnFV9030ZV6F084G14710V8F0	CHEMBL392004	fikQA`JIzBPQHXdKRCiCtadTaTTRRdTZbrQ`ykUUAATTuLP@@	CCCc1cc(=O)[nH]c2ccc(N(CC(F)(F)F)CC(F)(F)F)cc12	7.44	group2-a	a	Androgen Receptor	Antagonist activity at human AR	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	366.304	3.6117	3	1	32.34	7	-0.3339252746044592	-0.9542595229900478	-0.14922404678893708	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	gC`HL@IST@@		dcv@xJBPRPrPx@fPVPvPrJPjKRUUUT@@								37
<v<U:vizU;@Uj:yUbyryOKIf7SyzlAzSAwt9AyyKHbJK@BDa20FEg@2B5OaWKimNFX1WNy283c10	CHEMBL3920247	fewQ``LS`aH@alavPGHYIHXiELideiUHf\LztPyVjjBhJJjzbaIrBQeY@@	C[C@@]12[C@H]3C[C@H](C[C@@H]3O)[C@@H]1CN(c1ccc(C#N)c(C(F)(F)F)c1)S2(=O)=O	6.97	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of testosterone-induced transactivation	2016	fdu@@@LddTTJbfJuARUipXuUUUUUU@@@	fdu`b@LPP@HrRPqQSJIHlyhu`~bmUPUAEQcdEMH@	386.393	2.1078	5	1	89.78	2	0.46337719764908525	1.1424689491895084	0.06875867287255559	11	8	fewPa`CSUhGcqqDDMdNr@yCHhheIYD]DeLiEQcIFlgMUURu@AUWTXQFRR@@	eFBH@c@@	eFJB@Hp@									6
?tzvwIxwrD0lVUDCqHNV5A_@0Fc8l2V10k1k10FF_1W$46k8N4#40c#649808)VcFF	CHEMBL3920715	ek`\DH@INca@`ICHhdihUDedhheDYjNGOFnimh@ajjj@@BL`PTgd@@	N#Cc1cccc2c(O[C@H]3CC[C@H](NC(=O)c4cccc(F)c4)CC3)ccnc12	7.28	group2-a	a	Androgen Receptor	Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37° C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 μg/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Cölbe, Germany), 600 μg/ml Geneticin (G418-sulphate, Invitrogen) and 10 μg/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.12×10^−12 to 1×10^−5 M in the presence of 1×10^−1° R1881 (methyltrienolone). The test plates were incubated overnight at 37° C. and 5% CO2. After 16 hours, 15 μl of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).	2016	few@@@LdbbbRubRrTTrSIBUxHyuUUUUUUUUT@@	fewP`@DMA{HheEDdebeEDhbjqgUZN[TEAQT@@@PHIGP@	389.429	3.9998	5	1	75.01	4	0.46986179219846536	-0.35615073718836515	0.09823266078440097	16	16	ek`TDL@BDmB`@eYqN|\bbbRfQTRVRfbRaXdDTBbfv`@@Jjjf@H`a@rQP@	eFABP`BL@		eMbA@Dg`@								15
:Uvzv;S:vyvzUzUeUf;UjzbqSKMfbSDzlEzSAgdhAzyKmjop@CDb20JEgD2wCOaWGinSFX1WFq28WcF0	CHEMBL3921315	fcq``LVwAA`A@yB\`nPrRPqRJZIQKHrjQLD{pRijmUTCUAQUWTDIART\`@	CNC(=O)[C@@]12[C@@H]3CC[C@@H](C3)[C@@H]1CN(c1ccc(C#N)c(C(F)(F)F)c1)S2(=O)=O	7.36	group2-a	a	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of testosterone-induced transactivation	2016	fdu@@@LddTTJbfJuARUipXuUUUUUU@@@	fdu`b@LPP@HrRPqQSJIHlyhu`~bmUPUAEQcdEMH@	413.419	1.6373	6	1	98.65	3	1.1738296488355358	1.3901804599624448	0.24800766349462175	11	8	fewPa`CSUhGcqqDDMdNr@yCHhheIYD]DeLiEQcIFlgMUURu@AUWTXQFRR@@	gJYHDL@ILmP@										6
?vzvyIxyrDFloUTja0PV_e_8OF89l2VFFk0l1VFFV0_#42Ds8N4#40c4$18(k!VVFF	CHEMBL3921830	ek`\D@@DHi`DlbbTRRbrRrrbbTQdL\BFfvNZ``hjn`@@BACbAP@	N#Cc1ccc(C(=O)NC[C@H]2CC[C@H](Oc3ccnc4ccccc34)CC2)cc1	6.48	group3-int	int	Androgen Receptor	Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37° C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 μg/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Cölbe, Germany), 600 μg/ml Geneticin (G418-sulphate, Invitrogen) and 10 μg/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.12×10^−12 to 1×10^−5 M in the presence of 1×10^−1° R1881 (methyltrienolone). The test plates were incubated overnight at 37° C. and 5% CO2. After 16 hours, 15 μl of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).	2016	fmo@@@LdbbbRubRrRbfRYHRoAfnjjjjjjjjjh@@	fmoP`@D]@GHheDdhlmdhheDYF]yoYkZ``hjh@@@`Qr^`@	385.466	4.0937	5	1	75.01	5	0.6031111137017178	-0.5187263278244827	0.11830807131689189	4	4	fcPb@ICEDCcdTRVTrTRVRbbTQhsp^cWn@BZjjh@@@`QjA`@	eMbA@Dg`@										1
:Uvvv;S:vivUUzU@Uf:yUbybqOKIf7SDylAzS9gd9AyyKHbJK@BDa20FEg@2B5OXWGimN0X1WFq281c!	CHEMBL3926358	figP``LC``@QVP[H]dLddLTbfTrQaTbYpugQBeZjhJ`bjnhHR\`hY@@	C[C@@]12[C@@H]3CC[C@@H](C3)[C@@H]1CN(c1ccc(C#N)c(C(F)(F)F)c1)S2(=O)=O	7.14	group2-a	a	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of testosterone-induced transactivation	2016	fdu@@@LddTTJbfJuARUipXuUUUUUU@@@	fdu`b@LPP@HrRPqQSJIHlyhu`~bmUPUAEQcdEMH@	370.394	2.9599	4	0	69.55	2	-0.5072184752814579	0.43419305312410755	0.9935584321727329	11	8	fewPa`CSUhGcqqDDMdNr@yCHhheIYD]DeLiEQcIFlgMUURu@AUWTXQFRR@@	eFBH@c@@										6
:xjxyyirjyjzfxsijzDUjp5UtpePwFpIsFSsuSmggOoS4@Txo870k8FHV080F6d6#8Q1VF0GVVV3$F!	CHEMBL3926496	emhPL@@@FelbbRfbbeRfbbeRhXTtTL|BRJJjFfZZjjjjjjfjjTXgBDbdLSbBdRRaR@@	C[C@@]12CCC(=O)C=C1[C@H]1C[C@H]1[C@H]1[C@H]2CC[C@]2(C)[C@@H]1[C@H]1C[C@H]1[C@]21CCC(=O)O1	6.2	group3-int	int	Androgen Receptor	Receptor Binding Assay: Using cytosol from progesterone receptor-expressing insect cells (Hi5), competitive binding to the progesterone receptor was determined from the ability to displace 3H-progesterone as reference substance from the receptor. If a compound has an affinity corresponding to progesterone, this corresponds to a competition factor (CF) of 1. CF values greater than 1 are characterized by a lower affinity for the progesterone receptor, and CF values of less than 1 are characterized by higher affinity. The test was carried out as test above, with the following modifications: cytosol from androgen receptor-expressing insect cells (Hi5) was used, and the reference substance was 3H-testosterone.	2015	fi@@@LddTTRRNaTTJVis`iJLzJXy[vjjjjjjjjjj@@	fiA`@@EGdTRTrbaRfTTJUFRUKSoQRgK^mMUUUUUTuUPnHTeMJrBhqJ@@	366.499	3.4384	3	0	43.37	0	-1.5331837297579765	0.0897467897525433	0.7822444118021339	5	1	emhPL@@@FelbbRfbbeRfbbeRhXTtTL|BRJJjFfZZjjjjjjfjjTXgBDbdLSbBdRRaR@@											1
yLul2F8G8V4k!20FF21082m040F108202F440V83FV!9WV#V50JJ&VFV8J02_04c022#H!W8F0	CHEMBL3927163	fmwa``LPPT@QFPSHYdLddJbbRRfLbjbRtzpYkVh@@BJj@@@@@	O=S(=O)(Nc1ccc(Oc2ccccc2)cc1)c1cccc(C(F)(F)F)c1	5.28	group4-ia	ia	Androgen Receptor	Antagonist activity at human AR expressed in HEK293 cells measured after 24 hrs by luciferase reporter gene assay	2016	fns@@@LddTQRbrvRbRdYwjmjjjjjjjj`@@	fnsab@LPPD@QddaTTRRVJTRVgV}Uju@@@E@@@@@	393.384	4.2026	4	1	63.78	5	0.21427291003946122	-0.8167806407658298	0.014774239519017358	1	1	fmwa``LPPT@QFPSHYdLddJbbRRfLbjbRtzpYkVh@@BJj@@@@@											1
?tzvwnxwrDFtXUDSqHNZ5Q_@9Fc8n6W10k1t18FF_1W2!467k9N4!@4Fc048659808!1!F!VBFF	CHEMBL3927231	e`\TDJ@BDmB`LQZPndGiCzPrJJIJYEQIYJZIJERLRBJAQS[P@@EUUS@DUPP`YHh@@	O=C(N[C@H]1CC[C@H](Oc2ccnc3c(Br)cccc23)CC1)c1ccc(C(F)(F)F)c(F)c1	6.33	group3-int	int	Androgen Receptor	Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37° C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 μg/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Cölbe, Germany), 600 μg/ml Geneticin (G418-sulphate, Invitrogen) and 10 μg/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.12×10^−12 to 1×10^−5 M in the presence of 1×10^−1° R1881 (methyltrienolone). The test plates were incubated overnight at 37° C. and 5% CO2. After 16 hours, 15 μl of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).	2016	few@@@LdbbbRubRrTTrSIBUxHyuUUUUUUUUT@@	fewP`@DMA{HheEDdebeEDhbjqgUZN[TEAQT@@@PHIGP@	511.312	5.7377	4	1	51.22	5	0.5610632522827448	-2.269047608022516	0.18485234291856595	16	16	ek`TDL@BDmB`@eYqN|\bbbRfQTRVRfbRaXdDTBbfv`@@Jjjf@H`a@rQP@	eFABP`BL@	gJPBAHJPt`PAIjj@@	eFACD`BL@								15
?tzvwIxwrD0lVUDCqHNV5A_@0Fc8l2V10k1k10FF_1W$46k8N4#40c#649808)VcFF	CHEMBL3928026	egh\DD@EAkiH`IAbPrJIJHsJIKIQQJHsT\^A]CKGPADuUU@@AFPHZPJ@@	N#Cc1cccc2c(O[C@H]3CC[C@H](NC(=O)c4cc(F)cc(F)c4)CC3)ccnc12	7.41	group2-a	a	Androgen Receptor	Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37° C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 μg/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Cölbe, Germany), 600 μg/ml Geneticin (G418-sulphate, Invitrogen) and 10 μg/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.12×10^−12 to 1×10^−5 M in the presence of 1×10^−1° R1881 (methyltrienolone). The test plates were incubated overnight at 37° C. and 5% CO2. After 16 hours, 15 μl of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).	2016	few@@@LdbbbRubRrTTrSIBUxHyuUUUUUUUUT@@	fewP`@DMA{HheEDdebeEDhbjqgUZN[TEAQT@@@PHIGP@	407.419	4.1006	5	1	75.01	4	0.5598578563688532	-0.4834589874621803	0.1283602432279553	16	16	eghTDB@BDmB`@eYqNdKoGHhhdidUDedihdhlqHHhEEMm@@@UUUL@QPP`YHh@@	eFABP`BL@		eMbA@Dg`@								1
kHHF0F!8!k#4FN21080H040F021#H408!1808*2(2$482502(2080c!	CHEMBL392827	fle`C@E@dDRFICHiCEDdcDeiZCFjBCH@H@@@	Cc1ccc(-c2ccc(C#N)c(C(F)(F)F)c2)cc1	6.7	group3-int	int	Androgen Receptor	Displacement of [3H]DHT from human recombinant AR expressed in Sf9 cells	2007	dcl@@DjYU_egZjjjh@@	dcl@@DjYU_egX@@@@@@	261.245	4.3466	1	0	23.79	2	-2.617630000254619	-0.6928773042577697	0.43906822920149774	30	18	fle`B`N@BSNKoDLBeArJJIIFJJZU`oQ``rBHb@@@			gJPBAHJPt`PAIjj@@		eFBH@c@@						17
?tzvwIxwrDFtVUDSqHNV5A_89Fc8n2W10k1l10FF_1W#467k8N4!840c#649808%F!VBFF	CHEMBL3929024	ek`TDL@BDmB`LQZPNdLbbbRfQTRVRfbRaXdDTBbfv`@@Jjjf@H`a@rQP@	O=C(N[C@H]1CC[C@H](Oc2ccnc3c(Br)cccc23)CC1)c1ccc(F)c(F)c1	6.77	group3-int	int	Androgen Receptor	Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37° C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 μg/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Cölbe, Germany), 600 μg/ml Geneticin (G418-sulphate, Invitrogen) and 10 μg/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.12×10^−12 to 1×10^−5 M in the presence of 1×10^−1° R1881 (methyltrienolone). The test plates were incubated overnight at 37° C. and 5% CO2. After 16 hours, 15 μl of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).	2016	few@@@LdbbbRubRrTTrSIBUxHyuUUUUUUUUT@@	fewP`@DMA{HheEDdebeEDhbjqgUZN[TEAQT@@@PHIGP@	461.305	4.9902	4	1	51.22	4	0.17435021974490839	-1.5134237873276382	0.07256401807041546	16	16	ek`TDL@BDmB`@eYqN|\bbbRfQTRVRfbRaXdDTBbfv`@@Jjjf@H`a@rQP@	eFABP`BL@	eFABP`BL@	eFACD`BL@								15
?xzvwQzwriBdcyDCqbPVSAh@0GhQl2WA0k1VGcJG4WW280802o8N481GJVV1!J0C808)WVFk	CHEMBL3930760	fcI`@DT[lDoYEDhhdedThheDYiJLzkQkZfjZj`@@chDDch@	Cc1cc(C(=O)N[C@H]2CC[C@H](Oc3ccnc4c(C#N)cccc34)CC2)no1	7.75	group2-a	a	Androgen Receptor	Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37° C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 μg/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Cölbe, Germany), 600 μg/ml Geneticin (G418-sulphate, Invitrogen) and 10 μg/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.12×10^−12 to 1×10^−5 M in the presence of 1×10^−1° R1881 (methyltrienolone). The test plates were incubated overnight at 37° C. and 5% CO2. After 16 hours, 15 μl of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).	2016	fig@@@LdbbbRubRrTTrYHRoAzNjjjjjjjjj@@	figq`@DTjBSlbbTTRRNRbbTQdhubuzMjZijh@@B`PRV`@	376.415	2.7612	7	1	101.04	4	1.367847785385659	0.8693318862927064	0.31371119595869135	2	2	fmoqb@BI[hhpNNQQQISHjIKISQKLdIPXcg@@@UUULtpT`tc@@	eMbA@Dg`@										2
:Uvzv;S:vyvzUzUmUvvUzCfz_qSSjjjKEbnjQEfwck7fyMojnh@CBaLYmEhi1w5taYMbI10k1GNjXV0c!	CHEMBL3931647	e`\RHBDDLAie@@aZPvdCiBZ_nRYfYYeuVZUhxBjRzJFZj`Ph@hbjjxH@@	[C-]#[N+]c1ccc(N2C(=O)C3(CCN(C)CC3)N(c3ccc(C)cc3)C2=S)cc1C(F)(F)F	6.2	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	fa{@@@DjfYVWwo]gE^bUoZjjjjjjjj`@@	fa{qB@DXzh@PdsLrsKjotxFjVezuU@aPAPTD@@	458.507	3.9925	5	0	63.24	3	0.21005487375168816	-0.5595597682954331	1.242518795326716	2	1	e`\RHBDDLAie@@aZPvdCiBZ_nRYfYYeuVZUhxBjRzJFZj`Ph@hbjjxH@@											1
xfZDcTaX6Eu28co0V2r@Ca_0FFZVHR0FFc0Okk10Z480F!J8!40F+20V!F1*202010	CHEMBL393278	fn{@`@@MrJJIQZKPiSQIgIZMXL\ujjjjjjjjjeAHaIqJUizQVT@	C[C@]12CC[C@H]3[C@@H](CC[C@H]4[C@H]5CCC[C@]43CC[C@@H]5O)[C@@H]1CC[C@@H]2O	7.17	group2-a	a	Androgen Receptor	Binding affinity to androgen receptor	2007	fbc@@@LddTTRTRecPcR\ku`isUUUUUUUT@@	fbc@@@LddTTRTRecPcR\ku`isUUUUUUUTpD`dJbyMP@	318.499	3.7751	2	2	40.46	0	-1.5412291079603022	-0.10461278677261049	-1.564384867529011	2	1	fn{@`@@MrJJIQZKPiSQIgIZMXL\ujjjjjjjjjeAHaIqJUizQVT@											1
?tzvwIxwrDFlVUDCq2NV5A_@9Fc8l2V10k1l10FFZ1W#466k8N4#40c#409808%F!VcFF	CHEMBL3932783	ek`\DH@INca@`ICHhdlieDedhheDYjFGOFnimh@Ijjj@@BL`PTgd@@	N#Cc1cccc2c(O[C@H]3CC[C@H](NC(=O)c4ccc(F)cc4)CC3)ccnc12	6.85	group3-int	int	Androgen Receptor	Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37° C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 μg/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Cölbe, Germany), 600 μg/ml Geneticin (G418-sulphate, Invitrogen) and 10 μg/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.12×10^−12 to 1×10^−5 M in the presence of 1×10^−1° R1881 (methyltrienolone). The test plates were incubated overnight at 37° C. and 5% CO2. After 16 hours, 15 μl of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).	2016	few@@@LdbbbRubRrTTrSIBUxHyuUUUUUUUUT@@	fewP`@DMA{HheEDdebeEDhbjqgUZN[TEAQT@@@PHIGP@	389.429	3.9998	5	1	75.01	4	0.46986179219846536	-0.35615073718836515	0.09823266078440097	16	16	ek`TDL@BDmB`@eYqN|\bbbRfQTRVRfbRaXdDTBbfv`@@Jjjf@H`a@rQP@		eFABP`BL@	eMbA@Dg`@								15
zrzxySSn@o_k6HeCHP2KFtAH04F01b8B0HuZ78X1YGVO60YkBHOX944J10W8GTlFV9032ZV6J084G14710V8F0	CHEMBL393280	fasPa`JEStD`bPqHVdGRGiCHiBhhdeHhxdbZIVuUPPUQMRP@@	COc1cc(=O)[nH]c2ccc(N(CC(F)(F)F)CC(F)(F)F)cc12	7.82	group2-a	a	Androgen Receptor	Antagonist activity at human AR	2007	dmL@@DjYUVGijjjj@@	dmNH@DAIe[VfeVi@B@@	354.249	2.6704	4	1	41.57	6	-0.11841328742987411	-0.034314570872917394	-0.08803351463299683	41	37	dg~HpIl@doEWGHhhldhbwZ\DATrP@@	eMJA@Hz@		dcv@xJBPRPrPx@fPVPvPrJPjKRUUUT@@								37
:Uvzv;S:vyQzUzUeHQvUECfrhnR5b7jpE6nfQEWRco7fTHoblh2CBZXYnEdX1wCtXYHbG10l1GFb1Z0c!	CHEMBL3932857	ek`\HBDDLAe@@bZPVdMi@ZSnrJJJJIQQKQKSURZcaphJkKijjAB`HbJkh@@@	[C-]#[N+]c1ccc(N2C(=O)C3(CCC3)N(c3ccccc3C)C2=S)cc1C(F)(F)F	6.59	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	ffs@@@LddTTVbQVbrqILyyIZuUUUUUUUP@@	ffsQB@DXT@HRYfYYeu~gGYBUMVjhDJ@HJ@@@	415.438	4.3631	4	0	60	3	-0.33109343941934855	-0.7672506497641375	1.0767885105052857	13	10	egh\HJDACIh`GGPHVdMi@zPff{lbbRftTTfRtJTrdUCAegbSWT@ETuTp@UUe@@@											1
xvwjgyqabEuD9dpVZ7z@Cbp1IGZXHR0GHc0Okk50Z09ZF48RN4040F#1&2#8F)2#6030	CHEMBL393319	ehRPB@@@Ao`\bbRfbTrRTrbRNRRThXTt|bJZZjjjjjjjjjZjDHcBDRbtcdbQR@@	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@H](CCCCCCCCCC(=O)O)C[C@H]1CC(=O)CC[C@@]13C	6.04	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HeLa cells assessed as inhibition of dihydrotestosterone induced transcriptional activity by reporter gene assay	2007	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmUUUUUUDIAITM@@	460.696	6.6833	4	2	74.6	10	1.6948288820520063	-3.096292468886381	-0.7901843186149222	50	19	ffs@b@Bu@xyEEDhheDhdbV\d{tTyjjjjjjijnHQIRLWEI^P@	dkLD`@PpAImUUVjjj`@										19
;jj:ibEvj9wpWh7z@Cbp9IOaYmR0GHcZOsk10Z29Zk48SN4F4FF#1!2#2#8F08+2010	CHEMBL393320	ehRXL@@G`AklbbRfbTrRTrbRNRTthXTt|bJZZjjjjjjjjfjjDHcBDRbtcdbQR@@	CN(C)C(=O)CCCCCCC[C@@H]1C[C@H]2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@@H]21	6.72	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HeLa cells assessed as inhibition of dihydrotestosterone induced transcriptional activity by reporter gene assay	2007	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmUUUUUUDIAITM@@	459.712	5.9947	4	1	57.61	8	0.8556233509437412	-2.5477931469695205	0.1958712419361549	50	19	ffs@b@Bu@xyEEDhheDhdbV\d{tTyjjjjjjijnHQIRLWEI^P@	dkNH`D@pCHhhbddfjjj`@										19
[rvyQzyriBdwyTjaYPVxfh8FJBQl2WPFk0VGgJG0V_28080@o8N481GJ0V5!F098(V!W8Fk	CHEMBL3933747	fcqb@BY{jlpRFQQQISHjIKIJZIYdaJCFZx@@BjjjYi`iAiF@@	Cc1cc(C(=O)NC[C@H]2CC[C@H](Oc3ccnc4c(F)cccc34)CC2)no1	6.32	group3-int	int	Androgen Receptor	Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37° C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 μg/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Cölbe, Germany), 600 μg/ml Geneticin (G418-sulphate, Invitrogen) and 10 μg/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.12×10^−12 to 1×10^−5 M in the presence of 1×10^−1° R1881 (methyltrienolone). The test plates were incubated overnight at 37° C. and 5% CO2. After 16 hours, 15 μl of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).	2016	few@@@LdbbbRubRrRbfSIBUxHyuUUUUUUUUT@@	fewq`@DTZ@WlbbTRRaRrTTRbHiV]UhymSTuUP@@E@cd]@@	383.422	3.2211	6	1	77.25	5	0.9142215138924857	0.15069887191140935	0.20464409841358022	10	7	fcqb@BY{jlpNNQQQISHjIKIJZIYdaJCFZx@@BjjjYi`iAiF@@	eFABP`BL@										4
:UvzvU:KjxfqQzUzUXQvvUiCfr5mU5_7jKEbnfIEYwck7eiIqblh2CBZ2YkEda1u5taYHbG10k1GFj0V0c!	CHEMBL3934779	eg`\HFDLIIa@HaRHlBEiCZPNdIin{HeHhheElmEdeBiEqHEeUuUUM@p@AEU\@@@	[C-]#[N+]c1ccc(N2C(=O)C(CCl)(CCl)N(c3ccc(C)cc3)C2=S)cc1C(F)(F)F	6.28	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	flu@@@LdbbRbbsbRxXRhijjjjjjj@@	fluQB@DXT@HRYfY[]^gGQBejjA@@B@@@	472.317	4.7729	4	0	60	5	0.2662347889037157	-1.4661738618531939	1.224731722029386	29	17	fakQA`AFB@IH`zBKNM_GlCdTTVVbbfrfRaYpsbm``JfjPBH`@@	gJPLADH@LPdkU@@	gJPBAHJPt`PAIjj@@		eMbQ@B[h~@	eFBH@c@@						16
:Uvzv;S:vivzUzUeUf;UjybqOKMf7SDzlEzSfwdhQyyKmjLp@BDb2VJEgD2wCSeYKimO0X9WNy@81c!	CHEMBL3935242	fewQ``LS`bH@alavPGHYIHXiEMEdeiUHfBLyrPyVjjBhFJjz`aErBcd@	C[C@@]12[C@@H]3CC[C@@H](C3=O)[C@@H]1CN(c1ccc(C#N)c(C(F)(F)F)c1)S2(=O)=O	7.17	group2-a	a	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of testosterone-induced transactivation	2016	flm@@@LddTTJbfVQhJRmNbfjjjjjjj@@	flmab@LPPD@QddabbfbRRsAZmZOdkUTEPLUFNPTl`@	384.377	2.2515	5	0	86.62	2	0.11909072249062927	1.0542576737067628	1.1448709756441426	1	1	fewQ``LS`bH@alavPGHYIHXiEMEdeiUHfBLyrPyVjjBhFJjz`aErBcd@											1
=v;S:vyQzUzUumQvUECfr_mx5j7jME6nfQEnRco7fTPoblh2CBgDnmEfm1wCtXYHbG10k1GFb0VXcG0	CHEMBL3936716	eb^RLBDDLN`UOlP@`ZPfdEiCjSnrJJJJIQQKIZXjQJySIT\NYAEIMMUPHT@QEU]MUP@@@	[C-]#[N+]c1ccc(N2C(=O)C3(CCC3)N(c3ccc(CCC(=O)NCCO)cc3)C2=S)cc1C(F)(F)F	6.13	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	ffs@@@LddTTVbQVbrqILyyIZuUUUUUUUP@@	ffsQB@DXT@HRYfYYeu~gGYBUMVjhDJ@HJ@@@	516.543	3.3901	7	2	109.33	8	3.1197650624762705	-0.4647319108322754	-0.41362744675560253	13	10	ek`\HJDNMA``GEPHfdEiCZPFd{lbbRrbbdrVaRfTbhXtL\bjZ`@jZjX@Jjr`@@	diFD`D@^@DfUUjj`@										9
?tzvwIxwrDFtVUDSqHNV5A_8AFc8n2W10k1l10FF_1W#467k8N4!840c2!649808%F!VBFF	CHEMBL3936931	ek`TDL@BDmB`LQZHNdLbbbRfQTRVRfbRaXdDTBbfv`@@Jjjf@H`a@rQP@	O=C(N[C@H]1CC[C@H](Oc2ccnc3c(Br)cccc23)CC1)c1ccc(F)c(Cl)c1	6.72	group3-int	int	Androgen Receptor	Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37° C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 μg/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Cölbe, Germany), 600 μg/ml Geneticin (G418-sulphate, Invitrogen) and 10 μg/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.12×10^−12 to 1×10^−5 M in the presence of 1×10^−1° R1881 (methyltrienolone). The test plates were incubated overnight at 37° C. and 5% CO2. After 16 hours, 15 μl of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).	2016	few@@@LdbbbRubRrTTrSIBUxHyuUUUUUUUUT@@	fewP`@DMA{HheEDdebeEDhbjqgUZN[TEAQT@@@PHIGP@	477.76	5.4954	4	1	51.22	4	0.23723544939269026	-1.8781442893545726	0.10227329308376389	16	16	ek`TDL@BDmB`@eYqN|\bbbRfQTRVRfbRaXdDTBbfv`@@Jjjf@H`a@rQP@	eFABH`BL@	eFABP`BL@	eFACD`BL@								15
?tzvwIxwrDFtVUDSqHNV5A_89Fc8n2W10k1l10FF_1W#467k8N4!840c#641808%F!V8FF	CHEMBL3937441	fcPa@ECeDD`RPrJJKKSJIKIQQJHlyxOQkwA@SUUT@@@PHu@p@	O=C(N[C@H]1CC[C@H](Oc2ccnc3ccccc23)CC1)c1ccc(F)c(F)c1	7.35	group2-a	a	Androgen Receptor	Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37° C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 μg/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Cölbe, Germany), 600 μg/ml Geneticin (G418-sulphate, Invitrogen) and 10 μg/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.12×10^−12 to 1×10^−5 M in the presence of 1×10^−1° R1881 (methyltrienolone). The test plates were incubated overnight at 37° C. and 5% CO2. After 16 hours, 15 μl of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).	2016	few@@@LdbbbRubRrTTrSIBUxHyuUUUUUUUUT@@	fewP`@DMA{HheEDdebeEDhbjqgUZN[TEAQT@@@PHIGP@	382.409	4.265	4	1	51.22	4	-0.2070095211106137	-0.7848998503471564	-0.0610373317894773	16	16	ek`TDL@BDmB`@eYqN|\bbbRfQTRVRfbRaXdDTBbfv`@@Jjjf@H`a@rQP@	eFABP`BL@	eFABP`BL@									15
:UvztOzfJbwYLQzUwQVHOvTDB8K1mC5Z7fKE6YfIAVR8k3eDHobph2CBZ2YkEWm1s5tXYHbG10k1GFb0V0c!	CHEMBL3938351	eoh\HNDDLFe@@cjPFdIi@zPndGiAj]nrJJJJIQQKHsYRIVRc`KIJijjAB`@bjnj@@@	[C-]#[N+]c1ccc(N2C(=O)C(C)(C)N(c3ccc(C(F)(F)F)cc3)C2=S)cc1C(F)(F)F	6.84	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	flu@@@LdbbRbbsbRxXRhijjjjjjj@@	fluQB@DXT@HRYfY[]^gGQBejjA@@B@@@	457.397	4.8187	4	0	60	4	0.026971375209880258	-1.3175546190089433	1.1743127578303185	29	17	fakQA`AFB@IH`zBKNM_GlCdTTVVbbfrfRaYpsbm``JfjPBH`@@	eMBH@RZ@	gJPBAHJPt`PAIjj@@		eMbQ@B[h~@	gJPBAHJPt`PAIjj@@						16
:Uvzv;S:vyQzUzUemQvUECfr_mS5b7jKE6nfQElRco7fTPoblh2CBZ@YmEfm1wCtXYHbG10k1GFb0W0cV0	CHEMBL3938936	ehRRDBDDLN`UO`@`ZPfdEiCjSnrJJJJIQQKIZXjQJyRcasHHiIijjAB`BHjkij@@@	[C-]#[N+]c1ccc(N2C(=O)C3(CCC3)N(c3ccc(CCC(N)=O)cc3)C2=S)cc1C(F)(F)F	6.65	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	ffs@@@LddTTVbQVbrqILyyIZuUUUUUUUP@@	ffsQB@DXT@HRYfYYeu~gGYBUMVjhDJ@HJ@@@	472.49	3.559	6	1	103.09	6	1.9415149415434942	-0.31400320498702217	0.4448456940688691	13	10	ek`\HJDNMA``GEPHfdEiCZPFd{lbbRrbbdrVaRfTbhXtL\bjZ`@jZjX@Jjr`@@	gGYHDJ@IMkU@@										9
<v<U:vizU;@Uj:yUbyryOKIf7SyzlAzS9gt9AyyKHjJK@BDa20FEgD2B_OaWKimN0X1WNq283c10	CHEMBL3939272	fewQ``LS``h@alavPGHYIHXiELidcLeIf\LztPiVjjBhHjjzbaIrBQeF@@	C[C@@]12[C@H]3C[C@H]([C@H](O)C3)[C@@H]1CN(c1ccc(C#N)c(C(F)(F)F)c1)S2(=O)=O	6.37	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of testosterone-induced transactivation	2016	fdu@@@LddTTJbfJuARUipXuUUUUUU@@@	fdu`b@LPP@HrRPqQSJIHlyhu`~bmUPUAEQcdEMH@	386.393	2.1078	5	1	89.78	2	0.46337719764908525	1.1424689491895084	0.06875867287255559	11	8	fmoQa`GKHZpOFSbhH{HCdIrFQQQSJ[RUQISJQTxpVgYKUUURt@EU]PQDqJPT@@	eFBH@c@@										1
:Uvzv;S:vyQzUzUeHQvUECfr_mS5b7jKE6nfQEWRco7fTHoblh2CBZ2YmEdX1wCtXYHbG10k1GFb0V0c!	CHEMBL3940023	ek`\HBDDLNe@@`ZPfdEiCjSnrJJJJIQQKIZXjQJcasHHiIijjAB`BHjkh@@@	[C-]#[N+]c1ccc(N2C(=O)C3(CCC3)N(c3ccc(C)cc3)C2=S)cc1C(F)(F)F	6.91	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	ffs@@@LddTTVbQVbrqILyyIZuUUUUUUUP@@	ffsQB@DXT@HRYfYYeu~gGYBUMVjhDJ@HJ@@@	415.438	4.3631	4	0	60	3	-0.33109343941934855	-0.7672506497641375	1.0767885105052857	13	10	ek`\HJDNMA``GEPHfdEiCZPFd{lbbRrbbdrVaRfTbhXtL\bjZ`@jZjX@Jjr`@@	eFBH@c@@										9
;vvtOzfJbwYLQUUwQVHOvTDB0K1mB7Z7AKE6YfIAVR8k3eDHoblh2CBZ2YkEWX1c5OXYHbG10k1GFb0V2c10	CHEMBL3940304	fcoqBbDXZl@PhH{HCdIrCYwvQQQQQJJIYF[JQJg@ySUjjAB`@bjn@@@	[C-]#[N+]c1ccc(N2C(=S)N(c3ccc(O)cc3)C(C)(C)C2=S)cc1C(F)(F)F	6.56	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	flu@@@LdbbRbbsbRxXRhijjjjjjj@@	fluPA@DX@DJBDfYfVwWiqtPiZj`P@@`@@	421.466	3.8441	4	1	95.25	3	0.5681095138117589	-0.23291944705930628	0.08700470305602315	29	1	fcoqBbDXZl@PhH{HCdIrCYwvQQQQQJJIYF[JQJg@ySUjjAB`@bjn@@@											1
:UvzvU:KjxfqQzUzUXHvvUiCfr5mS5_7jKE7nfIEYRck7eDIqblh2CBZ2YkEda1s5taYHbG10k1GFj0V0c!	CHEMBL3941698	fkqBbDXzh@QfPGHSdErGYOvQQQQQJJIYKSERITxDjVmUPHT@QEU\DNT@@	[C-]#[N+]c1ccc(N2C(=O)C(C)(CF)N(c3ccc(C)cc3)C2=S)cc1C(F)(F)F	6.9	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	flu@@@LdbbRbbsbRxXRhijjjjjjj@@	fluQB@DXT@HRYfY[]^gGQBejjA@@B@@@	421.417	4.0887	4	0	60	4	-0.12815909271247247	-0.7452911060209362	1.1113039060429302	29	17	fakQA`AFB@IH`zBKNM_GlCdTTVVbbfrfRaYpsbm``JfjPBH`@@	gC`DAHH@RVh@	gJPBAHJPt`PAIjj@@		eMbQ@B[h~@	eFBH@c@@						16
oHuF0F018!k#4FN210N0H040F0212!H418!18082)202$82#14@2582(2482c10	CHEMBL394392	fbu`c@E^bBPQHXdLbdLTRRLTTtmIsUAAdDP@@@	N#Cc1ccc(-c2c(O)cccc2O)cc1C(F)(F)F	6	group3-int	int	Androgen Receptor	Displacement of [3H]DHT from human recombinant AR expressed in Sf9 cells	2007	dcl@@DjYU_egZjjjh@@	dcl@@DjYU_egX@@@@@@	279.217	3.3113	3	2	64.25	2	-0.7817739244739458	0.37357910929484905	-1.4301248183823148	30	18	fle`B`N@BSNKoDLBeArJJIIFJJZU`oQ``rBHb@@@	eFJB@Hp@	eFJB@Hp@	gJPBAHJPt`PAIjj@@								17
;vzv;S:vyQzUzUeHQvUECfr_mR7b7jKE6nfQEWRco7fTHoblh2CBZ2YmEdX1wCtXYHbG10k1GFb0V2c10	CHEMBL3947344	ek`\DBDDLNeM`@`ZPfdEiCjSnrJJJJIQQKIZXjQJcasHHiIijjAB`BHjkh@@@	[C-]#[N+]c1ccc(N2C(=O)C3(CCC3)N(c3ccc(O)cc3)C2=S)cc1C(F)(F)F	6.79	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	ffs@@@LddTTVbQVbrqILyyIZuUUUUUUUP@@	ffsQB@DXT@HRYfYYeu~gGYBUMVjhDJ@HJ@@@	417.41	3.6735	5	1	80.23	3	0.5579880229139059	-0.10464487067836357	0.12975448294244832	13	10	ek`\HJDNMA``GEPHfdEiCZPFd{lbbRrbbdrVaRfTbhXtL\bjZ`@jZjX@Jjr`@@	eFJB@Hp@										9
[rvyQzyriBdwyTjaWPVxfh8FJBQl2WPFk0VGgJG0V_28080@o8N481GJ0V5!F018(V!W0Fk	CHEMBL3948034	fmoq`@DTz@P\bbTRRfRvRbbTQEIwf}fmjZfjj`@@JAGIz@@	Cc1cc(C(=O)NC[C@H]2CC[C@H](Oc3ccnc4ccccc34)CC2)no1	6.68	group3-int	int	Androgen Receptor	Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37° C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 μg/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Cölbe, Germany), 600 μg/ml Geneticin (G418-sulphate, Invitrogen) and 10 μg/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.12×10^−12 to 1×10^−5 M in the presence of 1×10^−1° R1881 (methyltrienolone). The test plates were incubated overnight at 37° C. and 5% CO2. After 16 hours, 15 μl of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).	2016	few@@@LdbbbRubRrRbfSIBUxHyuUUUUUUUUT@@	fewq`@DTZ@WlbbTRRaRrTTRbHiV]UhymSTuUP@@E@cd]@@	365.432	3.1203	6	1	77.25	5	0.8242256216509652	0.278007152341511	0.1745165649436649	10	7	fcqb@BY{jlpNNQQQISHjIKIJZIYdaJCFZx@@BjjjYi`iAiF@@											4
=v;S:vyQzUzUeHQvUECfr_mS5b7jKE6nfQEWRco7fTHobph2CBZ3YmEdm1wCtXYHbK10k1GFb0V2c10	CHEMBL3948211	egh\DBDDLNeK`@`ZPfdEiCjSnrJJJJIQQKIZXjQJt\NYAEIMMUPHT@QEU]P@@@	[C-]#[N+]c1ccc(N2C(=O)C3(CCC3)N(c3ccc(CO)cc3)C2=S)cc1C(F)(F)F	6.51	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	ffs@@@LddTTVbQVbrqILyyIZuUUUUUUUP@@	ffsQB@DXT@HRYfYYeu~gGYBUMVjhDJ@HJ@@@	431.437	3.4219	5	1	80.23	4	0.8022318725702583	-0.12623614405085756	0.17763155264986322	13	10	ek`\HJDNMA``GEPHfdEiCZPFd{lbbRrbbdrVaRfTbhXtL\bjZ`@jZjX@Jjr`@@	eMJA@Df`@										9
:UvztOzfJbwYLQzUwQWHOvTDB8K1nC5Z7vpEDYfIAVRDk3eDHpblj3SBZXYlEWXWt5vXYHbG10kGGFb1dVck0	CHEMBL3948452	ea]ZDJ@DLC`RUO`@bjPFdIiAZPrJJJJIQQKHsSJSJySJJKT\AYIML|mUPHT@EEU[MA@P@DAt@	CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(/C=C/C(=O)Nc2ccccc2N)c(F)c1	6.64	group3-int	int	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor (unknown origin) in membranes after 24 hrs by HAP adsorption assay	2016	eghP@@@LdbbRbbsbRrRbtRWA`bdRQuuUUUUUUUUUUP@@	egh\DH@DLNeF`@cHhhhheLlebdieDeQpyDDd]\uU@`@ALt@D@AAe@	567.566	4.9478	7	2	134.55	6	3.403730766438966	-1.163708776989215	-0.30957074521080563	1	1	ea]ZDJ@DLC`RUO`@bjPFdIiAZPrJJJJIQQKHsSJSJySJJKT\AYIML|mUPHT@EEU[MA@P@DAt@											1
:Uvvv;S:vivUUzU@Uf:yUbybqOKIf7SDzlAzSAwd9AyyKHbJK@BDa20FEg@2B5OaWKimNFX1WNy281c!	CHEMBL3949176	fewPb`LS``@PfP[H]dArFRRFJQSJYIZURIgCNmDNUjj`jBbjnhhR\`dYVP@	C[C@@]12[C@H]3C[C@H](C[C@@H]3F)[C@@H]1CN(c1ccc(C#N)c(C(F)(F)F)c1)S2(=O)=O	7.04	group2-a	a	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of testosterone-induced transactivation	2016	fdu@@@LddTTJbfJuARUipXuUUUUUU@@@	fdu`b@LPP@HrRPqQSJIHlyhu`~bmUPUAEQcdEMH@	388.384	2.8089	4	0	69.55	2	-0.40537527757457137	0.458253860303231	1.0223737212014932	11	8	fewPa`CSUhGcqqDDMdNr@yCHhheIYD]DeLiEQcIFlgMUURu@AUWTXQFRR@@	eFBH@c@@	eFABP`BL@									6
[rvyQzyriBdwyTjaYPVxfh8FJBQl2WHFk0VGgJG0V_2$@o8N4811J0V5!F098(V!W4Fk	CHEMBL3953928	fmoqb@BY{jlpXfQQQISHjIKIJZILdIPXsW@@@UUUSMHT`tc@@	O=C(NC[C@H]1CC[C@H](Oc2ccnc3c(Br)cccc23)CC1)c1ccon1	6.2	group3-int	int	Androgen Receptor	Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37° C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 μg/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Cölbe, Germany), 600 μg/ml Geneticin (G418-sulphate, Invitrogen) and 10 μg/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.12×10^−12 to 1×10^−5 M in the presence of 1×10^−1° R1881 (methyltrienolone). The test plates were incubated overnight at 37° C. and 5% CO2. After 16 hours, 15 μl of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).	2016	few@@@LdbbbRubRrRbfSIBUxHyuUUUUUUUUT@@	fewq`@DTZ@WlbbTRRaRrTTRbHiV]UhymSTuUP@@E@cd]@@	430.301	3.4476	6	1	77.25	5	1.150437975768009	-0.15930307083935602	0.28296307400567494	10	7	fmoqb@BY{jlpNNQQQISHjIKIJZILdIPXsW@@@UUUSMHT`tc@@	eFACD`BL@										3
:UvztOzfJbwYLQzUwQWHOvTDB8K1nC5Z7vpEDYfIQVR@kYeDHpbpj7SCZXYlEWmdt5tXYHbG10o1GFr1dVck0	CHEMBL3955013	efYZDJ@DLCgdUK`@bjPFdIiAZPrJJJJIQQKHsSJSJpjJKT\AYIMDtmUPHT@EEU[PPD@@@@	CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(C(=O)Nc2ccccc2N)c(F)c1	6.48	group3-int	int	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor (unknown origin) in membranes after 24 hrs by HAP adsorption assay	2016	fc@@@LdbbRbbsbRrbtRWCBUEJ}uUUUUUUUUUP@@	fcpb@DXjhh@cHhhhheLlebieDeSchaRo[UTB@@Dt@D@@@	541.528	4.6186	7	2	134.55	5	3.123561963124919	-0.7484299061044835	-0.38023845216185986	1	1	efYZDJ@DLCgdUK`@bjPFdIiAZPrJJJJIQQKHsSJSJpjJKT\AYIMDtmUPHT@EEU[PPD@@@@											1
:Uvzv;S:vyvzUzUeUQzUUCfz_mS5b7jKEanfQEWwco7fyHoblh2CBZ2YmEdX1wCtXYHjG10k1GFb0V0c!	CHEMBL3955747	eodRHBDDLAge@@bZPVdMi@Z[nrJJJJIQQKIISURIVc`JiKkHijjAB`BbJj~B@@@	[C-]#[N+]c1ccc(N2C(=O)C3(CCCC3)N(c3ccc(C#N)cc3)C2=S)cc1C(F)(F)F	6.33	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	fnk@@@LddTTRTRjtVVYrR`yjvjjjjjjjj`@@	fnkQB@DXT@HRYfYYeuWipMTmrUjjAB`B```@@	440.448	4.1968	5	0	83.79	3	0.43586332078465184	-0.46466777349052807	1.2661761852138467	3	3	egh\HJDNMI``GEPHVdMi@zPff{lbbRrbbdrRTjTrdUCFadRSWT@ESUSP@UUe@@@	eMbA@Dg`@										3
:UvztOzfJbwYLQzUwQVHOvTDB8K1mC5Z7fKE6YfIAVR8k3eDHoblh2CBZ2YkEWX1s5tXYHbG10k1GFb0V0c!	CHEMBL3958249	fcoq@bDXZh@QvPGHSdFsolbbbbbTTRrLvTbUNArfkUTBE@AEU\@@@	[C-]#[N+]c1ccc(N2C(=O)C(C)(C)N(c3ccc(C)cc3)C2=S)cc1C(F)(F)F	6.9	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	flu@@@LdbbRbbsbRxXRhijjjjjjj@@	fluQB@DXT@HRYfY[]^gGQBejjA@@B@@@	403.427	4.3143	4	0	60	3	-0.3920494297200814	-0.6933741284667471	1.056770320799935	29	17	fakQA`AFB@IH`zBKNM_GlCdTTVVbbfrfRaYpsbm``JfjPBH`@@	eMBH@RZ@	gJPBAHJPt`PAIjj@@		eMbQ@B[h~@	eFBH@c@@						16
~UzU:imQvUjhfr_uS5b7jKE6zvQjlRco7fTQoblh2CBZ@YmEfm1wCtXYHbG10kWGHb0V0c!	CHEMBL3958745	elV\LBDDLNe@XP@`ZPfdEiCjSnrJJJJIQQKIZXjQJyJZcasHHiIijjAB`BHjkjZh@@@	[C-]#[N+]c1ccc(N2C(=O)C3(CCC3)N(c3ccc(CCCC(=O)OC)cc3)C2=S)cc1C(F)(F)F	6.37	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	ffs@@@LddTTVbQVbrqILyyIZuUUUUUUUP@@	ffsQB@DXT@HRYfYYeu~gGYBUMVjhDJ@HJ@@@	501.528	4.8391	6	0	86.3	8	1.8051480835930571	-1.5421438487279597	1.5954991815087833	13	10	ek`\HJDNMA``GEPHfdEiCZPFd{lbbRrbbdrVaRfTbhXtL\bjZ`@jZjX@Jjr`@@	daxD`@S`AIeujj@@										9
]vyQzyriBdwyTjaYPVxfh@FJBQl2WHFk1VGgJG0V_2$@o8N4811J0V5!F098(V!WVFk	CHEMBL3959058	fcI`@DT[l@oYEDhdeBedhheDYaRlzkQkZfijj`@@chD\ch@	N#Cc1cccc2c(O[C@H]3CC[C@H](CNC(=O)c4ccon4)CC3)ccnc12	6.14	group3-int	int	Androgen Receptor	Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37° C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 μg/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Cölbe, Germany), 600 μg/ml Geneticin (G418-sulphate, Invitrogen) and 10 μg/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.12×10^−12 to 1×10^−5 M in the presence of 1×10^−1° R1881 (methyltrienolone). The test plates were incubated overnight at 37° C. and 5% CO2. After 16 hours, 15 μl of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).	2016	few@@@LdbbbRubRrRbfSIBUxHyuUUUUUUUUT@@	fewq`@DTZ@WlbbTRRaRrTTRbHiV]UhymSTuUP@@E@cd]@@	376.415	2.558	7	1	101.04	5	1.5359455899565309	0.8706614423761552	0.3387593016482321	10	7	fmoqb@BY{jlpNNQQQISHjIKIJZILdIPXsW@@@UUUSMHT`tc@@	eMbA@Dg`@										3
:UvztOzfJbwYLQzUwQVHOvTDB8K1mB5Z7fKE6YfIAVR8k3eDHoblh2CBZ2YkEWX1s5tXYHbG10k1GFb0V0c!	CHEMBL3959936	fmwq@bDXZh@QvPGHSdFrolbbbbbTTRrLvTfipNTuZj`Ph@Hjn@@@	[C-]#[N+]c1ccc(N2C(=O)C(C)(C)N(c3ccccc3)C2=S)cc1C(F)(F)F	6.83	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	flu@@@LdbbRbbsbRxXRhijjjjjjj@@	fluQB@DXT@HRYfY[]^gGQBejjA@@B@@@	389.4	3.9704	4	0	60	3	-0.4497375607871881	-0.43462266120893717	1.0318969007547614	29	17	fakQA`AFB@IH`zBKNM_GlCdTTVVbbfrfRaYpsbm``JfjPBH`@@	eMBH@RZ@	gJPBAHJPt`PAIjj@@		eMbQ@B[h~@							16
?tzvwIxwrDFtVUDSqHNV5A_@9Fc8n2W10k1l10FF_1W#467k8N4!840c#649808%F!VcFF	CHEMBL3960255	egh\DD@EAkiH`I@bPrJJKKSJIKIQQJHsL\^A]CKGPPDuUU@@AFPHZPJ@@	N#Cc1cccc2c(O[C@H]3CC[C@H](NC(=O)c4ccc(F)c(F)c4)CC3)ccnc12	7.14	group2-a	a	Androgen Receptor	Transactivation Assay: PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979) were plated out at a density of 10000 cells per well of a 96-well cell culture plate in RMPI 1640 medium (F1235, Biochrom AG, Berlin, Germany), which contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). On the next day the cells were transiently transfected with the pSG5-vector (#216201 Stratagene), which contained the sequence of the androgen receptor mutant W741C (Haapala et al., Lab Invest. 81(12): 1647-51, 2001), and with a reporter plasmid based on pGL4.14 (#E6691, Promega) with the luciferase-gene (from Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-8, 1987). The cells were treated with the test substances in concentrations from 1×10^−8 to 1×10^−10 M in the presence of 1×10^−10 M R1881 and were incubated overnight at 37° C. and 5% CO2. After 24 hours, 100 μl of Steady Glo Lysis and Detection reagent (E2550, Promega) was added per well and the luminescence was read in a Victor3 Luminometer (PerkinElmer) for 1 second per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).	2016	few@@@LdbbbRubRrTTrSIBUxHyuUUUUUUUUT@@	fewP`@DMA{HheEDdebeEDhbjqgUZN[TEAQT@@@PHIGP@	407.419	4.1006	5	1	75.01	4	0.5598578563688532	-0.4834589874621803	0.1283602432279553	16	16	ek`TDL@BDmB`@eYqN|\bbbRfQTRVRfbRaXdDTBbfv`@@Jjjf@H`a@rQP@	eFABP`BL@	eFABP`BL@	eMbA@Dg`@								15
:UvztOzfJbwYLQzUwQVHOvTDB8K1mB5Z7fKE6YfIAVR8k3eDHoblh2CBo2YkEWX1s5tXYHbG10k1IFb0V0c0F	CHEMBL3961165	fcoI@bDXuuP@`\aNPWH]g_YEEEEDhhedYdeHZ\CeMVjhDJ@BJjx@@@	[C-]#[N+]c1ccc(N2C(=O)C(C)(C)N(c3cc(C)ccn3)C2=S)cc1C(F)(F)F	6.34	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	flu@@@LdbbRbbsbRxXRhijjjjjjj@@	fluqB@DXth@PdsLrvz}NNbEKUTB@@D@@@	404.415	3.6648	5	0	72.89	3	0.09582403507848739	-0.09118873423483716	1.1763669087936228	29	4	fakqC@AFSXGbQqtDYEEElhhimEBdf\LzkXHBifj@BH@@	gJPBAHJPt`PAIjj@@	eMbQ@B[h~@									1
:UvztOzfJbwYLQzUwQVHOvTDB8K1mB5Z7fKE6YfIAVR8k3eDHoblh2CBo2YkEWX1s5tXYHbG10k1IFb0V0c0F	CHEMBL3962284	fmwI@bDXtuP@cl`NPgHMe_YEEEEDhhedYliMS`\ijuU@aP@QU\@@@	[C-]#[N+]c1ccc(N2C(=O)C(C)(C)N(c3ccccn3)C2=S)cc1C(F)(F)F	6.14	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	flu@@@LdbbRbbsbRxXRhijjjjjjj@@	fluqB@DXth@PdsLrvz}NNbEKUTB@@D@@@	390.388	3.3209	5	0	72.89	3	0.03813590401138059	0.1675627330229728	1.1514934887484494	29	4	fnsqC@AFSXGbQqtDYEEElhhimEBdsagU[A@ULuP@D@@@	gJPBAHJPt`PAIjj@@	eMbQ@B[h~@									1
=xOzfJbwYMQzUwQWHOvTDB8K9nB5ZMvpE6YfIAVSDkYeDHoblh2CBZYflElYdt5tXYmrK10l1GFb1Z6c30	CHEMBL3963614	eg`\LBDDLIeFn`@aZPvdCiBZ[nrJJJJIQQKQFZKJRt\AEYCMUPHTDALUW@@@@	[C-]#[N+]c1ccc(N2C(=O)C(C)(C)N(c3ccccc3C(=O)O)C2=S)cc1C(F)(F)F	6.28	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	flu@@@LdbbRbbsbRxXRhijjjjjjj@@	fluQB@DXT@HRYfY[]^gGQBejjA@@B@@@	433.409	3.4555	6	1	97.3	4	1.3303773971438533	0.09231695610892054	0.3130470772066313	29	17	fmwQa`A^UkH@ebBxHBxc|UpNQQQQQPrqSYSIP|ezOYpEDMSUHADP@@	eMBH@RZ@	gJPBAHJPt`PAIjj@@		eMbQ@B[h~@							1
:Uvzv;S:vyQzUzUemQvUjCfr_mS5b7jKE6nfQElRco7fTQoblh2CBZ@YmEfm1wCtXYHbG10k1GFb0W0cV0	CHEMBL3965705	edZRDBDDLNhU@P@`ZPfdEiCjSnrJJJJIQQKIZXjQJyJT\NYAEIMMUPHT@QEU]ST@@@	[C-]#[N+]c1ccc(N2C(=O)C3(CCC3)N(c3ccc(CCCC(N)=O)cc3)C2=S)cc1C(F)(F)F	6.95	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	ffs@@@LddTTVbQVbrqILyyIZuUUUUUUUP@@	ffsQB@DXT@HRYfYYeu~gGYBUMVjhDJ@HJ@@@	486.517	4.0134	6	1	103.09	7	2.1525411397375414	-0.7600053799834698	0.4964020542788423	13	10	ek`\HJDNMA``GEPHfdEiCZPFd{lbbRrbbdrVaRfTbhXtL\bjZ`@jZjX@Jjr`@@	gNyHDF@IMjuT@@										9
=tUzvrrxrLQzUxQlHOvUii8KCnh_a7vMEEYjIQZRekYeDIpbpj7SCg2noEVmdt5tXYLbG1Vo3GFrFcYcG0	CHEMBL3966165	eaUZJJ@DLCgfUKhZ^P@bjPFdIiAZPrJJJJIQQKHsSJSJpiIIST\AYIMMUPHT@EEU[UUMP@@@	CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(C(=O)NCCOCCC(=O)NO)c(F)c1	7.11	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor (unknown origin) in membranes after 24 hrs by HAP adsorption assay	2016	flu@@@LdbbRbbsbRxXRhijjjjjjj@@	fluQB@DXT@HRYfY[]^gGQBejjA@@B@@@	581.546	2.5647	10	3	167.09	10	5.757450183944451	0.3211188823630955	-0.9328185927260462	29	17	fakQA`AFB@IH`zBKNM_GlCdTTVVbbfrfRaYpsbm``JfjPBH`@@	eMBH@RZ@	gJPBAHJPt`PAIjj@@	eFABP`BL@	eMbA@Dg`@	dkMB`DdB[S@DfWUVZjjf@@						16
:Uvzv;S:vyQzUzUuHQvUECfr_mRCbEjKE6nfQEWRco7fTHoblh2CBZHYmEdm1wCtXYHbG10k1GFbVVVcF0	CHEMBL3966495	edVZHBDDLNmhU@@`ZPfdEiCjSnrJJJJIQQKIZXjQJsIT\NYAEIM@pmUPHT@QEU]UTD@@@	[C-]#[N+]c1ccc(N2C(=O)C3(CCC3)N(c3ccc(N4CCNCC4)cc3)C2=S)cc1C(F)(F)F	6.14	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	ec`P@@@LddTTVbQVbrRtrQDcGGbQSRvuUUUUUUUUUU@@@	ec`RHH@DLFme@@cHhhhheEDlemUDeQpydDTeTmluU@aPAAUUPP@@	485.533	3.5447	6	1	75.27	4	1.2463479712368708	-0.31619202863216844	0.34320538004953494	3	2	edVZHBDDLNmhU@@`ZPfdEiCjSnrJJJJIQQKIZXjQJsIT\NYAEIM@pmUPHT@QEU]UTD@@@											1
kHHF0F!8!k#4FN21080H040F021#H408!18086)2(2$4@25V2$F!2080c!	CHEMBL396656	ff}`A`E@dDRFICL`VPkHYEHXhddXhdiIZbfjBCHBBh@@@	N#Cc1ccc(-c2ccccc2C(F)(F)F)cc1C(F)(F)F	7.96	group2-a	a	Androgen Receptor	Displacement of [3H]DHT from human recombinant AR expressed in Sf9 cells	2007	dcl@@DjYU_egZjjjh@@	dcl@@DjYU_egX@@@@@@	315.216	4.851	1	0	23.79	3	-2.1986038918565116	-1.3170615293666308	0.5566123233647557	30	18	fle`B`N@BSNKoDLBeArJJIIFJJZU`oQ``rBHb@@@	gJPBAHJPt`PAIjj@@		gJPBAHJPt`PAIjj@@								17
?tzvwIxwrDFtVUDSqHNV5A_@9Fc8n2W10k1l10FF_1W#467k8N4!840c#649808%F!VcFF	CHEMBL3966897	egh\DH@EAkiH`ICHhhemLhdleEDhcLqqxEtLl]@PSUUT@@DY@ai@h@@	Cc1ccc(C(=O)N[C@H]2CC[C@H](Oc3ccnc4c(C#N)cccc34)CC2)cc1F	7.35	group2-a	a	Androgen Receptor	Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37° C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 μg/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Cölbe, Germany), 600 μg/ml Geneticin (G418-sulphate, Invitrogen) and 10 μg/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.12×10^−12 to 1×10^−5 M in the presence of 1×10^−1° R1881 (methyltrienolone). The test plates were incubated overnight at 37° C. and 5% CO2. After 16 hours, 15 μl of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).	2016	few@@@LdbbbRubRrTTrSIBUxHyuUUUUUUUUT@@	fewP`@DMA{HheEDdebeEDhbjqgUZN[TEAQT@@@PHIGP@	403.456	4.3437	5	1	75.01	4	0.527549923265572	-0.614902204446175	0.1231060808295746	16	16	ek`TDL@BDmB`@eYqN|\bbbRfQTRVRfbRaXdDTBbfv`@@Jjjf@H`a@rQP@	eFABP`BL@	eFBH@c@@	eMbA@Dg`@								15
?xrvwQzwriBdcyDCqbPVSAh80GhQl2WA0k0VGcJG4WW280802o8N481GJVV1!J0C808)W4Fk	CHEMBL3967143	fmoqb@BI[hhpXfQQQISHjIKISQKLdIPXcg@@@UUULtpT`tc@@	Cc1cc(C(=O)N[C@H]2CC[C@H](Oc3ccnc4c(Br)cccc34)CC2)no1	7.7	group2-a	a	Androgen Receptor	Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37° C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 μg/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Cölbe, Germany), 600 μg/ml Geneticin (G418-sulphate, Invitrogen) and 10 μg/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.12×10^−12 to 1×10^−5 M in the presence of 1×10^−1° R1881 (methyltrienolone). The test plates were incubated overnight at 37° C. and 5% CO2. After 16 hours, 15 μl of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).	2016	fig@@@LdbbbRubRrTTrYHRoAzNjjjjjjjjj@@	figq`@DTjBSlbbTTRRNRbbTQdhubuzMjZijh@@B`PRV`@	430.301	3.6508	6	1	77.25	4	0.9823401599794258	-0.16063277024777814	0.25791496955864285	2	2	fmoqb@BI[hhpNNQQQISHjIKISQKLdIPXcg@@@UUULtpT`tc@@	eFACD`BL@										2
:Uvzv;S:vyQzUzUemQvUECfr_mS5b7jKE6nfQElRco7fTPoblh2CBZ@YmEfm1wCtXYHbG10k1GFb0VVcF0	CHEMBL3967236	edZRDBDDLN`UO`@`ZPfdEiCjSnrJJJJIQQKIZXjQJyST\NYAEIMMUPHT@QEU]MT@@@	[C-]#[N+]c1ccc(N2C(=O)C3(CCC3)N(c3ccc(CCC(=O)NC)cc3)C2=S)cc1C(F)(F)F	6.63	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	ffs@@@LddTTVbQVbrqILyyIZuUUUUUUUP@@	ffsQB@DXT@HRYfYYeu~gGYBUMVjhDJ@HJ@@@	486.517	3.9105	6	1	89.1	6	1.7738326514409855	-0.6799428867356914	0.43414825639047183	13	10	ek`\HJDNMA``GEPHfdEiCZPFd{lbbRrbbdrVaRfTbhXtL\bjZ`@jZjX@Jjr`@@	gNyHDF@ILnuT@@										9
?vzvyIxyrD0loUTjaHPV_e_8FF89l2VFFk1k1VFFW0_%Ds8N4#40c4!2418(V!V8FF	CHEMBL3970563	fcPb@ICEDDadTRTtJTRVRbbTQisp^cWn@HZjjh@@@`QjA`@	O=C(NC[C@H]1CC[C@H](Oc2ccnc3ccccc23)CC1)c1cccc(F)c1	6.76	group3-int	int	Androgen Receptor	Transactivation Assay: PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979) were plated out at a density of 10000 cells per well of a 96-well cell culture plate in RMPI 1640 medium (F1235, Biochrom AG Berlin, Germany) that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). On the next day the cells were transiently transfected with the pSG5-vector (#216201 Stratagene), which contained the sequence of the androgen receptor mutant E709Y (Georget et al., Mol. Endocrinol. 20(4): 724-734, 2006), and with the MMTV-luciferase plasmid (see above, transactivation assay for the androgen receptor mutant W741C). The cells were treated with the test substances in concentrations from 1×10^−8 to 1×10^−10 M in the presence of 1×10^−10 M R1881 and were incubated overnight at 37° C. and 5% CO2. After 24 hours, 100 μl of Steady Glo Lysis and Detection reagent (E2550, Promega) was added per well and the luminescence was read in a Victor3 Luminometer (PerkinElmer) for 1 second per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).	2016	fmo@@@LdbbbRubRrRbfRYHRoAfnjjjjjjjjjh@@	fmoP`@D]@GHheDdhlmdhheDYF]yoYkZ``hjh@@@`Qr^`@	378.446	4.3589	4	1	51.22	5	-0.0737602108250727	-0.9474755843082474	-0.040961920014477744	4	4	ek`TDD@EIiD`GDbPrJJKYSIQIYJJIQEc`JHZ[XzB@fjjj@@@HDCIE@@											2
:Uvzv;S:vyvzUzUeUQzUUCjz_mS5r7jSEqnfvEWwco7fyHoblh2CDZ2YmEdX1wCtXYHjG10k1GFb0V0c!	CHEMBL3972532	e`\\HBDDLEe@@cZPNdKiAZ_nrJJJJIQQKIISYIRHt\AUI]CSMUPHT@TQUU\D@@@	[C-]#[N+]c1ccc(N2C(=O)C3(CCCCCC3)N(c3ccc(C)cc3)C2=S)cc1C(F)(F)F	6.63	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	fig@@@LddTTRTRrRtNVYspTuzNjjjjjjjjj@@	figQB@DXT@HRYfYYeuWvg@uRwhvjhDJ@JBhH@@	457.519	5.3891	4	0	60	3	-0.1577608643912934	-1.540078581396747	1.1513790659866656	1	1	e`\\HBDDLEe@@cZPNdKiAZ_nrJJJJIQQKIISYIRHt\AUI]CSMUPHT@TQUU\D@@@											1
;vztOzfJbwYLQzUwQVHOvTDB8K1mB7Z7fKE6YYIAVR8k3eDHoblh2CBg2YkEWX1s5tXYHbG10k1GFb0V2c10	CHEMBL3973262	fcoqcBNFCzNpRBICDarU]dTabbRQbbftTJVehJYkj``rifj@BH@@	[C-]#[N+]c1ccc(N2C(=O)N(c3ccc(O)cc3)C(C)(C)C2=O)cc1C(F)(F)F	6.43	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	flu@@@LdbbRbbsbRxXRhijjjjjjj@@	fluP`@DX@iIfYemuz\]DJVjhD@@H@@@	389.332	3.2642	6	1	65.21	3	0.4325931003084208	0.2562049613288055	0.13173247604409485	29	1	fcoqcBNFCzNpRBICDarU]dTabbRQbbftTJVehJYkj``rifj@BH@@											1
:pjtyqerjufzcxFXfziCj_5ytpePw0lKs0Out1LgcQZF0PRtoc52F!F0204F6720V01O1F0FF08V!202010	CHEMBL397343	ffk@`@@URfUWVunU`nBt[pTejjijjjjjkdDJJQhzART@	C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H]5CC[C@@]43CCO5)[C@@H]1CC[C@@H]2O	6.15	group3-int	int	Androgen Receptor	Binding affinity to androgen receptor	2007	fbc@@@LddTTRTRvcPcJ]XKoIsUUUUUUUT@@	fbcA@@@ISJkkZvlEpVc^BgMUUMUUUUUHHTTcQt@@	302.456	3.4141	2	1	29.46	0	-2.0617353357053565	0.10508406959644495	-0.5339401153116932	1	1	ffk@`@@URfUWVunU`nBt[pTejjijjjjjkdDJJQhzART@											1
[rvyUzyrDDhwyTjafPYpeh8oJ@fl2WPFk0V_goI!_ZV0c0eo8N4F0148V5$98!V0F40V!W8Fk	CHEMBL3973563	fmoqb@BYgjoPRFQQQISHjIKIJZILdIPXsW@@@UUUSSPR`tc@@	O=C(NC[C@H]1CC[C@H](Oc2ccnc3c(F)cccc23)CC1)c1ccno1	6.34	group3-int	int	Androgen Receptor	Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37° C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 μg/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Cölbe, Germany), 600 μg/ml Geneticin (G418-sulphate, Invitrogen) and 10 μg/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.12×10^−12 to 1×10^−5 M in the presence of 1×10^−1° R1881 (methyltrienolone). The test plates were incubated overnight at 37° C. and 5% CO2. After 16 hours, 15 μl of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).	2016	few@@@LdbbbRubRrRbfSIBUxHyuUUUUUUUUT@@	fewq`@DBZBglbbTRRaRrTTRbHiV]UhymTuUUP@@C@cd]@@	369.395	2.8232	6	1	77.25	5	0.8590741159362959	0.4419124423860508	0.1794892588582061	10	1	fmoqb@BYgjoPRFQQQISHjIKIJZILdIPXsW@@@UUUSSPR`tc@@											1
:UvztUzvKrxnLQzUxQlHOvyiB8KCnC5i7vMEEYfIQVR@tYeDHpbrj7xCg2YkEVmdt5taYHbl10q1GFr0dWck0	CHEMBL3974665	enYVBF@LBADffXDEM`@arPjBLY@fPidLddNRRfbbvTTTfQfRfTbBbZz~AVjjXHBiji@Bjl`@@	CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(C(=O)NCCCNS(N)(=O)=O)c(F)c1	6.46	group3-int	int	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor (unknown origin) in membranes after 24 hrs by HAP adsorption assay	2016	flu@@@LdbbRbbsbRxXRhijjjjjjj@@	fluQB@DXT@HRYfY[]^gGQBejjA@@B@@@	586.59	2.8147	10	3	189.1	8	5.8091813121456894	0.5552223284850932	-0.9194052599848678	29	17	fakQA`AFB@IH`zBKNM_GlCdTTVVbbfrfRaYpsbm``JfjPBH`@@	eMBH@RZ@	gJPBAHJPt`PAIjj@@	eFABP`BL@	eMbA@Dg`@	dcwLPLHXQPBM@LddNRRbuUS@@						16
=QzvUzrljTAUmvMlmtfL6akkhnsDhMza7BXY3QkODkMe4HSY1hxyx0ZvQRlIlh4Q0beL11eSK14b54VNF0	CHEMBL397563	ekhTDL@C@eG@IABPpdLbdLTRbbReVRbbQdLlbBRFfvNjiBbFbjB`Hh`RP@	O=c1cc(C(F)(F)F)c2c3c(ccc2[nH]1)N(CC1CC1)[C@H](c1ccccc1)CO3	7.35	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in CV1 cells by transcriptional activation assay	2007	fiw@@@LdbbbTRaJRbfQxhQmNKWhzjjjjjjjjj@@	fiwP`@DV@kHhdididddhhdZLejsbuzMjPBJj`hBJHNP@	400.399	3.537	4	1	41.57	4	-0.23322722691026418	-0.4847609677732341	-0.059792393116494466	1	1	ekhTDL@C@eG@IABPpdLbdLTRbbReVRbbQdLlbBRFfvNjiBbFbjB`Hh`RP@											1
:Uvzv;S:vyQzUzUfHQvUECfr_mS5b7zKE6nfQEWRco7fTHoblj2CBZ2YmEdX1wCtXYHbG10k1GFb0V0c!	CHEMBL3976056	edV\HBDDLNe@@`ZPfdEiCjSnrJJJJIQQKIZXjQJsIT\NYAEIM@pmUPHT@QEUX@T@@@@	[C-]#[N+]c1ccc(N2C(=O)C3(CCC3)N(c3ccc(-c4ccccc4)cc3)C2=S)cc1C(F)(F)F	6.55	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	ec`P@@@LddTTVbQVbrRtrQDcGGbQSRvuUUUUUUUUUU@@@	ec`THH@DLE@@cHhhhheEDlemUDeQpydDTeTmluU@aPAA@AP@@@	477.509	5.6784	4	0	60	4	0.09243553091537772	-1.9089436743203505	1.2118869979929896	3	1	edV\HBDDLNe@@`ZPfdEiCjSnrJJJJIQQKIZXjQJsIT\NYAEIM@pmUPHT@QEUX@T@@@@											1
:Uvzv;S:vyvzUzUeUQzUUCfz_mS5b7jKEanfQEWwco7fyHoblh2CBZ2YmEdX1wCtXYHjG10k1GFb0V0c!	CHEMBL3977051	egh\HBDDLAe@@bZPVdMi@Z[nrJJJJIQQKIISURIT\AUI]YEMUPHT@TQUWA@@@	[C-]#[N+]c1ccc(N2C(=O)C3(CCCC3)N(c3ccc(C)cc3)C2=S)cc1C(F)(F)F	6.83	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	fnk@@@LddTTRTRjtVVYrR`yjvjjjjjjjj`@@	fnkQB@DXT@HRYfYYeuWipMTmrUjjAB`B```@@	429.465	4.7051	4	0	60	3	-0.2733159144099968	-1.0248599603083404	1.101652028999079	3	3	egh\HJDNMI``GEPHVdMi@zPff{lbbRrbbdrRTjTrdUCFadRSWT@ESUSP@UUe@@@	eFBH@c@@										3
[rvyQzyriBdwyTjaYPVxfh8FJBQl2WPFk0VGgJG0V_28080@o8N481GJ0V5!F098(V!W4Fk	CHEMBL3982609	fcqb@BY{jlpXfQQQISHjIKIJZIYdaJCFZx@@BjjjYi`iAiF@@	Cc1cc(C(=O)NC[C@H]2CC[C@H](Oc3ccnc4c(Br)cccc34)CC2)no1	6.16	group3-int	int	Androgen Receptor	Transactivation Assay: For determining the androgen receptor-dependent transcription, a cellular assay system was used, consisting of PC-3 cells (Kaighn et al., Invest. Urol. 17: 16-23, 1979), which express the human androgen receptor stably and recombinantly (full length, wild-type form, see Swiss-Prot Acc. No. P10275, Entry Version 159, Sequence Version 2). In addition, these PC3 cells contain a stably integrated reporter gene plasmid, which is based on the commercially available plasmid pGL4.14 (#E6691, Promega Corporation, Madison, Wis., USA) and contains the luciferase gene from the American firefly (Photinus pyralis) under the control of the MMTV promoter (Cato et al., EMBO J. 6: 363-368, 1987). These cells were propagated in routine cell culture at 37° C. and 5% CO2 in a medium containing 90% RPMI 1640 (Invitrogen GmbH, Darmstadt, Germany), 100 U penicillin, 100 μg/ml streptomycin (Invitrogen), 4 mM L-glutamine (Invitrogen), 10% fetal calf serum (FCS Serum Gold, PAA Laboratories GmbH, Cölbe, Germany), 600 μg/ml Geneticin (G418-sulphate, Invitrogen) and 10 μg/ml puromycin (Sigma Aldrich GmbH, Germany). For carrying out the transactivation assays, approx. 1000 cells per well were plated out in a 384-well cell culture plate in a medium that contained activated charcoal-treated calf serum (FCS Serum Gold, PAA Laboratories) at a concentration of 5% (v/v). The test substances were added in a concentration series from 5.12×10^−12 to 1×10^−5 M in the presence of 1×10^−1° R1881 (methyltrienolone). The test plates were incubated overnight at 37° C. and 5% CO2. After 16 hours, 15 μl of Steady Glo Lysis and Detection reagent (E2550, Promega Corporation, Madison, Wis., USA) was added per well and the luminescence was read in a Topcount Luminometer (PerkinElmer, Waltham, Mass., USA) for 4 seconds per well. The luminescence values obtained were normalized, wherein 100% corresponded to the effect of the unstimulated control (without R1881), and 0% corresponded to the effect of the stimulated control (R1881 plus DMSO instead of test substance).	2016	few@@@LdbbbRubRrRbfSIBUxHyuUUUUUUUUT@@	fewq`@DTZ@WlbbTRRaRrTTRbHiV]UhymSTuUP@@E@cd]@@	444.328	3.8455	6	1	77.25	5	1.2055853737241988	-0.45051664131399755	0.308117913561049	10	7	fcqb@BY{jlpNNQQQISHjIKIJZIYdaJCFZx@@BjjjYi`iAiF@@	eFACD`BL@										4
=xU:KrxvTQzUzQnHOvUiBPKCnhCi7zMEEYfQQZRDmYeDHpbzjbxCg2nlEVqtt5tafHbG10oGKFr0cXcG0	CHEMBL3982650	ee[ZBJ@DLCgdUKjQP@bjPFdIiAZPrJJJJIQQKHsSJSJpiIQQZT\AYIM\rmUPHT@EEU[UULsA@@@	CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc(C(=O)NCCCn2cccc(O)c2=O)c(F)c1	6.25	group3-int	int	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor (unknown origin) in membranes after 24 hrs by HAP adsorption assay	2016	e`\P@@@LdbbRbbsbRrbrRbbWA`bdRSwuUUUUUUUUUUU@@@	e`\RLH@DLJieBc`@cHhhhheLlebiddhhmQpyDDd}|uU@`@AMUTrpP@@	601.58	3.2655	9	2	149.07	8	4.702200643355567	-0.17196664485440988	0.003895591671741125	1	1	ee[ZBJ@DLCgdUKjQP@bjPFdIiAZPrJJJJIQQKHsSJSJpiIQQZT\AYIM\rmUPHT@EEU[UULsA@@@											1
vzUQvQvIMN_k26@A1NHFH99F440kWV8B81B408012908!304FFV04!8F42H@#B49H104$130X#s0F	CHEMBL398431	fbupC@EZLBPQHXdLbdLTRRLRTTmQSUAAeUUD@@	CCCN(CC1CC1)c1cc(C(F)(F)F)c(C#N)cn1	9.1	group1-p	p	Androgen Receptor	Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cells	2007	dmL@@DjU_jzUjjjj@@	dmM@@@qJYWzneP`bh`@	283.296	3.1755	3	0	39.92	6	-1.0632427436485514	-0.19391742579926988	0.7918259430466212	3	1	fbupC@EZLBPQHXdLbdLTRRLRTTmQSUAAeUUD@@											1
vzUOvOtO1F5m14@A1N2F288F440FWV8888B408!2908!1#FV$8FF22@#8492104$1302V!c0F	CHEMBL398432	fdypC@EZLBPQHXdLbdLTRRLRTmAcUAAeUQ@@@	N#Cc1cnc(N2CCCCC2)cc1C(F)(F)F	6.68	group3-int	int	Androgen Receptor	Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cells	2007	dcl@@DjYU_egZjjjh@@	dcm@@@qJYYwhUtHJJb@@	255.242	2.527	3	0	39.92	2	-1.814616531961707	0.783255236052698	0.637855669562103	30	2	fdypC@EZLBPQHXdLbdLTRRLRTmAcUAAeUQ@@@											1
xvojcyqXbEue9cx0VAzeCj_1qOoXPw0GFu0Sst12g8OZF0PRNoc70F!F#1G2520V0WQ1#F!V$2010	CHEMBL398455	fnk@`@@MRZWmeW[eXKQ`qsVjijijjjjnPPiiFWiEYP@	C=C[C@]12CC[C@](C)(O)CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12	6.08	group3-int	int	Androgen Receptor	Binding affinity at AR	2007	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@DjVU]{ZBxhuoAZjjjjjkEDIZ`@	316.483	3.9194	2	2	40.46	1	-1.4000979210881819	-0.30470632257542896	-1.5408430593590765	35	9	fjc@C@@AKgDocdTTbRLrTaRqNRU[r\uUUUUUUSDPbPTT`@	eMBD@cX@	eMJB@Df`@	eFJB@Hp@								8
xvojcyqXbEuX9cx0VAr@Cj_0LFoXPw0FFuFOkt12g8tVJ0@R8F850k0FF!c1F212#VQ$F(2010	CHEMBL398456	ffsA@@@YEEHdcLeIddR\djslejjjjjififPRDRBbdZ@@	C=C[C@]12CCC(C)=CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12	6.25	group3-int	int	Androgen Receptor	Binding affinity at AR	2007	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@LdbRbRJTrYK`cV|FYjjjjjlLTej@@	298.468	4.6383	1	1	20.23	1	-2.375043272816311	-0.9254332704986437	-0.6200548046742783	35	5	fjc@C@@AKgDocdTTbRLrTaRqNRU[r\uUUUUUMSDPbPTT`@	eMBD@cX@	eFBH@c@@	eFJB@Hp@								5
;vztOzfJbwYLQzUwQVHOvTDB8K1mB7Z7fKE6YfIAVR8k3eDHoblh2CBZ2YkEWX1s5tXYHbG10k1GFb0V2c10	CHEMBL3985131	fcop`bDXZiX@cl`NPgHMg_YEEEEDhhedYliDj\CeMVjhDJ@BJjx@@@	[C-]#[N+]c1ccc(N2C(=O)C(C)(C)N(c3ccc(O)cc3)C2=S)cc1C(F)(F)F	6.86	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	flu@@@LdbbRbbsbRxXRhijjjjjjj@@	fluQB@DXT@HRYfY[]^gGQBejjA@@B@@@	405.399	3.6247	5	1	80.23	3	0.49703187190201714	-0.030768236212286373	0.10973624302094995	29	17	fakQA`AFB@IH`zBKNM_GlCdTTVVbbfrfRaYpsbm``JfjPBH`@@	eMBH@RZ@	gJPBAHJPt`PAIjj@@		eMbQ@B[h~@	eFJB@Hp@						16
xvojcyqXbEuX9cx0VAr@Cj_0LFoXPw0FFuFSkt12g8tVJ0@R8F870k0FF!c1F212#VQ$F(2010	CHEMBL398634	fnkA@@@YEHiEdYdiLdcPRmN|VmUUUUUSMSL`dJdeMJt@@	C=C[C@]12CCC(C)=CC1=CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O	6.28	group3-int	int	Androgen Receptor	Binding affinity at AR	2007	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@LdbRbRJTrYK`cV|FYjjjjjlLTej@@	312.495	4.9363	1	1	20.23	1	-2.3151955191658105	-1.1565919571883954	-0.5954205911506496	35	5	fjc@C@@AKgDocdTTbRLrTaRqNRU[r\uUUUUUMSDPbPTT`@	eMBD@cX@	eFBH@c@@	eMJB@Df`@								5
:Uvvv;S:vivUUzUeMf:yUbyjqOK7I7BDUlAUStwddQy6KH_Jp2BBa0VFUiA0g5SXWFTXO0X91Fq081c!	CHEMBL3987109	fa{P``L]``@PVPkHMdLddLTTtRRLJdSAFmXOhkUTEPIUWTDHnHTl`@	N#Cc1ccc(N2C[C@H]3[C@H]4C=C[C@H](C4)[C@H]3S2(=O)=O)cc1C(F)(F)F	6.66	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-MB-453 cells assessed as inhibition of testosterone-induced transactivation	2016	fdu@@@LddTTJbfJuARUipXuUUUUUU@@@	fdu`b@LPP@HrRPqQSQIHlDZu`~bmUPU@ePPbxaRr@@	354.351	2.1267	4	0	69.55	2	-0.5525013790562372	0.9945624171165477	0.9628177664684296	11	1	fa{P``L]``@PVPkHMdLddLTTtRRLJdSAFmXOhkUTEPIUWTDHnHTl`@											1
xvozcyqmjEuX9cx2VArAhj_0LFoXTw0FFuFOkt12g8tVJ0@R8N850k6NF!c1F212!2VQ$F(2010	CHEMBL398840	fmA@@@YEEHdcLeIddUDdSdeV]dluuUUUUTs@ASCHIBIAQRM@@	C=C[C@]12CCC(c3ccccc3)=CC1=CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12	5.5	group4-ia	ia	Androgen Receptor	Binding affinity at AR	2007	fn{@@@LdbbbTRaJQbRxhQmN|FkZjjjjjjjj`@@	fn{@@@LdbbRRtJRRTrxjQg^SfkXFBajjjhjlNWeF@@	360.539	5.4533	1	1	20.23	2	-1.9279749446767998	-1.7663717374692731	-0.4875636097492574	1	1	fmA@@@YEEHdcLeIddUDdSdeV]dluuUUUUTs@ASCHIBIAQRM@@											1
xvojcyqXbEue9cx0VAzeCj_1qOoXPw0GFu0Sst12g8OZF0PRNoc70F!F#1G2520V0WO1#F!V$2V10	CHEMBL398841	fa{@`@@]rJQJQYFYJSIHlehw`u[U]UUUUMUMrBpfQTLgQj@@	C#C[C@]1(O)CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C=C)[C@H]3CC[C@@]21C	6.54	group3-int	int	Androgen Receptor	Binding affinity at AR	2007	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@DjVU]{ZBxhuoAZjjjjjkEDIZ`@	326.478	3.5403	2	2	40.46	1	-1.3296256007151437	-0.11387542755670377	-1.5263721320618853	35	9	fjc@C@@AKgDocdTTbRLrTaRqNRU[r\uUUUUUUSDPbPTT`@	eMBD@cX@	eFJB@Hp@	gCaHA@AIZp@								8
;UdTyvCfyn_XbDktrB6C4HFo1uM@O20824VN0k3d08GF945!V04F08#8@#84821120V3#120N0c!	CHEMBL399439	fjmQC@EYLBPQHXdLbdLTRRJbbReiIZhHLjjnIEdz@@	N#Cc1ccc(O[C@H]2CCCC[C@@H]2C#N)cc1C(F)(F)F	6.71	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor expressed in MDA-MB-453 cells assessed as inhibition of dihydrotestosterone-induced response in reporter gene assay	2007	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]TzB`hb@@	294.275	3.3441	3	0	56.81	3	-1.2173134230693752	0.15037810203902935	0.7754413424895487	60	3	fjmQC@EYLBPQHXdLbdLTRRJbbReiIZhHLjjnIEdz@@											1
uTPI2G9G8F5kVFA11N30V8HF040F1080V!4080X2Pk80F1#FV18!4F0V0@!18482104#F1302#c0F	CHEMBL399876	ff}pC@EZLBPQHXdLbdLTRRLTtrTmEkUAAeU@@DKT@@	CC(c1ccccc1)N(C)c1cc(C(F)(F)F)c(C#N)cn1	6.91	group3-int	int	Androgen Receptor	Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cells	2007	dg|@@DjU_eZx{jjjjj@@	dg}@@@qJYWyVnNp`b@@@@	305.302	3.2952	3	0	39.92	4	-1.2700613091621895	-0.10583268861242967	0.7764461214119074	6	4	ff}pC@EZLBPQHXdLbdLTRRLTtrTmEkUAAeU@@DKT@@											1
;UdTyvCfyn_XbDktrB6C4HFo1uM@O20824VN0k3d08GF945!V04F08#8@#84821120V3#120N0c!	CHEMBL399887	fjmQC@EYLBPQHXdLbdLTRRJbbReiIZhHLjjnIEhy@@	N#Cc1ccc(O[C@@H]2CCCC[C@H]2C#N)cc1C(F)(F)F	7.92	group2-a	a	Androgen Receptor	Antagonist activity against human androgen receptor expressed in human MDA-MB-453 cells assessed as inhibition of dihydrotestosterone-induced effect by luciferase receptor gene assay	2008	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]TzB`hb@@	294.275	3.3441	3	0	56.81	3	-1.2173134230693752	0.15037810203902935	0.7754413424895487	60	3	fjmQC@EYLBPQHXdLbdLTRRJbbReiIZhHLjjnIEhy@@											1
uTPI2G9G8F5kVFA11N30V8HF040F1080V!4080X2Pk80F1#FV18!4F0V0@!18482104#F1302#c0F	CHEMBL400098	ff}pC@EZLBPQHXdLbdLTRRLTtrTmEkUAAeU@@DKH@	C[C@@H](c1ccccc1)N(C)c1cc(C(F)(F)F)c(C#N)cn1	5.77	group4-ia	ia	Androgen Receptor	Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cells	2007	dg|@@DjU_eZx{jjjjj@@	dg}@@@qJYWyVnNp`b@@@@	305.302	3.2952	3	0	39.92	4	-1.2700613091621895	-0.10583268861242967	0.7764461214119074	6	4	ff}pC@EZLBPQHXdLbdLTRRLTtrTmEkUAAeU@@DKH@											1
xvojcyqXbEue9cx0VAz@Cj_1LOoXPw0GFuFOss12g8OZJ0@RNo850k0FF!81G212#VO$F(2010	CHEMBL400480	ffsA@@@YEEHdcLeIddR\djslejjjjjeijfPRDRBbdZ@@	C=C[C@]12CCC(=C)C=C1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](O)CC[C@@H]12	6.48	group3-int	int	Androgen Receptor	Binding affinity at AR	2007	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fdu@@@Dj]m[VvcIJlxLYfjjjjjlBRhZ@@	298.468	4.7166	1	1	20.23	1	-2.378727326292086	-0.972503198336822	-0.61964674744062	50	2	fjcAB@B`\\bdTTRRVtLRyjRk^cfjZjjZjjjfErFgeE@@	eMBD@cX@										2
<Aztr1TDw0qjTz8IW2UGuXNFpfli103Hp_0m2L91NDXGbDYYX8LWC9HX01Cd!E161jF4N485F2V_F4X8GV	CHEMBL401458	fbuQB`ARLBHID^d@rDYAIf]WZzYgIJ``JZjjbah`@	CC(C)C(O)(c1nc2cc(Cl)c(Cl)cc2[nH]1)C(F)(F)F	8.7	group1-p	p	Androgen Receptor	Binding affinity at androgen receptor expressed in COS cells by whole cell binding assay	2007	diT@@DjYVnXZjjh@@	diU@@@iJYWrnFP`H@@	327.132	3.7936	3	2	48.91	3	-0.6403262272560493	-0.32738422942059087	-1.361707781610536	3	3	dcm@pDpGEXcXaIeUUJafZ`B`@@	dedHHJBPRPrPx@rJPrZUUUPQ@@										3
zTur6I9l8k4k4F34FN2WVN2H!FF13920LmZ58V03Nk96FGV029X12JLl0W89Tl1V9022bc640@BJ04458V8F0	CHEMBL401629	figac@ENcTD`bPqHYEHXheEEdcLheIQoQRwmUHTDe@PTP@@	COc1cccc2c1-c1ccc3[nH]c(=O)cc(C(F)(F)F)c3c1CO2	7.85	group2-a	a	Androgen Receptor	Activity at androgen receptor in human Saos2 cells assessed as IL6 repression	2008	flm@@@DjYee]YhTkA}Fjjjjjjj@@	flm``@D@ldrmkZvmFRUYtTmR@EP@Q@@@	347.291	2.5991	4	1	47.56	2	-0.6895071390650636	0.5615824742842972	-0.18903557675532007	11	9	ffs`c@L|j@I]xq\\bbbTTvRTLVsARuXNRpDPDEDtdP@@	gJPBAHJPt`PAIjj@@		eMJA@Hz@								8
yyuzLpOG8k4FZG34FNH5VSHH!F0939X0Hno58cV3Fk960WV128V16JLl0W89Dl0c9022aca40@4J!45BV0F0	CHEMBL401711	fcaP@G@QUo\bbTTTRRbfflvtcNZ}[HRmP@PDMDsUPP@@	Cc1cc(=O)[nH]c2ccc3c4c(C(=O)OC(C)(C)C)cccc4oc(=O)c3c12	8.72	group1-p	p	Androgen Receptor	Activity at androgen receptor in human Saos2 cells assessed as IL6 repression	2008	fb}@@@LdbbbbbRJvsCBTzHTuUUUUUUT@@	fb}a`@G@QgHheEEDdhmjsfoVbEKT@DABSA@@@	377.395	3.4144	6	1	81.7	3	0.6278860450197188	0.3311359825480332	0.15484711442173352	8	8	fnkaa@Dr|tGbQqrJJKSJIIJEQEgEF\GMXHB``Rfdb@@	daxD`@S@AIgijj@@										8
RuJfgem0b8se989V49Q889p1MONX8Z01FNFG8s02g8OZ44@BFo850k0FF1080F2120808Q/!	CHEMBL402063	fnk@`@@UrJIJZIPiSQKJcEZ]zNVfjjjjiZjhqBViZ^TLh	C/C=C1/C(=O)C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	6.66	group3-int	int	Androgen Receptor	Inhibitory concentration against Androgen receptor	2005	fb}@@@LdbbbTRaJRWEBMiw`uUUUUUUT@@	fb}@`@@YRYVum[UhrRkNCEijjjjejlBRhZ@@	312.451	4.2707	2	0	34.14	0	-2.250214843238718	-0.3987186067925918	0.585607416545756	2	2	fnk@`@@UrJIJZIPiSQKJcEZ]zNVfjjjjiZjhqBViZ^TLh											1
zTur6I9l8k4k4F34FN2WVN2H!FF13920LmZ58V03Nk96FGV029X12KLl0W89Tl1V9022bc640@BJ04458V8F0	CHEMBL402136	figac@CJ]TD`bPqHYEHXheEDeJlheHuhaRwmUHTPtPPT@@@	COc1cccc2c1-c1ccc3[nH]c(=O)cc(C(F)(F)F)c3c1OC2	6.32	group3-int	int	Androgen Receptor	Activity at androgen receptor in human Saos2 cells assessed as IL6 repression	2008	flm@@@DjYee]YhTkA}Fjjjjjjj@@	flm``@D@TdrmkZjmFRuYtTmR@QT@P@@@	347.291	2.5991	4	1	47.56	2	-0.6895071390650636	0.5615824742842972	-0.18903557675532007	11	2	figac@CJ]TD`bPqHYEHXheEDeJlheHuhaRwmUHTPtPPT@@@											1
[r:jzy;bxyUjxE:jjrwNxUfi@yrlMTbfotZPzrKm5HJ2g8j4XL5hD2w9KoVSB280VA1Og#4!	CHEMBL402930	fn{ab@ENBTFHdsKN}s^rsdm^cdmVp@@QSMUPUH|hp@	O=C1[C@@H]2C3CCC(O3)[C@@H]2C(=O)N1c1ccc(Br)c2ccccc12	6.17	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor in MDA453 cells by alkaline phosphatase reporter gene assay	2008	ffk@@@LdbbbTVtTNtSMBM[r\ekUUUUUUUUP@@	ffka`@D@T[HhhhhdhhlXkQfcVbEIZmUPMPD@U@cBX`@	372.217	2.7174	4	0	46.61	1	-1.013708890392417	0.5257654322221561	0.9107952781345913	6	2	fn{ab@ENBTCbdsKN}s^rsdm^cdmVp@@QSMUPUH|hp@	eFACD`BL@										1
[r<y;r:Ujxj:jjrwNxUfyUyrlMybfotguzrKm7LM@g8j6XL5hTXwdKoXSg@80VA1Og!34!	CHEMBL403039	ec`TJHDNGMCHln`LSbSNrJJIQSQIqQSYRJLJRVIEM]CKP@PCESMUUAT`eBd@@	CC12CCC(C)(O1)[C@@H]1C(=O)N(c3ccc([N+](=O)[O-])c4c(Br)cccc34)C(=O)[C@@H]12	7.4	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor in MDA453 cells by alkaline phosphatase reporter gene assay	2008	ffk@@@LdbbbTVtTNtSMBM[r\ekUUUUUUUUP@@	ffka`@D@T[HhhhhdhhlXkQfcVbEIZmUPMPD@U@cBX`@	445.268	2.3918	7	0	92.43	2	1.016180701443665	1.02843617052051	1.4376764803931361	6	2	feoaa@C^cTCcsDrJJIQPhqQSYRJLdkPTejt\@D@ULuUTER@qJ@@	gChhhE`BRnRYh@										1
}y>U>jrzOzUvy:rlMyrfxzZvzrMnbUMUy9z7eTEwTXxdMoXpg680ZE1Sy4$V	CHEMBL403061	fmQP@DK@kV^yEEEEDiDd\iUheSfgNbDlumUPMTEQTuTJLKd@@	COc1cc(N2C(=O)[C@H]3[C@@H](C2=O)C2(C)CCC3(C)O2)ccc1-c1cnco1	7.7	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor in MDA453 cells by alkaline phosphatase reporter gene assay	2008	fn{@@@LdbbRbbvrbTjxXRgAbfkZjjjjjjjj`@@	fn{PP@DM@hv\bbbbbRbVITRhsQkA}FkVjhFhHijhTXSD@	368.388	1.6464	7	0	81.87	3	0.6350798289007009	1.5633438070097843	1.3065145495812376	1	1	fmQP@DK@kV^yEEEEDiDd\iUheSfgNbDlumUPMTEQTuTJLKd@@											1
[r:jzyzvjjzyUzxS:jjrwPxUfgUzrGMybfotZQzrKmbHKAg8z6XL9gD2ydKo2Kg280VA1Oe#V0F	CHEMBL403213	fnkqb@BBdYrPQFQQQIHqQSYRJLy[tTyk@P]SMUUERKSr@@	CC12CCC(C)(O1)[C@@H]1C(=O)N(c3cnc(C#N)c(Cl)c3)C(=O)[C@@H]12	7.42	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor in MDA453 cells by alkaline phosphatase reporter gene assay	2008	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fduQ`@DN@hvQQQQQIQKFcMFlGtVjhFhHjDXSD@	331.758	0.8885	6	0	83.29	1	-0.06118670384764452	2.286000721435107	1.105145913896193	47	1	fnkqb@BBdYrPQFQQQIHqQSYRJLy[tTyk@P]SMUUERKSr@@											1
}y>Uzx;jzryNxUvy:rlMzjfxzgvzrMmbLM@g9j6eLExTXwhSqYpi@80VQ1Oi!38!	CHEMBL403214	fmoQSBNVUhJV`dDRFICdz{HiCEDheXhiliEIFcfk^sj``XjYjjhjQFYP@	CC12CCC(C)(O1)[C@@H]1C(=O)N(c3ccc([N+](=O)[O-])c(C(F)(F)F)c3)C(=O)[C@@H]12	7.96	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor in MDA453 cells by alkaline phosphatase reporter gene assay	2008	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdua`@D@T[HhhhhdhecQfcVCzKUTCTDUBLIb@@	384.309	1.3205	7	0	92.43	3	0.9041017026693756	1.7776777937862536	1.3578935121703732	47	25	fnkac@AZmD@RSqZxiLs{LwmMlxYpXiKA@ULuUUERCIt@@		gJPBAHJPt`PAIjj@@	gChhhE`BRnRYh@								6
zTur6M9l8k4k4G34FN2_VN2H!FF13920LmZ58c03Nk96FlV029X12KLl0W89Tl1c9022bc640@BJ04458V8F0	CHEMBL403219	few`S@CJ\ehIADabPrJPqQJJIJVHjIRMZH\}GUREDMCAAP@@@	COc1cccc2c(=O)oc3c(ccc4[nH]c(=O)cc(C(F)(F)F)c43)c12	7.05	group2-a	a	Androgen Receptor	Activity at androgen receptor in human Saos2 cells assessed as IL6 repression	2008	fb}@@@LdbbbTRRRqsMBeZHTuUUUUUUT@@	fb}a`@O@QgHheEDeDmDSPRgVCEKT@@PPsA@@@	361.274	2.7695	5	1	64.63	2	-0.10454597089913178	0.6533578076124982	-0.033143213289251905	2	2	figa``HzLLCcVP[H]dLbbbTTtrLrbtbXJQg^RV@b@XBfjdb@@	eMJA@Hz@										2
{jzy;jzyUzxU:jjryOxUfiUzrlMybfotZQzrKmbHKAg8j6XLCgD2wdKoXKg280VA1Oi#Z!	CHEMBL403668	fnkQb@NRLyHJsHhhddXhiliEFBmzJ\u``rifjjbiEiy@@	CC12CCC(C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(I)c3)C(=O)[C@@H]12	8.15	group1-p	p	Androgen Receptor	Antagonist activity at human androgen receptor in MDA453 cells by alkaline phosphatase reporter gene assay	2008	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdua`@D@T[HhhhhdhecQfcVCzKUTCTDUBLIb@@	422.217	1.6665	5	0	70.4	1	-0.07352938616282295	1.267453780486454	1.1366934920746554	47	25	fnkac@AZmD@RSqZxiLs{LwmMlxYpXiKA@ULuUUERCIt@@		eFABl`BL@	eMbA@Dg`@								6
}y=yUjxU:jzryOxUfiUyzlMzjfwtZQzrKmbHK@g8j6XLEgD2whSqYKi280VA1Oi080c!	CHEMBL403669	fewQc@EF}FhIADabPrJPqQIHqQSYRJRtEIZmGUAAeSMUUER@qJ@@	CC12CCC(C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)[C@@H]12	8.15	group1-p	p	Androgen Receptor	Antagonist activity at human androgen receptor in MDA453 cells by alkaline phosphatase reporter gene assay	2008	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdua`@D@T[HhhhhdhecQfcVCzKUTCTDUBLIb@@	364.322	2.0777	5	0	70.4	2	-0.23922517070625013	1.1141305864995723	1.0696782623816248	47	25	fnkac@AZmD@RSqZxiLs{LwmMlxYpXiKA@ULuUUERCIt@@		gJPBAHJPt`PAIjj@@	eMbA@Dg`@								6
=QUvUrblbPvUmv7nmtfLaZJFCntT_Lva7BXYYQkODkMeBISY1jxTx0ctORlIld4Q0bXLGWeSKG471JV8F0	CHEMBL404222	eghTDF@EOK@`IABPpdAiBZPVdLbdLTRbVVTRVbdRlbacdVQuuUHTBUUPU@QDDR@@	O=c1cc(C(F)(F)F)c2cc3c(cc2[nH]1)OC[C@H](c1ccccc1)N3CC(F)(F)F	6.47	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor in CV1 cells by transcriptional activation assay	2008	fjc@@@DjYUUv]U`nRlEIZjjjjjjj`@@	fjcP`@DFAiIe[UUvUhrRkNrUjP@jh@HbCd@	428.331	3.7032	4	1	41.57	4	-0.0939519622705351	-0.6882525298132987	-0.012964612984571746	3	3	eghTDF@EOK@`IABPpdAiBZPVdLbdLTRbVVTRVbdRlbacdVQuuUHTBUUPU@QDDR@@											1
]x<vzUzUyUjzUzUjUbqSSzjjTDjvbzEfydZUvrKqhmx@hDjHYqEgi3gCxqYLj2SGk9lNEce0c!	CHEMBL404315	eodRBL@EC@noHie`IABPpdLbdLTRRLTTvTQTrddtBRJZjzj``rifjjZjJhDd@@	CC(C)(C)OC(=O)N1CC2CC1[C@@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)N21	6.11	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor in MDA453 cells by alkaline phosphatase reporter gene assay	2008	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdup`@DXBAVQQQQQIQKFcMVLGtVjhFhHjHL`@	436.389	2.8066	8	0	93.95	4	1.5362179016082114	0.7023602208477527	1.5698563184929522	47	1	eodRBL@EC@noHie`IABPpdLbdLTRRLTTvTQTrddtBRJZjzj``rifjjZjJhDd@@											1
}yzvjrzyUjxU:jzrwFxUfgUyrlMxafotZQzrKmbHK@g8j6XL5gD2ohKq3Kg280V@1Oi#8!	CHEMBL404506	fnkac@IV}dD`bPqHYEHXdiihiliDIS`irUmT@QSMUTUH\`p@	CC12CCC(O1)[C@H]1C(=O)N(c3cccc(C(F)(F)F)c3)C(=O)[C@H]12	6.46	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor in MDA453 cells by alkaline phosphatase reporter gene assay	2008	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdua`@D@T[HhhhhdhecQfcVCzKUTCTDUBLIb@@	325.285	1.9441	4	0	46.61	2	-1.065940135516206	1.043848368798148	0.855646523435457	47	25	ffsac@AZmD@RSqjxiLs{LwmNsagAbdlDATsUUQT`r]@@		gJPBAHJPt`PAIjj@@									1
=QUvUrjlbuvUmf7nmvfLaZKHCntTWLui7gmYYAlODFMXBIQX1ExLt0cOOwlIk90Q0bVLFWeSKG47GJX8G0	CHEMBL404512	fegQa`E^lEhIADabP{HCdIrFQRFJIQKKJIKJRRcNcfjdJAJjjjbaF@@	O=c1cc(C(F)(F)F)c2cc3c(cc2[nH]1)OC[C@@H](CO)N3CC(F)(F)F	7.22	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor in CV1 cells by transcriptional activation assay	2008	foQ@@@DjYUU}`nRlzjjjjj`@@	foQP`@DFAiIe[UUhrRkNZd@JjH@@	382.259	1.585	5	2	61.8	4	0.609337237734996	1.0113161684621643	-1.0464993235638438	38	9	fj}Pb`DVXTGbQqcHIdLrBSL}jkORsbmNCUT@EMULP@@	gGPBAHJPtaPCHiCUP@	eMJA@Df`@									8
=QUvUrjlbuvUmf7nmvfLaZKHCntTlLui7gmYYAlODFMXBIQX1ExLv0cOOwlIk90Q0bVLFWeSKG47GJV8F0	CHEMBL404568	fmwQa`E^lEhIADabP{HCdIrFQRFJIQKKJIKJQRTYt\uTaPIUUUUEBJ@@	COC[C@H]1COc2cc3[nH]c(=O)cc(C(F)(F)F)c3cc2N1CC(F)(F)F	7.77	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor in CV1 cells by transcriptional activation assay	2008	foQ@@@DjYUU}`nRlzjjjjj`@@	foQP`@DFAiIe[UUhrRkNZd@JjH@@	396.286	2.0129	5	1	50.8	5	0.36860418770226544	0.5144341895309377	0.06364350048057396	38	9	fj}Pb`DVXTGbQqcHIdLrBSL}jkORsbmNCUT@EMULP@@	gGPBAHJPtaPCHiCUP@	gCaHA`AJZ`@									8
zyvG2GOG0F4k042BFF2!80H040F1%24!V/$F#4$402W04(6!X8GF	CHEMBL405835	fleQC@E^lBPQHXdLbdLTRbVQRdhsjh@@Hj`@@	CCCNc1ccc2nc(O)cc(C(F)(F)F)c2c1	7.56	group2-a	a	Androgen Receptor	Antagonist activity against human androgen receptor in CV1 cells measured as inhibition of DHT-stimulated luciferase reporter gene activity by cotransfection assay	2006	det@@DjYUX^fjjj`@	dev@@@rQQJHtpr@@@@@@	270.253	3.3373	3	2	45.15	4	-0.8203303532186942	0.009440809087253116	-1.4411428924547829	5	5	f`qa@`A^@xfdKRCiAIe[YzZLej@@BJh@@@	gJXH@`AJ^j@@										5
[xzjjYq;jdu6USQrS13rmdAc3iXj6XYL31FWLUY4GkZFRli8A0HNCV0FB1GkVFB081k71k7402V10	CHEMBL4059588	fleQ`@DI@ivQQQJIIKPkTX[sUPTEE\HhfP@	CC[C@H]1[C@@H](O)CC(=O)N1c1ccc(C#N)c(OC)c1	8.04	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from human AR after 3 hrs	2017	dcl@@DjYVWmEZjjjh@@	dcnH@DCHhheBeSKkUP@P@@	260.292	1.277	5	1	73.56	3	-0.2639469747234977	1.8697243000753054	-0.15824774075257556	17	16	fdyQ@`JQd@IIxl\WPNQQQSYSIPjgK^jji@Hn@@@		eMBD@ch@	eFJB@Hp@	eMJA@Hz@							14
zrztUWOMdkEw0HAEUN0l2A@u08F68Y9@4Hv25BH83QW@6lWV6XN0CXJJ1N0d138FdW02X4V60V85F20G08080V	CHEMBL4059979	figQa@LDekh@al`eL|ls^jo~JJLfnRtsTs@@@UP@@@	COc1ccc(-c2csc(N3C(=O)c4ccc(F)cc4C3=O)n2)cc1	5.09	group4-ia	ia	Androgen Receptor	Antagonist activity at AR T877A mutant in human LNCAP cells assessed as inhibition of DHT-induced proliferation after 48 hrs by MTT assay	2017	ffs@@@LdbbRRqbbbvWEBdxIZuUUUUUUUP@@	ffsPb@LDeh@PeL|ls^jnJJLfnRtsTs@@@P@@@	354.36	3.8951	5	0	87.74	3	0.06023432099847417	0.06491399208837954	1.1330019633324262	14	14	fa{Pc@AF}DCchH{HILklksMzmFJtEMVp@TmTs@DP@@@	eMJA@Hz@										7
;UvUxvUT7XWqzUmcIPLSdHqJ0WfnfNc1DrY4XX7A0F1H97BGFb0BWc96aHHB10FD0O0V86F81p31VbF42V10	CHEMBL4060271	fdyQB@AJBBHrJJJIJqQJLe[tDEeUUDcRl`@	Cc1c(N2CC[C@](C)(O)[C@@H]2C)ccc(C#N)c1Cl	9.31	group1-p	p	Androgen Receptor	Displacement of [17-alpha-methyl-H-3] mibolerone from wild-type androgen receptor (unknown origin) expressed in Freestyle293F cells measured after 3 hrs dextran/charcoal based method	2017	dmL@@DjYU^TYjjjj@@	dmN@@@rRJIIEneZ`hB@@	264.755	2.7067	3	1	47.26	1	-1.5373722122894224	0.8007387339883194	-0.4397022419574267	36	5	fhiPA@AJAxa\\bbbbRlTRYJwhHKJjhhZP@	eMJB@Df`@	eFABH`BL@									3
yqulPWOG8FCk0F95FN0G0N@H!F28Y9@02Q218#QV@6FV!2G0C25J1!V82!W122V!40V04#F0F2c1V	CHEMBL4060340	fhiQB@NATBPrJJIQIQEYdmV``djjq@@	CCn1c(C#N)ccc1-c1ccc(O)cc1F	6.9	group3-int	int	Androgen Receptor	Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting	2017	dmL@@DjYU^TYjjjj@@	dmN@@@rQQJEHjeZe@B@@	230.241	2.1658	3	1	48.95	2	-1.5079608134750835	1.145461418561797	-0.46890447853939243	36	26	fdyPB`IQ@D||]HIhFscdTTRbbrbnXIwhBHfjkD@@	eMBD@ch@	eFABP`BL@			eFJB@Hp@						24
zrUtUWOMdFEw0H9EUN0l2A@u08F68Y984Hv25BH81QW@6lWV6XN0CX4J1N0d1380dW02X4V6!85F20G08080V	CHEMBL4060981	fa{Pa@LDeh@PvPRf^VYoUW|TTYM\eifif@@@j@@@	Cc1ccc(-c2csc(N3C(=O)c4ccc(F)cc4C3=O)n2)cc1	4.59	group4-ia	ia	Androgen Receptor	Antagonist activity at AR T877A mutant in human LNCAP cells assessed as inhibition of DHT-induced proliferation after 48 hrs by MTT assay	2017	ffs@@@LdbbRRqbbbvWEBdxIZuUUUUUUUP@@	ffsPb@LDeh@PeL|ls^jnJJLfnRtsTs@@@P@@@	338.361	4.309	4	0	78.51	2	-0.5952748919683964	-0.19230465856262466	0.9706864204573318	14	14	fa{Pc@AF}DCchH{HILklksMzmFJtEMVp@TmTs@DP@@@	eFBH@c@@										7
yyulPWtG8F5m0F95FN0GVN@H!F0839@0HI218!1Qk96FW!@G0CX4LW!c8PH1W102X4c60V84#F4N2V1V	CHEMBL4061510	fdeQ@@MQAdTTRbqbbQYpTk^`HJijld@@	Cn1c(C#N)ccc1-c1ccc(O)c2c1CCC2	8.09	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting	2017	fgA@@@DjYeeQRUhujjjjjh@@	fgA`@@@YHheCDhbTUhuje@`jH@@	238.289	2.6238	3	1	48.95	1	-1.6456648232821838	0.9611146668254441	-0.47938185223332763	1	1	fdeQ@@MQAdTTRbqbbQYpTk^`HJijld@@											1
yqulPWOG8F5k0F95FN0G0N@H!F#A@02I218!1QV04FW#F0C25L#V08!W302X4040V%F!2V1V	CHEMBL4062016	f`qQB@I^HBHrJJKKQQHlyjtDASUX`@@	Cn1c(C#N)ccc1-c1ccc(O)c(Cl)c1	7.32	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting	2017	dmL@@DjYU^TYjjjj@@	dmN@@@rQQJEHjeZe@B@@	232.669	2.415	3	1	48.95	1	-1.6654366005731345	1.1074752148557114	-0.4897176101682984	36	26	fdyPB`IQ@D||]HIhFscdTTRbbrbnXIwhBHfjkD@@	eFBH@c@@			eFABH`BL@	eFJB@Hp@						24
>x:TbyYq;iEuLxtTrS8KYmjSd3i7j6YYL76F9qQfDGmbFCWh8E2HFCVXFD9KVWF5FB1k31kE!2c10	CHEMBL4063939	flePc@NRLdDPFPcHYEEDdcEEMDpUgPPYTuUDcR\`@	C[C@H]1[C@@H](O)C(F)(F)C(=O)N1c1ccc(C#N)c(Cl)c1	8.96	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from human AR after 3 hrs	2017	dcl@@DjYVWmEZjjjh@@	dcnH@DCHhheBeSKkUP@P@@	286.664	1.6378	4	1	64.33	1	-0.8523615055663379	1.608125420549893	-0.2772263325757957	17	16	fdyQ@`JQd@IIxl\WPNQQQSYSIPjgK^jji@Hn@@@	eMCBP`AdDf`@	eFBH@c@@	eFJB@Hp@	eFABH`BL@							14
:Uvzv:rSyjvyvuCbUPUfpCzQhjboFKvfVQ4mlXw49Zd4DzyJ250J@g@fL!5gc2Jd0FHGBF81$V20V0F0	CHEMBL4064645	ekhTD@@DF`JlbbRfbTJTtRLrbRhXTt\|brvNZjjjjjih@JhxHcBDVdlgbbP@	C[C@]12CC[C@H]3[C@@H](CC[C@H]4NC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2C(=O)Nc1ccccc1	4.64	group4-ia	ia	Androgen Receptor	Displacement of [3H]-DHT from recombinant human androgen receptor expressed in CHO cells	2017	fm@@@LdbbbTRaJRLVbRxhQmN|FZzjjjjjjjjjh@@	fmP`@DEAeIe[Vum^vUhrRkNCFZvjjjjjf`@jbaHIJahE@@	394.557	3.9983	4	2	58.2	2	-0.059212763162064974	-0.3906520764744472	-1.1636092025051685	1	1	ekhTD@@DF`JlbbRfbTJTtRLrbRhXTt\|brvNZjjjjjih@JhxHcBDVdlgbbP@											1
yqulPWOG8F5k0F95FN0G0N@H!F!29@02I218!1QV04FW#F0C24L#V08!W102X4060V%F402V1V	CHEMBL4065842	f`qQ@@I^AdTTRJbbQYsUhBBfjq@@	Cc1cc(-c2ccc(C#N)n2C)ccc1O	8.54	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting	2017	dmL@@DjYU^TYjjjj@@	dmN@@@rQQJEHjeZe@B@@	212.251	2.1529	3	1	48.95	1	-1.7606295913953303	1.3407525300549377	-0.5246809986063885	36	26	fdyPB`IQ@D||]HIhFscdTTRbbrbnXIwhBHfjkD@@	eFBH@c@@			eFBH@c@@	eFJB@Hp@						24
yqulPWOG8F5k0F95FN0G08@H!F0839@02I218!1QV86FV#F0C24J1!V82!W102V!60V04#F0N2V1V	CHEMBL4066319	fhiq@@AJBCHhdiehhdZ\Lz@HzZkD@@	Cn1c(C#N)ccc1-c1ccc(O)cc1C#N	8.17	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting	2017	dmL@@DjYU^TYjjjj@@	dmN@@@rQQJEHjeZe@B@@	223.234	1.6446	4	1	72.74	1	-1.0514504923023698	1.9009448171380097	-0.36015687783096806	36	26	fdyPB`IQ@D||]HIhFscdTTRbbrbnXIwhBHfjkD@@	eFBH@c@@	eMbA@Dg`@			eFJB@Hp@						24
[xUjjYq;jdu6USQrS13rmf9c3i2j6XYL31FWLUY4GkZFRWg8A0HFCV0FD1GkVFB081k31k7!2V10	CHEMBL4067691	fdyPb@NRLDDQdTTRRLTTJXJshHLjZjIFdz@@	CC[C@H]1[C@H](O)CC(=O)N1c1ccc(C#N)c(Cl)c1	8.47	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from human AR after 3 hrs	2017	dcl@@DjYVWmEZjjjh@@	dcnH@DCHhheBeSKkUP@P@@	264.711	1.953	4	1	64.33	2	-0.8242632024770284	1.3792282625625885	-0.2855998945683256	17	16	fdyQ@`JQd@IIxl\WPNQQQSYSIPjgK^jji@Hn@@@		eMBD@ch@	eFJB@Hp@	eFABH`BL@							14
yTur23dG8s4V4F@4F8F0VN0H0JFV13920H2V58!18F1!140@1V80G6lFc09FX#F8V!4020458J050VVFF	CHEMBL4068008	fegH`@LJSLF\dTRTrTrTRTQQWIZmWmAAEUA\DVI@T@@	CCOc1nccc2c1[C@H](c1ccc(C#N)cc1OC)C(C#N)=C(C)N2	5.55	group4-ia	ia	Androgen Receptor	Antagonist activity at GAL4-fused human AR LBD (667 to 919 residues) expressed in CHO-K1 cells assessed as inhibition of dihydrotestosterone-induced transactivation activity after 5 to 6 hrs by luciferase reporter gene assay	2017	f`i@@@LdbbbTRQpiZ][uUUUUUP@@	f`iP@@@\rQISJIPiDiISo@AUP@BPX`@	346.389	2.1607	6	1	90.96	4	0.8310635789110862	1.1468759548417333	0.1469713990131159	4	2	fegH`@LJSLF\dTRTrTrTRTQQWIZmWmAAEUA\DVI@T@@											1
yqulPWOG8F5k0F95FN0G0N@H!F#9@02I218!1QV04FW#F0C25L#V08!W102X4040V%F!2c1V	CHEMBL4068562	f`qQB@I^HBPrJJKKQQHlyjtDASUX`@@	Cn1c(C#N)ccc1-c1ccc(O)c(F)c1	7.23	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting	2017	dmL@@DjYU^TYjjjj@@	dmN@@@rQQJEHjeZe@B@@	216.214	1.9098	3	1	48.95	1	-1.7283217498653385	1.4721956602983024	-0.519426860073573	36	26	fdyPB`IQ@D||]HIhFscdTTRbbrbnXIwhBHfjkD@@	eFBH@c@@			eFABP`BL@	eFJB@Hp@						24
;UvUxvUT7XWqzUmcIPLSdHqJ0WYmfNc1DMY4XX630F1H97BGFb0BWc866HHB!FD0G0V04F81k31Vb!2V10	CHEMBL4068946	fhiQB@NR|BHrJJIIFJIQ`cN``rjjbPiFP@	C[C@@H]1N(c2ccc(C#N)c(Cl)c2)CC[C@]1(C)O	9.28	group1-p	p	Androgen Receptor	Displacement of [17-alpha-methyl-H-3] mibolerone from wild-type androgen receptor (unknown origin) expressed in Freestyle293F cells measured after 3 hrs dextran/charcoal based method	2017	dmL@@DjYU^TYjjjj@@	dmN@@@rRJIIEneZ`hB@@	250.728	2.3628	3	1	47.26	1	-1.5950603321388175	1.0594903445711028	-0.4645756632451089	36	5	f`qPA@NRAx~\\bbbRQbbSAF]AAeUTTEH@	eMJB@Df`@	eFABH`BL@									1
yqulPWOG8F5k0F95FN0G0N@H!F0839@02I218!1QV86FW!2G0C25L1!V8@!W102X4840V04#F0F2c1V	CHEMBL4069026	fhiQA@EAXBPIHYEEEMCMDcrQgPQDSUX`@@	Cn1c(C#N)ccc1-c1ccc(O)c(F)c1F	7.43	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting	2017	dmL@@DjYU^TYjjjj@@	dmN@@@rQQJEHjeZe@B@@	234.205	2.0106	3	1	48.95	1	-1.6383205541556718	1.344883645301536	-0.48929766947078335	36	26	fdyPB`IQ@D||]HIhFscdTTRbbrbnXIwhBHfjkD@@	eFBH@c@@	eFABP`BL@		eFABP`BL@	eFJB@Hp@						24
zrUtUWOMdFEw0H9EUN0l2A@u08F68Y984Hv25BH81QW@6lWV6XN0CX4J1N0d1380dW02X4V6!85F20G08080V	CHEMBL4069656	fa{Pc@LDeh@PvP{HISOKLwjk~JJLfnRtsTs@@@U@@@@	O=C1c2ccc(F)cc2C(=O)N1c1nc(-c2ccc(F)cc2)cs1	4.67	group4-ia	ia	Androgen Receptor	Antagonist activity at AR T877A mutant in human LNCAP cells assessed as inhibition of DHT-induced proliferation after 48 hrs by MTT assay	2017	ffs@@@LdbbRRqbbbvWEBdxIZuUUUUUUUP@@	ffsPb@LDeh@PeL|ls^jnJJLfnRtsTs@@@P@@@	342.325	4.0659	4	0	78.51	2	-0.5629616553969695	-0.06086517614529435	0.9759422399885869	14	14	fa{Pc@AF}DCchH{HILklksMzmFJtEMVp@TmTs@DP@@@	eFABP`BL@										7
zrUtUWOLdFEw0H9EUN0l2A@c08F68Y184Ht25BH80PW@6lVV6XN0CX4J0N0d1380dW02V0V4#1F2#8#V	CHEMBL4070425	fnkPb@LDeh@QdbbtRbbfrRRnJJLfnRtsTs@@@T@@@	Cc1ccc(-c2csc(N3C(=O)c4ccccc4C3=O)n2)cc1	4.54	group4-ia	ia	Androgen Receptor	Antagonist activity at AR T877A mutant in human LNCAP cells assessed as inhibition of DHT-induced proliferation after 48 hrs by MTT assay	2017	ffs@@@LdbbRRqbbbvWEBdxIZuUUUUUUUP@@	ffsPb@LDeh@PeL|ls^jnJJLfnRtsTs@@@P@@@	320.371	4.2082	4	0	78.51	2	-0.685270784209917	-0.06499637813252299	0.9405588869874165	14	14	fnkPa@AF}DCchHRYWYWf[uhqV`ijv@BejfX@H@@@	eFBH@c@@										6
>xzxT7iWq;g9u6SOPrS01Ymf9c3i2j4XXL30F1LOY4GkZFBWg8A0HFCV0FD1GVVF4081k31k7!2V10	CHEMBL4071751	fhiPb@NRLDDQdTTRRLTTKAV]AAeSUDcR\`@	C[C@H]1[C@@H](O)CC(=O)N1c1ccc(C#N)c(Cl)c1	8.11	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from human AR after 3 hrs	2017	dcl@@DjYVWmEZjjjh@@	dcnH@DCHhheBeSKkUP@P@@	250.684	1.4986	4	1	64.33	1	-1.0352893259243536	1.825230309312206	-0.3371562290489706	17	16	fdyQ@`JQd@IIxl\WPNQQQSYSIPjgK^jji@Hn@@@		eFBH@c@@	eFJB@Hp@	eFABH`BL@							14
[xUjjYq;jdu6USQrS13rmf9c3i2j6XYL31FWLUY4GkZFRWg8A0HFCV0FD1GkVFB081k31k7!2V10	CHEMBL4072533	fdyPb@NRLDDQdTTRRLTTJXJshHLjZjIFdy@@	CC[C@H]1[C@@H](O)CC(=O)N1c1ccc(C#N)c(Cl)c1	8.41	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from human AR after 3 hrs	2017	dcl@@DjYVWmEZjjjh@@	dcnH@DCHhheBeSKkUP@P@@	264.711	1.953	4	1	64.33	2	-0.8242632024770284	1.3792282625625885	-0.2855998945683256	17	16	fdyQ@`JQd@IIxl\WPNQQQSYSIPjgK^jji@Hn@@@		eMBD@ch@	eFJB@Hp@	eFABH`BL@							14
yqulPWOG8F5k0F95FN0G0N@H!F0839@02I218!1QV86FW#F0C24L1!V8@!W102X4860V04#F4N2V1V	CHEMBL4072730	fhiQ@@EAAdTTRatTRKNF]@PUMUb@@	Cc1c(O)ccc(-c2ccc(C#N)n2C)c1C	8.31	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting	2017	dmL@@DjYU^TYjjjj@@	dmN@@@rQQJEHjeZe@B@@	226.278	2.4968	3	1	48.95	1	-1.7029415406838013	1.082001119381471	-0.4998076036692888	36	26	fdyPB`IQ@D||]HIhFscdTTRbbrbnXIwhBHfjkD@@	eFBH@c@@	eFBH@c@@		eFBH@c@@	eFJB@Hp@						24
zrUtUWOLdFEw0H9EEN0l2A@c08F68Y084Ht25BH80PW@6lVV6XN09V4J0N0d1380dW02V0V4#1F2#8#V	CHEMBL4073161	ffsPb@LDeh@PeL|ls^jnJJLfnRtsTs@@@P@@@	O=C1c2ccccc2C(=O)N1c1nc(-c2ccccc2)cs1	4.43	group4-ia	ia	Androgen Receptor	Antagonist activity at AR T877A mutant in human LNCAP cells assessed as inhibition of DHT-induced proliferation after 48 hrs by MTT assay	2017	ffs@@@LdbbRRqbbbvWEBdxIZuUUUUUUUP@@	ffsPb@LDeh@PeL|ls^jnJJLfnRtsTs@@@P@@@	306.344	3.8643	4	0	78.51	2	-0.7429589152770237	0.19375508912528694	0.9156854669422428	14	14	ffsPb@LDeh@PeL|ls^jnJJLfnRtsTs@@@P@@@											1
yqulPlOG8F5k0F95FN2G08@H04FF839@0HI618!1QV96FV#F0C24J1!c82F1W14@X1V60V04F!H0N2c1V	CHEMBL4073399	fleQC@EIlBPQHXdLbdLTRbRbIdYpZhHIJjq@@	Cn1c(C#N)ccc1-c1ccc(O)cc1C(F)(F)F	7.83	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting	2017	dmL@@DjYU^TYjjjj@@	dmN@@@rQQJEHjeZe@B@@	266.221	2.6573	3	1	48.95	2	-1.34160879768308	0.7165718961877676	-0.4071385603334964	36	26	fdyPB`IQ@D||]HIhFscdTTRbbrbnXIwhBHfjkD@@	eFBH@c@@	gJPBAHJPt`PAIjj@@			eFJB@Hp@						24
yqulPWOG8F5k0F91FN0G08@#F#9@0HG218#QV84FV!2N0C24J#c10F0W102V!40V%F!2Z1V	CHEMBL4073869	f`qQB@BV|CDrJJIJKIHdXYtuLDFT@@@	Cn1c(C#N)cc(Br)c1-c1ccc(O)cc1	6.78	group3-int	int	Androgen Receptor	Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting	2017	dmL@@DjYU^TYjjjj@@	dmN@@@rQQJEHjeZe@B@@	277.12	2.5342	3	1	48.95	1	-1.4369579703892033	0.8709802036572388	-0.41595307003417803	36	26	flePA`II@D||]HIhFsc{DrJJIQQYQRe`gA`HbZjkD@@	eFBH@c@@				eFJB@Hp@						1
>xzxTbiYq;iSuLSOTrS8_Ymf9d3i2j6YYL72F9qQj6GmZFBWg8A0HHCVXFT9KVVF4081k31kb!2V10	CHEMBL4074501	fdyPb@NRMDDQdTTRRLTTrXJshHLjZjKFeYNP@	C[C@@H]1C(=O)N(c2ccc(C#N)c(Cl)c2)[C@@H](C)[C@H]1O	8.89	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from human AR after 3 hrs	2017	dcl@@DjYVWmEZjjjh@@	dcnH@DCHhheBeSKkUP@P@@	264.711	1.7679	4	1	64.33	1	-0.9740913094004584	1.6113245662135893	-0.3126716088538901	17	16	fdyQ@`JQd@IIxl\WPNQQQSYSIPjgK^jji@Hn@@@	eFBH@c@@	eFBH@c@@	eFJB@Hp@	eFABH`BL@							14
yqulPWOG8F5k0F95FN0G0N@H!F083A@02I218#QV86FV!2G0C25J1!V82!W302V0840V04#F0F2V1V	CHEMBL4074555	fhiQA@IAtBHyDYEEDhhcEbpQgPDQMUX`@@	Cn1c(C#N)ccc1-c1c(Cl)cc(O)cc1Cl	7.54	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting	2017	dmL@@DjYU^TYjjjj@@	dmN@@@rQQJEHjeZe@B@@	267.115	3.021	3	1	48.95	1	-1.5125503359268424	0.615442811000698	-0.42987919476830805	36	26	fdyPB`IQ@D||]HIhFscdTTRbbrbnXIwhBHfjkD@@	eFBH@c@@	eFABH`BL@	eFABH`BL@		eFJB@Hp@						24
yqulPWOG8F5k0FA5FN0G0N@m!F0839@0HIX18080QV96NV!2GVC25J1!c82F1W102V4V4cV04F04F0F2V1V	CHEMBL4074927	fleQb@EI`bp@cIICMDhdhbYF\EZBBRjlP@@	Cn1c(C#N)ccc1-c1ccc(O)cc1S(C)(=O)=O	5.83	group4-ia	ia	Androgen Receptor	Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting	2017	dmL@@DjYU^TYjjjj@@	dmN@@@rQQJEHjeZe@B@@	276.315	0.811	5	1	91.47	2	-0.028116926305491008	2.3426383815171907	-0.11482922835936625	36	26	fdyPB`IQ@D||]HIhFscdTTRbbrbnXIwhBHfjkD@@	eFBH@c@@	gJPdH`DD@cuh@			eFJB@Hp@						24
>x:TbiYq;iUuLxtTrS8_YmfCd3iIj6YYL72F9qQjDGm_FCWg8E2HHCVXFT9KVlF4F81k31kj!2V10	CHEMBL4077666	flePb@NRLdDQdTTRRLTTtSAV]AAeSUTRMIr@@	C[C@H]1[C@@H](O)C(C)(C)C(=O)N1c1ccc(C#N)c(Cl)c1	7.85	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from human AR after 3 hrs	2017	dcl@@DjYVWmEZjjjh@@	dcnH@DCHhheBeSKkUP@P@@	278.738	2.0994	4	1	64.33	1	-0.9158197563805067	1.3600272875011394	-0.2878628104407582	17	16	fdyQ@`JQd@IIxl\WPNQQQSYSIPjgK^jji@Hn@@@	eMBH@RZ@	eFBH@c@@	eFJB@Hp@	eFABH`BL@							14
zyQvTYOM8F5s0LAhSNHlVO@H0BN_93984Mnm58V03Qk14kWVD2G0Ca5JW0VV1BWFWt1@Xp@6F04408Fm14VcFV	CHEMBL407848	fj}qB@BNKhDadTTRTRtTlRKA\dELDDTuMUd`@@	Cn1c(C#N)ccc1-c1cc(F)c2c(c1)C(C)(C)C(=O)N2	6.71	group3-int	int	Androgen Receptor	Antagonist activity at human AR ligand binding domain expressed in african green monkey COS7 cells in presence of 5-alpha-dihydrotestosterone by Gal4 hybrid assay	2008	foQ@@@LdbbRReVxhTcVjjjjjh@@	foQQ@@DZ@drjnrdhJUgMT@TtB@@	283.305	1.8158	4	1	57.82	1	-0.9831314554392622	1.4658250796786283	-0.29839659445260214	1	1	fj}qB@BNKhDadTTRTRtTlRKA\dELDDTuMUd`@@											1
zrUtUWOMdFEw0HAEUN0l2A@c08F68Y184Ht25Bm82PW@6tVV6XN0CX4J0N0d138FdW02VVV48!1F2#83!V	CHEMBL4079171	figpRBLD[KWQ`BFrOldTVbTTTvRRUTqQQdurVfZfX@@BZ@@@	O=C1c2ccccc2C(=O)N1c1nc(-c2ccc([N+](=O)[O-])cc2)cs1	4.88	group4-ia	ia	Androgen Receptor	Antagonist activity at AR T877A mutant in human LNCAP cells assessed as inhibition of DHT-induced proliferation after 48 hrs by MTT assay	2017	ffs@@@LdbbRRqbbbvWEBdxIZuUUUUUUUP@@	ffsPb@LDeh@PeL|ls^jnJJLfnRtsTs@@@P@@@	351.341	2.9427	7	0	124.33	3	1.1672353411869245	1.1587432309594312	1.3932982911271696	14	14	fnkPa@AF}DCchHRYWYWf[uhqV`ijv@BejfX@H@@@	gChhhE`BRnRYh@										6
yqulPWOG8F5k0F95FN0G08@H!F0839@02I218!1QV86FV#F0C24J1!V82!W102V!60V04#F0N2V1V	CHEMBL4079377	f`qQ@@I^AdTRTvbbQhsUh@Jfjq@@	Cc1cc(O)ccc1-c1ccc(C#N)n1C	8.43	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting	2017	dmL@@DjYU^TYjjjj@@	dmN@@@rQQJEHjeZe@B@@	212.251	2.1529	3	1	48.95	1	-1.7606295913953303	1.3407525300549377	-0.5246809986063885	36	26	fdyPB`IQ@D||]HIhFscdTTRbbrbnXIwhBHfjkD@@	eFBH@c@@	eFBH@c@@			eFJB@Hp@						24
yqulPWOG8FCk0F95FN0G0N@H!F28Y9@02Q218#QV@6FV!2G0C25J1!V82!W122V!40V04#F0F2c1V	CHEMBL4080698	fdyqB@NAbhDadTTRbRbJrYKUhHIJjoD@@	N#CCn1c(C#N)ccc1-c1ccc(O)cc1F	5.22	group4-ia	ia	Androgen Receptor	Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting	2017	dmL@@DjYU^TYjjjj@@	dmN@@@rQQJEHjeZe@B@@	241.225	1.4114	4	1	72.74	2	-0.7871971957020569	1.8535926752872398	-0.3056612165525461	36	26	fdyPB`IQ@D||]HIhFscdTTRbbrbnXIwhBHfjkD@@	gChHA`AI^`@	eFABP`BL@			eFJB@Hp@						24
>x:TbiYq;iUuLxtTrS8_YmfCd3iIj6YYL72F9qQjDGm_FCWg8E2HHCVXFT9KVlF4F81k31kj!2V10	CHEMBL4082265	flePb@NRLdDQdTTRRLTTtSAV]AAeSUTRMQt@@	C[C@@H]1[C@H](O)C(C)(C)C(=O)N1c1ccc(C#N)c(Cl)c1	5.18	group4-ia	ia	Androgen Receptor	Displacement of [3H]mibolerone from human AR after 3 hrs	2017	dcl@@DjYVWmEZjjjh@@	dcnH@DCHhheBeSKkUP@P@@	278.738	2.0994	4	1	64.33	1	-0.9158197563805067	1.3600272875011394	-0.2878628104407582	17	16	fdyQ@`JQd@IIxl\WPNQQQSYSIPjgK^jji@Hn@@@	eMBH@RZ@	eFBH@c@@	eFJB@Hp@	eFABH`BL@							14
zrUtUWOMdFEw0H9EUN0l2A@u08F68YA84Hv25BH81QW@6lWV6XN0CX4J1N0d1380dY02X4V6!85F20G08080V	CHEMBL4082860	fa{Pc@AF}DDQhH{HILklksMzmFJtEMVp@TmTs@DP@@@	O=C1c2ccc(F)cc2C(=O)N1c1nc(-c2ccc(Cl)cc2)cs1	4.55	group4-ia	ia	Androgen Receptor	Antagonist activity at AR T877A mutant in human LNCAP cells assessed as inhibition of DHT-induced proliferation after 48 hrs by MTT assay	2017	ffs@@@LdbbRRqbbbvWEBdxIZuUUUUUUUP@@	ffsPb@LDeh@PeL|ls^jnJJLfnRtsTs@@@P@@@	358.78	4.5711	4	0	78.51	2	-0.5000766088957664	-0.42558585165348883	1.0056514672708048	14	14	fa{Pc@AF}DCchH{HILklksMzmFJtEMVp@TmTs@DP@@@	eFABH`BL@										7
[xUjjYq;jdu6USQrS13rmf9c3i2j6XYL31FWLUY4GkZFRWg8A0HFCV0FD1GkVFB081k31k7!2V10	CHEMBL4083012	flepb@NRRXHHcHhhddXhhUfBlzBCJfjldZSd@	N#CC[C@H]1[C@@H](O)CC(=O)N1c1ccc(C#N)c(Cl)c1	7.85	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from human AR after 3 hrs	2017	dcl@@DjYVWmEZjjjh@@	dcnH@DCHhheBeSKkUP@P@@	275.694	1.1986	5	1	88.12	2	-0.10350483803489302	2.087363138511292	-0.12235827876182605	17	16	fdyQ@`JQd@IIxl\WPNQQQSYSIPjgK^jji@Hn@@@		gChHA`AI^`@	eFJB@Hp@	eFABH`BL@							14
<jUtvETimWqzTmsndXUbHyJ0vfndHVMmxnBnX_SlOEmxjBQ3Y5JbTh0eV9TI1c5ZU2MeLFD9CGNVrJBX8G0	CHEMBL4085241	eodTLB@KGb@k`I@jPjdFiCHhhmLiEJhiiEEXmFNEGImcghHBjjjBhbEbIBQNP@	CC1(C)C[C@](O)(C(F)(F)F)[C@@H](Nc2cccc3c(=O)[nH]ccc23)c2ccc(F)c(O)c21	6.5	group3-int	int	Androgen Receptor	Binding affinity to recombinant human androgen receptor expressed in baculovirus infected sf9 cells	2017	ffs@@@LdbbbTV\TRbKMBeEIZuUUUUUUUP@@	ffsQ@@DJ@drro_Ll}NRuGIZmPHQTDPQDCP@	436.404	3.3694	5	4	81.59	3	1.5224474655075748	-0.02392632408442187	-3.097286952958847	1	1	eodTLB@KGb@k`I@jPjdFiCHhhmLiEJhiiEEXmFNEGImcghHBjjjBhbEbIBQNP@											1
>x:T7iWq;gQuLStPrS0WYmfOc3iMj4XXL30F1LObBGkbFBWg8E6HHCV0FD1GVXF4F81k31kb!2V10	CHEMBL4085514	fdyPb@NRLDDQdTTRRLTTLXJshHLjZjIFdy@@	C[C@@H]1N(c2ccc(C#N)c(Cl)c2)C(=O)C[C@]1(C)O	7.82	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from human AR after 3 hrs	2017	dcl@@DjYVWmEZjjjh@@	dcnH@DCHhheBeSKkUP@P@@	264.711	1.7966	4	1	64.33	1	-0.9754416582382869	1.5940716075443107	-0.3125220400121615	17	16	fdyQ@`JQd@IIxl\WPNQQQSYSIPjgK^jji@Hn@@@		eFBH@c@@	eMJB@Df`@	eFABH`BL@							14
yqulPWOG8F5k0F91FN0G08@#F#9@02G218#QV04FV#F0C24J#V$W102V!40V%F!2V1V	CHEMBL4087256	foAQ@@ANAdTRVTTRMFJM@ASUX`@@	Cn1c(C#N)ccc1-c1ccc(O)cc1	8.2	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting	2017	dmL@@DjYU^TYjjjj@@	dmN@@@rQQJEHjeZe@B@@	198.224	1.809	3	1	48.95	1	-1.818317722462437	1.5995039973127474	-0.5495544186515622	36	26	fdyPB`IQ@D||]HIhFscdTTRbbrbnXIwhBHfjkD@@	eFBH@c@@				eFJB@Hp@						24
yqupT_OG8k5k4G95FN0K08@H!F0839@0HI218801QV96FW#F0C24J101c8HF1d102X4V64V84F!F0N2V1V	CHEMBL4087674	fleQ`@EI@bvQQJZIQIQDrLxKTDDeUX`@@	COC(=O)c1cc(O)ccc1-c1ccc(C#N)n1C	6.48	group3-int	int	Androgen Receptor	Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting	2017	dmL@@DjYU^TYjjjj@@	dmN@@@rQQJEHjeZe@B@@	256.26	1.722	5	1	75.25	3	-0.27893588152794757	1.6295615360553213	-0.15826142724403922	36	26	fdyPB`IQ@D||]HIhFscdTTRbbrbnXIwhBHfjkD@@	eFBH@c@@	gJPh@l@ILmP@			eFJB@Hp@						24
[xUjjYq;jdu6USQrS13znf9c3iXj6XYMA1FWLUY4GkZFRWg9AVHGCW0FD1OkVND081p31k7G42V10	CHEMBL4087902	flePb@AJmDDQdTTTRUbbaSIN}AAYTuTRCKr@@	CC[C@H]1[C@@H](O)CC(=O)N1c1ccc(C#N)c(Cl)c1C	8.05	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from human AR after 3 hrs	2017	dcl@@DjYVWmEZjjjh@@	dcnH@DCHhheBeSKkUP@P@@	278.738	2.2969	4	1	64.33	2	-0.7665750770187774	1.1204767236422917	-0.2607264739018976	17	16	fleQ@`JId@IIxl\_PNQQQSYSQJUTxxMUUHDQ\@@@		eMBD@ch@	eFJB@Hp@	eFABH`BL@							2
yqulPWOG8F5k0F95FN0G0N@H!F083A@02I218#QV86FV!2G0C25J1!V82!W302V!40V04#F0F2V1V	CHEMBL4088158	f`qQB@N^TBHrJJIQIQDlejtDDeUX`@@	Cn1c(C#N)ccc1-c1ccc(O)cc1Cl	8.85	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting	2017	dmL@@DjYU^TYjjjj@@	dmN@@@rQQJEHjeZe@B@@	232.669	2.415	3	1	48.95	1	-1.6654366005731345	1.1074752148557114	-0.4897176101682984	36	26	fdyPB`IQ@D||]HIhFscdTTRbbrbnXIwhBHfjkD@@	eFBH@c@@	eFABH`BL@			eFJB@Hp@						24
zrUtUWOMdFEw0H9EUN0l2A@u08F68Y984Hv25BH81QW@6lWV6XN0CX4J1N0d1380dW02X4V6!85F20G080c0V	CHEMBL4088224	figpa@LDGKP@al`eL|ls^jo~JJLfnRtsTs@@@Up@@@	N#Cc1ccc(-c2csc(N3C(=O)c4ccc(F)cc4C3=O)n2)cc1	5.22	group4-ia	ia	Androgen Receptor	Antagonist activity at AR T877A mutant in human LNCAP cells assessed as inhibition of DHT-induced proliferation after 48 hrs by MTT assay	2017	ffs@@@LdbbRRqbbbvWEBdxIZuUUUUUUUP@@	ffsPb@LDeh@PeL|ls^jnJJLfnRtsTs@@@P@@@	349.345	3.8007	5	0	102.3	2	0.11390965791210952	0.36788393701349686	1.1352122325624652	14	14	fa{Pc@AF}DCchH{HILklksMzmFJtEMVp@TmTs@DP@@@	eMbA@Dg`@										7
zyunPnOl8F5k0F91FN2l08@#FF!9@0HG618#Qk84Fk!2N2C24JF!c1FF1W102V3040V%F!2c1V	CHEMBL4088572	fleQC@NZRBPQHXdLbdLTRRLRVyHLZij[`@h@@	Cn1c(-c2ccc(O)cc2)cc(C(F)(F)F)c1C#N	7.96	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting	2017	dmL@@DjYU^TYjjjj@@	dmN@@@rQQJEHjeZe@B@@	266.221	2.6573	3	1	48.95	2	-1.34160879768308	0.7165718961877676	-0.4071385603334964	36	26	ff}P@PII@D||]HIhFscfPKHUdLbbbTTVTURTcAN}@QDuUWTH@@	eFBH@c@@				eFJB@Hp@						1
[xUjzYq<fu6ESQrS1Irmd9c3i6iDXYMA1NWLUY4GkZFRVg8A0HFEV0FB5OmWFD081k31k7082c10	CHEMBL4088914	fjmPc@EF}dD`bPqHYEHXhddXhhUKPXuPPYTuTRGJJ@@	CC[C@H]1[C@@H](O)CC(=O)N1c1ccc(C#N)c(C(F)(F)F)c1	8.44	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from human AR after 3 hrs	2017	dcl@@DjYVWmEZjjjh@@	dcnH@DCHhheBeSKkUP@P@@	298.263	2.1953	4	1	64.33	3	-0.5004354051958295	0.9883248722321577	-0.20302084411226923	17	16	fdyQ@`JQd@IIxl\WPNQQQSYSIPjgK^jji@Hn@@@		eMBD@ch@	eFJB@Hp@	gJPBAHJPt`PAIjj@@							14
<jrOzdFaw1qAiURPW2CFuVB8p12h043mK4BXB39VN0fGVD1XX0aZK8!V0EV!s582Y06t!204Vb08XcG0	CHEMBL409	fkoPR`OG`aS`A@YB\`nPwHYIHXdeHcMmDeLiEJuVkPPUCT@EUXPyP@	CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	6.4	group3-int	int	Androgen Receptor	In vitro antagonistic activity against mutant androgen receptor of LNCap cells	2004	fbu@@@LddTQRVftRTmIsUUUUUUT@@	fbuab@KPPX@QddabRRtJbReiNUhHHZ@@@@@	430.377	2.1426	6	2	115.64	6	2.2643186916316047	0.7718113671479796	-0.6866111446476576	4	4	fcw`Q`MV}dhODTaJPUHIBMnNQQQIRZjZSZPqIYgIk`HJjZjV@BBCb@@	eFABP`BL@	eMbA@Dg`@									2
;UvUxvST7XWqzUmc1P6S9HqJ01fnf8c1DXY4XX7A0F1H934GFZ0BWc92VHFB10FD0O0V86081p31V7F42V10	CHEMBL4090028	fhiQB@AJBBHrJJJIJqQIdk^``ljjbQiVP@	Cc1c(N2CC[C@H](O)[C@@H]2C)ccc(C#N)c1Cl	9.14	group1-p	p	Androgen Receptor	Displacement of [17-alpha-methyl-H-3] mibolerone from wild-type androgen receptor (unknown origin) expressed in Freestyle293F cells measured after 3 hrs dextran/charcoal based method	2017	dmL@@DjYU^TYjjjj@@	dmN@@@rRJIIEneZ`hB@@	250.728	2.4087	3	1	47.26	1	-1.5972199547222115	1.0318975640030448	-0.46433645672356394	36	5	fhiPA@AJAxa\\bbbbRlTRYJwhHKJjhhZP@	eFJB@Hp@	eFABH`BL@									3
zrUtUWOMdFEw0H9EUN0l2A@u08F68Y984Hv25BH81QW@6lWV6XN0CX4J1N0d1380dW02X4V6!85F20G08080V	CHEMBL4090670	fnkPa@LDeh@PvPRf^VYoUWqQQdurVfZfX@@B`@@@	O=C1c2ccc(F)cc2C(=O)N1c1nc(-c2ccccc2)cs1	4.65	group4-ia	ia	Androgen Receptor	Antagonist activity at AR T877A mutant in human LNCAP cells assessed as inhibition of DHT-induced proliferation after 48 hrs by MTT assay	2017	ffs@@@LdbbRRqbbbvWEBdxIZuUUUUUUUP@@	ffsPb@LDeh@PeL|ls^jnJJLfnRtsTs@@@P@@@	324.334	3.9651	4	0	78.51	2	-0.6529628623243473	0.06644669552649837	0.9458130506283059	14	14	fa{Pc@AF}DCchH{HILklksMzmFJtEMVp@TmTs@DP@@@											7
:Uvzv;RjxYqAzUxEVmQQUbCAMdnS5_MjZEEmfIElOckUf6QrZlg2Cg0VYnUfX1g5taWHM134t9GJ71g0c!	CHEMBL4090771	fewq@`DXfh@PvP{HCdDfYfVUwoZz\u[rXeZj`P`@bjzBGJ@@	N#Cc1ccc(N2C(=O)C3Cc4ccccc4N3C2=S)cc1C(F)(F)F	4.73	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) expressed in African green monkey COS7 cells assessed as inhibition of R1881-induced protein activation after 24 hrs by luciferase reporter gene assay	2018	fb}@@@LdbbRbbvLrWCBT{r\uUUUUUUT@@	fb}QB@DXT@HRYfYYW_isUoIcejjAB@@hH\h@@	373.357	3.4974	4	0	79.43	2	-0.357996256985711	0.1725597465967297	1.026383902367776	1	1	fewq@`DXfh@PvP{HCdDfYfVUwoZz\u[rXeZj`P`@bjzBGJ@@											1
zrztUWOMdkEw0HAEUN0l2A@c08F68Y1@4Ht25BH82PW@6lVV6XN0CXJJ0N0d138FdW02V0V40V01F2#8#V	CHEMBL4091358	fa{Qb@LDeih@cIEEheEEMddeUbbcIkdmLuLp@@EP@@@	COc1ccc(-c2csc(N3C(=O)c4ccccc4C3=O)n2)cc1	4.86	group4-ia	ia	Androgen Receptor	Antagonist activity at AR T877A mutant in human LNCAP cells assessed as inhibition of DHT-induced proliferation after 48 hrs by MTT assay	2017	ffs@@@LdbbRRqbbbvWEBdxIZuUUUUUUUP@@	ffsPb@LDeh@PeL|ls^jnJJLfnRtsTs@@@P@@@	336.37	3.7943	5	0	87.74	3	-0.029761571243046375	0.19222227251848129	1.102874429862511	14	14	fnkPa@AF}DCchHRYWYWf[uhqV`ijv@BejfX@H@@@	eMJA@Hz@										6
yqulPWOG8F5k0F95FN0G0N@H!F0839@02I218!1QV86FW!2G0C25L1!V8@!W102X4060V84#F0F2c1V	CHEMBL4091403	fhiQA@EAHBPeHYEEEdeMDbsagPPESUX`@@	Cn1c(C#N)ccc1-c1cc(F)c(O)cc1F	7.07	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting	2017	dmL@@DjYU^TYjjjj@@	dmN@@@rQQJEHjeZe@B@@	234.205	2.0106	3	1	48.95	1	-1.6383205541556718	1.344883645301536	-0.48929766947078335	36	26	fdyPB`IQ@D||]HIhFscdTTRbbrbnXIwhBHfjkD@@	eFBH@c@@		eFABP`BL@	eFABP`BL@	eFJB@Hp@						24
<jUtvETimWqzTmsndXUbHyJ0vfndHVMmxrBnX_SlOEmSjBQ3Y5JYTh0eV9Tn1V5ZU2IeLFD9CGNVrKBX8G0	CHEMBL4092066	eodTLB@KEb@g`I@jPjdFiCHhhmLiEJhiiEEXlVNEGImckhHBjjjBhbFRIBQNP@	CC1(C)C[C@](O)(C(F)(F)F)[C@@H](Nc2cccc3[nH]c(=O)ccc23)c2ccc(F)c(O)c21	6.1	group3-int	int	Androgen Receptor	Binding affinity to recombinant human androgen receptor expressed in baculovirus infected sf9 cells	2017	ffs@@@LdbbbRvttRbKEBeEIZuUUUUUUUP@@	ffsQ@@DJ@drmk_Ll}FRuGIZmR@QTDPQDCP@	436.404	3.1766	5	4	81.59	3	1.531518802453707	0.09197513561424192	-3.098291722483546	1	1	eodTLB@KEb@g`I@jPjdFiCHhhmLiEJhiiEEXlVNEGImckhHBjjjBhbFRIBQNP@											1
;UvUxvUT7XWqzUmcIPLSdHqJ0WfndNc1DrY4XX7A0F1H97BGFb0BWc96aHHB10FB0O0V86F81p31VbF42c10	CHEMBL4092535	fdyQB@AJBBPrJJJIJqQJLe[tDEeUUDcRl`@	Cc1c(N2CC[C@](C)(O)[C@@H]2C)ccc(C#N)c1F	9.54	group1-p	p	Androgen Receptor	Agonist activity at androgen receptor (unknown origin) expressed in African green monkey COS7 cells after 24 hrs by MMTV-promoter driven luciferase reporter gene assay	2017	dmL@@DjYU^TYjjjj@@	dmN@@@rRJIIEneZ`hB@@	248.3	2.2015	3	1	47.26	1	-1.6002573503639148	1.1654593227558838	-0.4694114931052099	36	5	fhiPA@AJAxa\\bbbbRlTRYJwhHKJjhhZP@	eMJB@Df`@	eFABP`BL@									3
]UzjYy;jtu6UxQrU13rufOe3i@jLYYL71FWLUf4Kk_FRWg8E4HHCV0FD1GkVFB081k31k7!2V10	CHEMBL4093265	fbuPb@NRLDDQdTTRRLTTJtXJshHLjZjhdZSd@	CC(C)C[C@H]1[C@@H](O)CC(=O)N1c1ccc(C#N)c(Cl)c1	8.26	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from human AR after 3 hrs	2017	dcl@@DjYVWmEZjjjh@@	dcnH@DCHhheBeSKkUP@P@@	292.765	2.6257	4	1	64.33	3	-0.5496393323641481	0.7499788612963142	-0.20982467345788264	17	16	fdyQ@`JQd@IIxl\WPNQQQSYSIPjgK^jji@Hn@@@		gJPHB@ITuP@	eFJB@Hp@	eFABH`BL@							14
yqulPWOG8F5k0F95FN0G0N@H!F0839@02I218#QV86FV!2G0C25J1!V82!W102V0840V04#F0F2c1V	CHEMBL4095364	fhiQA@IAtBPyHYEEDhhcEbpQgPDQMUX`@@	Cn1c(C#N)ccc1-c1c(F)cc(O)cc1F	8.8	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting	2017	dmL@@DjYU^TYjjjj@@	dmN@@@rQQJEHjeZe@B@@	234.205	2.0106	3	1	48.95	1	-1.6383205541556718	1.344883645301536	-0.48929766947078335	36	26	fdyPB`IQ@D||]HIhFscdTTRbbrbnXIwhBHfjkD@@	eFBH@c@@	eFABP`BL@	eFABP`BL@		eFJB@Hp@						24
yqulPWOG8F5k0F95FN0G0N@H!F0839@02I218#QV86FV!2G0C25J1!V82!W102V!40V04#F0F2c1V	CHEMBL4095883	f`qQB@N^TBPrJJIQIQDlejtDDeUX`@@	Cn1c(C#N)ccc1-c1ccc(O)cc1F	8.49	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting	2017	dmL@@DjYU^TYjjjj@@	dmN@@@rQQJEHjeZe@B@@	216.214	1.9098	3	1	48.95	1	-1.7283217498653385	1.4721956602983024	-0.519426860073573	36	26	fdyPB`IQ@D||]HIhFscdTTRbbrbnXIwhBHfjkD@@	eFBH@c@@	eFABP`BL@			eFJB@Hp@						24
yTur23dG8s4V4F@4F8F0VN0H0JFV13920H2V58!38F1!140@1V80G6lFc09NX!8F8V!4028458J250VVFF	CHEMBL4096901	fmwH`@LJrlA\dTRTrTRRfRbJJyKSfchHHjjBxHlR@h@	CCOc1ncc(C)c2c1[C@H](c1ccc(C#N)cc1OC)C(C#N)=C(C)N2	5.62	group4-ia	ia	Androgen Receptor	Antagonist activity at GAL4-fused human AR LBD (667 to 919 residues) expressed in CHO-K1 cells assessed as inhibition of dihydrotestosterone-induced transactivation activity after 5 to 6 hrs by luciferase reporter gene assay	2017	f`i@@@LdbbbTRQpiZ][uUUUUUP@@	f`iP@@@\rQISJIPiDiISo@AUP@BPX`@	360.416	2.5046	6	1	90.96	4	0.8887515492670369	0.88812460075261	0.1718447688421418	4	2	fmwH`@LJrlA\dTRTrTRRfRbJJyKSfchHHjjBxHlR@h@											1
zrUtUWOMdFEw0HAEUN0l2A@u08F68Y984Hv25Bm83QW@6tWV6XN0CX4J1N0d138FdW02XZV68085F20G08380V	CHEMBL4098395	fewpQBLD{KPy`BFrGYgrTsrsMzjvJJLfnRtsTs@@@Tt@@@	O=C1c2ccc(F)cc2C(=O)N1c1nc(-c2ccc([N+](=O)[O-])cc2)cs1	5.11	group4-ia	ia	Androgen Receptor	Antagonist activity at AR T877A mutant in human LNCAP cells assessed as inhibition of DHT-induced proliferation after 48 hrs by MTT assay	2017	ffs@@@LdbbRRqbbbvWEBdxIZuUUUUUUUP@@	ffsPb@LDeh@PeL|ls^jnJJLfnRtsTs@@@P@@@	369.332	3.0435	7	0	124.33	3	1.257236536896591	1.0314312159626648	1.4234274817299593	14	14	fa{Pc@AF}DCchH{HILklksMzmFJtEMVp@TmTs@DP@@@	gChhhE`BRnRYh@										7
yqulPWOG8F5k0FA5FN0G0N@m!F0839@0HIX18V!QV96NV!2GVC25J1!c82G1W102X4V48V04F04J0F3V1V	CHEMBL4100251	fdyq`BHRbAAhRclbfbbTRTQHmV|tDDeUX`@@	Cn1c(C#N)ccc1-c1ccc(O)cc1[N+](=O)[O-]	7.19	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting	2017	dmL@@DjYU^TYjjjj@@	dmN@@@rQQJEHjeZe@B@@	243.221	0.8874	6	1	94.77	2	0.09187638948653984	2.564492131918421	-0.07194162897410095	36	26	fdyPB`IQ@D||]HIhFscdTTRbbrbnXIwhBHfjkD@@	eFBH@c@@	gChhhE`BRnRYh@			eFJB@Hp@						24
>xzxT7iWq;g9u6SOPrS01fnf9c3iXj4XXMA0F1LOY4GkZFBWg9AVHGCW0FD1OVVN6081p31k7G42V10	CHEMBL4100278	fdyPb@AJmDDQdTTTRUbbaYIwhHKJfjIAey@@	Cc1c(N2C(=O)C[C@H](O)[C@@H]2C)ccc(C#N)c1Cl	7.96	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from human AR after 3 hrs	2017	dcl@@DjYVWmEZjjjh@@	dcnH@DCHhheBeSKkUP@P@@	264.711	1.8425	4	1	64.33	1	-0.9776012752128249	1.5664788986387392	-0.31228283411187086	17	16	fleQ@`JId@IIxl\_PNQQQSYSQJUTxxMUUHDQ\@@@		eFBH@c@@	eFJB@Hp@	eFABH`BL@							2
]Ujjfq;jxuLUSUrSdbrmvCd3i2j6YYL73FdqUj6GmZFRWg8A0HHCVXFT9KkVFB081k31kb!2V10	CHEMBL4100995	flePb@NRMDDQdTTRRLTTrSAV]AAeSUTVMJr\`@	CC[C@H]1[C@@H](O)[C@H](C)C(=O)N1c1ccc(C#N)c(Cl)c1	8.74	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from human AR after 3 hrs	2017	dcl@@DjYVWmEZjjjh@@	dcnH@DCHhheBeSKkUP@P@@	278.738	2.2223	4	1	64.33	2	-0.7630651112064107	1.1653223912171418	-0.2611152486439169	17	16	fdyQ@`JQd@IIxl\WPNQQQSYSIPjgK^jji@Hn@@@	eFBH@c@@	eMBD@ch@	eFJB@Hp@	eFABH`BL@							14
]Ujifq;ixuLUSTrSehnmf9d3i2j6nYL73F9qQj6GmZFBWg8A4HHCcXFT9KVVF4081k3Wkb!2V10	CHEMBL4101232	flePb@NRMDDQdTTRRLTTrsAV]AAeSUTVMJr\`@	CC[C@@H]1C(=O)N(c2ccc(C#N)c(Cl)c2)[C@@H](C)[C@H]1O	8.49	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from human AR after 3 hrs	2017	dcl@@DjYVWmEZjjjh@@	dcnH@DCHhheBeSKkUP@P@@	278.738	2.2223	4	1	64.33	2	-0.7630651112064107	1.1653223912171418	-0.2611152486439169	17	16	fdyQ@`JQd@IIxl\WPNQQQSYSIPjgK^jji@Hn@@@	eMBD@ch@	eFBH@c@@	eFJB@Hp@	eFABH`BL@							14
]Ujifq;jxuqUSTrSejrmf9d3i2j6nYL7nF9qQj6OmZGBYg8A4nHCeXFT9KVVF40A1k3Wkb!2V10	CHEMBL4101935	fakPb@NRMDDQdTTRRLTTrvbRXJsf}``rijj@@cFeYNP@	C[C@H]1[C@@H](O)[C@H](Cc2ccccc2)C(=O)N1c1ccc(C#N)c(Cl)c1	8.22	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from human AR after 3 hrs	2017	flu@@@LdbbRbVjbRyhRhijjjjjjj@@	flua@@D@rJJJJEIQYZcC^bejjB@@BBFD@	340.809	3.2098	4	1	64.33	3	-0.3241131486859833	0.22068598258289795	-0.12772512780879833	1	1	fakPb@NRMDDQdTTRRLTTrvbRXJsf}``rijj@@cFeYNP@											1
zrUtUWOLdFEw0H9EUN0l2A@c08F68Y184Ht25BH80PW@6lVV6XN0CX4J0N0d1380dW02V0V4#1F2#80V0V	CHEMBL4103425	fa{pb@LD{KP@cIEEheEEMddeUbbcIkdmLuLp@@Ep@@@	N#Cc1ccc(-c2csc(N3C(=O)c4ccccc4C3=O)n2)cc1	4.96	group4-ia	ia	Androgen Receptor	Antagonist activity at AR T877A mutant in human LNCAP cells assessed as inhibition of DHT-induced proliferation after 48 hrs by MTT assay	2017	ffs@@@LdbbRRqbbbvWEBdxIZuUUUUUUUP@@	ffsPb@LDeh@PeL|ls^jnJJLfnRtsTs@@@P@@@	331.354	3.6999	5	0	102.3	2	0.023908462202443165	0.495195952010263	1.1050830419596753	14	14	fnkPa@AF}DCchHRYWYWf[uhqV`ijv@BejfX@H@@@	eMbA@Dg`@										6
yyulPWOG8F5k0F95FN0GVN@H!F!29@02I218!1Qk04FW!2F0C24LV!V08!W102X4060V%F402V1V	CHEMBL4103641	fhiQ@@EAAdTTRVtTRKNF]@PUMUb@@	CCc1cc(-c2ccc(C#N)n2C)ccc1O	8.15	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting	2017	dmL@@DjYU^TYjjjj@@	dmN@@@rQQJEHjeZe@B@@	226.278	2.5685	3	1	48.95	2	-1.5477779144193264	0.9180749745008641	-0.4733268681186297	36	26	fdyPB`IQ@D||]HIhFscdTTRbbrbnXIwhBHfjkD@@	eFBH@c@@			eMBD@ch@	eFJB@Hp@						24
yqulPWOG8F5k0F95FN0G0N@H!F0839@02I218!1QV86FV!2G0C25J1!V82!W102V0860V04#F0N2c1V	CHEMBL4104046	fdyqB@IFchDadTTRbbVbIXJwhBHfzkD@@	Cn1c(C#N)ccc1-c1c(F)cc(O)cc1C#N	7.17	group2-a	a	Androgen Receptor	Displacement of [3H]mibolerone from human androgen receptor expressed in African green monkey COS cells after 3.5 hrs by scintillation and luminescene counting	2017	dmL@@DjYU^TYjjjj@@	dmN@@@rQQJEHjeZe@B@@	241.225	1.7454	4	1	72.74	1	-0.9614492106282696	1.7736328172193867	-0.33002766274135875	36	26	fdyPB`IQ@D||]HIhFscdTTRbbrbnXIwhBHfjkD@@	eFBH@c@@	eFABP`BL@	eMbA@Dg`@		eFJB@Hp@						24
:Uvzv;S:vyQzUzUfHQvUECfrhnS5b7zKEDnfPUWReorfTHpbpj7SCo2YmEcmdxCtXYH_G10p1GFr0ZVdFF	CHEMBL4105484	eb^ZDA@DLOKoeG`@ajPfdEiCZPa`DXCF@rJJJJIQQKIYJERYVERT\NYAEI]MUPHT@QQUVuUP@@LXPhBJAb`@	[2H]C([2H])([2H])NC(=O)c1ccc(N2C(=S)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=O)C23CCC3)cc1F	7.81	group2-a	a	Androgen Receptor	Displacement of [3H]-R1881 from AR in human LNCaP cells preincubated for 30 mins followed by [3H]-R1881 addition measured after 30 mins by microbeta scintillation counter method	2017	ffs@@@LddTTVbQVbrqILyyIZuUUUUUUUP@@	ffsqB@DX|h@PdsLrsKk}NNrDjZmUPHT@PT@@@	480.46	2.6891	7	1	121.42	5	2.4054857477008884	0.5555110728691135	0.5625224638194475	13	2	eghRHF@ACJkh`GDbPtBEiCZPNdLbbbvTTTfRtJRRdSGAegbSWTDATuTp@UUe@@@	dazHHDC@BhAhChAIgijj@FLi@Y@y@@										2
RuJfgem0b8se989V49Q889p1MONX8Z01FNFG8s02g8OZ44@BFo850k0FF1080F2120808Q/!	CHEMBL410683	fnk@`@@UrJIJZIPiSQKJcEZ]zNVfjjjjiZjhqBViZ^TLp	C/C=C1\C(=O)C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C	6.18	group3-int	int	Androgen Receptor	Inhibitory concentration against Androgen receptor	2005	fb}@@@LdbbbTRaJRWEBMiw`uUUUUUUT@@	fb}@`@@YRYVum[UhrRkNCEijjjjejlBRhZ@@	312.451	4.2707	2	0	34.14	0	-2.250214843238718	-0.3987186067925918	0.585607416545756	2	2	fnk@`@@UrJIJZIPiSQKJcEZ]zNVfjjjjiZjhqBViZ^TLp											1
vzUvvtOzfJbwYLQUUwQVHOvyDBFK9mC5ZMQKE6YfIAVRBl3eDmwbth2SBo2flUlYWd5OYfHrG10kGIFb0VVcF0	CHEMBL4114736	eh\Z@JDDLENi`@ahHVdMi@zPfg{lbbbbbTTRRQfbrdrUhxBJrFZj`PhHBXjjz@BBQ@	[C-]#[N+]c1ccc(N2C(=S)N(c3ccc(C)cc3)C(C)(C)/C2=N/C(=S)NCC)cc1C(F)(F)F	6.8	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	flu@@@LdbbRbbsbRxXRhijjjjjjj@@	flupB@DXT@HRYfY[]^gGQBejjA@@B@@@	489.589	5.0294	5	1	99.41	4	1.3413251626204987	-1.1675387697582869	0.3305182645636085	29	1	eh\Z@JDDLENi`@ahHVdMi@zPfg{lbbbbbTTRRQfbrdrUhxBJrFZj`PhHBXjjz@BBQ@											1
vzUvvv;S:vyQUUzUeHQvzDCnrhmS5bMUKEDnfQEWRgl7fTmwbth2SBo2fnUtYWh5OYfHrG10kGIFb0cVcF0	CHEMBL4114783	ecPv@ADDLEAemP@chHvdCiBzPEdIYAVPVdGlbbbbbTTRRRttQTfRlJTrdUGCaPUVTqMKUTBEAADqUU`AUWP@DDb@	[C-]#[N+]c1ccc(N2C(=S)N(c3ccc(C)cc3)C3(CCC3)/C2=N/C(=S)Nc2ccc(C#N)c(C(F)(F)F)c2)cc1C(F)(F)F	6.84	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	eolP@@@LddTTVbRrtTVRNfRHdXxBjzfn^jjjjjjjjjjjh@@	eolR@D@DLEN`@ahHrJJJJIQQIIKZIzIJcaphJkHZyyjjAB``ab@B`@HID	642.651	7.0645	6	1	123.2	5	2.8375873036653765	-2.784004614146354	0.76819285557313	2	2	ecPv@ADDLEAemP@chHvdCiBzPEdIYAVPVdGlbbbbbTTRRRttQTfRlJTrdUGCaPUVTqMKUTBEAADqUU`AUWP@DDb@											1
vzUvvv;S:vyQUUzUeHQvzDCnrhmS5b7EKE6nfQEWRck7fTmobth2CBo2YnEdX1g5OYfHbG10k1IFb0V0c!	CHEMBL4114801	eghR@BDDLEA`@bZPVdMi@Z[nrJJJJIQQIIKPeRIT\NEAUY]MUPHTDDQUWP@PRH	[C-]#[N+]c1ccc(N2C(=S)N(c3ccc(C)cc3)C3(CCC3)/C2=N/C)cc1C(F)(F)F	6.65	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	ffs@@@LddTTVbQVbrqILyyIZuUUUUUUUP@@	ffspB@DXT@HRYfYYeu~gGYBUMVjhDJ@HJ@@@	428.481	4.4895	4	0	55.29	3	-0.34410865204517294	-0.9261521115772907	1.0869203279505617	13	1	eghR@BDDLEA`@bZPVdMi@Z[nrJJJJIQQIIKPeRIT\NEAUY]MUPHTDDQUWP@PRH											1
vzUvvv;S:vyQUUzUeHQvzDCnrhmS5bMUKE6nfQEWRgl7fTmwbth2SBo2fnUtYWh5OYfHrG10kGIFb0VVcF0	CHEMBL4115695	efUZ@JDDLEAe`@chHvdCiBzPVdGlbbbbbTTRRRttQTfRlJUGCaPUVTqMKUTBEAADqUU`AP@DDb@	[C-]#[N+]c1ccc(N2C(=S)N(c3ccc(C)cc3)C3(CCC3)/C2=N/C(=S)Nc2ccccc2)cc1C(F)(F)F	6.75	group3-int	int	Androgen Receptor	Reporter Assay: The compounds were subjected to tests using an artificial AR response reporter system in a hormone refractory prostate cancer cell line. In this system, the prostate cancer LNCaP cells were engineered to stably express about 5-fold higher level of AR than endogenous level. The exogenous AR has similar properties to endogenous AR in that both are stabilized by a synthetic androgen R1881. The AR-over expressed cells were also engineered to stably incorporate an AR response reporter and the reporter activity of these cells shows features of hormone refractory prostate cancer.	2015	eolP@@@LddTTVbRrtTVRNfRHdXxBjzfn^jjjjjjjjjjjh@@	eolR@D@DLEN`@ahHrJJJJIQQIIKZIzIJcaphJkHZyyjjAB``ab@B`@HID	549.644	6.3806	5	1	99.41	4	1.5940111241164843	-2.2025133199432085	0.43637944165766934	2	2	efUZ@JDDLEAe`@chHvdCiBzPVdGlbbbbbTTRRRttQTfRlJUGCaPUVTqMKUTBEAADqUU`AP@DDb@											1
yTur2K9G8k4kZFA4FNH5VN2H!FF1392VHHo58VV3Nk96FW!29V92JLp0Wc1Dl1V9022bca40@4J!458V8F0	CHEMBL413309	ekhXHH@Bb@ICHhhdihldhieDd]FIAEO@jiaehHJIBBBXHhB@HED	CC1=CC(C)(C)Nc2ccc3c(c21)/C(=C/c1ccccc1)Oc1c(F)cccc1-3	6.05	group3-int	int	Androgen Receptor	Inhibition of human androgen receptor at 10e-12 to 10e-5 M	2003	fiw@@@LdbbbbbRrVtQVXXRgIcWhzjjjjjjjjj@@	fiwa@@L`RfYeUygU~gIV\doVchI`HB@dH@`DJH	383.465	6.0712	2	1	21.26	1	-1.7334952376969244	-1.973606608603523	-0.3815592270345163	10	9	egdXHD@Fi@GGJPrJJIHqJJJIQJJGNL\V^I]UKC[PDCT@DPPqTPPDGB@											1
]x<vzUzUyUjzUzUjUbqSSzjjTDjvbzEfydZUvrKqhmx@hDjHYqEgi3gCxqYLj2SGk9lNEce0c!	CHEMBL414845	eodRBL@EC@noHie`IABPpdLbdLTRRLTTvTQTrddtBRJZjzj``rifjjZjJlDidbd@@	CC(C)(C)OC(=O)N1C[C@@H]2C[C@H]1[C@H]1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=O)N21	6.19	group3-int	int	Androgen Receptor	In vitro antagonistic activity against androgen receptor of MDA-453 cells	2004	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdup`@DXBAVQQQQQIQKFcMVLGtVjhFhHjLLWEi@@	436.389	2.8066	8	0	93.95	4	1.5362179016082114	0.7023602208477527	1.5698563184929522	47	2	eodRBL@EC@noHie`IABPpdLbdLTRRLTTvTQTrddtBRJZjzj``rifjjZjJlDidbd@@											1
<7Utl9w4k45ATH8H_XN2H64FkW3920LHZ78e039k96FGX0@9X12KLt2c89RnIV90@0bV64V@BKN475FV8F0	CHEMBL415289	fbm`c@@jlBPQHXdLbdLTRbVVTTeF]GMUHTBUUECu@@	CC1CCNc2cc3oc(=O)cc(C(F)(F)F)c3cc21	9	group1-p	p	Androgen Receptor	In vitro binding affinity at human androgen receptor transfected into COS cells.	1999	foQ@@@DjYUU}`nRlzjjjjj`@@	foQ``@M@PdrmjjtYIUgMR@EUD@@	283.248	2.7564	3	1	38.33	1	-1.5859517987921214	0.636780587597172	-0.4317439718451014	38	15	fj}`b`DFbCqDxidLrAYAIeYWUYzhqVg^jhHBifjH@@	eFBH@c@@										11
zvyziyznjEve9czYkAz@hj_1rSoXTw9GFsFSssW2i9OZJJ@RNxP70o2NF0880J2G2!18s0412F019$2V10	CHEMBL4159987	el^XD@@M`IlbbRfRfbTRRTRtNTQdhXdt\bJFjzZZjjhJBhjzjjbxXPdTfd\dTjP@	CN(C)c1ccc([C@H]2C[C@@]3(C)[C@@H](CC[C@@]3(O)C#CC(C)(C)C)[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@@H]23)cc1	6.78	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay	2019	fag@@@LdbbbbbTRrRJHcR]xjVykUUUUUUUUU@@@	fagA@@@ILkZwKJjmFRtzI^uZtuUUPTEEQTXaQTuGP@	473.698	6.883	3	1	40.54	3	-0.4245461364477545	-2.775603391550832	-0.039016630849496935	15	4	fmAA@E`|^nNQQIYQQJJJJIZ[tX[pRuft\@EUUUSUTeTsbDeKRMOP@	daxH`@`@RUZkj`@	gChHA`BOT@@									4
:yzi:njUzedszYkAz@hj_1rSoXUw9GksFSssWXiAOZJJ@RNxP70w2NF0880J2G28018s0412FF19$2V10	CHEMBL4161754	ejYXD@@M`IlbbRfRfbTRRTRtNTRfdhXdt\bJFjzZZjjhJBhjzjjjKaaBQRZQrQRi@@	CC(C)N(C)c1ccc([C@H]2C[C@@]3(C)[C@@H](CC[C@@]3(O)C#CC(C)(C)C)[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@@H]23)cc1	6.32	group3-int	int	Androgen Receptor	Antagonist activity at AR (unknown origin) expressed in human LNCaP cells assessed as reduction in R1881-induced response incubated for 20 hrs by luciferase reporter gene assay	2018	fag@@@LdbbbbbTRrRJHcR]xjVykUUUUUUUUU@@@	fagA@@@ILkZwKJjmFRtzI^uZtuUUPTEEQTXaQTuGP@	501.752	7.6486	3	1	40.54	4	-0.1542932644132626	-3.46069958371834	0.037242735617662934	15	4	fmAA@E`|^nNQQIYQQJJJJIZ[tX[pRuft\@EUUUSUTeTsbDeKRMOP@	daxH`@`@RUZkj`@	gGXHA`AJfjh@									4
=v;wzxrrAzUxEkmQQUbEAMhnSChMjaEEufIUlQckUf6QrZpg3Ch0cYrUvm1g5taWHM13Bx9GFMGeVcF0	CHEMBL4161910	edZRLJ@DLEmeGo`@ajPzdAi@zPrJJJJIIKISIJQIUFYTLF^NQESMUPMAAAUEtuPDCE@@	CCOC(=O)Nc1cc2c(cc1F)CC1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=S)N1C2	5.13	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) expressed in African green monkey COS7 cells assessed as inhibition of R1881-induced protein activation after 24 hrs by luciferase reporter gene assay	2018	fjc@@@LdbbRRvbQbRXKdmFrVjjjjjjjh@@	fjcQB@DXT@HRYfYU]]zLMyt\eZj`ZB@B@`r`@	492.452	3.5963	7	1	117.76	5	2.3670868629607607	-0.06116766478133867	0.5776666959516623	2	1	edZRLJ@DLEmeGo`@ajPzdAi@zPrJJJJIIKISIJQIUFYTLF^NQESMUPMAAAUEtuPDCE@@											1
zvyziyznjEve9czYkAz@hj_1rSoXTw9GFuFSwtW2i9tZJ4@RNxPE0o2NF0881K2K2011cs4402!19N#2V10	CHEMBL4163069	el^XD@@M`IlbbRfRfbTRRTRtNTQdhXdt\bJFjzZZfjhJBhjzjjbhTfd\dTjP@	CN(C)c1ccc([C@H]2C[C@@]3(C)[C@@H](CC[C@@]3(O)C#CC(C)(C)C)[C@@H]3CCC4=CC(=O)CCC4=C32)cc1	6.89	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay	2019	fag@@@LdbbbbbTRrRJHcR]xjVykUUUUUUUUU@@@	fagA@@@ILkZwKJjmFRtzI^uZtuMUPTEEQXUMQt@@	471.683	6.9494	3	1	40.54	3	-0.43828156700439636	-2.8080474944295153	-0.04198621129211357	15	5	fmAA@E`|^nNQQIYQQJJJJIZ[tX[pRuft\@ESUUSUTeTSbtcSt@@	daxH`@`@RUZkj`@	gChHA`BOT@@									4
zNsp448K8X#16ZF80VVN0H&92062V504030F#1V020V!G6108098VF!F#8!V204F!1F6430	CHEMBL41632	fjm@S@BAbTEXJlSVYEEDeDhTeEFrWlpPTPPMD@@@	O=C(O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1	4.46	group4-ia	ia	Androgen Receptor	Transcriptional activity at human androgen receptor BF3 site stably transfected in eGFP-expressing human LNCAP cells after 5 days by fluorometric analysis	2011	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	621.921	3.504	4	2	66.76	4	1.6161368025205365	-1.1154990335702373	-0.7180586968387765	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@	eFABl`BL@	eFABl`BL@				eFABl`BL@		gJPh@b@IMmP@	eFJB@Hp@		34
:uzDM9n8J7k0kA5GNIWVR3H040k3n9!6mp58V27Pk86klV80F2524J10fV1DWFd94EXbe6448BGOF2182810	CHEMBL4173799	fco`c`IBrBP[H]dArDyA\anPrJIJZKQKJHrZQRTxkW`pACU@EUUU@@@@	Cc1cc(C(O)(C(F)(F)F)C(F)(F)F)cc2c3ccc(F)cc3c(=O)n(C)c12	6.52	group3-int	int	Androgen Receptor	Antagonist activity at human CMX-AR expressed in HEK293 cells assessed as reduction in dihydrotestosterone-induced transactivation activity after 24 hrs by luciferase reporter gene assay	2018	foQ@@@LdbbbTRQYHUmNjjjjjh@@	foQa@@D@RYYeUz\UXsfh@@@`@@	407.284	4.4867	3	1	40.54	3	-0.6615473463542626	-1.0887875075894828	-0.16078794146786715	2	2	fco`c`IBrBP[H]dArDyA\anPrJIJZKQKJHrZQRTxkW`pACU@EUUU@@@@											1
:UvzfzPzSynOTOyFQMQvAMHzJVXgrO0NtnQ0OG2_OGWDJf6BO282o6sWAB80N2Fe4V9BKV@G@84180XFBV0F0	CHEMBL4174074	eghXD@@J`NlbbbTRRbTftsTtRS@dfgbQusPQDUUUTp@QFCBDRb@@	CC(C)c1ccc2c(c1)C(=O)C[C@H]1[C@@](C)(CNC(=O)c3ccccc3)CCC[C@]21C	4.08	group4-ia	ia	Androgen Receptor	Binding affinity to androgen receptor (unknown origin)	2018	fig@@@DjYegUnuYhToQzNjjjjjjjjj@@	fig``@@`RdsKJo_mrkARu[wQmADQUTp@QDFH@	403.564	5.692	3	1	46.17	4	-0.48875840037182094	-1.8790833734034038	-0.1201899694011687	2	2	eghXD@@J`NlbbbTRRbTftsTtRS@dfgbQusPQDUUUTp@QFCBDRb@@											1
:uzDM9n8J6k0kA4FNIWVR3H040k3n9!6mp58V27Fk86klV8!2524J10f01DWFc9472be6448BGN0218X8G0	CHEMBL4175249	fmw`c`IBRBPkHMdNr@yB\`nPrJIJZKIIQFSRJRgEZ]z@HZ`Bjjj`@@@	Cc1cc(C(O)(C(F)(F)F)C(F)(F)F)cc2c1[nH]c(=O)c1cc(F)ccc12	5.75	group4-ia	ia	Androgen Receptor	Antagonist activity at human CMX-AR expressed in HEK293 cells assessed as reduction in dihydrotestosterone-induced transactivation activity after 24 hrs by luciferase reporter gene assay	2018	foQ@@@LdbbbTRQYHUmNjjjjjh@@	foQa@@D@RYYeUz\UXsfh@@@`@@	393.257	4.1284	3	2	49.33	3	-0.30109711653041615	-0.770779911024622	-1.2500863581683723	2	2	fmw`c`IBRBPkHMdNr@yB\`nPrJIJZKIIQFSRJRgEZ]z@HZ`Bjjj`@@@											1
TuwvceuGjcse18A6F9Q8VO4ILO0XBY93082l9F0231k!F940D1V14G2l08V882&H0202844V!4J2410	CHEMBL417729	fbu@b@BRAbILrk{LulDGLDDUTuTTMP@	C=C1CCCC(C)(C)[C@H]1Cc1cc(OC)c(Br)cc1O	6.42	group3-int	int	Androgen Receptor	Inhibitory activity against human Androgen receptor	1996	dg|@@LdbbRLrSB]uUUUU@@	dg|@@LdfbRLRS\]mUT@DPd@	339.272	4.9166	2	1	29.46	3	-1.4629374111833975	-1.2971381931471624	-0.3872085685516883	4	2	fbu@b@BRAbILrk{LulDGLDDUTuTTMP@											1
;QfQtQCRam16ATHNI8XO0HLJ0kdn1!G2Z34X218F18F064@1!4!cHc!J32044O2W0602#84a!X8GF	CHEMBL418198	ffcQC@EAlBPQHXdLbdLTRbVVTRTeF]GMT@@DUUPTHh@	CCC1c2cc3c(C(F)(F)F)cc(O)nc3cc2NC[C@@H]1C	5.57	group4-ia	ia	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in CV-1 cells using cotransfection assay	1999	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	310.318	4.2498	3	2	45.15	2	-0.9693485947977047	-0.4460333244135116	-1.4226753127571077	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@	eMBD@ch@		eFBH@c@@							49
yTuM2G9G8k4kZFA4FNH1VN2H!FF1392VFHo18VV3Nk96F1!29V12G2p0Wc0DG109022bca40@4J!448V8F0	CHEMBL418684	fnkaA@HdAHJdLbbbRbRJTrbLYHVg^RVBBb`Bfj@`@@	CC1=CC(C)(C)Nc2ccc3c(c21)COc1c(F)cc(F)cc1-3	6.19	group3-int	int	Androgen Receptor	Inhibition of antagonist activity towards human Androgen receptor	2003	fdu@@@DjYee]}faRlGtZjjjjjj`@@	fdua@@O@RfVU^]zLEhs`qhJ@@bXB@@	313.346	3.5753	2	1	21.26	0	-2.1438585039469378	-0.09235330361951971	-0.5360531642202729	10	8	fnkaA@Hr@xldLbbRbrbRtrbLiqQg^RV@HhHBfjH`@@	eFABP`BL@										4
JPsH02018!V$F0H0V8#40V!12020F4%F/08(F0VG#V!18F#2010	CHEMBL418971	fhi@`@@ArJIKJQPiZcG^`@j`@`@@	CC(C)(c1ccc(O)cc1)c1ccc(O)cc1	5.23	group4-ia	ia	Androgen Receptor	Antagonist activity at human pSG5-AR assessed as inhibition of dihydrotestosterone-induced effect by reporter gene assay	2013	dk\@@DjU^ukmNjjjj`@	dk\@@DjU^ukmLHH@@@@	228.29	2.8655	2	2	40.46	2	-1.6564147920950987	0.5350675046567165	-1.6653484146528446	60	4	f`qAA@O@|QNJSJ{\ktYYt@EP@P@@@	eMBH@RZ@	eFJB@Hp@									1
yqPlP1OG8F5k!A50N0F0N@m04!1Y08029V50V80NV80O1V!FV1V04!VV16W01!92084W!2010610W0F0	CHEMBL419633	fmwPb@LZ``@QddatTRafRbbRRrcMfMZu@QET@@@@@@@	Cc1c(NS(C)(=O)=O)cccc1N(Cc1ccccc1)Cc1ccccc1	6.77	group3-int	int	Androgen Receptor	Displacement of [3H]dexamethasone from human androgen receptor	2004	fj}@@@DjYU^[U_b`yRVjjjjjjj`@@	fj}`@@@ITrjsNk|gArdmPT@@@@@@@@	380.511	3.7848	4	1	57.79	6	0.228333947763829	-0.6826452451963461	0.00227456003995042	2	2	fmwPb@LZ``@QddatTRafRbbRRrcMfMZu@QET@@@@@@@											1
?y=yxvzxxvyjvCzQxUqoxxvrt@hjIaNUyLgqyQHUuGxbgpLfBsW0@wd5@ak0J41TZ80ZcN01XVlV	CHEMBL4225186	ec~N@@DOCb^URpE@maWT|bbTRRVRRTRbbVrTVRVRRabRbfefTRTfaSTNJ~{TDDUUTsUVDDU[USUUP@DFDl}fZ@@	Cc1c(C#N)c(-c2ccc(C#N)cc2)c(C)n1Cc1ccc(C(=O)NCCOCCOCCOCCNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](O)[C@H](N)Cc2ccccc2)cc1	7.57	group2-a	a	Androgen Receptor	Displacement of [17-alpha-methyl-H-3] mibolerone from wild-type androgen receptor (unknown origin) expressed in human Freestyle293F cells measured after 3 hrs	2018	e`|p@@@LdbbRRqTRVTVRRRRRRbrbrTRWB`d`TSomUUUUUUUUUUUUUUUUP@@	e`|rF@@DO@RPE@adVTfVUWUVUWYU_[VuYVSPjj{ywujBBJjjVhHHijZh@B@@@	820.001	3.1293	14	5	213.75	24	11.487954691002194	-1.79617092989265	-1.872501931458578	2	1	ec~N@@DOCb^URpE@maWT|bbTRRVRRTRbbVrTVRVRRabRbfefTRTfaSTNJ~{TDDUUTsUVDDU[USUUP@DFDl}fZ@@											1
<jrOzdFaw1rAiURPW2CFuVB8p12h043mK4BXB39VN0flVD1XX4aZK801V0EVFcs582Y06x!204Vb08acI0	CHEMBL4225339	eo`TFB@OGhDEGDl`@cZPNdKiCIICDdiDYlhhTieHiKNaehHJajX@Jjp`xh@@	CC(O)(CS(=O)(=O)c1ccc(C(=O)O)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	7.27	group2-a	a	Androgen Receptor	Binding affinity to androgen receptor (unknown origin)	2018	fbu@@@LddTQRVftRTmIsUUUUUUT@@	fbuab@KPPX@QddabRRtJbReiNUhHHZ@@@@@	456.396	1.5269	8	3	152.94	7	3.954437585392258	1.4260592347396528	-1.435588550639342	4	4	fcw`Q`MV}dhODTaJPUHIBMnNQQQIRZjZSZPqIYgIk`HJjZjV@BBCb@@	gC`h@l@ILt@@	eMbA@Dg`@									2
yyurTbtF8NCk0G91FN0GV8@!FF20V980HO258#Qk24FV!@N0C24JF09c102Fd122V!442%F!6V3V	CHEMBL4226259	fmwp`@EYVABS\kkLs{Z{pUo]Ft@ETsU`AY@@@	Cc1c(C#N)c(-c2ccc(C#N)cc2)c(C)n1Cc1ccc(C(=O)O)cc1	8.85	group1-p	p	Androgen Receptor	Binding affinity to androgen receptor (unknown origin)	2018	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fde`@@@ITj|rjyJVCzMRt@@@P@@@	355.396	3.4837	5	1	89.81	4	0.5529612938623522	0.1888678328275577	0.07721458251214795	38	11	fi{`a@C]FCqTxyEDeeEELbhdliQfcEk@ASMU@ALP@@	eMbA@Dg`@	eMbA@Dg`@									1
}y;xxvyzr:UxUzqzpvrn@hjnaPUyRgrzQHzulxbhpLvBsWRuwcEBZmVJ41TZ81_sT01YVlV	CHEMBL4226314	ec~NH@NIEEfURyk`\QWTpHcHhhddXeDbeDeeLddddddihdhiiYeDdpHYXutooAAeRuT@DuUUUTuTuUT@AAaKOYf`@	Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1CCc1ccc(C(=O)NCCOCCOCCOCCNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](O)[C@H](N)Cc2ccccc2)cc1	6.72	group3-int	int	Androgen Receptor	Displacement of [17-alpha-methyl-H-3] mibolerone from wild-type androgen receptor (unknown origin) expressed in human Freestyle293F cells measured after 3 hrs	2018	ehrp@@@LdbbRRqRbRrbrRRRRRTVTVRbRxTDdbR}Cjjjjjjjjjjjjjjjjj`@@	ehrzF@@DFn`ZPE@al^TfVUWUUYUueU~umVUdtZz~a}CZ``bjjfZhHHfij`@H@@@	844.451	3.3979	14	5	202.85	25	11.587298606551444	-2.249085057435141	-1.8325080847905324	1	1	ec~NH@NIEEfURyk`\QWTpHcHhhddXeDbeDeeLddddddihdhiiYeDdpHYXutooAAeRuT@DuUUUTuTuUT@AAaKOYf`@											1
zwur6bsF8c4P4G!FN0CV82VFFF#9!HF0588!Gk801V!e80C24JFF901FHFc11$442%F!W0FV	CHEMBL4226575	fdyP`@GA@aIem]YfEIpVh@JejH@@	COC(=O)c1ccc(Cc2c(C)n[nH]c2C)cc1	5.82	group4-ia	ia	Androgen Receptor	Binding affinity to androgen receptor (unknown origin)	2018	dcl@@DjU^vnWZjjjh@@	dcm@@@aJWVUpevZh@D@@	244.293	2.0779	4	1	54.98	4	-0.7709743352304689	1.06962950307017	-0.29013201445852854	1	1	fdyP`@GA@aIem]YfEIpVh@JejH@@											1
zyyr6rtldN5u0G@7FN09VN4mFJFF92A!HH058V02Ak841W!eNVCX1JFF981RmFcA40XV045#11F6!7V3V	CHEMBL4226844	fmwpb@NRUMXHcHhhddXeDbeDeeFBMYoXHLjVj`@fH@@	Cc1nn(-c2ccc(C#N)c(Cl)c2)c(C)c1CCc1ccc(C(=O)O)cc1	7.28	group2-a	a	Androgen Receptor	Binding affinity to androgen receptor (unknown origin)	2018	flu@@@LdbbRRqRbRxhThijjjjjjj@@	fluP@@@PRfVuWyTeEFbfZ``b@A@@@	379.846	3.7523	5	1	78.91	5	0.6523052094116002	-0.26404629471493307	0.11720842918019339	3	2	fi{pA@CNFAqkDYEDedeEEChdhUQagE[@AUKU@DVP@@	gC`h@l@ILt@@										2
}y;xzvyjn:UxUrqxpvrnDhjnaQUyRgrzQHzulxbgpLvBsWTuwcCCgmWJ61TZ81_sT09YclV	CHEMBL4226899	ggtGapp@EAbp\EFfvsxbiJ`qXAHHICAHYEHXhddXeDbhdliddddddeMDeEMKLhdiFcpDFSCuzjBCJej`@fjjjjfjfjj`@HLFjQiVP@	Cc1nn(-c2ccc(C#N)c(C(F)(F)F)c2)c(C)c1Cc1ccc(C(=O)NCCOCCOCCOCCNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](O)[C@H](N)Cc2ccccc2)cc1	6.72	group3-int	int	Androgen Receptor	Displacement of [17-alpha-methyl-H-3] mibolerone from wild-type androgen receptor (unknown origin) expressed in human Freestyle293F cells measured after 3 hrs	2018	e`|p@@@LdbbRRqTRVTVRRRRRRbrbrTRWB`d`TSomUUUUUUUUUUUUUUUUP@@	e`|zF@@DBj`RPE@adVTfVUWUVU]YU_[VuYVSPjj{ywujBBJjfZhHHijZh@B@@@	863.976	3.2547	14	5	202.85	25	11.696858599190687	-2.235405368384381	-1.8011262761041864	2	1	ggtGapp@EAbp\EFfvsxbiJ`qXAHHICAHYEHXhddXeDbhdliddddddeMDeEMKLhdiFcpDFSCuzjBCJej`@fjjjjfjfjj`@HLFjQiVP@											1
:UvEItl9NCmVoAEIcHdXO6HF4Gnd390VLmp58XV3AlO6FKW0@OX165Jl0cc1RnGW90@VbVa!8BGGJ714V8F0	CHEMBL422707	fnsQC@EQlBPQHXdLbdLTRbRRJVbdhwdyjiB`XjjhhYh@@	CCC1(C)CCc2cc3c(C(F)(F)F)cc(=O)n(C)c3cc2N1	7.32	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	foQ@@@DjYUU}`nRlzjjjjj`@@	foQQ@@DZ@drmjjtYIUgMR@EUD@@	324.345	2.9625	3	1	32.34	2	-1.3170295491486321	0.1957217472281491	-0.3521854770466139	38	10	ffcQB`DFRCqDxydBrEYCHhdhdldhhcIQbmNCUPPETsUD@@		gC`HD@IWT@@									4
^y:yzyzxzvyjn:UhzrqxpzbnUgjniQSyRc:vTSXnobgpDf4kVEewcwCgHYJ6tTZ@0Zcz09Xcl0	CHEMBL4227287	g`JEahH@OFQDj]ChBAPxRGBWHtf[@@ayH_I@EHYIHXdeHcMeELdeLeHe\dddeMDeEMKLhdiE`Xl__ehHJajXHHjjnjjijijjh@@LEjYivP@	CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(=O)NCCOCCOCCOCCNC(=O)c1ccc(S(=O)(=O)CC(C)(O)C(=O)Nc2ccc(C#N)c(C(F)(F)F)c2)cc1	5.96	group4-ia	ia	Androgen Receptor	Displacement of [17-alpha-methyl-H-3] mibolerone from wild-type androgen receptor (unknown origin) expressed in human Freestyle293F cells measured after 3 hrs	2018	edrp@@@LddTQRVbVbbrRvRRRRRbrbrTRTfcPp\]UUUUUUUUUUUUUUUUT@@@	edrrIH@KHdVXDC@icobQP@cIICDdehlhiddmdddddidideDeIhtLGFmAACTpPQUUUSTuP@@@@@	921.001	1.1725	17	7	276.88	27	14.889430988140957	-0.558979456318069	-3.3853050652313215	1	1	g`JEahH@OFQDj]ChBAPxRGBWHtf[@@ayH_I@EHYIHXdeHcMeELdeLeHe\dddeMDeEMKLhdiE`Xl__ehHJajXHHjjnjjijijjh@@LEjYivP@											1
zyur6rtl8N5u0G@5FN29V80mFJFF129!HH458V03Ak841W!eNVC20JFF981TmFc958XW0642!11F6087c3V	CHEMBL4227715	fkpc@EFmlxIADabPrJPqQIHqJIEQIYRVoAGNjBCJej`@fH@@	Cc1nn(-c2ccc(C#N)c(C(F)(F)F)c2)c(C)c1Cc1ccc(C(=O)O)cc1	8.85	group1-p	p	Androgen Receptor	Binding affinity to androgen receptor (unknown origin)	2018	fde@@@LdbbRRqTRWEBdFMUUUUUU@@@	fdeP@@@PRfVuWmRTTXLYjBB@@P@@	399.371	3.6091	5	1	78.91	5	0.7618650301219757	-0.2503666358204592	0.14859018889290054	38	14	fakpA@MVzCqJxyEDedhhh]DeBjLu[MX@Jej`BKH@@	gJPBAHJPt`PAIjj@@	gC`h@l@ILt@@									10
;QfQzvEOyndyfDFtMcaO5HJJWvjbG0ZS2p1FVX_8F11kT5BP1!o20cFc!J302Z4C2l3DF258084a04X8GF	CHEMBL423620	figQC@EAlBPQHXdLbdLTRbVVTfVddhs`qjvj@@BJjjhJQyQP@	CC1(C)CCC[C@]2(C)c3cc4c(C(F)(F)F)cc(O)nc4cc3N[C@H]12	7.29	group2-a	a	Androgen Receptor	Antagonistic activity (IC50) against human androgen receptor (hAR) in co-transfected CV-1 cell	1998	fhe@@@DjYU_mVByKQoAjjjjjjh@@	fheP@@@JRfV_UUipTmF|D@@BjjBhF`@	350.383	4.2724	3	2	45.15	1	-0.9179594316469452	-0.4873688701595702	-1.3827383392827732	2	1	figQC@EAlBPQHXdLbdLTRbVVTfVddhs`qjvj@@BJjjhJQyQP@											1
;vzv:rx:vzvzUrCvUfzjzUjUboRUzjz@DbvbT7fqdgyvqKqCqzPhDjFYq5hyYg9poVTC@SIk9GNCcX38!	CHEMBL426623	elQRFHDE@bonILjhTPICzT^rJIKISQQJEQ[QQJKKRaasspIHkXyxF@Bfjjif@@BFJ`ptUd|P@	O=C1[C@H]2[C@@H]3C[C@@H](CN3C(=O)Oc3ccc(F)cc3)N2C(=O)N1c1ccc([N+](=O)[O-])c2ccccc12	4.52	group4-ia	ia	Androgen Receptor	In vitro antagonistic activity against mutant androgen receptor of LNCap cells	2004	eobP@@@LdbbbTVtTNtRLVbRXtDLl|RJrjn^jjjjjjjjjjjj@@@	eob\B@@DLH`ENalbbbbbRbbqbvtJbRhXtlLbBRJZn^Zj`Z`HBF`@j@pXgBtP@	476.419	2.8676	10	0	115.98	4	2.5880611509686116	0.9205459753152118	1.8692089378248742	2	2	ehV\BD@EOFg@ai`GDFPrJJIQYZZJ[JHjYQIYcbSSrKJhii{z@@BJYjjf`@`jLHddld@@	gChhhE`BRnRYh@										2
;jj:ibEuE9wpVg7z@Cbp9IGZYmR0GHcVOkk10Z09Zk48SN4040F#1&2#8F08+X0G0	CHEMBL427078	e`\XL@@G`AklbbRfbTrRTrbRNRTuCBfgdQSSUUUUUUUUTuU\DQaBKRNRIEH@	CNC(=O)CCCCCCCC1C[C@H]2CC(=O)CC[C@]2(C)[C@H]2CC[C@]3(C)[C@@H](O)CC[C@H]3[C@H]12	6.32	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor expressed in HeLa cells assessed as inhibition of dihydrotestosterone-induced transcriptional activity by reporter gene assay	2007	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmUUUUUUDIAITM@@	445.685	5.7282	4	2	66.4	8	1.2117543356008	-2.2849711115407763	-0.8929487617212603	50	19	ffs@b@Bu@xyEEDhheDhdbV\d{tTyjjjjjjijnHQIRLWEI^P@	dcvH`DCPAIeuUZjjh@@										19
LNsF!818V$24F8!VN0H&12022V5#10F&20V!G2!8088,V!4%2010	CHEMBL42710	dcLD@@iJ[g]xZB@i@@	C=CCc1ccc(O)c(OC)c1	4.72	group4-ia	ia	Androgen Receptor	Antagonist activity at AR in human MDA-kb2 cells co-transfected with MMTV-luc assessed as decrease in DHT-induced luciferase activity by reporter gene assay	2010	gFp@DiTvjh@	gFp@DiTt@@@	164.203	2.2723	2	1	29.46	3	-2.260467205640514	0.9416893363185633	-0.6890622468137614	19	15	dmt@h@BR|VPQ\U`TfYn~fBHb@@	eMJA@Hz@	eFJB@Hp@		gC`HL@IVt@@							14
;j;irUzjQwxdh7zPEbx9IQaYmw0OPcgQsm11Z29ak48SN4F4FF0V09422#2020NF08#V&2010	CHEMBL427243	el^XL@@G`AklbbRfbTrRTrbRNRTtRhXTt|bJZaQZjjjjjjjjfjjjxHcBDVd\dRJP@	C[C@]12CC[C@H]3[C@@H](C(CCCCCCCC(=O)N4CCCC4)C[C@H]4CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O	6.52	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor expressed in HeLa cells assessed as inhibition of dihydrotestosterone-induced transcriptional activity by reporter gene assay	2007	e`RP@@@LdbbbbbrRVNRrRbfSB`acgdVSwuUUUUUUUUUUUP@@	e`RXD@@M`ElbbRfRbRRfRQRRfbUCDbc`VQSwsUUUUUUUTuUUQADDRdl`@	485.75	6.7857	4	1	57.61	8	0.9555272645855151	-3.1198585462840374	0.24283857544399318	1	1	el^XL@@G`AklbbRfbTrRTrbRNRTtRhXTt|bJZaQZjjjjjjjjfjjjxHcBDVd\dRJP@											1
]UzjQy;ExuEzxQzUibzyNOPvi@:l3UEvJsZQzLJHxFo@g8j4XHSeE2R9KoVKT29FV11Ni!2410	CHEMBL427502	fnk`R@AZmUhLSHhhdUEEMeEMf\LzNTe`HJfZjjbXahyIQX@	Cc1cc(N2C(=O)[C@H]3C4C=CC([C@@H](O)[C@H]4O)[C@H]3C2=O)ccc1Br	5.28	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor in human MDA-453 cells	2005	flm@@@LdbbRbeQbRXK`iJbfjjjjjjj@@	flm``@D@TdsLrrn}NVCZOdmUPMPLUBLKd@@	378.221	1.2825	5	2	77.84	1	0.38467842692617726	1.6882655568071352	-1.0922128794978068	4	4	fnk`Q@AZmUhODcbdsOls^s^sagQrdlDATsUUTSDMGIJK@@	eFBH@c@@	eFACD`BL@									1
qHuF0F818V0k!24FN210N0H040F0212!HZ18!18086&V02F2$82#14@25c2$4!2480c!	CHEMBL427678	ff}`c@E^bBPQHXdLbdLTRRLTTRTmIKUAAdDQD@@@	COc1cccc(OC)c1-c1ccc(C#N)c(C(F)(F)F)c1	7.83	group2-a	a	Androgen Receptor	Displacement of [3H]DHT from human recombinant AR expressed in Sf9 cells	2007	dcl@@DjYU_egZjjjh@@	dcl@@DjYU_egX@@@@@@	307.27	3.8627	3	0	42.25	4	-1.2489233093261278	-0.4371912709254563	0.7885727531743896	30	18	fle`B`N@BSNKoDLBeArJJIIFJJZU`oQ``rBHb@@@	eMJA@Hz@	eMJA@Hz@	gJPBAHJPt`PAIjj@@								17
}y=yUjxU:jzryOxUfiDyzlMUjfwtZQzrKm_HJ2g8j4XLEgD2wCSqWKD280VA1Oi080c!	CHEMBL427721	fa{Qc@EF}FhIADabPrJPqQIHqQSYQRtEIZm{UAAeSMUQT`JS@@	N#Cc1ccc(N2C(=O)[C@@H]3C4CCC(O4)[C@@H]3C2=O)cc1C(F)(F)F	5.54	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor in MDA453 cells by alkaline phosphatase reporter gene assay	2008	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdua`@D@T[HhhhhdhecQfcVCzKUTCTDUBLIb@@	336.268	1.4817	5	0	70.4	2	-0.3589205060783839	1.5764479900353623	1.0204098843080065	47	25	fjcac@AZmD@RSqJxiLs{Lwl{NF\FJ\pPESMUTUHLgP@		gJPBAHJPt`PAIjj@@	eMbA@Dg`@								8
yRur619G8k4F4F24FN01VN2H!F013920HmV58V03Fk9601V028V12GLl0W89Dl0V9022Zc640@4J!45NX0G0	CHEMBL427731	fnk`P@D@]FjSJroZwJuFJtxNVmRDATDEDP@@	COc1c(O)ccc2c1-c1ccc3[nH]c(=O)cc(C)c3c1CO2	8.92	group1-p	p	Androgen Receptor	Activity at androgen receptor in human Saos2 cells assessed as IL6 repression	2008	flm@@@DjYee]YhTkA}Fjjjjjjj@@	flm``@D@ldrmkZvmFRUYtTmR@EP@Q@@@	309.32	1.7691	5	2	67.79	1	-0.16270410989253664	1.577534380109215	-1.2286338825647016	11	9	fnkac@BlDt@S{qRxyEEEEECdeCEmrRcNbVlAQ@PTSRQ@@@	eFBH@c@@		eMJA@Hz@								1
yRsr468G8V4F4024FN05VN2H!F013820HHV58!3Fk960V!21V90JLW0W89@kFc90284V2402440405F$	CHEMBL4278241	fj}@P@@\LEIfVWVv]YrVdeZA`bB`b@@@	COc1ccc2oc(-c3ccccc3OC)cc(=O)c2c1	5.21	group4-ia	ia	Androgen Receptor	Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay	2018	fhy@@@LdbbbRnbRYHRoAjjjjjj`@@	fhy@`@@\RYee~uYrVoAZA``@H@@@	282.294	3.2328	4	0	44.76	3	-1.2241905523654362	0.2941784275032922	0.8130196216764677	32	23	fns@Q@FJCTGceqrJIJYZIJIKPjgKNRV@HjZABJH@@											1
JNsH42018&40801V80H!F!2020HF048!10F16,k!89#80F284V*182010	CHEMBL4278637	fnk@`@@UrJJJJIIKXqIQ`eNMxkV`B@DH@b@@@	O=C1c2ccccc2C(=Cc2cccc(O)c2)c2ccccc21	6.5	group3-int	int	Androgen Receptor	Inhibition of R1881-induced full length AR transcriptional activity in human LNCAP cells harboring AR2PB-eGFP construct after 72 hrs by fluorescence assay	2018	ffs@@@LdbbbTRVJbrsIBuyIZuUUUUUUUP@@	ffsA@@@YEEEEDdelXdfBTxwbuZ@H@P`@`@@@	298.34	4.8127	2	1	37.3	1	-1.8645813135211267	-0.7837345163469096	-0.48736098025423225	5	5	fa{AA@J`|RNNQQQZEQQQQIIYgGARtoXHBZ@H@PH@@@		eFJB@Hp@									1
yRur659G8k4F4G24FN05VN2H!F013920HmV58c03Fk960WV028V12KLl0W89Dl0c9022Zc640@4J!45NX0G0	CHEMBL427898	fa{aP@G@Peo\bbTTTRRbffjSNZ}[HRmP@PDMESA@@@	COc1c(O)ccc2oc(=O)c3c(ccc4[nH]c(=O)cc(C)c43)c12	9.7	group1-p	p	Androgen Receptor	Activity at androgen receptor in human Saos2 cells assessed as IL6 repression	2008	fb}@@@LdbbbbbRJvsCBTzHTuUUUUUUT@@	fb}a`@G@QgHheEEDdhmjsfoVbEKT@DABSA@@@	323.303	1.9395	6	2	84.86	1	0.4222571140195055	1.6693096697565	-1.0727415087673604	8	8	fnkaa@Dr|tGbQqrJJKSJIIJEQEgEF\GMXHB``Rfdb@@	eMJA@Hz@	eFJB@Hp@									8
:xzCqslde4mZ0EgHsVhXSHH1Z0F9Y@24FHVl02k3tkO6FG01@101ZJH_1Wc02208A4984V250@44#402010	CHEMBL4279318	fluAb@AR|BHrJIJYQEQQZcEZbf@BfhH@bFb@@	O=C1CC(c2ccccc2O)Oc2ccc(Cl)cc21	5.78	group4-ia	ia	Androgen Receptor	Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay	2018	fhy@@@LdbbbRnbRYHRoAjjjjjj`@@	fhy@`@@\RYee~uYrVoAZB``@HHLh@@	274.702	3.4531	3	1	46.53	1	-1.5318492105029295	0.309800324384476	-0.42130296554758484	32	9	fluAb@AR|AqrJIJYQEQQZcEZbf@BfhH@bFb@@	eFABH`BL@										5
yTsM4L8G8V40Z034F805VR0H$130202HV580V10F06F!12$F2V0V01#810284V2!204#502410	CHEMBL4279841	ff}Ab@AR|CDrJIJYPiQQIZTYGL@ELpPQP@`j@	CC(C)Oc1ccccc1/C=C/C(=O)c1cc(Br)ccc1O	5.04	group4-ia	ia	Androgen Receptor	Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced cell growth treated for every 2 days for 4 days by hemocytometry	2018	f`q@@@DjYW~UyIwjjjjjj@@	f`qA@@@ILrj}jISoM@a@@@BEH	361.234	4.3789	3	1	46.53	5	-0.485566526506226	-1.0509256339399393	-0.16966296989604154	17	17	fjm@``MQ@Dr`_NN_EIfU_nYnYqIXBAi`bH@DNP		eFACD`BL@	gJQH@`AJZj@@								12
:xzhyyzjjyiCdzemEz@jj_1MtoXUw9IFsFSst56idOZJ4@RNw870kHNN0880F2G28!BO#VH!V$6030	CHEMBL428021	efUPJ@@@AobZ\bbRfbTrRTrbRaaRrRReCBfgdQSUssSUUUUUUT@EUMUGCBDRbtcdbQR@@	C[C@]1(O)CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CCC(=O)C=C1C[C@H]3CCCc1ccc(OCCCC(=O)O)cc1	6.18	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HeLa cells assessed as inhibition of dihydrotestosterone induced transcriptional activity by reporter gene assay	2007	fm@@@LdbbbbbrRVNRfRXhQg^cfZzjjjjjjjjjh@@	fmA@@@YEDeLeDdeLdcDeQdeNCdlumMUUUUU@AUAAJRUKP@	522.723	6.383	5	2	83.83	9	2.2703109483243042	-2.836402840311786	-0.6037525787046696	4	4	e`RPDH@Ko`GGHhdldeEDhheDhdcCPqxDetLml]@AUUUUMUUTeUpiMEYGHDddL`@	daxL`@Qn@DfuVjh@@										3
:xzCqslde4mZ0EgHsVhXSHH1Z0F9Y824FHVl02k3tkO6FG01@101ZKH_1Wc0220894984c250@44#402410	CHEMBL4282772	fbmAa@BVBCDUbYEEDeDhcCEfRDYNXHJJdH@bGJ@@	O=C1CC(c2ccccc2O)Oc2c(Br)cc(Br)cc21	5.45	group4-ia	ia	Androgen Receptor	Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay	2018	fhy@@@LdbbbRnbRYHRoAjjjjjj`@@	fhy@`@@\RYee~uYrVoAZB``@HHLh@@	398.049	4.2975	3	1	46.53	1	-0.9220106787523201	-0.6552187369631655	-0.21393702533742404	32	9	fbmAa@IJBAqYbYEDeEeDUEEj\tYNX@bfhH@bAb@@	eFACD`BL@										1
LNsH42818V$24F801VN0H%20202HV58!10F06$2$F2V#1#810284V2$4#502410	CHEMBL4283232	fbuAb@AR|CDrJIJYPiQQITYGL@ELpPP@HJ`	COc1ccccc1/C=C/C(=O)c1cc(Br)ccc1O	5.31	group4-ia	ia	Androgen Receptor	Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced cell growth treated for every 2 days for 4 days by hemocytometry	2018	f`q@@@DjYW~UyIwjjjjjj@@	f`qA@@@ILrj}jISoM@a@@@BEH	333.18	3.6133	3	1	46.53	4	-0.7558194097584293	-0.36582958509740454	-0.24592233512069278	17	17	fjm@``MQ@Dr`_NN_EIfU_nYnYqIXBAi`bH@DNP		eFACD`BL@	eMJA@Hz@								12
zwtM42NG8X40402BF801VN0H0V!930202HV58!10F06$2$F2V0V01#810284V2!204#502410	CHEMBL4284351	ff}Ab@AR|CDrJIJYPiQQI[TYGL@ELpPQP@`j@	CCCOc1ccccc1/C=C/C(=O)c1cc(Br)ccc1O	5.4	group4-ia	ia	Androgen Receptor	Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay	2018	f`q@@@DjYW~UyIwjjjjjj@@	f`qA@@@ILrj}jISoM@a@@@BEH	361.234	4.474	3	1	46.53	6	-0.3315038737460274	-1.2289185516670322	-0.14306028709205393	17	17	fjm@``MQ@Dr`_NN_EIfU_nYnYqIXBAi`bH@DNP		eFACD`BL@	gJQH@`AJ^j@@								12
LNsH42818V$24F801VN0H%20202HV58!10F06$2$F2V#1#810284V2$4#502810	CHEMBL4285137	fbuAb@AR|BPrJIJYPiQQITYGL@ELpPP@HJ`	COc1ccccc1/C=C/C(=O)c1cc(F)ccc1O	5.3	group4-ia	ia	Androgen Receptor	Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay	2018	f`q@@@DjYW~UyIwjjjjjj@@	f`qA@@@ILrj}jISoM@a@@@BEH	272.274	2.9889	3	1	46.53	4	-1.047183258372431	0.23538607145297574	-0.34939615151067027	17	17	fjm@``MQ@Dr`_NN_EIfU_nYnYqIXBAi`bH@DNP		eFABP`BL@	eMJA@Hz@								12
LNsH42818V$24F801VN0H%23202HV58!10F06$20V02G2V#9#830284020V!4#502010	CHEMBL4285568	fjm@R@ARbTDQdTRTraRbRfUFAS@ASL@QP@`j@	COc1cc(/C=C/C(=O)c2cc(Cl)ccc2O)ccc1O	5.22	group4-ia	ia	Androgen Receptor	Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay	2018	f`q@@@DjYW~UyIwjjjjjj@@	f`qA@@@ILrj}jISoM@a@@@BEH	304.728	3.1484	4	2	66.76	4	-0.03752860725315524	0.2745198510977187	-1.2418475329886247	17	17	fncA``BVr@Ie@q\Z~NQQQQJZjZJJZLTUlDEPsADP@HJ`		eFABH`BL@		eFJB@Hp@							2
LNsH42818V$24F801VN0H%20202HV58!10F06$2$F2V#1#810284V2$4#502410	CHEMBL4286655	fbuAb@AR|BlrJIJYPiQQITYGL@ELpPP@HJ`	COc1ccccc1/C=C/C(=O)c1cc(I)ccc1O	5.76	group4-ia	ia	Androgen Receptor	Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay	2018	f`q@@@DjYW~UyIwjjjjjj@@	f`qA@@@ILrj}jISoM@a@@@BEH	380.176	3.3252	3	1	46.53	4	-0.49477460761117886	-0.36691451374882056	-0.17009264656438236	17	17	fjm@``MQ@Dr`_NN_EIfU_nYnYqIXBAi`bH@DNP		eFABl`BL@	eMJA@Hz@								12
yRsM428G8V404024F801VN0H$130202HV58!10F06$2$F2V0V01#810284V2!204#502410	CHEMBL4287759	fjmAb@AR|CDrJIJYPiQQIZcHy`@ifBBH@PU@	CCOc1ccccc1/C=C/C(=O)c1cc(Br)ccc1O	5.28	group4-ia	ia	Androgen Receptor	Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay	2018	f`q@@@DjYW~UyIwjjjjjj@@	f`qA@@@ILrj}jISoM@a@@@BEH	347.207	4.0196	3	1	46.53	5	-0.5425300719400749	-0.7829163766705847	-0.19461664730202707	17	17	fjm@``MQ@Dr`_NN_EIfU_nYnYqIXBAi`bH@DNP		eFACD`BL@	gCaH@`AJZ`@								12
:xzCqslde4mZ0EgHsVhXSHH1Z0F9Y824FHVl02k3tkO6FG01@101ZJH_1Wc0220894984V250@44#402410	CHEMBL4290001	fluAb@AR|CDrJIJYQEQQZcEZbf@BfhH@bFb@@	O=C1CC(c2ccccc2O)Oc2ccc(Br)cc21	5.75	group4-ia	ia	Androgen Receptor	Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay	2018	fhy@@@LdbbbRnbRYHRoAjjjjjj`@@	fhy@`@@\RYee~uYrVoAZB``@HHLh@@	319.153	3.5723	3	1	46.53	1	-1.3033704196078424	0.07330520001731664	-0.3475383751973168	32	9	fluAb@AR|AqrJIJYQEQQZcEZbf@BfhH@bFb@@	eFACD`BL@										5
zwtI42NG8V4#2BF80WVN0H$12A246HV58!30F0601!20V0XG2W#9#8A0284020V204F!502010	CHEMBL4290022	fj}@R@ARbTDQdTRTraRbRfUFASdl@ELpAEA@`j@	O=C(/C=C/c1ccc2c(c1)OCO2)c1cc(Cl)ccc1O	5.36	group4-ia	ia	Androgen Receptor	Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay	2018	flu@@@DjYW~UmyIwhijjjjjjj@@	fluA`@@^RdsJkvmheNCEKPHP@QPPHT`	302.712	3.6755	4	1	55.76	3	-0.6844887913461424	0.019143966234326834	-0.20980036819820608	1	1	fj}@R@ARbTDQdTRTraRbRfUFASdl@ELpAEA@`j@											1
JNsH42018&4F801VN0H%20202H058!10F06$2%2V#1#81028402)502810	CHEMBL4292968	fleAb@AR|BPrJIJYPiQQZcHi`@ifB@@DEP	O=C(/C=C/c1ccccc1O)c1cc(F)ccc1O	5.85	group4-ia	ia	Androgen Receptor	Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay	2018	f`q@@@DjYW~UyIwjjjjjj@@	f`qA@@@ILrj}jISoM@a@@@BEH	258.247	2.7132	3	2	57.53	3	-0.8136111429336906	0.6407730005996307	-1.4587457401261315	17	17	fjm@``MQ@Dr`_NN_EIfU_nYnYqIXBAi`bH@DNP		eFABP`BL@	eFJB@Hp@								12
:xzCqslde4mZ0EgHsVhXSHH1Z0F9Y824FHVl02k3tkO6FG01@101ZJH_1Wc0220894984V250@44#402410	CHEMBL4293380	fluAb@AR|BlrJIJYQEQQZcEZbf@BfhH@bFb@@	O=C1CC(c2ccccc2O)Oc2ccc(I)cc21	5.37	group4-ia	ia	Androgen Receptor	Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay	2018	fhy@@@LdbbbRnbRYHRoAjjjjjj`@@	fhy@`@@\RYee~uYrVoAZB``@HHLh@@	366.149	3.2842	3	1	46.53	1	-1.0423257781717479	0.0722203845345874	-0.2717087368571541	32	9	fluAb@AR|AqrJIJYQEQQZcEZbf@BfhH@bFb@@	eFABl`BL@										5
JNsH42018&4F801VN0H%20202H058!10F06$2%2V#1#81028402)502410	CHEMBL4293816	fleAb@AR|CDrJIJYPiQQZcHi`@ifB@@DEP	O=C(/C=C/c1ccccc1O)c1cc(Br)ccc1O	5.06	group4-ia	ia	Androgen Receptor	Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay	2018	f`q@@@DjYW~UyIwjjjjjj@@	f`qA@@@ILrj}jISoM@a@@@BEH	319.153	3.3376	3	2	57.53	3	-0.5222472831019775	0.039557487374223724	-1.3552719249786624	17	17	fjm@``MQ@Dr`_NN_EIfU_nYnYqIXBAi`bH@DNP		eFACD`BL@	eFJB@Hp@								12
JNsH42018&4F801VN0H%20202H058!10F06$2%2V#1#81028402)502410	CHEMBL4294564	fleAb@AR|BlrJIJYPiQQZcHi`@ifB@@DEP	O=C(/C=C/c1ccccc1O)c1cc(I)ccc1O	5.79	group4-ia	ia	Androgen Receptor	Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay	2018	f`q@@@DjYW~UyIwjjjjjj@@	f`qA@@@ILrj}jISoM@a@@@BEH	366.149	3.0495	3	2	57.53	3	-0.26120264166588314	0.03847267189149449	-1.2794422866384998	17	17	fjm@``MQ@Dr`_NN_EIfU_nYnYqIXBAi`bH@DNP		eFABl`BL@	eFJB@Hp@								12
JNsH42018&4F801VN0H%20202H058!10F06$2$12V#1#81028482)502410	CHEMBL4294994	fbuAa@BJBCDebYEEEheJeEEfBSfBBIfB@@DMP	O=C(/C=C/c1ccccc1O)c1cc(Br)cc(Br)c1O	5.54	group4-ia	ia	Androgen Receptor	Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay	2018	f`q@@@DjYW~UyIwjjjjjj@@	f`qA@@@ILrj}jISoM@a@@@BEH	398.049	4.0628	3	2	57.53	3	-0.14088753102874402	-0.6889663062812846	-1.2216705763612783	17	17	fjmAB`M@BYPOgEObWDRYeW{f^V\cf@`ZXHH`ACd@	eFJB@Hp@	eFACD`BL@	eFJB@Hp@								1
>UjzKbtYTdxTfBlXSIra8TK82r1hIn27E0Z18HN430e6qP8@2Wp0N88lOFXV302V40K41!F0V#YVGV	CHEMBL4297185	fcoXb@NJLFo\kADYEEDdcDeeEiheeFBM[hxHLffjfZZbh^`@	CC(O)c1cc(C(=O)N[C@@H](C)Cn2ccc(-c3ccc(C#N)c(Cl)c3)n2)n[nH]1	7.58	group2-a	a	Androgen Receptor	Inhibition of androgen receptor (unknown origin)	2020	fj}@@@LdbbRRqRTTrxhTlejjjjjjjh@@	fj}i@@DTDkPLbbTRRLRVbREJsleZfijV@B`@@	398.853	0.7475	8	3	119.62	6	2.9936261989613753	1.9843966297823636	-1.6452569472356133	1	1	fcoXb@NJLFo\kADYEEDdcDeeEiheeFBM[hxHLffjfZZbh^`@											1
yTuM2M9G8k4kZFA4FNH5VR2H04FF1392VHHo58VV3Nk96F10128V12F2p0Wc1DG109J@Xbca40@4J0F658V4F0	CHEMBL430855	ec`XHH@Ba@LSHhdhXeEEDdhilyPpYYEUdLuM@AU@A@PqTPTGE@@	CC1=CC(C)(C)Nc2ccc3c(c21)C(c1cccc(Br)c1)Oc1ccccc1-3	6.4	group3-int	int	Androgen Receptor	Antagonistic activity was determined in Human androgen receptor(hAR) of CV-1 cells in cotransfection assay.	1998	fag@@@DjYfYUUW}aaNCUKR}jjjjjjjjj`@@	faga@@B`rQQQQIQKQIYHtyIwli[WmAT@@DAI@EAE@@	432.36	6.2271	2	1	21.26	1	-1.483340441810085	-2.2486435136345415	-0.3002909006566863	14	13	egdXHL@Fe@@dcqX\\bbbfJbTTTRRbfsg@cgfWURpvtDPUP@PDLUDEAIP@@	eFACD`BL@										13
:UvEQtl9N5mVJAEIcIdXO2H64FGd390VLqp58XX3AkO6FGW0@OX1D5Jl0cd3RnGW90@VbVa018RGGJ71408!	CHEMBL435651	fnsQC@EQlBPQHXdLbdLTRbRRJTtdhwdyjiB`Xjjh`@@	CN1c2cc3c(cc2CCC1(C)C)c(C(F)(F)F)cc(=O)n3C	7.72	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	foQ@@@DjYUU}`nRlzjjjjj`@@	foQQ@@DZ@drmjjtYIUgMR@EUD@@	324.345	2.8664	3	0	23.55	1	-1.8885059659488146	0.32371646898470957	0.6855565782014094	38	10	fnsQB`DVrCqdxedJrCYCHhheLedeEDYF\t[tZj``JifjH@@		eMBH@RZ@									3
=QUvUrjlbuvUmf7nmvfLaZKHCntTWLui7gmYYAlODFMXBIQX1ExLt0cOOwlIk90Q0bVLFWeSKG47GJX8G0	CHEMBL436644	fegQa`E^lEhIADabP{HCdIrFQRFJIQKKJIKJRRcNcfjdJAJjjjbaE@@	O=c1cc(C(F)(F)F)c2cc3c(cc2[nH]1)OC[C@H](CO)N3CC(F)(F)F	6.78	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor in CV1 cells by transcriptional activation assay	2008	foQ@@@DjYUU}`nRlzjjjjj`@@	foQP`@DFAiIe[UUhrRkNZd@JjH@@	382.259	1.585	5	2	61.8	4	0.609337237734996	1.0113161684621643	-1.0464993235638438	38	9	fj}Pb`DVXTGbQqcHIdLrBSL}jkORsbmNCUT@EMULP@@	gGPBAHJPtaPCHiCUP@	eMJA@Df`@									8
xvojcyqXbEue9cx0VAzeCj_1qOoXPw0GFs0Ost12g8OZF0PRNoc50F!F$F2520V01O1#F!V$2V10	CHEMBL437065	ffs@`@@URYVvU]nVgEZ|EIZjZjzjjjhdErART@	C#C[C@]12CC[C@H](O)CC1=CCC1C2CC[C@@]2(C)C1CC[C@@H]2O	5.75	group4-ia	ia	Androgen Receptor	Inhibitory activity against AR	2006	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@DjVU]{ZBxhuoAZjjjjjh@@	300.44	2.9734	2	2	40.46	0	-1.5986106859456184	0.44429626184976984	-1.5982786504665547	35	20	fjcAA@B`|WNNQQRIHsIREKDyIUoIsUUUUUUULaBr`@	eMBD@cx@	eFJB@Hp@									20
{jzy;jxyUzxU:jjryQxUfi@zrlMTbfotZQzrKm_HJ3g8j4XLCgD2y9KoVKB280VA1Oi&	CHEMBL437214	fb}ab@AZmDDPdsK|s^rsagAbgLAATsUTUHLgP@	Cc1ccc(N2C(=O)[C@@H]3C4CCC(O4)[C@@H]3C2=O)cc1Cl	5.64	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor in MDA453 cells by alkaline phosphatase reporter gene assay	2008	fdu@@@LdbbRbbvLWCBT{pXuUUUUUU@@@	fdua`@D@T[HhhhhdhecQfcVCzKUTCTDUBLIb@@	291.733	1.7477	4	0	46.61	1	-1.3919275553807986	1.40715897856052	0.7733066795009454	47	25	fjcac@AZmD@RSqJxiLs{Lwl{NF\FJ\pPESMUTUHLgP@		eFABH`BL@	eFBH@c@@								8
:UvztU:KzxvTvUUzEmIftUDBXR5mOSzEeD6jnbQA3ycF3e6JJW0C@g8wF3kEce285O6WF6010F1107VcVcFF	CHEMBL439685	fkiC@EFRu]PRBICDadTabbRQbbVVfTRTmQSl}TDFUUUM@@Pbrb`@	C[C@H]1CN(C(=O)Nc2cccnc2)[C@H](C)CN1c1ccc(C#N)c(C(F)(F)F)c1	6.92	group3-int	int	Androgen Receptor	Inhibition of AR mediated transcriptional activation using reporter assay	2006	fj}@@@DjYU_yyWbiZrVjjjjjjj`@@	fj}I@@DXtXBSLjsj}jKUoYJuUPPP@D@@@	403.407	3.2648	6	1	72.26	3	0.6200775519035308	0.25536287075332237	0.17284103427253691	23	18	eh\ZHN@JIKL`S@@dbAX|UGFzP^dOiAIf[u{fW^UmixDRrfV`bBijjj@BjlaArIP@											16
xvojcyqXbEue9cx0VAzeCj_1qOoXPw0GFs0Ost12g8OZF0PRNoc50F!F$F2520V01O1#F!V$2010	CHEMBL440283	fjc@`@@ERYVvWVyZ\eiwhyjijjjjjjyA\TeiVgeE@@	C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2O	6.67	group3-int	int	Androgen Receptor	Inhibitory activity against AR	2006	fhe@@@LdbbbTReryHQmN|Fjjjjjj`@@	fhe@@@DjVU]{ZBxhuoAZjjjjjkEDIZ`@	290.445	3.3525	2	2	40.46	0	-1.6690829951009452	0.25346551015601804	-1.6127495790062543	35	9	fjc@C@@AKgDocdTTbRLrTaRqNRU[r\uUUUUUUSDPbPTT`@	eFBH@c@@	eFJB@Hp@	eFJB@Hp@								8
qHuF0F818V0k!24FN21080H040F0212!H408!1808(V02F%82$482502(2080c!	CHEMBL443579	fbuaC@EQAHHdLRFQRFJIIFIJZV`ij``r@H`@@	COc1cccc(-c2ccc(C#N)c(C(F)(F)F)c2)c1	6.02	group3-int	int	Androgen Receptor	Displacement of [3H]DHT from human recombinant AR expressed in Sf9 cells	2007	dcl@@DjYU_egZjjjh@@	dcl@@DjYU_egX@@@@@@	277.244	3.9327	2	0	33.02	3	-1.962120714715071	-0.4356584823002215	0.6013837805441026	30	18	fle`B`N@BSNKoDLBeArJJIIFJJZU`oQ``rBHb@@@			gJPBAHJPt`PAIjj@@	eMJA@Hz@							17
>U:KrxQqujUUTmqS9QgBepCYxBDMip79Y1fCFSVX3VDIqX0ZY5dVcHJEW0Fs59LW0LG0B10KVbFBXcG0	CHEMBL4436972	fkp``FAN[pIB\`nPwHYEDeMEmIhUDeLiES`eU[@DUUSP@UUdPt`@	C[C@](O)(CN1CCc2ccc(F)cc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	7.41	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	fbm@@@DjU^}fUz\\ENZjjjjjjh@@	fbmQ@@DB@drljssnjs`iruPPTA@D@@@	407.366	3.0837	5	2	76.36	5	1.0637585307186554	0.003247193175661328	-0.9342073457132443	26	9	fmwpc@IQWXHODdauqrJJKIIYRZEQIPigIJZNB@jjih@brHFP@	gJPBAHJPt`PAIjj@@										4
>U:KrxQqujUUTmqS9QgBepCYxBDMip79Y1fCFSVX3VDIrX0ZX5cVVHJEW0Fs59LW8LG04105VbFBXcG0	CHEMBL4438211	fkp``NAN[pIB\`nPwHYEEDhlUIhUDeLiDpWIU[@QEUSP@UUdPt`@	C[C@](O)(CN1CCc2c(F)cccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	7.23	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	fbm@@@DjU^}fUz\\ENZjjjjjjh@@	fbmQ@@DB@drljssnjs`iruPPTA@D@@@	407.366	3.0837	5	2	76.36	5	1.0637585307186554	0.003247193175661328	-0.9342073457132443	26	9	fmwpc@IQWXHODdauqrJJKSIYRZEQIPigIJZNB@jjih@brHFP@	gJPBAHJPt`PAIjj@@										2
JFeF#18&4F8010N0H&12!H01#1-21!F!8)48+F281F	CHEMBL4439327	fj}`c@GIJBPIHLdLbbbfJbbTVRxIwhy`bB@@BH@@@	Oc1ccc2c(O)ncc(-c3cc(F)c(F)c(F)c3)c2c1	5.68	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) expressed in human HeLa cells harboring AR3A-PSA-(ARE)4-Luc13 in presence of DHT by BrightGlo luciferase assay	2020	f`i@@@LdbbbTRQpiZ][uUUUUUP@@	f`i`@@@YHdhdhddRTtYw`@`@@@@@@	291.228	3.4747	3	2	53.35	1	-1.060060908120371	0.27168104140372956	-1.463361586012189	4	1	fj}`c@GIJBPIHLdLbbbfJbbTVRxIwhy`bB@@BH@@@											1
zwvG!NG8V4#2BF8#N0H$1292!2V1!821$1$V!G2$88#8+4#4!V!	CHEMBL443970	dg^H`Kd@cIEDdeBmrtDEEX@@	CCCSc1ccc(C#N)c(OC)c1	7.4	group2-a	a	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells	2009	gFp@DiTvjh@	gFp@DiTt@@@	207.296	2.8538	2	0	58.32	4	-1.714258639671028	0.5370663088352455	0.5711692191709865	19	15	dmt@h@BR|VPQ\U`TfYn~fBHb@@	gJPD@DH@Rgj`@		eMJA@Hz@		eMbA@Dg`@						14
zRur26dG8s4F4024F805VN0m0FF!2A!HHV58V030F8411V0@8V825JFF801Bn!3F20Z0402!F!410WVFV	CHEMBL4441215	fakqB@NRZTDQdTTRRJbbVtTTXKpRm``r`HIjXH@@	Cc1ccc(-c2c(C)noc2C)cc1Nc1ccc(C#N)c(Cl)c1	6.19	group3-int	int	Androgen Receptor	Competitive displacement of [3H]R1881 from human AR-LBD expressed in LNCaP cells incubated for 24 hrs by scintillation counting method based radioligand competitive binding assay	2019	fde@@@LdbbRRcTRWEBdFMUUUUUU@@@	fdeQ@@HJ@eKlk_JxIKPXtl@Q@A@@@	337.809	4.8408	4	1	61.85	3	-0.4565390089058452	-0.7668535065338927	-0.13047434551927475	1	1	fakqB@NRZTDQdTTRRJbbVtTTXKpRm``r`HIjXH@@											1
<jzOzfJbw1qPjURPWXS1PgBPp93h04Iyp78Y03CFS6X1VDIuX0ZX5tVV@GEW0Ft5@X_VLG!515kbFBXcGV	CHEMBL4442857	eg`\DB@AHkk@`IAZPvdCiCHhdieDUIhUDeLiEPpIHuu@ASUTt@EUYDAb@@	Cc1cn(C[C@](C)(O)C(=O)Nc2ccc(C#N)c(C(F)(F)F)c2)c2ccc(F)cc12	6.8	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	fbm@@@DjU^}fUz\\ENZjjjjjjh@@	fbmQ@@DB@drljssnjs`iruPPT@`D@@@	419.377	3.4157	5	2	78.05	5	1.1385717036944552	-0.2284782072004552	-0.9084114490498296	26	16	fcop``AIvzH@ddB[qFxyEEEdeEmIhUDeBf\dklxHBjjih@bqHVP@	gJPBAHJPt`PAIjj@@	eFBH@c@@		eFABP`BL@							12
>U:KrxQqujUUTmqS9QgBepCYxBDMip79Y1fCFSVX3VDIqX0ZX5cVVHJEW0Fs59LW0LG04105VbFBXcG0	CHEMBL4443566	fcopc@EFrxHIADabPrJPqQIHjZSZJIKRttZ}uPPYSUUA@DP}@@	C[C@](O)(CN1CCc2ccccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	6.85	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	fbm@@@DjU^}fUz\\ENZjjjjjjh@@	fbmQ@@DB@drljssnjs`iruPPTA@D@@@	389.376	2.9829	5	2	76.36	5	0.9737626384771348	0.13055547360576308	-0.9643348791831595	26	9	fegpa@AAf[pOEkcdTRTrVTfaTRTJhpTj}`@jjih@brHZP@	gJPBAHJPt`PAIjj@@										3
<jzOzfJbw1qPjURPW2S1PgB@p93h043yp78Y03C0R6X1VDGmX0ZX59VV2GEW0Ft5@X_V6G!515kbFBXcGV	CHEMBL4444904	fkp``AAN[pIB\`nPwHYEDeLeeIhUDeLiEQ`iU[@ASUSP@UUdPt`@	C[C@](O)(Cn1ccc2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	7.07	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	fbm@@@DjU^}fUz\\ENZjjjjjjh@@	fbmQ@@DB@drljssnjs`iruPPT@`D@@@	405.35	3.0718	5	2	78.05	5	1.0808835726273482	0.030273260057354756	-0.9332848690950033	26	16	fcop``AIvzH@ddB[qFxyEEEdeEmIhUDeBf\dklxHBjjih@bqHVP@	gJPBAHJPt`PAIjj@@			eFABP`BL@							12
<jzOzfJbw1qPjURPW2S1PgB@p93h043yp78Y03C0R6X1VDGmX0ZX58VV2GEW0Ft5@XWV6G!105kbFBXcGV	CHEMBL4446471	fcopc@EFrxHIADabPrJPqQIHjZSZJIKRttZ}uPPYSUU@`DP}@@	C[C@](O)(Cn1ccc2ccccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	7.19	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	fbm@@@DjU^}fUz\\ENZjjjjjjh@@	fbmQ@@DB@drljssnjs`iruPPT@`D@@@	387.36	2.971	5	2	78.05	5	0.9908875196746718	0.1575816536561433	-0.963412452781066	26	16	fcop``AIvzH@ddB[qFxyEEEdeEmIhUDeBf\dklxHBjjih@bqHVP@	gJPBAHJPt`PAIjj@@										12
vzUvAItl9N4mVJABHcHdXO2H!FGd390VJHp18XV39kO6FK10@9X165Fp0cc0RIG09020bVa!8BFF4504VcF0	CHEMBL4447539	ffcpC@EAbBPQHXdLbdLTRbVRRvdeF\gMUHTDWUTTIT@@	CC1(C)CCc2cc3c(cc2N1)NC(C#N)C=C3C(F)(F)F	8.05	group1-p	p	Androgen Receptor	Inhibition of human androgen receptor	2018	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcVhH`jd`@@	307.318	2.2863	3	2	47.85	1	-1.0078743336100855	0.8860756246209287	-1.4570789005594307	70	2	fj}P@`D^@xzdCREiCHhdhdeHeTeJLTzJZiBBhjjb@@	eMbA@Dg`@										2
<jzOzfJbw1qPjUBPW2S1PgB@p93j043yp70Y03C0J6X1VDGmX0aY59VV2GCW0Fv1@V_V6G08515kbF4XcGV	CHEMBL4447959	e`\\DD@NI@mK@HaZPrJJIIESR[QQIYISILBYU]CO_PPYSUU@`T@AA@Y@@	C[C@](O)(Cn1ccc2cc(F)c(-c3ccccc3)cc21)C(=O)Nc1ccc(C#N)c(Cl)c1	6.69	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	few@@@LdbbRRfreRbtRWERMYpyuUUUUUUUUT@@	fewQ@@DB@drljssn|jjs`irN[UAAPBA@@P@@@	447.896	4.4887	5	2	78.05	5	1.2382727104279707	-0.9792677999200377	-0.8558920616130754	4	3	e`\\DD@NI@mK@GEZPrJJIIESR[QQIYISILBYU]CO_PPYSUU@`T@AA@Y@@	eFABH`BL@										2
zvyziyznjUve9czYkAz@hj_1rSoXTw9GFuNSxsW2i9OZJJ@RNxP70o2RF0881JXG2101ct0412F019F#2V1V	CHEMBL4448048	elQXD@@C`ElbbRfbTLRbRRbVarbRhXTL|RjfZFaQZZjjjB`jJniZbnFDIMHYOHeFd@@	CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](c3ccc(-n4cccc4)cc3)C[C@@]21C	6.45	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay	2019	ekdP@@@LdbbbbbTRrRJNtRDLd\|JRZrjvNjjjjjjjjjjj`@@	ekdXH@@A`LbbRfRfbTRRRUTRhXdt\bJzjZvNZZjjhJBbiZbbAHiMHy@@	467.651	6.2645	3	1	42.23	2	-0.5586455028031969	-2.2481488178817948	-0.073995457912724	2	1	elQXD@@C`ElbbRfbTLRbRRbVarbRhXTL|RjfZFaQZZjjjB`jJniZbnFDIMHYOHeFd@@											1
>Ozfqbw5rTjzRP_XS3PggPp93hV4Mzp78jF3CFS6X1VDIzX0ZaKsVVDGUl0kt5@XWVLK!1V5obGBXcGV	CHEMBL4448937	eh\\BL@ECLg@kg`IABPpdLbdLTRRJfdvbbRRtJdtZFVNj``rfjjABFhbCr@@	CCOC(=O)c1cn(C[C@](C)(O)C(=O)Nc2ccc(C#N)c(C(F)(F)F)c2)c2ccccc12	6.01	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	fbm@@@DjU^}fUz\\ENZjjjjjjh@@	fbmQ@@DB@drljssnjs`iruPPT@`D@@@	459.423	3.2903	7	2	104.35	8	2.743558631463694	-0.2294476988185204	-0.5208137826436422	26	16	fcop``AIvzH@ddB[qFxyEEEdeEmIhUDeBf\dklxHBjjih@bqHVP@	gJPBAHJPt`PAIjj@@	gGPh@l@IL{U@@									12
:UtzdzSzKxx3RAOEE8F38uQ6AH2dV49@Hx2EeV1G@ZeZ0120XN_t!o0B4eWKk3W12VV8FK010VF!4!V0FV	CHEMBL444991	ffcq@@DLlCHhhhdhfeDeDJRcIruTuUP@UH@@	Cc1cc(C)cc(Nc2cc(C(=O)N3CCCC3)n(C)c2)c1	4.82	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	flu@@@DjU^uymiqVhijjjjjjj@@	fluq@@DLLCHhhhdeThdaRUjJVjfjh@I@@@	297.401	3.2834	4	1	37.27	3	-0.9913991205000547	0.13892122262611029	-0.2676478165052488	7	7	fnsqB@HJSDCcdTTTRRTRSfbTcJuUmPLDeTuTT@@											4
>U:KrxQqujUETmqS9QgBepCYzBDMip71Y1fCFKVX3VDIqX0ZY5dVVHJCW0Fu19JW0LG04515V_F4XZG0	CHEMBL4449952	fegpa@AAf[pLQlQdTRTrVTfaTRTJhpTj}`@jjih@brHZP@	C[C@](O)(CN1CCc2cc(Br)ccc21)C(=O)Nc1ccc(C#N)c(Cl)c1	6.08	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	fbm@@@DjU^}fUz\\ENZjjjjjjh@@	fbmQ@@DB@drljssnjs`iruPPTA@D@@@	434.72	3.4658	5	2	76.36	4	1.0312945764426023	-0.2070651447067751	-0.9133125791580688	26	9	fegpa@AAf[pOEkcdTRTrVTfaTRTJhpTj}`@jjih@brHZP@	eFABH`BL@	eFACD`BL@									3
<jzOzfJbw1qPjUBPWXS1PgBPp93j04Iyp70Y03CFK6X1VDIuX0ZY5tVV@GCW0FvG@V_VLG!515k_G4XcGV	CHEMBL4451795	e`\\DD@NI@mK@H`zPrJJIIESR[QQIIZIKLBYU]SO_PPYSUU@a@PAA@Y@@	C[C@](O)(Cn1cc(-c2ccccc2)c2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(Cl)c1	5.99	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	few@@@DjYVWW}ge^ZDjwasjjjjjjjjjh@@	fewQ@@DB@drljssj}jjs`iJN[UAAPBD@@P@@@	447.896	4.4887	5	2	78.05	5	1.2382727104279707	-0.9792677999200377	-0.8558920616130754	1	1	e`\\DD@NI@mK@H`zPrJJIIESR[QQIIZIKLBYU]SO_PPYSUU@a@PAA@Y@@											1
:yzi:njUzedszYkAz@hj_1rSoXUw9GksFSssWXiAOZJJ@RNxP70w2NF0880J2G28018t0412FF19$2V10	CHEMBL4452917	el^XD@@C`ElbbRfbTLRbRRbVarbThXTL|RjfZFZZjjjB`jJnjjbxXPdtad|bTZP@	CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](c3ccc(N(C)C(C)C)cc3)C[C@@]21C	5.65	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay	2019	fag@@@LdbbbbbTRrRJHcR]xjVykUUUUUUUUU@@@	fagA@@@ILkZwKJjmFRtzI^uZtuUUPTEEQDEEST]@@	473.698	6.7416	3	1	40.54	3	-0.4178932034695877	-2.690601076233276	-0.0397535304207536	15	6	ec`PHD@M`ODYqrJIKJJIRJJJKZ[tLFAQUMK]SP@UUUUSUTeTqpaDhmDY@h@@	gJQHA@AIVn@@	gGXHA`AJfjh@									6
?njUze9gzfkAzPjjh1rSoXzw9OFsRSssW2i9OZJJ@RNxP70o2NN08@0J2G28018t0412FV19$2V10	CHEMBL4453035	elQXD@@C`ElbbRfbTLRbRRbVarbRhXTL|RjfZFaQZZjjjB`jJnjjbnFDIMHYOHeFd@@	CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](c3ccc(N4CCCC4)cc3)C[C@@]21C	5.5	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay	2019	ekdP@@@LdbbbbbTRrRJNtRDLd\|JRZrjvNjjjjjjjjjjj`@@	ekdXH@@A`LbbRfRfbTRRRUTRhXdt\bJzjZvNZZjjhJBbjjbbAHiMHy@@	471.683	6.5706	3	1	40.54	2	-0.5789959957299683	-2.4595087509674762	-0.07006738495125253	2	1	elQXD@@C`ElbbRfbTLRbRRbVarbRhXTL|RjfZFaQZZjjjB`jJnjjbnFDIMHYOHeFd@@											1
yTuI0F8G8V40V034F8#N0H$1292!2V1!c2$F1$V!G2$88#8+4#4!V!	CHEMBL445429	dg^H`Kd@cIEEDcLlJtEAEX@@	COc1cc(SC(C)C)ccc1C#N	7.54	group2-a	a	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells	2009	gFp@DiTvjh@	gFp@DiTt@@@	207.296	2.8058	2	0	58.32	3	-1.8705373625384474	0.686745234727764	0.5448119951920382	19	15	dmt@h@BR|VPQ\U`TfYn~fBHb@@	gJPD@DH@Rfj`@		eMJA@Hz@		eMbA@Dg`@						14
<jzOzfJbw1qPjURPW2S1PgB@p93h043yp78Y03C0R6X1VDGmX0ZX58VV2GEW0Ft5@XWc6G!105kbFBXcGV	CHEMBL4456765	fkp``NAN[pIB\`nPwHYEEDhlUIhUDeLiDpWIU[@QCUSP@UUdPt`@	C[C@](O)(Cn1ccc2c(F)cccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	6.9	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	fbm@@@DjU^}fUz\\ENZjjjjjjh@@	fbmQ@@DB@drljssnjs`iruPPT@`D@@@	405.35	3.0718	5	2	78.05	5	1.0808835726273482	0.030273260057354756	-0.9332848690950033	26	16	fkpb`IYOyH@ddCrPmxs\\bbbtVTVtfaTRTJXIVak``bjjih@bqHNP@	gJPBAHJPt`PAIjj@@										2
<jzOzfJbw1qPjURPW2S1PgB@p93h043yp78Y03C0R6X1VDGmX0ZX59VV2GEW0Ft5@X_V6G!515kbFBXgGV	CHEMBL4456781	fkp``AAN[pLR\`nPwHYEDeLeeIhUDeLiEQ`iU[@ASUSP@UUdPt`@	C[C@](O)(Cn1ccc2cc(Br)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	6.04	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	fbm@@@DjU^}fUz\\ENZjjjjjjh@@	fbmQ@@DB@drljssnjs`iruPPT@`D@@@	466.256	3.6962	5	2	78.05	5	1.3722474324590612	-0.5709422531680521	-0.8298110539475344	26	16	fcop``AIvzH@ddB[qFxyEEEdeEmIhUDeBf\dklxHBjjih@bqHVP@	gJPBAHJPt`PAIjj@@			eFACD`BL@							12
zvyziyznjEve9czYkAz@hj_1rSoXTw9GFsFSssW2i9OZJJ@RNxP70o2NF0880J2G2!18s0412F019$2V10	CHEMBL4460554	ebQXD@@M`IlbbRfRfbTRRTRtNTQdUCDfcdQPuWSSUUUAPUEWUUUEppaHiMHyHiT`@	CCC(C)(C)C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C	6.76	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay	2019	fag@@@LdbbbbbTRrRJHcR]xjVykUUUUUUUUU@@@	fagA@@@ILkZwKJjmFRtzI^uZtuUUPTEEQTXaQTuGP@	487.725	7.3374	3	1	40.54	4	-0.213519938253707	-3.2216055665472796	0.012539729360476272	15	4	fmAA@E`|^nNQQIYQQJJJJIZ[tX[pRuft\@EUUUSUTeTsbDeKRMOP@	diDH`@`@RUZZzj@@	gChHA`BOT@@									4
<jzOzfJbw1qPjURPW2S1PgB@p93h043yp78Y03C0R6X1VDGmX0aY59VV2GEW0Ft5@X_V6G08515kbFBXcGV	CHEMBL4460567	elV\DB@KFdTj`ICzPAdHYCHhheDddebiMBhdieHfICOKGMchH@HIJjZ@BjlH`bP@	C[C@](O)(Cn1ccc2cc(F)c(-c3ccccc3)cc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	6.67	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	few@@@LdbbRRfreRbtRWERMYpyuUUUUUUUUT@@	fewQ@@DB@drljssn|jjs`irN[UAAPBA@@P@@@	481.448	4.731	5	2	78.05	6	1.5621005133180252	-1.3701711185879817	-0.7733130117782734	4	3	e`\\DD@NI@mK@GEZPrJJIIESR[QQIYISILBYU]CO_PPYSUU@`T@AA@Y@@	gJPBAHJPt`PAIjj@@										2
:UvUItl9F5k0JAEF82lXN@H04FFWY880LyZ58V039k96FGV02Oa104Jt0V@1RlGV9030bV6!8gG14610V8F0	CHEMBL446191	fbmQC@E^lBPQHXdLbdLTRbVQbTeF\gMUHTBUUD@@	O=c1cc(C(F)(F)F)c2cc(N3CCCC3)ccc2[nH]1	7.6	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor by luciferase reporter gene assay	2007	f`i@@@DjYU_mYK`g^jjjjjj@@	f`iQ@@DZ@drmklmFRT{sT`AUTP@@	282.264	2.0006	3	1	32.34	2	-1.4933779012672983	0.9300159299489749	-0.42644192765048805	4	1	fbmQC@E^lBPQHXdLbdLTRbVQbTeF\gMUHTBUUD@@											1
=yztzvwfxdzD0dvjDxpGyxKeBj8lJuFlxscmidO_LFQwlocW2q3BGF!5RbK61kA1SW4!849X0294V0Fk	CHEMBL4463558	elYTD@@Ik`DLbbtRTrbVRfbVTTJfRDTL\bRJZfvn^aQZjijjjj`Hh@J`a`aJHqNHJIH@	CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4Cc5c(c(C)nc6[nH]c7ccccc7c56)[C@@]4(C)CC[C@@H]32)C1	6.5	group3-int	int	Androgen Receptor	Inhibition of R1881 induced-AR transcriptional activity in AR-positive human 22Rv1 cells harboring ARE14 construct after 24 hrs by luciferase assay	2019	ecdP@@@LdbbbTRerrRfbRwD`afcg`VUSPrvuUUUUUUUUUUT@@@	ecdT@@@@LLdTRTRRTRrLrTrU@cGAeg`RVSWRvpPTPUAUUUPQMaYHid`@	468.639	6.34	4	1	54.98	2	-0.10713537857704916	-2.082823102702698	0.04902308088753349	1	1	elYTD@@Ik`DLbbtRTrbVRfbVTTJfRDTL\bRJZfvn^aQZjijjjj`Hh@J`a`aJHqNHJIH@											1
:UvUtOrdJ7wVLQzUwHVHOvT6B8K1XB1Z7fKE4YVIAVN0V1XDHobk50CBg2YkEVX0s5dXYHbF!V1GFb0VV8F0	CHEMBL4465426	fbuP``M^\DD`JPeHJdLbbbRdubbecN^c@PUULuD@@	CC1(C)NC(=O)N(c2ccc(F)c(C(F)(F)F)c2)C1=O	5.36	group4-ia	ia	Androgen Receptor	Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay	2016	dk\@@DjYVYxqVjjjj`@	dk]D@DpIRYeg^ftvj`PH@@	290.215	2.2042	4	1	49.41	2	-0.9417444342268058	1.024201728504972	-0.2803021070112272	33	14	fhiP``AFuX@RRA|xa|TfYwf[v\LzB@jYjH@@		eMBH@RZ@	gJPBAHJPt`PAIjj@@	eFABP`BL@							14
;j;ir<yxtjjzyUjzhzvzjuwJxUvxUvzGUwizyx_Pzrqm7ul8oFz6eM1TEYpeJl@Kg290VPV9c801V0V	CHEMBL446626	fiwIb@HHyYpR`BLdRRTTTvbardTpPRoQrVoZVifmfjjjjQzQP@	CC12CCC(C)(O1)[C@@H]1C(=O)N(c3ccc(C#N)c4nsnc34)C(=O)[C@@H]12	7.8	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor in MDA453 cells by alkaline phosphatase reporter gene assay	2008	fjs@@@LdbbbTTTVsbEZVg^bgIZjjjjjjjh@@	fjsqb@HHxYrPAFRIIJIPqSYQXHJUoQSdmKTmLuUUTbr}@@	354.389	1.746	7	0	124.42	1	0.9239651904595779	2.109142236986317	1.3400921089839213	4	1	fiwIb@HHyYpR`BLdRRTTTvbardTpPRoQrVoZVifmfjjjjQzQP@											1
>U:KrxQqujUUTmqS9QgBepCYxBDMip79Y1fCFSVX3VDIqX0ZY5dVcHJEW0Fs59LW0LG0B51KVbFBXcG0	CHEMBL4469605	eg`\DJ@AHkk@`I@bPVdMi@zPrJJKIJERZEQISJQL\RJM]PPEUUM@AUVQ@X`@	C[C@](O)(CN1CCc2cc(F)c(F)cc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	7	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	fbm@@@DjU^}fUz\\ENZjjjjjjh@@	fbmQ@@DB@drljssnjs`iruPPTA@D@@@	425.356	3.1845	5	2	76.36	5	1.153754422960176	-0.1240610872544404	-0.904079812243329	26	9	fmwpc@IQWXHODdauqrJJKIIYRZEQIPigIJZNB@jjih@brHFP@	gJPBAHJPt`PAIjj@@	eFABP`BL@									4
:Uvzv;S:vyvzUzEvzfzUzUjUbqSSzjzDDjnbUUvydozvqSqhqzDxDjRYqEiyfgExqWLE2SGk9GNUcc0c!	CHEMBL447184	ebQRLL@EC@noHi`IABPpdLbdLTRRLTTvTQTtRVRTf`RQSUWSwuTDFULuUS@AUEQ`dldT`@	CCCCc1ccc(C(=O)N2C[C@@H]3C[C@H]2[C@@H]2C(=O)N(c4ccc(C#N)c(C(F)(F)F)c4)C(=O)N32)cc1	4.75	group4-ia	ia	Androgen Receptor	In vitro antagonistic activity against androgen receptor of MDA-453 cells	2004	feo@@@LdbbRbbvLRLTrWCBTxOhcgUUUUUUUUUT@@	feoq`@DXBAV\bbbbbRbVNttRUFZlXOhcfuU@uADp@UAadxmH@	496.488	4.5693	7	0	84.72	6	1.6936043933204448	-1.0103539268255344	1.6181091441465147	5	5	el^\LB@MOFg@a`GDRPddEICHhhdiMXhilhbihdldfNOHljbfkghBBjifjjX@JhjLHddld@@	eMbA@Dg`@										1
<jzOzfJbw1qPjURPW2S1PgB@p93h043yp78Y03C0R6X1VDGmX0aY58VV2GEW0Ft5@XWV6G08105kbFBXcGV	CHEMBL4474096	fkp``FAN[pIB\`nPwHYEDeMEmIhUDeLiES`eU[@DUUSP@UUbPt`@	C[C@](O)(Cn1ccc2ccc(F)cc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	7.07	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	fbm@@@DjU^}fUz\\ENZjjjjjjh@@	fbmQ@@DB@drljssnjs`iruPPT@`D@@@	405.35	3.0718	5	2	78.05	5	1.0808835726273482	0.030273260057354756	-0.9332848690950033	26	16	fcop``AIvzH@ddB[qFxyEEEdeEmIhUDeBf\dklxHBjjih@bqHVP@	gJPBAHJPt`PAIjj@@		eFABP`BL@								12
<jzOzfJbw1qPjUBPW2S1PgB@p93j043yp70Y03C0J6X1VDGmX0ZY59VV2GCW0Fv1@V_V6G!515k_F4XcGV	CHEMBL4474118	fegpa@NRCjpHb\adTTRRJfdvbbRvXKM^c``rfjjA@bHF`@	C[C@](O)(Cn1ccc2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(Cl)c1	7.03	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	fbm@@@DjU^}fUz\\ENZjjjjjjh@@	fbmQ@@DB@drljssnjs`iruPPT@`D@@@	371.798	2.8295	5	2	78.05	4	0.7570557697372937	0.42117657872529857	-1.015863918929805	26	16	fcop``AIvzH@ddB[qFxyEEEdeEmIhUDeBf\dklxHBjjih@bqHVP@	eFABH`BL@			eFABP`BL@							12
<jzOzfJbw1qPjURPW2S1PgB@p93h043yp78Y03C0R6X1VDGmX0aY58VV2GEW0Ft5@X_c6G08105kbFBXcGV	CHEMBL4475563	eb^\DJ@NFlXj`ICjPAdHYAFPrJJIQIFIIRHs[QISJQLB\RAEGWPDPtDEPu@AUVPPNH@	C[C@](O)(Cn1ccc2c(F)cc(-c3ccc(F)cc3)cc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	6.05	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	few@@@LdbbRRfreRbtRWERMYpyuUUUUUUUUT@@	fewQ@@DB@drljssn|jjs`irN[UAAPBA@@P@@@	499.438	4.8318	5	2	78.05	6	1.6520964055595457	-1.4974793990180835	-0.7431854783083581	4	3	ehR\DL@NI@mK@GDZPAdLbbbRQTtftTRVbLRVXDrjzf^~``rfjjABH@H``L`@	gJPBAHJPt`PAIjj@@										1
<jzOzfJbw1qPjURPW2S1PgB@p93h043yp78Y03C0R6X1VDGmX0ZX59VV2GEW0Ft5@X_V6G!515kbFBXcGV	CHEMBL4475765	fkp``AAN[pIB\`nPwHYEDeLeeIhUDeLiEQ`iU[@ASUSP@UUdPu@@	C[C@@](O)(Cn1ccc2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	6.22	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	fbm@@@DjU^}fUz\\ENZjjjjjjh@@	fbmQ@@DB@drljssnjs`iruPPT@`D@@@	405.35	3.0718	5	2	78.05	5	1.0808835726273482	0.030273260057354756	-0.9332848690950033	26	16	fcop``AIvzH@ddB[qFxyEEEdeEmIhUDeBf\dklxHBjjih@bqHV`@	gJPBAHJPt`PAIjj@@			eFABP`BL@							1
LFuF!818V$24F8#N0H&120H2V5#3!1%20V!G61#90V#F&V204#1!V!	CHEMBL447604	fdy``@H`ydbbbbRRtIe[Sj@H@`k@@@	COc1cc(C#N)ccc1Oc1cccc(C)c1	6.45	group3-int	int	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells	2009	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	239.273	3.1647	3	0	42.25	3	-1.7327038438950966	0.35538813703787525	0.6469402023833175	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@	eMJA@Hz@					eFBH@c@@		eMbA@Dg`@			34
zvyziyznjEve9czYkAz@hj_1rSoXTw9GFsFSssW2i9OZJJ@RNxP70o2NF0880J2G2!18t0412F019$2V10	CHEMBL4476493	edVXD@@C`ElbbRfbTLRbRRbVarbMCBagbUTsPsSUUUPTEQUuUQ\LHRZPr^QJMH@	CCC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C	5.53	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay	2019	fag@@@LdbbbbbTRrRJHcR]xjVykUUUUUUUUU@@@	fagA@@@ILkZwKJjmFRtzI^uZtuUUPTEEQDEEST]@@	459.672	6.4304	3	1	40.54	3	-0.47711457384188627	-2.4515107936288802	-0.06445487954506582	15	6	ec`PHD@M`ODYqrJIKJJIRJJJKZ[tLFAQUMK]SP@UUUUSUTeTqpaDhmDY@h@@	gGQHA@AIUkh@	gChHA`BOT@@									6
?vzUzftczvnfzPjjhWzSreUw9OFsNSusYDi9OaJS@TNxP70o2NN4N9VJ2I28018s14W3F21901V03V10	CHEMBL4483408	ee_TBH@LIHD@ZP@cIICLeeDeeEDhhhheiL|mHIHyyTMM\}c|bmUU@AUUUTuUVuTUW@RbVRJUTFbr@@	CC(C)(C)C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3[C@@H](c3ccc(N4CCN(S(C)(=O)=O)CC4)cc3)C[C@@]21C	6.45	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay	2019	eglP@@@LdbbbbbTRrRJNtRPadcgaRSVUQuuUUUUUUUUUUU@@@	eglTH@@Ak`LbbRfRfbTRRRUTRUCDfcdQWUSQusSUUUAPTUUUETLHRJSRNP@	592.842	6.3836	6	1	86.3	3	1.6967527782273746	-2.2189968445041663	0.5365442438468855	3	2	enSTDH@HFKdPGGHhdlhdlhheEEEDmIgeiJFMCDjfem`Sojjh@JjjjfjjvjbjxlSbBTRReTzP@	gJPdH`DD@cuh@										2
<jzOzfJbw1qPjUBPW2S1PgB@p93j043yp70Y02C0J6X1VDGmX0ZY58VV2GCW0Fv1@VWc4G!105kbF4XcGV	CHEMBL4483663	fegpa@NRCjpH`\adTTRRJfdvbbRtXKM^s``rfjjABBHF`@	C[C@](O)(Cn1ccc2c(F)cccc21)C(=O)Nc1ccc(C#N)c(Cl)c1	6.85	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	fbm@@@DjU^}fUz\\ENZjjjjjjh@@	fbmQ@@DB@drljssnjs`iruPPT@`D@@@	371.798	2.8295	5	2	78.05	4	0.7570557697372937	0.42117657872529857	-1.015863918929805	26	16	fkpb`IYOyH@ddCrPmxs\\bbbtVTVtfaTRTJXIVak``bjjih@bqHNP@	eFABH`BL@										2
zvyziyznjEve9czYkAz@hj_1rSoXTw9GFsFSssW2i9OZJJ@RNxP70o2NF0880J2G2!18t0412F019$2c10	CHEMBL4483697	ebQXDL@@^HPIABPpdLbdJTfdRQbRTTfRVvRbeg`QWVsuwuUuUUUUATCEMUEpqADiGIy@ed`@	CN(C)c1ccc([C@H]2C[C@@]3(C)[C@@H](CC[C@@]3(O)C#CC(F)(F)F)[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@H]23)cc1	6.19	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay	2019	fag@@@LdbbbbbTRrRJHcR]xjVykUUUUUUUUU@@@	fagA@@@ILkZwKJjmFRtzI^uZtuUUPTEEQDEEST]@@	499.615	6.4603	3	1	40.54	3	-0.2681742691630655	-2.617606240610957	0.0014264488266598	15	6	ec`PHD@M`ODYqrJIKJJIRJJJKZ[tLFAQUMK]SP@UUUUSUTeTqpaDhmDY@h@@	daxHHNBPRPrPX@rJPiUWP@@	gChHA`BOT@@									6
LFuF!818V$24F8#N0H%212022V5!83+V!G6$98V#F#8%4#5!V!	CHEMBL448454	fleaB@Dn@DYHhhhhdkBmJqoT@DPDU`@@	COc1cc(Sc2c(C)cccc2C)ccc1C#N	7.52	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in human MDA-MB453 cells by luciferase reporter gene assay	2009	dk\@@DjU^ukmNjjjj`@	dk\@`@BDifUWGUN`@@@@@	269.367	3.9341	2	0	58.32	3	-1.5967471799316284	-0.22170920121701126	0.6528288411134691	60	9	fle`@`D`BVNL`cwcdTRTVrbRaUNNC@DU@DV@@@	eFBH@c@@	eMJA@Hz@									4
uTPI0F8G804kV034FNH!80H040F129#2J080c38080F1$V*@#848230X(2080c!	CHEMBL448978	fhq`@`@`BKRCiCtadbbdRlrdTeTEPEUX@@	CC(C)(C)Sc1ccc(C#N)c(C(F)(F)F)c1	6.5	group3-int	int	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells	2009	gFp@DiTvjh@	gFp@DiTt@@@	259.294	4.1098	1	0	49.09	3	-2.051304504036741	-0.4785335094446895	0.5251301149173189	19	15	dmt@h@BR|VPQ\U`TfYn~fBHb@@	gGPD@DH@Rfjj@@		gJPBAHJPt`PAIjj@@		eMbA@Dg`@						14
vzUI9Hsl984kV03DFs20280H040F129#24080c39080F1$V$8$@#8482102(2080c!	CHEMBL449371	fhi`@`@`BKRCiCtadbbbRtJdSIBUPTDUUp@@	N#Cc1ccc(SC2CCC2)cc1C(F)(F)F	6.78	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in human MDA-MB453 cells by luciferase reporter gene assay	2009	dmL@@DjU^zzUjjjj@@	dmL@`@BDifUvdUhJBH@@	257.278	3.7642	1	0	49.09	3	-2.0456604382022863	-0.26330072737168303	0.5200117565528388	7	1	fhi`@`@`BKRCiCtadbbbRtJdSIBUPTDUUp@@											1
yLuK0F8G8V4k4024FN2!N0H040F13120H2Z58!3809%21V!F6!V09@V#J821020V2040421N0c!	CHEMBL449804	ff}`c@EFBBPQHXdLbdLTRRJbbRtmIKUAAeAAD@@@	CCOc1ccccc1Oc1ccc(C#N)c(C(F)(F)F)c1	7.33	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in human MDA-MB-231 cells assessed as inhibition of DHT-induced response	2009	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	307.27	4.0754	3	0	42.25	5	-1.1003937927200695	-0.6858792318181313	0.8157883033668014	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@			gCaH@`AJZ`@		gJPBAHJPt`PAIjj@@			eMbA@Dg`@			34
LFuF!818V$24F8#N0H%2120H2V5#3!1%20V!G61#90V#F&V204#5!V!	CHEMBL449867	fdy``@H`ydbbbbTRVndxwj@HBHK@@@	COc1cc(C#N)ccc1Oc1ccccc1C	7.32	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in human MDA-MB453 cells by luciferase reporter gene assay	2009	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	239.273	3.1647	3	0	42.25	3	-1.7327038438950966	0.35538813703787525	0.6469402023833175	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@	eMJA@Hz@		eFBH@c@@					eMbA@Dg`@			34
zTur6I9l8k4k4F34FN2WVN2H!FF13920LmZ58V03Nk96FGV029X12KLl0W89Tl1V9020bc640@BJ04458V8F0	CHEMBL450334	fnk`c@CJ\BPQHXdLbdLTRbbReVRdZtPijvjdJHZH@`@@@	O=c1cc(C(F)(F)F)c2c3c(ccc2[nH]1)-c1ccccc1CO3	7.4	group2-a	a	Androgen Receptor	Activity at androgen receptor in human Saos2 cells assessed as IL6 repression	2008	flm@@@DjYee]YhTkA}Fjjjjjjj@@	flm``@D@TdrmkZjmFRuYtTmR@QT@P@@@	317.265	2.6691	3	1	38.33	1	-1.4027043837428512	0.5631151497408454	-0.3762244991694593	11	2	fnk`c@CJ\BPQHXdLbdLTRbbReVRdZtPijvjdJHZH@`@@@											1
yRur659G8k4F4G24FN05VN2H!F013920HmV58c03Fk960WV028V12JLl0W89Dl0c9022Zc640@4J!458V0F0	CHEMBL450933	fnk`P@G@PenQQJJJIIQSSWLykulaJu@A@PtTpP@@	COc1cccc2oc(=O)c3c(ccc4[nH]c(=O)cc(C)c43)c12	7.68	group2-a	a	Androgen Receptor	Activity at androgen receptor in human Saos2 cells assessed as IL6 repression	2008	fb}@@@LdbbbbbRJvsCBTzHTuUUUUUUT@@	fb}a`@G@QgHheEEDdhmjsfoVbEKT@DABSA@@@	307.304	2.2852	5	1	64.63	1	-0.5245124849897116	1.2654552862660493	-0.1505809006284421	8	8	fnkaa@Dr|tGbQqrJJKSJIIJEQEgEF\GMXHB``Rfdb@@	eMJA@Hz@										8
qHuJ0F818V0k!24FN2!N0H040F02120H2Z58!3809%20V40G610109@VF!J821024V204!21N2c10	CHEMBL451153	fncac@EFBtD`bPqHYEHXhddUEDdcKRRuPPYPPQP@@@	COc1ccc(CO)cc1Oc1ccc(C#N)c(C(F)(F)F)c1	6.67	group3-int	int	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system	2009	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	323.269	3.0718	4	1	62.48	5	-0.12266974883667667	0.11347057022894813	-0.109800931972132	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@			eMJA@Hz@		gJPBAHJPt`PAIjj@@		eMJA@Df`@	eMbA@Dg`@			34
zvwzgyynjjue9czXkAz@hj_1rSoXTw9IFsFSss12i9OZJJ@RNx@70oHNF0880F2G2!18O!1XF018$2V10	CHEMBL4515467	e`RPL@@@EclbbRfbTLRbRRbVarUCBagbUTsPsSUUUPTEQUuTWCBDfdLgdRcR@@	CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](c3ccc(OC)cc3)C[C@@]21C	6.25	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay	2019	fag@@@LdbbbbbTRrRJHcR]xjVykUUUUUUUUU@@@	fagA@@@ILkZwKJjmFRtzI^uZtuUUPTEEQDEEST]@@	432.602	6.0096	3	1	46.53	2	-0.6620663626499227	-1.93340206512521	-0.12205108348215968	15	6	ec`PHD@M`ODYqrJIKJJIRJJJKZ[tLFAQUMK]SP@UUUUSUTeTqpaDhmDY@h@@	gJQHA@AIVn@@	eMJA@Hz@									6
<jzOzfJbw1qPjURPW2S1PgB@p93h043yp78Y03C0R6X1VDGmX0aY59VV2GEW0Ft5@X_c6G!515kbFBXcGV	CHEMBL4520679	elV\DB@MFdTj`ICzPAdHYCHhhhhddmmiMBhdieHfEMCG@mchHHBPbjZ@Bjl``bP@	C[C@](O)(Cn1ccc2c(F)c(-c3ccccc3)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	5.99	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	few@@@DjYU[wuge^JdZsasjjjjjjjjjh@@	fewQ@@DB@drljssoljjs`irN[UAAPBA@@P@@@	481.448	4.731	5	2	78.05	6	1.5621005133180252	-1.3701711185879817	-0.7733130117782734	1	1	elV\DB@MFdTj`ICzPAdHYCHhhhhddmmiMBhdieHfEMCG@mchHHBPbjZ@Bjl``bP@											1
>U:KrxQqujUETmqS9QgBepCYzBDMip71Y1fCFKVX3VDIqX0ZY5dVcHJCW0Fu19JW0LG0B51KVbF4XcG0	CHEMBL4521365	fmwpc@NRCjpHb\`nPrJJIIESR[QQIYI`luzNBCJZjhHBbHF`@	C[C@](O)(CN1CCc2cc(F)c(F)cc21)C(=O)Nc1ccc(C#N)c(Cl)c1	7.5	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	fbm@@@DjU^}fUz\\ENZjjjjjjh@@	fbmQ@@DB@drljssnjs`iruPPTA@D@@@	391.804	2.9422	5	2	76.36	4	0.8299266200701213	0.2668422314135034	-0.986658862078131	26	9	fmwpc@IQWXHODdauqrJJKIIYRZEQIPigIJZNB@jjih@brHFP@	eFABH`BL@	eFABP`BL@									4
FF2F,4#108-F/)F/.F	CHEMBL452153	f`iP@@@^RfYeU~dmNmxH@@@@@@@	c1ccc2nc(-c3ccncc3)ccc2c1	5.38	group4-ia	ia	Androgen Receptor	Inhibition of androgen receptor transcriptional activity in human LNCaP cells after 3 days by eGFP assay	2014	f`i@@@DjYU[wxjQg^jjjjjj@@	f`iP@@@^RfYeU~dmNmxH@@@@@@@	206.247	2.7249	2	0	25.78	1	-2.712697581536597	0.7422282311657483	0.40762204315844	4	1	f`iP@@@^RfYeU~dmNmxH@@@@@@@											1
>U:KrxQqujUETmqS9QgBepCYzBDMip71Y1eCFKVX3VDIqX0ZY5dVcHJCW0Fu19JW0JG0B10KVbF4XcG0	CHEMBL4527176	fegpa@NRCjpHb\adTTRRJfdvbbRrXKM^c``rfjjB@bHF`@	C[C@](O)(CN1CCc2ccc(F)cc21)C(=O)Nc1ccc(C#N)c(Cl)c1	7.43	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	fbm@@@DjU^}fUz\\ENZjjjjjjh@@	fbmQ@@DB@drljssnjs`iruPPTA@D@@@	373.814	2.8414	5	2	76.36	4	0.7399307278286008	0.39415051184360517	-1.016786395548046	26	9	fmwpc@IQWXHODdauqrJJKIIYRZEQIPigIJZNB@jjih@brHFP@	eFABH`BL@										4
>U:KrxQqujUETmqS9QgBepCYzBDMip71Y1eCFKVX3VDIrX0ZY5cVVHJCW0Fu19JW8JG04105VbF4XcG0	CHEMBL4527241	fegpa@NRCjpH`\adTTRRJfdvbbRtXKM^s``rfjjBBBHF`@	C[C@](O)(CN1CCc2c(F)cccc21)C(=O)Nc1ccc(C#N)c(Cl)c1	6.9	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	fbm@@@DjU^}fUz\\ENZjjjjjjh@@	fbmQ@@DB@drljssnjs`iruPPTA@D@@@	373.814	2.8414	5	2	76.36	4	0.7399307278286008	0.39415051184360517	-1.016786395548046	26	9	fmwpc@IQWXHODdauqrJJKSIYRZEQIPigIJZNB@jjih@brHFP@	eFABH`BL@										2
zvyziyznjEve9czYkAz@hj_1rSoXTw9GFsFSssW2i9OZJJ@RNxP70o2NF0880J2G2!18t0412F019$2k10	CHEMBL4527872	elQXD@@C`ElbbRfbTLRbRRbVarbLhXTL|RjfZFaQZZjjjB`jJnjjbnFDIMHYOHeFd@@	CN(C)c1ccc([C@H]2C[C@@]3(C)[C@@H](CC[C@@]3(O)C#CC3CC3)[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@H]23)cc1	5.84	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay	2019	ekdP@@@LdbbbbbTRrRJrNTDLd\|JRZrjvNjjjjjjjjjjj`@@	ekdPH@@@LbbRfRfbTRRRVJThXdt\bJzjZvNZZjjhJBbzjbbAHiMHy@@	471.683	6.2941	3	1	40.54	3	-0.40744937309163864	-2.414114791739579	-0.045401281089115196	1	1	elQXD@@C`ElbbRfbTLRbRRbVarbLhXTL|RjfZFaQZZjjjB`jJnjjbnFDIMHYOHeFd@@											1
vyQn@ntl8NBmVoAB0c0dVN20FFGI9Y!ZMFV50VV08k96FJ!@501V4Jo0VV14n10102#41248!4#V0FV	CHEMBL4528089	fduP@@@JRfUWmU\TyHu`qhDHj`B@`H`@	c1ccc2c(c1)CC(c1c[nH]c3ccccc13)N2	6.51	group3-int	int	Androgen Receptor	Inhibition of AR transcriptional activity in human ARR2PB-eGFP expressing LNCaP cells after 3 days by fluorescence assay	2016	fdu@@@LdbbbTqVRUNBtZpXuUUUUUU@@@	fduP@@@JRfUWmU\TyHu`qhDHj`B@`H`@	234.301	2.8907	2	2	27.82	1	-1.9877822661184226	0.5257346230592503	-1.7136073070994022	1	1	fduP@@@JRfUWmU\TyHu`qhDHj`B@`H`@											1
;Qd2sQ9c62122DF8F82O0H#V1292!2V1!821$104!V04G28#88#8+4#4!V!	CHEMBL453244	f`qaB@OJ@DYHhdeEMd^ZdZ``jJl`@@	COc1cc(SCC2CCC2)ccc1C#N	6.36	group3-int	int	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells	2009	dcl@@DjU_fnWZjjjh@@	dcl@`@BDieV_egZBBbH@@	233.334	3.0595	2	0	58.32	4	-1.5868160746225846	0.31685311334903016	0.6150862859045828	2	2	foA`A@N@\YAFQQQIHiQLEYtDFUUD@@	eMJA@Hz@										2
:xzxyqvzjuvxexmmvzDSjb1UtpeTwQlFsGSuxGLgxQoS4@Rto874o@NH0380F6322VF8O5F40F#1F!2V10	CHEMBL4534324	ehZPLH@AEo`HcHhdldhheHhhhmiL|jFGDlnakich@JjjjjfjjvJkbQJHqVIrIPi@@	CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](OCc3ccc(Cl)cc3)C[C@@]21C	7.07	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay	2019	feo@@@LdbbbbbTJJRLrWMBlXLTcgUUUUUUUUUT@@	feo@`@@FrJIJYJZIIIIPiTYKS`yJN[SUUUUU@AUAAQTuGP@	467.047	5.9351	3	1	46.53	3	-0.3186302285694901	-2.1371730074542117	-0.03965359954821365	1	1	ehZPLH@AEo`HcHhdldhheHhhhmiL|jFGDlnakich@JjjjjfjjvJkbQJHqVIrIPi@@											1
vzUQ1HsI984k022DFNH0290H040k129#2408083908!104!V04!8$@#8482102(2080s!	CHEMBL453623	fhi`@`@`BKRCiCtadbbRTTjdWEBePPTUUd@@	N#Cc1ccc(SCC2CC2)cc1C(F)(F)F	7.46	group2-a	a	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells	2009	dmL@@DjU_jzUjjjj@@	dmL@`@BDieV^TYhHJB@@	257.278	3.6358	1	0	49.09	4	-1.8810819998859452	-0.30693694519085485	0.5454496782066423	3	2	dg~@PNAqdHrJJIIEJLIwAAeUD@@	gJPBAHJPt`PAIjj@@										2
vzUQdHsQ986m122DFNH8290H040k129#2408083908!104!V04!8$@#8482102(2080c!	CHEMBL453624	fdy`@`H`BGRGi@L`eLjs^u|UHuAAQUUd@@	N#Cc1ccc(SCC2CCC2)cc1C(F)(F)F	6.15	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in human MDA-MB453 cells by luciferase reporter gene assay	2009	dcl@@DjU_fnWZjjjh@@	dcl@`@BDieV_egZBBbH@@	271.305	3.9778	1	0	49.09	4	-1.8233046355877494	-0.5645461425663713	0.5703131464842877	2	2	foA`A@N@\YAFQQQIHiQLEYtDFUUD@@	gJPBAHJPt`PAIjj@@										2
uTPI0F8G804kV034FN2!80H040F129#24080c38080F1$V*@#8482102(2080c!	CHEMBL453740	f`a`@`O@BCREiAtadbbbQfTbEJ`hBjl@@	CC(C)Sc1ccc(C#N)c(C(F)(F)F)c1	7.05	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in human MDA-MB453 cells by luciferase reporter gene assay	2009	gFp@DiTvjh@	gFp@DiTt@@@	245.267	3.7241	1	0	49.09	3	-2.107025934721323	-0.19465416451261092	0.5000388570142518	19	15	dmt@h@BR|VPQ\U`TfYn~fBHb@@	gJPD@DH@Rfj`@		gJPBAHJPt`PAIjj@@		eMbA@Dg`@						14
>U:KrxQqujUETnqS9QgBepCYzBDMyp71Y1fCFKXX3VDIqX0aY5dVcHJCW0Fv1AJ_0LG0B51KVbF4XcG0	CHEMBL4539953	e`\\DD@NI@mK@HaZPrJJIIESR[QQIYISILBYU]CO_PPYSUUA@T@AA@Y@@	C[C@](O)(CN1CCc2cc(F)c(-c3ccccc3)cc21)C(=O)Nc1ccc(C#N)c(Cl)c1	6.61	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	few@@@LdbbRRfreRbtRWERMYpyuUUUUUUUUT@@	fewQ@@DB@drljssn|jjs`irN[UAAPDA@@P@@@	449.912	4.5006	5	2	76.36	5	1.221147668519278	-1.006293866801731	-0.8568145382313166	4	1	e`\\DD@NI@mK@HaZPrJJIIESR[QQIYISILBYU]CO_PPYSUUA@T@AA@Y@@											1
?Uzu7xpUEjzSPpmxQUalNWhYCdBIzn5Bik1QoCakWgCzt0hX5ws@ZjMSndd_12YM0JK301X04kN0V8FV	CHEMBL454138	e`\TLD@EBiJf`I@bPrJJKKSQIQRIQGIJIL\^Q]CO_PPDuMUTuPT@`@@@	CC(C)OC(=O)C1=CN(C(=O)c2ccc(F)c(F)c2)CC(C)(C)c2c1[nH]c1ccccc21	5	group4-ia	ia	Androgen Receptor	Antagonist activity at gal-AR expressed in african green monkey CV1 cells co-expressing MH100 with GRIP1 co-factor by luciferase reporter gene assay	2009	ffs@@@LdbbRfRRRtJRmVCzIZuUUUUUUUP@@	ffsQ@@D^@dsLjj{jngFlFIZmTCAQT@B@@@	438.473	4.1898	5	1	62.4	4	0.5163797430927116	-0.7447361865243715	0.1478261142674921	1	1	e`\TLD@EBiJf`I@bPrJJKKSQIQRIQGIJIL\^Q]CO_PPDuMUTuPT@`@@@											1
>U:KrxQqujUETmqS9QgBepCYzBDMip71Y1fCFKVX3VDIqX0ZY5dVVHJCW0Fu19JW0LG04515V_F4XcG0	CHEMBL4542153	fegpa@NRCjpHb\adTTRRJfdvbbRvXKM^c``rfjjB@bHF`@	C[C@](O)(CN1CCc2cc(F)ccc21)C(=O)Nc1ccc(C#N)c(Cl)c1	6.89	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	fbm@@@DjU^}fUz\\ENZjjjjjjh@@	fbmQ@@DB@drljssnjs`iruPPTA@D@@@	373.814	2.8414	5	2	76.36	4	0.7399307278286008	0.39415051184360517	-1.016786395548046	26	9	fegpa@AAf[pOEkcdTRTrVTfaTRTJhpTj}`@jjih@brHZP@	eFABH`BL@	eFABP`BL@									3
<jzOzfJbw1qPjURPW2S1PgB@p93h043yp78Y03C0R6X1VDGmX0ZX59VV2GEW0Ft5@X_V6G!515kbFBXgGV	CHEMBL4542693	fkp``AAN[pJr\`nPwHYEDeLeeIhUDeLiEQ`iU[@ASUSP@UUdPt`@	C[C@](O)(Cn1ccc2cc(I)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	6.01	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	fbm@@@DjU^}fUz\\ENZjjjjjjh@@	fbmQ@@DB@drljssnjs`iruPPT@`D@@@	513.252	3.4081	5	2	78.05	5	1.6332922346063117	-0.572027181819468	-0.753981365391224	26	16	fcop``AIvzH@ddB[qFxyEEEdeEmIhUDeBf\dklxHBjjih@bqHVP@	gJPBAHJPt`PAIjj@@			eFABl`BL@							12
?v;eCczvmAzPjjh1rSoXUwdtFsNSusY2i9OZJJ@RNxP70o2NN0NO0J2IH8018s0412k01901V02V10	CHEMBL4545820	ef]XL@@M`Ij\bbRfRfbTRRTRtNTRRdUCDfcdQPuWTMKSUUUAPUEWUUUTUppaHiMHyHiT`@	CC(C)(C)C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3[C@@H](c3ccc(N4CCOCC4)cc3)C[C@@]21C	6.68	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay	2019	eglP@@@LdbbbbbTRrRJNtRPadcgaRSVUQuuUUUUUUUUUUU@@@	eglXD@@A`KlbbRfRfbTRRRUTRUCDfcdQWUSQusSUUUAPTUUUETLHRJSRNP@	515.735	6.6556	4	1	49.77	3	0.200771914169629	-2.6062322093325783	0.14100885580687753	3	1	ef]XL@@M`Ij\bbRfRfbTRRTRtNTRRdUCDfcdQPuWTMKSUUUAPUEWUUUTUppaHiMHyHiT`@											1
vzUvAItl9N4mVJABHcHdXO2H!FGd390VJHp18XV39kO6FG10@9X165Fp0cc0RIG09020bVa!8BFF4504V8F0	CHEMBL4548397	fj}P@`EAAHHdLREiCHiCEDheedmIJLzJZjPhHjjbaH`@	CC1(C)CCc2cc3c(cc2N1)NC(F)C=C3C(F)(F)F	7.66	group2-a	a	Androgen Receptor	Inhibition of human androgen receptor	2018	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcVhH`jd`@@	300.298	3.0666	2	2	24.06	1	-1.708981335917811	0.14767478348905277	-1.6136644645065514	70	2	fj}P@`D^@xzdCREiCHhdhdeHeTeJLTzJZiBBhjjb@@	eFABP`BL@										2
<jzOzfJbw1qPjURPW2S1ugB@p93h043yp78Y03C0R6eWVDGmX4aY58VV2GEW0kt5@X_V6O08105kbFBYcGV	CHEMBL4554646	eohRBLDECLcg@kg`IABPpdCi^{HiCEDdbiiMhhdlmIMFaemjhHLijj`PIbHOH@@	C[C@](O)(Cn1ccc2ccc([N+](=O)[O-])cc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	7.24	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	fbm@@@DjU^}fUz\\ENZjjjjjjh@@	fbmQ@@DB@drljssnjs`iruPPT@`D@@@	432.357	2.0494	8	2	123.87	6	2.9010817649209093	1.1225696521653143	-0.4857996273536308	26	16	fcop``AIvzH@ddB[qFxyEEEdeEmIhUDeBf\dklxHBjjih@bqHVP@	gJPBAHJPt`PAIjj@@		gChhhE`BRnRYh@								12
zxzG10sG9V4#2DF8!2N0H$1292!2V1!821$1$V!G28#88#8+4#4!V!	CHEMBL455566	do~H`Gd@cIEDdeLd^V``hjp@@	CCCCSc1ccc(C#N)c(OC)c1	7.08	group2-a	a	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells	2009	gFp@DiTvjh@	gFp@DiTt@@@	221.323	3.3082	2	0	58.32	5	-1.5032325106148472	0.09106433374811496	0.6227255530303771	19	15	dmt@h@BR|VPQ\U`TfYn~fBHb@@	gGPD@DH@RgZj@@		eMJA@Hz@		eMbA@Dg`@						14
<j:nj:eCczvmAz@jj_1rSoXUwdGFsFSusY2i9OZJJ@RNxP70o2NN0890J2IH8018t0412k01901!2V10	CHEMBL4562338	ebQXL@@C`Ed\bbRfbTLRbRRbVarbQUCBagbUTsPsSUUUPTEQUuUUEppaIiCIyDht`@	CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](c3ccc(N(C)CCOC)cc3)C[C@@]21C	5.89	group4-ia	ia	Androgen Receptor	Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay	2019	fag@@@LdbbbbbTRrRJHcR]xjVykUUUUUUUUU@@@	fagA@@@ILkZwKJjmFRtzI^uZtuUUPTEEQDEEST]@@	489.697	5.8835	4	1	49.77	5	0.4170530522146416	-2.287175945231436	0.14635416532677198	15	6	ec`PHD@M`ODYqrJIKJJIRJJJKZ[tLFAQUMK]SP@UUUUSUTeTqpaDhmDY@h@@	gJQHA@AIVn@@	gNyHBF@ISmUT@@									6
vzTvPvtldN5u0kd5LN2t0OPmmNFF8YE90LI698#QoN4GkV0Xt2CX5KGF0c1IH1W302WA0J1!BFF0F!180V	CHEMBL456237	ek`T@F@AE@HbRPFdIiAZPNdLbbbRVfTRbTRVdWXxL\rzZv`HJifBXFhb`@@	Fc1ccc(-c2c3cccc(C(F)(F)F)c3nn2Cc2ccc(F)cc2Cl)cc1	5.64	group4-ia	ia	Androgen Receptor	Displacement of radiolabeled mibolerone from human androgen receptor by filter paper assay	2008	ffs@@@DjYVYw~uxXRgAKVjjjjjjjj@@	ffsP@@@PRfYUYgUEE^bWMYjjd@P@F@@@	422.783	5.8024	2	0	17.82	4	-1.3695931616966215	-2.3316487214925	0.8380261983945003	1	1	ek`T@F@AE@HbRPFdIiAZPNdLbbbRVfTRbTRVdWXxL\rzZv`HJifBXFhb`@@											1
<jzOzfJbw1qPjURPW2S1PgBPp93j04Iyp70Y02C0S6XWVDIuX8ZY58VV@GEl0kv1@VWVJG!105k_F4XcGV	CHEMBL4567476	fegpa@NRCjpH`\adTTRRJfdvbbRRXKM^s``rfjjABBHF`@	C[C@](O)(Cn1cc(F)c2ccccc21)C(=O)Nc1ccc(C#N)c(Cl)c1	7.35	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	fbm@@@DjU^}fUz\\ENZjjjjjjh@@	fbmQ@@DB@drljssnjs`iruPPT@`D@@@	371.798	2.8295	5	2	78.05	4	0.7570557697372937	0.42117657872529857	-1.015863918929805	26	16	fcop``AIvzH@ddB[qFxyEEEdeEmIhUDeBf\dklxHBjjih@bqHVP@	eFABH`BL@	eFABP`BL@									12
:yUcTylEjwmCcz6FQn@_hbHqJ4XCj9HFN2Kkt02YSldFF3R090Y14H8WF808P2F28V94G124X@418!FN2V1F	CHEMBL457036	ek`XD@@C@IldTRRbfbRQdJRLrxT\bBRZFhH@Hbbjjk`kCrIHZ@@	CC#C[C@@]1(O)CC[C@@]2(CC)c3ccc(OCc4cccnc4C)cc3CC[C@@H]2C1	6.06	group3-int	int	Androgen Receptor	Binding affinity to human androgen receptor	2009	ffs@@@LdbbbTRnrTRWIBMjqZuUUUUUUUP@@	ffsa@@C@rQQIJJYIKPi\UXOhekPP@PTUTEPb`@	389.537	5.1139	3	1	42.35	4	-0.5968675668339408	-1.5075635331110995	-0.15600742775788268	1	1	ek`XD@@C@IldTRRbfbRQdJRLrxT\bBRZFhH@Hbbjjk`kCrIHZ@@											1
zvyziyznjEve9czYkAz@hj_1rSoXTw9GFsFSssW2i9OZJJ@RNxP70o2NF0880J2G2!18t0412F019$2V10	CHEMBL4571052	ehZXD@@C`ElbbRfbTLRbRRbVarbhXTL|RjfZFZZjjjB`jJnjhnFDIMHYOHeFd@@	CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C	6.04	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay	2019	fag@@@LdbbbbbTRrRJHcR]xjVykUUUUUUUUU@@@	fagA@@@ILkZwKJjmFRtzI^uZtuUUPTEEQDEEST]@@	445.645	5.976	3	1	40.54	2	-0.6881407720359338	-2.0055086186324327	-0.11601123975503905	15	6	ec`PHD@M`ODYqrJIKJJIRJJJKZ[tLFAQUMK]SP@UUUUSUTeTqpaDhmDY@h@@	gJQHA@AIVn@@	gChHA`BOT@@									6
<jrtzdPay1qDiURu9XS0uWB8pW2h!Imp_0X039FO6DWWDA2X4aV590880EnFVRC82WV6O#F4Vb01Y8l0	CHEMBL4571680	fcwpSBNVvkWh`dDRFICdz{HiCEDheUMIlhdmHtuuPPLTuU@AA@I@@	CC(O)(CCc1ccc(N)cc1)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1	6.41	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	fdy@@@DjU^}YVg@qjjjjjj`@@	fdya@@D@RYVUWmUFCEj```@@@@	397.352	2.3222	7	3	121.17	7	2.8503077305057816	0.8130275680500081	-1.6980130559299058	3	1	fcwpSBNVvkWh`dDRFICdz{HiCEDheUMIlhdmHtuuPPLTuU@AA@I@@											1
=xSzhL6wYGEyzwTV2NHT648J12c1_6YK77ZZI9X8021X824X!VBB82Z0EVX0N5c6YFa%F060Va8I0	CHEMBL4572306	fjuQ``MNmdhI@TaJPUHYEEDeIjieHhsdAAUSUS@@@	CC(C)(NC(=O)Nc1ccc(F)c(C(F)(F)F)c1)C(=O)O	5.51	group4-ia	ia	Androgen Receptor	Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay	2016	gFp@DiTvjh@	gFp@DiTt@@@	308.23	1.9113	5	3	78.43	4	0.747692538073173	1.1977914499188569	-2.211006084292716	19	15	dmt@h@BR|VPQ\U`TfYn~fBHb@@	eFABP`BL@	gJPBAHJPt`PAIjj@@			dmUL`DpIV`AIeZyjjf@@						14
:yzy:njUze9czYkAzPhjh1rSoXUw9OFsNSssW2i9OZJJ@RNxP70o2NF0880J2G28018s0412F019$2V10	CHEMBL4576596	ejYXD@@M`IlbbRfRfbTRRTRtNTRRdhXdt\bJFjzZZjjhJBhjzjjjKaaBQRZQrQRi@@	CCN(CC)c1ccc([C@H]2C[C@@]3(C)[C@@H](CC[C@@]3(O)C#CC(C)(C)C)[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@@H]23)cc1	6.58	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay	2019	fag@@@LdbbbbbTRrRJHcR]xjVykUUUUUUUUU@@@	fagA@@@ILkZwKJjmFRtzI^uZtuUUPTEEQTXaQTuGP@	501.752	7.6956	3	1	40.54	5	0.002032516753531527	-3.6097772613471384	0.06359474727285169	15	4	fmAA@E`|^nNQQIYQQJJJJIZ[tX[pRuft\@EUUUSUTeTsbDeKRMOP@	daxH`@`@RUZkj`@	gGXHA`AJejh@									4
xvqUcTqmCA2m1Vh6kOrcZB4HJJ0kLe9!B24VN0219F8FkG408)8!@2#4C213202081N02082c10	CHEMBL458084	fleaC@E^AHHdLRFQRFJIIFJKRuEMTDFUUQHLkH@	N#Cc1ccc([C@H]2CCCC[C@H]2O)cc1C(F)(F)F	7.37	group2-a	a	Androgen Receptor	Antagonist activity against human androgen receptor expressed in human MDA-MB-453 cells assessed as inhibition of dihydrotestosterone-induced effect by luciferase receptor gene assay	2008	dcl@@DjYU_egZjjjh@@	dcl@@DjUg^aWP`hjH@@	269.265	3.6282	2	1	44.02	2	-1.6953436470143308	-0.035386353177121715	-0.49816401177611574	30	3	fleaC@E^AHHdLRFQRFJIIFJKRuEMTDFUUQHLkH@											1
<jzOzfJbw1qPjURPW2S1PgB@p93h043yp78Y03C0R6X1VDGmX0ZX59kV2GEV0Ft5@X_V6G!515kbFBXcGk	CHEMBL4583465	eg`ZDL@ECLikg@`IABPpdLbdLTRRJfdvbbRvTfcPrvuTDFTuUPHEdP^P@	C[C@](O)(Cn1ccc2nc(C#N)ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	6.16	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	fbm@@@DjU^}fUz\\ENZjjjjjjh@@	fbmq@@DBbAIeYUgg]UgASej``hA@H@@	413.358	1.9822	7	2	114.73	5	2.253857478734856	1.1663486031258232	-0.6553297723669427	26	1	eg`ZDL@ECLikg@`IABPpdLbdLTRRJfdvbbRvTfcPrvuTDFTuUPHEdP^P@											1
<jzOzfJbw1qPjURPW2C1PgB@p12h043qK68Y03C0R2X1VDGmX0ZX58V!FEV0Fs5@2_06G#15Vb08XcG0	CHEMBL4584527	elZRDL@ECLog@`IABPpdLbdLTRRJfdvbfRfTRVdtfVaQj``rfjj@B`p@HOH@@	CN(C[C@](C)(O)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1)c1ccc(C#N)c(-c2ccccc2)c1	7.32	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	fak@@@LdbbRRfNRbtRWERLwmUUUUUUUU@@@	fakQ@@DB@drljoZwZjLEK^mTDD@D@@@@@	478.473	4.3403	6	2	100.15	7	2.3235966152971113	-0.9621335799544155	-0.6093383469362834	1	1	elZRDL@ECLog@`IABPpdLbdLTRRJfdvbfRfTRVdtfVaQj``rfjj@B`p@HOH@@											1
xvqUcTqmCA2m1Vh6kOrcZB4HJJ0kLe9!B24VN0219F8FkG408)8!@2#4C213202081N02082c10	CHEMBL458506	fleaC@E^AHHdLRFQRFJIIFJKRuEMTDFUUQHMKP@	N#Cc1ccc([C@@H]2CCCC[C@@H]2O)cc1C(F)(F)F	5.8	group4-ia	ia	Androgen Receptor	Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cells	2008	dcl@@DjYU_egZjjjh@@	dcl@@DjUg^aWP`hjH@@	269.265	3.6282	2	1	44.02	2	-1.6953436470143308	-0.035386353177121715	-0.49816401177611574	30	3	fleaC@E^AHHdLRFQRFJIIFJKRuEMTDFUUQHMKP@											1
<jzOzfJbw1qPjUBPW2S1PgB@p93j043yp70Y03C0J6X1VDInX0ZY58VV2GCW0Fv1@V_c4G!105k_G4XcGV	CHEMBL4585987	fegpa@NRCjpHaladTTRRJfdvbbTQXHmQs``rfjjA`BHF`@	C[C@](O)(Cn1ccc2cccc(F)c21)C(=O)Nc1ccc(C#N)c(Cl)c1	6.63	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	fbm@@@DjU^}fUz\\ENZjjjjjjh@@	fbmQ@@DB@drljssnjs`iruPPT@`D@@@	371.798	2.8295	5	2	78.05	4	0.7570557697372937	0.42117657872529857	-1.015863918929805	26	16	fkpb`AYOyH@dd`rA]xs\\bbbfabrTaaTRTJyIQak`bHjjih@bqHVP@	eFABH`BL@										1
<jzOzfJbw1qPjURPW2S1ugB@p93h043yp78Y03C0R6eWVDGmX4aX59VV2GEWFkt5@X_V6O!515kbFBYcGV	CHEMBL4586748	eohRBLDECLcg@kg`IABPpdCi^{HiCEDdbiiMhhdmeIMFaemjhHLijj`PIbHOH@@	C[C@](O)(Cn1ccc2cc([N+](=O)[O-])ccc21)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	7.06	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	fbm@@@DjU^}fUz\\ENZjjjjjjh@@	fbmQ@@DB@drljssnjs`iruPPT@`D@@@	432.357	2.0494	8	2	123.87	6	2.9010817649209093	1.1225696521653143	-0.4857996273536308	26	16	fcop``AIvzH@ddB[qFxyEEEdeEmIhUDeBf\dklxHBjjih@bqHVP@	gJPBAHJPt`PAIjj@@			gChhhE`BRnRYh@							12
<jzOzfJbw1qPjUBPW2S1PgB@p93j043yp70Y02C0J6X1VDGmX0aY58VV2GCW0Fv1@VWV4G08105kbF4XcGV	CHEMBL4590504	fegpa@NRCjpHb\adTTRRJfdvbbRrXKM^c``rfjjA@bHF`@	C[C@](O)(Cn1ccc2ccc(F)cc21)C(=O)Nc1ccc(C#N)c(Cl)c1	7	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in HEK293 cells assessed as inhibition of R1881-induced receptor transactivation after 24 hrs by luciferase reporter gene assay	2019	fbm@@@DjU^}fUz\\ENZjjjjjjh@@	fbmQ@@DB@drljssnjs`iruPPT@`D@@@	371.798	2.8295	5	2	78.05	4	0.7570557697372937	0.42117657872529857	-1.015863918929805	26	16	fcop``AIvzH@ddB[qFxyEEEdeEmIhUDeBf\dklxHBjjih@bqHVP@	eFABH`BL@		eFABP`BL@								12
?vzUze9czvmAzPjjh1rSoXUw9OFsNSusY2i9OZJJ@TNxP70o2NN4N9VJ2I28018s0413F01901V02V10	CHEMBL4591353	enSTD@@MjPIlbbRfRfbTRRTRtNTRRdShXdt\bJFjzaiZZjjhJBhjzjjjhkaaBQRZQrQRi@@	CN1CCN(c2ccc([C@H]3C[C@@]4(C)[C@@H](CC[C@@]4(O)C#CC(C)(C)C)[C@@H]4CCC5=CC(=O)CC[C@@H]5[C@@H]34)cc2)CC1	6	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor in human LNCAP cells harboring firefly luciferase gene after 20 hrs by One-Glo luciferase reporter gene assay	2019	eglP@@@LdbbbbbTRrRJNtRPadcgaRSVUQuuUUUUUUUUUUU@@@	eglTH@@Ak`LbbRfRfbTRRRUTRUCDfcdQWUSQusSUUUAPTUUUETLHRJSRNP@	528.778	6.765	4	1	43.78	3	0.16796937788264146	-2.7643032165295653	0.14779397932939908	3	2	enSTDH@HFKdPGGHhdlhdlhheEEEDmIgeiJFMCDjfem`Sojjh@JjjjfjjvjbjxlSbBTRReTzP@	eFBH@c@@										2
LFuF!818V$24F8#N0H%212022V5!83+V!G61#98V#F#82$4#5!V!	CHEMBL462022	fbuaB@Ln@DYHhhhhdkLdYVMz`@b@bk@@@	COc1cc(Sc2c(C)cc(C)cc2C)ccc1C#N	7.41	group2-a	a	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells	2009	dk\@@DjU^ukmNjjjj`@	dk\@`@BDifUWGUN`@@@@@	283.394	4.278	2	0	58.32	3	-1.5390590488645217	-0.4804606684748211	0.6777022611586426	60	9	fle`@`D`BVNL`cwcdTRTVrbRaUNNC@DU@DV@@@	eFBH@c@@	eMJA@Hz@	eFBH@c@@								4
mHPF0F818!k!24FN2!N0H040F021!22Z58083808(V#4$1@V#J82102(2180c!	CHEMBL462025	fbu`@`L`B@rDYALadbbbbRQaTbd[Uj@B@Bjl@@@	Cc1ccccc1Sc1ccc(C#N)c(C(F)(F)F)c1	6.65	group3-int	int	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells	2009	dk\@@DjU^ukmNjjjj`@	dk\@`@BDifUWGUN`@@@@@	293.311	4.5085	1	0	49.09	3	-1.890923802826033	-0.8443571897839196	0.583182307998583	60	9	fdy`@`H`BVNH`awcdTRTJTRTJirwh@b`BK@@@	eFBH@c@@	gJPBAHJPt`PAIjj@@									4
qHuF0F818V0k!24FN2!N0H040F02120H2Z58083809%20V!F6$1@V#J82102$4!2180c!	CHEMBL462026	fjma@`B|@DQdDrFYCIEEEDdeiUHiVtz`B@HJjp@@	COc1ccccc1Sc1ccc(C#N)c(C(F)(F)F)c1	7.25	group2-a	a	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells	2009	dk\@@DjU^ukmNjjjj`@	dk\@`@BDifUWGUN`@@@@@	309.31	4.0946	2	0	58.32	4	-1.2354145285041962	-0.5871385111513449	0.7454978605836962	60	9	fdy`@`H`BVNH`awcdTRTJTRTJirwh@b`BK@@@	eMJA@Hz@	gJPBAHJPt`PAIjj@@									4
mHPF0F818!k!24FN2!N0H040F021!22Z58083808(V#4$1@V#J82182(2180c!	CHEMBL462027	fjm`@`B`BHrBYCLadbbbbbRlJdTkF]P@Q@EUX@@@	Cc1cccc(C)c1Sc1ccc(C#N)c(C(F)(F)F)c1	6.39	group3-int	int	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells	2009	dk\@@DjU^ukmNjjjj`@	dk\@`@BDifUWGUN`@@@@@	307.338	4.8524	1	0	49.09	3	-1.8332356605412146	-1.103108513716756	0.6080557268012479	60	9	fle`@`D`BVNL`cwcdTRTVrbRaUNNC@DU@DV@@@	eFBH@c@@	gJPBAHJPt`PAIjj@@									4
mHPF0F818!k!24FN2!N0H040F021!22Z58083808(V#41#1@V#J82182(2180c!	CHEMBL462234	ff}`@`J`BDrFY@ladbbbbbRlrTfeXsj@BH@jjp@@	Cc1cc(C)c(Sc2ccc(C#N)c(C(F)(F)F)c2)c(C)c1	5.87	group4-ia	ia	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells	2009	dk\@@DjU^ukmNjjjj`@	dk\@`@BDifUWGUN`@@@@@	321.365	5.1963	1	0	49.09	3	-1.7755477014029755	-1.3618600111308528	0.6329290978727824	60	9	fle`@`D`BVNL`cwcdTRTVrbRaUNNC@DU@DV@@@	eFBH@c@@	gJPBAHJPt`PAIjj@@	eFBH@c@@								4
;Q18sG9g4#2TF8F02N0H2#1292!2V1!821$12#V!G@8#88#8+4#4!V!	CHEMBL462663	f`aaB@OR@DYHhddihe^JhHJJk@@@	COc1cc(SCCC(C)C)ccc1C#N	5.76	group4-ia	ia	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells	2009	gFp@DiTvjh@	gFp@DiTt@@@	235.35	3.5265	2	0	58.32	5	-1.4396348443048697	-0.09218296418419819	0.6469444145521013	19	15	dmt@h@BR|VPQ\U`TfYn~fBHb@@	gNpD@DH@RgZjh@		eMJA@Hz@		eMbA@Dg`@						14
vyQG0FNG804k!2BFN2!80H040F129#2408083908!1$V*@#8482102(2080c!	CHEMBL462664	f`a`@`O@BCREiAtadbbRRaTbyJ``bjl@@	CCCSc1ccc(C#N)c(C(F)(F)F)c1	7.96	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in human MDA-MB453 cells by luciferase reporter gene assay	2009	gFp@DiTvjh@	gFp@DiTt@@@	245.267	3.7721	1	0	49.09	4	-1.9507472006361928	-0.3443329470801558	0.5263960797506915	19	15	dmt@h@BR|VPQ\U`TfYn~fBHb@@	gJPD@DH@Rgj`@		gJPBAHJPt`PAIjj@@		eMbA@Dg`@						14
vzUG1FsG904k!2DFN20280H040F129#2408083908!1$V$8$@#8482102(2080c!	CHEMBL462665	fhq`@`@`BKRCiCt`eLjmkWrUAAEUV@@@	CCCCSc1ccc(C#N)c(C(F)(F)F)c1	6.08	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in human MDA-MB453 cells by luciferase reporter gene assay	2009	gFp@DiTvjh@	gFp@DiTt@@@	259.294	4.2265	1	0	49.09	5	-1.739721002442145	-0.7903351220766033	0.5779524399606647	19	15	dmt@h@BR|VPQ\U`TfYn~fBHb@@	gGPD@DH@RgZj@@		gJPBAHJPt`PAIjj@@		eMbA@Dg`@						14
zxzrbbOSdm4R5J6igB8_2N2PVWN1934243kV58VF10Z8601V0YWVWVFLNFV095V0V11204c45020L!4K0m8O0	CHEMBL4634960	ffcQb@FNeXhIAIe[{fWUj\|GMX@bZYhB@@@@	N=c1oc2c(O)cccc2cc1C(=O)Nc1cccc(F)c1	5.48	group4-ia	ia	Androgen Receptor	Antagonistic activity at AR in human 22Rv1 cells assessed as reduction in cell number by CCK8 assay	2020	fbm@@@LdbbbVrTRRHi^BgMUUUUUUT@@	fbmP`@DJAIIefYUw_SkASejdI``@@@@	298.272	1.6798	5	3	82.41	2	0.45308344968403635	1.6447262731135972	-2.2706816204303433	8	8	fakQc@IAuyh@dgcqqrJJKPiSQQKIJLEEM^pPQSSM@P@@@		eFABP`BL@									8
zxzrbbOSdm4R5J6igB8_2N2PVWN1936243kV58VF10Z86!V0YW0WVFLNFV095W0V31204c45020L#K0m0O0	CHEMBL4640248	ffcQb@BNeXhHcHhhdmCEDldhpW`ykAACSM@P@@@	N=c1oc2c(O)cccc2cc1C(=O)Nc1ccccc1Cl	5.48	group4-ia	ia	Androgen Receptor	Antagonistic activity at AR in human 22Rv1 cells assessed as reduction in cell number by CCK8 assay	2020	fbm@@@LdbbbVrTRRHi^BgMUUUUUUT@@	fbmP`@DJAIIefYUw_SkASejdI``@@@@	314.727	2.185	5	3	82.41	2	0.5159685186206624	1.2800058842553494	-2.240972395633143	8	8	fakQc@IAuyh@dgcqqrJJKPiSQQKIJLEEM^pPQSSM@P@@@	eFABH`BL@										8
zxzrbbOSdm4R5J6iwB8_XN2PVWN193C243kV58VF31o86!V0YW0WVFLNFc095VFV9120Zc45020L#K0m0O0	CHEMBL4641012	fnsQ`@DJAHjSKLrknk^gVBfkUHSA@ED@@@	CCc1ccc(NC(=O)c2cc3cccc(O)c3oc2=N)cc1	5.44	group4-ia	ia	Androgen Receptor	Antagonistic activity at AR in human 22Rv1 cells assessed as reduction in cell number by CCK8 assay	2020	fbm@@@LdbbbVrTRRHi^BgMUUUUUUT@@	fbmP`@DJAIIefYUw_SkASejdI``@@@@	308.336	2.3385	5	3	82.41	3	0.6336272851300482	1.0906055873161586	-2.2245816284754003	8	8	fakQc@IAuyh@dgcqqrJJKPiSQQKIJLEEM^pPQSSM@P@@@			eMBD@ch@								8
zxzrbbOSdm4R5J6igB8_XN2PVWN193424IkV58VF10o96!V0YW0WVFLsFV095W0V11204c45020L#K0m0O0	CHEMBL4642187	fnsQ`@DJAJnQQJJJIQKIYFZ|zIVmTaLQAA@@@@	CCc1ccccc1NC(=O)c1cc2cccc(O)c2oc1=N	5.09	group4-ia	ia	Androgen Receptor	Antagonistic activity at AR in human 22Rv1 cells assessed as reduction in cell number by CCK8 assay	2020	fbm@@@LdbbbVrTRRHi^BgMUUUUUUT@@	fbmP`@DJAIIefYUw_SkASejdI``@@@@	308.336	2.3385	5	3	82.41	3	0.6336272851300482	1.0906055873161586	-2.2245816284754003	8	8	fakQc@IAuyh@dgcqqrJJKPiSQQKIJLEEM^pPQSSM@P@@@	eMBD@ch@										8
zxzrbbOSdm4R5J6igB8_2N2PVWN1934243kV58VF10Z86!V0YW0WVFLNFV095W0V11204c45020L#K0m8O0	CHEMBL4642678	ffcQb@BNeXhICHhhdmCEDldhpW`ykAACSM@P@@@	N=c1oc2c(O)cccc2cc1C(=O)Nc1ccccc1F	5.36	group4-ia	ia	Androgen Receptor	Antagonistic activity at AR in human 22Rv1 cells assessed as reduction in cell number by CCK8 assay	2020	fbm@@@LdbbbVrTRRHi^BgMUUUUUUT@@	fbmP`@DJAIIefYUw_SkASejdI``@@@@	298.272	1.6798	5	3	82.41	2	0.45308344968403635	1.6447262731135972	-2.2706816204303433	8	8	fakQc@IAuyh@dgcqqrJJKPiSQQKIJLEEM^pPQSSM@P@@@	eFABP`BL@										8
zxzrbbOSdm4R5J6iwB8_2N2PVWN193B243kV58VF31Z86!V0YW0WVFLNFV095V0V9120Zc45020L#K0m8O0	CHEMBL4644092	ffcQb@NNeXhIAIe][fWUjL|GMX@JZYhB@@@@	N=c1oc2c(O)cccc2cc1C(=O)Nc1ccc(F)cc1	5.19	group4-ia	ia	Androgen Receptor	Antagonistic activity at AR in human 22Rv1 cells assessed as reduction in cell number by CCK8 assay	2020	fbm@@@LdbbbVrTRRHi^BgMUUUUUUT@@	fbmP`@DJAIIefYUw_SkASejdI``@@@@	298.272	1.6798	5	3	82.41	2	0.45308344968403635	1.6447262731135972	-2.2706816204303433	8	8	fakQc@IAuyh@dgcqqrJJKPiSQQKIJLEEM^pPQSSM@P@@@			eFABP`BL@								8
zxzrbbOSdm4R5J6igB8_XN2PVWN1934243kV58VF10o8601V0YWVWVFLNFV095V0V11204c45020L!4K0m0O0	CHEMBL4646593	fnsQ`@DJAJjSKLrkmnvgVCekUHSAAAP@@@	CCc1cccc(NC(=O)c2cc3cccc(O)c3oc2=N)c1	5.24	group4-ia	ia	Androgen Receptor	Antagonistic activity at AR in human 22Rv1 cells assessed as reduction in cell number by CCK8 assay	2020	fbm@@@LdbbbVrTRRHi^BgMUUUUUUT@@	fbmP`@DJAIIefYUw_SkASejdI``@@@@	308.336	2.3385	5	3	82.41	3	0.6336272851300482	1.0906055873161586	-2.2245816284754003	8	8	fakQc@IAuyh@dgcqqrJJKPiSQQKIJLEEM^pPQSSM@P@@@		eMBD@ch@									8
qHuF0F818V0k!24FN2!80H040F0212022448!3808(V!F4$8@V#J821020V2$20N0c!	CHEMBL464764	fbuaC@EFAHHdLRFQRFJIIEQIRVhij``r`@`@@	Cc1cccc(Oc2ccc(C#N)c(C(F)(F)F)c2)c1	5.78	group4-ia	ia	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells	2009	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	277.244	4.083	2	0	33.02	3	-1.9691924160779724	-0.5260112622024996	0.6021670642055311	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@					gJPBAHJPt`PAIjj@@	eFBH@c@@		eMbA@Dg`@			34
zxzrbbOSdm4R5J6iwB8_2N2PVWN193C243kV58VF31Z86!V0YW0WVFLNFV095V0V9120Zc45020L#K0m0O0	CHEMBL4648793	ffcQ`@DJAHjSKLrknkZ]XJZmTaLD@T@@@@	Cc1ccc(NC(=O)c2cc3cccc(O)c3oc2=N)cc1	5.62	group4-ia	ia	Androgen Receptor	Antagonistic activity at AR in human 22Rv1 cells assessed as reduction in cell number by CCK8 assay	2020	fbm@@@LdbbbVrTRRHi^BgMUUUUUUT@@	fbmP`@DJAIIefYUw_SkASejdI``@@@@	294.309	1.9229	5	3	82.41	2	0.42077552779846683	1.5132831994545757	-2.275935784071233	8	8	fakQc@IAuyh@dgcqqrJJKPiSQQKIJLEEM^pPQSSM@P@@@			eFBH@c@@								8
LFuF!818V$24F8#N0H&120H2V5#3!1%20V!G61#90V#F&V204#1!V!	CHEMBL464929	fdy``@H`ydbbbbRRqRe[Sj@H@`k@@@	COc1cc(C#N)ccc1Oc1ccc(C)cc1	5.28	group4-ia	ia	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells	2009	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	239.273	3.1647	3	0	42.25	3	-1.7327038438950966	0.35538813703787525	0.6469402023833175	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@	eMJA@Hz@							eMbA@Dg`@	eFBH@c@@		34
qHuF0F818V0k!24FN2!80H040F0212022448!3808(V!F4$8@V#J821020V2$20N0c!	CHEMBL465539	fbuaC@EFAHHdLRFQRFJIIEQIZVhij``r`@`@@	Cc1ccc(Oc2ccc(C#N)c(C(F)(F)F)c2)cc1	5.27	group4-ia	ia	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells	2009	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	277.244	4.083	2	0	33.02	3	-1.9691924160779724	-0.5260112622024996	0.6021670642055311	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@					gJPBAHJPt`PAIjj@@			eMbA@Dg`@	eFBH@c@@		34
qHuF0F818V0k!24FN2!N0H040F02120H2Z58!3809%20V!F6$9@V#J821820V204!21N0c!	CHEMBL469333	fncac@EFBdD`bPqHYEHXhddUEEDeKVZuPPYPQDP@@@	COc1cccc(OC)c1Oc1ccc(C#N)c(C(F)(F)F)c1	6.8	group3-int	int	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system	2009	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	323.269	3.5991	4	0	51.48	5	-0.600485564438325	-0.270325342038873	0.9516716383945704	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@			eMJA@Hz@	eMJA@Hz@	gJPBAHJPt`PAIjj@@			eMbA@Dg`@			34
qHuF0F818V0k!24FN2!N0H040F02120H2Z58!3809%20V!G61#9@V#J821020V204!21N0c!	CHEMBL469334	ff}`c@EFBBPQHXdLbdLTRRJbbRLmIKUAAeAAD@@@	COc1cc(C)ccc1Oc1ccc(C#N)c(C(F)(F)F)c1	6.52	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in human MDA-MB-231 cells assessed as inhibition of DHT-induced response	2009	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	307.27	4.013	3	0	42.25	4	-1.2559949994713175	-0.5275439075027611	0.7893560355933095	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@			eMJA@Hz@		gJPBAHJPt`PAIjj@@			eMbA@Dg`@	eFBH@c@@		34
qHuF0F818V0k!24FN2!N0H040F02120H2Z58!3809%20V!F6$9@V#J821020V204!21N0c!	CHEMBL469380	fjm`c@EFBBPQHXdLbdLTRRJbbReiIZhHLhHH@@@	COc1ccccc1Oc1ccc(C#N)c(C(F)(F)F)c1	7.08	group2-a	a	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system	2009	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	293.243	3.6691	3	0	42.25	4	-1.3136829698272683	-0.268792553413638	0.7644826657642836	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@			eMJA@Hz@		gJPBAHJPt`PAIjj@@			eMbA@Dg`@			34
yPuG0FcG8V0k!24FN20VN0H040F03120H2Z58!38F9%@1V!F6V#9@X#J821020V2040425N0c!	CHEMBL469602	ff}aC@EFAHHdLRFQRFJIIEQQIFVdyj``r`HJ@@@	CCCc1ccccc1Oc1ccc(C#N)c(C(F)(F)F)c1	6.7	group3-int	int	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system	2009	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	305.298	4.953	2	0	33.02	5	-1.5453144493346316	-1.3946909060123904	0.7050775787688283	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@			gC`HL@IST@@		gJPBAHJPt`PAIjj@@			eMbA@Dg`@			34
qHuF0F818V0k!24FN2!N0H040F0212022Z58!3808%20V!G6$9@V#J821020V204!21N2c10	CHEMBL469982	fjm`c@EFBBPQHXdLbdLTRRJbbreiNZhHLhHB@@@	Cc1ccc(O)c(Oc2ccc(C#N)c(C(F)(F)F)c2)c1	6.09	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in human MDA-MB-231 cells assessed as inhibition of DHT-induced response	2009	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	293.243	3.7373	3	1	53.25	3	-1.0224228728148657	-0.12215683503113288	-0.3199935542646603	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@			eFJB@Hp@		gJPBAHJPt`PAIjj@@		eFBH@c@@	eMbA@Dg`@			34
qHuF0F818V0k!24FN2!N0H040F02120H2Z58!3809%20V!F6$9@V#J821820V204!21N0c!	CHEMBL469983	ff}```JdDBPSHYdBrBSLk\{vtld{tDE@PEUX@@@	COc1cccc(F)c1Oc1ccc(C#N)c(C(F)(F)F)c1	6.8	group3-int	int	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system	2009	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	311.233	3.7699	3	0	42.25	4	-1.2236870775857478	-0.39610083384373973	0.7946101992341988	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@	eFABP`BL@	eMJA@Hz@				gJPBAHJPt`PAIjj@@			eMbA@Dg`@		34
LFuF!818V$24F8#N0H%232022V5#2+V!G6$98V!2F&V204#5F0V!	CHEMBL470204	fhiaB@NRADYEEDdbhhdpW`pPYPD@@@@	Cc1ccccc1Oc1ccc(C#N)c(Cl)c1	7.52	group2-a	a	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system	2009	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	243.692	3.8407	2	0	33.02	2	-2.2930201273947373	-0.13510785679392576	0.5195880382362942	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@			eFBH@c@@		eFABH`BL@			eMbA@Dg`@			34
yLuG0F8G8V4k!24FN2!N0H040F13120H2Z58083809%21V!F6!V09@V#J821020V2040421N0c!	CHEMBL470395	ff}a@`Jl@DIdLrAYAJYYwm[ZQJ]z`hH@Bjl@@@	CCSc1ccccc1Oc1ccc(C#N)c(C(F)(F)F)c1	6.26	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in human MDA-MB-231 cells assessed as inhibition of DHT-induced response	2009	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	323.337	4.7133	2	0	58.32	5	-1.0321187244694714	-1.1319093651674346	0.7979104633201376	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@	gC`D@DH@Rfh@					gJPBAHJPt`PAIjj@@			eMbA@Dg`@		34
qHuF0F818V0k!24FN2!N0H040F0232022Z58!3808%20V!F6$9@V!2J821020V204!21N0c!	CHEMBL470629	fbua@`LdADAdHrBYAIfU{Vve`cV```@Jjp@@	N#Cc1ccc(Oc2ccccc2Cl)cc1C(F)(F)F	6.91	group3-int	int	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system	2009	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	297.663	4.3451	2	0	33.02	3	-1.8739941105699194	-0.7592921686434168	0.6371321085339869	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@	eFABH`BL@					gJPBAHJPt`PAIjj@@			eMbA@Dg`@		34
qHuF0F818V0k!24FN2!80H040F0232022448!3808(V!F4$8@V!2J821020V2$20N0c!	CHEMBL470841	fbua@`LlADAdHrBYAIe[yVvfgCV`BH@Jjp@@	N#Cc1ccc(Oc2cccc(Cl)c2)cc1C(F)(F)F	5.57	group4-ia	ia	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system	2009	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	297.663	4.3451	2	0	33.02	3	-1.8739941105699194	-0.7592921686434168	0.6371321085339869	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@					eFABH`BL@	gJPBAHJPt`PAIjj@@			eMbA@Dg`@		34
qHuF0F818V0k!24FN2!80H040F0232022448!3808(V!F4$8@V!2J821020V2$20N0c!	CHEMBL470842	fbua@`L|ADAdHrBYAIe]YVvfcCV`@h@Jjp@@	N#Cc1ccc(Oc2ccc(Cl)cc2)cc1C(F)(F)F	5.18	group4-ia	ia	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system	2009	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	297.663	4.3451	2	0	33.02	3	-1.8739941105699194	-0.7592921686434168	0.6371321085339869	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@						gJPBAHJPt`PAIjj@@		eFABH`BL@	eMbA@Dg`@		34
qHuF0F818V0k!24FN2!N0H040F0212022Z58!3808(V!F6$9@V#J821820V204!25N0c!	CHEMBL471644	fjmaC@EFAHHdLRFQRFJIIEQQQRtdmTDFTAD@@@	Cc1cccc(C)c1Oc1ccc(C#N)c(C(F)(F)F)c1	8	group1-p	p	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system	2009	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	291.271	4.4269	2	0	33.02	3	-1.911504273793154	-0.7847625861353361	0.627040483008196	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@			eFBH@c@@	eFBH@c@@	gJPBAHJPt`PAIjj@@			eMbA@Dg`@			34
qHuF0F818V0k!24FN2!N0H040F0212022Z58!3808%20V!F6$9@V#J821020V204!21N2c10	CHEMBL471645	fbu`c@EFBBPQHXdLbdLTRRJbbtmIsUAAeA@@@@	N#Cc1ccc(Oc2ccccc2O)cc1C(F)(F)F	7.01	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in human MDA-MB-231 cells assessed as inhibition of DHT-induced response	2009	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	279.217	3.3934	3	1	53.25	3	-1.0801057004138266	0.13659089766001262	-0.3448653171769595	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@			eFJB@Hp@		gJPBAHJPt`PAIjj@@			eMbA@Dg`@			34
qHuF0F818V0k!24FN210N0H040F021202HZ58!38086&V!F6$9@V!1J@21V20V204!25N0c!	CHEMBL471876	fi{aC@EFAHHdLRFQRFJIIEQQJKKRtfoQuPPYPP@@@@@@	N#Cc1ccc(Oc2ccccc2-c2ccccc2)cc1C(F)(F)F	6.37	group3-int	int	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system	2009	flu@@@LdbbbRRqfREiUhijjjjjjj@@	fluA@@@YHhhhdeElcIvoQSPA@@@@@@@	339.315	5.3983	2	0	33.02	4	-1.545663445743246	-1.6677042867587126	0.737265551693235	1	1	fi{aC@EFAHHdLRFQRFJIIEQQJKKRtfoQuPPYPP@@@@@@											1
<jzSzfJbw1qujUTPV2C1ugBPp92h04IqK79Y03C2R4Y1VDIuX8ZX5Nk28GEk0kt58aW0LF$4Vb08YgGV	CHEMBL4739997	fmgh``DDDyZk@qNr@yB\adTRbVtfaTRTrdQFYKMS]Tt@EU\Pd`@	C[C@](O)(Cn1cc(C#N)c(Br)n1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	6.74	group3-int	int	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	f`q@@@DjU^}eiqwjjjjjj@@	f`qq@@DBtAIeYUgUV]yj``hT`@@	442.194	1.5193	7	2	114.73	5	2.427492803232473	1.337687407937791	-0.6102930194084586	29	22	ff}I@`DDMWP@fdCIqSxyEDhbiieDeBbLcfZfjZ@Hn@@@	eMJB@Df`@	gJPBAHJPt`PAIjj@@	eFACD`BL@	eMbA@Dg`@							21
<jzSzfJbw1qujUTPV2C1ugBPp92h04IqK79Y03C2R4Y1VDIuX8ZX58k28GEk0kt58aW0LF$4Vb08YcGV	CHEMBL4740374	fikH``DDLLV`REYAlavPrJIKJSPjIJYRHeHiffjf`@jkbGD@	C[C@](O)(Cn1ccc(F)n1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	6.66	group3-int	int	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	f`q@@@DjU^}eiqwjjjjjj@@	f`qq@@DBtAIeYUgUV]yj``hT`@@	356.278	1.3133	6	2	90.94	5	1.3573109097350258	1.484770326307587	-0.9018406496675494	29	22	ff}I@`DDMWP@fdCIqSxyEDhbiieDeBbLcfZfjZ@Hn@@@	eMJB@Df`@	gJPBAHJPt`PAIjj@@	eFABP`BL@								21
zrUl7lOKdF4w0F2DTN2W282u040F12C042m448X839V8091V#VWX4J8!10EV!8582W06d!2#708VcF0	CHEMBL4740742	fe{Qb`MS`aP@at`vP{HCdLddLRRbJTrTrdTcIrmA@qP@UU`@@	N#Cc1ccc(NC(=O)CS(=O)(=O)c2ccc(F)cc2)cc1C(F)(F)F	6.61	group3-int	int	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	fle@@@LddTQRbqbRdZJZjjjjjj@@	fleab@MPPh@QddabRTQtRTcQRmA@q@@@@@	386.324	2.3294	5	1	95.41	5	1.018750967652509	0.6883362801597093	0.16245195914660931	1	1	fe{Qb`MS`aP@at`vP{HCdLddLRRbJTrTrdTcIrmA@qP@UU`@@											1
:UvztU:JjxnyvzUyQVHvvziCAU3mB5Z7fKE6njIEbT9dIeDIqbkh0CBg2YoEcX1s5xXYHbl50m1GFj8V18!	CHEMBL4740944	fasPR`LB`ce`AAYBl`vP{HYIHYhiLcLeLiARbeZiji@Bjh@@	CC1(C)C(=O)N(c2ccc(F)c(C(F)(F)F)c2)C(=O)N1S(C)(=O)=O	5.2	group4-ia	ia	Androgen Receptor	Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay	2016	dk\@@DjYVYxqVjjjj`@	dk]D@DpIRYeg^ftvj`PH@@	368.306	2.0757	6	0	83.14	2	0.2315479839468648	1.3148617537381664	1.197197324006741	33	14	fhiP``AFuX@RRA|xa|TfYwf[v\LzB@jYjH@@	gJPdH`DD@cuh@	eMBH@RZ@	gJPBAHJPt`PAIjj@@	eFABP`BL@							14
<jzSzYJbw1qufEDPV2C1sg8Pp90a04IoK713!B2R4Y1VDIuX8ZX58k28G1k0kn10Z10JF$4VV!Y8Gk	CHEMBL4741021	fbuHa@D\]zV`QFYAIeW[ky^cHi`@ijjeb`j@@	C[C@](O)(Cn1cc(F)cn1)C(=O)Nc1ccnc(Cl)c1	5.61	group4-ia	ia	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	f`q@@@DjU^}eiqwjjjjjj@@	f`qI@@DBuXBSJrkNjl{sUAAPi@@@	298.704	-0.0195	6	2	80.04	4	0.7829735595514707	2.540353453624361	-1.0573757035254219	29	1	fbuHa@D\]zV`QFYAIeW[ky^cHi`@ijjeb`j@@											1
<jzSzfJbw1qvjUTPV2C1ugBPp92h04IqK79Y03CHR4YGVDIuX0ZXK8k28GUk1Ft58aY0LF$4Vb08YcGV	CHEMBL4741569	fcwHa`EFrUpPRBICDaNPWH[dLbdLTRRJfdvbRtdmM{UAAeMUTmTTOP@	C[C@](O)(Cn1ccc(C(F)(F)F)n1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	6.69	group3-int	int	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	f`q@@@DjU^}eiqwjjjjjj@@	f`qq@@DBtAIeYUgUV]yj``hT`@@	406.285	1.7634	6	2	90.94	6	1.7580165977295092	0.9079281841420499	-0.7911022629223726	29	22	ff}I@`DDMWP@fdCIqSxyEDhbiieDeBbLcfZfjZ@Hn@@@	eMJB@Df`@	gJPBAHJPt`PAIjj@@	gJPBAHJPt`PAIjj@@								21
<jzSzfobw1rujUTPWXC1ugBPp92h04MqK79f03CHR4Y1VDIyX0aX5Nk@8GEVFFt5@aW0LF#FJVb0@YcGV	CHEMBL4741767	elZZBL@ECLbgg@`XPIABPpdLbdLTRRJfdvbVTRVRfdtZzNnj``rfjjV@BfbHOH@@	COC(=O)Nc1ccc(-c2cnn(C[C@](C)(O)C(=O)Nc3ccc(C#N)c(C(F)(F)F)c3)c2)cc1	6.08	group3-int	int	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	ffc@@@LdbbRRqRbtRWEBdVmUUUUUUUP@@	ffcq@@DBtCHhdhdeEdUDdjsoEjuPPTK@@P@@	487.437	2.4272	9	3	129.27	8	4.09816897909737	0.5961399899371107	-1.3254171280577351	9	6	eohRDB@EMDggH`GGZPNdKiCHhdlhediMBhdieHjFEMNah@JVjih@JjrHKD@@	gGXhLEPAIeZh@										5
<jzxzfRbw1qujUTPV2C1ugRPp92h04IqK79Y03CHR4Y1VDIuX0ZXKNk28GUk0Ft58iW0LF#F4Vb08YcGV	CHEMBL4742694	fmgIc@EFrUpY`dDRFICHiCEDdbiiMheeIZ[vjBCJZjiYbaz@@	CC(=O)c1cnn(C[C@](C)(O)C(=O)Nc2ccc(C#N)c(C(F)(F)F)c2)c1	6.12	group3-int	int	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	f`q@@@DjU^}eiqwjjjjjj@@	f`qq@@DBtAIeYUgUV]yj``hT`@@	380.325	0.7323	7	2	108.01	6	2.189161869662161	1.8701044691980038	-0.7071969624371193	29	22	ff}I@`DDMWP@fdCIqSxyEDhbiieDeBbLcfZfjZ@Hn@@@	eMJB@Df`@	gJPBAHJPt`PAIjj@@		gCaHA`AIf`@							21
=xOzfobwbMQzUwQ_H9vTDB8K1mC_Z7vKDDffIQVRDkYeDFobpj6SCZ3YkEVmhs5tXYmbK10kGGFr0c0c!	CHEMBL4743145	eod\LB@DLKeCg`@`ZPfdEiCHhhhheEDlcMLiDeZN@ldjmcfjhDJ@BJjkXH@@	CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc2c(c1)COC2=O	6.83	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay	2021	fnk@@@DjYVV}V}~ZDkpZmjjjjjjjjh@@	fnkQb@DXUUh@cHhhhheLlehTj\]DJRuZj`P@@jXH@@	445.42	3.1018	6	0	105.73	3	1.1112370728189933	0.4569390075601555	1.413042772934983	4	1	eod\LB@DLKeCg`@`ZPfdEiCHhhhheEDlcMLiDeZN@ldjmcfjhDJ@BJjkXH@@											1
:UvztOzfJbwYLQzUwQlH9vTDB8K1nCCZ7vMDDYfIQVRDkYeDFobpj6SCg2YkEVmds5tXYmbG18oGGFr0c0c!	CHEMBL4743302	e`\RDB@DLCkeG`@`ZPfdEiCHhhhheEDlcMLiDeUQpEdeUl\uU@aP@QUU[PP@@	CN1Cc2cc(N3C(=S)N(c4ccc(C#N)c(C(F)(F)F)c4)C(=O)C3(C)C)ccc2C1=O	6.23	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay	2021	fnk@@@DjYVV}V}~ZDkpZmjjjjjjjjh@@	fnkpb@DXjih@cHhhhheLlehTj\]DJRuZj`P@@jXH@@	458.463	3.2112	6	0	99.74	3	1.0784343032481727	0.298867942225311	1.4198278377738465	4	1	e`\RDB@DLCkeG`@`ZPfdEiCHhhhheEDlcMLiDeUQpEdeUl\uU@aP@QUU[PP@@											1
:UvztO:JEwWLtzUwHkHQvTaC8U0XC9g3fMA43VlQZP0k1eDIk7p12C4g2YkA8X1k4cX3FYF!V#n0VV8F0	CHEMBL4743529	fjmP``CA}DD`JPeHJdLbbbRduTTTlYpJXBBjjYjH@@	CC1(C)NC(=O)N(Cc2ccc(F)c(C(F)(F)F)c2)C1=O	5.38	group4-ia	ia	Androgen Receptor	Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay	2016	dg|@@DjU^yjySjjjjj@@	dg}D@DpNrJJIHqIDqvuTp@P@@	304.242	2.1271	4	1	49.41	3	-0.7057108948594193	0.8977100470977116	-0.2315156377725562	1	1	fjmP``CA}DD`JPeHJdLbbbRduTTTlYpJXBBjjYjH@@											1
=xOzfqbwbMQzUwQ_m9vTDg8K1nC_ZMvKDDffIQkSDkYeDFobpj6ShZ3fkEkmhs5tXYmbK18o1GFr0c0c!	CHEMBL4745209	e`\\LB@DLKeGo`@`ZPfdEiCHhhhheEDlcMLiDeYQpEdeT]|uU@aP@QUU[PP@@	CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc2c(c1)CCOC2=O	6.71	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay	2021	fa{@@@LdbbbRnbbVTrSEBdxK^uUUUUUUUU@@@	fa{Qb@DXTwh@cHhhhheLlehTiSchaSWkUTB@@ESPP@@	459.447	3.8273	6	0	105.73	3	1.150970568827045	-0.03121070284633791	1.439904836245895	1	1	e`\\LB@DLKeGo`@`ZPfdEiCHhhhheEDlcMLiDeYQpEdeT]|uU@aP@QUU[PP@@											1
>U:rzx:Q;UbHfvUihfr5mx_b7zKDEvjQUYRikbeTGqbrjaSCo3YkEcqxs5taYmbK1VkIGGz0c0c0F	CHEMBL4745855	e`RRBB@DLOGeLko`@bZPVdMiCHhhhheEDledhUHdkQpydDTdt]\uU@aPADUUVtD@@@	N#Cc1ncc(N2C(=O)C3(COC3)N(c3ccc4c(c3)COC4=O)C2=S)cc1C(F)(F)F	4.57	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay	2021	feo@@@LddTTVbQVbfRRqILyyMQm{UUUUUUUUUT@@	feopR@DX|kHy`BLbbbbbTTRrVtjUNNrDjZ}FuU@aPAATtD@@	460.391	1.0397	8	0	127.85	3	2.1324551815266433	2.0450097864775993	1.6603258178546276	2	1	e`RRBB@DLOGeLko`@bZPVdMiCHhhhheEDledhUHdkQpydDTdt]\uU@aPADUUVtD@@@											1
<jzSzfJbw1qujUTPV2C1ugBPp92h04IqK79Y03C2R4Y1VDIuX8ZX58k28GEk0kt58aW0LF$4Vb08YgGV	CHEMBL4746345	fe{Hb`JLmNQ`XaIAlavPGHYEEDTiMBhdieHjLSffZjf`@jkb@d@	C[C@](O)(Cn1cc(Br)c(F)n1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	7.08	group2-a	a	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	f`q@@@DjU^}eiqwjjjjjj@@	f`qq@@DBtAIeYUgUV]yj``hT`@@	435.174	2.0385	6	2	90.94	5	1.7386706561994036	0.7562464609895916	-0.7682393004289109	29	22	ff}I@`DDMWP@fdCIqSxyEDhbiieDeBbLcfZfjZ@Hn@@@	eMJB@Df`@	gJPBAHJPt`PAIjj@@	eFABP`BL@	eFACD`BL@							21
:UvUtOrdJ7wVLQzUwHWHOvT6B8K1YB1Z7vKE4YVIIVN2kWXDHpbk54SBg2YkEVXdt1WXbHbF08V1GFb0VV8F0	CHEMBL4746443	fjmqb@AFCstPRFQQQJHqFJJVLdELDCEULuD@@	CN(C)C(=O)c1cc(N2C(=O)NC(C)(C)C2=O)ccc1F	5.04	group4-ia	ia	Androgen Receptor	Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay	2016	dk\@@DjYVYxqVjjjj`@	dk]D@DpIRYeg^ftvj`PH@@	293.297	1.0612	6	1	69.72	2	-0.05549160275911294	2.0905683192277174	-0.05239951699516413	33	14	fhiP``AFuX@RRA|xa|TfYwf[v\LzB@jYjH@@		eMBH@RZ@	gGYHDL@ILsU@@	eFABP`BL@							14
]x<vzUzUjUAzUUCfz_mS_b7zKDivfQUWwiobfyFobpj6SCo3YmEcmhwCtXYmjK10kGGFr0c0c0F	CHEMBL4746653	ehZRLB@DLOOeG`P@aZPvdCiCHhhhheEDlddeJiDeZN@jdnlbkgfjhDJ@JHjjm`h@@	N#Cc1ncc(N2C(=O)C3(CCCC3)N(c3ccc4c(c3)COC4=O)C2=S)cc1C(F)(F)F	7.2	group2-a	a	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay	2021	fm@@@LddTTRTRjtTrRVYrR`y[Ohzjjjjjjjjjh@@	fmqb@DX|jZpAFQQQQQJJIYIKQiTxFjVyJN[UTBE@EATpT@@	472.446	2.5457	7	0	118.62	3	1.7318368578777383	0.9064199919861528	1.5759711824834972	5	1	ehZRLB@DLOOeG`P@aZPvdCiCHhhhheEDlddeJiDeZN@jdnlbkgfjhDJ@JHjjm`h@@											1
<jzSzfJbw1qujUTPWXC1ugBPp92h04IqK79Y03CHR4Y1VDIuX0aX5Nk@8GEV0Ft5@aW0LF#F4Vb08YcGV	CHEMBL4746814	eohRDB@EMDggH`ICZPNdKiCHhdlhediMBhdieHjFEMNah@JVjih@JjrHKD@@	C[C@](O)(Cn1cc(-c2ccc(F)cc2)cn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	6.01	group3-int	int	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	ffc@@@LdbbRRqRbtRWEBdVmUUUUUUUP@@	ffcq@@DBtCHhdhdeEdUDdjsoEjuPPTK@@P@@	432.376	2.6211	6	2	90.94	6	1.8550613940955667	0.29556954457724977	-0.7437000991265917	9	6	eohRDB@EMDggH`GGZPNdKiCHhdlhediMBhdieHjFEMNah@JVjih@JjrHKD@@	eFABP`BL@										5
:UvjvSzfJbw1LujUTPV291ugBPp92904Iq479W0392R4W1V6IuV8Z248k08GEk0Vt58aW06(a08WcFV	CHEMBL4746960	fasI@`BTuuPI@laVP[HYEDleEBhdieHbTCFejih@Jjxap`@	CC(Cn1cc(F)cn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	6.33	group3-int	int	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	f`q@@@DjU^}eiqwjjjjjj@@	f`qq@@DBtAIeYUgUV]yj``hT`@@	340.279	1.8214	5	1	70.71	5	0.4029003161175866	0.9832894921735873	0.02116629882520261	29	22	ff}I@`DDMWP@fdCIqSxyEDhbiieDeBbLcfZfjZ@Hn@@@	eFBH@c@@	gJPBAHJPt`PAIjj@@		eFABP`BL@							21
:UtbtSxfF5w1JujTR@V290ug4HG92904Hq459V0392R411V03sV8V248k081Ek0V958aW06(608WcFV	CHEMBL4747056	fncI@`BTTvPICL`VPkHILnk[JvtdixMKUM@AUW@@@	N#Cc1ccc(NC(=O)CCn2cc(F)cn2)cc1C(F)(F)F	5.67	group4-ia	ia	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	f`q@@@DjU^}eiqwjjjjjj@@	f`qq@@DBtAIeYUgUV]yj``hT`@@	326.252	1.6031	5	1	70.71	5	0.3393028105187652	1.1665366769372139	-0.0030525124803737827	29	22	ff}I@`DDMWP@fdCIqSxyEDhbiieDeBbLcfZfjZ@Hn@@@		gJPBAHJPt`PAIjj@@		eFABP`BL@							21
:Uvzv;S:vyvzUzTeUQzUMCfz_XR5bEjKEqnVQEWsVZ7YDHobk50CBg2YmEcX0wCdXYIjF!V1GFb2VV8F0	CHEMBL4747499	fnsP``M^\DD`JPeHJdLbbbRdubbebRYstZm`HJjfZjb`@@	O=C1NC2(CCCCC2)C(=O)N1c1ccc(F)c(C(F)(F)F)c1	5.38	group4-ia	ia	Androgen Receptor	Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay	2016	fde@@@LddTRRvTJUIBtFMUUUUUU@@@	fdeP`@DXAIIfVVWWhrp_QZjAhJJH@@	330.28	2.937	4	1	49.41	2	-0.7652333939073694	0.4351065861191752	-0.21055688031829	1	1	fnsP``M^\DD`JPeHJdLbbbRdubbebRYstZm`HJjfZjb`@@											1
<jzSzfJbw1qujUTPV2C1ugBPp92h04IqK79Y03C2R4Y1VDIuX0ZX5Nk28GEV0Ft58aW0LF$4Vb08YcGV	CHEMBL4747667	fikHc@EFrUpPRBICDadTabbRQTtftRtmM{UAAeMUTlTOP@	Cc1cnn(C[C@](C)(O)C(=O)Nc2ccc(C#N)c(C(F)(F)F)c2)c1	5.09	group4-ia	ia	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	f`q@@@DjU^}eiqwjjjjjj@@	f`qq@@DBtAIeYUgUV]yj``hT`@@	352.315	1.205	6	2	90.94	5	1.3415365259104644	1.564570777901078	-0.9089261194629566	29	22	ff}I@`DDMWP@fdCIqSxyEDhbiieDeBbLcfZfjZ@Hn@@@	eMJB@Df`@	gJPBAHJPt`PAIjj@@		eFBH@c@@							21
:UvUtOrWJ7wVLQvEoHVH9vR6B8K1V41Z7dKD43VF2VF0V1XDFobk50CBw2Yk1VX0k5WX3H_F!V01FX0VV8FF	CHEMBL4748422	flepc@JJ][pIADabPrJPqIKQQRpTgAj`@jYjH@@	CC1(C)NC(=O)N(c2ccnc(C(F)(F)F)c2)C1=O	5.35	group4-ia	ia	Androgen Receptor	Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay	2016	dk\@@DjYVYxqVjjjj`@	dk_D@DppeIfV]z[SZjA@`@@	273.213	1.1565	5	1	62.3	2	-0.5298740511108103	1.9324768968651513	-0.19238293975302645	33	2	flepc@JJ][pIADabPrJPqIKQQRpTgAj`@jYjH@@											1
:UvztU:JjxnyvzUzQWHvvziCAU7mB5Z7vKE6njIUbT9tveDIqblh6SBg2YoEcXWs5xXYHbt51m1GFj8V18!	CHEMBL4748557	fkPR`LJ`bTPADyA\anPOHYIHXhhiDlchTieHkWdmzmTCUAH@EUP@@@	CC1(C)C(=O)N(c2ccc(F)c(C(F)(F)F)c2)C(=O)N1S(=O)(=O)c1ccccc1	5.37	group4-ia	ia	Androgen Receptor	Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay	2016	ffc@@@LddTTJTRvtrRgZlVmUUUUUUUP@@	ffcPR@LJ`bW`AFRRFJJIKIZEIVkAKUZhF`d@B@@@	430.377	3.3261	6	0	83.14	3	0.6581305275051462	0.21218322021105207	1.3319575882165882	1	1	fkPR`LJ`bTPADyA\anPOHYIHXhhiDlchTieHkWdmzmTCUAH@EUP@@@											1
:UvUtOrdJ7wVLQzUwHVHOvT6B8K1XD1Z7fKE4YVIAVN0V1XDHobk50CBg2YkEVX0u5dXYHbF!V1GFb0VV8F0	CHEMBL4750103	fbuP``M^\DDPJPeHJdLbbbRdubbecN^c@PUULuD@@	CC1(C)NC(=O)N(c2ccc(Cl)c(C(F)(F)F)c2)C1=O	5.89	group4-ia	ia	Androgen Receptor	Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay	2016	dk\@@DjYVYxqVjjjj`@	dk]D@DpIRYeg^ftvj`PH@@	306.67	2.7094	4	1	49.41	2	-0.878859204579024	0.6594812264780375	-0.25059283199787874	33	14	fhiP``AFuX@RRA|xa|TfYwf[v\LzB@jYjH@@		eMBH@RZ@	gJPBAHJPt`PAIjj@@	eFABH`BL@							14
:Uvzv;S:vyAzUzEdmQQUbCfMhnS5bMzZEEmfQElOco7fLQrZli2Ch0VYnUfX1gCta_HM118p1GJ7Gg0c!	CHEMBL4750351	ehZ\HB@DLMe@@cjPFdIiCHhhhheDehmLUHeYdjNKHoLdjo`VjhDHBBJjp@hBCb`@	N#Cc1ccc(N2C(=O)C3CCc4cc(-c5ccccc5)ccc4N3C2=S)cc1C(F)(F)F	5.46	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay	2021	fm@@@DjYeUo^yU]baRtYlqkjjjjjjjjjj`@@	fmQB@DXT@HrJJJJIQIZKZjIJgKQ}eIYkZj`P`HB@B`H\h@@	463.482	5.4986	4	0	79.43	3	0.1809982087143178	-1.4854939425928098	1.2112192781782993	4	1	ehZ\HB@DLMe@@cjPFdIiCHhhhheDehmLUHeYdjNKHoLdjo`VjhDHBBJjp@hBCb`@											1
:Uvzv;S:vyAzUzEcmQQUbCfMhnS5bMjZEEmfQElOco7fLQrZlg2Ch0VYnUfX1gCtaWHM118p1GJ7Gg0g!	CHEMBL4750503	fcqB`AVvDFHXHGHSdErBSJvmskZvttYKUgEk@AUST`AUVTPtP@	N#Cc1ccc(N2C(=O)C3CCc4cc(Br)ccc4N3C2=S)cc1C(F)(F)F	5.36	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay	2021	fjc@@@LdbbbRReQbRYHRmFrVjjjjjjjh@@	fjcQB@DXT@HRYfYYWgz\mGvTeZj`P`HB`ar`@	466.28	4.5646	4	0	79.43	2	0.08114102009687432	-0.8135733576029819	1.1848487694789536	4	2	fcqB`AVvDFHXHGHSdErBSJvmskZvttYKUgEk@AUST`AUVTPtP@											1
<jzSzfJbw1qvjUTPV2CGugBPp92h04IqK79Y03C2R4YGVDIuX0ZXKNk28GUk1Ft58aY0LF$4Vb08YcGV	CHEMBL4751646	fcwHa`EFrUpPRBICDaNPWH[dLbdLTRRJfdvbVTdmM{UAAeMUTmTTOP@	C[C@](O)(Cn1cc(C(F)(F)F)cn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	7.15	group2-a	a	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	f`q@@@DjU^}eiqwjjjjjj@@	f`qq@@DBtAIeYUgUV]yj``hT`@@	406.285	1.7094	6	2	90.94	6	1.7605573196227147	0.940390144033908	-0.7913836811900645	29	22	ff}I@`DDMWP@fdCIqSxyEDhbiieDeBbLcfZfjZ@Hn@@@	eMJB@Df`@	gJPBAHJPt`PAIjj@@		gJPBAHJPt`PAIjj@@							21
<jzSzfJbw1qujUTPV2C1ugBPp92j04IqK79Y03C2R4Y1VDIuX8ZX5Nk28GEk0kv58aW0LF$4Vb08YcGV	CHEMBL4752477	fe{H``DDmNQ`QCYCl`NPrJIQERZEQISJQDhgLtuUM@AUWDAH@	Cc1cn(C[C@](C)(O)C(=O)Nc2ccc(C#N)c(C(F)(F)F)c2)nc1Cl	6.48	group3-int	int	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	f`q@@@DjU^}eiqwjjjjjj@@	f`qq@@DBtAIeYUgUV]yj``hT`@@	386.76	1.9084	6	2	90.94	5	1.4898349266361817	1.0139900889934772	-0.848581714514838	29	22	ff}I@`DDMWP@fdCIqSxyEDhbiieDeBbLcfZfjZ@Hn@@@	eMJB@Df`@	gJPBAHJPt`PAIjj@@	eFABH`BL@	eFBH@c@@							21
]x<vzUzUjUAzUUCfz_mS_b7zKDivfQUWwiobfyFobpj6SCZ3YmEcmhwCtXYmjK10kGGFr0c0c!	CHEMBL4752689	ehZ\LB@DLOeG`P@aZPvdCiCHhhhheEDldeMJiDeZN@jdnlbkgfjhDJ@JHjjm`h@@	N#Cc1ccc(N2C(=O)C3(CCCC3)N(c3ccc4c(c3)COC4=O)C2=S)cc1C(F)(F)F	7.09	group2-a	a	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay	2021	fm@@@LddTTRTRjtTrRVYrR`y[Ohzjjjjjjjjjh@@	fmQb@DXUMX@cHhhhheEDldehtj\CUK\eGMjjAB`B`jXJ@@	471.458	3.4926	6	0	105.73	3	1.229970588129078	0.1254531757185619	1.457924481134127	5	1	ehZ\LB@DLOeG`P@aZPvdCiCHhhhheEDldeMJiDeZN@jdnlbkgfjhDJ@JHjjm`h@@											1
>Szfobw_rvzUTP_XCGyiBPp92h14MqK79fVICHR4Y1XEIyX0aXCNk@8GEVkFt5@aYFqF#FJVb0@YcGV	CHEMBL4752893	efQZBL@ECLbgg@`XPIABPpdLbdLTRRJfdvbVTRVRfTdfcWQuuTDFTuURp@TuTQAy@@	CC(C)(C)OC(=O)Nc1ccc(-c2cnn(C[C@](C)(O)C(=O)Nc3ccc(C#N)c(C(F)(F)F)c3)c2)cc1	5.94	group4-ia	ia	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	ffc@@@LdbbRRqRbtRWEBdVmUUUUUUUP@@	ffcq@@DBtCHhdhdeEdUDdjsoEjuPPTK@@P@@	529.517	3.5734	9	3	129.27	9	4.42437793641312	-0.3697659480882496	-1.2240947393227766	9	6	eohRDB@EMDggH`GGZPNdKiCHhdlhediMBhdieHjFEMNah@JVjih@JjrHKD@@	diFD`LAJ@DfUijj`@										5
<jzSzfJbw1qujUTPV2C1ugBPp92j04IqK79Y03C2R4Y1VDIuX8ZX58k28GEk0kv58aW0LF$4Vb08YcGV	CHEMBL4752991	fikH``BTLLV`QEYAlavPrJIYJSPjIJYRHeHiiZjf`@jkbGD@	C[C@](O)(Cn1cc(Cl)cn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	6.87	group3-int	int	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	f`q@@@DjU^}eiqwjjjjjj@@	f`qq@@DBtAIeYUgUV]yj``hT`@@	372.733	1.4671	6	2	90.94	5	1.4367295167326601	1.3312934627018518	-0.8739627310248667	29	22	ff}I@`DDMWP@fdCIqSxyEDhbiieDeBbLcfZfjZ@Hn@@@	eMJB@Df`@	gJPBAHJPt`PAIjj@@		eFABH`BL@							21
<jzSzfJbw1qujUTPV2C3ugBPp92h04IqK79Y03C2R4f1VDIuX8ZXK8k28GUk0kt58aW0LF!2F4Vb08YcGV	CHEMBL4753877	fmghSBEFrT[`sVBPQHXdArolbdLTRRJfdvbVTeioZhHLijjefJGh@	C[C@](O)(Cn1cc([N+](=O)[O-])cn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	7.44	group2-a	a	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	f`q@@@DjU^}eiqwjjjjjj@@	f`qq@@DBtAIeYUgUV]yj``hT`@@	383.285	-0.0605	9	2	136.76	6	3.1940425273704367	2.7883103153537223	-0.45618673460734194	29	22	ff}I@`DDMWP@fdCIqSxyEDhbiieDeBbLcfZfjZ@Hn@@@	eMJB@Df`@	gJPBAHJPt`PAIjj@@		gChhhE`BRnRYh@							21
:UvzvU:KzxvyQzUzEXHvQUiCfMCnS5bMjZEEnjQEYOck7eLIrZng3CC0VYlUda1c5taWHM118p1GJEGgVgF0	CHEMBL4754074	fcIB`FR]opLRpPNPgHKdDfUmUY~UmiirRcNKV@Hjif@Bjlh`j`@	N#Cc1ccc(N2C(=O)C3CNc4cc(Br)ccc4N3C2=S)cc1C(F)(F)F	5.01	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay	2021	fjc@@@LdbbbRReQbRYHRmFrVjjjjjjjh@@	fjcqB@DXBh@QdTTTTRbRtVMNVC{JRmUPHPPAPPyP@	467.268	3.4253	5	1	91.46	2	0.854311593085467	0.06286930716005132	0.2129794968224149	4	1	fcIB`FR]opLRpPNPgHKdDfUmUY~UmiirRcNKV@Hjif@Bjlh`j`@											1
]x<vzUzUjUAzUUCfz_mS_bEzKDyvfQUWwiobfyFobpj6SCo3YmEcmhwCtXYnjK10kGGFr2c0c0F	CHEMBL4754309	edVRLB@DLO@UOhP@cZPNdKiCHhhhheEDlddeMeHekQpETetUL}|uU@aPAQEUU[AP@@	N#Cc1ncc(N2C(=O)C3(CCCCC3)N(c3ccc4c(c3)COC4=O)C2=S)cc1C(F)(F)F	7.03	group2-a	a	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay	2021	ec`P@@@DjfYVWwnuWXxT|bJzVFfjjjjjjjjjjh@@	ec`\LH@DLOEEm`@cHhhhheEDldeibmQpETdtTMLluU@aPAPUSAP@@	486.473	2.8877	7	0	118.62	3	1.7896142221759341	0.6488107946106364	1.6008346507611428	3	1	edVRLB@DLO@UOhP@cZPNdKiCHhhhheEDlddeMeHekQpETetUL}|uU@aPAQEUU[AP@@											1
:Uvzv;S:vyvzUzTeMQzUMCfz_XR5b7jKEanVQEWsVZ7YDHobk50CBg2YmEcX0wCdXYHjF!V1GFb0VV8F0	CHEMBL4755665	ffcP``M^\DD`JPeHJdLbbbRdubbebSN^bVlAAUTsUQP@@	O=C1NC2(CCCC2)C(=O)N1c1ccc(F)c(C(F)(F)F)c1	6	group3-int	int	Androgen Receptor	Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay	2016	fhy@@@LddTRRqfRipToAjjjjjj`@@	fhyP`@DXAIIfVVWVcKA]yjhF`hb@@	316.253	2.595	4	1	49.41	2	-0.8230109189167212	0.6927158966633783	-0.23542039881208326	1	1	ffcP``M^\DD`JPeHJdLbbbRdubbebSN^bVlAAUTsUQP@@											1
:Uvzv;S:vyAzUzEdmQQUbCfMhnU5bMzZEEmfQElOco7fLQrZli2ChFVYnUfX1iCta_HM118p1GJ7Gg0c0F	CHEMBL4755743	edVZHJ@DLGLhV`HaHH^dOi@FPRYWYVun][VvfacPsrKHi[Z@B@Bjfi@BjlJHHb@@	N#Cc1ccc(N2C(=O)C3CCc4cc(-c5cnc(Cl)nc5)ccc4N3C2=S)cc1C(F)(F)F	5.09	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay	2021	fm@@@DjYeUo^yU]baRtYlqkjjjjjjjjjj`@@	fmIB@DXGMP@cHhhhheDehmjhdj\mGvTefmjjAB@`H@J@ar`@	499.903	4.7835	6	0	105.21	3	1.3106660523069908	-0.7598668581448617	1.5101340920377522	4	1	edVZHJ@DLGLhV`HaHH^dOi@FPRYWYVun][VvfacPsrKHi[Z@B@Bjfi@BjlJHHb@@											1
[rx<vvEzUjUAzSUCfz_kR_b7xKDiQfPUWwiobfyFobpj6SCo2YmAcm_wCtX3mhK10kGGFn0V0c0F	CHEMBL4756685	ehZZLB@DLOHoeG`P@aZPvdCiCHhhhheEDldddbiDeZN@jdnlbkgfjhDJ@JHjjm`h@@	N#Cc1ncc(N2C(=O)C3(CCCC3)N(c3cnc4c(c3)COC4=O)C2=S)cc1C(F)(F)F	5.65	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay	2021	fm@@@LddTTRTRjtTrRVYrR`y[Ohzjjjjjjjjjh@@	fmIb@DX}ETu`BLbbbbbTTRrRVURipMTmrT\vjhDJ@JBi`h@@	473.434	1.5988	8	0	131.51	3	2.2337028554230227	1.6873870087842626	1.6940178129541732	5	1	ehZZLB@DLOHoeG`P@aZPvdCiCHhhhheEDldddbiDeZN@jdnlbkgfjhDJ@JHjjm`h@@											1
=v;wzxrrAzUxEkmQQUbEAMhnSChMjaEEufIUlQckUf6QrZpg3ChFcYrUvm1g5taWHM13Bx9GFMGeVcFF	CHEMBL4756936	edZZLJ@DLKEmeGo`@ajPzdAi@zPrJJJJIIKIIIJQIUFYTLF^NQESMUPMAAAUEtuPDCE@@	CCOC(=O)Nc1cc2c(cc1F)CC1C(=O)N(c3cnc(C#N)c(C(F)(F)F)c3)C(=S)N1C2	5.21	group4-ia	ia	Androgen Receptor	Antagonist activity at Androgen receptor (unknown origin) expressed in COS7 cells by dual luciferase reporter gene assay relative to control	2020	fjc@@@LdbbRRvbQbRXKdmFrVjjjjjjjh@@	fjcqB@DXlh@PdsLrjz{tX[shyJuU@tD@DAAe@@	493.44	2.6494	8	1	130.65	5	2.8689530099994887	0.7197990955231108	0.6957133778809949	2	1	edZZLJ@DLKEmeGo`@ajPzdAi@zPrJJJJIIKIIIJQIUFYTLF^NQESMUPMAAAUEtuPDCE@@											1
:vr22NG8V4k402BHNH0VN2m040V91A2022k50283Gk!91V021V10G61Fc!8VF0@F0XG80ZV275@F3!W8FF	CHEMBL4757339	edR\BB@AckbJo`PH`RP|bG`cHhhdhdYDiTldhdhUHqIdUl]AAQUT@EP@Tl@@@@	CC(C)(c1ccc(OCc2ccnc(NS(C)(=O)=O)n2)cc1)c1cc(F)c(OCCCl)c(Cl)c1	6.3	group3-int	int	Androgen Receptor	Modulation of AR in human LNCAP cells transfected with PSA reporter gene assessed as inhibition of R1881-induced PSA luciferase activity pretreated for 1 hr followed by R1881 addition and measured after 24 hrs by luciferase assay	2020	fj}@@@DjU^UWyVgCNrVjjjjjjj`@@	fj}Q@@AN@eLjsjJ|TYvRtD@@Q@@@@@	528.431	4.0864	7	1	98.79	9	2.8625378069029983	-1.1116558298707175	0.6955653249705824	1	1	edR\BB@AckbJo`PH`RP|bG`cHhhdhdYDiTldhdhUHqIdUl]AAQUT@EP@Tl@@@@											1
<jzSzfJbw1qujUTPV2C1ugBPp92j04IqK79Y03C2R4Y1VDIuX8ZX58k28GEk0kv58aW0LF$4Vb08YgGV	CHEMBL4757702	fe{Hb`DDmNQ`XeHalavPGHYEDhbiMBhdieHbLSfZfjf`@jkb@d@	C[C@](O)(Cn1cc(Cl)c(Br)n1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	6.86	group3-int	int	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	f`q@@@DjU^}eiqwjjjjjj@@	f`qq@@DBtAIeYUgUV]yj``hT`@@	451.629	2.2897	6	2	90.94	5	1.8135065476423082	0.5442177625957787	-0.7398537859426275	29	22	ff}I@`DDMWP@fdCIqSxyEDhbiieDeBbLcfZfjZ@Hn@@@	eMJB@Df`@	gJPBAHJPt`PAIjj@@	eFACD`BL@	eFABH`BL@							21
:Uvzv;S:vyAzUzEdmQQUbCfMhnS5bMzZEEmfQElOco7fLQrZpi2ChFVYnUfX1gCta_HM118p1GJ7Gg0c0F	CHEMBL4757852	ejYRHN@DLMge@@cjPFdIiAFPqdBYCHhhhheDehmLUHeYdliJNKHoLdjo`VjhDHBBJjp@jj@`xh@@	N#Cc1ccc(N2C(=O)C3CCc4cc(-c5ccc(C(F)(F)F)nc5)ccc4N3C2=S)cc1C(F)(F)F	5.66	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay	2021	fm@@@DjYeUo^yU]baRtYlqkjjjjjjjjjj`@@	fmqB@DXFh@QdTTTTRbRtVuTRUNVc{JRsVuU@a@PD@E@PyP@	532.467	5.4	5	0	92.32	4	1.159573242531179	-1.5874591142815122	1.4716817876295878	4	2	ejYRHN@DLMge@@cjPFdIiAFPqdBYCHhhhheDehmLUHeYdliJNKHoLdjo`VjhDHBBJjp@jj@`xh@@											1
<jzxzfRbw1qufETPWXC1sgRPp90g04IoK79302CHR4Y1VDQuX0ZaKNk28GAm0Ft5@a10JF2!F4VY!YcGk	CHEMBL4758119	e`TVDL@NMCLbeg@`IABPpdLbdLTRRJfdvbRRTrTbcWSwuTAAtuURu`@QAy@@	C[C@](O)(Cn1cc(-c2ccccc2)c(C#N)n1)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1	6.24	group3-int	int	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	ffc@@@LdbbRRqRbtRWEBdVmUUUUUUUP@@	ffcI@@DBehFQQIQIJKHjIIUg^KUj``hV@@`@@	440.384	1.463	8	2	127.62	6	3.0312582552601013	1.4728235141117736	-0.4661019869356514	9	1	e`TVDL@NMCLbeg@`IABPpdLbdLTRRJfdvbRRTrTbcWSwuTAAtuURu`@QAy@@											1
:UvztQ:JjwnTQzUwQkHQvUDC@M1mBCZ7fME6nYIAWT8V3XDHobkC0CBg2YoEcX1s5tXYHbF10k1GFb0V0c!	CHEMBL4758277	fncp``M^ZxHI@TaJPUHYEEDeIkEEMhbsghpDEUSMUY@@@	CC1(C)C(=O)N(c2ccc(F)c(C(F)(F)F)c2)C(=O)N1CC#N	6.54	group3-int	int	Androgen Receptor	Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay	2016	dk\@@DjYVYxqVjjjj`@	dk]D@DpIRYeg^ftvj`PH@@	329.252	2.109	5	0	64.41	3	-0.3631877689651698	1.0606034202326589	1.022994334182073	33	14	fhiP``AFuX@RRA|xa|TfYwf[v\LzB@jYjH@@	gChHA`AI^`@	eMBH@RZ@	gJPBAHJPt`PAIjj@@	eFABP`BL@							14
<jzSzfJbw1qujUTPWXC1ugBPp92h04IqK79Y03CHR4Y1VDIuX0ZX5Nk28GEV0Ft5@aW0LF#F4Vb08YcGV	CHEMBL4758685	eg`RDL@ECLbg@`IABPpdLbdLTRRJfdvbVTRTfcWQuuTDFTuURp@DP^P@	C[C@](O)(Cn1cc(-c2ccccc2)cn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	5.94	group4-ia	ia	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	ffc@@@LdbbRRqRbtRWEBdVmUUUUUUUP@@	ffcq@@DBtCHhdhdeEdUDdjsoEjuPPTK@@P@@	414.386	2.5203	6	2	90.94	6	1.7650653411428905	0.4228779381760382	-0.7738276828126548	9	6	eohRDB@EMDggH`GGZPNdKiCHhdlhediMBhdieHjFEMNah@JVjih@JjrHKD@@											5
=xOzfobwbMQzUwQ_H9vTDB8K1mC_Z7vKDDffIQVRDkYeDFobpj6SCo3YkEVmhs5tXYmbK10kGGFr0c0c0F	CHEMBL4759470	eodRLB@DLOKeCg`@`ZPfdEiCHhhhheEDlbeLiDeZN@ldjmcfjhDJ@BJjkXH@@	CC1(C)C(=O)N(c2cnc(C#N)c(C(F)(F)F)c2)C(=S)N1c1ccc2c(c1)COC2=O	6.03	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay	2021	fnk@@@DjYVV}V}~ZDkpZmjjjjjjjjh@@	fnkqb@DXljkPAFQQQQQJYYKPiTxzHTejuU@`@ATpP@@	446.408	2.1549	7	0	118.62	3	1.6131031818564978	1.2379059369964331	1.5310894240682056	4	1	eodRLB@DLOKeCg`@`ZPfdEiCHhhhheEDlbeLiDeZN@ldjmcfjhDJ@BJjkXH@@											1
vzUQfQzvESyndTvTHvK@fvb2TJZvjrFFkt2c3onX5Ntl9FDUZP151o28g2VV0J73244O0V8D1D1!84Z04V0F0	CHEMBL4759623	fio`@@@YHhhheDhleDdjpTk^SGnVuGPTPDDEAADP@@	c1ccc(C2Nc3ccc4ccccc4c3C3C4CCC(C4)C23)cc1	5.25	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor in human LNCaP cells transfected with ARR2 PB-eGFP assessed as inhibition of DHT-induced transcriptional activity measured after 3 days by fluorescence assay	2020	fio@@@LdbbbbbVTvUfRxhUcQ]xN^cjjjjjjjjjj@@	fio`@@@YHhhheDhleDdjpTk^SGnVuGPTPDDEAADP@@	325.454	5.6302	1	1	12.03	1	-2.4114867684221273	-1.6819336830395788	-0.5913529938031235	2	2	fio`@@@YHhhheDhleDdjpTk^SGnVuGPTPDDEAADP@@											1
:Uvzv;S:vyAzUzEdmQQUbCfMhnS5bMzZEEmfQElOco7fLQrZli2ChFVYnUfX1gCta_HM118p1GJ7Gg0c0F	CHEMBL4759704	ejURHB@DLMge@@cjPFdIiCHhhhheDehmLUHeYdddjNKHoLdjo`\RVjhDHBBJjp@@J@HNJ@@	N#Cc1ccc(N2C(=O)C3CCc4cc(-c5cnc6ccccc6c5)ccc4N3C2=S)cc1C(F)(F)F	5.05	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay	2021	eobP@@@DjYeUo^yU[wXTDdtLZfFvn^jjjjjjjjjjjj@@@	eob\HH@DLAe@@cHhhhheDehmjhdddjNKHoLdbiekgfjhDHB@`@@J@HNJ@@	514.53	5.8146	5	0	92.32	3	0.887069694886365	-1.649355683526489	1.4182204419882345	1	1	ejURHB@DLMge@@cjPFdIiCHhhhheDehmLUHeYdddjNKHoLdjo`\RVjhDHBBJjp@@J@HNJ@@											1
{x:v<bUfvUjhfzpmx_b7zKTjvjQzYwikbfyGqjrjiSCZ3YqEcqxw5taYqbK1VkIGOz0c0c!	CHEMBL4759832	ehZ\BB@DLOeLg`P@aZPvdCiCHhhhheEDldeMJiDeZN@jdnlbkgfjhDJ@JHjjm`jCb`@	N#Cc1ccc(N2C(=O)C3(CCOC3)N(c3ccc4c(c3)COC4=O)C2=S)cc1C(F)(F)F	6.62	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay	2021	fm@@@LddTTRTRjtTrRVYrR`y[Ohzjjjjjjjjjh@@	fmPR@DXUfZpAFQQQQQJJIYIKQiTxFjVyJN[UTBE@EATpUCe@@	473.43	2.3286	7	0	114.96	3	1.6883664367873343	1.0064336596658052	1.5671426349990505	5	1	ehZ\BB@DLOeLg`P@aZPvdCiCHhhhheEDldeMJiDeZN@jdnlbkgfjhDJ@JHjjm`jCb`@											1
]x<QzUzUjHAvUECfr_mS_b7zKDDvfQUWRiobfTFobpj6SCZ3YmEcmhwCtXYmbK10kGGFr0c0c!	CHEMBL4759841	e`R\LB@DLGeKo`@bZPVdMiCHhhhheEDleihUHdkQpydDTdt]\uU@aPADUUVtD@@@	N#Cc1ccc(N2C(=O)C3(CCC3)N(c3ccc4c(c3)COC4=O)C2=S)cc1C(F)(F)F	6.66	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay	2021	feo@@@LddTTVbQVbfRRqILyyMQm{UUUUUUUUUT@@	feoQb@DXTNX@cHhhhheEDlemJeSclaJfoQmUPHT@PUMA@@@	457.431	3.1506	6	0	105.73	3	1.1721930631197262	0.3830624862627652	1.4330609626403337	2	1	e`R\LB@DLGeKo`@bZPVdMiCHhhhheEDleihUHdkQpydDTdt]\uU@aPADUUVtD@@@											1
vzUQAQtn9RDmVLATHsG8XQ32LJ0nfn90VI2V7BmX5OlG9FBE4P105o!g2cV1J33044OVV8L161018Jo10V4F0	CHEMBL4760141	fag`B@A@qLbbRrbTTRRLrUFZmxJ\m{@AUTE@@AH@@@	Brc1ccc(C2Nc3ccc4ccccc4c3C3C=CCC32)cc1	6.82	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor in human LNCaP cells transfected with ARR2 PB-eGFP assessed as inhibition of DHT-induced transcriptional activity measured after 3 days by fluorescence assay	2020	fn{@@@LdbbbbbVVubRxhUcA]zkZjjjjjjjj`@@	fn{`@@@YHhhheDhldebpTk^SFiVtEDAAA@DH@@@	376.296	5.8346	1	1	12.03	1	-2.1533607132241745	-1.9933463765236918	-0.5066281713392302	4	4	fiw`A@I@|VNNQQIPjIQQIHsITxYpXyKt\@QUTE@@AH@@@		eFACD`BL@									4
<nvNUvV4wbHHBUBPVmO2y8BFZ93j64HIkC22831kB490V6Xd0tVlL1kc81OFF0AF0VG8L_VX7K@F342WVFV	CHEMBL4761957	ebV\JL@CIkbFco`PH`JH^BLbbbRbRtbtjVRTRVTacDaUVqtDEE]T@ETmRuA@@@	CC(C)S(=O)(=O)Nc1nc(COc2ccc(C(C)(C)c3cc(Cl)c(OCCCl)c(C#N)c3)cc2)co1	6.3	group3-int	int	Androgen Receptor	Modulation of AR in human LNCAP cells transfected with PSA reporter gene assessed as inhibition of R1881-induced PSA luciferase activity pretreated for 1 hr followed by R1881 addition and measured after 24 hrs by luciferase assay	2020	fbm@@@DjU^UWyZ\LyNZjjjjjjh@@	fbm``@L@XeKjrnlk`fcIsRu@AP@P@@@	552.477	4.8602	8	1	122.83	10	3.7427436577633997	-1.4896274367275648	0.9150093919170041	1	1	ebV\JL@CIkbFco`PH`JH^BLbbbRbRtbtjVRTRVTacDaUVqtDEE]T@ETmRuA@@@											1
]wjxbrQzUxU_HAvUECAr_mS__7zKDDvfIUWRikbfDFobpj6SCZ3YmEcmhw5tXYmbK10kGGFr0c0s!	CHEMBL4762417	eol\LB@DLKeCg`@`ZPfdEiCHhhhheEDlcMLiDeZNKG@ldjmcfjhDJ@BJjkZB@@@	N#Cc1ccc(N2C(=O)C3(CC3)N(c3ccc4c(c3)COC4=O)C2=S)cc1C(F)(F)F	6.17	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay	2021	fiw@@@LddTTLRrtTrRVpQgGQKvkZjjjjjjjjj@@	fiwQb@DXUtX@cHhhhheEDlchTj\lxNTe[ujjAB`@Jf``@@	443.404	2.8086	6	0	105.73	3	1.1144155381103744	0.6406717968069683	1.4081974441465404	1	1	eol\LB@DLKeCg`@`ZPfdEiCHhhhheEDlcMLiDeZNKG@ldjmcfjhDJ@BJjkZB@@@											1
:xzCqslde4mZ0EgHsVhXSHH1Z0F9Y824FHVl02k3lkG6FG01@1V1ZJH_1Wc882F894184V250@44#4F$	CHEMBL476292	fluA`@@\LdsKKkZ{NRuEKPTDPPDDFT@@	COc1ccc2c(c1)C(=O)CC(c1ccccc1)O2	4.4	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor in human MDA-kb2 cells assessed as inhibition of DHT-induced luciferase activity by luciferase reporter gene assay	2009	fhy@@@LdbbbRnbRYHRoAjjjjjj`@@	fhy@`@@\RYee~uYrVoAZB``@HHLh@@	254.284	3.1228	3	0	35.53	2	-1.9183022983375275	0.39644192120119687	0.6282098660432687	32	9	fde@b@AR@xyEDeLhbhdjLUhLX@JZ`@Hah`@	eMJA@Hz@										2
:UvUvOrdJ7wVLAzUw0VmOQTaB8K1XB1Z7j0E4XVIQkN0V5X6IqZlZ0CB80YkEVX0c5dXVH7114V1GF70VV8F0	CHEMBL4763136	fnsPc@ENmxD`JPeHYEEDeLXhiUDdsc`u[@PUTsP@DPB`@	O=C1N[C@H](c2ccccc2)C(=O)N1c1ccc(F)c(C(F)F)c1	5.28	group4-ia	ia	Androgen Receptor	Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay	2016	flu@@@LdbbRbbsbRxXRhijjjjjjj@@	fluP`@DXAIIfVU^]zLMzJVj`X@@HHL`@	320.269	2.9471	4	1	49.41	3	-0.659891135138005	0.34533517065349134	-0.20087007682070265	29	1	fnsPc@ENmxD`JPeHYEEDeLXhiUDdsc`u[@PUTsP@DPB`@											1
:UvUtOrWJ7wVLQvEZHVH9vB6B8K1V41Z7dKD43VF2VF0V0XDFo7k50CBw2Yk1VX0k1WV3H_F!V01FV0VV0FF	CHEMBL4763876	foAp`@DXLBVQQQJIQJtYYsUPM@P@@	CC1(C)NC(=O)N(c2cccnc2)C1=O	5.02	group4-ia	ia	Androgen Receptor	Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay	2016	dk\@@DjYVYxqVjjjj`@	dk_D@DqPeIfV]z[SZjA@`@@	205.216	0.2542	5	1	62.3	1	-1.00404224979032	2.847871011628854	-0.3350802168047249	33	1	foAp`@DXLBVQQQJIQJtYYsUPM@P@@											1
{x:v<bUfvUjhfzpmx_b7zKTjvjQzYwikbfyGqjrjiSCo3YqEcqxw5taYqbK1VkIGOz0c0c0F	CHEMBL4764992	ehZRBB@DLOOeLg`P@aZPvdCiCHhhhheEDlddeJiDeZN@jdnlbkgfjhDJ@JHjjm`jCb`@	N#Cc1ncc(N2C(=O)C3(CCOC3)N(c3ccc4c(c3)COC4=O)C2=S)cc1C(F)(F)F	6.29	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay	2021	fm@@@LddTTRTRjtTrRVYrR`y[Ohzjjjjjjjjjh@@	fmpR@DX|kLu`BLbbbbbTTRrRVcRipMTmrT\vjhDJ@JBi`jGJ@@	474.418	1.3817	8	0	127.85	3	2.1902327065359946	1.7874004759333961	1.6851893363484207	5	1	ehZRBB@DLOOeLg`P@aZPvdCiCHhhhheEDlddeJiDeZN@jdnlbkgfjhDJ@JHjjm`jCb`@											1
>Sznobw_rvvETPZ2CIwiCPp90g14IpK79AVmCXR4Y1XEIuX8ZXK8s28KQkVkt58b3FoF$4VY02YcGk	CHEMBL4776221	e`XVBL@NMCLbag@em`IABPpdLbdLTRRJfdvbVRfTdbcWUTAAtuURtuTTGd@@	CC(C)(C)OC(=O)Nc1cnn(C[C@](C)(O)C(=O)Nc2cnc(C#N)c(C(F)(F)F)c2)c1	5.21	group4-ia	ia	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	f`q@@@DjU^}eiqwjjjjjj@@	f`qI@@DBehBSJrkNjl{sUAAPi@@@	454.408	0.9673	10	3	142.16	8	4.44503225593022	1.8116418460891166	-1.2660183395214386	29	6	fe{hb`JLmF\c@|RNKYCl`NPrJJHiRZEQIIJQTXgMLuUM@AUWDAH@		diFD`LAJ@DfUijj`@									6
<jzSzfJbw1qujUTPV2C1ugBPp92h04IqK79Y03C2R4Y1VDIuX0ZX5Nk28GEV0Ft58aW0LF$4Vb08YcGV	CHEMBL4776248	fe{hc@EFrV[``dDRFICHiCEDdbiiMheeKS^uPPYSUUKYP}@@	C[C@](O)(Cn1cc(C#N)cn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	7.37	group2-a	a	Androgen Receptor	Antagonist activity at recombinant human AR F876L mutant expressed in COS cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	f`q@@@DjU^}eiqwjjjjjj@@	f`qq@@DBtAIeYUgUV]yj``hT`@@	363.298	0.6967	7	2	114.73	5	2.0507157723228246	2.124763108043864	-0.7444019644906978	29	22	ff}I@`DDMWP@fdCIqSxyEDhbiieDeBbLcfZfjZ@Hn@@@	eMJB@Df`@	gJPBAHJPt`PAIjj@@		eMbA@Dg`@							21
:UvzvOUfFbw3LPjSRPVHO9PgB@p1a844EiKC2W1YA0B0V3VDIqVFZ248cF2FEV02s_9Xl26H#1GFaVVV8F0	CHEMBL4777133	fjmP``M^\DD`JPeHJdLbbbRdubbftYrJXBBjifjH@@	CC1(C)CNC(=O)N(c2ccc(F)c(C(F)(F)F)c2)C1=O	5.16	group4-ia	ia	Androgen Receptor	Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay	2016	dg|@@LdbbbbRhgmuUUUU@@	dg}D@DpIrJJIQSHlivuTC@P@@	304.242	2.5243	4	1	49.41	2	-0.8829365063356729	0.7797575333991358	-0.25555271914888594	1	1	fjmP``M^\DD`JPeHJdLbbbRdubbftYrJXBBjifjH@@											1
:UvUtOrdJ7wVLQUUwHVHOtT6B0J1X81Z7eKE4YVI90N0V1XDHJbF50B8g23kEVV0c59XYHaF!V1GFb0VV8F0	CHEMBL4777511	fleQ@`M^\BPEHRdERFQQQIRZqQFLyxLAAUTuQ@@@	CC1(C)CN(c2ccc(F)c(C(F)(F)F)c2)C(=O)N1	5.09	group4-ia	ia	Androgen Receptor	Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay	2016	dcl@@DjYVWmEZjjjh@@	dcmH@DpLbbbTJULnmU@A@@@	276.232	2.7704	3	1	32.34	2	-1.5613630523812263	0.4896204218508481	-0.4323557199129014	17	1	fleQ@`M^\BPEHRdERFQQQIRZqQFLyxLAAUTuQ@@@											1
<jzSzfJbw1qujUTPWXC1ugBPp92h04IqK79Y03CHR4Y1VDIuX0ZX58k28GEk0Ft5@aW0LF$4Vb08YcGV	CHEMBL4778019	eg`RDL@ECLbg@`IABPpdLbdLTRRJfdvbRtRTfcWQuuTDFTuURp@DP^P@	C[C@](O)(Cn1ccc(-c2ccccc2)n1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	5.32	group4-ia	ia	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	ffc@@@LdbbRRqRbtRWEBdVmUUUUUUUP@@	ffcq@@DBtAIeYUg_eUV]xmVjBBaX@B@@@	414.386	2.6113	6	2	90.94	6	1.7607837426156028	0.3681733756508974	-0.7733534396285725	9	2	eg`RDL@ECLbg@`IABPpdLbdLTRRJfdvbRtRTfcWQuuTDFTuURp@DP^P@											1
:Uvzv;S:vyAzUzEsHQQUbCfM_mRCj7j6E6mYQEWPcZ7Y6HoZmB0hB80YqEcX1gCtXWH7090k1GF70V08!	CHEMBL4778185	fj}P``M^\DD`JPeHJdLbbbRdubbfrYst\e`HJjfZhjDR@@	O=C1C2CCCN2C(=O)N1c1ccc(F)c(C(F)(F)F)c1	5.46	group4-ia	ia	Androgen Receptor	Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay	2016	f`i@@@LdbbRbbvOCBT{uUUUUUP@@	f`iP`@DX@kHhhhhddkQfcN|uU@tAQAe@@	302.226	2.3641	4	0	40.62	2	-1.3034764132421817	0.8329380753908565	0.8046450761613172	1	1	fj}P``M^\DD`JPeHJdLbbbRdubbfrYst\e`HJjfZhjDR@@											1
:UvUtOrWJ7wVLQzEZHVH9vB6B8K1V41Z7dKD43VF2VF0V0XDFo7k50CBw2Yk1VX0k1WV3H_F!V01FV0VV0FF	CHEMBL4778298	flup`@DX|BVQQQJIQQVHtX{tTmU@t@@P@@@	CC1(C)NC(=O)N(c2ccnc3ccccc23)C1=O	5.89	group4-ia	ia	Androgen Receptor	Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay	2016	fhy@@@DjYegyfZDZwjjjjjjh@@	fhyp`@DXlBVQQQJKQZHtXZw`mU@`@D@@@	255.276	1.5711	5	1	62.3	1	-0.8023779257867921	1.8705804822950607	-0.24584438520542093	1	1	flup`@DX|BVQQQJIQQVHtX{tTmU@t@@P@@@											1
;xzxzxxlKxrKfEEx8_XN@va7FNhY4V6HpV5Aeg1Nq9ZOWVFflVdV4Jg0VW5Mn0d149Y404g102F1J090W0FV	CHEMBL4778550	e`\TJD@LJhDBck`@chHrRPqQQIJKSFUQIZYZ^VIAYSKKU@DADCTuMTB@@@	CCOC(=O)c1ccc(NC(=O)c2cccc(S(=O)(=O)N3CCCc4ccccc43)c2)s1	5.69	group4-ia	ia	Androgen Receptor	Antagonist activity at recombinant androgen receptor (unknown origin) transfected in human LNCaP cells co-transfected with PSA and luciferase incubated for 24 hrs by dual luciferase reporter gene assay	2019	fmo@@@LddTTLRRbtNatRtzrPyfnjjjjjjjjjh@@	fmoQa@LU``h@chQddabbbRTVfLjbVoVRGLukU@DADCTu@`@@	470.569	4.1412	7	1	129.4	6	2.5719620506190646	-0.34302669171335415	0.6002341081193413	1	1	e`\TJD@LJhDBck`@chHrRPqQQIJKSFUQIZYZ^VIAYSKKU@DADCTuMTB@@@											1
<jzSzYJbw1qufETPV2C1sgBPp90g04IoK79302C2R4Y1VDIuX0ZX5Nk28GAV0Ft58a10JF$4VY!YcGk	CHEMBL4778795	fe{Xc@NZMdlwAAHHdLRFQRFJIIESR[QKJRf}j`HNfjjVraz@@	C[C@](O)(Cn1cc(C#N)cn1)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1	7.23	group2-a	a	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	f`q@@@DjU^}eiqwjjjjjj@@	f`qI@@DBehBSJrkNjl{sUAAPi@@@	364.286	-0.2502	8	2	127.62	5	2.552582046278127	2.90572997805832	-0.6263552636072681	29	6	fe{hb`JLmF\c@|RNKYCl`NPrJJHiRZEQIIJQTXgMLuUM@AUWDAH@		eMbA@Dg`@									6
:UvztOzfJbwXLQzUwQVHOvTDB8K1mB5Z7fKE6YYIAVR8V3XDHobkC0CBg2YkEVX1s5tXYHbF10k1GFb0V08!	CHEMBL4778974	fjmP``M^\DD`JPeHJdLbbbRdubbftYstXBBjifjH@@	CN1C(=O)N(c2ccc(F)c(C(F)(F)F)c2)C(=O)C1(C)C	5.89	group4-ia	ia	Androgen Receptor	Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay	2016	dk\@@DjYVYxqVjjjj`@	dk]D@DpIRYeg^ftvj`PH@@	304.242	2.4571	4	0	40.62	2	-1.29723552697177	0.7695553795380509	0.8084470202256346	33	14	fhiP``AFuX@RRA|xa|TfYwf[v\LzB@jYjH@@	eFBH@c@@	eMBH@RZ@	gJPBAHJPt`PAIjj@@	eFABP`BL@							14
<jzSzfJbw1qujUTPV2C1ugB@p92h043qK79Y03C2R4Y1VDGmX0ZX58k20FEV0Ft58aW06F$4Vb08YcGV	CHEMBL4779474	fasHc@EFrUpPRBICDadTabbRQTtftReioZhHLijjeJGh@	C[C@](O)(Cn1cccn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	5.84	group4-ia	ia	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	f`q@@@DjU^}eiqwjjjjjj@@	f`qq@@DBtAIeYUgUV]yj``hT`@@	338.288	0.8611	6	2	90.94	5	1.2838483976477855	1.8233222809901315	-0.9337995398187574	29	22	ff}I@`DDMWP@fdCIqSxyEDhbiieDeBbLcfZfjZ@Hn@@@	eMJB@Df`@	gJPBAHJPt`PAIjj@@									21
<jzSzfJbw1qujUDPV2S1ug8Pp92j04IqK71Y02C2R4Y1VDIuX8ZY58k28GCk0kv10ZW0JF$4V_!YcGV	CHEMBL4779527	ff}Ha@NRCGU`QEYCHhhddUMImDlpVRpPYSUUKE@t@@	C[C@](O)(Cn1cc(F)cn1)C(=O)Nc1ccc(C#N)c(Cl)c1	6.37	group3-int	int	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	f`q@@@DjU^}eiqwjjjjjj@@	f`qq@@DBtAIeYUgUV]yj``hT`@@	322.726	0.7196	6	2	90.94	4	1.0500166477104071	2.0869172060592867	-0.9862510059674965	29	22	ff}I@`DDMWP@fdCIqSxyEDhbiieDeBbLcfZfjZ@Hn@@@	eMJB@Df`@	eFABH`BL@		eFABP`BL@							21
~v<jUfvUjhfzpux_bjzSDjvjQzYwiobfyGqbrjiSCZIYqEcqxwhtaYrbK1kkIGOz2c0c!	CHEMBL4780549	edV\BB@DL@ULohP@cZPNdKiCHhhhheEDldeMMeHekQpETetUL}|uU@aPAQEUU[ATGE@@	N#Cc1ccc(N2C(=O)C3(CCCOC3)N(c3ccc4c(c3)COC4=O)C2=S)cc1C(F)(F)F	6.85	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay	2021	ec`P@@@DjfYVWwnuWXxT|bJzVFfjjjjjjjjjjh@@	ec`TBH@DLELem`@cHhhhheEDldeibmQpETdtTMLluU@aPAPUSATGE@@	487.457	2.6706	7	0	114.96	3	1.746143961796686	0.7488243491216021	1.5920061534928436	3	1	edV\BB@DL@ULohP@cZPNdKiCHhhhheEDldeMMeHekQpETetUL}|uU@aPAQEUU[ATGE@@											1
<jzSzYJbw1qufETPV2C1sgBPp90g04IoK79302C2R4Y1VDIuX8ZX58k28GAk0kt58a10JF$4VY!YcGk	CHEMBL4781335	fikh``BTLDXm@dJrCYCladTRrTfaTRRRdQJQSRuUM@AUWDNH@	C[C@](O)(Cn1cc(F)cn1)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1	7.2	group2-a	a	Androgen Receptor	Antagonist activity at recombinant human AR F876L mutant expressed in COS cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	f`q@@@DjU^}eiqwjjjjjj@@	f`qI@@DBehBSJrkNjl{sUAAPi@@@	357.266	0.015	7	2	103.83	5	1.875710567393962	2.4769809159234035	-0.7856253058585502	29	6	fe{hb`JLmF\c@|RNKYCl`NPrJJHiRZEQIIJQTXgMLuUM@AUWDAH@		eFABP`BL@									6
:UvUtOrdJ7wVLQvEoHVH9vT6B8K1V41Z7dKD4YVG2VF0V1XDFobk50CBg2Yk5VX0k5WX3H_F!V01Fa0VV8F0	CHEMBL4781708	flePc@INmxD`bPqHYEHXdiihiXIS`uPAELuD@@	CC1(C)NC(=O)N(c2cccc(C(F)(F)F)c2)C1=O	5.22	group4-ia	ia	Androgen Receptor	Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay	2016	dk\@@DjYVYxqVjjjj`@	dk]D@DpIRYeg^ftvj`PH@@	272.225	2.1034	4	1	49.41	2	-1.0317403264683263	1.1515100089350736	-0.31042964048114247	33	14	fhiP``AFuX@RRA|xa|TfYwf[v\LzB@jYjH@@		eMBH@RZ@	gJPBAHJPt`PAIjj@@								14
:Uvzv;S:vyAzUzEcmQQUbCfMhnS5bMjZEEmfQElOco7fLQrZlg2Cg0VYnUfX1gCtaWHM110l1GJ7Gg0c!	CHEMBL4781726	fmoq@`DXVh@QvPGHSdLbbbbbTRVbtqTfirt_YSUjjAB@`bjzBGJ@@	N#Cc1ccc(N2C(=O)C3CCc4ccccc4N3C2=S)cc1C(F)(F)F	5.55	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay	2021	fjc@@@LdbbbRReQbRYHRmFrVjjjjjjjh@@	fjcQB@DXT@HRYfYYWgz\mGvTeZj`P`HB`ar`@	387.384	3.8394	4	0	79.43	2	-0.3002187319763593	-0.08504956394747346	1.0512474208615694	4	2	fmoq@`DXVh@QvPGHSdLbbbbbTRVbtqTfirt_YSUjjAB@`bjzBGJ@@											1
:UvUtOrWJ7wVLQvEZHVH9vB6B8K1V41Z7dKD43VF2VF0V0XDFo7k50CBw2Yk1VX0k1WV3H_F!V01FV0VV0FF	CHEMBL4782426	foAp`@DX\BVQQQJIQJtYYsUPM@P@@	CC1(C)NC(=O)N(c2ccncc2)C1=O	5.42	group4-ia	ia	Androgen Receptor	Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay	2016	dk\@@DjYVYxqVjjjj`@	dk_D@DppeIfV]z[SZjA@`@@	205.216	0.2542	5	1	62.3	1	-1.00404224979032	2.847871011628854	-0.3350802168047249	33	2	foAp`@DX\BVQQQJIQJtYYsUPM@P@@											1
vzUQfQzvESyndTvTHvK@fvb2TJZvjrQFkt2c3onX5Otl9FDUZP155o28g2cV0J73264O0V8D1D10184o04V0F0	CHEMBL4782786	fe`B@A@bLbbRrbTTRbRLJUFZmxLRyjN\@EUPUA@@U@@@	Clc1ccc(C2Nc3ccc4ccccc4c3C3C4CCC(C4)C23)cc1	5.13	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor in human LNCaP cells transfected with ARR2 PB-eGFP assessed as inhibition of DHT-induced transcriptional activity measured after 3 days by fluorescence assay	2020	fio@@@LdbbbbbVTvUfRxhUcQ]xN^cjjjjjjjjjj@@	fio`@@@YHhhheDhleDdjpTk^SGnVuGPTPDDEAADP@@	359.899	6.2362	1	1	12.03	1	-2.2586058072439807	-2.1739623523279272	-0.5315162355360074	2	2	fe`B@A@bLbbRrbTTRbRLJUFZmxLRyjN\@EUPUA@@U@@@											1
>U:pjxbzvzUzTa3EIziBUrCXzWKIrS7EvZ3CbRZY3eEMuecZX5Dk2dGEsaov_8aY0qF1V!4Vb09WckV	CHEMBL4782924	fkoi``EZmT~BRADSdErFyCHeLiEDUEDdlhUHhiJvfjfj`THjkbED@	C[C@@](Cn1cc(N)cn1)(OC(=O)CCl)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	6.04	group3-int	int	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	f`q@@@DjU^}eiqwjjjjjj@@	f`qq@@DBtAIeYUgUV]yj``hT`@@	429.785	0.8977	8	2	123.03	8	3.245289060491076	1.5766411063745978	-0.4459578504867681	29	22	ff}I@`DDMWP@fdCIqSxyEDhbiieDeBbLcfZfjZ@Hn@@@	gNpdLQDT@RVvfh@	gJPBAHJPt`PAIjj@@		eFbB@Hp@							21
<jzSzfJbw1qujUTPWXC1ugBPp92h04MqK79Y03CHR4Y1VDIuX8aaKNk@8GEk0kt5@aW0LF#FJVb08YcGV	CHEMBL4782992	e`TRDJ@MCLooD`IARPNdKiAzPrJIKJJHiRZEQISJQTLZFCSP@TsUTt@EUYDCb@@	C[C@](O)(Cn1cc(-c2ccc(F)cc2)c(F)n1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	6.54	group3-int	int	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	ffc@@@LdbbRRqRbtRWEBdVmUUUUUUUP@@	ffcq@@DBtCHhdhdeEdUDdjsoEjuPPTK@@P@@	450.366	3.0733	6	2	90.94	6	1.9285237482760789	-0.04298226110536435	-0.7117412595021585	9	6	e`TRDJ@MCLooD`GERPNdKiAzPrJIKJJHiRZEQISJQTLZFCSP@TsUTt@EUYDCb@@	eFABP`BL@										1
<jzSzfJbw1qujUTPV2C1ugBPp92h04IqK79Y03C2R4Y1VDIuX8ZX58k28GEk0kt58aW0LF$4Vb08YcGV	CHEMBL4783581	fikH``BTLLV`REYAlavPrJIYJSPjIJYRHeHiiZjf`@jkbGD@	C[C@](O)(Cn1cc(F)cn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	6.7	group3-int	int	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	f`q@@@DjU^}eiqwjjjjjj@@	f`qq@@DBtAIeYUgUV]yj``hT`@@	356.278	0.9619	6	2	90.94	5	1.37384445340489	1.6960139232225862	-0.9036719564433217	29	22	ff}I@`DDMWP@fdCIqSxyEDhbiieDeBbLcfZfjZ@Hn@@@	eMJB@Df`@	gJPBAHJPt`PAIjj@@		eFABP`BL@							21
<jzSzYJbw1qufETPV2C1sgBPp90g04IoK79302C2R4Y1VDIuX8ZX5Nk28GAk0kt58a10JF$4VY!YgGk	CHEMBL4784244	fmgX``DDDyJuVAb]dArDyCHheDmiMBhddeHbLrVZfzih@JjxaI@@	C[C@](O)(Cn1cc(C#N)c(Br)n1)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1	5.26	group4-ia	ia	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	f`q@@@DjU^}eiqwjjjjjj@@	f`qI@@DBehBSJrkNjl{sUAAPi@@@	443.182	0.5724	8	2	127.62	5	2.9293590785899895	2.1186542958678687	-0.4922463186803426	29	6	fe{hb`JLmF\c@|RNKYCl`NPrJJHiRZEQIIJQTXgMLuUM@AUWDAH@	eFACD`BL@	eMbA@Dg`@									6
:UvztU:JzxvTQzUzUkmQvUiC@M5mRCh7jME7nYQAlTcV3XTIqbkh2hBg2YoEcX1s5taYHbG14k1GFb0V08!	CHEMBL4786505	fcoP``M^\DD`JPeHJdLbbbRdubbftQTRSN^bo\AAUTsUT@A@@@	CC1(C)C(=O)N(c2ccc(F)c(C(F)(F)F)c2)C(=O)N1CCc1ccccc1	5.62	group4-ia	ia	Androgen Receptor	Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay	2016	fj}@@@LdbbRbbsRbRxXRlejjjjjjjh@@	fj}P`@DX@iIfYgW^uhrwleZj`XH@B@@@	394.367	4.3053	4	0	40.62	5	-0.4339680508743634	-1.0381702823157675	1.0446991915744095	1	1	fcoP``M^\DD`JPeHJdLbbbRdubbftQTRSN^bo\AAUTsUT@A@@@											1
:UvztOzfJ7wYLQzUwQVHOPT@B8K1mB5Z7fKE6XXIAVR8k1XD2oalc25Bc2WVEVV1s5tXYHaG!k1GFb0VV8F0	CHEMBL4786811	fbuP``M^]dD`JPeHJdLbbbRdubbdKN^C@PUUMTd@@	CC1(C)C(=O)NC(=O)N1c1ccc(F)c(C(F)(F)F)c1	5.55	group4-ia	ia	Androgen Receptor	Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay	2016	dk\@@LdbbRbU{QVjjjj`@	dk]D@DpIRYem^ftvj`PH@@	290.215	2.2042	4	1	49.41	2	-0.9417444342268058	1.024201728504972	-0.2803021070112272	1	1	fbuP``M^]dD`JPeHJdLbbbRdubbdKN^C@PUUMTd@@											1
:Uvzv;S:vyAzUzEdmQQzbCvMjnS5bMzZEEmfQElOgp7fLQzZli2ChFcfnUvn1hCva_HM158p1GJ7Gg1s0V	CHEMBL4787221	elQZHB@DLMcge@@cjPFdIiCHhhhheDehmLUHeYdmJNKHoLdjgohTVjhDHBBJjvfj`jCb`@	N#Cc1ccc(N2C(=O)C3CCc4cc(-c5ccn(C6CC6)n5)ccc4N3C2=S)cc1C(F)(F)F	5.34	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay	2021	ekdP@@@DjYeUo^yU_fEAIMCJfaemcjjjjjjjjjjjh@@	ekdRHH@DLFae@@cHhhhheDehmjhdmJNKHoLdbaimcfjhDHB@ffj`jCb`@	493.512	4.4697	6	0	97.25	4	1.3222840509876088	-0.7267382860096124	1.503827925672972	1	1	elQZHB@DLMcge@@cjPFdIiCHhhhheDehmLUHeYdmJNKHoLdjgohTVjhDHBBJjvfj`jCb`@											1
=xOzfobwbMQzUwQ_H9vTDB8K1mC_Z7vKDDffIQVRDkYeDFobpj6SCo2YkEVm_s5tXYmbK10kGGFr0c0c0F	CHEMBL4787631	eodRLB@DLHkeCg`@`ZPfdEiCHhhhheEDlcLdiDeZN@ldjmcfjhDJ@BJjkXH@@	CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=S)N1c1cnc2c(c1)COC2=O	5.64	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay	2021	fnk@@@DjYVV}V}~ZDkpZmjjjjjjjjh@@	fnkqb@DX|jkPABSLsK[knmNNbEIZmUPH@@ULD@@	446.408	2.1549	7	0	118.62	3	1.6131031818564978	1.2379059369964331	1.5310894240682056	4	1	eodRLB@DLHkeCg`@`ZPfdEiCHhhhheEDlcLdiDeZN@ldjmcfjhDJ@BJjkXH@@											1
:UvUvtMdR7w0LAzUNHFHOtP7B8pWX8983iME4V0IAV8!1YDHF_F40g8E2XHEV20R59XnF6F!V11Fa#8!	CHEMBL4787997	fbu```MNBBPEHRdERFQQQIRZqQSQgOQ`HJjfZb@@	CC1(C)CC(=O)N(c2ccc(F)c(C(F)(F)F)c2)C1=O	6.04	group3-int	int	Androgen Receptor	Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay	2016	dk\@@DjYVYxqVjjjj`@	dk^D@DBTfYYwimMjhDB@@	289.227	2.5681	3	0	37.38	2	-1.6784320482266304	0.6138897152692951	0.6875261995142494	33	1	fbu```MNBBPEHRdERFQQQIRZqQSQgOQ`HJjfZb@@											1
:UvzvU:KzxvyQzUzEXHvQUiCfMCnS5bMjZEEnjQEYOck7eLIrZng3CC0VYlUda1c5taWHM118p1GJEGg0g!	CHEMBL4788710	fcqA`INwxFHpHlDCdIrByAIe[UV_e[ZZ\dhsbu`BJjY`@jkJHJh@@	N#Cc1ccc(N2C(=O)C3CSc4cc(Br)ccc4N3C2=S)cc1C(F)(F)F	4.74	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay	2021	fjc@@@LdbbbRReQbRYHRmFrVjjjjjjjh@@	fjcQA@DXT@HBDYEEEEDhdmEcSe`~rdkUTBDD@TDNT@@	484.319	3.5973	4	0	104.73	2	0.6285707487801301	-0.11339607453076392	1.2738898056821453	4	1	fcqA`INwxFHpHlDCdIrByAIe[UV_e[ZZ\dhsbu`BJjY`@jkJHJh@@											1
]x;yAzUzEhmQQzbSvMhnS5bMzZEEmfQElOgp7fLQzZti6SxFcYnUvm1hCva_HM138pGGJ7Gg1c0V	CHEMBL4788869	edVRDB@DLM`UG`@cjPFdIiCHhhhheDehmLUHeYhiQqYEydeT|BuU@a@PQUVuMPTGE@@	Cc1noc(C)c1-c1ccc2c(c1)CCC1C(=O)N(c3ccc(C#N)c(C(F)(F)F)c3)C(=S)N21	5.22	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay	2021	feo@@@LdbbbRRfrttRRKEBehuVcgUUUUUUUUUT@@	feopb@DXfhX@cHhhhheDehmjheSeh~rdhymUPHPDAMMAPyP@	482.485	4.7047	6	0	105.46	3	1.2266680644989831	-0.6460709536309627	1.481698716651531	1	1	edVRDB@DLM`UG`@cjPFdIiCHhhhheDehmLUHeYhiQqYEydeT|BuU@a@PQUVuMPTGE@@											1
>v:yiyx:yzhtBzQI@zx9:vZWVI2VUBzmKgpK9LBE6Q30loV1gYV_1JA3048sVVNL16W1VcLZG0V0F0	CHEMBL4790160	ffs``@J@QdTRbRfbRQfRejs`qKUjjjB`@BP@@	CCOC(=O)C1Nc2ccc3ccccc3c2C2C=CCC12	6.09	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor in human LNCaP cells transfected with ARR2 PB-eGFP assessed as inhibition of DHT-induced transcriptional activity measured after 3 days by fluorescence assay	2020	fhe@@@DjYfYuvJEXpW^jjjjjjh@@	fhe`@@@YHheDeEdcS`eFmxMADPTAB@@@	293.365	3.4758	3	1	38.33	3	-1.249447619034634	-0.07485008946374942	-0.35913334575472183	1	1	ffs``@J@QdTRbRfbRQfRejs`qKUjjjB`@BP@@											1
<UxOrdo7wZMQzUwHZHSvT6B8K1Xg147fKE4fVIAVN0X1XEHobk5VCBg2YFEVXJs59XYHbF0VV1Kkb0208!	CHEMBL4790269	fbua``MN|DD`JPeHJdLbbbRdubbecN^c@PUULuD@@	CC1(C)OC(=O)N(c2ccc(F)c(C(F)(F)F)c2)C1=O	5.68	group4-ia	ia	Androgen Receptor	Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay	2016	dk\@@DjYVYxqVjjjj`@	dk^L@LAIRY[e\ftvj`PH@@	291.199	2.3477	4	0	46.61	2	-1.2644328299736265	0.9276262735663513	0.8016619469192608	33	1	fbua``MN|DD`JPeHJdLbbbRdubbecN^c@PUULuD@@											1
<jzSzYJbw1qvfETPV2CGsgBPp90g04IoK79302C2R4YGVDIuX0ZXKNk28GQk1Ft58a30JF$4VY!YcGk	CHEMBL4790541	fcwha`NZMdk``dDRFIB\`nPwHYEHXhddUMImDliIJ[vj@`zZjiZhh^`@	C[C@](O)(Cn1cc(C(F)(F)F)cn1)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1	6.68	group3-int	int	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	f`q@@@DjU^}eiqwjjjjjj@@	f`qI@@DBehBSJrkNjl{sUAAPi@@@	407.273	0.7625	7	2	103.83	6	2.2624235977846583	1.7213570677952286	-0.6733369807725756	29	6	fe{hb`JLmF\c@|RNKYCl`NPrJJHiRZEQIIJQTXgMLuUM@AUWDAH@		gJPBAHJPt`PAIjj@@									6
~vzUzUjzAzUUhfz_nS_bMzKDivfQUlxiobfyFobpj6ShZ3fmEsmhwCtXYmjK18o1GFr0c0c!	CHEMBL4792484	edV\LB@DLOe@XP@aZPvdCiCHhhhheEDldeMJiDeYQpETeudT}BuU@aPAQEUUmAP@@	N#Cc1ccc(N2C(=O)C3(CCCC3)N(c3ccc4c(c3)CCOC4=O)C2=S)cc1C(F)(F)F	6.87	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay	2021	ec`P@@@LddTTRTRjtTrRVcGDb`VSTpruUUUUUUUUUU@@@	ec`TLH@DLEEm`@cHhhhheEDldehtiQpETdudUMluU@aPAPUMAP@@	485.485	4.2181	6	0	105.73	3	1.2697040841371294	-0.3626965346879314	1.484786544445039	1	1	edV\LB@DLOe@XP@aZPvdCiCHhhhheEDldeMJiDeYQpETeudT}BuU@aPAQEUUmAP@@											1
<jzSzfJbw1qujUTPV2C1ugBPp92h04IqK79Y03C2R4Y1VDIuX8ZX58k28GEk0kt58aW0LF$4Vb08YcGV	CHEMBL4792938	fikH``BTLLV`REYAlavPrJIYJSPjIJYRHeHiiZjf`@jkbGH@	C[C@@](O)(Cn1cc(F)cn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	6.72	group3-int	int	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	f`q@@@DjU^}eiqwjjjjjj@@	f`qq@@DBtAIeYUgUV]yj``hT`@@	356.278	0.9619	6	2	90.94	5	1.37384445340489	1.6960139232225862	-0.9036719564433217	29	22	ff}I@`DDMWP@fdCIqSxyEDhbiieDeBbLcfZfjZ@Hn@@@	eMJB@Df`@	gJPBAHJPt`PAIjj@@		eFABP`BL@							21
zrUtUlOM9J7w0H@EUN2V2N@P0B0J1XB046f470X03AV80V1V22JZV!48801VEV!c5dXW27#V1GF70VV8F0	CHEMBL4793070	fdyP``M^\DD`JPeHJdLbbbRdubbcN^c@PUULq@@@	O=C1CNC(=O)N1c1ccc(F)c(C(F)(F)F)c1	6.58	group3-int	int	Androgen Receptor	Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay	2016	dk\@@DjYVYxqVjjjj`@	dk]D@DpIRYeg^ftvj`PH@@	262.162	1.5815	4	1	49.41	2	-1.0601783777763036	1.5025661877720844	-0.3297080242260911	33	14	fhiP``AFuX@RRA|xa|TfYwf[v\LzB@jYjH@@			gJPBAHJPt`PAIjj@@	eFABP`BL@							14
=vS:LEwYqQ:wTXHvvTaCAr1Xg5_7jKE7nVIEYN0V5XDIqbk5VCBg2YkEca0s5daYHbF!V3GFj0VX8G0	CHEMBL4793158	fjmQ``M^\DhI@TaJPUHYEEDeIkEEKDsghpDEUSMTTHd@@	CC1(CO)NC(=O)N(c2ccc(F)c(C(F)(F)F)c2)C1=O	5.32	group4-ia	ia	Androgen Receptor	Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay	2016	dk\@@DjYVYxqVjjjj`@	dk]D@DpIRYeg^ftvj`PH@@	306.214	1.2775	5	2	69.64	3	0.19089842253285863	1.6564996528311704	-1.1793835585233883	33	14	fhiP``AFuX@RRA|xa|TfYwf[v\LzB@jYjH@@		gCaH@`AIZ`@	gJPBAHJPt`PAIjj@@	eFABP`BL@							14
<jzSzfJbw1qujUTPWXC1ugBPp92h04IqK79Y03CHR4Y1VDIuX0aX58k@8GEk0Ft5@aW0LF$4Vb08YcGV	CHEMBL4793442	eohRDB@AEDggH`ICZPNdKiCHhdlhdliMBhdieHjFEMNah@Iijih@JjrHKD@@	C[C@](O)(Cn1ccc(-c2ccc(F)cc2)n1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	5.97	group4-ia	ia	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	ffc@@@LdbbRRqRbtRWEBdVmUUUUUUUP@@	ffcq@@DBtAIeYUg_eUV]xmVjBBaX@B@@@	432.376	2.7121	6	2	90.94	6	1.8507797955682792	0.240864982052109	-0.7432258559425096	9	2	eohRDB@AEDggH`ICZPNdKiCHhdlhdliMBhdieHjFEMNah@Iijih@JjrHKD@@											1
<jzSzfJbw1qujUTPWXC1ugBPp92h04IqK79Y03CHR4Y1VDIuX0aX5Nk@8GEV0Ft5@aW0LF#F4Vb08YcGV	CHEMBL4794197	e`TRDL@ECLbg@`IABPpdLbdLTRRJfdvbVTRVTfcWQuuTDFTuURp@VQAy@@	C#Cc1ccc(-c2cnn(C[C@](C)(O)C(=O)Nc3ccc(C#N)c(C(F)(F)F)c3)c2)cc1	6.56	group3-int	int	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	ffc@@@LdbbRRqRbtRWEBdVmUUUUUUUP@@	ffcq@@DBtCHhdhdeEdUDdjsoEjuPPTK@@P@@	438.408	2.6215	6	2	90.94	6	1.8868080950131854	0.27296057531312773	-0.7337724913052884	9	6	eohRDB@EMDggH`GGZPNdKiCHhdlhediMBhdieHjFEMNah@JVjih@JjrHKD@@	eMBD@cx@										5
<jzSzYJbw1qufETPV2C1sgBPp90g04IoK79302C2R4Y1VDIuX8ZX58k28GAk0kt58a10JF$4VY!YgGk	CHEMBL4794467	fe{hb`JLmF\c@qBRCYCl`NPrJJHiRZEQIIJQTXgMLuUM@AUWDAH@	C[C@](O)(Cn1cc(Br)c(F)n1)C(=O)Nc1cnc(C#N)c(C(F)(F)F)c1	7.46	group2-a	a	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	f`q@@@DjU^}eiqwjjjjjj@@	f`qI@@DBehBSJrkNjl{sUAAPi@@@	436.162	1.0916	7	2	103.83	5	2.2405367764546193	1.5372135337508426	-0.650192650538197	29	6	fe{hb`JLmF\c@|RNKYCl`NPrJJHiRZEQIIJQTXgMLuUM@AUWDAH@	eFABP`BL@	eFACD`BL@									6
]x<vzUzUjUAzUUCfz_mS_bEzKDyvfQUWwiobfyFobpj6SCZ3YmEcmhwCtXYnjK10kGGFr2c0c!	CHEMBL4794639	edV\LB@DL@UOhP@cZPNdKiCHhhhheEDldeMMeHekQpETetUL}|uU@aPAQEUU[AP@@	N#Cc1ccc(N2C(=O)C3(CCCCC3)N(c3ccc4c(c3)COC4=O)C2=S)cc1C(F)(F)F	7.02	group2-a	a	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay	2021	ec`P@@@DjfYVWwnuWXxT|bJzVFfjjjjjjjjjjh@@	ec`TLH@DLEEm`@cHhhhheEDldeibmQpETdtTMLluU@aPAPUSAP@@	485.485	3.8346	6	0	105.73	3	1.2877479524272737	-0.13215602165695456	1.4827879494117724	3	1	edV\LB@DL@UOhP@cZPNdKiCHhhhheEDldeMMeHekQpETetUL}|uU@aPAQEUU[AP@@											1
vzUQAQtn9RDmVLATHsG8XQ32LJ0nfnA0VI2V7BmX5OlG9FBE4P105o!g2cV1J33064OVV8L161018Jo10V0F0	CHEMBL4796332	fag`B@A@bLbbRrbTTRRLrUFZmxJ\m{@AUTE@@AH@@@	Clc1ccc(C2Nc3ccc4ccccc4c3C3C=CCC32)cc1	5.72	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor in human LNCaP cells transfected with ARR2 PB-eGFP assessed as inhibition of DHT-induced transcriptional activity measured after 3 days by fluorescence assay	2020	fn{@@@LdbbbbbVVubRxhUcA]zkZjjjjjjjj`@@	fn{`@@@YHhhheDhldebpTk^SFiVtEDAAA@DH@@@	331.845	5.7154	1	1	12.03	1	-2.3818393546258174	-1.7568515086501926	-0.5803927102308419	4	4	fiw`A@I@|VNNQQIPjIQQIHsITxYpXyKt\@QUTE@@AH@@@		eFABH`BL@									4
<jzSzfJbw1qujUTPV2C1ugBPp92h04IqK79Y03C2R4Y1VDIuX8ZX58k28GEk0kt58aW0LF$4Vb08YgGV	CHEMBL4797334	fikH``BTLLV`XeYAlavPrJIYJSPjIJYRHeHiiZjf`@jkbGD@	C[C@](O)(Cn1cc(Br)cn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	6.37	group3-int	int	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	f`q@@@DjU^}eiqwjjjjjj@@	f`qq@@DBtAIeYUgUV]yj``hT`@@	417.184	1.5863	6	2	90.94	5	1.6652081469165911	1.0947984515033795	-0.8001981908907462	29	22	ff}I@`DDMWP@fdCIqSxyEDhbiieDeBbLcfZfjZ@Hn@@@	eMJB@Df`@	gJPBAHJPt`PAIjj@@		eFACD`BL@							21
vzUQAQtn9RDmVLATHsG8XQ32LJ0nfn20VI2V7BmX5NlO9FBE4P101o!g2VV1L33064OVV8L161!8JZ14V0F0	CHEMBL4797715	fag`B@A@bLbbbRaTTRRLrSNZmxJ\m{@PUTE@@AH@@@	Clc1ccccc1C1Nc2ccc3ccccc3c2C2C=CCC21	5.4	group4-ia	ia	Androgen Receptor	Displacement of fluormone-AL green from GST-tagged androgen receptor LBD (unknown origin) measured after 4 hrs by fluorescence polarization assay	2020	fn{@@@LdbbbbbVVubRxhUcA]zkZjjjjjjjj`@@	fn{`@@@YHhhheDhldebpTk^SFiVtEDAAA@DH@@@	331.845	5.7154	1	1	12.03	1	-2.3818393546258174	-1.7568515086501926	-0.5803927102308419	4	4	fiw`A@I@|VNNQQIPjIQQIHsITxYpXyKt\@QUTE@@AH@@@	eFABH`BL@										4
;UvUzvUzynzTzTmvpDmz7Lqo4vzvQVWO3cn5mm5tlOOFDE5Q305o10h2tW0LI3064O4V865615305p04V0F0	CHEMBL4798254	feoaA@AAADJbLbbbRbrfbRRtJSNF]DnZcg@PUUAPP@E@@@	Clc1ccc(C2Nc3ccc4ccccc4c3C3OCCCC23)c(Cl)c1	4.69	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor in human LNCaP cells transfected with ARR2 PB-eGFP assessed as inhibition of DHT-induced transcriptional activity measured after 3 days by fluorescence assay	2020	fag@@@LdbbbbbTQQtJPeRlZOdm{UUUUUUUUU@@@	faga@@E@rQQJJZJHiJ[KTdIQoQJwmUATA@@@T@@@	384.305	5.5466	2	1	21.26	1	-1.7043889737424762	-1.661359051175858	-0.38291095909744366	1	1	feoaA@AAADJbLbbbRbrfbRRtJSNF]DnZcg@PUUAPP@E@@@											1
vzUQAQtn9RDmVLATHsG8XQ32LJ0nfn!VI2V7BmX5NlO9FBE4P101o!g2VV1L33044OVV8L161!8JZ14V8F0	CHEMBL4798606	fag`B@A@dLbbbRaTTRRLrSNZmxJ\m{@PUTE@@AH@@@	Fc1ccccc1C1Nc2ccc3ccccc3c2C2C=CCC21	6.66	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor in human LNCaP cells transfected with ARR2 PB-eGFP assessed as inhibition of DHT-induced transcriptional activity measured after 3 days by fluorescence assay	2020	fn{@@@LdbbbbbVVubRxhUcA]zkZjjjjjjjj`@@	fn{`@@@YHhhheDhldebpTk^SFiVtEDAAA@DH@@@	315.39	5.2102	1	1	12.03	1	-2.4447244011270204	-1.3921308331419986	-0.61010193751306	4	4	fiw`A@I@|VNNQQIPjIQQIHsITxYpXyKt\@QUTE@@AH@@@	eFABP`BL@										4
<jzSzfJbw1qujUTPV2C1ugBPp92h04IqK79Y03C2R4Y1VDIuX8ZX58k28GEk0kt58aW0LF$4Vb08YgGV	CHEMBL4798843	fikH``BTLLV`UeYAlavPrJIYJSPjIJYRHeHiiZjf`@jkbGD@	C[C@](O)(Cn1cc(I)cn1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	5.69	group4-ia	ia	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	f`q@@@DjU^}eiqwjjjjjj@@	f`qq@@DBtAIeYUgUV]yj``hT`@@	464.18	1.2982	6	2	90.94	5	1.9262529490638416	1.0937135228519634	-0.7243685023344357	29	22	ff}I@`DDMWP@fdCIqSxyEDhbiieDeBbLcfZfjZ@Hn@@@	eMJB@Df`@	gJPBAHJPt`PAIjj@@		eFABl`BL@							21
:Uvzv;S:vyAzUzEdmQQUbCfMhnS5bMzZEEmfQElOco7fLQrZli2ChFVYnUfX1gCta_HM118p1GJ7Gg0c0F	CHEMBL4798945	ehZRHB@DLMge@@cjPFdIiCHhhhheDehmLUHeYdjNKHoLdjo`VjhDHBBJjp@hBCb`@	N#Cc1ccc(N2C(=O)C3CCc4cc(-c5cccnc5)ccc4N3C2=S)cc1C(F)(F)F	5.41	group4-ia	ia	Androgen Receptor	Antagonist activity at androgen receptor (unknown origin) expressed in HEK293 cells using DHT as substrate preincubated for 30 mins followed by substrate addition measured after 24 hrs by Steady-Glo luciferase assay	2021	fm@@@DjYeUo^yU]baRtYlqkjjjjjjjjjj`@@	fmqB@DXFh@QdTTTTRbRtVuTRUNVc{JRsVuU@a@PD@E@PyP@	464.47	4.4977	5	0	92.32	3	0.6854052003561835	-0.6720651664333609	1.328984561259978	4	2	ehZRHB@DLMge@@cjPFdIiCHhhhheDehmLUHeYdjNKHoLdjo`VjhDHBBJjp@hBCb`@											1
:UvztQ:JjwnTQzUwQkHQvUDC@M1mBCZ7fME6nYIAWT8V3XDHobkC0CBg2YoEcX1s5tXYHbF10k1GFb0V08!	CHEMBL4799175	ff}P``M^\DD`JPeHJdLbbbRdubbftSN^c@PUULuTP@@	CCN1C(=O)N(c2ccc(F)c(C(F)(F)F)c2)C(=O)C1(C)C	6.85	group3-int	int	Androgen Receptor	Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay	2016	dk\@@DjYVYxqVjjjj`@	dk]D@DpIRYeg^ftvj`PH@@	318.269	2.8634	4	0	40.62	3	-1.0839462003711269	0.35246844463989735	0.8597527092868089	33	14	fhiP``AFuX@RRA|xa|TfYwf[v\LzB@jYjH@@	eMBD@ch@	eMBH@RZ@	gJPBAHJPt`PAIjj@@	eFABP`BL@							14
:UvUtOrdJ7wVLQzUgHVHOvT6B8K1XB1Z7fKE4YVI3VF0V1XDFobk50CBg2YkCVX0s1WVYHbF!V1GFb0VVcF0	CHEMBL4799429	fdypb@NRlYpICHhhdbhhiXpUoPPYTsTP@@	CC1(C)NC(=O)N(c2ccc(F)c(C#N)c2)C1=O	5.43	group4-ia	ia	Androgen Receptor	Inhibition of wild-type androgen receptor in human LAPC4 cells assessed as inhibition of DHT-induced luciferase activity measured after 24 hrs by luciferase reporter assay	2016	dk\@@DjYVYxqVjjjj`@	dk]D@DpIRYeg^ftvj`PH@@	247.228	1.1915	5	1	73.2	1	-0.6515860428816619	2.2085746645333573	-0.2333204000218793	33	14	fhiP``AFuX@RRA|xa|TfYwf[v\LzB@jYjH@@		eMBH@RZ@	eMbA@Dg`@	eFABP`BL@							14
:UvzdzSzKxx3RAOUU8GY8u96EH2dVC9@Hx2EeV1HPoeZF020XN5tX0o0BBeWKkId92WccFK110VG1F&V	CHEMBL479988	egh\D@@DFK@ClbbbbRbZbbRTVRV`dbaaWTvsUSUUPP@ACR@@@	CC(=O)c1ccc(N(Cc2ccccc2)c2cc(C(=O)N3CCCC3)n(C)c2)cc1	5.7	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	few@@@LdbbRbVRfrTVaWMFlfhyuUUUUUUUUT@@	fewq@@DLLCHhhhdeUEDdhllJRmYZN[USUUA@@AH@@@	401.508	2.9099	5	0	45.55	6	0.15191295658226844	-0.18961723703560965	1.1763786885102152	14	13	egh\HL@AHia`@gIqz|\bbRrTTTRRTrvabUC@QTRQut@ETCALUMUAP@@		gCaHA`AIf`@									10
<jzSzfJbw1qujUTPV2S1ugBPp93h04Iqp79Y03C2R4Y1VDIvXBZY59kX8GEl0kt58aW0LF08514VbGBYgGV	CHEMBL4800363	fe{Hb`BVKUS`UdYALafPgHYEEDdeDmHiBxefBzNBBIkjjjVJFh@	C[C@](O)(Cn1cc(F)cn1)C(=O)Nc1cc(C(F)(F)F)c(C#N)cc1I	5.26	group4-ia	ia	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	f`q@@@DjU^}eiqwjjjjjj@@	f`qq@@DBtAIeYUgUV]yj``hT`@@	482.17	1.399	6	2	90.94	5	2.0162490020165182	0.9664051292531748	-0.6942409186483728	29	22	fmgI@PDDLoP@fdCIqCVY|^r@yB\adTRbJffTTVbrdQFIKMSUMAAEU\@@@	eMJB@Df`@			eFABP`BL@							1
>U:pjx:vzUzTaIjvziCzrCax57MzKEEvZQEfRZY3uEMyju_eCBw2fGEsiot59aYHrH1VV1Ksj0@1c0V	CHEMBL4800572	fmwI``BTllQg@dNr@yB\`drztmJvtdijvRtmUTs@AUWQCb@@	C[C@@]1(Cn2cc(F)cn2)OC(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C1=O	5.95	group4-ia	ia	Androgen Receptor	Antagonist activity at recombinant human AR expressed in HEK293 cells assessed as inhibition of R1881-induced transcriptional activity measured after 24 hrs by dual luciferase reporter gene assay	2020	flu@@@LdbbRbbsTRxXRhijjjjjjj@@	fluq`@LZ\ABdfVVU^]HrpXiZj`XJEb@@	382.272	1.184	7	0	88.22	4	0.9906211619600597	1.7155834215701635	1.3692211646754204	1	1	fmwI``BTllQg@dNr@yB\`drztmJvtdijvRtmUTs@AUWQCb@@											1
zrQtTWOK8J5w0FA9PN0G08PV0BF09VB80Ht278V0HPV84NV!XN0CX0J#cWJkGW90WVV0K9#G1F!130VV	CHEMBL480162	fegI`BHR|LBNpeGIMrnsJlj||ExKYm@ATuHTCA@@@	Cn1cc(N(Cc2ccccc2)c2ccc([N+](=O)[O-])cc2)cc1C(N)=O	5.71	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	flu@@@LdbbRbVReRyhuhijjjjjjj@@	fluP@@@ZrRJJIIIQUYWmFbfhF`d@@`@@	350.377	0.7081	7	1	97.08	6	1.580708624879475	1.929411977497568	0.30230075319631566	8	6	fakpbBD\JwhGDl}{HhhbhhdeEdehQchykSUTD@@Pr@@@	gCiHDL@ILt@@										6
<UbtK9u5w45Dfy8VpX8@cWoN0lVE802R0K8iF2Wo8410V0fk4W24JNG871520VA131V04420Vl101!1#	CHEMBL480182	figPb@AEUXDPdrnrv|klmFJtgOQp@STl@EUDPHZ`	O=C1ON=C(c2ccc(Cl)cc2)/C1=C/c1ccc(N2CCCC2)cc1	6.4	group3-int	int	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	fa{@@@LdbbRbVUbRrbWMBUEK^uUUUUUUUU@@@	fa{P`@BY@cHheLeEDdebhdRchaRwkUM@@@EUHPHTP	352.82	4.8877	4	0	41.9	3	-0.9766512963013689	-0.9831733188896935	0.9304134798071669	1	1	figPb@AEUXDPdrnrv|klmFJtgOQp@STl@EUDPHZ`											1
:UtzdzSzKxx3RAOEE8F38uQ6EH2dV49@Hx2EeV1G@ZeZ0120XN_t!o0B4eWKk3W12VV8FK010VF1F6%V	CHEMBL480183	fnsq@@DLlCHhhhdhfhidhaRT[IVjfjj`@jP@@	Cc1cc(C)cc(N(C)c2cc(C(=O)N3CCCC3)n(C)c2)c1	4.58	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	flu@@@DjU^uymiqVhijjjjjjj@@	fluq@@DLLCHhhhdeThdaRUjJVjfjh@I@@@	311.428	2.3084	4	0	28.48	3	-1.2891169129771045	0.6224251454904642	0.8147021601107933	7	7	fnsqB@HJSDCcdTTTRRTRSfbTcJuUmPLDeTuTT@@	eFBH@c@@										4
;tzdzSzKxx3RAOUU8G38ud6EH2dVCA@Hx2EeV1HQZeZNV20XN5xX0o0B4eWKkIW92WVcFK9W0VG1FF!301V	CHEMBL480934	eodRB@DHIOA`DNchIP{HihdlhhdeDdmDXdnAO@fikgf`@jZdJAbjbH@@	Cn1cc(N(Cc2ccc(O)cc2)c2ccc([N+](=O)[O-])cc2)cc1C(=O)N1CCCC1	5.32	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	few@@@LdbbRbVRfrTVaWMFlfhyuUUUUUUUUT@@	fewq@@DLLCHhhhdeUEDdhllJRmYZN[USUUA@@AH@@@	420.468	1.7714	8	1	94.53	6	2.103568410225371	1.1324393073765908	0.5052299256238019	14	13	egh\HL@AHia`@gIqz|\bbRrTTTRRTrvabUC@QTRQut@ETCALUMUAP@@		gChhhE`BRnRYh@	eFJB@Hp@								10
:UtzdzSzKxx3RAOUU8F38u96EH2dVC9@Hx2EeV1HPZeZF020XN5tV0o0B4eWKk3W92WVcFK110VG1F$V0V	CHEMBL480955	ek`RH@@DFKC`LbbbbRbZbbRTVRVDdTLJzfvZjZjjB@@Hy@@@	Cn1cc(N(Cc2ccccc2)c2ccc(C#N)cc2)cc1C(=O)N1CCCC1	6.21	group3-int	int	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	few@@@LdbbRbVRfrTVaWMFlfhyuUUUUUUUUT@@	fewq@@DLLCHhhhdeUEDdhllJRmYZN[USUUA@@AH@@@	384.482	2.8743	5	0	52.27	5	0.01347215990665021	0.06503763141234264	1.139175343900138	14	13	egh\HL@AHia`@gIqz|\bbRrTTTRRTrvabUC@QTRQut@ETCALUMUAP@@		eMbA@Dg`@									10
;xzhzSzpxx7SAOUU8K38u96EH2dVC9@Hx2Eec1HPZeZFV20XN5xX4o0B5eWKkId92WVcFK510VG1FF%V	CHEMBL480959	eod\L@@E@i`DAlbbTrVTTRRbRVbLrDdBbzVn^Z`@jZdJAbjH`@@	COC(=O)c1ccc(N(Cc2ccccc2)c2cc(C(=O)N3CCCC3)n(C)c2)cc1	5.21	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	few@@@LdbbRbVRfrTVaWMFlfhyuUUUUUUUUT@@	fewq@@DLLCHhhhdeUEDdhllJRmYZN[USUUA@@AH@@@	417.507	2.9517	6	0	54.78	7	0.7859813255023824	-0.2063418865009085	1.3410691025361	14	13	egh\HL@AHia`@gIqz|\bbRrTTTRRTrvabUC@QTRQut@ETCALUMUAP@@		gJPh@l@ILmP@									10
zrvxPWOK8J5s0FA9PN0G08@V0BF09Vg80HO278V02PV84NV!XN0CXVJ#c1JkGl901VV0KC#G1F#301V	CHEMBL480960	fi{q`BHR|AGXRcdfyWYeVU]xKpVcZ@BijPhHH@@	Cn1cc(N(Cc2ccccc2)c2ccc([N+](=O)[O-])cc2)cc1CO	5.68	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	flu@@@LdbbRbVReRyhuhijjjjjjj@@	fluP@@@ZrRJJIIIQUYWmFbfhF`d@@`@@	337.378	1.0235	6	1	74.22	6	0.8849466569567215	1.4994790433649052	0.1358212225780143	8	6	fakpbBD\JwhGDl}{HhhbhhdeEdehQchykSUTD@@Pr@@@	eMJA@Df`@										6
;rUbdK8u5w41DWw8Vp08@c1oN0GVC802N0G8gF2Vo8410V0Xk0V20JFG0414!V9031V044#l1$1#	CHEMBL480982	fleP`@BN@aIemyWYRTMYjf`@ji@Ph`	CCN(CC)c1ccc(/C=C2\C(=O)ON=C2C)cc1	6.22	group3-int	int	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	dk\@@DjU^ykeNjjjj`@	dk^D@BALbbTJbRJmMjf@A@bd	258.32	3.2767	4	0	41.9	4	-1.239970108408829	0.2148886672130897	0.792626774712116	31	1	fleP`@BN@aIemyWYRTMYjf`@ji@Ph`											1
:UtzdzSzKxx3RAOUU8G38ud6EH2dVC9@Hx2EeV1HQZeZNV20XN5xX0o0B4eWKkIW92WVcFK910VG1FF!380V	CHEMBL481107	eodRLHDAHfanie`IAjUnrJIKIQQQIIYKQSPja`KJIJyz@BjA`djYjhJ@@@	Cn1cc(N(Cc2ccc(F)cc2)c2ccc([N+](=O)[O-])cc2)cc1C(=O)N1CCCC1	5.4	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	few@@@LdbbRbVRfrTVaWMFlfhyuUUUUUUUUT@@	fewq@@DLLCHhhhdeUEDdhllJRmYZN[USUUA@@AH@@@	422.459	2.2179	7	0	74.3	6	1.2467951531987742	0.6012765447442927	1.4575181864637143	14	13	egh\HL@AHia`@gIqz|\bbRrTTTRRTrvabUC@QTRQut@ETCALUMUAP@@		gChhhE`BRnRYh@	eFABP`BL@								10
zrUtzdOSzJCw1FAOUR8G38uc6CH29VB90Ht2EcV0HPZe4NV20XN1xX0J0B0cWKkIW92WVcFK91!G1F#3!V	CHEMBL481139	eg`RL@DHIOA`DNhIP{HihdlhhdeDdmDYepIxDuLt@ESTaPLUQ@@@	CCN(CC)C(=O)c1cc(N(Cc2ccccc2)c2ccc([N+](=O)[O-])cc2)cn1C	6	group3-int	int	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	flu@@@LdbbRbVReRyhuhijjjjjjj@@	fluP@@@ZrRJJIIIQUYWmFbfhF`d@@`@@	406.484	2.1387	7	0	74.3	8	1.4834685475551752	0.4664803457529292	1.4830329890167784	8	6	fakpbBD\JwhGDl}{HhhbhhdeEdehQchykSUTD@@Pr@@@	dazH`DC@AIfujj@@										6
:UtzdzSzKxx3RAOEE8F38uQ6EH2dV49@Hx2EeV1G@ZeZ0120XN_t!o0B4eWKk3W12WV8FK010VF1F6%V	CHEMBL481152	fakq@@DLlCHhhhdhfhhdmDJRcEjuTuUTDAT`@@	CCN(c1cc(C)cc(C)c1)c1cc(C(=O)N2CCCC2)n(C)c1	4.65	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	flu@@@DjU^uymiqVhijjjjjjj@@	fluq@@DLLCHhhhdeThdaRUjJVjfjh@I@@@	325.454	2.7147	4	0	28.48	4	-1.0758328898446075	0.20534194515897514	0.8660061920390932	7	7	fnsqB@HJSDCcdTTTRRTRSfbTcJuUmPLDeTuTT@@	eMBD@ch@										4
:UtzdzSzKxx3RAOUU8G38ud6EH2dVB9PHx2EeV1HPZeZNX20XN1xX0o0B4eYKkIW92WkcFK91!G1F#3!V	CHEMBL481302	edRRL@DHIOA`DNhIP{HihdlhhdeDdmDYddepIxDuLt@ESTaPLUUTP@@@	CCCCN(CCCC)C(=O)c1cc(N(Cc2ccccc2)c2ccc([N+](=O)[O-])cc2)cn1C	5.21	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	flu@@@LdbbRbVReRyhuhijjjjjjj@@	fluP@@@ZrRJJIIIQUYWmFbfhF`d@@`@@	462.592	3.9563	7	0	74.3	12	2.3275731908379207	-1.3175280977392008	1.6892583783980148	8	6	fakpbBD\JwhGDl}{HhhbhhdeEdehQchykSUTD@@Pr@@@	dcvH`DC@AIfuUZjjh@@										6
:UtzdzSrKxx3RAOUU8G38ud6EH2dVB9@Hx2EeV1H@ZeZ8V20XN5x20o0B4eWKkIW92WVcFK810VG1F#3!V	CHEMBL481355	fi{I`BHR|TBLpeGIMrnsJ{wKpW`}Ft@ESTtuTT@@	CCN(c1ccc([N+](=O)[O-])cc1)c1cc(C(=O)N2CCCC2)n(C)c1	4.81	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	flu@@@DjU^uymiqVhijjjjjjj@@	fluq@@DLLCHhhhdeThdaRUjJVjfjh@I@@@	342.398	1.1053	7	0	74.3	5	0.7189904693082394	1.6878293149236454	1.2938738429765662	7	7	fakIbBHJ}DJ\`\_SglbbbbRRrVbfaTcJtwmPLDeSMUE@@@	eMBD@ch@										3
:UvztzSrKxxYRAOUU9G39ud6EH2dVB9eHx2EeVYH@ZeZNc20XN5x@0o0B4eWKkIW92WVcFK810kG1F#3!V	CHEMBL481356	fegI`BHRCTBBpeGYEMDeeEEDbmMDnBCD\v`@jZiijhh@@	CC(C)N(c1ccc([N+](=O)[O-])cc1)c1cc(C(=O)N2CCCC2)n(C)c1	4.84	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	flu@@@DjU^uymiqVhijjjjjjj@@	fluq@@DLLCHhhhdeThdaRUjJVjfjh@I@@@	356.425	1.4646	7	0	74.3	5	0.7759538596397881	1.4198202424854645	1.3188274695451496	7	7	fakIbBHJ}DJ\`\_SglbbbbRRrVbfaTcJtwmPLDeSMUE@@@	gC`HL@Qz`@										3
;tzdzSzKxx3RAOUU8F38uQ6EH2dVCA@Hx2EeV1GQZeZF120XN_xV0o0B4eWKk3W12WV8FK1W0VF1FL!201V	CHEMBL481515	egh\D@@DFK@KlbbbbRbZbbRTTRUpdbaaWVqsUSUUPP@TAR@@@	Cc1cc(C)cc(N(Cc2ccc(O)cc2)c2cc(C(=O)N3CCCC3)n(C)c2)c1	5.18	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	few@@@LdbbRbVRfrTVaWMFlfhyuUUUUUUUUT@@	fewq@@DLLCHhhhdeUEDdhllJRmYZN[USUUA@@AH@@@	403.524	3.3808	5	1	48.71	5	0.30874511242749014	-0.3500480344065087	0.07736228439634786	14	13	eod\HL@AHei`@gIqF|\bbRrTTTRRTRVLLRhXBJbRn^`@j`XIbjZjB`@@	eFBH@c@@		eFJB@Hp@								2
;xzdzSzKxx3RAOUU8F38uQ6EH2dVC9@Hx2EeV1GQZeZF120XN_xV0o0B5eWKkIW12WV8FK510VF1FL!201V	CHEMBL481686	eod\D@@DFK@GlbbbbRbZbbRTTRUrDdTLJzvNZjZjjB@B`Jd@@@	Cc1cc(C)cc(N(Cc2ccc(CO)cc2)c2cc(C(=O)N3CCCC3)n(C)c2)c1	5.24	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	few@@@LdbbRbVRfrTVaWMFlfhyuUUUUUUUUT@@	fewq@@DLLCHhhhdeUEDdhllJRmYZN[USUUA@@AH@@@	417.551	3.1292	5	1	48.71	6	0.5529889620838426	-0.3716393077790027	0.1252393541037628	14	13	eod\HL@AHei`@gIqF|\bbRrTTTRRTRVLLRhXBJbRn^`@j`XIbjZjB`@@	eFBH@c@@		eMJA@Df`@								2
;xzdzSzKxx3RAOUU8G38ud6EH2dVC9@Hx2EeV1HQZeZNV20XN5xX0o0B5eWKkIW92WVcFKC10VG1FF!301V	CHEMBL481746	e`\RB@DHIOA`DNohIP{HihdlhhdeDdmDXdepIxDuM\|t@ESTaPLUUDP@@	Cn1cc(N(Cc2ccc(CO)cc2)c2ccc([N+](=O)[O-])cc2)cc1C(=O)N1CCCC1	5.26	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	few@@@LdbbRbVRfrTVaWMFlfhyuUUUUUUUUT@@	fewq@@DLLCHhhhdeUEDdhllJRmYZN[USUUA@@AH@@@	434.494	1.5198	8	1	94.53	7	2.347806956413578	1.1108517685707613	0.5531053381983424	14	13	egh\HL@AHia`@gIqz|\bbRrTTTRRTrvabUC@QTRQut@ETCALUMUAP@@		gChhhE`BRnRYh@	eMJA@Df`@								10
:UtztzSzKxx3RASUU@G3Nuv6EHHdXB9@HzaEeV1IPZfaNW20XN_xX0o1B4eWUlIW96dXdkM910VG1F6!380V	CHEMBL481924	edZRLLDNKLceMM`IABPpdNIt{HiCEDheXhdeDdmDYeHYdTm\CCUA@qTuHTCETQ@@@	Cn1cc(N(Cc2ccccc2)c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)cc1C(=O)N1CCCC1	5.6	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	few@@@LdbbRbVRfrTVaWMFlfhyuUUUUUUUUT@@	fewq@@DLLCHhhhdeUEDdhllJRmYZN[USUUA@@AH@@@	472.466	2.9654	7	0	74.3	7	1.6335080250254548	-0.15434716278189842	1.569806461095717	14	13	egh\HL@AHia`@gIqz|\bbRrTTTRRTrvabUC@QTRQut@ETCALUMUAP@@	gJPBAHJPt`PAIjj@@	gChhhE`BRnRYh@									10
:UtzdzSzKxx3RAOUU8G38ud6EH2dVC9@Hx2EeV1HQZeZNV20XN5xX0o0B4eWKkIW92WVcFK910VG1FF!3!V	CHEMBL481939	eodRL@DHIOA`DNhIP{HihdlhhdeDdmDXdnAO@fikgf`@jZdJAbjbH@@	Cc1ccc(CN(c2ccc([N+](=O)[O-])cc2)c2cc(C(=O)N3CCCC3)n(C)c2)cc1	5.33	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	few@@@LdbbRbVRfrTVaWMFlfhyuUUUUUUUUT@@	fewq@@DLLCHhhhdeUEDdhllJRmYZN[USUUA@@AH@@@	418.495	2.461	7	0	74.3	6	1.2144819278450587	0.46983720565193604	1.4522623656899505	14	13	egh\HL@AHia`@gIqz|\bbRrTTTRRTrvabUC@QTRQut@ETCALUMUAP@@		gChhhE`BRnRYh@	eFBH@c@@								10
:UtzWtGtFCk1JAAGF0G28@V0402WV9882x240V02IV20NV#F4524o084X04VFd8H0VV048!V11FF!3#	CHEMBL482063	egh\L@DHII`DAhIP{HihdlhhdeEdehXepHEeUt]\t@EPP@ACUPD@@@	O=C(c1ccc(N(Cc2ccccc2)c2ccc([N+](=O)[O-])cc2)cc1)N1CCCC1	5.43	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	fmo@@@LdbbRbVRbVRftJyjt\mfnjjjjjjjjjh@@	fmoQ@@DVAdTTTRRNTTRRbrpiZLWlumTE@UA@@A@@@@	401.465	3.2078	6	0	69.37	6	0.7655777113432705	-0.07296293019842015	1.3270375969813628	1	1	egh\L@DHII`DAhIP{HihdlhhdeEdehXepHEeUt]\t@EPP@ACUPD@@@											1
:UtzWtGtFCk1JAAGF0G28@m0402WV8882x240V03HV20NW#FZ524o084X04VFd8H0XZ048!V11F6!3#	CHEMBL482064	egh\L@DHIA`DNhIP{HihdlhhdeELeLYepHDTuL]\t@EPPA@LUPD@@@	O=C(c1cccc(N(Cc2ccccc2)c2ccc([N+](=O)[O-])cc2)c1)N1CCCC1	5.31	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	fmo@@@LdbbRbTrTTvRarxYvZcfnjjjjjjjjjh@@	fmoQ@@DFAdTTTRRLttRRbrpiZlWlumTEAEA@@A@@@@	401.465	3.2078	6	0	69.37	6	0.7655777113432705	-0.07296293019842015	1.3270375969813628	1	1	egh\L@DHIA`DNhIP{HihdlhhdeELeLYepHDTuL]\t@EPPA@LUPD@@@											1
>U:nzxjmUEyxTreU@UgiloCYxcMLnz58mFfQlSZkYVjYrHjXaKjVWW1ztJWd_AY_2qK0c5FBKI90VVFV	CHEMBL483246	egd\B@@DNk`JG@lbbRbRTVbbRRT\RK@befQUSTvsUAAQLuUMUpj@@@	Cn1c(C#N)ccc1-c1ccc2c(c1)C(c1ccco1)(c1ccco1)OCC(=O)N2	6.13	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor by Gal4-DNA binding domain-hormone receptor LBD one-hybrid assay	2008	fm@@@LddTTTRbRRVStrMeq_AbfZzjjjjjjjjjh@@	fmPP@D]AQp\bbRbRTVbbRRTZXIUlejvZvjBBbYjjZaT@@	399.405	2.2937	7	1	93.33	3	1.228369874858412	1.1293840985324222	0.3033721868834288	2	1	egd\B@@DNk`JG@lbbRbRTVbbRRT\RK@befQUSTvsUAAQLuUMUpj@@@											1
yRsr468G8V4F4024FN05VN2H!F013920HFV58#Fk160W!20VC2JLV0W890V0c10280c04V204!F502010	CHEMBL484662	flu@P@@\dgHhheEEcLef\TXLV`Xb@@h@@@	O=c1cc(-c2ccc(O)cc2)oc2cccc(O)c12	6.07	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor LBD expressed in human MDA-kb2 cells by luciferase reporter gene assay	2013	fhy@@@LdbbbRnbRYHRoAjjjjjj`@@	fhy@`@@\RYee~uYrVoAZA``@H@@@	254.24	2.6814	4	2	66.76	1	-0.757046489982012	1.104952626856176	-1.4056796224111658	32	23	flu@a@ANAxq\TfUvUe^hsQ`i`@ihDHH@@	eFJB@Hp@	eFJB@Hp@									18
:xzCqslde4mZ0EgHsVhXSHH1Z0F9Y824FHVl02k3tkO6FG01@101ZJH_1Wc8220894984V250@44#4F2010	CHEMBL485349	flu@P@@\M{HhheDleCEf\ejJV`hH``HHLh@@	O=C1CC(c2ccccc2O)Oc2ccc(O)cc21	5.56	group4-ia	ia	Androgen Receptor	Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay	2018	fhy@@@LdbbbRnbRYHRoAjjjjjj`@@	fhy@`@@\RYee~uYrVoAZB``@HHLh@@	256.256	2.5014	4	2	66.76	1	-0.7379607389918705	1.205683418669476	-1.4033003815485126	32	9	fluAb@AR|AqrJIJYQEQQZcEZbf@BfhH@bFb@@	eFJB@Hp@										5
>U:nrxjHUEyxTrXS@UgikoCYxc7Lnr58XFfQkSZkYVEYMHjXaKhVWW1UlJWd_AX_2qK0c5FBKI90VVFV	CHEMBL489788	fewq`@DYfBclbbRbRTVfRTLRKAJmEM^mTDEDuSU\K@U@@	Cn1c(C#N)ccc1-c1ccc2c(c1)C(C)(c1ccco1)OCC(=O)N2	6.67	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor by Gal4-DNA binding domain-hormone receptor LBD one-hybrid assay	2008	ffs@@@LdbbbTRRrNfTgZ|ZqZuUUUUUUUP@@	ffsQ`@DIARvQQIQIIZIIPi`eFCDmVjBBIjfhT@@	347.373	1.6935	6	1	80.19	2	0.36793021635624434	1.5867310543830013	0.06652737818509068	2	1	fewq`@DYfBclbbRbRTVfRTLRKAJmEM^mTDEDuSU\K@U@@											1
LFuF!818V$24F8#N0H%232022V5#3)2$G61#10V!2F&V204#5!V!	CHEMBL490955	fhiaB@CDADILrjvslExLDDPY@@@@	Cc1ccccc1Oc1ccc(C#N)cc1Cl	7.34	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in human MDA-MB453 cells by luciferase reporter gene assay	2009	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	243.692	3.8407	2	0	33.02	2	-2.2930201273947373	-0.13510785679392576	0.5195880382362942	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@	eFABH`BL@		eFBH@c@@					eMbA@Dg`@			34
HFPF!818%24F8#N0H%23!22V5!83)2$141#10V!2F.1!V!	CHEMBL490956	fhi`A@C@bBABSLjml{A^CAADFP@@@	Cc1ccccc1Sc1ccc(C#N)cc1Cl	7.11	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in human MDA-MB453 cells by luciferase reporter gene assay	2009	dk\@@DjU^ukmNjjjj`@	dk\@`@BDifUWGUN`@@@@@	259.759	4.2662	1	0	49.09	2	-2.2147516057160876	-0.4534538711159759	0.5006032581637807	60	9	fhi@@`@AKGDPQ{qrJIJEJJIRgGA`BJ@b@@@	eFABH`BL@		eMbA@Dg`@								1
LFuF!818V$24F8#N0H%212022V5#3+V!G6$88V#F&V204#4F0V!	CHEMBL490957	fdy``@H`udbbbRRffUDYUj@@BBk@@@	COc1cc(Oc2cccc(C)c2)ccc1C#N	7.24	group2-a	a	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells	2009	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	239.273	3.1647	3	0	42.25	3	-1.7327038438950966	0.35538813703787525	0.6469402023833175	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@					eMJA@Hz@	eFBH@c@@		eMbA@Dg`@			34
:vz6KOr8F4s0L2gUNH10S0m0B8K12g!Imo50X0390O6@WVD20X46V51!80DlFVN582WV6N#F4Vb!Y8G0	CHEMBL491	fbePSBNVUktPRBICDar]]dTabbTRjfddZjBAbfj@@@	CC(C)(O)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1	7.82	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	gFp@DiTvjh@	gFp@DiTt@@@	292.212	1.1032	6	2	95.15	4	0.9389886649824756	2.0003533106517066	-1.0237459337006174	19	15	dmt@h@BR|VPQ\U`TfYn~fBHb@@	gJPBAHJPt`PAIjj@@	gChhhE`BRnRYh@		dazD`DBb@DfVfjh@@							14
LFuF!818V$24F8#N0H%212022V5#2+V!G6$98V#F&V204#5F0V!	CHEMBL491493	fdy``@H`mdbbbbRQaVd[Sj@B@Hk@@@	COc1cc(Oc2ccccc2C)ccc1C#N	7.62	group2-a	a	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells	2009	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	239.273	3.1647	3	0	42.25	3	-1.7327038438950966	0.35538813703787525	0.6469402023833175	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@	eFBH@c@@					eMJA@Hz@			eMbA@Dg`@		34
qHuF0F818V0k!24FN2!N0H040F0212022Z58!3808(V!F6$9@V#J821020V204!25N0c!	CHEMBL499137	fbuaC@EFAHHdLRFQRFJIIEQQJVdyj``r`H@@@	Cc1ccccc1Oc1ccc(C#N)c(C(F)(F)F)c1	6.27	group3-int	int	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells	2009	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	277.244	4.083	2	0	33.02	3	-1.9691924160779724	-0.5260112622024996	0.6021670642055311	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@			eFBH@c@@		gJPBAHJPt`PAIjj@@			eMbA@Dg`@			34
yuTveesGh8cm10A2FNI9V94VJFFX8V9!FFG0NV221k04Nc408805a0FF08c0F2GV$u0492)3#	CHEMBL50023	fbu``BH@QBT]dTtRVRbbdSxKrV`@jijXhJh@@	C=C1C=C(C)CC(C)(C)C1Cc1ccc([N+](=O)[O-])cc1	6.6	group3-int	int	Androgen Receptor	Inhibitory activity against human Androgen receptor	1996	dg|@@LdbbRLrSB]uUUUU@@	dg|@@Dj^_eZx{fZh@HcJ@@	271.359	3.8503	3	0	45.82	3	-1.5385715473079848	-0.1495575766133495	0.7123973204476661	4	1	fbu``BH@QBT]dTtRVRbbdSxKrV`@jijXhJh@@											1
]vyxjmTDyxybeU2UgiloSYxV7Lnp_8mFftGSZV3Vjf7HeXX5hVW11Mv40d_9X_2qK0c5FBK390VcFV	CHEMBL501080	fcQb@IAbvXIAIeY^umiVWZ\lxmU{`BK@BjjfZBX^H@@	CCC1(c2ccco2)OCC(=O)Nc2ccc(-c3cc(F)cc(C#N)c3)cc21	6.16	group3-int	int	Androgen Receptor	Antagonist activity at cloned androgen receptor-ligand binding domain expressed in african green monkey COS7 cells by two hybrid luciferase assay	2008	fnk@@@LdbbbTRRrNfRd{WcVjvjjjjjjjj`@@	fnka`@D@i[HhdhddmDdhTfBTXLZmZhHHfh@HP@@	376.386	3.2484	5	1	75.26	3	0.2820125164162728	0.2665772929400911	0.04738402288460832	1	1	fcQb@IAbvXIAIeY^umiVWZ\lxmU{`BK@BjjfZBX^H@@											1
xvqUcTqmCA2m1Vh6kOrcZB4HJJ0kLe9!B24VN0219F8FkG408)8!@2#4C213202081N02082c10	CHEMBL501627	fleaC@E^AHHdLRFQRFJIIFJKRuEMTDFUUQ@@@	N#Cc1ccc(C2CCCCC2O)cc1C(F)(F)F	7.05	group2-a	a	Androgen Receptor	Antagonist activity against human androgen receptor expressed in human MDA-MB-453 cells assessed as inhibition of dihydrotestosterone-induced effect by luciferase receptor gene assay	2008	dcl@@DjYU_egZjjjh@@	dcl@@DjUg^aWP`hjH@@	269.265	3.6282	2	1	44.02	2	-1.6953436470143308	-0.035386353177121715	-0.49816401177611574	30	3	fleaC@E^AHHdLRFQRFJIIFJKRuEMTDFUUQ@@@											1
LFuF!818V$24F8#N0H%212022V5#2+V!G6$88V#F&V204#4F0V!	CHEMBL501649	fdy``@H`teLrjwkbLju@@AAU`@@	COc1cc(Oc2ccc(C)cc2)ccc1C#N	6.7	group3-int	int	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells	2009	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	239.273	3.1647	3	0	42.25	3	-1.7327038438950966	0.35538813703787525	0.6469402023833175	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@					eMJA@Hz@			eMbA@Dg`@	eFBH@c@@		34
LFuF!818V$24F8010N0H%212!HV1#1#2&V02G2$8$10204&4#402V10	CHEMBL503575	fhi``@A@mdbfbRQbbwI^CPPYA@@@@	COc1cc(-c2ccccc2O)ccc1C#N	7.43	group2-a	a	Androgen Receptor	Displacement of [3H]dihydrotestosterone from human androgen receptor expressed in Sf9 cells	2008	dcl@@DjYU_egZjjjh@@	dcl@@DjYU_egX@@@@@@	225.246	2.7387	3	1	53.25	2	-1.492060107449033	0.8511279026711518	-0.463192695001646	30	18	fle`B`N@BSNKoDLBeArJJIIFJJZU`oQ``rBHb@@@	eFJB@Hp@		eMJA@Hz@								17
:UtzdUSzJ_x3RAUUU8lXOud6CH0CYB9BLxXEAX1HPo9ZNXX0XR1xX0wcBVfWKlIW91dZcFK9141G1F0103!V	CHEMBL503676	edVRL@DHIOA`DNhIP{HihdlhhdeDdmDYhdmpIxDuL\|CBt@ESTaPLTD@Q@@@	Cn1cc(N(Cc2ccccc2)c2ccc([N+](=O)[O-])cc2)cc1C(=O)N1CCc2ccccc21	6	group3-int	int	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	egdP@@@LdbbRbVRfrTVabRwFaebUPrquuUUUUUUUUUUT@@@	egd\H@@DFO@LbbbbbRRJttRRbrpbfac`WRqusUREPQPP@@R@@@@	452.513	3.1551	7	0	74.3	6	1.3609692217371476	-0.07356942141214756	1.5118556803859045	1	1	edVRL@DHIOA`DNhIP{HihdlhhdeDdmDYhdmpIxDuL\|CBt@ESTaPLTD@Q@@@											1
vzUQ1NsG9B4k!2TFNH0280H240F129#2408083908!12#V#88$@#8482102(2080c!	CHEMBL503687	fdi`@`H`BGRGi@LadbbRRfbTayJ``bjjp@@	CC(C)CCSc1ccc(C#N)c(C(F)(F)F)c1	6.29	group3-int	int	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells	2009	gFp@DiTvjh@	gFp@DiTt@@@	273.321	4.4448	1	0	49.09	5	-1.6761233249144563	-0.973582276683943	0.6021713002398802	19	15	dmt@h@BR|VPQ\U`TfYn~fBHb@@	gNpD@DH@RgZjh@		gJPBAHJPt`PAIjj@@		eMbA@Dg`@						14
;Q12sI9c4!22DF8F02O0H#V1292!2V1!821$104!V04G28#88#8+4#4!k!	CHEMBL504110	foAaB@GJ@DYHhdeEJmsPiTDEQVP@@	COc1cc(SCC2CC2)ccc1C#N	6.77	group3-int	int	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in Sf9 cells	2009	dmL@@DjU_jzUjjjj@@	dmL@`@BDieV^TYhHJB@@	219.307	2.7175	2	0	58.32	4	-1.6445935192763586	0.5744623673088899	0.5902227925188633	3	2	dg~@PNAqdHrJJIIEJLIwAAeUD@@	eMJA@Hz@										2
qHuF0F818V0k!24FN2!N0H040F02120H2Z58083809%20V!F6$9@V#J821020V204!21N0c!	CHEMBL504179	fjma@`Bt@DQdDrFYAJ[e^umiyJsjBB@@jk@@@	CSc1ccccc1Oc1ccc(C#N)c(C(F)(F)F)c1	7.66	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in human MDA-MB-231 cells assessed as inhibition of DHT-induced response	2009	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	309.31	4.2163	2	0	58.32	4	-1.2411405644237836	-0.6602981705607693	0.7461320941507548	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@	eMA@HPBN`@					gJPBAHJPt`PAIjj@@			eMbA@Dg`@		34
qPuH0F818V0k!24FNH0VN0H040F02120H2Z58!38F9%20V!F6V#9@V#J821020V2048025N0c!	CHEMBL507267	ff}aC@EFAHHdLRFQRFJIIEQQIRVdyj``r`HJ@@@	CC(C)c1ccccc1Oc1ccc(C#N)c(C(F)(F)F)c1	5.64	group4-ia	ia	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system	2009	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	305.298	4.9261	2	0	33.02	4	-1.7025859284443325	-1.2576960969472637	0.6788303155623243	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@			gC`HL@Qz`@		gJPBAHJPt`PAIjj@@			eMbA@Dg`@			34
mHPF0F818!k!24FN2!N0H040F021!22Z58083808%20V#4$1@V#J82102(2180c!	CHEMBL507671	fbu`B`L`BNR@YBL`fPrQQQQI[PjQRMju@D@AUV@@@	N#Cc1ccc(Sc2ccccc2F)cc1C(F)(F)F	6.74	group3-int	int	Androgen Receptor	Displacement of [3H]DHT from human AR expressed in baculovirus Sf9 cells system by scintillation counting	2010	dk\@@DjU^ukmNjjjj`@	dk\@`@BDifUWGUN`@@@@@	297.275	4.2654	1	0	49.09	3	-1.8586107269657617	-0.7129175941979023	0.5884380773136904	60	9	fdy`@`H`BVNH`awcdTRTJTRTJirwh@b`BK@@@	eFABP`BL@	gJPBAHJPt`PAIjj@@									4
LFuF!818V$24F8#N0H%2120H2V5!82!1%20V!G6$98V#F*4#5!V!	CHEMBL510145	fle`b@D|\@HrQQQQIIZUZUm^h@`BHk@@@	COc1cc(Sc2ccccc2OC)ccc1C#N	7.46	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in human MDA-MB453 cells by luciferase reporter gene assay	2009	dk\@@DjU^ukmNjjjj`@	dk\@`@BDifUWGUN`@@@@@	271.339	3.1763	3	0	67.55	4	-0.9989259753219323	0.2942609726549442	0.7902709833634278	60	9	fdy`@`H`BVNH`awcdTRTJTRTJirwh@b`BK@@@	eMJA@Hz@	eMJA@Hz@									4
yLuK0F8G8V4k4024FN2!N0H040F13120H2Z58!3809!1!21V!G610V09@V#J821020V@040421N0c!	CHEMBL510289	fnc`c@EFBBPQHXdLbdLTRRJbbRreiIZhHLhHHh@@@	CCOc1cc(C)ccc1Oc1ccc(C#N)c(C(F)(F)F)c1	6.59	group3-int	int	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system	2009	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	321.297	4.4193	3	0	42.25	5	-1.0427056728706745	-0.9446308424009147	0.8406617246544837	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@			gCaH@`AJZ`@		gJPBAHJPt`PAIjj@@			eMbA@Dg`@	eFBH@c@@		34
zvwvcuynjhue9cf6HAU8ht5IqO4XDn93082lAJ0275mJ0F9B8U3V14G@l08V88202!F0H1202844V08JJ2410	CHEMBL51093	fjm@a@BRAbEqDfYU}fZu``y``bjfjhdZ`X@	C=C1CC[C@@H](Br)C(C)(C)[C@H]1Cc1cc(OC)c(Br)cc1O	6.35	group3-int	int	Androgen Receptor	Inhibitory activity against human Androgen receptor	1996	dg|@@LdbbRLrSB]uUUUU@@	dg|@@LdfbRLRS\]mUT@DPd@	418.168	5.3326	2	1	29.46	3	-1.0670296447514296	-1.8397868385299152	-0.25521860330142493	4	2	fjm@a@BRAbEqDfYU}fZu``y``bjfjhdZ`X@											1
qHuF0F818V0k!24FN2!N0H040F0212022Z58!3808%20V!G61#9@V#J821020V204!21N2c10	CHEMBL511145	fjm`c@EFBBPQHXdLbdLTRRJbbveiNZhHLhHB@@@	Cc1ccc(Oc2ccc(C#N)c(C(F)(F)F)c2)c(O)c1	6.45	group3-int	int	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system	2009	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	293.243	3.7373	3	1	53.25	3	-1.0224228728148657	-0.12215683503113288	-0.3199935542646603	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@			eFJB@Hp@		gJPBAHJPt`PAIjj@@			eMbA@Dg`@	eFBH@c@@		34
qHuF0F818V0k!24FN2!N0H040F02120H2Z58!3809%20V!G61#9@V#J821020V204!21N0c!	CHEMBL512837	ff}`c@EFBBPQHXdLbdLTRRJbbRTmIKUAAeAAD@@@	COc1ccc(C)cc1Oc1ccc(C#N)c(C(F)(F)F)c1	6.32	group3-int	int	Androgen Receptor	Antagonist activity at human androgen receptor expressed in human MDA-MB-231 cells assessed as inhibition of DHT-induced response	2009	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	307.27	4.013	3	0	42.25	4	-1.2559949994713175	-0.5275439075027611	0.7893560355933095	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@			eMJA@Hz@		gJPBAHJPt`PAIjj@@		eFBH@c@@	eMbA@Dg`@			34
qPuF0F818V0k!24FN20VN0H040F02120H2Z58!38F9%20V!F6V#9@V#J821020V204!25N0c!	CHEMBL513195	fjmaC@EFAHHdLRFQRFJIIEQQIRtgMTDFTAA@@@	CCc1ccccc1Oc1ccc(C#N)c(C(F)(F)F)c1	7.7	group2-a	a	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system	2009	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	291.271	4.4986	2	0	33.02	4	-1.7563406475286794	-0.9486887310159429	0.6535212185588553	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@			eMBD@ch@		gJPBAHJPt`PAIjj@@			eMbA@Dg`@			34
qHuF0F818V0k!24FN2!N0H040F0212022Z58!3808(V!F61#9@V#J821820V204!25N0c!	CHEMBL513768	ff}aC@EFAHHdLRFQRFJIIEQQQVVdej``r`Hb@@@	Cc1cc(C)c(Oc2ccc(C#N)c(C(F)(F)F)c2)c(C)c1	6.7	group3-int	int	Androgen Receptor	Displacement of [3H]DHT from human cloned androgen receptor expressed in insect Sf9 cell system	2009	dk\@@DjU^ukmNjjjj`@	dk\H@@RfYU\]Tz@@@@@@	305.298	4.7708	2	0	33.02	3	-1.853816153943759	-1.0435141967181196	0.6519139042958784	60	34	ff}ABPF@BRXHfGTBXa|xq|\hMZGHhhiheeCEMKrRRpQDUADQ@@@			eFBH@c@@	eFBH@c@@	gJPBAHJPt`PAIjj@@			eMbA@Dg`@	eFBH@c@@		34
zvwvcuynjhue9cf6HAU8ht5IqO4XDn93082lAJ0275mJ0F9B8U3V14G@l08V88202!F0H1202844V08JJ2410	CHEMBL51639	fjm@a@BRAbEqDfYU}fZu``y``bjfjhdZPX@	C=C1CC[C@@H](Br)C(C)(C)[C@@H]1Cc1cc(OC)c(Br)cc1O	6.62	group3-int	int	Androgen Receptor	Inhibitory activity against human Androgen receptor	1996	dg|@@LdbbRLrSB]uUUUU@@	dg|@@LdfbRLRS\]mUT@DPb@	418.168	5.3326	2	1	29.46	3	-1.0670296447514296	-1.8397868385299152	-0.25521860330142493	4	1	fjm@a@BRAbEqDfYU}fZu``y``bjfjhdZPX@											1
:UtzdzSrKxx3RAOUU8G38ud6AH2dVB9@Hx2EeV1H@ZeZ8V20XN5x20o0B4eWKkIW92VVcFK810VF%Y0FV	CHEMBL516610	fnsI`BHRldBHpeGIMrnlj}r|EYuVm@ASSSUQP@@	Cn1cc(Nc2ccc([N+](=O)[O-])cc2)cc1C(=O)N1CCCC1	4.83	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	flu@@@DjU^uymiqVhijjjjjjj@@	fluq@@DLLCHhhhdeThdaRUjJVjfjh@I@@@	314.344	1.674	7	1	83.09	4	0.8034188124747143	1.6214122709943037	0.1602181578793118	7	7	fakIbBHJ}DJ\`\_SglbbbbRRrVbfaTcJtwmPLDeSMUE@@@											3
:UvztzSzKxxYRAOEE9F39uQ6EH2dV49eHx2EeVYG@ZeZF920XN_t80o0B4eWKk3W12WV8FK010kF1F6%V	CHEMBL516752	fi{q@@DLlCHhhhdhfhhhdXaRTZkVjfjj`hBi@@@	Cc1cc(C)cc(N(c2cc(C(=O)N3CCCC3)n(C)c2)C(C)C)c1	5	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	flu@@@DjU^uymiqVhijjjjjjj@@	fluq@@DLLCHhhhdeThdaRUjJVjfjh@I@@@	339.481	3.074	4	0	28.48	4	-1.018869493904203	-0.06266705561671926	0.8909598179864224	7	7	fnsqB@HJSDCcdTTTRRTRSfbTcJuUmPLDeTuTT@@	gC`HL@Qz`@										4
:UtzdzSzKxx3RAOUU8G38ud6EH2dVB9@Hx2EeV1HPZeZNV20XN5xX0o0B4eWKkIW92WVcFK910VG1F#3!V	CHEMBL518945	eghRL@DHIOA`DNhIP{HihdlhhdeDdmDYepIxDuL]\t@ESTaPLUQD@@@	Cn1cc(N(Cc2ccccc2)c2ccc([N+](=O)[O-])cc2)cc1C(=O)N1CCCC1	6.36	group3-int	int	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	few@@@LdbbRbVRfrTVaWMFlfhyuUUUUUUUUT@@	fewq@@DLLCHhhhdeUEDdhllJRmYZN[USUUA@@AH@@@	404.469	2.1171	7	0	74.3	6	1.1567991002460976	0.7285849383430814	1.4273906027776513	14	13	egh\HL@AHia`@gIqz|\bbRrTTTRRTrvabUC@QTRQut@ETCALUMUAP@@		gChhhE`BRnRYh@									10
zrvxT_OK8J5w0GA9PN0G08PV0BF09Vg80HO278V0HPV84PV!XN0CXVJ#c1JkGl90WVV0KC#G1F#703V	CHEMBL519112	fegpPBHR|AGQpeGIMrnsJlj||ExKYm@ATuHTCA@@@	Cn1cc(N(Cc2ccccc2)c2ccc([N+](=O)[O-])cc2)cc1C(=O)O	5.21	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	flu@@@LdbbRbVReRyhuhijjjjjjj@@	fluP@@@ZrRJJIIIQUYWmFbfhF`d@@`@@	351.361	1.1059	7	1	91.29	6	1.474048321324494	1.644155365733633	0.2912549882987894	8	6	fakpbBD\JwhGDl}{HhhbhhdeEdehQchykSUTD@@Pr@@@	gC`h@l@ILt@@										6
]UzxAyzOzUCIMhvdaUq2fkgCPIx2jfW1HTiygPX@4qPSxX0o0D4ulKkUlC2WVcJK910VI1k#301V	CHEMBL519292	e`\RJ@DHIOA`DNgohIP{HihdlhhdeDdmDYdepIxDuL]\t@ESTaPLUUDRAtn`@	Cn1cc(N(Cc2ccccc2)c2ccc([N+](=O)[O-])cc2)cc1C(=O)N1C[C@H](O)[C@@H](O)C1	4.86	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	few@@@LdbbRbVRfrTVaWMFlfhyuUUUUUUUUT@@	fewq@@DLLCHhhhdeUEDdhllJRmYZN[USUUA@@AH@@@	436.467	0.4129	9	2	114.76	6	3.0979907393437696	2.1451367986776897	-0.422208847273713	14	13	e`\\LL@AHiago`@gIqz|\bbRrTTTRRTrvabRUC@QTRQut@ETCALUMUTEHGRz@@		gChhhE`BRnRYh@									1
:UvzfzUrS:QTAQUUROIAzdLEHXhVR9@Qx2Euk1PA_eZ8V@4mN5x60o8B4enKkIWC2WVcFS810VG1FV!3!V	CHEMBL519780	eghRL@DHIOA`DNhIP{HihdlhhdeDdmDYepIxDuL]\t@ESTuUMUQT@@@	Cn1cc(N(CC2CCCCC2)c2ccc([N+](=O)[O-])cc2)cc1C(=O)N1CCCC1	6.06	group3-int	int	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	few@@@LdbbRbVRfrTVaWMFlfhyuUUUUUUUUT@@	fewq@@DLLCHhhhdeUEDdhllJRmYZN[USUUAAQUI@@@	410.516	2.4494	7	0	74.3	6	1.173008818390132	0.5063991710879274	1.4390725995587	14	1	eghRL@DHIOA`DNhIP{HihdlhhdeDdmDYepIxDuL]\t@ESTuUMUQT@@@											1
RuwQ82kG9802!16F8G8VO4HFF0V!92!201#11F!F9408#412!80882+X)2010	CHEMBL52	ff}@P@@DsWHhhllhimDeBsbRpPEUT@Q@@@	CC(Cc1ccc(O)c(O)c1)C(C)Cc1ccc(O)c(O)c1	4.41	group4-ia	ia	Androgen Receptor	Transcriptional activity at human androgen receptor BF3 site stably transfected in eGFP-expressing human LNCAP cells after 5 days by fluorometric analysis	2011	f`q@@@DjU_VUiqwjjjjjj@@	f`q@@@DjU_VUiqw``bh@@@@	302.369	3.8236	4	4	80.92	5	0.8567319116223654	-0.16733895428879214	-3.35350865360675	1	1	ff}@P@@DsWHhhllhimDeBsbRpPEUT@Q@@@											1
>U:lzxjmQETxTreU@UgDloCYxcMLnz58m8fQlSZkYVjYr2jXaKjVWW1UtJWd_AY_2qK0c5FBJI90VVFV	CHEMBL520169	egd\DD@ONkfB`@`pHrQQZSJJIQIKIqQHxTN^QUIYS[TsUAMARTuWPh@@	Cn1c(C#N)ccc1-c1ccc2c(c1)C(c1cccs1)(c1cccs1)OCC(=O)N2	6.11	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor by Gal4-DNA binding domain-hormone receptor LBD one-hybrid assay	2008	fm@@@LddTTTRbRRVStrMeq_AbfZzjjjjjjjjjh@@	fmPa@O]XT@PXHrQQZSJJIQIKIqKEG^cUNYkifjBZBdijaP@@	431.539	3.6495	5	1	123.53	3	1.3299531670338827	0.17500223250874636	0.2630952419385877	2	1	egd\DD@ONkfB`@`pHrQQZSJJIQIKIqQHxTN^QUIYS[TsUAMARTuWPh@@											1
:UtzdzSzKxzIRAOUU8G38ud6EH2dVB9@Px2EeV1HPZeZNV20XN1xX0o0BJeYKkIW92WVcFK91!G1F0X03!V	CHEMBL520428	eodRL@DHIOA`DNhIP{HihdlhhdeDdmDYdnAO@fikgf`@jZdJAbjbH@@	Cn1cc(N(Cc2ccccc2)c2ccc([N+](=O)[O-])cc2)cc1C(=O)N1CCCCC1	5.77	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	fmo@@@LdbbRbVRfrTVaRyhudufnjjjjjjjjjh@@	fmoq@@DLlCHhhhddchhdeEeiFUhoYkZjZjjB@@BP@@	418.495	2.4591	7	0	74.3	6	1.2145713217873038	0.4709793623655428	1.4522524641385701	1	1	eodRL@DHIOA`DNhIP{HihdlhhdeDdmDYdnAO@fikgf`@jZdJAbjbH@@											1
:UtztzSzKxx3RAOUU@F38u96EHHdVC9@Hx6EeV1HPZeZF020XN5xV0o0B4eWKkIW96WVdFK110VG1F$80V	CHEMBL521249	eod\HL@E@ia`IABPpdLbdLRVTTRRbRVbLrDdBbzVn^j`@jZdJAbjH`@@	Cn1cc(N(Cc2ccccc2)c2ccc(C(F)(F)F)cc2)cc1C(=O)N1CCCC1	5.77	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	few@@@LdbbRbVRfrTVaWMFlfhyuUUUUUUUUT@@	fewq@@DLLCHhhhdeUEDdhllJRmYZN[USUUA@@AH@@@	427.469	3.887	4	0	28.48	6	-0.2766862927934597	-1.1193353325976134	1.0921936272007715	14	13	egh\HL@AHia`@gIqz|\bbRrTTTRRTrvabUC@QTRQut@ETCALUMUAP@@		gJPBAHJPt`PAIjj@@									10
zrzxzhOSvo5w5GAOTR8K28Pc4CH09Vgd0HO2E8c0HPZ84PV!XN0hXVJ#c1KkIl90WVVFKC0V0G1F#3!V	CHEMBL521251	fcopPBHR|AGQpeGYEMDeeEDdhdehcnB|Elv`@jZdJAbb@@@	CCOC(=O)c1cc(N(Cc2ccccc2)c2ccc([N+](=O)[O-])cc2)cn1C	6.02	group3-int	int	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	flu@@@LdbbRbVReRyhuhijjjjjjj@@	fluP@@@ZrRJJIIIQUYWmFbfhF`d@@`@@	379.415	1.9401	7	0	80.29	8	1.4466046091101177	0.7301865952292264	1.4527035001618727	8	6	fakpbBD\JwhGDl}{HhhbhhdeEdehQchykSUTD@@Pr@@@	gGPh@l@IL{U@@										6
?xzu5xjFUEyxPrXS@UgoFkCYhc5Hnr_9XNfQkCZFlZ1AG2jXaJxVWW1UnKW9_AXb0q52c58BJI90VVFV	CHEMBL522432	fewpb@KYfpH@cIDeiDieDlcEDc`ak^cWmKUPTBTuWPpiP@	Cn1c(C#N)ccc1-c1ccc2c(c1)C(C)(c1ccsc1)OCC(=O)N2	6.49	group3-int	int	Androgen Receptor	Antagonist activity at androgen receptor by Gal4-DNA binding domain-hormone receptor LBD one-hybrid assay	2008	ffs@@@LdbbbTRRrNfTgZ|ZqZuUUUUUUUP@@	ffsPb@CIYx@QdbRtRbTRrLRpSQgAKVej`hDija@@	363.44	2.2892	5	1	95.29	2	0.42258948998976	1.1589544308785835	0.04596054925194894	2	1	fewpb@KYfpH@cIDeiDieDlcEDc`ak^cWmKUPTBTuWPpiP@											1
;j;erUzntyxOWfruUjz0TFbfuwFNwtpQks1XgDOcSVTUgFF50s8k2D48HFL1YZ040G18H81F#V202010	CHEMBL538137	fnk``@D@kdTTRabTJTtRsNZMxJRmTuUUUUUTHdxiHt]@iJJ`@	C[C@@H]1C[C@H]2[C@@H]3CC[C@H]4N(C)C(=O)C=C[C@]4(C)[C@H]3CC[C@]2(C)[C@H]1O	7.51	group2-a	a	Androgen Receptor	Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells	2009	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fdua@@D@RYVum[ZLdjs`qZfjjjjjHRBRhZ@@	317.471	2.7376	3	1	40.54	0	-1.527834431865918	0.6582070891115792	-0.3960102455072068	50	3	fnk`b@LdZAqRYge{VmuhqVgArVjjjjjfijnHUDqRfeZA`@	eFBH@c@@										3
;j;er:nxyxOWfruUjz0TkbfuwFNwtpQksGXgiOcSVTUgFF50s8k2D48HkL1YZV40G18H81F!1V202010	CHEMBL538877	figa`@D@kwHhheCDhTihelf\t[pTeZijjjjjjjaDgEIFchEIQT@	COC[C@@H]1C[C@H]2[C@@H]3CC[C@H]4N(C)C(=O)C=C[C@]4(C)[C@H]3CC[C@]2(C)[C@H]1O	7.62	group2-a	a	Androgen Receptor	Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells	2009	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fdua@@D@RYVum[ZLdjs`qZfjjjjjHRBRhZ@@	347.497	2.2388	4	1	49.77	2	-0.6359246195301286	0.7936231061690381	-0.18494887359620438	50	3	fnk`b@LdZAqRYge{VmuhqVgArVjjjjjfijnHUDqRfeZA`@	gCaHA`AJZ`@										3
?erUzvtyxOWfzvUjz1yOrvuwJOwtpQss1XgDSgSVTUwoH50u8lHT48HFL1YZ060Q18LB1FFV0V20201F	CHEMBL549375	egd\D@@DEm`JlbbbTLRaRfbVrbRsGFag`RQVqsUMUUUUS@AUQpQNEHcHy@ddhJd	Cc1ncc(/C=C2\C[C@H]3[C@@H]4CC[C@H]5N(C)C(=O)C=C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2O)cn1	7.37	group2-a	a	Androgen Receptor	Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells	2009	fiw@@@LdbbbTRaJVrbRxhQmN|Ghzjjjjjjjjj@@	fiwq@@DMzAIe[VumueZLdjs`qzMjZjjjf@BjBD`djFdHh	407.556	2.8857	5	1	66.32	1	0.0023608917971814636	0.5450964928294173	0.021813308991188177	11	4	egd\DH@DLEmK`GEIe]Yge{VmuhXLlbRjzVv`@fjjjjjZdjnIDXkDEDdUNiAq@	eFBH@c@@										4
:UvztU:KbxXTvzUyEHHdvUaBDK1mSSW1f6@BXYnAcNcF3@DJFflC89B40WkD0D184t2WF7F10F1107080c!	CHEMBL549725	fisqA`EFrdD`bPqHEdJrCYCHiCEDdcEDiiMIZj``rjijjHVh@@	CC(C(=O)N(C)C)N(CC(F)(F)F)c1ccc(C#N)c(C(F)(F)F)c1	5.8	group4-ia	ia	Androgen Receptor	Binding affinity to AR by fluorescence polarization based competition binding assay	2009	gFp@DiTvjh@	gFp@DiTt@@@	367.292	2.84	4	0	47.34	6	-0.2409863733172657	-0.12843577830304098	1.035723694585174	19	15	dmt@h@BR|VPQ\U`TfYn~fBHb@@	gJPBAHJPt`PAIjj@@	eMbA@Dg`@		dgmHHJuPdDdLdN@LbdJbfaeUUSUCT@@							14
?erUzvtyxOWfzvUjz1yOrvuwJOwtpQss1XgDSgSVTUwoH50s8lHT48HFL1YZ060Q18LB1FFV0V20201F	CHEMBL551269	ekh\D@@DEm`JlbbbTLRaRfbVrbRXxtL|BRJvNZijjjjjX@JhxHgBdQd\`RRTER@	CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](C/C(=C\c5cncnc5)[C@@H]4O)[C@@H]3CC[C@@H]12	7.23	group2-a	a	Androgen Receptor	Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells	2009	fiw@@@LdbbbTRaJVrbRxhQmN|Ghzjjjjjjjjj@@	fiwq@@DMzAIe[VumueZLdjs`qzMjZjjjf@BjBD`djFdHh	393.529	2.6523	5	1	66.32	1	-0.060526311978206127	0.7374211346316726	-0.002484245572965671	11	4	egd\DH@DLEmK`GEIe]Yge{VmuhXLlbRjzVv`@fjjjjjZdjnIDXkDEDdUNiAq@											4
?urUzvtyxOWfzvUjz1ySrvuwROwtpQss1XgDSgSVTUwoH50u8lHT48HFL1YZ060Q18LB1FGV0V202F1F	CHEMBL551270	e`Z\D@@DEm`JlbbbTLRaRfbVrbRrcGFag`RQVqswsUMUUUUS@AUUEpQNEHcHy@ddhJd	CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](C/C(=C\c5cnc(C6CC6)nc5)[C@@H]4O)[C@@H]3CC[C@@H]12	7.29	group2-a	a	Androgen Receptor	Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells	2009	echP@@@LdbbbTRaJVrbRrgB`afcg`WPrvuUUUUUUUUUUP@@	ech\H@@DFn`DfUm[VwVUvhXdTl\BbzFVvZfjjji`@jjbHH`bTad`bP	433.594	3.6526	5	1	66.32	2	0.2619358651968714	-0.1333050704746063	0.09476212068159165	1	1	e`Z\D@@DEm`JlbbbTLRaRfbVrbRrcGFag`RQVqswsUMUUUUS@AUUEpQNEHcHy@ddhJd											1
?vzUzntyxQYfruzjzHTFbfywFNwtpQkw3XhDOsSkUUgNF50w@s2D48HFL1YZ040G18H@1F#V202810	CHEMBL556229	egdXDH@EmK`ICHhdhUEEheidiLlePpYYDeUtmm@AUUUUUTuIUBBRQFJqAQIESj@@	CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](O)[C@H](Cc5cccc(F)c5)C[C@H]4[C@@H]3CC[C@@H]12	7.64	group2-a	a	Androgen Receptor	Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells	2009	fiw@@@LdbbbTRaJVrbRxhQmN|Ghzjjjjjjjjj@@	fiwa@@D@RYVum[]YVcIJlxL^cZfjjjj`@jbaHIJaiE@@	411.559	4.2803	3	1	40.54	2	-0.7878603789099226	-0.8597397749492138	-0.1809362309921998	11	1	egdXDH@EmK`ICHhdhUEEheidiLlePpYYDeUtmm@AUUUUUTuIUBBRQFJqAQIESj@@											1
?fzUzvtyxOWfzvUjzIyOrvuwJOwtpQss1XhDSgSVTUwoH50s8lHD48HFL1YZ060U18LB1FFV0V202810	CHEMBL556431	eolXDD@McG`IAbPrJIJHjJKQKSIRYYJcbqqKIh[Xz@HfjjjjjZdjnEEXgEELeUAi@I@	CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](C/C(=C\c5cc(F)cc(F)c5)[C@@H]4O)[C@@H]3CC[C@@H]12	7.39	group2-a	a	Androgen Receptor	Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells	2009	fiw@@@LdbbbTRaJVrbRxhQmN|Ghzjjjjjjjjj@@	fiwa@@D@RYVum[]YVcIJlxL^cZfjjji`@j`aHIJaiBJ@	427.533	4.4171	3	1	40.54	1	-0.8687120237993573	-0.8803896040156227	-0.18004543833116676	11	3	eolXDD@McG`IAbPrJIJHjJKQKSIRYYJcbqqKIh[Xz@HfjjjjjZdjnEEXgEELeUAi@I@											1
?erUzvtyxOWfzvUjz1yOrvuwJOwtpQss1XgDSgSVTUwoH50s8lHT48HFL1YZ060Q18LB1FFV0V20201F	CHEMBL556848	ekhTD@@DC`JlbbbTLRaRfbVrbRXxtL|BRJvNZijjjjjX@JhxHgBdQd\`RRTER@	CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](C/C(=C\c5ccncc5)[C@@H]4O)[C@@H]3CC[C@@H]12	6.89	group3-int	int	Androgen Receptor	Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells	2009	fiw@@@LdbbbTRaJVrbRxhQmN|Ghzjjjjjjjjj@@	fiwQ@@DC@drmkZvzrmFRUYpX}FuMUUUS@AUABPRUCRDT	392.541	3.2146	4	1	53.43	1	-0.5442969773516885	0.1876558461727164	-0.12253527240546648	11	1	ekhTD@@DC`JlbbbTLRaRfbVrbRXxtL|BRJvNZijjjjjX@JhxHgBdQd\`RRTER@											1
;j;erUzvtyxOWfzuUjz1yOrvuwJOwtpQss1XgDSgSVTUwoH50s8lHD48HFL1YZ040Q18LB1F0V0V202010	CHEMBL557116	fa{``@D@kdTTRabTJTtRvYsQoARUjfjjjjijkaIqRQhzARUBj@	C/C=C1\C[C@H]2[C@@H]3CC[C@H]4N(C)C(=O)C=C[C@]4(C)[C@H]3CC[C@]2(C)[C@H]1O	7.46	group2-a	a	Androgen Receptor	Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells	2009	flm@@@LdbbbTRaJVxhQmN|Fjjjjjjj@@	flma@@D@RYVum[^cIJlxLVijjjjZhaHIJah@	329.482	3.0991	3	1	40.54	0	-1.4815911319274528	0.3963514089308485	-0.37436243240784833	1	1	fa{``@D@kdTTRabTJTtRvYsQoARUjfjjjjijkaIqRQhzARUBj@											1
vzUQvQzvURjltyvUHv3H2QfHi43QhrA8cGE63CmX2QW98FC@01H_1B38860YkDF31D4O4W04210k1107FB0c!	CHEMBL558664	fmwp@`NR|BHGHSdErFQQQIHqQIJKQYRLExK^pPYUUPQATQAR@@	CN1CC[C@H](N(Cc2ccccc2C(F)(F)F)c2ccc(C#N)c(Cl)c2)C1	6.6	group3-int	int	Androgen Receptor	Binding affinity to AR by fluorescence polarization based competition binding assay	2009	flu@@@LdbbRbVReRyhuhijjjjjjj@@	fluP@@@ZrRJJIIIQUYWmFbfhJ`h@@bBD@	393.839	4.4231	3	0	30.27	5	-0.8535493936765871	-1.3037991647060951	0.9295539541624808	8	1	fmwp@`NR|BHGHSdErFQQQIHqQIJKQYRLExK^pPYUUPQATQAR@@											1
;j;erUzntyxOWfruUjz0TFbfuwFNwtpQks1XgDOcSVTUgFF50s8k2D48HFL1YZ040G18H81F#V202010	CHEMBL559246	ffs``@D@kdTTRabTJTtRYsQoARUjfjjjjjjxR\TdZN`Te@@	CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@]4(C)[C@@H](O)CC[C@H]4[C@@H]3CC[C@@H]12	8.15	group1-p	p	Androgen Receptor	Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells	2009	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fdua@@D@RYVum[ZLdjs`qZfjjjjjHRBRhZ@@	303.444	2.4683	3	1	40.54	0	-1.5890325287453915	0.8721128887945391	-0.4204948908103612	50	3	fnk`b@LdZAqRYge{VmuhqVgArVjjjjjfijnHUDqRfeZA`@											3
?erUzvtyxOWfzvUjz1yOrvuwJOwtpQss1XgDSgSVTUwoH50s8lHT48HFL1YZ060Q18LB1FFV0V20201F	CHEMBL559485	ekhTD@@DA`JlbbbTLRaRfbVrbRXxtL|BRJvNZijjjjjX@JhxHgBdQd\`RRTER@	CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](C/C(=C\c5ccccn5)[C@@H]4O)[C@@H]3CC[C@@H]12	6.54	group3-int	int	Androgen Receptor	Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells	2009	fiw@@@LdbbbTRaJVrbRxhQmN|Ghzjjjjjjjjj@@	fiwQ@@DE@drmkZvzrmFRUYpX}FuMUUUS@AUABPRUCRDT	392.541	3.2686	4	1	53.43	1	-0.546837699244894	0.15519388628085828	-0.12225385413777465	11	1	ekhTD@@DA`JlbbbTLRaRfbVrbRXxtL|BRJvNZijjjjjX@JhxHgBdQd\`RRTER@											1
?fr:vtyzOWfzvUjz1yOrvuwJOwtpQss1XiDSgSVTUwoH50u8lHT48HFL1YZ060Q18LB1FFV0V20201F	CHEMBL559878	eol\L@@DEm`JklbbbTLRaRfbVrbRrXxtL|BRJvNZijjjjjX@Jjc`b\JQFQrAIIPUH	COc1ncc(/C=C2\C[C@H]3[C@@H]4CC[C@H]5N(C)C(=O)C=C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2O)cn1	7.96	group2-a	a	Androgen Receptor	Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells	2009	fiw@@@LdbbbTRaJVrbRxhQmN|Ghzjjjjjjjjj@@	fiwq@@DMzAIe[VumueZLdjs`qzMjZjjjf@BjBD`djFdHh	423.555	2.9518	6	1	75.55	2	0.6352859904896923	0.5137639033993687	0.1866303716930583	11	4	egd\DH@DLEmK`GEIe]Yge{VmuhXLlbRjzVv`@fjjjjjZdjnIDXkDEDdUNiAq@	eMJA@Hz@										4
?ezUzvtyxOWfzvUjz1yOrvuwJOwtpQss1XgDSgSVTUwoH50s8lHD48HFL1YZ060Q18LB1FFV0V202010	CHEMBL560935	ekhXD@@D@JlbbbTLRaRfbVrbRXxtL|BRJvNZijjjjjX@JhxHgBdQd\`RRTER@	CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](C/C(=C\c5ccccc5)[C@@H]4O)[C@@H]3CC[C@@H]12	6.94	group3-int	int	Androgen Receptor	Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells	2009	fiw@@@LdbbbTRaJVrbRxhQmN|Ghzjjjjjjjjj@@	fiwa@@D@RYVum[]YVcIJlxL^cZfjjji`@j`aHIJaiBJ@	391.553	4.2155	3	1	40.54	1	-1.0487038082823985	-0.6257730431554194	-0.2403005052709973	11	3	ekhXD@@D@JlbbbTLRaRfbVrbRXxtL|BRJvNZijjjjjX@JhxHgBdQd\`RRTER@											1
?erUzvtyxOWfzvUjz1yOrvuwJOwtpQss1XgDSgSVTUwoH50u8lHT48HFL1YZ060Q18LB1FFV0V20201F	CHEMBL562394	elQRD@@DEmg`JlbbbTLRaRfbVrbRrbRXxtL|BRJvNaQZijjjjjX@H@JhNBIpiDYGHDdeAT`	CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](C/C(=C\c5cnc(-c6ccccn6)nc5)[C@@H]4O)[C@@H]3CC[C@@H]12	6.15	group3-int	int	Androgen Receptor	Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells	2009	eobP@@@LdbbbTRaJVrbRrbRxTDLt\|BzFn^jjjjjjjjjjjj@@@	eobRH@@DFne`DfUm[VwVUvUhXdTl\BbzFn^Zfjjji`@`@j`HH`bTad`bP	470.615	3.3854	6	1	79.21	2	0.9215782428820951	0.10543961491819125	0.2756427120322139	1	1	elQRD@@DEmg`JlbbbTLRaRfbVrbRrbRXxtL|BRJvNaQZijjjjjX@H@JhNBIpiDYGHDdeAT`											1
?fzUzvtyxOWfzvUjzIyOrvuwJOwtpQss1XhDSgSVTUwoH50s8lHD48HFL1YZ060U18LB1FFV0V202810	CHEMBL562471	egdXDH@EmK`ICHhdhUEEheidiLlePpYYDeUtmm@AMUUUUTuIU\RHqVHJIHj]RCb@	CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](C/C(=C\c5cccc(F)c5)[C@@H]4O)[C@@H]3CC[C@@H]12	7.57	group2-a	a	Androgen Receptor	Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells	2009	fiw@@@LdbbbTRaJVrbRxhQmN|Ghzjjjjjjjjj@@	fiwa@@D@RYVum[]YVcIJlxL^cZfjjji`@j`aHIJaiBJ@	409.543	4.3163	3	1	40.54	1	-0.9587079160408779	-0.7530813235855209	-0.21017297180108205	11	3	egdXDH@EmK`ICHhdhUEEheidiLlePpYYDeUtmm@AMUUUUTuIU\RHqVHJIHj]RCb@											1
?erUzvtyxOWfzvUjz1yOrvuwJOwtpQss1XgDSgSVTUwoH50s8lHT48HFL1YZ060Q18LB1FFV0V20201F	CHEMBL562780	ekhTD@@DE`JlbbbTLRaRfbVrbRXxtL|BRJvNZijjjjjX@JhxHgBdQd\`RRTER@	CN1C(=O)C=C[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](C/C(=C\c5cccnc5)[C@@H]4O)[C@@H]3CC[C@@H]12	7.21	group2-a	a	Androgen Receptor	Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells	2009	fiw@@@LdbbbTRaJVrbRxhQmN|Ghzjjjjjjjjj@@	fiwQ@@DM@drmkZvzrmFRUYpX}FuMUUUS@AUABPRUCRDT	392.541	3.2146	4	1	53.43	1	-0.5442969773516885	0.1876558461727164	-0.12253527240546648	11	1	ekhTD@@DE`JlbbbTLRaRfbVrbRXxtL|BRJvNZijjjjjX@JhxHgBdQd\`RRTER@											1
vzUQvQzvURjltyvUHv3H2QfHi43QhrA8cGE63CmX2QW98FC@01H_1B38860YkDF31D4O4W04210k1107FB0c!	CHEMBL563341	fmwp@`NR|BHGHSdErFQQQIHqQIJKQYRLExK^pPYUUPQATQAT@@	CN1CC[C@@H](N(Cc2ccccc2C(F)(F)F)c2ccc(C#N)c(Cl)c2)C1	6.6	group3-int	int	Androgen Receptor	Binding affinity to androgen receptor	2009	flu@@@LdbbRbVReRyhuhijjjjjjj@@	fluP@@@ZrRJJIIIQUYWmFbfhJ`h@@bBH@	393.839	4.4231	3	0	30.27	5	-0.8535493936765871	-1.3037991647060951	0.9295539541624808	8	1	fmwp@`NR|BHGHSdErFQQQIHqQIJKQYRLExK^pPYUUPQATQAT@@											1
?frUzvtyzOWfzvUjz1yOrvuwJOwtpQss1XiDSgSVTUwoH50u8lHT48HFL1YZ060Q18LB1FFX0V20X0GF	CHEMBL563597	eolRD@@DEmk`JlbbbTLRaRfbVrbRrXxtL|BRJvNZijjjjjX@Jjc`b\JQFQrAIIPUH	CNc1ncc(/C=C2\C[C@H]3[C@@H]4CC[C@H]5N(C)C(=O)C=C[C@]5(C)[C@H]4CC[C@]3(C)[C@H]2O)cn1	7.51	group2-a	a	Androgen Receptor	Displacement of [3H]methyltrienolone from androgen receptor in human MDA-MB-453 cells	2009	fiw@@@LdbbbTRaJVrbRxhQmN|Ghzjjjjjjjjj@@	fiwq@@DMzAIe[VumueZLdjs`qzMjZjjjf@BjBD`djFdHh	422.571	2.6688	6	2	78.35	2	0.9645380246286248	0.694199375791681	-0.8960606397511774	11	4	egd\DH@DLEmK`GEIe]Yge{VmuhXLlbRjzVv`@fjjjjjZdjnIDXkDEDdUNiAq@	eMbA@Hz@										4
:UvzfzSzSJjQRAyDCNdXsFOpKFWhY@14LkV7A28H9k1aJ1_FfhV9X5JtIVW1OX30A1AZ4FJ1@850NJ0G0VVFk	CHEMBL570708	figqC@DR\TDQhHkDYEDhhdeJheLhbsfcAct\AA]MU@pAQBq@@	Cc1c(C#N)c(Cl)nc2c3c(sc12)NC(=O)CC3c1ccccc1Cl	5.7	group4-ia	ia	Androgen Receptor	Binding affinity to androgen receptor	2009	fb}@@@LdbbbRTTRrXkJCir\uUUUUUUT@@	fb}QB@LRt@HrQQQIIQJsIDhHrgIsTaPM@@TDAT@@	388.277	3.6938	4	1	94.02	1	0.06354440093217173	0.21313347989618153	-0.02373552396214445	1	1	figqC@DR\TDQhHkDYEDhhdeJheLhbsfcAct\AA]MU@pAQBq@@											1
:UOQ1tG1F5k04@EFF0G288X04!WV88!T#V021#8V#F442!8!2041FV8010V848!V1104!3#	CHEMBL570897	fdeP`BHF@bDhyInYYwmEKU`qZ@@BJhH@@	O=[N+]([O-])c1ccc(N2CCCC2)c2ccccc12	8.6	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor (unknown origin) after 3 hrs	2015	foQ@@@DjYegufaFlzjjjjj`@@	foQ`@@@YIEDeDXbsbmV]TE@@D@@@	242.277	2.4234	4	0	49.06	2	-1.4862214094758461	1.081508757932325	0.7277924158281857	14	14	fde`C@E@BWNL_EIfV]{gYrVoA`@@bjhH@@			gChhhE`BRnRYh@								14
vzUOQ1tG9F5V04@EF!F288204!WX98!D#V031)F4$8!2041!8010V84#V1104#V!	CHEMBL570898	fhyP@@@ZRVYYwmxIQoAx@@Hj``@@	N#Cc1ccc(N2CCCC2)c2ccccc12	8.6	group1-p	p	Androgen Receptor	Displacement of [3H]mibolerone from androgen receptor (unknown origin) after 3 hrs	2015	foQ@@@DjYegufaFlzjjjjj`@@	foQ`@@@YIEDeDXbsbmV]TE@@D@@@	222.29	3.1806	2	0	27.03	1	-2.6295483191378106	0.4179614649923714	0.43957716180568196	14	14	fde`C@E@BWNL_EIfV]{gYrVoA`@@bjhH@@			eMbA@Dg`@								14
zwvr4aNG8V4F412BF80_VN2H!F093924LHV588801k9601V02CV1XKLlFc89Fk0V102!V05V@4JF405F201F	CHEMBL589158	fj}ab@L^RT@QdbbRTTtQbVOEN}GMAAIAPID@@@	Cc1cccc(SCc2cc(=O)oc3cc(O)ccc23)n1	4.3	group4-ia	ia	Androgen Receptor	Antagonist activity at AR by reporter gene assay	2010	flu@@@DjYe_~UYHRhijjjjjjj@@	flu`b@LNb@HRfUYyy_bkNBf``dB`P`@@	299.349	2.3809	4	1	84.72	3	-0.17549948960987508	1.0222893468289203	-0.14836542896172936	1	1	fj}ab@L^RT@QdbbRTTtQbVOEN}GMAAIAPID@@@											1
zqvK@GOl8k4kZFABFs0V0N2H040F1W92442V10VV1FV!FG!25V5VG240VV8B1#4120841V@85!L0VX0G0	CHEMBL591628	fnkP`@MF@sIEDhbmDeDdeAR]{MRmhJ@jh@@@@@@	CCOc1cc(C2Nc3cccc4cccc(c34)N2)ccc1O	4.96	group4-ia	ia	Androgen Receptor	Inhibition of human AR AF2 site expressed in human LNCap cells coexpressing eGFP -ARR2PB assessed as inhibition of transcriptional activity	2011	flm@@@LdbbbbVIbRXhViFbfjjjjjjj@@	flmP@@@TrQQQQZISIFgIV]DJZB`@@@H@@@	306.364	3.0141	4	3	53.52	3	-0.11799744422890485	0.3590159211976656	-2.3863880980131422	5	5	fjcPA@IJAxd\TfY}eYUYgCVceIXHBj`@@@@@@	gCaH@`AJZ`@	eFJB@Hp@									5
:xr5qsp9e4w417iy8X_XN2P1VNFO3C20LHZ58DF0ck96FGV0e9XW2KLt0cC9Gm1V11203V04X@BoF405F2810	CHEMBL592043	fnsAc@MNrBPQHXdLbdLTTTRVLRVejpZmjiBhF@`H@@@	O=c1oc2cc(O)ccc2c(C(F)(F)F)c1Cc1ccccc1	5.22	group4-ia	ia	Androgen Receptor	Antagonist activity at AR by reporter gene assay	2010	fde@@@DjYU_yU`nRCFjjjjjj`@@	fde@`@@HRYYmV]z\txLVi``@@`@@	320.265	3.5963	3	1	46.53	3	-0.9815693328859398	-0.18689344031332955	-0.29336937767692733	1	1	fnsAc@MNrBPQHXdLbdLTTTRVLRVejpZmjiBhF@`H@@@											1
LNsH42818V$240801VN(20202FV58$F06$2$F2V#1#810280V%4#502010	CHEMBL594854	fleA`@@\\dsKK}rlmARtCA@PP@HT`	COc1ccccc1/C=C/C(=O)c1ccccc1O	5.46	group4-ia	ia	Androgen Receptor	Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced transcriptional activation after 24 hrs by luciferase reporter gene assay	2018	f`q@@@DjYW~UyIwjjjjjj@@	f`qA@@@ILrj}jISoM@a@@@BEH	254.284	2.8881	3	1	46.53	4	-1.1371791506139517	0.36269435188307747	-0.37952368498058553	17	17	fbuA@`M@BYPOgEObdsJowL|sd\pDCSAA@@ar@	eFJB@Hp@		eMJA@Hz@								2
yTuM2G9G8k4kZFA4FNH1VN2H!FF1392VFHo18VV3Nk96F1!29V12G2p0Wc0DG109022bca4V@4J!448VcF0	CHEMBL62227	fa{QB@KIHBPrJJIJIKIZYQFLdKW`ykAAQQ`TuPD@@	CC1=CC(C)(C)Nc2ccc3c(c21)COc1c(F)cc(C#N)cc1-3	7.22	group2-a	a	Androgen Receptor	Inhibition of antagonist activity towards Androgen receptor	2003	fdu@@@DjYee]}faRlGtZjjjjjj`@@	fdua@@O@RfVU^]zLEhs`qhJ@@bXB@@	320.366	3.3101	3	1	45.05	0	-1.466987221315342	0.33639579554848614	-0.3767831765014042	10	8	fnkaA@Hr@xldLbbRbrbRtrbLiqQg^RV@HhHBfjH`@@	eMbA@Dg`@										4
yTur2K9G8k4kZFA4FNH5VN2H!FF1392VHHo58VV3Nk96FW!28V92JLp0Wc1Dl1V9022bca40@4J!458VBF0	CHEMBL62700	fa{aA@OXAbUdLbTRbbbRTTvjgAFB{LRsT@DACEUA@aA@	CC1=CC(C)(C)Nc2ccc3c(c21)/C(=C/Br)Oc1ccc(F)cc1-3	6.6	group3-int	int	Androgen Receptor	Antagonist activity against Androgen receptor	2003	flm@@@LdbbbbbRJvXXRgQBfjjjjjjj@@	flma@@@`RfYewg^gIFmzJZBX@BI`H@@	386.263	4.8214	2	1	21.26	0	-1.8184938944860285	-1.1118434967502318	-0.4095755129827444	2	2	fa{aA@OX@xudLbTRbbbRTTvjgAFB{LRsT@DACEUA@aA@	eFACD`BL@										1
yTuM2G9G8k4kZFA4FNH1VN2H!FF1392VFHo18VV3Nk96F1!29V12G2p0Wc0DG109022bca40@4J!448VBF0	CHEMBL62761	fnkaA@HrAbLdLbbRbrbRtrbLiqQg^RV@HhHBfjH`@@	CC1=CC(C)(C)Nc2ccc3c(c21)COc1c(F)cc(Br)cc1-3	7.05	group2-a	a	Androgen Receptor	Inhibition of antagonist activity towards Androgen receptor	2003	fdu@@@DjYee]}faRlGtZjjjjjj`@@	fdua@@O@RfVU^]zLEhs`qhJ@@bXB@@	374.252	4.1997	2	1	21.26	0	-1.8524946441152248	-0.6935688168449266	-0.4325793490728041	10	8	fnkaA@Hr@xldLbbRbrbRtrbLiqQg^RV@HhHBfjH`@@	eFACD`BL@										4
yTur2KdG8s4kZFA4FNH5VN2H!FF1392VHHo58VV3Nk96FW!28V92JLp0Wc1Dl1V9022bca40@4J!458V8F0	CHEMBL62981	fewaB@LbAHYEDeLhddiheEkJLejwb}`@hHDjfjbHDKH	CC/C(C)=C1\Oc2ccc(F)cc2-c2ccc3c(c21)C(C)=CC(C)(C)N3	6.6	group3-int	int	Androgen Receptor	Antagonist activity against human Androgen receptor	2003	flm@@@LdbbbbbRJvXXRgQBfjjjjjjj@@	flma@@@`RfYewg^gIFmzJZBX@BI`H@@	349.448	6.0156	2	1	21.26	1	-1.910018988434377	-1.8140373111902084	-0.43782336568714375	2	2	fa{aA@OX@xudLbTRbbbRTTvjgAFB{LRsT@DACEUA@aB@	gC`HD@IWT@@										1
<jrOzdFaw1qAiURPW2CFuVB8p12h043mK4BXB39VN0fGVD1XX0aZK8!V0EV!s582Y06t!204Vb08XcG0	CHEMBL63560	fkoPR`OG`aS`A@YB\`nPwHYIHXdeHcMmDeLiEJuVkPPUCT@EUXPx`@	C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1	6.57	group3-int	int	Androgen Receptor	Antagonist activity at wild type human recombinant androgen receptor assessed as inhibition of testosterone-induced growth of mouse androgen dependent SC3 cells by WST-1 method	2008	fbu@@@LddTQRVftRTmIsUUUUUUT@@	fbuab@KPPX@QddabRRtJbReiNUhHHZ@@@@@	430.377	2.1426	6	2	115.64	6	2.2643186916316047	0.7718113671479796	-0.6866111446476576	4	4	fcw`Q`MV}dhODTaJPUHIBMnNQQQIRZjZSZPqIYgIk`HJjZjV@BBCh@	eFABP`BL@	eMbA@Dg`@									1
;UAQtl9w4mZJATHsH9XO3H640Wd392VFHp38XV3OkO6F1A0P1X16G2d2W!TI3090@2acq40@5J8064BV8F0	CHEMBL63788	fnkaA@HdAHJdLbbbRbRJTrbLYHVg^RVBBb`Bjj@hAh@@	CC1CC(C)(C)Nc2ccc3c(c21)COc1c(F)cc(F)cc1-3	6.83	group3-int	int	Androgen Receptor	Inhibition of antagonist activity towards human androgen receptor	2003	fdu@@@DjYee]}faRlGtZjjjjjj`@@	fdua@@O@RfVU^]zLEhs`qhJ@@bhB@@	315.362	4.3399	2	1	21.26	0	-2.169216732865412	-0.5594674006236933	-0.5287512037705213	10	2	fnkaA@Hr@xldLbbRbrbRtrbLiqQg^RV@HhHBjjHhAh@@	eFABP`BL@										1
yTuM2G9G8k4kZFA4FNH1VN2H!FF1392VFHo18VV3Nk96F1!28V12F2p0Wc0DG109022bca40@4J!448V4F0	CHEMBL63870	ffsaB@@bAbYEDeLhdmLhcJLejshy`@hHBfjH`@@	CC1=CC(C)(C)Nc2ccc3c(c21)COc1ccc(Br)cc1-3	6.4	group3-int	int	Androgen Receptor	Inhibition of antagonist activity towards Androgen receptor	2003	fdu@@@DjYee]}faRlGtZjjjjjj`@@	fdua@@O@RfVU^]zLEhs`qhJ@@bXB@@	356.262	4.0989	2	1	21.26	0	-1.9424906970679015	-0.5662604232461381	-0.4627069327588671	10	8	ffsaB@@b@xyEDeLhdmLhcJLejshy`@hHBfjH`@@	eFACD`BL@										4
yTuM2G9G8k4kZFA4FNH1VN2H!FF13A2VFHo18VV3Nk96F1!28V12F2p0Wc0DG10A022bca40@4J!448V0F0	CHEMBL64123	ffsaB@@bADYEDeLhdmLhcJLejshy`@hHBfjH`@@	CC1=CC(C)(C)Nc2ccc3c(c21)COc1ccc(Cl)cc1-3	6.1	group3-int	int	Androgen Receptor	Inhibition of antagonist activity towards Androgen receptor	2003	fdu@@@DjYee]}faRlGtZjjjjjj`@@	fdua@@O@RfVU^]zLEhs`qhJ@@bXB@@	311.811	3.9797	2	1	21.26	0	-2.170969338469544	-0.329765555372639	-0.5364714716504789	10	8	ffsaB@@b@xyEDeLhdmLhcJLejshy`@hHBfjH`@@	eFABH`BL@										4
yTuM2G9G8k4kZFA4FNH1VN2m!FF1392VFHo18VV3Nk96NW!28V52F2p0Wc0DGGV9022bcaB0@4J!448Y0F0	CHEMBL64294	fa{Q`BHI@aTIQvQSQISJIKSJHs`mV|GMV`@hHBfjH`@@	CC1=CC(C)(C)Nc2ccc3c(c21)COc1ccc([N+](=O)[O-])cc1-3	7.22	group2-a	a	Androgen Receptor	Inhibition of antagonist activity towards Androgen receptor	2003	fdu@@@DjYee]}faRlGtZjjjjjj`@@	fdua@@O@RfVU^]zLEhs`qhJ@@bXB@@	322.363	2.4521	5	1	67.08	1	-0.41365617321741505	1.1272513829093267	-0.1186954510938063	10	8	ffsaB@@b@xyEDeLhdmLhcJLejshy`@hHBfjH`@@	gChhhE`BRnRYh@										4
yTur2L8G8V4kZ0A4FN05VR2m040F139202HV58Vc3Nk86O1V1!V52F6Z0WV9@V!9J@XVc6Z0@2J0FL58W0F0	CHEMBL65021	fmo`R@LPQXh@cIIChdieEMDhdeiJmzh~kVh@Jh@H@``ah`@	COc1cccc2c1-c1ccc(NS(C)(=O)=O)cc1C(c1ccccc1)O2	5.18	group4-ia	ia	Androgen Receptor	Displacement of [3H]mibolerone from human Androgen receptor	2004	fb}@@@DjYeeU_QRtFtTyjjjjjjjh@@	fb}A@@@YHhhhdheddZ\d{rXyhJ`@@@@BBJ@@	381.451	3.926	5	1	73.01	3	0.24061569538573643	-0.17604783336922653	0.05352248007139323	2	2	fewaa@D|zLCcTHRYef}WeUzXJVk^Jv@b@``HHVHHZh@@	eMJA@Hz@										2
yTuM2G9G8k4kZFA4FNH1VN2H!FF1392VFHo18VV3Nk96F1!28V12F2p0Wc0DG109022bca40@4J!448V8F0	CHEMBL65079	ffsaB@@bAHYEDeLhdmLhcJLejshy`@hHBfjH`@@	CC1=CC(C)(C)Nc2ccc3c(c21)COc1ccc(F)cc1-3	5.9	group4-ia	ia	Androgen Receptor	Inhibition of antagonist activity towards Androgen receptor	2003	fdu@@@DjYee]}faRlGtZjjjjjj`@@	fdua@@O@RfVU^]zLEhs`qhJ@@bXB@@	295.356	3.4745	2	1	21.26	0	-2.2338545568996144	0.03495508997926883	-0.566180747906336	10	8	ffsaB@@b@xyEDeLhdmLhcJLejshy`@hHBfjH`@@	eFABP`BL@										4
zTur2L8l8V4kZ0A4FN0_VR2m040F139206HV58Vc3Nk86OGV1!V52F6Z0WV9@V!9J@XVc6Z0@@J0FL58W8F0	CHEMBL65221	ek`XBL@LHDKB`@cZPNdLddNbRfTTtRbRVLdTl|jFzVVh@Jh@H@bbBCP`@	CS(=O)(=O)Nc1ccc2c(c1)C(c1ccccc1)Oc1cccc(OC(F)F)c1-2	5.06	group4-ia	ia	Androgen Receptor	Displacement of [3H]mibolerone from human Androgen receptor	2004	fb}@@@DjYeeU_QRtFtTyjjjjjjjh@@	fb}A@@@YHhhhdheddZ\d{rXyhJ`@@@@BBJ@@	417.431	4.1654	5	1	73.01	4	0.5773662907947072	-0.5742115609505377	0.1400816629590234	2	2	fewaa@D|zLCcTHRYef}WeUzXJVk^Jv@b@``HHVHHZh@@	gJQLLIARA@Dfzh@										2
<jUttEw5m55AUH8H_XNXHL4HkWY920LLZ78e039k96FGX0@OY12KLt6c9ARnIV90A0bV64W@BKO475F08!	CHEMBL6530	ffc`c@@jlBPQHXdLbdLTRbVVTTteF]GMUHTBUUTTOT@@	CCC1CCN(C)c2cc3oc(=O)cc(C(F)(F)F)c3cc21	6.56	group3-int	int	Androgen Receptor	In vitro binding affinity at human androgen receptor transfected into COS cells.	1999	foQ@@@DjYUU}`nRlzjjjjj`@@	foQ``@M@PdrmjjtYIUgMR@EUD@@	311.302	3.5691	3	0	29.54	2	-1.7353758079864974	-0.1272288973141891	0.7091108025803595	38	15	ffc`b`DVRCqdxydBrEYAIfVuuV^f\t[pZj``JfZh`@@	eMBD@ch@										1
yTuM2G9G8k4kZFA4FNH1VN2H!FF13A2VFHo18VV3Nk96F1!29V12G2p0Wc0DG10A022bca40@4J!448V8F0	CHEMBL65743	fnkaA@HrADLdLbbRbrbRtrbLiqQg^RV@HhHBfjH`@@	CC1=CC(C)(C)Nc2ccc3c(c21)COc1c(F)cc(Cl)cc1-3	6.37	group3-int	int	Androgen Receptor	Inhibition of antagonist activity towards human Androgen receptor	2003	fdu@@@DjYee]}faRlGtZjjjjjj`@@	fdua@@O@RfVU^]zLEhs`qhJ@@bXB@@	329.801	4.0805	2	1	21.26	0	-2.0809734462280236	-0.4570738358027407	-0.5063439381805636	10	8	fnkaA@Hr@xldLbbRbrbRtrbLiqQg^RV@HhHBfjH`@@	eFABH`BL@										4
;rIpOKdk4wZFABNRH5XN2PV0FF9392VPHo58Vc3Nk96FW!X8V92JLp0lc1Dl1V9022bca40@4J!458V8F0	CHEMBL65929	ec`XHL@Ln@@c@HfdLdTRTJbbbRTTvjeCFa`QRWUPuSUP@PDLUUA@@@	CC1=CC(C)(C)Nc2ccc3c(c21)C(=C1SCCCS1)Oc1ccc(F)cc1-3	6.75	group3-int	int	Androgen Receptor	Antagonist activity against human Androgen receptor	2003	fag@@@DjYfYUUW}aaNCUKR}jjjjjjjjj`@@	fagaA@L|@DXBLdTRTJbbbRTVuFZLDjVu{TuT@DABUA@@@	411.564	6.235	2	1	71.86	0	-0.9379226769511949	-1.6842898154243147	-0.2317778296355421	14	1	ec`XHL@Ln@@c@HfdLdTRTJbbbRTTvjeCFa`QRWUPuSUP@PDLUUA@@@											1
<EMtn9sDmZr3DHcIhXO6HFFGnf392VMHZ5BeV39lO7FS_4@9X16KLl0c89RnGVC020bV64XABJF4_5FV8F0	CHEMBL6654	ffc`c@@jlBPQHXdLbdLTRbVVRRteF]EMUHTBUUTP@@	CCC1Nc2cc3oc(=O)cc(C(F)(F)F)c3cc2CC1C	8.15	group1-p	p	Androgen Receptor	In vitro binding affinity at human androgen receptor transfected into COS cells.	1999	foQ@@@DjYUU}`nRlzjjjjj`@@	foQ``@M@PdrmjjtYIUgMR@EUD@@	311.302	3.1258	3	1	38.33	2	-1.2970575021982609	0.1898596864725767	-0.3575493876041405	38	15	ffc`b`DVRCqdxydBrEYAIef]uV^j\t[pZj``JfZh`@@		eMBD@ch@									1
zRPn63cF884F0F040N0WV82V!F!3#Lk058#Fk961VV0@80104JVF081HH0c102!V!2!F$8W0F0	CHEMBL66761	fdeQ@@DD@drrjJtyKPXmPHQ@A@@@	O=c1[nH]nc(Cc2ccccc2)c2ccccc12	5.27	group4-ia	ia	Androgen Receptor	Antagonist activity at wild type AR expressed in human SC cells assessed as inhibition of 1 nM DHT-induced cell proliferation after 3 days by WST-8 assay	2015	fde@@@LdbbbTV\RSIBtFMUUUUUU@@@	fdeQ@@DD@drrjJtyKPXmPHQ@A@@@	236.273	2.9076	3	1	41.46	2	-1.63156521599127	0.6222203622766378	-0.47417829521406274	16	16	fdeQ@@DD@drrjJtyKPXmPHQ@A@@@											1
;QAItn9NDmVq3DHsI8XO4HFJ1nf310VG2p14XV10GG1FB5B@1!4!VFc!J3104402n06F21#4a04X8GF	CHEMBL6689	fnsQC@EAlBPQHXdLbdLTRbVVRTQdhshij`@@bjj`hI`@	CC[C@H]1Nc2cc3nc(O)cc(C(F)(F)F)c3cc2CC1(C)C	7.38	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) expressed in CV-1 cell lines	1999	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	324.345	4.227	3	2	45.15	2	-0.8944070514751248	-0.4843436728961229	-1.3997129343736339	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@		eMBD@ch@	eMBH@RZ@							49
<jUttCwBm_pfTHcHhaO7HL4GvdY92VLHZ7NeV3ClO6FKf0P9X16KLt2c89RnIV90A0bV64V@BKN475FV8F0	CHEMBL6721	fns`c@@jlBPQHXdLbdLTRbVVTVVdhshyjiB`Rjjh`@@	CCC1CC(CC)c2cc3c(C(F)(F)F)cc(=O)oc3cc2N1	8.15	group1-p	p	Androgen Receptor	In vitro binding affinity at human androgen receptor transfected into COS cells.	1999	foQ@@@DjYUU}`nRlzjjjjj`@@	foQ``@M@PdrmjjtYIUgMR@EUD@@	325.329	3.9899	3	1	38.33	3	-1.105307897819172	-0.5024331262147748	-0.303857891843554	38	15	fj}`b`DFbCqDxidLrAYAIeYWUYzhqVg^jhHBifjH@@	eMBD@ch@	eMBD@ch@									11
<jUttCw4m55ATH8H_XN2HL4FkWY920LHZ78e039k96FGX0@9X12KLt2c89RnIV90A0bV64V@BKN475FV8F0	CHEMBL6843	fj}`c@@jlBPQHXdLbdLTRbVVTVdhshyjiB`RjjJGj@@	CCC1CCNc2cc3oc(=O)cc(C(F)(F)F)c3cc21	9	group1-p	p	Androgen Receptor	In vitro binding affinity at human androgen receptor transfected into COS cells.	1999	foQ@@@DjYUU}`nRlzjjjjj`@@	foQ``@M@PdrmjjtYIUgMR@EUD@@	297.275	3.2108	3	1	38.33	2	-1.3749255893803627	0.190778555925698	-0.38018761287763686	38	15	fj}`b`DFbCqDxidLrAYAIeYWUYzhqVg^jhHBifjH@@	eMBD@ch@										11
<jUztCwZn55ATHAHhXN6HL4FkhY920LHZ78e039k96FIX0@9X12KLt2c89RnIV90A0bVD4V@BKN475FV8F0	CHEMBL6855	ffc`c@@jlBPQHXdLbdLTRbVVTVteF]GMUHTBUUTTOT@@	CCCC1CCNc2cc3oc(=O)cc(C(F)(F)F)c3cc21	8.3	group1-p	p	Androgen Receptor	In vitro binding affinity at human androgen receptor transfected into COS cells.	1999	foQ@@@DjYUU}`nRlzjjjjj`@@	foQ``@M@PdrmjjtYIUgMR@EUD@@	311.302	3.6652	3	1	38.33	3	-1.1638993911863151	-0.25522361907074964	-0.32863125266766363	38	15	fj}`b`DFbCqDxidLrAYAIeYWUYzhqVg^jhHBifjH@@	gC`HL@IST@@										11
;QAGtl9N4mVJ3BHsH8XO0H040Gd310VF2p10XV10FG0F010@1204!VFc!431!402Y0a(604X8GF	CHEMBL6874	fj}QC@EAlBPQHXdLbdLTRbVVRtdhshij`@@bjhH@@	CC1(C)CCc2cc3c(C(F)(F)F)cc(O)nc3cc2N1	7.57	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) in co-transfected CV-1 cells.	1998	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	296.291	3.4698	3	2	45.15	1	-1.165055145918097	0.19570289380598277	-1.4759285247762646	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@		eMBH@RZ@								49
;QAItn9N6mVL3BHsI8XO0HFJ0lf310VG2Z14XV10FG1F854@1!4!VFc!J3!4402W06021#4a!X8GF	CHEMBL6983	fj}QC@EAlBPQHXdLbdLTRbVVRRdhshij`@@bjhIDXf@@	C[C@H]1Cc2cc3c(C(F)(F)F)cc(O)nc3cc2N[C@@H]1C	7.48	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) expressed in CV-1 cell lines	1999	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	296.291	3.4411	3	2	45.15	1	-1.1637047914714125	0.21295592413774816	-1.4760780942392477	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@		eFBH@c@@	eFBH@c@@							49
yqPlP1OG8F5k!A5FN0F0N@m04!9YA802AV50V80OV80O1V02GV5V1410VV16W012092084W!6010L10W8F0	CHEMBL70381	fkPc@IEWlDPrPFDYEDeBeEDheEBemISdZ}g@DUPQ@PDK@@@@	Cc1c(NS(C)(=O)=O)cccc1N(Cc1ccccc1)Cc1ccc(Cl)cc1F	6.52	group3-int	int	Androgen Receptor	Displacement of [3H]dexamethasone from human androgen receptor	2004	fj}@@@DjYU^[U_b`yRVjjjjjjj`@@	fj}`@@@ITrjsNk|gArdmPT@@@@@@@@	432.946	4.4916	4	1	57.79	6	0.4712111226058078	-1.3019824212521707	0.09223895220927711	2	2	fkPc@IEWlDPrPFDYEDeBeEDheEBemISdZ}g@DUPQ@PDK@@@@											1
;QAItn9N6mVL3BHsI8XO0HFJ0lf310VG2Z14XV10FG1F854@1!4!VFc!J3!4402W06021#4a!X8GF	CHEMBL7058	fj}QC@EAlBPQHXdLbdLTRbVVRRdhshij`@@bjhIDTf@@	C[C@@H]1Cc2cc3c(C(F)(F)F)cc(O)nc3cc2N[C@@H]1C	7.13	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) expressed in CV-1 cell lines	1999	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	296.291	3.4411	3	2	45.15	1	-1.1637047914714125	0.21295592413774816	-1.4760780942392477	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@		eFBH@c@@	eFBH@c@@							49
;QAItn9NDmVq3DHsI8XO4HFJ1nf310VG2Z14XV10GG1FB54@1!4!VFc!J3!4402W06021#4a!X8GF	CHEMBL7089	ffcQC@EAlBPQHXdLbdLTRbVVRRteF]EMT@@DUUPRHiL@@	CC[C@H]1Nc2cc3nc(O)cc(C(F)(F)F)c3cc2C[C@H]1C	7.82	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) expressed in CV-1 cell lines	1999	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	310.318	3.8955	3	2	45.15	2	-0.9526785932773649	-0.23304625085869943	-1.4245217340292744	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@		eMBD@ch@	eFBH@c@@							49
:xjxyyerjyvxfxsWfzDUjr1UtxuPwFlFsGSssOmggtZS4@Txo870k8FL10c0F616F808Q0VF4G!41(	CHEMBL717	fc@P@@UFoHhdihhiTiheBhiQbc^BdkSUUUUUULuUqbxaHt]@iL@@	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C	8.21	group1-p	p	Androgen Receptor	Inhibition of human androgen receptor at 10e-12 to 10e-5 M	2003	fdu@@@LdbbbTRaJWEBMiw`uUUUUUU@@@	fduA@@@ILkZvmmFRUYpXmMUUUUUXDePt@@	386.53	3.9495	4	0	60.44	3	-0.45679125909229057	-0.4081883364242083	1.0281854365229954	50	7	ffsAA@J`|WNNQQRIHsIRKKXgIJm{IZjjjjjZZjbDRBbeZ@@	eFBH@c@@	daxL`@Qb@Df]fjX@@									1
;QAItl9NBmVo3DHs28XO4HF41Id310VF2Z10XV10GG0F410@1!4!VFc!43#402W06(6!X8GF	CHEMBL7177	fj}QC@EAlBPQHXdLbdLTRbVVRrdhshij`@@bjhJBX@	CC[C@@H]1CCc2cc3c(C(F)(F)F)cc(O)nc3cc2N1	7.96	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) expressed in CV-1 cell lines	1999	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	296.291	3.6262	3	2	45.15	2	-1.0138766901568383	-0.01914045117573962	-1.4490063793324288	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@		eMBD@ch@								49
<EMtl9s4mZK3BHcHhXO2H!FGd392VLHp58eV39kO6FGW0@9X16KLl0c89RnGV9020bVa4V@BJF455JV8F0	CHEMBL7289	fj}`c@@jlBPQHXdLbdLTRbVVRtdhshijiB`RjjH@@	CC1(C)CCc2cc3c(C(F)(F)F)cc(=O)oc3cc2N1	9	group1-p	p	Androgen Receptor	In vitro binding affinity at human androgen receptor transfected into COS cells.	1999	foQ@@@DjYUU}`nRlzjjjjj`@@	foQ``@M@PdrmjjtYIUgMR@EUD@@	297.275	2.7001	3	1	38.33	1	-1.5094340548389926	0.618608831137259	-0.40895617835113074	38	15	fj}`b`DFbCqDxidLrAYAIeYWUYzhqVg^jhHBifjH@@		eMBH@RZ@									11
;QAQtl9RBmVoATHsH8XO5HL41nd310VF2Z30XV1BGG0F4A0P1!4!cHc!433!482W06%806!X8GF	CHEMBL7373	ffcQC@EAlBPQHXdLbdLTRbVVTQTeF]GMT@@DUUPROKL@@	CC[C@@H]1C[C@H](C)c2cc3c(C(F)(F)F)cc(O)nc3cc2N1	6.86	group3-int	int	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) expressed in CV-1 cell lines	1999	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	310.318	4.3052	3	2	45.15	2	-0.9719551870923235	-0.4793368885496033	-1.422386598478661	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@	eFBH@c@@	eMBD@ch@								49
;QAItn9NDmVq3DHsI8XO4HFJ1nf310VG2Z14XV10GG1FB54@1!4!VFc!J3!4402W06021#4a!X8GF	CHEMBL7455	ffcQC@EAlBPQHXdLbdLTRbVVRRteF]EMT@@DUUPRHqL@@	CC[C@H]1Nc2cc3nc(O)cc(C(F)(F)F)c3cc2C[C@@H]1C	7.96	group2-a	a	Androgen Receptor	Antagonistic activity against human androgen receptor (hAR) expressed in CV-1 cell lines	1999	fgA@@@DjYU_VByHujjjjjh@@	fgAP@@@JRfV_UipTcV@@@j``@@	310.318	3.8955	3	2	45.15	2	-0.9526785932773649	-0.23304625085869943	-1.4245217340292744	70	59	ffcPC`DV@Dt`Y^JWGL`VPkHILlvnjstsfc^CUTD@@UU@@@	eFJB@Hp@		eMBD@ch@	eFBH@c@@							49
:xzCqslde4mZ0Eg2sVhXSH01Z0F9Y024FFVl02k0skO6FF01@101ZJHZ1Wc0220814980V050204#402010	CHEMBL75897	fdeA`@@\\dsKK}slyKPXmAPPDAAAe@@	O=C1CC(c2ccccc2O)Oc2ccccc21	5.19	group4-ia	ia	Androgen Receptor	Antagonist activity at AR in human LNCAP cells assessed as reduction in DHT-induced cell growth treated for every 2 days for 4 days by hemocytometry	2018	fhy@@@LdbbbRnbRYHRoAjjjjjj`@@	fhy@`@@\RYee~uYrVoAZB``@HHLh@@	240.257	2.8471	3	1	46.53	1	-1.6847302520366538	0.8018290502571686	-0.4811397489227748	32	9	fluAb@AR|AqrJIJYQEQQZcEZbf@BfhH@bFb@@											5
zyQv6GOM8F4s0L2gSNH10O0m0B8K128!ImZ50V0390968WV620V46041!80DlFVN582WV68#F!a!Y8F0	CHEMBL806	flyQcBNVUkpIADabPyNnrJPqQJIUSRQjhHFJZ`@@	CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1	5.7	group4-ia	ia	Androgen Receptor	Antiandrogenic activity in human MDA-MB-453 cells expressing androgen receptor assessed as inhibition of DHT-induced androgen-dependent transcription by luciferase reporter gene assay	2009	gFp@DiTvjh@	gFp@DiTt@@@	276.213	1.9627	5	1	74.92	4	-0.03195531159367168	1.2876287664340211	-0.09890762821594543	19	15	dmt@h@BR|VPQ\U`TfYn~fBHb@@	gJPBAHJPt`PAIjj@@	gChhhE`BRnRYh@		gNyHDB@ILluT@@							14
=t;MzxvTQzU:kPfvUDEeM_mSCjbjMDEnYvAWTcV3XTFobkC0hBg6YqEcX1s5tXYLbF1Fk1GNb0c2c10	CHEMBL9337	fe{qc@EFCzLpRBICDadTabbRQbbftQRehJZhHLjYjjh`@@	CC1(C)C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)N1CCCCO	7.51	group2-a	a	Androgen Receptor	Antagonist activity at human androgen receptor expressed in MDA-MB-453 cells	2007	dk\@@DjYVYxqVjjjj`@	dk]D@DpIRYeg^ftvj`PH@@	369.342	2.5803	6	1	84.64	6	1.1476203716945672	0.5215112037944787	0.22305397014721848	33	14	fhiP``AFuX@RRA|xa|TfYwf[v\LzB@jYjH@@	gGQHAPAIUjh@	eMBH@RZ@	gJPBAHJPt`PAIjj@@	eMbA@Dg`@							14
<datawarrior properties>
<axisColumn_2D View_0="Ring Systems 2">
<axisColumn_2D View_1="pIC50">
<axisColumn_2D-PCA_0="pc1">
<axisColumn_2D-PCA_1="pc2">
<axisColumn_3D View_0="pIC50">
<axisColumn_3D View_1="YEAR">
<axisColumn_3D View_2="ID">
<axisColumn_3D-PCA_0="pc1">
<axisColumn_3D-PCA_1="pc2">
<axisColumn_3D-PCA_2="pc3">
<chartType_2D View="scatter">
<chartType_2D-PCA="scatter">
<chartType_3D View="scatter">
<chartType_3D-PCA="scatter">
<colorColumn_2D View="Murcko frequency">
<colorColumn_2D-PCA="cLogP">
<colorColumn_3D-PCA="H-Donors">
<colorListMode_2D View="HSBLong">
<colorListMode_2D-PCA="HSBLong">
<colorListMode_3D-PCA="HSBLong">
<color_2D View_0="-14936833">
<color_2D View_1="-64512">
<color_2D-PCA_0="-65536">
<color_2D-PCA_1="-16776961">
<color_3D-PCA_0="-65536">
<color_3D-PCA_1="-16776961">
<columnAliasCount="3">
<columnAlias_0="Ring Systems	CSK">
<columnAlias_1="Ring Systems 2	Murcko">
<columnAlias_2="Core Fragment	Core">
<columnFilter_Table="">
<columnOrder_Table="ID	Structure of SMILES	SMILES	pIC50	bioactivity	bioactivity1	TARGET	ASSAY_DESCRIPTION	YEAR	Total Molweight	cLogP	H-Acceptors	H-Donors	Polar Surface Area	Rotatable Bonds	pc1	pc2	pc3	Ring Systems	Ring Systems 2	CSK frequency	Murcko frequency	Core Fragment	Core frequency	R1	R2	R3	R4	R5	R6	R7	R8	R9	R10">
<columnWidth_Table_ASSAY_DESCRIPTION="80">
<columnWidth_Table_CSK frequency="80">
<columnWidth_Table_Core Fragment="100">
<columnWidth_Table_Core frequency="80">
<columnWidth_Table_H-Acceptors="80">
<columnWidth_Table_H-Donors="80">
<columnWidth_Table_ID="80">
<columnWidth_Table_Murcko frequency="80">
<columnWidth_Table_Polar Surface Area="80">
<columnWidth_Table_R1="100">
<columnWidth_Table_R10="100">
<columnWidth_Table_R2="100">
<columnWidth_Table_R3="100">
<columnWidth_Table_R4="100">
<columnWidth_Table_R5="100">
<columnWidth_Table_R6="100">
<columnWidth_Table_R7="100">
<columnWidth_Table_R8="100">
<columnWidth_Table_R9="100">
<columnWidth_Table_Ring Systems="100">
<columnWidth_Table_Ring Systems 2="100">
<columnWidth_Table_Rotatable Bonds="80">
<columnWidth_Table_SMILES="80">
<columnWidth_Table_Structure of SMILES="100">
<columnWidth_Table_TARGET="80">
<columnWidth_Table_Total Molweight="80">
<columnWidth_Table_YEAR="80">
<columnWidth_Table_bioactivity="80">
<columnWidth_Table_bioactivity1="80">
<columnWidth_Table_cLogP="80">
<columnWidth_Table_pIC50="80">
<columnWidth_Table_pc1="80">
<columnWidth_Table_pc2="80">
<columnWidth_Table_pc3="80">
<detailView="height[Data]=0.066667;height[Structure of SMILES]=0.066667;height[Ring Systems]=0.066667;height[Ring Systems 2]=0.066667;height[Core Fragment]=0.066667;height[R1]=0.066667;height[R2]=0.066667;height[R3]=0.066667;height[R4]=0.066667;height[R5]=0.066667;height[R6]=0.066667;height[R7]=0.066667;height[R8]=0.066667;height[R9]=0.066667;height[R10]=0.066667">
<faceColor3D_3D View="-1250054">
<faceColor3D_3D-PCA="-1250054">
<fastRendering_2D View="false">
<fastRendering_2D-PCA="false">
<fastRendering_3D View="false">
<fastRendering_3D-PCA="false">
<filter0="#double#	pIC50">
<filter1="#category#	bioactivity">
<filter2="#category#	bioactivity1">
<filter3="#double#	CSK frequency">
<filter4="#double#	Murcko frequency">
<filter5="#double#	Core frequency">
<filterAnimation0="state=stopped low2=80% high1=20% time=10">
<filterAnimation3="state=stopped low2=80% high1=20% time=10">
<filterAnimation4="state=stopped low2=80% high1=20% time=10">
<filterAnimation5="state=stopped low2=80% high1=20% time=10">
<headerLines_Table="2">
<mainSplitting="0.72708">
<mainView="Table">
<mainViewCount="6">
<mainViewDockInfo0="root">
<mainViewDockInfo1="Table	center">
<mainViewDockInfo2="2D-PCA	bottom	0.5">
<mainViewDockInfo3="2D-PCA	right	0.499">
<mainViewDockInfo4="2D View	right	0.499">
<mainViewDockInfo5="3D-PCA	bottom	0.5">
<mainViewInFront0="true">
<mainViewName0="Table">
<mainViewName1="2D-PCA">
<mainViewName2="2D View">
<mainViewName3="Structure of SMILES">
<mainViewName4="3D-PCA">
<mainViewName5="3D View">
<mainViewType0="tableView">
<mainViewType1="2Dview">
<mainViewType2="2Dview">
<mainViewType3="structureView">
<mainViewType4="3Dview">
<mainViewType5="3Dview">
<rightSplitting="0.65768">
<rotationMatrix_3D View00="1">
<rotationMatrix_3D View01="0">
<rotationMatrix_3D View02="0">
<rotationMatrix_3D View10="0">
<rotationMatrix_3D View11="1">
<rotationMatrix_3D View12="0">
<rotationMatrix_3D View20="0">
<rotationMatrix_3D View21="0">
<rotationMatrix_3D View22="1">
<rotationMatrix_3D-PCA00="1">
<rotationMatrix_3D-PCA01="0">
<rotationMatrix_3D-PCA02="0">
<rotationMatrix_3D-PCA10="0">
<rotationMatrix_3D-PCA11="1">
<rotationMatrix_3D-PCA12="0">
<rotationMatrix_3D-PCA20="0">
<rotationMatrix_3D-PCA21="0">
<rotationMatrix_3D-PCA22="1">
<rowHeight_Table="80">
<scaleStyle_2D View="frame">
<scaleStyle_2D-PCA="frame">
<scaleStyle_3D View="arrows">
<scaleStyle_3D-PCA="arrows">
<scatterplotMargin_2D View="0.025">
<scatterplotMargin_2D-PCA="0.025">
<scatterplotMargin_3D View="0.025">
<scatterplotMargin_3D-PCA="0.025">
<showNaNValues_2D View="true">
<showNaNValues_2D-PCA="true">
<showNaNValues_3D View="true">
<showNaNValues_3D-PCA="true">
<structureGridColumn_Structure of SMILES="Structure of SMILES">
<structureGridColumns_Structure of SMILES="6">
</datawarrior properties>
